0001493152-23-021280.txt : 20230614 0001493152-23-021280.hdr.sgml : 20230614 20230614171540 ACCESSION NUMBER: 0001493152-23-021280 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 101 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMMO, INC. CENTRAL INDEX KEY: 0001015383 STANDARD INDUSTRIAL CLASSIFICATION: ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480] IRS NUMBER: 300957912 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13101 FILM NUMBER: 231015020 BUSINESS ADDRESS: STREET 1: 7681 E. GRAY RD STREET 2: SCOTTSDALE CITY: SCOTTSDALE STATE: AZ ZIP: 85260 BUSINESS PHONE: 480-947-0001 MAIL ADDRESS: STREET 1: 7681 E. GRAY RD STREET 2: SCOTTSDALE CITY: SCOTTSDALE STATE: AZ ZIP: 85260 FORMER COMPANY: FORMER CONFORMED NAME: RETROSPETTIVA INC DATE OF NAME CHANGE: 19970602 10-K 1 form10-k.htm
0001015383 false FY http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember 0001015383 2022-04-01 2023-03-31 0001015383 POWW:CommonStock0.001ParValueMember 2022-04-01 2023-03-31 0001015383 POWW:Sec8.75SeriesCumulativeRedeemablePerpetualPreferredStock0.001ParValueMember 2022-04-01 2023-03-31 0001015383 2022-09-30 0001015383 2023-06-09 0001015383 2023-03-31 0001015383 2022-03-31 0001015383 2021-04-01 2022-03-31 0001015383 2020-04-01 2021-03-31 0001015383 POWW:AmmunitionSalesMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionSalesMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionSalesMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceRevenueMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceRevenueMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceRevenueMember 2020-04-01 2021-03-31 0001015383 POWW:CasingSalesMember 2022-04-01 2023-03-31 0001015383 POWW:CasingSalesMember 2021-04-01 2022-03-31 0001015383 POWW:CasingSalesMember 2020-04-01 2021-03-31 0001015383 us-gaap:PreferredStockMember 2020-03-31 0001015383 us-gaap:CommonStockMember 2020-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001015383 us-gaap:RetainedEarningsMember 2020-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2020-03-31 0001015383 2020-03-31 0001015383 us-gaap:PreferredStockMember 2021-03-31 0001015383 us-gaap:CommonStockMember 2021-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001015383 us-gaap:RetainedEarningsMember 2021-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2021-03-31 0001015383 2021-03-31 0001015383 us-gaap:PreferredStockMember 2022-03-31 0001015383 us-gaap:CommonStockMember 2022-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001015383 us-gaap:RetainedEarningsMember 2022-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2022-03-31 0001015383 us-gaap:PreferredStockMember 2020-04-01 2021-03-31 0001015383 us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2021-03-31 0001015383 us-gaap:RetainedEarningsMember 2020-04-01 2021-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2020-04-01 2021-03-31 0001015383 us-gaap:PreferredStockMember 2021-04-01 2022-03-31 0001015383 us-gaap:CommonStockMember 2021-04-01 2022-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2022-03-31 0001015383 us-gaap:RetainedEarningsMember 2021-04-01 2022-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2021-04-01 2022-03-31 0001015383 us-gaap:PreferredStockMember 2022-04-01 2023-03-31 0001015383 us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2023-03-31 0001015383 us-gaap:RetainedEarningsMember 2022-04-01 2023-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2022-04-01 2023-03-31 0001015383 us-gaap:PreferredStockMember 2023-03-31 0001015383 us-gaap:CommonStockMember 2023-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001015383 us-gaap:RetainedEarningsMember 2023-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2023-03-31 0001015383 2016-12-13 2016-12-15 0001015383 POWW:DefinitiveAgreementMember POWW:PRIVCOMember 2017-03-15 2017-03-17 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2023-03-31 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2022-04-01 2023-03-31 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2021-04-01 2022-03-31 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2020-04-01 2021-03-31 0001015383 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2023-03-31 0001015383 us-gaap:SellingAndMarketingExpenseMember 2021-04-01 2022-03-31 0001015383 us-gaap:SellingAndMarketingExpenseMember 2020-04-01 2021-03-31 0001015383 us-gaap:CostOfSalesMember 2022-04-01 2023-03-31 0001015383 us-gaap:CostOfSalesMember 2021-04-01 2022-03-31 0001015383 srt:MaximumMember 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerAMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerAMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerAMember 2021-04-01 2022-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerAMember 2021-04-01 2022-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerAMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerAMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerBMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerBMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerBMember 2021-04-01 2022-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerBMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerBMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerCMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerCMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerCMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerCMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerDMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerDMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerDMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerDMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerMember 2022-04-01 2023-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerMember 2021-04-01 2022-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerMember 2021-04-01 2022-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember POWW:CustomerMember 2020-04-01 2021-03-31 0001015383 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember POWW:CustomerMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceFeeRevenueMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceFeeRevenueMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceFeeRevenueMember 2020-04-01 2021-03-31 0001015383 POWW:AmmunitionCasingsSalesMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionCasingsSalesMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionCasingsSalesMember 2020-04-01 2021-03-31 0001015383 us-gaap:MeasurementInputRiskFreeInterestRateMember POWW:ConvertiblePromissoryNoteMember 2023-03-31 0001015383 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember POWW:ConvertiblePromissoryNoteMember 2022-03-31 0001015383 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember POWW:ConvertiblePromissoryNoteMember 2022-03-31 0001015383 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember POWW:ConvertiblePromissoryNoteMember 2021-03-31 0001015383 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember POWW:ConvertiblePromissoryNoteMember 2021-03-31 0001015383 us-gaap:MeasurementInputPriceVolatilityMember POWW:ConvertiblePromissoryNoteMember 2023-03-31 0001015383 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember POWW:ConvertiblePromissoryNoteMember 2022-03-31 0001015383 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember POWW:ConvertiblePromissoryNoteMember 2022-03-31 0001015383 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember POWW:ConvertiblePromissoryNoteMember 2021-03-31 0001015383 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember POWW:ConvertiblePromissoryNoteMember 2021-03-31 0001015383 us-gaap:MeasurementInputExpectedTermMember POWW:ConvertiblePromissoryNoteMember 2023-03-31 0001015383 us-gaap:MeasurementInputExpectedTermMember POWW:ConvertiblePromissoryNoteMember 2022-03-31 0001015383 us-gaap:MeasurementInputExpectedTermMember POWW:ConvertiblePromissoryNoteMember 2021-03-31 0001015383 us-gaap:MeasurementInputExpectedDividendRateMember 2023-03-31 0001015383 us-gaap:MeasurementInputExpectedDividendRateMember 2022-03-31 0001015383 us-gaap:MeasurementInputExpectedDividendRateMember 2021-03-31 0001015383 us-gaap:FairValueInputsLevel1Member 2022-04-01 2023-03-31 0001015383 us-gaap:FairValueInputsLevel2Member 2022-04-01 2023-03-31 0001015383 us-gaap:FairValueInputsLevel3Member 2022-04-01 2023-03-31 0001015383 us-gaap:FairValueInputsLevel1Member 2021-04-01 2022-03-31 0001015383 us-gaap:FairValueInputsLevel2Member 2021-04-01 2022-03-31 0001015383 us-gaap:FairValueInputsLevel3Member 2021-04-01 2022-03-31 0001015383 us-gaap:FairValueInputsLevel1Member 2020-04-01 2021-03-31 0001015383 us-gaap:FairValueInputsLevel2Member 2020-04-01 2021-03-31 0001015383 us-gaap:FairValueInputsLevel3Member 2020-04-01 2021-03-31 0001015383 us-gaap:WarrantMember 2023-03-31 0001015383 us-gaap:WarrantMember 2022-04-01 2023-03-31 0001015383 us-gaap:WarrantMember 2021-04-01 2022-03-31 0001015383 POWW:EquityIncentiveAwardsMember 2021-04-01 2022-03-31 0001015383 us-gaap:LeaseholdImprovementsMember 2023-03-31 0001015383 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001015383 us-gaap:BuildingImprovementsMember 2023-03-31 0001015383 us-gaap:BuildingImprovementsMember 2022-03-31 0001015383 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001015383 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001015383 us-gaap:VehiclesMember 2023-03-31 0001015383 us-gaap:VehiclesMember 2022-03-31 0001015383 us-gaap:EquipmentMember 2023-03-31 0001015383 us-gaap:EquipmentMember 2022-03-31 0001015383 POWW:ToolingMember 2023-03-31 0001015383 POWW:ToolingMember 2022-03-31 0001015383 us-gaap:ConstructionInProgressMember 2023-03-31 0001015383 us-gaap:ConstructionInProgressMember 2022-03-31 0001015383 us-gaap:CostOfSalesMember 2020-04-01 2021-03-31 0001015383 us-gaap:OperatingExpenseMember 2022-04-01 2023-03-31 0001015383 us-gaap:OperatingExpenseMember 2021-04-01 2022-03-31 0001015383 us-gaap:OperatingExpenseMember 2020-04-01 2021-03-31 0001015383 POWW:FactoringAndSecurityAgreementMember 2019-07-01 0001015383 POWW:FactoringAndSecurityAgreementMember 2019-06-28 2019-07-01 0001015383 POWW:FactoringAndSecurityAgreementMember us-gaap:PrimeRateMember 2019-06-28 2019-07-01 0001015383 2021-06-16 2021-06-17 0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember POWW:EligibleInventoryMember 2020-06-17 0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-06-15 2020-06-17 0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-06-17 0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-07-31 0001015383 POWW:InventoryCreditFacilityMember 2023-03-31 0001015383 POWW:InventoryCreditFacilityMember 2022-04-01 2023-03-31 0001015383 POWW:InventoryCreditFacilityMember 2021-04-01 2022-03-31 0001015383 POWW:InventoryCreditFacilityMember 2020-04-01 2021-03-31 0001015383 2021-09-30 0001015383 2022-01-31 0001015383 POWW:LeaseAgreementMember 2022-01-31 0001015383 POWW:JagemannStampingCompanyMember POWW:PromissoryNoteMember 2020-04-13 2020-04-14 0001015383 POWW:JagemannStampingCompanyMember POWW:PromissoryNoteMember 2019-03-24 2019-03-25 0001015383 POWW:JagemannStampingCompanyMember POWW:PromissoryNoteMember 2019-03-30 2019-03-31 0001015383 2019-04-01 2019-04-30 0001015383 POWW:JagemannStampingCompanyMember POWW:PromissoryNoteMember 2019-05-01 2019-05-31 0001015383 POWW:PostClosingTransactionNoteReductionMember 2020-03-13 2020-03-14 0001015383 POWW:DecreasedEquipmentMember 2020-03-13 2020-03-14 0001015383 POWW:OtherIntangibleAssetReductionMember 2020-03-13 2020-03-14 0001015383 POWW:IncreasedAccountsReceivableMember 2020-03-13 2020-03-14 0001015383 POWW:IncreaseToDepositsMember 2020-03-13 2020-03-14 0001015383 POWW:DecreasedAccumulatedDepreciationMember 2020-03-13 2020-03-14 0001015383 POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:PromissoryNoteMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:InventoryAndServicesMember 2020-06-25 2020-06-26 0001015383 POWW:JagemannStampingCompanyMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:JagemannStampingCompanyMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember 2020-11-03 2020-11-05 0001015383 POWW:SettlementAgreementMember POWW:NoteBMember 2020-11-03 2020-11-05 0001015383 POWW:SettlementAgreementMember POWW:AmendedNoteBMember us-gaap:RelatedPartyMember 2020-11-05 0001015383 POWW:SettlementAgreementMember POWW:AmendedNoteBMember 2020-11-05 0001015383 POWW:SettlementAgreementMember POWW:NoteAMember 2020-04-01 2021-03-31 0001015383 POWW:SettlementAgreementMember POWW:NoteBMember 2020-04-01 2021-03-31 0001015383 POWW:AmendedNoteBMember us-gaap:RelatedPartyMember 2023-03-31 0001015383 POWW:AmendedNoteBMember us-gaap:RelatedPartyMember 2022-03-31 0001015383 POWW:AmendedNoteBMember 2022-04-01 2023-03-31 0001015383 POWW:AmendedNoteBMember 2021-04-01 2022-03-31 0001015383 POWW:AmendedNoteBMember 2020-04-01 2021-03-31 0001015383 POWW:PromissoryNoteMember POWW:ShareholderMember 2019-05-03 0001015383 POWW:PromissoryNoteMember 2019-05-02 2019-05-03 0001015383 POWW:PromissoryNoteMember POWW:ShareholderMember 2020-04-01 2020-12-31 0001015383 POWW:PromissoryNoteMember POWW:ShareholderMember 2020-04-01 2021-03-31 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2019-12-31 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2019-01-01 2019-03-31 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2020-04-01 2021-03-31 0001015383 POWW:ForestStreetLLCMember POWW:PromissoryNoteMember 2020-09-23 0001015383 POWW:ForestStreetLLCMember POWW:PromissoryNoteMember 2020-09-22 2020-09-23 0001015383 POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember POWW:ForestStreetNoteMember 2020-12-13 2020-12-14 0001015383 POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember POWW:ForestStreetNoteMember us-gaap:CommonStockMember 2020-12-13 2020-12-14 0001015383 POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember POWW:ForestStreetNoteMember 2020-04-01 2021-03-31 0001015383 POWW:JagemannStampingCompanyMember POWW:AmendedAPAMember 2021-01-19 2021-01-22 0001015383 POWW:AmendedAPAMember POWW:JagemannStampingCompanyMember 2021-01-22 0001015383 POWW:ConstructionLoanAgreementMember POWW:HiawathaNationalBankMember srt:MaximumMember 2021-10-14 0001015383 POWW:ConstructionLoanAgreementMember POWW:HiawathaNationalBankMember 2021-10-14 0001015383 POWW:ConstructionLoanAgreementMember POWW:HiawathaNationalBankMember POWW:FirstAdvanceMember 2021-10-13 2021-10-14 0001015383 POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember srt:MaximumMember 2021-10-14 0001015383 POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember 2021-10-14 0001015383 POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember 2021-10-13 2021-10-14 0001015383 POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember srt:MaximumMember 2021-10-13 2021-10-14 0001015383 POWW:ConstructionLoanAgreementMember POWW:HiawathaNationalBankMember 2021-10-13 2021-10-14 0001015383 POWW:ConstructionLoanAgreementMember POWW:HiawathaNationalBankMember 2022-04-01 2023-03-31 0001015383 POWW:ConstructionLoanAgreementMember POWW:HiawathaNationalBankMember 2023-03-31 0001015383 POWW:NewIssuanceOfSharesMember 2020-04-01 2021-03-31 0001015383 us-gaap:InvestorMember 2020-04-01 2021-03-31 0001015383 us-gaap:ConvertibleNotesPayableMember 2020-04-01 2021-03-31 0001015383 POWW:InvestorsMember us-gaap:WarrantMember 2020-04-01 2021-03-31 0001015383 us-gaap:WarrantMember us-gaap:WarrantMember 2020-04-01 2021-03-31 0001015383 us-gaap:WarrantMember 2020-04-01 2021-03-31 0001015383 POWW:DebtConversionAgreementMember 2020-04-01 2021-03-31 0001015383 POWW:SharesIssuedForServicesMember 2020-04-01 2021-03-31 0001015383 POWW:EmployeesMembersBoardOfDirectorsMember 2020-04-01 2021-03-31 0001015383 us-gaap:InvestorMember POWW:LiquidationDamageFeesMember 2020-04-01 2021-03-31 0001015383 POWW:JagemannStampingCompanyMember POWW:AmendedAPAMember 2020-04-01 2021-03-31 0001015383 POWW:NewIssuanceOfSharesMember 2021-04-01 2022-03-31 0001015383 POWW:GeminiDirectInvestmentsLLCMember 2021-04-01 2022-03-31 0001015383 us-gaap:WarrantMember POWW:InvestorsMember 2021-04-01 2022-03-31 0001015383 us-gaap:WarrantMember 2021-04-01 2022-03-31 0001015383 POWW:SharesIssuedForServicesMember 2021-04-01 2022-03-31 0001015383 POWW:EmployeesMembersBoardOfDirectorsMember 2021-04-01 2022-03-31 0001015383 POWW:NewIssuanceOfSharesMember 2022-04-01 2023-03-31 0001015383 us-gaap:WarrantMember POWW:InvestorsMember 2022-04-01 2023-03-31 0001015383 us-gaap:WarrantMember 2022-04-01 2023-03-31 0001015383 POWW:EmployeesMembersBoardOfDirectorsMember 2022-04-01 2023-03-31 0001015383 us-gaap:WarrantMember 2023-03-31 0001015383 POWW:WarrantOneMember POWW:UntilAprilTwoThousandTwentyFiveMember 2023-03-31 0001015383 POWW:WarrantTwoMember POWW:UntilAugustTwoThousandTwentyFourMember 2023-03-31 0001015383 POWW:WarrantThreeMember POWW:UntilSeptemberTwoThousandTwentyFourMember 2023-03-31 0001015383 POWW:WarrantFourMember POWW:UntilNovemberTwoThousandTwentyFiveMember 2023-03-31 0001015383 POWW:WarrantFiveMember POWW:UntilFebrauryTwoThousandTwentyFourMember 2023-03-31 0001015383 us-gaap:WarrantMember 2020-03-31 0001015383 us-gaap:WarrantMember 2021-03-31 0001015383 us-gaap:WarrantMember 2022-03-31 0001015383 us-gaap:SeriesAPreferredStockMember 2021-05-18 0001015383 us-gaap:SeriesAPreferredStockMember 2021-05-17 2021-05-18 0001015383 POWW:UnderwritingAgreementMember us-gaap:SeriesAPreferredStockMember 2021-05-19 2021-05-19 0001015383 POWW:UnderwritingAgreementMember us-gaap:SeriesAPreferredStockMember 2021-05-19 0001015383 POWW:UnderwritingAgreementMember us-gaap:SeriesAPreferredStockMember POWW:UnderwritersMember 2021-05-19 2021-05-19 0001015383 POWW:UnderwritingAgreementMember us-gaap:SeriesAPreferredStockMember 2021-05-24 2021-05-25 0001015383 POWW:UnderwritingAgreementMember us-gaap:SeriesAPreferredStockMember 2021-05-25 0001015383 POWW:UnderwritingAgreementMember us-gaap:SeriesAPreferredStockMember us-gaap:OverAllotmentOptionMember 2021-05-24 2021-05-25 0001015383 us-gaap:SeriesAPreferredStockMember POWW:AugustTwentySevenTwoThousandTwentyOneMember 2021-04-01 2022-03-31 0001015383 us-gaap:SeriesAPreferredStockMember 2021-08-26 2021-08-27 0001015383 us-gaap:SeriesAPreferredStockMember 2021-09-15 2021-09-15 0001015383 us-gaap:SeriesAPreferredStockMember 2021-11-17 2021-11-17 0001015383 us-gaap:SeriesAPreferredStockMember 2021-12-15 2021-12-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-02-17 2022-02-18 0001015383 us-gaap:SeriesAPreferredStockMember 2022-03-15 2022-03-15 0001015383 us-gaap:SeriesAPreferredStockMember POWW:FebruarySeventeenTwoThousandTwentyThreeMember 2022-04-01 2023-03-31 0001015383 us-gaap:SeriesAPreferredStockMember 2023-02-17 2023-02-17 0001015383 us-gaap:SeriesAPreferredStockMember 2023-03-14 2023-03-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-11-17 2022-11-18 0001015383 us-gaap:SeriesAPreferredStockMember 2022-12-14 2022-12-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-08-16 2022-08-17 0001015383 us-gaap:SeriesAPreferredStockMember 2022-09-14 2022-09-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-05-11 2022-05-12 0001015383 us-gaap:SeriesAPreferredStockMember 2022-06-14 2022-06-15 0001015383 POWW:MergerAgreementMember POWW:GeminiDirectInvestmentsLLCMember 2021-04-30 0001015383 POWW:MergerAgreementMember POWW:GeminiDirectInvestmentsLLCMember 2021-04-29 2021-04-30 0001015383 POWW:WithoutBeingHeldInEscrowOrRequiringPriorStockholderApprovalMember 2021-04-29 2021-04-30 0001015383 POWW:PledgeAndEscrowAgreementMember 2021-04-29 2021-04-30 0001015383 POWW:WillNotBeIssuedPriorToTheStockholderApprovalMember 2021-04-29 2021-04-30 0001015383 POWW:GeminiDirectInvestmentsLLCMember 2021-04-29 2021-04-30 0001015383 POWW:GeminiDirectInvestmentsLLCMember 2021-04-30 0001015383 2021-04-29 2021-04-30 0001015383 2021-04-01 2021-04-01 0001015383 2021-04-30 0001015383 POWW:SettlementAgreementMember 2022-11-02 2022-11-03 0001015383 POWW:SettlementAgreementMember us-gaap:CommonStockMember 2022-11-02 2022-11-03 0001015383 POWW:TwoIndependentContractorsMember 2022-04-01 2023-03-31 0001015383 POWW:TwoIndependentContractorsMember POWW:ProxySettlementAgreementMember 2022-04-01 2023-03-31 0001015383 POWW:ForegoingMember 2022-04-01 2023-03-31 0001015383 POWW:AdvisoryCommitteeMember 2022-04-01 2023-03-31 0001015383 POWW:BoardOfDirectorsMember POWW:MarketplaceRevenueMember 2022-04-01 2023-03-31 0001015383 us-gaap:RelatedPartyMember 2023-03-31 0001015383 POWW:IndependentContractorMember 2021-04-01 2022-03-31 0001015383 POWW:AdvisoryCommitteeMember 2021-04-01 2022-03-31 0001015383 POWW:BoardOfDirectorsMember POWW:MarketplaceRevenueMember 2021-04-01 2022-03-31 0001015383 us-gaap:RelatedPartyMember 2022-03-31 0001015383 2019-04-29 2019-04-30 0001015383 POWW:JagemannStampingCompanyMember 2022-03-31 0001015383 POWW:PostClosingTransactionNoteReductionMember 2019-10-29 2019-10-31 0001015383 POWW:DecreasedEquipmentMember 2019-10-29 2019-10-31 0001015383 POWW:OtherIntangibleAssetReductionMember 2019-10-29 2019-10-31 0001015383 POWW:IncreasedAccountsReceivableMember 2019-10-29 2019-10-31 0001015383 POWW:IncreaseToDepositsMember 2019-10-29 2019-10-31 0001015383 POWW:DecreasedAccumulatedDepreciationMember 2019-10-29 2019-10-31 0001015383 POWW:AdministrativeAndManagementServicesAgreementMember 2022-04-01 2023-03-31 0001015383 POWW:AdministrativeAndManagementServicesAgreementMember 2021-04-01 2022-03-31 0001015383 POWW:AdministrativeAndManagementServicesAgreementMember 2020-04-01 2021-03-31 0001015383 POWW:SettlementAgreementMember POWW:SellerNoteMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:MonthlyPaymentsMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:NinetyPercentMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:HundredPercentMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember srt:MaximumMember 2020-06-25 2020-06-26 0001015383 POWW:JagemannStampingCompanyMember POWW:SettlementAgreementMember 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:AmendedNoteBMember 2020-11-03 2020-11-05 0001015383 POWW:PromissoryNoteMember POWW:ShareholderMember 2019-05-02 2019-05-03 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2021-03-31 0001015383 POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember POWW:ForestStreetNoteMember 2021-01-13 2021-01-14 0001015383 POWW:MergerAgreementMember POWW:GeminiDirectInvestmentsLLCMember 2022-03-31 0001015383 POWW:JesseJamesMember 2023-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JesseJamesMember 2023-03-31 0001015383 POWW:JeffRannMember 2023-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JeffRannMember 2023-03-31 0001015383 POWW:StreakVisualAmmunitionPatentMember 2023-03-31 0001015383 POWW:SWKPatentAcquisitionMember 2023-03-31 0001015383 us-gaap:CustomerRelationshipsMember 2023-03-31 0001015383 us-gaap:IntellectualPropertyMember 2023-03-31 0001015383 POWW:TradenameMember 2023-03-31 0001015383 POWW:TradenameMember POWW:GDIAcquisitionMember 2023-03-31 0001015383 us-gaap:CustomerListsMember POWW:GDIAcquisitionMember 2023-03-31 0001015383 us-gaap:IntellectualPropertyMember POWW:GDIAcquisitionMember 2023-03-31 0001015383 us-gaap:OtherIntangibleAssetsMember POWW:GDIAcquisitionMember 2023-03-31 0001015383 us-gaap:LicensingAgreementsMember 2023-03-31 0001015383 us-gaap:PatentsMember 2023-03-31 0001015383 us-gaap:OtherIntangibleAssetsMember 2023-03-31 0001015383 POWW:JesseJamesMember 2022-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JesseJamesMember 2022-03-31 0001015383 POWW:JeffRannMember 2022-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JeffRannMember 2022-03-31 0001015383 POWW:StreakVisualAmmunitionPatentMember 2022-03-31 0001015383 POWW:SWKPatentAcquisitionMember 2022-03-31 0001015383 us-gaap:CustomerRelationshipsMember 2022-03-31 0001015383 us-gaap:IntellectualPropertyMember 2022-03-31 0001015383 POWW:TradenameMember 2022-03-31 0001015383 POWW:TradenameMember POWW:GDIAcquisitionMember 2022-03-31 0001015383 us-gaap:CustomerListsMember POWW:GDIAcquisitionMember 2022-03-31 0001015383 us-gaap:IntellectualPropertyMember POWW:GDIAcquisitionMember 2022-03-31 0001015383 us-gaap:OtherIntangibleAssetsMember POWW:GDIAcquisitionMember 2022-03-31 0001015383 us-gaap:LicensingAgreementsMember 2022-03-31 0001015383 us-gaap:PatentsMember 2022-03-31 0001015383 us-gaap:OtherIntangibleAssetsMember 2022-03-31 0001015383 POWW:AmmunitionMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceMember 2022-04-01 2023-03-31 0001015383 POWW:CorporateAndOtherExpensesMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceMember 2021-04-01 2022-03-31 0001015383 POWW:CorporateAndOtherExpensesMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceMember 2020-04-01 2021-03-31 0001015383 POWW:CorporateAndOtherExpensesMember 2020-04-01 2021-03-31 0001015383 POWW:AmmunitionMember 2023-03-31 0001015383 POWW:AmmunitionMember 2022-03-31 0001015383 POWW:AmmunitionMember 2021-03-31 0001015383 POWW:MarketplaceMember 2023-03-31 0001015383 POWW:MarketplaceMember 2022-03-31 0001015383 POWW:MarketplaceMember 2021-03-31 0001015383 POWW:AmmunitionMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceMember 2020-04-01 2021-03-31 0001015383 us-gaap:SubsequentEventMember POWW:MembersOfBoardOfDirectorsMember 2023-04-01 2023-04-01 0001015383 us-gaap:SubsequentEventMember POWW:MembersOfBoardOfDirectorsMember 2023-04-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended March 31, 2023

 

OR

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

AMMO, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

delaware   001-13101   83-1950534

(State

of incorporation)

 

(Commission

File No.)

 

(I.R.S. Identification

Number)

 

7681 E Gray Road, Scottsdale, AZ 85260

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number including area code: (480) 947-0001

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   POWW  

The Nasdaq Stock Market LLC (Nasdaq

Capital Market)

8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value   POWWP  

The Nasdaq Stock Market LLC (Nasdaq

Capital Market)

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer
Non-accelerated filer ☐ Smaller reporting company
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes ☒ No

 

The aggregate market value of the Common Stock of the registrant by non-affiliates as of the last business day of the registrant’s most recently completed second fiscal quarter (September 30, 2022) was $258,196,798.

 

As of June 9, 2023, there were 117,580,758 shares of $0.001 par value Common Stock outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Part III incorporates information by reference from the definitive proxy statement for the registrant’s 2023 Annual Meeting of Stockholders to be filed within 120 days after the end of the registrant’s fiscal year.

 

 

 

 
 

 

TABLE OF CONTENTS

 

PART I    
     
ITEM 1: BUSINESS 4
ITEM 1A: RISK FACTORS 11
ITEM 1B: UNRESOLVED STAFF COMMENTS 27
ITEM 2: PROPERTIES 27
ITEM 3: LEGAL PROCEEDINGS 28
ITEM 4: MINE SAFETY DISCLOSURE 28
     
PART II    
     
ITEM 5: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND PURCHASES OF EQUITY SECURITIES 28
ITEM 6: RESERVED 29
ITEM 7: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION 29
ITEM 7A: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 41
ITEM 8: FINANCIAL STATEMENTS 41
ITEM 9: CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 41
ITEM 9A: CONTROLS AND PROCEDURES 42
ITEM 9B: OTHER INFORMATION 44
ITEM 9C: DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 44
     
PART III    
     
ITEM 10: DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE 45
ITEM 11: EXECUTIVE COMPENSATION 45
ITEM 12: SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 45
ITEM 13: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 45
ITEM 14: PRINCIPAL ACCOUNTING FEES AND SERVICES 45
     
PART IV    
     
ITEM 15: EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 46
     
SIGNATURES 48

 

2

 

 

ADDITIONAL INFORMATION

 

Descriptions of agreements or other documents contained in this report are intended as summaries and are not necessarily complete. Please refer to the agreements or other documents filed or incorporated herein by reference as exhibits. Please see the exhibit index at the end of this report for a complete list of those exhibits.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This document contains certain “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies, goals and objectives of management for future operations; any statements concerning proposed new products and services or developments thereof; any statements regarding future economic conditions or performance; any statements or belief; and any statements of assumptions underlying any of the foregoing.

 

Forward looking statements may include the words “may,” “could,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words, or the negative thereof. These forward-looking statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however, consult further disclosures and risk factors we include in Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports filed on Form 8-K.

 

In our Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission, references to: (a) “Common Stock” refers to our Common Stock, $0.001 par value per share; (b) “2024 fiscal year” refers to the year that will end on March 31, 2024; and (c) “AMMO, Inc.”, “AMMO”, “the Company”, “we,” “us,” “our” and similar terms refer to AMMO, Inc. and its wholly owned operating subsidiaries Enlight Group II, LLC, AMMO Munitions, Inc., Firelight Group I LLC, Speedlight Group I, LLC, SNI, LLC, GB Investments, Inc., IA Tech, LLC, Outdoors Online, LLC, Enthusiast Commerce, LLC, five (5) other subsidiaries listed on Exhibit 21.1 filed with this Annual Report on Form 10-K, and AMMO Technologies, Inc. (with AMMO Technologies, Inc. currently being inactive).

 

3

 

 

PART I

 

ITEM 1. BUSINESS.

 

Introduction

 

Ammo Inc. is a conglomerate of two premium positions in the shooting sports industry. Ammo Inc. started in ammunition manufacturing and in 2021 broadened its portfolio with the acquisition of Gunbroker.com. Gunbroker.com is an ecommerce marketplace that connects buyers and sellers with new/used firearms and ancillary gear and componentry for the firearm community. Gunbroker.com helps facilitate this community with a state and federal compliant solution that connects buyers with sellers across the US with their local federally licensed firearm dealers. This allows our base of approximately 7.8 million users to follow ownership policies and regulations through our network of over 35,000 federally licensed firearms dealers as transfer agents. The nature and operation of the Marketplace as an online auction and sales platform also affords our Company a unique view into the total domestic market for the purpose of understanding sales trends at a granular level across all elements of the outdoor and sports shooting space.

 

Reportable Segments

 

We operate our business within two operating segments. Our Chief Executive Officer reviews financial performance based on two operating segments as described below.

 

  Ammunition – which consists of our manufacturing business. The Ammunition segment engages in the design, production and marketing of ammunition, ammunition component and related products.
  Marketplace – which consists of the GunBroker.com Ecommerce marketplace. In its role as an auction site, GunBroker.com supports the lawful sale of firearms, ammunition and hunting/shooting accessories.

 

See Note 19 of our consolidated financial statements for more information regarding our reportable segments.

 

Marketplace Segment - GunBroker.com

 

On April 30, 2021 (the “Effective Date”), we entered into an agreement and plan of merger (the “Merger Agreement”), by and among us, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Sub”), Gemini Direct Investments, LLC, a Nevada limited liability company (“Gemini”), and Steven F. Urvan, an individual (the “Seller”), whereby Sub merged with and into Gemini, with Sub surviving the merger as our wholly owned subsidiary (the “Merger”). At the time of the Merger, Gemini had nine subsidiaries, all of which are related to Gemini’s ownership of the GunBroker.com business. The Merger was completed on the Effective Date.

 

GunBroker.com is a large online marketplace dedicated to firearms, hunting, shooting and related products. Aside from merchandise bearing its logo, GunBroker.com does not hold any inventory and serves to facilitate transactions between buyers and sellers. Third-party sellers list items on the site and federal and state laws govern the sale of firearms and other restricted items. Ownership policies and regulations are followed using licensed firearms dealers as transfer agents offering a compliant solution to transact online. GunBroker.com has approximately 7.8 million registered users and averages over 1.8 million items listed for sale on its site on a daily basis.

 

Our vision is to expand the services on GunBroker.com and to become a partner to those in our industry. In the short term, we will be implementing the following services;

 

● Payment Processing – facilitating payment between parties allowing sellers of all sizes to offer fast and secure electronic payments and allowing buyers to experience the ease of instant checkout using a single platform for payment of all items purchased.

 

● Carting Ability – enables our buyers to checkout multiple items from multiple sellers in a single transaction. Our buyers will be able finalize transactions including both regulated and nonregulated items, allowing one payment, while also affording them the ability to ship their purchases to more than one location. By way of example, a buyer will be able to complete a transaction with a single payment, ship regulated items to a registered federal firearms license dealer, and also ship nonregulated items directly to their address.

 

● GunBroker.com Analytics – launched in January 2023 through the compilation and refinement of vast Marketplace data, we offer ecommerce market analytics to our industry peers allowing them to better manage business strategy and planning.

 

● GunBroker.com Advertising – effective as of January 2023 we offer additional resources to our seller community to promote their seller stores within GunBroker.com as well as the products they supply. Content creation for manufactures, email campaigns and banner ads are all part of our advertising offerings that are ever evolving resources to the outdoor industry.

 

Enhance Market Share, Brand Recognition, and Customer Loyalty

 

Our work to enhance and simplify the user experience on the GunBroker.com marketplace platform, while adding to its merchandise and related offerings, is designed to enhance the GunBroker.com brand by ensuring customer (both buyers and sellers) adhesion is amplified as they access one of the largest single on-line destinations for outdoor and shooting sports enthusiasts within the US market.

 

Ammunition Segment – Manufacturing

 

Our manufacturing operations are currently based out of Manitowoc, Wisconsin. We manufacture small arms ammunition and their components for the commercial, military, and law enforcement community. Our core competency lies in our ability to deep draw rifle brass casings with a high degree of precision up to 50 caliber. Our capacities are dependent upon mix, labor and the number of shifts we are running but our case capacity resides in excess of 750 million to 1.0 billion pieces based on full utilization of the factory. We emphasize an American heritage by using predominantly American-made components and raw materials in our products that are produced, inspected, and packaged at our facilities in Manitowoc.

 

We are focused on manufacturing premium pistol and rifle ammunition and supporting industry partners for manufactured components. We will continue to leverage our proprietary brands like Streak Visual AmmunitionTM and Stelth subsonic ammunition and extend our product offering with premium rifle lines and brands. We also support the US military with our cutting-edge developmental ammunition programs as we seek out and effectively execute upon new governmental-based opportunities. Our production processes focus on safety, consistency, precision, and cleanliness. Each round is developed for consistency, velocity, accuracy, and repeatability. Each round is chamber gauged and inspected with redundant seven-step quality control processes and meet and exceed SAAMI and CIP standards.

 

4

 

 

Our Growth Strategy

 

Our goal is to enhance our position as a designer, producer, and marketer of ammunition products via our manufacturing and related sales operations, while simultaneously enhancing and embracing the data we have in Gunbroker.com to allow us to see growing trends and demands form the US customer base.

 

Design, Produce, and Market Innovative, Distinctive, Performance-Driven, High-Quality Ammunition and Ammunition Components

 

We are focused on designing, producing, and marketing innovative, distinctive, performance-driven, high-quality products that appeal to retailers, manufacturers, and consumers that will enhance our users’ shooting experiences. Our research and development activities continue to drive opportunity and market attractiveness for our brands. We balance our R&D prowess with best-in-class operational efficiencies and continue to drive our cost down through rigorous continuous improvement initiatives.

 

Continue to Strengthen Relationships with Channel Partners and Retailers.

 

We continue to strive to strengthen our relationships with our current distributors, specialty retailers, dealers, and OEM manufacturers. The success of our efforts depends on new caliber introduction, innovation in our operations, quality, performance of our products, attractiveness of our retail packaging, and the guarantees we bring to our user community through our customer support efforts.

 

Emphasis on Customer Satisfaction and Loyalty

 

We plan to continue to emphasize customer satisfaction and loyalty by offering innovative, distinctive, high-quality products on a timely basis and by offering effective customer service, training, and support for the user community. We regard the features, quality, and performance of our products as the most important components of our customer satisfaction and loyalty efforts.

 

Continuously Improving Operations

 

We continue our efforts to enhance our production and lean out our operations by increasing daily production quantities through equipment acquisition, shift expansion, process improvements, increased operational availability of our equipment, and increased overall efficiency. Further, the Company opened its new state-of-the-art manufacturing plant in Manitowoc, WI. The opening and full operation of this new plant has positioned Ammo Inc. to be the leader in brass case supply to the OEM market and under the many brands we go to market under. The plant will allow us to exponentially increase capacity through the end of calendar 2023 and into 2024.

 

Products

 

We design, produce, and sell ammunition and ammunition components in a variety of types, sizes, and calibers for use in handguns and long guns. We ship our ammunition in the form of cartridges (or rounds), and also ammunition casings. A cartridge consists of four components: a case made of brass, steel, or polymer that holds together all the other components of the cartridge; the primer, which is an explosive chemical compound that ignites the gunpowder when struck by the firing pin; the gun powder, which is a chemical mixture that burns rapidly and creates an expanding gas when ignited and pushes the bullet out the barrel; and the bullet, or projectile, usually containing lead that is fired through the barrel to strike the target. We also offer ammunition casings for pistol ammunition through large rifle ammunition.

 

5

 

 

STREAK Visual Ammunition

 

STREAK VISUAL AMMUNITION™ enables shooters to see the path of the bullets. STREAK VISUAL AMMUNITION™ rounds utilize non-flammable phosphor material that produces a glow by the utilization of the light emitted during the round discharge to make STREAK VISUAL AMMUNITION™ glow. The luminescent material is applied only to the base of the projectile, making it visible only to the shooter and those within a 30-degree viewing window. As a result, the glow of STREAK VISUAL AMMUNITION™ is not visible to the target unlike conventional tracers, which we believe is important to the military and law enforcement. We refer to the technology used by our STREAK VISUAL AMMUNITION™ as one-way luminescent or O.W.L. Technology™. Unlike conventional tracer ammunition, STREAK VISUAL AMMUNITION™ rounds are not incendiary and do not utilize burning metals to generate light, thereby eliminating heat generation and making them safer for use in various environments and avoiding serious fire hazards. STREAK VISUAL AMMUNITION™ comes in 380 auto, 9 mm, 40 S&W, 44 magnum, 45 long colt, and 38 special among other calibers.

 

We hold the exclusive worldwide sales and distribution rights for the patented O.W.L. Technology™ used by our STREAK VISUAL AMMUNITION™ and pay a royalty based on our product sales incorporating this technology. On October 13, 2020, the Company further expanded its patent portfolio as a result of the U.S. Patent and Trademark Office (USPTO)’s issuance of Patent No. 10,801,821 recognizing the Company’s development of both a protectable and cutting-edge process to mass-produce luminescent projectiles, as well as the luminescent projectiles manufactured as a result of the protected process.

 

Stelth Subsonic Ammunition

 

Stelth Subsonic ammunition is designed specifically for superior performance in suppressed firearms. Stelth ammunition finds applications in which silence is paramount, such as in tactical training, predator night hunts, and clandestine operations. The Stelth ammunition is produced to be a clean burning total metal jacket round to slow baffle corrosion and reduce lead emissions that collect in the suppressor body. Stelth ammunition comes in 9mm, 40 S&W, and 45 ACP, 223, and 300BLK.

 

JMC

 

Through Jagemann Munitions Components (“JMC”), we offer ammunition casings for pistol and rifle ammunition. Jagemann Munitions Components is backed by decades of manufacturing experience that allows the production of high-quality pistol brass and rifle brass components. Borne from the automotive industry and refined over time to deliver durable and consistent sporting components, Jagemann Munitions Components has become one of the largest brass manufacturers in the country, with the capacity to produce more than 750 million pieces of brass each year with the ability to scale to over 1 billion pieces of brass each year. Proud of its American-made components and capabilities, the Company now has complete control over the manufacturing process.

 

Marketing

 

We market our products and services to consumers through distributors, dealers, mass market, and specialty retailers. We maintain consumer-focused product marketing and promotional campaigns, which include print and digital advertising campaigns; social and electronic media; product demonstrations; point-of-sales materials; in-store training, and in-store retail merchandising. Our use of social media includes Instagram, Facebook, Twitter, and You Tube. We also utilize third-party endorsements, social influencers, and brand ambassadors.

 

Product Innovation and Development

 

The Company was founded on delivering new and innovative products such as Streak to the industry. Since initiating operations in 2017 and has developed proprietary products for the commercial and military sectors. We continue this passion with developing new calibers and products to meet and create market demand. The core competency of our manufacturing facility lies in its ability to deep draw rifle cases. Our goal is to fill the capacity of our new facility with innovative products around this core competency. In our 2024 fiscal year, we will be delivering on calibers with high demand in premium segments of the market such as 7mm PRC, 35 Whelan, 350 Legend, and 45-70 both in our AMMO, Inc. Signature lines as well as brass for OEM manufacturers. We will provide our ammunition customers with a stronger line up of high precision hunting cartridges and continue to deliver to the OEM market with an offering that provides our customers the ability to reach their fullest potential. The competition will continue to fight for shelf space at retail and our market continues to normalize so we must default to new caliber design and introduction to create brand strength, market positioning, and loyalty. We will continue to push into niche markets to find margins and create opportunities for our newfound capacity at the new 185,000 sq ft facility in Manitowoc. We do all this while following strict industry standards to ensure we deliver safe and effective products to our customers. We will continue to add talent and engage best in class resources to enable AMMO, Inc. to continue down this path.

 

Since the acquisition, we have evolved the GunBroker.com marketplace to push best in class ecommerce standards. By streamlining customer service, we push proactive customer engagement based around outreach to the seller and buyer community. We are in the final testing stages of a centralized payment system that will allow all, including smaller sellers, merchant processing and carting ability for the entire platform. Centralized payment processing will allow for advanced fraud prevention, reduce manual reviews & reductions in chargebacks for the seller community. There is continued development around listing processes and communication flow between buyers and sellers, as well as optimization of the immense amount of self-data. We currently use our platform data to present personalized marketing campaigns to the user base and will continue to evolve how we engage with our customer base. Marketing, Analytics, and Advertising programs have been instrumental in the success of the prior year, we are continuing to build out teams and structure for our aggressive go to market campaigns for this fiscal year.

 

Research and Development

 

We conduct research and development activities to enhance existing products and develop new products at our facilities in Manitowoc, Wisconsin, utilizing our personnel and strategic relationships. We expense all costs associated with our research and development efforts through either our cost of goods sold, as they are performed by the same employees who produce our finished product, or through or general and administrative expenses if the product has not been brought to market.

 

6

 

 

Suppliers

 

We purchase certain raw materials and components for our ammunition products, including brass, steel, or copper casings; ammunition primers to ignite gun powder; gun powder; and projectiles. We believe we have reliable sources of supply for all our raw material and component needs, but from time to time raw materials and components are subject to shortages and price increases. Most of our suppliers are U.S.-based and provide us the materials and components at competitive rates. Our ownership of JMC supplies our ammunition casings. We plan to continue to broaden our supplier base and secure multiple sources for all the raw materials and components we require.

 

Customers

 

We sell our products through distribution, “Big Box” retailers, manufacturers, specialty retailers, local ammunition stores, and shooting range operators. Our consumers include sport and recreational shooters, hunters, competitive shooters, individuals desiring home and personal protection, manufacturers, and law enforcement and military agencies, and selected international markets. We distribute our products under four primary product lines: AMMO Inc. Signature, STREAK VISUAL AMMUNITION™, Stelth, and JMC.

 

Competition

 

The ammunition and ammunition casing industry is dominated by a small number of companies, a number of which are divisions of large public companies. We compete primarily on the quality, reliability, features, performance, brand awareness, and price of our products. Our primary competitors include Federal Premium Ammunition, Remington Arms, the Winchester Ammunition division of Olin Corporation, and various smaller manufacturers and suppliers, including Black-Hills Ammunition, CBC Group, Fiocchi Ammunition, Hornady Manufacturing Company, PMC, Rio Ammunition, and Wolf.

 

Human Capital

 

As of June 9, 2023, we had a total of 342 employees. Of these employees, 236 were engaged in manufacturing, 31 in sales, marketing and customer service, 34 in research and development, manufacturing engineering, and software engineering, and 41 in various corporate and administrative functions (information technology, accounting, executives, etc.). None of our employees are represented by a union in collective bargaining with us. We believe that our employee relations are good.

 

Our human capital proposition is centered around a team-oriented work environment that promotes a culture that fosters engagement, hard work, a desire to win, and accountability. At our core, we strive to attract, develop, and retain employees that want to be a part of a dynamic workforce centered around delivering new products and services to our passionate userbase. We value diversity, engagement, and unique viewpoints that enable us to excel in the marketplace.

 

Seasonality

 

Our business has not exhibited a material degree of seasonality to date but as we move into more rifle production and strive to meet our customers projections and needs, seasonality will have a larger effect on our sales pipeline. Our net sales could be moderately higher in our second and third fiscal quarters because of the fall hunting and holiday seasons.

 

Intellectual Property

 

We believe our tradenames, trademarks, and service markets are important factors in distinguishing our products. In addition, we regard our trade secrets, technological resources, knowhow, licensing arrangements, and endorsements as important competitive factors.

 

Under the terms of the 2017 merger between our wholly-owned subsidiary, AMMO Technologies Inc., an Arizona corporation (“ATI”) and Hallam, Inc. (“Hallam”), ATI succeeded to all of the assets of Hallam and assumed the liabilities of Hallam, which were none. The primary asset of Hallam was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette (“ULL”). The license was formally amended and assigned to ATI pursuant to an Assignment and First Amendment to Exclusive License Agreement Assumption Agreement. Under the terms of the merger with Hallam, we, the sole shareholder of ATI, issued to Hallam’s two shareholders, 600,000 shares of our Common Stock, subject to restrictions, and payment of $200,000. The first payment of $100,000 to Hallam’s shareholders was paid on September 13, 2017, and the second payment of $100,000 was paid on February 6, 2018.

 

7

 

 

We hold the exclusive worldwide sales and distribution rights for the patented O.W.L. Technology™ used by our STREAK VISUAL AMMUNITION™ via our license agreement with ULL. We pay ULL a royalty based on our product sales incorporating this patented technology. We have been using our O.W.L. Technology™ to compete for military contracts in part because we believe the glow of STREAK VISUAL AMMUNITION™ not being visible to the target (which is unlike conventional tracers) is important to the military and law enforcement.

 

Such military use is allowed pursuant to that certain Amended and Restated Exclusive License Agreement between ATI and ULL which was dated as of November 16, 2017 and effective as of January 1, 2018 (the “A&R License Agreement”). The A&R License Agreement expires on January 1, 2022 and is renewable in the Company’s sole discretion for successive four (4) year periods provided the Company is not in breach of the A&R License Agreement. While the parties have agreed that, effective January 1, 2022, the A&R License Agreement was extended to January 1, 2026, the parties are still finalizing the documentation of this extension via the signing of an amendment. On July 7, 2022, the Company and the Licensor entered into a Second Amendment to Amended and Restated Exclusive License Agreement, effective as of January 1, 2022 (the “Second Amendment”). Pursuant to the Second Amendment, the term of the Original License Agreement is extended for a period of four (4) years from the date of the start of the current term, such that the term will expire on January 1, 2026.

 

We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The licensing agreement grants us the exclusive worldwide rights through April 12, 2027 to Mr. James’ image rights and all trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. In addition, Mr. James agreed to make himself available for certain promotional activities and to promote Jesse James Branded Products through his own social media outlets. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

 

Through our acquisition of SW Kenetics, Inc. (“SWK”), we acquired the rights to a patent for modular projectiles. This technology is used in connection with our AP and HAPI lines of ammunition. The Company acquired SWK for a total of up to $1,500,000 in cash and issued 1,700,002 restricted shares of the Common Stock. The agreement specifies that $1,250,000 of the cash is deferred pending completion of specific milestones and the 1,700,002 shares of Common Stock are subject to claw back provisions to ensure agreed upon objective are met. As of March 31, 2023, the Company has made $350,000 in payments. As of March 31, 2023, 1,550,134 shares remain subject to clawback provisions. The patent will be amortized over 15 years.

 

Included in the acquisition of JMC for $7,000,000 in cash, $10,400,000 delivered in the form of a Promissory Note, and 4,750,000 shares of Common Stock, we acquired customer relationships, intellectual property, and the use of a tradename, which will be amortized over 3 years, 3 years and 5 years, respectively. These intangible assets are used in the operation and production of our ammunition casing business through our wholly owned subsidiary, Jagemann Munition Components.

 

8

 

 

Environmental Matters

 

Our operations are subject to a variety of federal, state, and local laws and regulations relating to environmental protection, including those governing the discharge, treatment, storage, transportation, remediation, and disposal of hazardous materials and wastes; the restoration of damages to the environment; and health and safety matters. We believe that our operations are in material compliance with these laws and regulations. We incur expenses in complying with environmental requirements and could incur higher costs in the future as a result of more stringent requirements that may be enacted in the future.

 

Some environmental laws, such as the U.S. federal Superfund law and similar state laws, can impose liability, without regard to fault, for the entire cost of the cleanup of contaminated sites on current or former site owners and operators or parties who sent wastes to such sites. Based on currently available information, we do not believe that environmental matters will have a material adverse effect on our business, operating results, or financial condition.

 

Regulatory Matters

 

The manufacture, sale, and purchase of ammunition are subject to extensive federal, state, local, and foreign governmental laws. We are also subject to the rules and regulations of the U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (“ATF”) and various state and international agencies that control the manufacture, export, import, distribution and sale of firearms, explosives, and ammunition. Such regulations may adversely affect demand for our products by imposing limitations that increase the costs or limit the availability of our products.

 

Our failure to comply with applicable rules and regulations may result in the limitation of our growth or business activities and could result in the revocation of licenses necessary for our business. Applicable laws and regulations provide for the following:

 

  require the licensing of all persons manufacturing, exporting, importing, or selling ammunition as a business;
     
  require serialization, labeling, and tracking of the acquisition and disposition of certain types of ammunition;
     
  regulate the interstate sale of certain ammunition;
     
  restrict or prohibit the ownership, use, or sale of specified categories of ammunition;
     
  require registries of so-called “ballistic images” of ammunition fired from new guns;
     
  govern the sale, export, and distribution of ammunition;
     
  regulate the use and storage of gun powder or other energetic materials;
     
  regulate the employment of personnel with certain criminal convictions;
     
  restrict access to ammunition manufacturing facilities for certain individuals from other countries or with criminal convictions; and
     
  require compliance with International Traffic in Arms Regulations.

 

9

 

 

The handling of our technical data and the international sale of our products may also be regulated by the U.S. Department of State and Department of Commerce. These agencies can impose civil and criminal penalties, including denying us from exporting our products, for failure to comply with applicable laws and regulations.

 

In addition, bills have been introduced in Congress to establish, and to consider the feasibility of establishing a nationwide database recording so-called “ballistic images” of ammunition fired from new guns. Should such a mandatory database be established, the cost to us, our distributors, and our customers could be significant, depending on the type of firearms and ballistic information included in the database. Bills have been introduced in Congress in the past several years that would affect the manufacture and sale of ammunition, including bills to regulate the manufacture, importation, and sale.

 

We believe that existing federal, state, and local legislation relating to the regulation of firearms and ammunition have not had a material adverse effect on our sales of these products. However, the regulation of firearms and ammunition may become more restrictive in the future, and any such developments might have a material adverse effect on our business, operating results, financial condition, and cash flows. In addition, regulatory proposals, even if never enacted, may affect firearms or ammunition sales as a result of consumer perceptions.

 

Transactions taking place on the GunBroker.com site involving the lawful sale of firearms are facilitated from a listing and documentation standpoint by GunBroker.com. The transaction is consummated between a third-party buyer and seller and requires the direct involvement of an ATF Federal Firearms License (“FFL”) holder such as a gun shop or range that accepts receipt of the firearms and completes the transaction and delivery subject to confirmation of compliance with applicable federal and/or state laws.

 

Available Information

 

You can find reports on our company including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports on our website www.ammoinc.com under the “Investor Relations” heading. These reports are free of charge and are available as soon as reasonably practicable after they have been filed with, or furnished to, the U.S. Securities and Exchange Commission (SEC). We are providing the address to our website solely for the information of investors and the information on our website is not a part of this or any report that we file with the SEC.

 

10

 

 

ITEM 1A. RISK FACTORS

 

Purchasing our Common Stock or Series A Preferred Stock involves a high degree of risk. You should carefully consider the following risk factors, together with all of the information included in this Form 10-K Report, before you decide to purchase shares of our Common Stock or Series A Preferred Stock. We believe the risks and uncertainties described below are the most significant we face. Additional risks and uncertainties of which we are unaware, or that we currently deem immaterial, also may become important factors that affect us. If any of the following risks occur, our business, operating results, and financial condition could be materially and adversely affected. In that case, the trading price of our Common Stock or Series A Preferred Stock could decline, and you may lose all or part of your investment.

 

Risks Related to Our Business

 

We have a limited operating history on which you can evaluate our company.

 

With the exception of GunBroker.com’s approximate 20 year history operating as a private company preceding the merger, we have a limited operating history on which you can evaluate our company. Although the corporate entity has existed since 1990, we have only operated as an ammunition manufacturer since March 2017. As a result, our business will be subject to many of the problems, expenses, delays, and risks inherent in the establishment of a new business enterprise.

 

Our performance is influenced by a variety of economic, social, and political factors.

 

Our performance is influenced by a variety of economic, social, and political factors. In the year ended March 31, 2023, we believe that general economic conditions and consumer spending patterns negatively impacted our operating results because consumers bought fewer discretionary items such as our products. These economic conditions included, but were not limited to, declines in consumer confidence and increases in consumer debt levels. In times of economic uncertainty, consumers tend to defer expenditures for discretionary items, which affects demand for our products. Economic conditions also affect governmental political and budgetary policies. As a result, economic conditions also can have an adverse effect on the sale of our products to law enforcement, government, and military customers.

 

Political and other factors also can adversely affect our performance. Concerns about presidential, congressional, and state elections and legislature and policy shifts resulting from those elections can adversely affect the demand for our products. In addition, uncertainty surrounding the control of firearms, firearm products, and ammunition at the federal, state, and local level and heightened fears of terrorism and crime can adversely affect consumer demand for our products. Often, such concerns result in an increase in near-term consumer demand and subsequent softening of demand when such concerns subside. We believe that one of the reasons our sales went down in the year ended March 31, 2023 as compared to the year ended March 31, 2022 was due to decreased demand. We believe there was heightened demand for our products during the year ended March 31, 2022 due to the pandemic and the political environment. Inventory levels in excess of customer demand may negatively impact operating results and cash flow.

 

Federal and state legislatures frequently consider legislation relating to the regulation of firearms, including amendment or repeal of existing legislation. Existing laws may also be affected by future judicial rulings and interpretations. If restrictive changes to legislation develop, we could find it difficult, expensive, or even impossible to comply with them, impeding new product development and distribution of existing products.

 

11

 

 

War, terrorism, other acts of violence or natural or manmade disasters, such as a global pandemic, may affect the markets in which the Company operates, the Company’s customers, the Company’s delivery of products and customer service, and could have a material adverse impact on our business, results of operations, or financial condition.

 

The Company’s business and supply chain has been adversely affected by instability, disruption or destruction in a geographic region in which it operates, regardless of cause, including war, terrorism, riot, civil insurrection or social unrest, and natural or manmade disasters, including famine, food, fire, earthquake, storm or pandemic events and spread of disease.

 

In building our main new manufacturing facility in Manitowoc, Wisconsin, the delivery of some of the main components needed in the building process were delayed due to supply chain disruptions. These delays caused our manufacturing capacity to be lower than it otherwise would have been causing a drop in sales in the year ended March 31, 2023, but have since been corrected.

 

Such events may cause customers to suspend their decisions on using the Company’s products and services, make it impossible to access some of our inventory, and give rise to sudden significant changes in regional and global economic conditions and cycles that could interfere with purchases of goods or services and commitments to develop new products and services. These events also pose significant risks to the Company’s personnel and to physical facilities, transportation and operations, which could materially adversely affect the Company’s financial results.

 

Any significant disruption to communications and travel, including travel restrictions and other potential protective quarantine measures against a pandemic by governmental agencies, could make it difficult for the Company to deliver goods services to its customers. War, riots, or other disasters may increase the need for our products and demand by our government and military and may make it more difficult to provide our products to other customers.

 

Worldwide economic and social instability could adversely affect our revenue, financial condition, or results of operations.

 

The health of the global economy, and the credit markets and the financial services industry in particular, as well as the stability of the social fabric of our society, affects our business and operating results. For example, the credit and financial markets may be adversely affected by the current conflict between Russia and Ukraine and measures taken in response thereto. If the credit markets are not favorable, we may be unable to raise additional financing when needed or on favorable terms. Our customers may experience financial difficulties or be unable to borrow money to fund their operations, which may adversely impact their ability to purchase our products or to pay for our products on a timely basis, if at all.

 

We are engaged in legal proceedings that could cause us to incur unforeseen expenses and could occupy a significant amount of our management’s time and attention.

 

On September 24, 2019, the Company received notice that an individual who was former member of the Board of Directors (the “Board”) who had been removed as a director by majority vote of the stockholders and who had voluntarily resigned as an employee filed a complaint against the Company, and certain individuals (the “Complaint”), with the U.S. Department of Labor (“DOL”). The Complaint alleges that the individual reported potential violations of SEC rules and regulations by management and that as a result of such reports, the individual experienced a hostile work environment; that the Company lacks sufficient internal controls, and that the individual was the victim of retaliation and constructive discharge after being removed as a director by majority vote of the stockholders. The claims were investigated by a Special Committee of the Board made up of independent directors represented by independent legal counsel. The Special Investigative Committee and legal counsel found the material claims were unsubstantiated, including those concerning alleged SEC violations, and recommended enhancements to certain corporate governance charter documents and processes which the Company promptly implemented. The parties participated in a successful mediation at the end of June 2022 and all matters relating to this former employee/claimant were confidentially resolved with the lawsuit dismissed with prejudice. The settlement was covered by our Employment Practices Liability Policy and did not amount to a material amount.

 

On April 30, 2023, Director and shareholder Steve Urvan filed suit in the Delaware Chancery Court against the Company, certain Directors, former directors, employees, former employees and consultants, seeking rescission of the Company’s acquisition of GunBroker.com and certain affiliated companies. Plaintiff Urvan’s claims include rescission, misrepresentation and fraud. The Company is currently in communications with its insurance carriers as concerns coverage (defense and indemnification), has engaged counsel and formal/legal service of process is being coordinated at this time. The Company and named defendants are in alignment and reasonably believe at this date that the claims are without merit and the Company has engaged Delaware Chancery Court litigation specialists to defend its interests in all respects in this case.

 

The claims made by Mr. Urvan and such other litigation or claims that may be made against the Company or its officers or directors, from time to time, could negatively affect our business, operations or financial position. As we grow, we will likely see a rise in the number of litigation matters against us. These matters may include employment and labor claims, product liability, and other claims related to our products, as well as consumer and securities class actions, each of which are typically expensive to defend. Litigation disputes could cause us to incur unforeseen expenses and otherwise occupy a significant amount of our management’s time and attention, any of which could negatively affect our business operations and financial position.

 

12

 

 

An inability to expand our E-commerce business could reduce our future growth.

 

Consumers are increasingly purchasing products online. We operate direct-to-consumer e-commerce stores to maintain an online presence with our end users. The future success of our online operations depends on our ability to use our marketing resources to communicate with existing and potential customers. We face competitive pressure to offer promotional discounts, which could impact our gross margin and increase our marketing expenses. We are limited, however, in our ability to fully respond to competitor price discounting because we cannot market our products at prices that may produce adverse relationships with our customers that operate brick and mortar locations as they may perceive themselves to be at a disadvantage based on lower e-commerce pricing to end consumers. There is no assurance that we will be able to successfully expand our e-commerce business to respond to shifting consumer traffic patterns and direct-to-consumer buying trends.

 

In addition, e-commerce and direct-to-consumer operations are subject to numerous risks, including implementing and maintaining appropriate technology to support business strategies; reliance on third-party computer hardware/software and service providers; data breaches; violations of state, federal or international laws, including those relating to online privacy; credit card fraud; telecommunication failures; electronic break-ins and similar disruptions; and disruption of Internet service. Our inability to adequately respond to these risks and uncertainties or to successfully maintain and expand our direct-to-consumer business may have an adverse impact on our business and operating results.

 

The GunBroker.com auction website facilitates the lawful sale of firearms, ammunition and accessories between listing sellers and interested buyers and includes the direct transactional involvement of FFLs regulated by the ATF. A change in applicable federal or state law that prohibited GunBroker.com from providing its facilitative auction platform services would have a direct substantial financial impact on the operations and adverse effect on the continuity of operations.

 

If we are unable to protect our intellectual property, we may lose a competitive advantage or incur substantial litigation costs to protect our rights.

 

Our future success depends upon our proprietary technology. Our protective measures, including patent and trade secret protection, may prove inadequate to protect our proprietary rights. The right to stop others from misusing our trademarks, service marks, and patents in commerce depends to some extent on our ability to show evidence of enforcement of our rights against such misuse in commerce. Our efforts to stop improper use, if insufficient, may lead to loss of trademark and service mark rights, brand loyalty, and notoriety among our customers and prospective customers. The scope of any patent that we have or may obtain may not prevent others from developing and selling competing products. The validity and breadth of claims covered in technology patents involve complex legal and factual questions, and the resolution of such claims may be highly uncertain, and expensive. In addition, our patents may be held invalid upon challenge, or others may claim rights in or ownership of our patents.

 

13

 

 

We may be subject to intellectual property infringement claims, which could cause us to incur litigation costs and divert management attention from our business.

 

Any intellectual property infringement claims against us, with or without merit, could be costly and time-consuming to defend and divert our management’s attention from our business. If our products were found to infringe a third party’s proprietary rights, we could be required to enter into costly royalty or licensing agreements to be able to sell our products. Royalty and licensing agreements, if required, may not be available on terms acceptable to us or at all.

 

Breaches of our information systems could adversely affect our reputation, disrupt our operations, and result in increased costs and loss sales.

 

There have been an increasing number of cyber security incidents affecting companies around the world, which have caused operational failures or compromised sensitive corporate data. Although we do not believe our systems are at a greater risk of cyber security incidents than other similar organizations, such cyber security incidents may result in the loss or compromise of customer, financial, or operational data; disruption of billing, collections, or normal operating activities; disruption of electronic monitoring and control of operational systems; and delays in financial reporting and other management functions. Possible impacts associated with a cyber security incident may include among others, remediation costs related to lost, stolen, or compromised data; repairs to data processing systems; increased cyber security protection costs; reputational damage; and adverse effects on our compliance with applicable privacy and other laws and regulations.

 

A failure of our information technology systems, or an interruption in their operation due to internal or external factors including cyber-attacks, could have a material adverse effect on our business, financial condition or results of operations.

 

Our operations depend on our ability to protect our information systems, computer equipment, and information databases from systems failures. We rely on our information technology systems generally to manage the day-to-day operations of our business, operate elements of our manufacturing facility, manage relationships with our customers, fulfill customer orders, and maintain our financial and accounting records. Failure of our information technology systems could be caused by internal or external events, such as incursions by intruders or hackers, computer viruses, cyber-attacks, failures in hardware or software, or power or telecommunication fluctuations or failures. The failure of our information technology systems to perform as anticipated for any reason or any significant breach of security could disrupt our business and result in numerous adverse consequences, including reduced effectiveness and efficiency of operations, increased costs, or loss of important information, any of which could have a material adverse effect on our business, operating results, and financial condition. Any technology and information security processes and disaster recovery plans we use to mitigate our risk to these vulnerabilities may not be adequate to ensure that our operations will not be disrupted should such an event occur.

 

Risks Related to Our Products and Our Dependence on Third Parties

 

Our success depends upon our ability to introduce new products that match customer preferences.

 

Our success depends upon our ability to introduce new products that match consumer preferences. Our efforts to introduce new products into the market may not be successful, and any new products that we introduce may not result in customer or market acceptance. We develop new products that we believe will match consumer preferences. The development of a new product is a lengthy and costly process and may not result in a successful product. Failure to develop new products that are attractive to consumers could decrease our sales, operating margins, and market share and could adversely affect our business, operating results, and financial condition.

 

We depend on the sale of our ammunition products.

 

We manufacture ammunition and ammunition casings for sale to a wide variety of consumers, including gun enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, manufacturers, law enforcement and security agencies and officers in the United States and throughout the world. The sale of ammunition and ammunition components is influenced by the sale and usage of firearms. Sales of firearms are influenced by a variety of economic, social, and political factors, which may result in volatile sales. Ammunition sales represented a substantial amount of our net sales for the fiscal years ended March 31, 2023, 2022, and 2021. If ammunition sales decline, our financial results could be adversely impacted and the stock price of our Common Stock could decline.

 

14

 

 

Our manufacturing facilities are critical to our success.

 

Our manufacturing operations are currently based out of two facilities in Manitowoc, Wisconsin and are critical to our success, as we currently produce all of our products at these facilities. These facilities also house our principal research, development, engineering, and design functions.

 

Any event that causes a disruption to the operation of these facilities for even a relatively short period of time would adversely affect our ability to produce and ship our products and to provide service to our customers. We make certain changes in our manufacturing operations from time to time to enhance the facilities and associated equipment and systems and to introduce certain efficiencies in manufacturing and other processes to produce our products in a more efficient and cost-effective manner. We have incurred significant capital and other expenditures with respect to our $26 million manufacturing plant, but we may not be successful in continuing to improve efficiencies.

 

Shortages of components and materials may delay or reduce our sales and increase our costs, thereby harming our results of operations.

 

The inability to obtain sufficient quantities of raw materials and components, including casings, primers, gun powder, projectiles, and brass necessary for the production of our products could result in reduced or delayed sales or lost orders. Any delay in or loss of sales or orders could adversely impact our operating results. Many of the materials used in the production of our products are available only from a limited number of suppliers. We do not have long-term supply contracts with any suppliers. As a result, we could be subject to increased costs, supply interruptions, and difficulties in obtaining raw materials and components.

 

Our reliance on third-party suppliers for various raw materials and components for our products exposes us to volatility in the availability, quality, and price of these raw materials and components. Our orders with certain of our suppliers may represent a very small portion of their total orders. As a result, they may not give priority to our business, leading to potential delays in or cancellation of our orders. A disruption in deliveries from our third-party suppliers, capacity constraints, production disruptions, price increases, or decreased availability of raw materials or commodities could have an adverse effect on our ability to meet our commitments to customers or increase our operating costs. Quality issues experienced by third party suppliers can also adversely affect the quality and effectiveness of our products and result in liability and reputational harm.

 

We rely on third-party suppliers for most of our manufacturing equipment.

 

We also rely on third-party suppliers for most of the manufacturing equipment necessary to produce our products. The failure of suppliers to supply manufacturing equipment in a timely manner or on commercially reasonable terms could delay our plans to expand our business and otherwise disrupt our production schedules and increase our manufacturing costs. Our orders with certain of our suppliers may represent a very small portion of their total orders. As a result, they may not give priority to our business, leading to potential delays in or cancellation of our orders. If any single-source supplier were to fail to supply our needs on a timely basis or cease providing us with manufacturing equipment or components, we would be required to locate and contract with substitute suppliers. We may have difficulty identifying a substitute supplier in a timely manner and on commercially reasonable terms. If this were to occur, our business would be harmed. In addition, adverse economic conditions, such as recent supply chain disruptions and labor shortages and persistent inflation, have impacted, and may continue to adversely impact our suppliers’ ability to provide us with materials and components, which may negatively impact our business. These economic conditions make it more difficult for us to accurately forecast and plan our future business activities.

 

Our revenue depends primarily on sales by various retailers and distributors, some of which account for a significant portion of our sales.

 

Our loaded ammunition and munition components revenue depends on our sales through various leading national and regional retailers, local specialty firearms stores, and online merchants. The U.S. retail industry serving the outdoor recreation market has become relatively concentrated. Our sales could become increasingly dependent on purchases by several large retail customers. Consolidation in the retail industry could also adversely affect our business. If our sales were to become increasingly dependent on business with several large retailers, we could be adversely affected by the loss or a significant decline in sales to one or more of these customers. In addition, our dependence on a smaller group of retailers could result in their increased bargaining position and pressures on the prices we charge.

 

15

 

 

The loss of any one or more of our large or “Big Box” retail customers or significant or numerous cancellations, reductions, delays in purchases or changes in business practices by our large or “Big Box” retail customers could have an adverse effect on our business, operating results, and financial condition.

 

These sales channels involve a number of special risks, including the following:

 

  we may be unable to secure and maintain favorable relationships with retailers and distributors;

 

  we may be unable to control the timing of delivery of our products to end-user consumers;

 

  our retailers and distributors are not subject to minimum sales requirements or any obligation to market our products to their customers;

 

  our retailers and distributors may terminate their relationships with us at any time;

 

  our retailers and distributors market and distribute competing products; and

 

  our retailers may experience closure due to COVID-19 outbreaks or other natural or manmade disasters in a particular region.

 

We have one customer that accounted for approximately 12% of our revenues for the years ended March 31, 2023 in comparison to two customers that accounted for approximately 18% of our revenues for the year ended March 31, 2022 and one customer that accounted for approximately 17% of our revenues for the year ended March 31, 2021. Although we intend to expand our customer base, our revenue would likely decline if we lost any major customers or if one of these sizable customers were to significantly reduce its orders for any reason. Because our sales are made by means of standard purchase orders rather than long-term contracts, we cannot assure you that our customers will continue to purchase our products at current levels, or at all.

 

In addition, periods of sluggish economies and consumer uncertainty regarding future economic prospects in our key markets can have an adverse effect on the financial health of our customers, which may in turn have a material adverse effect on our business, operating results, and financial condition.

 

General inflation, including rising energy prices, and interest rates and wages could have negative impacts on our business by increasing our operating costs and our borrowing costs as well as decreasing the capital available for our customers to purchase our products. General inflation in the United States, Europe and other geographies has risen to levels not experienced in recent decades. Additionally, inflation and price volatility may cause our customers to reduce use of our products would harm our business operations and financial position.

 

We extend credit to our customers for periods of varying duration based on an assessment of the customer’s financial condition, generally without requiring collateral, which increases our exposure to the risk of uncollectable receivables. In addition, we face increased risk of order reduction or cancellation when dealing with financially ailing retailers or retailers struggling with economic uncertainty. We may reduce our level of business with customers and distributors experiencing financial difficulties and may not be able to replace that business with other customers, which could have a material adverse effect on our business, operating results, and financial condition.

 

Our gross margins depend upon our sales mix.

 

Our gross margin is higher when our sales mix is skewed toward our higher-margin proprietary product lines versus a lower contribution from mid-market ammunition that we also manufacture. If our actual sales mix results in a lower overall percentage from our proprietary lines, our gross margins will be reduced, affecting our results of operations.

 

We face intense competition that could result in our losing or failing to gain market share and suffering reduced sales.

 

We operate in intensely competitive markets that are characterized by price erosion and competition from major domestic and international companies. Competition in the markets in which we operate is based on a number of factors, including price, quality, product innovation, performance, reliability, styling, product features, and warranties, and sales and marketing programs. This intense competition could result in pricing pressures, lower sales, reduced margins, and lower market share.

 

16

 

 

Our competitors include Federal Premium Ammunition, Remington Arms, the Winchester Ammunition Division of Olin Corporation, and various smaller manufacturers and importers, including Black Hills Ammunition, CBC Group, Fiocchi Ammunition, Hornady, PMC, Rio Ammunition, and Wolf. Most of our competitors have greater market recognition, larger customer bases, long-term government contracts, and substantially greater financial, technical, marketing, distribution, and other resources than we possess and that afford them competitive advantages. As a result, they may be able to devote greater resources to the promotion and sale of products, to invest more funds in intellectual property and product development, to negotiate lower prices for raw materials and components, to deliver competitive products at lower prices, and to introduce new products and respond to consumer requirements more quickly than we can.

 

Our competitors could introduce products with superior features at lower prices than our products and could also bundle existing or new products with other more established products to compete with us. Certain of our competitors may be willing to reduce prices and accept lower profit margins to compete with us. Our competitors could also gain market share by acquiring or forming strategic alliances with other competitors.

 

Finally, we may face additional sources of competition in the future because new distribution methods offered by the Internet and electronic commerce have removed many of the barriers to entry historically faced by start-up companies. Retailers also demand that suppliers reduce their prices on products, which could lead to lower margins. Any of the foregoing effects could cause our sales to decline, which would harm our financial position and results of operations.

 

Our ability to compete successfully depends on a number of factors, both within and outside our control. These factors include the following:

 

  our success in developing, producing, marketing, and successfully selling new products;

 

  our ability to address the needs of our consumer customers;

 

  the pricing, quality, performance, and reliability of our products;

 

  the quality of our customer service;

 

  the efficiency of our production; and

 

  product or technology introductions by our competitors.

 

Because we believe technological and functional distinctions among competing products in our markets are perceived by many end-user consumers to be relatively modest, effectiveness in marketing and manufacturing are particularly important competitive factors in our business.

 

Seasonality and weather conditions may cause our operating results to vary from quarter to quarter.

 

Because many of our products are used for seasonal outdoor sporting activities, our operating results may be significantly impacted by unseasonable weather conditions. Accordingly, our operating results could suffer when weather patterns do not conform to seasonal norms.

 

Shipments of ammunition for hunting are highest during the months of June through September to meet consumer demand for the fall hunting season and holidays. The seasonality of our sales may change in the future. Seasonal variations in our operating results may reduce our cash on hand, increase our inventory levels, and extend our accounts receivable collection periods. This in turn may cause us to increase our debt levels and interest expense to fund our working capital requirements.

 

17

 

 

We manufacture and sell products that create exposure to potential product liability, warranty liability, or personal injury claims and litigation.

 

Our products are used in activities and situations that involve risk of personal injury and death. Our products expose us to potential product liability, warranty liability, and personal injury claims and litigation relating to the use or misuse of our products, including allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product or activities associated with the product, negligence, and strict liability. If successful, any such claims could have a material adverse effect on our business, operating results, and financial condition. Defects in our products may result in a loss of sales, recall expenses, delay in market acceptance, and damage to our reputation and increased warranty costs, which could have a material adverse effect on our business, operating results, and financial condition. Although we maintain product liability insurance in amounts that we believe are reasonable, we may not be able to maintain such insurance on acceptable terms, if at all, in the future and product liability claims may exceed the amount of insurance coverage or may not be covered by our insurance policies. In addition, our reputation may be adversely affected by such claims, whether or not successful, including potential negative publicity about our products.

 

Our business is highly dependent upon our brand recognition and reputation, and the failure to maintain or enhance our brand recognition or reputation would likely have a material adverse effect on our business.

 

Our brand recognition and reputation are critical aspects of our business. We believe that maintaining and further enhancing our brands, particularly our STREAK VISUAL AMMUNITION™ brands, and our reputation are critical to retaining existing customers and attracting new customers. We also believe that the importance of our brand recognition and reputation will continue to increase as competition in our markets continues to develop.

 

We anticipate that our advertising, marketing, and promotional efforts will increase in the foreseeable future as we continue to seek to enhance our brands and consumer demand for our products. Historically, we have relied on print and electronic media advertising to increase consumer awareness of our brands to increase purchasing intent and conversation. We anticipate that we will increasingly rely on other forms of media advertising, including social media and e-marketing. Our future growth and profitability will depend in large part upon the effectiveness and efficiency of our advertising, promotion, public relations, and marketing programs. These brand promotion activities may not yield increased revenue and the efficacy of these activities will depend on a number of factors, including our ability to do the following:

 

  determine the appropriate creative message and media mix for advertising, marketing, and promotional expenditures;

 

  select the right markets, media, and specific media vehicles in which to advertise;

 

  identify the most effective and efficient level of spending in each market, media, and specific media vehicle; and

 

  effectively manage marketing costs, including creative and media expenses, to maintain acceptable customer acquisition costs.

 

In addition, certain of our current or future products may benefit from endorsements and support from particular sportsmen, athletes, or other celebrities, and those products and brands may become personally associated with those individuals. As a result, sales of the endorsed products could be materially and adversely affected if any of those individuals’ images, reputations, or popularity were to be negatively impacted.

 

18

 

 

Increases in the pricing of one or more of our marketing and advertising channels could increase our marketing and advertising expenses or cause us to choose less expensive but possibly less effective marketing and advertising channels. If we implement new marketing and advertising strategies, we may incur significantly higher costs than our current channels, which in turn could adversely affect our operating results. Implementing new marketing and advertising strategies also could increase the risk of devoting significant capital and other resources to endeavors that do not prove to be cost effective. We also may incur marketing and advertising expenses significantly in advance of the time we anticipate recognizing revenue associated with such expenses and our marketing and advertising expenditures may not generate sufficient levels of brand awareness and conversation or result in increased revenue. Even if our marketing and advertising expenses result in increased sales, the increase might not offset our related expenditures. If we are unable to maintain our marketing and advertising channels on cost-effective terms or replace or supplement existing marketing and advertising channels with similarly or more effective channels, our marketing and advertising expenses could increase substantially, our customer base could be adversely affected, and our business, operating results, financial condition, and reputation could suffer.

 

A portion of our revenue is contingent on an exclusive license agreement with the University of Louisiana at Lafayette.

 

A significant portion of our revenue is attributable to the sale of our STREAK VISUAL AMMUNITION. The manufacturing of our STREAK product relies, in part, on a patent that is held by ULL. We have an exclusive license to use the licensed technology, derivative and related technology worldwide. We may renew this license agreement for successive four-year periods provided we are in compliance with the agreement. If we breach the license agreement, the licensor may terminate the agreement and if we fail to renew the license, we may be unable to use the technology, which, in either case, could significantly harm our results of operations.

 

Regulatory Risks

 

We are subject to extensive regulation and could incur fines, penalties and other costs and liabilities under such requirements.

 

Like many other manufacturers and distributors of consumer products, we are required to comply with a wide variety of laws, rules, and regulations, including those relating to labor, employment, the environment, the export and import of our products, and taxation. These laws, rules, and regulations currently impose significant compliance requirements on our business, and more restrictive laws, rules and regulations may be adopted in the future.

 

Our operations are subject to a variety of laws and regulations relating to environmental protection, including those governing the discharge, treatment, storage, transportation, remediation, and disposal of certain materials and wastes, and restoration of damages to the environment, and health and safety matters. We could incur substantial costs, including remediation costs, resource restoration costs, fines, penalties, and third-party property damage or personal injury claims as a result of liabilities under or violations of such laws and regulations or the permits required thereunder. While environmental laws and regulations have not had a material adverse effect on our business, operating results, financial condition, the ultimate cost of environmental liabilities is difficult to accurately predict and we could incur material additional costs as a result of requirements or obligations imposed or liabilities identified in the future.

 

As a manufacturer and distributor of consumer products, we are subject to the Consumer Products Safety Act, which empowers the Consumer Products Safety Commission to exclude from the market products that are found to be unsafe or hazardous. Under certain circumstances, the Consumer Products Safety Commission could require us to repurchase or recall one or more of our products. In addition, laws regulating certain consumer products exist in some cities and states, and in other countries in which we sell our products, and more restrictive laws and regulations may be adopted in the future. Any repurchase or recall of our products could be costly to us and could damage our reputation. If we were required to remove, or we voluntarily removed, our products from the market, our reputation could be tarnished, and we could have large quantities of finished products that we are unable to sell. We are also subject to the rules and regulations of the Bureau of Alcohol, Tobacco, Firearms and Explosives, or the ATF. If we fail to comply with ATF rules and regulations, the ATF may limit our growth or business activities, levy fines against or revoke our license to do business. Our business, and the business of all producers and marketers of ammunition and firearms, is also subject to numerous federal, state, local, and foreign laws, regulations, and protocols. Applicable laws have the following effects:

 

  require the licensing of all persons manufacturing, exporting, importing, or selling firearms and ammunition as a business;

 

19

 

 

  require background checks for purchasers of firearms;

 

  impose waiting periods between the purchase of a firearm and the delivery of a firearm;

 

  prohibit the sale of firearms to certain persons, such as those below a certain age and persons with criminal records;

 

  regulate the use and storage of gun powder or other energetic materials;

 

  regulate our employment of personnel with criminal convictions; and

 

  restrict access to firearm manufacturing facilities for individuals from other countries or with criminal convictions.

 

Also, the export of our products is controlled by International Traffic in Arms Regulations, or “ITAR”, and Export Administration Regulations, or “EAR”. The ITAR implements the provisions of the Arms Export Control Act and is enforced by the U.S. Department of State. The EAR implements the provisions of the Export Administration Act and is enforced by the U.S. Department of Commerce. Among their many provisions, the ITAR and the EAR require a license application for the export of many of our products. In addition, the ITAR requires congressional approval for any firearms export application with a total value of $1 million or higher. Further, because our manufacturing process includes certain toxic, flammable and explosive chemicals, we are subject to the Chemical Facility Anti-Terrorism Standards, as administered by the U.S. Department of Homeland Security, which require that we take additional reporting and security measures related to our manufacturing process.

 

Several states currently have laws in effect that are similar to, and, in certain cases, more restrictive than, these federal laws. Compliance with all of these regulations is costly and time-consuming. Any violation of any of these regulations could cause us to incur fines and penalties, may also lead to restrictions on our ability to manufacture and sell our products and services and to import or export the products we sell and may cause our business to be harmed.

 

Changes in government policies and firearms legislation could adversely affect our financial results.

 

The sale, purchase, ownership, and use of firearms are subject to numerous and varied federal, state, and local governmental regulations. Federal laws governing firearms include the National Firearms Act, the Federal Firearms Act, the Arms Export Control Act, and the Gun Control Act of 1968. These laws generally govern the manufacture, import, export, sale, and possession of firearms and ammunition. We hold all necessary licenses to legally sell ammunition in the United States.

 

Currently, the federal legislature and several state legislatures are considering additional legislation relating to the regulation of firearms and ammunition. These proposed bills are extremely varied. If enacted, such legislation could effectively ban or severely limit the sale of affected firearms and ammunition. In addition, if such restrictions are enacted and are incongruent, we could find it difficult, expensive, or even practically impossible to comply with them, which could impede new product development and the distribution of existing products. We cannot assure you that the regulation of our business activities will not become more restrictive in the future and that any such restriction will not have a material adverse effect on our business.

 

Any adverse change to the interpretations of the Second Amendment (Right to Bear Arms) could impact our ability to conduct business by restricting the ownership and use of firearms in the United States.

 

20

 

 

Risks Related to our Common Stock

 

Our shares are listed on the Nasdaq Capital Market; however, if we fail to comply with Nasdaq’s rules for continued listing or other requirements, our shares may be delisted.

 

Our Common Stock is listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “POWW.” If we fail to comply with Nasdaq’s rules for continued listing, including, without limitation, minimum market capitalization and other requirements, Nasdaq may take steps to delist our shares. Failure to maintain our Nasdaq listing would make it more difficult for shareholders to sell our Common Stock and more difficult to obtain accurate price quotations on our Common Stock. The delisting of our shares could have an adverse effect on the price of our Common Stock. Our ability to issue additional securities for financing or other purposes, or otherwise to arrange for any financing we may need in the future, may also be materially and adversely affected if our Common Stock is not traded on a national securities exchange.

 

The exercise of warrants, and issuance of incentive stock grants may have a dilutive effect on our stock, and negatively impact the price of our Common Stock.

 

As of June 9, 2023, we had 2,460,946 warrants outstanding with a weighted average exercise price of $2.46. As of June 9, 2023, there were no options outstanding and 1,428,659 shares of Common Stock are reserved for future issuance under the 2017 Equity Incentive Plan. We plan to adopt a new Incentive Stock Plan designed to assist us in attracting, motivating, retaining, and rewarding high-quality executives, directors, officers, employees, and individual consultants by enabling such persons to acquire or increase a proprietary interest in our company to strengthen the mutuality of interests between such persons and our stockholders and providing such persons with performance incentives to expand their maximum efforts in the creation of stockholder value under the plan. We will be able to grant stock options, restricted stock, restricted stock units, stock appreciation rights, bonus stocks, and performance awards under the plan.

 

To the extent that any of the outstanding warrants and future options are exercised, dilution to the interests of our stockholders may occur. For the life of such warrants and options, the holders will have the opportunity to profit from a rise in the price of the Common Stock with a resulting dilution in the interest of the other holders of Common Stock. The existence of such warrants and options may adversely affect the market price of our Common Stock.

 

Our management has concluded that we have material weaknesses in our internal controls over financial reporting and that our disclosure controls and procedures are not effective. If we fail to develop or maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent financial fraud. As a result, current and potential stockholders could lose confidence in our financial reporting.

 

As a public company, we are required to comply with Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”). Section 404 requires us to include management’s assessment of the effectiveness of our internal control over financial reporting as of the end of the fiscal year in our Annual Report on Form 10-K. This report must also include disclosure of any material weaknesses in internal control over financial reporting that we have identified.

 

During the audit of our financial statements for the year ended March 31, 2023, our management identified material weaknesses in our internal control over financial reporting. The Company failed to maintain an effective control environment due to the following:

 

the Company’s management and the governance did not maintain appropriately designed entity-level controls impacting the control environment to prevent or detect material misstatements to the consolidated financial statements. These deficiencies were attributed to limited personnel to assist with the accounting and financial reporting function and inadequate oversight and accountability over the performance of control activities, including establishment of a Whistleblower Hotline and lack of formalization of certain key governance elements: management delegation, annual board committee charter review, acknowledgement of code of conduct, and approval of the annual budget;
   
the Company failed to maintain properly designed segregation of duties, both within manual processes and system access;
   
the Company failed to maintain effectively designed controls over journal entries, both recurring and nonrecurring, account reconciliations, and periodic flux analysis. Journal entries were not always accompanied by sufficient supporting documentation and were not adequately reviewed and approved for validity, completeness, and accuracy. In most instances, persons responsible for reviewing journal entries and account reconciliations for validity, completeness, and accuracy were also responsible for preparation.
   
the Company failed to maintain effectively designed controls over the period-end financial reporting process, including adequate tie-out and review of documentation that supports the financial statements; and
   
 the Company failed to maintain effectively designed controls over information technology general controls in the areas of user provisioning and de-provisioning, application change management, operating system and logical access controls, and segregation of duties for information technology (“IT”) systems that supports the Company’s financial reporting process.

 

These material weaknesses, if not remediated, create an increased risk of misstatement of the Company’s financial results, which, if material, may require future restatement thereof. A failure to implement improved internal controls, or difficulties encountered in their implementation or execution, could cause future delays in our reporting obligations and could have a negative effect on us and the trading price of our Common Stock. If these weaknesses and inadequate disclosure controls and procedures continue, investors could lose confidence in the accuracy and completeness of our financial reports and other disclosures.

 

21

 

 

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, we could be subject to regulatory action or other litigation and our operating results could be harmed.

 

General Risk Factors

 

Our operating results may experience significant fluctuations.

 

Many factors can contribute to significant fluctuations in our results of operations. These factors include the following:

 

  the cyclicality of the markets we serve;

 

  the timing and size of new orders;

 

  the cancellation of existing orders;

 

  the volume of orders relative to our capacity;

 

  product introductions and market acceptance of new products or new generations of products;

 

  timing of expenses in anticipation of future orders;

 

  changes in product mix;

 

  availability of production capacity;

 

  changes in cost and availability of labor and raw materials;

 

  timely delivery of products to customers;

 

  pricing and availability of competitive products;

 

  new product introduction costs;

 

  changes in the amount or timing of operating expenses;

 

  introduction of new technologies into the markets we serve;

 

  pressures on reducing selling prices;

 

  our success in serving new markets;

 

  adverse publicity regarding the safety, performance, and use of our products;

 

  the institution and adverse outcome of any litigation;

 

  political, economic, or regulatory developments;

 

  changes in economic conditions; and

 

  natural and manmade disasters, including COVID-19.

 

22

 

 

As a result of these and other factors, we believe that period-to-period comparisons of our results of operations may not be meaningful in the short term, and our performance in a particular period may not be indicative of our performance in any future period.

 

We may not be able to secure additional financing on favorable terms, or at all, to meet our future capital needs.

 

In the future, we may require additional capital to fund the planned expansion of our business and to respond to business opportunities, challenges, potential acquisitions, or unforeseen circumstances. We could encounter unforeseen difficulties that may deplete our capital resources rapidly, which could require us to seek additional financing in the near future. The timing and amount of any additional financing that is required to continue the expansion of our business and the marketing of our products will depend on our ability to improve our operating results and other factors. We may not be able to secure additional debt or equity financing on a timely basis or on favorable terms, or at all. Such financing could result in substantial dilution of the equity interests of existing stockholders. If we are unable to secure any necessary additional financing, we may need to delay expansion plans, conserve cash, and reduce operating expenses. There is no assurance that any additional financing will be sufficient, that the financing will be available on terms favorable to us or to existing stockholders and at such times as required, or that we will be able to obtain the additional financing required for the continued operation and growth of our business. Any debt financing obtained by us in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities. If we raise additional funds through further issuances of equity, convertible debt securities, or other securities convertible into equity, our existing stockholders could suffer significant dilution in their percentage ownership of our company, and any new equity securities we issue could have rights, preferences, and privileges senior to those of holders of our Common Stock. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to grow or support our business and to respond to business challenges could be significantly limited.

 

Our charter documents and Delaware law could make it more difficult for a third party to acquire us and discourage a takeover.

 

Our certificate of incorporation, bylaws, and Delaware law contain certain provisions that may have the effect of deterring or discouraging, among other things, a non-negotiated tender or exchange offer for shares of Common Stock, a proxy contest for control of our company, the assumption of control of our company by a holder of a large block of Common Stock, and the removal of the management of our company. Such provisions also may have the effect of deterring or discouraging a transaction which might otherwise be beneficial to stockholders. Our certificate of incorporation also may authorize our board of directors, without stockholder approval, to issue one or more series of preferred stock, which could have voting and conversion rights that adversely affect or dilute the voting power of the holders of Common Stock. Delaware law also imposes conditions on certain business combination transactions with “interested stockholders.” Our certificate of incorporation authorizes our Board of Directors to fill vacancies or newly created directorships. A majority of the directors then in office may elect a successor to fill any vacancies or newly created directorships. Such provisions could limit the price that investors might be willing to pay in the future for shares of our Common Stock and impede the ability of the stockholders to replace management.

 

The elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence of indemnification rights to our directors, officers, and employees may result in substantial expenditures by us and may discourage lawsuits against our directors, officers, and employees. We also may have entered into contractual indemnification obligations under employment agreements with our executive officers. The foregoing indemnification obligations could result in our incurring substantial expenditures to cover the cost of settlement or damage awards against directors and officers, which we may be unable to recoup. These provisions and resultant costs may also discourage us from bringing a lawsuit against our directors and officers for breaches of their fiduciary duties and may similarly discourage the filing of derivative litigation by our stockholders against our directors and officers even though such actions, if successful, might otherwise benefit our company and our stockholders.

 

23

 

 

Our certification of incorporation designates the Court of Chancery in the State of Delaware as the sole and exclusive forum for actions or proceedings that may be initiated by our stockholders, which could discourage claims or limit stockholders’ ability to make a claim against the Company, our directors, officers, and employees.

 

Our Amended and Restated Certificate of Incorporation states that unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery in the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial) to bring (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) an action asserting a claim of breach of fiduciary duty owed by any director, officer, or other employee of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim against the Corporation, its directors, officers, or employees arising pursuant to any provision of the Delaware General Corporation Law or the Corporation’s certificate of incorporation or bylaws, or (iv) any action asserting a claim against the Corporation, its directors, officers, or employees governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not have subject matter jurisdiction.

 

These exclusive forum provisions do not apply to claims under the Securities Act or the Exchange Act. The exclusive forum provision may discourage claims or limit stockholders’ ability to submit claims in a judicial forum that they find favorable and may create additional costs as a result. If a court were to determine the exclusive forum provision to be inapplicable and unenforceable in an action, we may incur additional costs in conjunction with our efforts to resolve the dispute in an alternative jurisdiction, which could have a negative impact on our results of operations.

 

Risks Related to our Series A Preferred Stock

 

The Series A Preferred Stock ranks junior to all of our indebtedness and other liabilities.

 

In the event of our bankruptcy, liquidation, dissolution or winding-up of our affairs, holders of the Series A Preferred Stock will be entitled to receive any of our assets remaining only after all of our indebtedness and other liabilities have been paid. The rights of holders of the Series A Preferred Stock to participate in the distribution of our assets will rank junior to the prior claims of our current and future creditors and any future series or class of preferred stock we may issue that ranks senior to the Series A Preferred Stock. Also, the Series A Preferred Stock effectively ranks junior to all existing and future indebtedness and to the indebtedness and other liabilities of our existing subsidiaries and any future subsidiaries. Our existing subsidiaries are, and future subsidiaries would be, separate legal entities and have no legal obligation to pay any amounts to us in respect of dividends due on the Series A Preferred Stock. If we are forced to liquidate our assets to pay our creditors, we may not have sufficient assets to pay amounts due on any or all of the Series A Preferred Stock then outstanding. We have incurred and may in the future incur substantial amounts of debt and other obligations that will rank senior to the Series A Preferred Stock. At March 31, 2023, our total liabilities equaled approximately $38.9 million.

 

Certain of our existing or future debt instruments may restrict the authorization, payment or setting apart of dividends on the Series A Preferred Stock. Also, future offerings of debt or senior equity securities may adversely affect the market price of the Series A Preferred Stock. If we decide to issue debt or senior equity securities in the future, it is possible that these securities will be governed by an indenture or other instruments containing covenants restricting our operating flexibility. Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of the Series A Preferred Stock and may result in dilution to owners of the Series A Preferred Stock. We and, indirectly, our shareholders, will bear the cost of issuing and servicing such securities. Because our decision to issue debt or equity securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. The holders of the Series A Preferred Stock will bear the risk of our future offerings, which may reduce the market price of the Series A Preferred Stock and will dilute the value of their holdings in us.

 

24

 

 

The trading market for the Series A preferred stock may not provide investors with adequate liquidity.

 

The Series A Preferred Stock is listed on Nasdaq under the symbol “POWWP.” We cannot assure you that holders of the Series A Preferred Stock will be able to sell their shares at favorable prices or at all. The difference between bid and ask prices in any secondary market for the Series A Preferred Stock could be substantial. Accordingly, no assurance can be given as to the liquidity of, or trading markets for, the Series A Preferred Stock, and holders of the Series A Preferred Stock may be required to bear the financial risks of an investment in the Series A Preferred Stock for an indefinite period of time.

 

We may issue additional shares of Series A Preferred Stock and additional series of preferred stock that rank on parity with the Series A Preferred Stock as to dividend rights, rights upon liquidation or voting rights.

 

We are allowed to issue additional shares of Series A Preferred Stock and additional series of preferred stock that would rank junior to the Series A Preferred Stock as to dividend payments and rights upon our liquidation, dissolution or winding up of our affairs pursuant to our certificate of incorporation and the certificate of designations relating to the Series A Preferred Stock without any vote of the holders of the Series A Preferred Stock. The issuance of additional shares of Series A Preferred Stock and additional series of preferred stock that have been authorized pursuant to our certificate of incorporation and the certificate of designations could have the effect of reducing the amounts available to the Series A Preferred Stock upon our liquidation or dissolution or the winding up of our affairs. It also may reduce dividend payments on the Series A Preferred Stock if we do not have sufficient funds to pay dividends on all Series A Preferred Stock outstanding and other classes or series of stock with greater or equal priority with respect to dividends.

 

Also, although holders of Series A Preferred Stock are entitled to limited voting rights, as described in this prospectus supplement under “Description of the Series A Preferred Stock—Voting Rights,” with respect to the circumstances under which the holders of Series A Preferred Stock are entitled to vote, the Series A Preferred Stock votes separately as a class along with all other series of our preferred stock that we may issue upon which like voting rights have been conferred and are exercisable. As a result, the voting rights of holders of Series A Preferred Stock may be significantly diluted, and the holders of such other series of preferred stock that we may issue may be able to control or significantly influence the outcome of any vote.

 

Future issuances and sales of senior or pari passu preferred stock, or the perception that such issuances and sales could occur, may cause prevailing market prices for the Series A Preferred Stock and our Common Stock to decline and may adversely affect our ability to raise additional capital in the financial markets at times and prices favorable to us.

 

Market interest rates may materially and adversely affect the value of the Series A Preferred Stock.

 

One of the factors that influences the price of the Series A Preferred Stock is the dividend yield on the Series A Preferred Stock (as a percentage of the market price of the Series A Preferred Stock) relative to market interest rates. An increase in market interest rates, which in recent years have been at low levels relative to historical rates, may lead prospective purchasers of the Series A Preferred Stock to expect a higher dividend yield (and higher interest rates would likely increase our borrowing costs and potentially decrease funds available for dividend payments). Thus, higher market interest rates could cause the market price of the Series A Preferred Stock to materially decrease.

 

25

 

 

We may not be able to pay dividends on the Series A Preferred Stock if we have insufficient cash to make dividend payments.

 

Our ability to pay cash dividends on the Series A Preferred Stock requires us to have either net profits or positive net assets (total assets less total liabilities) over our capital, to be able to pay our debts as they become due in the usual course of business. Further, notwithstanding these factors, we may not have sufficient cash to pay dividends on the Series A Preferred Stock. Our ability to pay dividends may be impaired if any of the risks described in this prospectus, including the documents incorporated by reference herein, were to occur. Also, payment of our dividends depends upon our financial condition and other factors as our board of directors may deem relevant from time to time. We cannot assure you that our businesses will generate sufficient cash flow from operations or that future borrowings will be available to us in an amount sufficient to enable us to make distributions on our Common Stock, if any, and preferred stock, including the Series A Preferred Stock to pay our indebtedness or to fund our other liquidity needs.

 

Dividends or other payments with respect to the Series A Preferred Stock may be subject to withholding taxes in circumstances where we are not obliged to make gross up payments, and this could result in holders receiving less than expected in such circumstances.

 

In the event of certain changes to current tax law that require tax to be withheld from dividends or other payments on the Series A Preferred Stock, we are not required to make gross up payments in respect of such taxes. This would result in holders of Series A Preferred Stock receiving less than expected and could materially adversely affect the return on your investment.

 

Our Series A Preferred Stock has not been rated.

 

We have not sought to obtain a rating for the Series A Preferred Stock. No assurance can be given, however, that one or more rating agencies might not independently determine to issue such a rating or that such a rating, if issued, would not adversely affect the market price of the Series A Preferred Stock. Also, we may elect in the future to obtain a rating for the Series A Preferred Stock, which could adversely affect the market price of the Series A Preferred Stock. Ratings only reflect the views of the rating agency or agencies issuing the ratings and such ratings could be revised downward, placed on a watch list or withdrawn entirely at the discretion of the issuing rating agency if in its judgment circumstances so warrant. Any such downward revision, placing on a watch list or withdrawal of a rating could have an adverse effect on the market price of the Series A Preferred Stock.

 

We may redeem the Series A Preferred Stock.

 

On or after May 18, 2026, we may, at our option, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time. Also, upon the occurrence of a Change of Control (as defined below under “Description of the Series A Preferred Stock - Redemption”), we may, at our option, redeem the Series A Preferred Stock, in whole or in part, within 120 days after the first date on which such Change of Control occurred. We may have an incentive to redeem the Series A Preferred Stock voluntarily if market conditions allow us to issue other preferred stock or debt securities at a rate that is lower than the dividend on the Series A Preferred Stock. If we redeem the Series A Preferred Stock, then from and after the redemption date, dividends will cease to accrue on shares of Series A Preferred Stock, the shares of Series A Preferred Stock shall no longer be deemed outstanding and all rights as a holder of those shares will terminate, except the right to receive the redemption price plus accumulated and unpaid dividends, if any, payable upon redemption.

 

The market price of the Series A Preferred Stock could be substantially affected by various factors.

 

The market price of the Series A Preferred Stock depends on many factors, which may change from time to time, including:

 

  prevailing interest rates, increases in which may have an adverse effect on the market price of the Series A Preferred Stock;
     
  trading prices of similar securities;
     
  our history of timely dividend payments;
     
  the annual yield from dividends on the Series A Preferred Stock as compared to yields on other financial instruments;
     
  general economic and financial market conditions;

 

26

 

 

  government action or regulation;
     
  the financial condition, performance and prospects of us and our competitors;
     
  changes in financial estimates or recommendations by securities analysts with respect to us or our competitors in our industry;
     
  our issuance of additional preferred equity or debt securities; and
     
  actual or anticipated variations in quarterly operating results of us and our competitors.

 

As a result of these and other factors, holders of the Series A Preferred Stock may experience a decrease, which could be substantial and rapid, in the market price of the Series A Preferred Stock, including decreases unrelated to our operating performance or prospects.

 

A holder of Series A Preferred Stock has extremely limited voting rights.

 

The voting rights for a holder of Series A Preferred Stock are limited. Our shares of Common Stock are the only class of our securities that carry full voting rights. Voting rights for holders of the Series A Preferred Stock exist primarily with respect to the ability to elect, voting together with the holders of any other series of our preferred stock having similar voting rights, two additional directors to our board of directors, subject to limitations described in this prospectus supplement entitled “Description of the Series A Preferred Stock—Voting Rights,” in the event that dividends payable on the Series A Preferred Stock are in arrears for four or more consecutive or non-consecutive quarterly dividend periods, and with respect to voting on amendments to our certificate of incorporation or certificate of designations relating to the Series A Preferred Stock that materially and adversely affect the rights of the holders of Series A Preferred Stock or authorize, increase or create additional classes or series of our capital stock that are senior to the Series A Preferred Stock. Other than the limited circumstances described in the prospectus and except to the extent required by law, holders of Series A Preferred Stock do not have any voting rights. Please see the section in this prospectus supplement entitled “Description of the Series A Preferred Stock—Voting Rights.”

 

The Series A Preferred Stock is not convertible, and investors will not realize a corresponding upside if the price of the Common Stock increases.

 

The Series A Preferred Stock is not convertible into the Common Stock and earns dividends at a fixed rate. Accordingly, an increase in market price of our Common Stock will not necessarily result in an increase in the market price of our Series A Preferred Stock. The market value of the Series A Preferred Stock may depend more on dividend and interest rates for other preferred stock, commercial paper and other investment alternatives and our actual and perceived ability to pay dividends on, and in the event of dissolution satisfy the liquidation preference with respect to, the Series A Preferred Stock.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 2. PROPERTIES

 

Our executive offices are located in Scottsdale, Arizona where we lease approximately 21,000 square feet under a month-to-month triple net lease for approximately $20,000 per month. This space houses our principal executive, administration, and marketing functions.

 

27

 

 

We lease a 10,000 square foot facility located in Atlanta, Georgia for approximately $19,000 per month. This space houses our GunBroker.com offices and operations.

 

We lease a 36,000 square foot facility located in Manitowoc, Wisconsin for approximately $10,000 per month. We utilize this facility for manufacturing and packaging.

 

We lease a 5,000 square foot facility located in Marietta, Georgia for approximately $3,000 per month. The purpose of this space is for warehousing related to our GunBroker.com operations.

 

We own a 185,000 square foot facility in Manitowoc, Wisconsin. Since our second fiscal quarter in the year ended March 31, 2023, we have utilized this facility for ammunition and casing manufacturing, research and development, packing, and shipping activities. A portion of this facility was financed by our Construction Loan. The terms of the Construction Loan are documented in Note 11 of our financial statements.

 

ITEM 3. LEGAL PROCEEDINGS

 

We are involved in or subject to, or may become involved in or subject to, routine litigation, claims, disputes, proceedings and investigations in the ordinary course of business. While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position, results of operations or cash flows. We record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated. 

 

Please reference the Contingencies section of Note 2 of our Financial Statements for additional disclosure.

 

ITEM 4. MINE SAFETY DISCLOSURE

 

None.

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information

 

Our Common Stock has been listed on Nasdaq since December 1, 2020 and is trading on Nasdaq under the symbol “POWW”.

 

Holders of Common Equity

 

As of June 9, 2023, there were 117,580,758 shares of $0.001 par value Common Stock outstanding and there were approximately 290 holders of record.

 

Dividend Information

 

We have never declared or paid dividends on our Common Stock. Payment of future dividends, if any, will be at the discretion of our Board of Directors after taking into account various factors, including the terms of any credit arrangements, our financial condition, operating results, current and anticipated cash needs and plans for expansion. At the present time, we intend to retain any earnings in our business, and therefore do not anticipate paying dividends in the foreseeable future. We paid preferred dividends on our Series A Preferred Stock in the amount of $3.0 million for the year ended March 31, 2023.

 

We currently have $0.1 million of unpaid accrued dividends on our Series A Preferred Stock as of the date of this filing. Accordingly, we may not be able to declare a dividend on our Common Stock unless full cumulative dividends on the Series A Preferred Stock have been or contemporaneously are declared and paid or declared.

 

28

 

 

Securities Authorized for Issuance under Equity Compensation Plans

 

The following table sets forth information as of March 31, 2023 with respect to our compensation plans under which equity securities may be issued.

 

Plan Category  

Number of Securities

to be Issued

upon Exercise

of

Outstanding

Options,

Warrants

and Rights

   

Weighted-

Average

Exercise

Price of

Outstanding
Options,

Warrants

and Rights

   

Number of

Securities

Remaining

Available for

Future Issuance

under Equity

Compensation

Plans

(Excluding

Securities

Reflected in

Column (a))

 
    (a)     (b)     (c)  
Equity compensation plans approved by security holders:                                  
2017 Equity Incentive Plan     -       -       1,946,929  
                         
Total     -       -       1,946,929  

 

Transfer Agent

 

We have appointed Securities Transfer Corporation (“STC”) as the transfer agent for our Common Stock and Series A Preferred Stock. The principal office of STC is located at 2901 N. Dallas Parkway, Suite 380 Plano, Texas 75093, and its telephone number is (469) 633-0101.

 

Recent Sales of Unregistered Securities

 

None.

 

Issuers Repurchase of Equity Securities

 

On February 8, 2022, we announced that our Board of Directors authorized a share repurchase program for up to $30 million of our outstanding common stock. On March 28, 2023, we announced that our Board of Directors authorized the extension of our repurchase program until February 2024.

 

The following table summarizes our share repurchases under our repurchase program for our fourth fiscal quarter of our 2023 fiscal year:

 

Period 

Total Number

of Shares

Repurchased

  

Average

Price Paid

per Share

  

Total

Number of

Shares

Repurchased

as Part of

Publicly Announced

Plan or

Programs

  

Maximum
Number of
Shares that
may yet be
Repurchased
Under the
Plan or
Programs (1)

 
                 
March 2023   118,328    1.93    118,328      
                     
Total   118,328    -    118,328    14,963,235 

 

(1)As reported on the Current Report on Form 8-K filed with the Commission on December 6, 2022, we initiated our Common Stock share repurchase program in December of 2022. We previously reported the repurchase of 150,000 shares of our Common Stock under this plan. The maximum number of shares that may yet be repurchased included herein is determined based on the closing price of our Common Stock of $1.97 on March 31, 2023. This amount may change based on the price that our Common Stock trades at.

 

As of June 9, 2023, approximately 1 million shares have been repurchased in total. The current plan is in effect until February 2024 and the remaining funds available to the Company pursuant to the repurchase plan is approximately $28 million. 

 

Performance Graph

 

The following graph compares the cumulative total stockholder return of our common stock (Nasdaq: POWW) in comparison to the cumulative total return of the NASDAQ Capital Market Composite (“NASDAQ CMC”) and the Russell 2000 Index (“Russell 2000”) for the period from March 31, 2018 through March 31, 2023. The graph assumes an investment of $100 in our common stock and in each of the indexes on March 31, 2018. The calculation of cumulative stockholder return on the NASDAQ CMC and Russell 2000 include reinvestment of dividends, but the calculation of cumulative stockholder return on our common stock does not include reinvestment of dividends because we did not pay any dividends during the measurement period. The performance shown is not necessarily indicative of future performance.

 

 

ITEM 6. RESERVED

 

Not required.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

This document contains certain “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies, goals and objectives of management for future operations; any statements concerning proposed new products and services or developments thereof; any statements regarding future economic conditions or performance; any statements or belief; and any statements of assumptions underlying any of the foregoing.

 

29

 

 

Forward looking statements may include the words “may,” “could,” “estimate,” “intend,” “continue,” “believe,” “expect,” or “anticipate,” or other similar words, or the negative thereof. These forward-looking statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however, consult further disclosures and risk factors we included in the section titled Risk Factors contained herein.

 

Overview

 

AMMO, Inc., owner of the GunBroker.com Marketplace, the largest online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and premium components began its operations in 2016.

 

Through our GunBroker.com Marketplace segment (acquired in April 2021), we allow third party sellers to list items consisting of firearms, hunting gear, fishing equipment, outdoor gear, collectibles, and much more on our site, while facilitating compliance with federal and state laws that govern the sale of firearms and restricted items. This allows our base of over 7.6 million users to follow ownership policies and regulations through our network of over 35,000 federally licensed firearms dealers as transfer agents. The nature and operation of the Marketplace as an online auction and sales platform also affords our Company a unique view into the total domestic market for the purpose of understanding sales trends at a granular level across all elements of the outdoor sports and shooting space. Our vision is to expand the services on GunBroker.com and to become a peer to those in our industry. In the short term, we will be implementing the following services;

 

● Payment Processing - facilitating payment between parties allowing sellers of all sizes to offer fast and secure electronic payments and allowing buyers to experience the ease of using a single form of payment for all items purchased,

 

● Carting Ability - allowing our buyers to purchase multiple items from multiple sellers at one point in time, and,

 

● GunBroker.com Analytics – through the compilation and refinement of vast Marketplace data, we plan to offer domestic market analytics to our industry peers to allow them to better manage their businesses.

 

Through our Ammunition segment, we are tailoring our focus to build a new future for our manufacturing operations focused on premium pistol and rifle ammunition and supporting industry partners for manufactured components. We will continue to leverage our proprietary brands like Streak Visual AmmunitionTM and Stelth subsonic ammunition and extend our product offering with premium rifle lines and brands that complement our technologically innovative heritage. We also continue to ensure dynamic performance under the exacting standards of the US military complex in support of our cutting-edge developmental ammunition programs as we seek out and effectively execute upon new governmental-based opportunities.

 

Results of Operations

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to provide our financial statements with a narrative from the perspective of management on our financial condition, results of operations, liquidity, and certain other factors that may affect our future results. The following information should be read in conjunction with our consolidated financial statements included in this Annual Report beginning on page F-1.

 

Fiscal Year 2023 Compared to Fiscal Year 2022

 

Our financial results for the year ended March 31, 2023 reflect our newly positioned organization as we transition into our new manufacturing facility. We believe that we have hired a strong team of professionals, developed innovative products, and continue to raise capital sufficient to establish our presence as a high-quality ammunition provider and marketplace. We continue to focus on growing our top line revenue and streamlining our operations. We continue to focus on growing our top line revenue, and streamlining our operations. We experienced a 20.3% decrease in our Net Revenues for the year ended March 31, 2023 compared with the year ended March 31, 2022. This was the result of decreased ammunition sales due to changes in market demand.

 

30

 

 

The following table presents summarized financial information taken from our consolidated statements of operations for the year ended March 31, 2023 compared with the year ended March 31, 2022:

 

   For the Year Ended 
   March 31, 2023   March 31, 2022 
         
Net Sales  $191,439,801   $240,269,166 
Cost of Revenues   136,031,204    151,505,657 
Gross Margin   55,408,597    88,763,509 
Sales, General & Administrative Expenses   58,667,516    51,614,147 
Income (loss) from Operations   (3,258,919)   37,149,362 
Other income (expense)          
Other income (expense)   (606,881)   (615,957)
Income (loss) before provision for income taxes  $(3,865,800)  $36,533,405 
Provision for income taxes   730,238    3,285,969 
Net Income (Loss)  $(4,596,038)  $33,247,436 

 

Non-GAAP Financial Measures

 

We analyze operational and financial data to evaluate our business, allocate our resources, and assess our performance. In addition to total net sales, net loss, and other results under accounting principles generally accepted in the United States (“GAAP”), the following information includes key operating metrics and non-GAAP financial measures we use to evaluate our business. We believe these measures are useful for period-to-period comparisons of the Company. We have included these non-GAAP financial measures in this Quarterly Report on Form 10-Q because they are key measures we use to evaluate our operational performance, produce future strategies for our operations, and make strategic decisions, including those relating to operating expenses and the allocation of our resources. Accordingly, we believe these measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.

 

Adjusted EBITDA

 

   For the   For the 
   Year Ended   Year Ended 
   March 31, 2023   March 31, 2022 
         
Reconciliation of GAAP net income to Adjusted EBITDA          
Net Income (Loss)  $(4,596,038)  $33,247,436 
Provision for income taxes   730,238    3,285,969 
Depreciation and amortization   17,519,949    17,339,093 
Interest expense, net   632,062    637,797 
Employee stock awards   5,807,779    5,759,000 
Stock grants   179,094    252,488 
Stock for services   -    4,200 
Warrants issued for services   213,819    718,045 
Contingent consideration fair value   (63,764)   (385,750)
Other income   (25,181)   (21,840)
Proxy contest fees(1)   4,724,385    - 
Other nonrecurring expenses(2)   1,248,865    - 
Adjusted EBITDA  $26,371,208   $60,836,438 

 

(1)

Includes proxy contest fees of $910,000 for Employee Stock Awards issued as a result of the Settlement Agreement as discussed in Note 16 of our financial statements.

(2) Other nonrecurring expenses consist of professional and legal fees that are nonrecurring in nature.

 

Adjusted EBITDA is a non-GAAP financial measures that displays our net loss, adjusted to eliminate the effect of certain items as described below.

 

31

 

 

We have excluded the following non-cash expenses from our non-GAAP financial measures: provision or benefit for income taxes, depreciation and amortization, share-based or warrant-based compensation expenses, and changes to the contingent consideration fair value. We believe it is useful to exclude these non-cash expenses because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations.

 

Adjusted EBITDA as a non-GAAP financial measure also excludes other cash interest income and expense, and non-recurring expenses incurred as a result of a proxy contest as these items are not components of our core operations.

 

We have modified our Adjusted EBITDA calculation in the current period to remove the adjustment for Excise Taxes as we believe this is a better representation of our operations. In prior periods, we included an adjustment for Excise Taxes.

 

Non-GAAP financial measures have limitations, should be considered as supplemental in nature and are not meant as a substitute for the related financial information prepared in accordance with GAAP. These limitations include the following:

 

  Employee stock awards and stock grants expense has been, and will continue to be for the foreseeable future, a significant recurring expense in the Company and an important part of our compensation strategy;
  the assets being depreciated or amortized may have to be replaced in the future, and the non-GAAP financial measures do not reflect cash capital expenditure requirements for such replacements or for new capital expenditures or other capital commitments; and
  non-GAAP measures do not reflect changes in, or cash requirements for, our working capital needs
  other companies, including companies in our industry, may calculate the non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures.

 

Because of these limitations, you should consider the non-GAAP financial measures alongside other financial performance measures, including our net loss and our other financial results presented in accordance with GAAP.

 

Net Sales

 

The following table shows our net sales by proprietary ammunition versus standard ammunition for the periods ended March 31, 2023 and March 31, 2022. “Proprietary Ammunition” include those lines of ammunition manufactured by our facilities that are sold under the brand names: STREAK VISUAL AMMUNITION™ and Stelth. We define “Standard Ammunition” as non-proprietary ammunition that directly competes with other brand manufacturers. Our “Standard Ammunition” is manufactured within our facilities and may also include completed ammunition that has been acquired in the open market for sale to others. Also included in this category is low cost target pistol and rifle ammunition, as well as bulk packaged ammunition manufactured by us using reprocessed brass casings. Ammunition within this product line typically carries much lower gross margins.

 

   For the Year Ended 
   March 31, 2023   March 31, 2022 
Proprietary Ammunition  $10,779,035   $10,071,659 
Standard Ammunition   103,337,009    151,387,366 
Ammunition Casings   14,174,084    14,201,625 
Marketplace Revenue   63,149,673    64,608,516 
Total Sales  $191,439,801   $240,269,166 

 

Sales for the year ended March 31, 2023 decreased 20.3%, or approximately $48.8 million from the prior year due to changes in market conditions. The decrease for period was largely the result of a decrease of $48.1 million in sales of bulk pistol and rifle ammunition, a decrease of $0.7 million of sales of Proprietary Ammunition, a decrease of $0.1 million of our casing sales, and a decrease of $1.5 million generated from our marketplace, GunBroker.com, which includes auction revenue, payment processing revenue, and shipping income. Management expects the sales growth rate of Proprietary Ammunition to greatly outpace the sales of our Standard Ammunition.

 

32

 

 

We are focused on continuing to grow top line revenue quarter-over-quarter as we continue to further expand distribution into commercial markets, introduce new product lines, and continue to initiate sales to U.S. law enforcement, military, and international markets.

 

Through our acquisition of SWK, the Company has developed and deployed a line of tactical armor piercing (AP) and hard armor piercing incendiary (HAPI) precision ammunition to meet the lethality requirements of both the US and foreign military customers. We continue to demonstrate our AP and HAPI ammunition to military personnel at scheduled and invite only events, resulting in increased interest and procurement discussions. The Company has since developed the ballistic match (BMMPR) and signature-on-target (SoT) rounds under contract with the U.S. Government in support of US special operations which have been publicly announced pursuant to governmental authorization. Additional work continues in support of the military operations of the U.S. and its ally military components which is not currently subject to disclosure.

 

It is important to note that, although U.S. law enforcement, military and international markets represent significant opportunities for our Company, they also have a long sales cycle. The Company’s sales team has been effective in establishing sales and distribution channels, both in the United States and abroad, which are reasonably anticipated to drive sustained sales opportunity in the military, law enforcement, and commercial markets.

 

Sales outside of the United States require licenses and approval from either the U.S. Department of Commerce or the U.S. State Department, which typically takes approximately 30 days to receive. On June 16, 2022, we renewed our annual registration with the International Traffic in Arms Regulations (“ITAR”), which remains valid through the report date. This permits the Company to export and broker ammunition and other controlled items covered under ITAR.

 

Cost of Revenues

 

Cost of Revenues decreased by approximately $15.5 million from $151.5 million to $136.0 million for the year ended March 31, 2023 compared to the comparable period ended in 2022. This was the result of a significant decrease in net sales as well increases to non-cash depreciation related to increases in production equipment, expensing of increased labor, overhead, and raw materials used to produce finished product during 2023 as compared to 2022.

 

Gross Margin

 

Our gross margin percentage decreased to 28.9% from 36.9% during the year ended March 31, 2023 as compared to the same period in 2022. This was a result of increased cost of materials, labor, and overhead in our ammunition segment, which was offset by our marketplace, GunBroker.com which, by nature has significantly higher margins than our manufactured products.

 

We believe as we continue to grow sales through new markets and expanded distribution that our gross margins will also increase, as evidenced by the improvement over this time last year. Our goal in the next 12 to 24 months is to continue to improve our gross margins. This will be accomplished through the following:

 

  Increased product sales, specifically of proprietary lines of ammunition, like the STREAK VISUAL AMMUNITION™, Stelth and now our tactical Armor Piercing (AP) and Hard Armor Piercing Incendiary (HAPI) precision ammunition, all of which carry higher margins as a percentage of their selling price;
     
  Introduction of new lines of ammunition that historically carry higher margins in the consumer and government sectors;
     
  Reduced component costs through operation of our ammunition segment and expansion of strategic relationships with component providers;
     
  Expanded use of automation equipment that reduces the total labor required to assemble finished products
     
  And, better leverage of our fixed costs through expanded production to support the sales objectives.

 

33

 

 

Operating Expenses

 

Overall, for the year ended March 31, 2023, our operating expenses increased by approximately $7.1 million and increased as a percentage of sales from 21.5% to 30.6% in comparison to the year ended March 31, 2022. Our operating expenses include non-cash depreciation and amortization expense of approximately $13.3 million. For the year ended March 31, 2023, we incurred additional expenses in the amounts of $5.6 million related to a proxy contest, of which $0.9 million was included non-cash stock compensation, and $1.2 million of nonrecurring expenses. Our operating expenses also consisted of commissions related to our sales, legal and professional fees, stock compensation expense associated with issuance of our Common Stock in lieu of cash compensation for employees, board members, and key consultants for the organization during the period. Operating expenses for the year ended March 31, 2023 and 2022 included noncash expenses of approximately $19.5 million and $20.1 million, respectively.

 

During the year ended March 31, 2023, our selling and marketing expenses decreased by approximately $2.6 million. The decrease was primarily related to decreases in sales commission due to the decrease in the sale of our products.

 

Our corporate general & administrative expenses increased approximately $8.0 million in the year ended March 31, 2023 from the comparable prior period due to $6.6 million of respective legal and professional fees and expenses largely related to our proxy contest and $1.2 million of nonrecurring expenses.

 

Employee salaries and related expenses increased approximately $2.1 million for the year ended March 31, 2023 compared to the comparable period ended in 2022. The increase when compared to the prior period, was primarily related to $2.1 million of additional payroll expenses incurred as a result of payments due upon termination without cause as a result of the proxy contest and the addition of employees in our Marketplace.

 

Depreciation and amortization expenses for the year ended March 31, 2023 decreased by approximately $0.4 million in comparison to the prior year period.

 

Interest and Other Expenses

 

For the year ended March 31, 2023, interest expense remained constant compared with year ended March 31, 2022. The change from the prior periods was mainly due to increases related to our Construction Note Payable of approximately $0.3 million and decreases in activity related to our Factoring Liability and our Inventory Credit Facility of approximately $0.3 million.

 

Income Taxes

 

For the year ended March 31, 2023, we recorded a provision for federal and state income taxes of approximately $0.7 million in comparison to $3.3 million in the prior year period ended March 31, 2022. The decreases was related to a decrease in Net Income(Loss) before Taxes.

 

Net Income

 

We ended the year ended March 31, 2023 with a net loss of approximately $4.6 million compared with a Net Income of approximately $33.2 million for the year ended March 31, 2022.

 

Our goal is to continue to improve our operating results as we focus on increasing sales and reducing our operating expenses.

 

34

 

 

Fiscal Year 2022 Compared to Fiscal Year 2021

 

Results of Operations

 

We experienced an increase in our gross profit margin for the year ended March 31, 2022. This was the result of our newly acquired marketplace, GunBroker.com which, by nature has significantly higher margins than our manufactured products.

 

The following table presents summarized financial information taken from our consolidated statements of operations for the year ended March 31, 2022 compared with the year ended March 31, 2021:

 

   For the Year Ended 
   March 31, 2022   March 31, 2021 
         
Net Sales  $240,269,166   $62,482,330 
Cost of Revenues   151,505,657    51,095,679 
Gross Margin   88,763,509    11,386,651 
Sales, General & Administrative Expenses   51,614,147    16,766,636 
Income (loss) from Operations   37,149,362    (5,379,985)
Other income (expense)          
Other income (expense)   (615,957)   (2,432,309)
Income (loss) before provision for income taxes  $36,533,405   $(7,812,294)
Provision for income taxes   3,285,969    - 
Net Income (Loss)  $33,247,436   $(7,812,294)

 

Non-GAAP Financial Measures

 

We analyze operational and financial data to evaluate our business, allocate our resources, and assess our performance. In addition to total net sales, net income (loss), and other results under generally accepted accounting principles (“GAAP”), the following information includes key operating metrics and non-GAAP financial measures we use to evaluate our business. We believe these measures are useful for period-to-period comparisons of the Company. We have included these non-GAAP financial measures in this Annual Report on Form 10-K because they are key measures we use to evaluate our operational performance, produce future strategies for our operations, and make strategic decisions, including those relating to operating expenses and the allocation of our resources. Accordingly, we believe these measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.

 

Adjusted EBITDA

 

   For the   For the 
   Year Ended   Year Ended 
   March 31, 2022   March 31, 2021 
         
Reconciliation of GAAP net income to Adjusted EBITDA          
Net Income (Loss)  $33,247,436   $(7,812,294)
Provision for income taxes   3,285,969    - 
Depreciation and amortization   17,339,093    4,876,756 
Interest expense, net   637,797    3,009,094 
Employee stock awards   5,759,000    1,450,359 
Stock grants   252,488    278,585 
Stock for services   4,200    1,707,500 
Warrants issued for services   718,045    - 
Contingent consideration fair value   (385,750)   (119,731)
Other income   (21,840)   (576,785)
Loss on purchase   -    1,000,000 
Adjusted EBITDA  $60,836,438   $3,813,484 

 

Adjusted EBITDA is a non-GAAP financial measures that displays our net loss, adjusted to eliminate the effect of certain items as described below.

 

35

 

 

We have excluded the following non-cash expenses from our non-GAAP financial measures: provision or benefit for income taxes, depreciation and amortization, loss on purchase, share-based or warrant-based compensation expenses, and changes to the contingent consideration fair value. We believe it is useful to exclude these non-cash expenses because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations.

 

Adjusted EBITDA as a non-GAAP financial measure also excludes other cash interest income and expense, as these items are not components of our core operations. We have included an adjustments for our provision or benefit for income taxes.

 

We have modified our Adjusted EBITDA calculation in the current period to remove the adjustment for Excise Taxes as we believe this is a better representation of our operations. In prior periods, we included an adjustment for Excise Taxes.

 

Non-GAAP financial measures have limitations, should be considered as supplemental in nature and are not meant as a substitute for the related financial information prepared in accordance with GAAP. These limitations include the following:

 

  Employee stock awards and stock grants expense has been, and will continue to be for the foreseeable future, a significant recurring expense in the Company and an important part of our compensation strategy;
  the assets being depreciated or amortized may have to be replaced in the future, and the non-GAAP financial measures do not reflect cash capital expenditure requirements for such replacements or for new capital expenditures or other capital commitments; and
  non-GAAP measures do not reflect changes in, or cash requirements for, our working capital needs; and
  other companies, including companies in our industry, may calculate the non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures.

 

Because of these limitations, you should consider the non-GAAP financial measures alongside other financial performance measures, including our net loss and our other financial results presented in accordance with GAAP.

 

Net Sales

 

The following table shows our net sales by proprietary ammunition versus standard ammunition for the periods ended March 31, 2022 and March 31, 2021. “Proprietary Ammunition” include those lines of ammunition manufactured by our facilities that are sold under the brand names: STREAK VISUAL AMMUNITION™ and Stelth. We define “Standard Ammunition” as non-proprietary ammunition that directly competes with other brand manufacturers. Our “Standard Ammunition” is manufactured within our facilities and may also include completed ammunition that has been acquired in the open market for sale to others. Also included in this category is low cost target pistol and rifle ammunition, as well as bulk packaged ammunition manufactured by us using reprocessed brass casings. Ammunition within this product line typically carries much lower gross margins.

 

    For the Year Ended  
    March 31, 2022     March 31, 2021  
Proprietary Ammunition   $ 10,071,659     $ 5,340,823  
Standard Ammunition     151,387,366       44,279,707  
Ammunition Casings     14,201,625       12,861,800  
Marketplace Revenue     64,608,516       -  
Total Sales   $ 240,269,166     $ 62,482,330  

 

Sales for the year ended March 31, 2022 increased 285% or $177.8 million over the year ended March 31, 2021. This increase was the result of our increased production capacity coupled with increased demand from our customers which resulted in approximately $107.2 million of increased sales in bulk pistol and rifle ammunition, an increase of approximately $4.7 million of respective sales of Proprietary Ammunition, an increase of approximately $1.3 million of sales from our casing operations and $64.6 million in respective revenue generated from our recently acquired marketplace, GunBroker.com, which includes auction revenue, payment processing revenue, and shipping income. Management expects the sales growth rate of Proprietary Ammunition to greatly outpace the sales of our Standard Ammunition.

 

36

 

 

Cost of Revenues

 

Cost of revenues increased by approximately $100.4 million from $51.1 million to $151.5 million, respectively for the year ended March 31, 2022 compared with the year ended March 31, 2021. This was the result of a significant increase in net sales as well increases to non-cash depreciation related to our newly acquired casing operations, expensing of increased labor, overhead, and raw materials used to produce finished product during our 2022 fiscal year as compared to the 2021 fiscal year and additional cost of revenues from our recent acquisition of our marketplace, GunBroker.com. As a percentage of sales, cost of goods sold decreased by 22.8% when comparing the year ended March 31, 2022 to the year ended March 31, 2021.

 

Gross Margin

 

Our gross margin percentage increased to 36.9% from 18.2% during the year ended March 31, 2022 as compared to the same period in 2021. This was a result of the inclusion of our newly acquired marketplace, GunBroker.com which, by nature has significantly higher margins than our manufactured products.

 

Operating Expenses

 

Overall, for the year ended March 31, 2022, our operating expenses increased by approximately $34.8 million over the year ended March 31, 2021, but decreased as a percentage of sales from 26.8% for the year ended March 31, 2021 to 21.5% for the year ended March 31, 2022. The increase was primarily related to approximately $20.6 million of additional operating expenses following our merger with Gemini, including $12.1 million of depreciation and amortization expenses. Our operating expenses include non-cash depreciation and amortization expense of approximately $13.7 million for the year ended March 31, 2022. Our operating expenses consisted of commissions related to our sales increases, stock compensation expense associated with issuance of our Common Stock in lieu of cash compensation for employees, and board members, and key consultants for the organization during the period. Operating expenses for the years ended March 31, 2022 and 2021 included noncash expenses of approximately $20.1 million and $3.2 million, respectively. We expect to see administrative expenditures to continue to decrease as a percentage of sales in the 2023 fiscal year, as we leverage our work force and expand our sales opportunities.

 

During the year ended March 31, 2022, our selling and marketing expenses increased by approximately $5.4 million. The increase was primarily related to commission on the increases in the sale of our products resulting of approximately $3.6 million of increase in commissions and a $1.1 million increase advertising expenses for the year ended March 31, 2022 in comparison to the comparable prior year.

 

Our corporate general & administrative expenses increased approximately $9.8 million in the current period from the prior year mainly due to increased general corporate expenses related to the addition of Gemini of approximately $5.3 million and increases in insurance expenses of $4.0 million.

 

Employee salaries and related expenses increased approximately $8.6 million for the year ended March 31, 2022 compared to the comparable period ended in 2021. This was a result of increased payroll and related expenses of $4.2 million, including $2.9 million from the addition of Gemini, and employee stock compensation of approximately $4.3 million.

 

Depreciation and amortization expenses increased approximately $12.0 million from the period principally due to the addition of assets from the Gemini Acquisition.

 

Interest and Other Expenses

 

For the year ended March 31, 2022, interest expense decreased by approximately $2.4 million compared with the year ended March 31, 2021. The change from the prior periods was mainly due to the repayment of notes and conversion of convertible promissory notes in current and prior periods. Interest expense for the year ended March 31, 2021 included approximately $1.3 million of non-cash interest expense recognized on the issuance of warrants to purchase Common Stock, approximately $0.4 million in debt discount amortization related to Convertible Promissory Notes as well interest expense and debt discount amortization related to Note Payables Related Party, Note Payable, and Convertible Promissory Notes.

 

Net Income

 

As a result of increases in revenues from increased production as well as our acquisition of Gemini, we ended the year ended March 31, 2022 with net income of approximately $33.2 million compared with net losses of approximately $7.8 million for the year ended March 31, 2021.

 

Our goal is to continue to improve our operating results as we focus on increasing sales and controlling our operating expenses.

 

37

 

 

Liquidity and Capital Resources

 

As of March 31, 2023, we had $39,134,027 of cash and cash equivalents, an increase of $15,852,552 from March 31, 2022.

 

Working Capital is summarized and compared as follows:

 

   March 31, 2023   March 31, 2022 
Current assets  $128,451,893   $129,691,636 
Current liabilities   25,463,399    35,823,311 
   $102,988,494   $93,868,325 

 

Liquidity

 

Existing working capital, cash flow from operations, bank borrowings, and sales of equity and debt securities are expected to be adequate to fund our operations over the next year. Generally, we have financed operations to date through the proceeds of stock sales, bank financings, and related-party notes. These sources have been adequate to fund our recurring cash expenditures including but not limited to our working capital requirements, capital expenditures to expand our operations, debt repayments, and acquisitions. We intend to continue to use the aforementioned sources of funding for capital expenditures, debt repayments, share repurchases and any potential acquisitions.

 

Leases

 

We lease four locations that are used for our offices, production, and warehousing. As of March 31, 2023, we had $1.6 million of fixed lease payment obligations with $0.6 million payable within the next 12 months. Please refer to Note 9 – Leases for additional information.

 

Related Party Note Payable

 

As of March 31, 2023, we had an outstanding balance on our Related Party Note Payable of approximately $0.2 million, of which the balance in its entirety million is due within the next 12 months.

 

Construction Note Payable

 

We financed a portion of our new production facility with our Construction Note Payable. We expect to make $0.8 million in principal and interest payments within the next 12 months. The total principal balance of the Construction Note is expected to be $11.4 million upon completion of the project and will mature on October 14, 2026.

 

 

Changes in cash flows are summarized as follows:

 

Operating Activities

 

For the year ended March 31, 2023, net cash provided by operations totaled approximately $35.6 million. This was primarily the result of net loss of approximately $4.6 million, decreases to our period end accounts receivable of $14.4 million, inventories of $4.7 million, prepaid expenses of 2.8 million, and deposits of $4.3 million which was offset by increases in accounts payable and accrued liabilities of $8.7 million and $2.8 million, respectively. The cash used in operations were partially offset by the benefit of non-cash expenses for depreciation and amortization of approximately $17.5 million, employee stock compensation of $5.8 million, $1.6 million of deferred income taxes, stock grants totaling $0.2 million, $0.2 million of allowance for doubtful accounts, and $0.2 million of warrants issued for services.

 

For the year ended March 31, 2022, net cash provided by operations totaled approximately $2.9 million. This was primarily the result of net income of approximately $33.2 million, increases to our period end inventories of $43.1 million, accounts receivable of $20.7 million, and deposits of $8.8 million which was offset by increases in accounts payable and accrued liabilities of $9.9 million and $2.3 million, respectively, and decreases of prepaid expenses of $1.9 million. The cash used in operations were partially offset by the benefit of non-cash expenses for depreciation and amortization of approximately $17.3 million, employee stock compensation of $5.8 million, stock grants totaling $0.3 million, $2.7 million of allowance for doubtful accounts, $0.8 million of warrants issued for services, $1.5 million of deferred income taxes and a decrease related to an adjustment to the fair value of contingent consideration of $0.4 million.

 

Investing Activities

 

During the year ended March 31, 2023, we used approximately $12.5 million in net cash for investing activities. Net cash used in investing activities consisted of approximately $12.5 million related to purchases of production equipment, the construction of our new manufacturing facility in Manitowoc, WI, and capitalized development costs related to our marketplace, GunBroker.com.

 

During the year ended March 31, 2022, we used approximately $69.7 million in net cash for investing activities. Net cash used in investing activities consisted of approximately $50.5 million uses in connection with the merger of Gemini, and approximately $19.2 million related to purchases of production equipment and the construction of our new manufacturing facility in Manitowoc, WI.

 

Financing Activities

 

During the year ended March 31, 2023, net cash used in financing activities was approximately $6.7 million. This was the result of approximately $3.0 million of preferred stock dividends paid, $2.1 million of insurance premium note payments, $0.7 million in payments of our related party note payable, and an approximate $0.8 million reduction in our Inventory Credit Facility. These items were offset by $1.0 million generated from our construction note payable and $0.1 million of proceeds from warrants exercised for common stock. Additionally, approximately $71.3 million was generated from accounts receivable factoring, which was offset by payments of approximately $72.3 million.

 

38

 

 

During the year ended March 31, 2022, net cash used in financing activities was approximately $28.2 million. This was the net effect of a $50.0 million payment on debt assumed from Gemini, $35.0 million of proceeds from the sale of our preferred stock net of approximately $3.2 million of issuance costs, approximately $2.5 million of preferred stock dividends paid, approximately $2.2 million of insurance premium note payments, approximately $0.9 million was generated from common stock issued for exercised warrants, the $4.0 million repayment of a note payable, and an approximate $0.3 million reduction in our Inventory Credit Facility. Additionally, approximately $121.5 million was generated from accounts receivable factoring, which was offset by payments of approximately $122.8 million.

 

Off-Balance Sheet Arrangements

 

As of March 31, 2023, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, net sales, expenses, results of operations, liquidity capital expenditures, or capital resources.

 

Critical Accounting Policies

 

Our discussion and analysis of our financial condition and results of operation are based upon our financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses. We have identified several accounting principles that we believe are key to the understanding of our financial statements. These important accounting policies require our most difficult subjective judgements.

 

Goodwill

 

We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline it is not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2023. As of March 31, 2023, the Company has a goodwill carrying value of $90,870,094, all of which is assigned to the Marketplace segment. However, due to declines in the value of the Company’s common stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2024.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation and warrant-based compensation.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Our accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts. At March 31, 2023 and March 31, 2022, we reserved $3,246,551 and $3,055,252, respectively, of allowance for doubtful accounts.

 

Inventory

 

We state inventories at the lower of cost or net realizable value. We determine cost by using the weighted-average cost of raw materials method, which approximates the first-in, first-out method and includes allocations of manufacturing labor and overhead. We make provisions when necessary, to reduce excess, potential damaged or obsolete inventories. These provisions are based on our best estimates. At March 31, 2023, and March 31, 2022, we conducted a full analysis of inventory on hand and expensed all inventory not currently in use, or for which there was no future demand.

 

39

 

 

Research and Development

 

To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.

 

Revenue Recognition

 

We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

 

  Identification of a contract with a customer
  Identification of the performance obligations in the contact
  Determination of the transaction price
  Allocation of the transaction price to the separate performance allocation
  Recognition of revenue when performance obligations are satisfied

 

We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services it transfers to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.

 

For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.

 

For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized as follows:

 

Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

 

Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.

 

Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.

 

Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.

 

Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.

 

Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.

 

Excise Tax

 

As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an 11% excise tax for all products sold into these channels. During the years ended March 31, 2023, 2022, and 2021, we recognized approximately $9.8 million, $14.6 million, and $4.3 million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of goods sold.

 

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2023. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include cash, accounts receivable, accounts payable, amounts due to related parties, factoring liability, and the construction note payable. Fair values were assumed to approximate carrying values because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.

 

40

 

 

Income Taxes

 

We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.

 

Stock-Based Compensation

 

We grant stock-based compensation to key employees and directors as a means of attracting and retaining highly qualified personnel. We also grant stock in lieu of cash compensation for key consultants and service providers. We recognize expense related to stock-based payment transactions in which we receive employee or non-employee services in exchange for equity.

 

We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”). Which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors. We measure stock compensation based on reference to the closing fair market value of our Common Stock on the date of grant. Stock-based compensation is recognized on a straight line basis over the vesting periods and forfeitures are recognized in the periods they occur.

 

In addition to our base of employees, we also use the services of several contract personnel and other professionals on an “as needed basis”. We plan to continue to use consultants, legal and patent attorneys, engineers and accountants as necessary. We may also expand our staff to support the market roll-out of our products to both the commercial and government related organizations. A portion of any key employee compensation likely would include direct stock grants, which would dilute the ownership interest of holders of existing shares of our Common Stock.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We have not entered into any market risk sensitive instruments for trading purposes. We are exposed to market risks in the ordinary course of business including fluctuations in interest rates and commodity prices, which can affect our operating, investing and financing activities. We believe our primary market risk is interest rate risk. Our Factoring Liability is indexed to market rates. Although we did not have a balance outstanding under our Factoring Liability at March 31, 2023, if were to make use of the maximum facility amount of $5.0 million, a 100 basis point increase would result in an impact of $50,000 additional interest expense for the year ended March 31, 2023. The interest rates on our Construction Note Payable are not indexed to market rates.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The consolidated financials are submitted as a separate section of this Annual Report on Form 10-K beginning on page F-1.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

Not applicable.

 

41

 

 

ITEM 9A. CONTROLS AND PROCEDURES

 

As of March 31, 2023, our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as required by Exchange Act Rule 13a-15.Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report. Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

a) Evaluation of Disclosure Controls and Procedures

 

Our management evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(c) and 15d-15(e) under the Exchange Act, as of March 31, 2023. Our disclosure controls and procedures are designed to provide reasonable assurance that information we are required to disclose in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures, and is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms.

 

Based on this evaluation, and because of the material weaknesses described below, our CEO and CFO have concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of March 31, 2023.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance of the reliability of financial reporting and of the preparation of financial statements for external reporting purposes, in accordance with U.S. GAAP.

 

42

 

 

Internal control over financial reporting includes policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and disposition of assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with the authorization of its management and directors; and (3) provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on tis financial statements.

 

Under the supervision and with the participation of our management, including our CEO and CFO, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on criteria established in the framework in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, and because of the material weaknesses described below, our management concluded that our internal control over financial reporting was not effective as of March 31, 2023.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

These material weaknesses did not result in any identified misstatements to the financial statements, and there were no changes to previously released financial results.

 

Material weaknesses and management’s remediation plan

 

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard AS 2201, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP. The following material weaknesses in our internal control over financial reporting were identified in the normal course as of March 31, 2023:

 

The Company failed to maintain an effective control environment due to the following:

 

the Company’s management and the governance did not maintain appropriately designed entity-level controls impacting the control environment to prevent or detect material misstatements to the consolidated financial statements. These deficiencies were attributed to limited personnel to assist with the accounting and financial reporting function and inadequate oversight and accountability over the performance of control activities, including establishment of a Whistleblower Hotline and lack of formalization of certain key governance elements: management delegation, annual board committee charter review, acknowledgement of code of conduct, and approval of the annual budget;
   
the Company failed to maintain properly designed segregation of duties, both within manual processes and system access;
   
the Company failed to maintain effectively designed controls over journal entries, both recurring and nonrecurring, account reconciliations, and periodic flux analysis. Journal entries were not always accompanied by sufficient supporting documentation and were not adequately reviewed and approved for validity, completeness, and accuracy. In most instances, persons responsible for reviewing journal entries and account reconciliations for validity, completeness, and accuracy were also responsible for preparation.
   
the Company failed to maintain effectively designed controls over the period-end financial reporting process, including adequate tie-out and review of documentation that supports the financial statements; and
   
the Company failed to maintain effectively designed controls over information technology general controls in the areas of user provisioning and de-provisioning, application change management, operating system and logical access controls, and segregation of duties for information technology (“IT”) systems that supports the Company’s financial reporting process.

 

43

 

 

Management’s Remediation Initiatives

 

We have concluded that these material weaknesses arose because we did not have the necessary business processes, systems, personnel, and related internal controls.

 

In response to the material weaknesses, management, with the oversight of the Audit Committee of the Board of Directors, has begun the process of, and is committed to, designing and implementing effective measures to strengthen our internal controls over financial reporting and remediate the material weaknesses. The Company is committed to ensuring that a proper, consistent tone is communicated throughout the organization, which emphasizes the expectation that previously existing deficiencies will be rectified through implementation of processes and controls to ensure strict compliance with U.S. GAAP and regulatory requirements.

 

Our current and planned internal remediation efforts include:

 

Retained a third–party consulting firm that specializes in internal audit work, and more specifically internal controls work. This firm will assist management with its risk assessment of internal control over financial reporting as well as documentation and testing of our internal control structure and evaluation of material weaknesses, with special focus on assisting management in the establishment and evaluation of proper segregation of duties procedures and monitoring and controls over ITGCs for the systems that support our financial reporting process.
Management has presented, and the Board of Directors has approved the formal management delegation, and the Company has formally initiated the implementation of a whistleblower hotline prior to the filing of this document.
Approved, adopted, and implemented accounting policies related to journal entries and invoice approval.
Improved formalization of procedures and documentation for all journal entries, account reconciliations, flux analysis and variance thresholds, vendor set-up.
Initiated IT Remediation Project with third-party consultants to design and implement controls over user provisioning and de-provisioning, application change management, operating system and logical access controls, segregation of duties, and third-party service provider report review process.
Implemented improvements surrounding review and approval of controls with a review element, including proper segregation, enhanced documentation, and consistency of application.

 

While these actions and planned actions are subject to ongoing management evaluation and will require validation and testing of the design and operating effectiveness of internal controls over a sustained period of financial reporting cycles, we are committed to the continuous improvement of our internal control over financial reporting and will continue to diligently review our internal control over financial reporting.

 

The effectiveness of the Company’s internal control over financial reporting as of March 31, 2023, has been audited by Pannell Kerr Forster of Texas, P.C., an independent registered public accounting firm, as stated in its report included herein.

 

Changes in Internal Controls over Financial Reporting

 

There was a change in our internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f)) that occurred during our most recent quarter that has materially affected or is reasonably likely to materially affect, our internal control over financial reporting.

 

Commencing in our fiscal quarter ended December 31, 2022, we have undertaken measures to remediate the previously disclosed material weaknesses. Management intends to implement certain remediation steps to address the material weaknesses described under Management’s Remediation Initiatives. However, management has not fully implemented those remediation steps and expects remediation efforts to continue into fiscal year 2024.

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and Board of Directors of

AMMO, Inc.

 

Opinion on Internal Control over Financial Reporting

 

We have audited AMMO, Inc.’s (the “Company’s”) internal control over financial reporting as of March 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, because of the effect of the material weaknesses described in the following paragraph on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of March 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by COSO.

 

A material weakness is a control deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management’s assessment.

 

  Controls were not appropriately designed or implemented at the entity level, affecting the control environment to prevent or detect material misstatements and to set the tone of the organization, including establishment of a whistleblower hotline and establishment of management delegation of authority policies;
  Controls were not appropriately designed or implemented to maintain effective segregation of duties, primarily related to insufficient personnel / resources;
  Controls were not appropriately designed or implemented over the year-end financial reporting process, including ineffective design of review and approval authorization controls;
  Controls were not appropriately designed or implemented related to journal entry access and approvals; and
  Controls were not appropriately designed or implemented related to information technology general controls. These controls specifically related to (i) user provisioning and deprovisioning, (ii) application change management, (iii) operating system and logical access controls, and (iv) segregation of duties for information technology systems that support the financial reporting process.

 

These material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2023 financial statements, and this report does not affect our report dated June 14, 2023, on those financial statements.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets and the related consolidated statements of operations, stockholders’ equity, and cash flows of the Company, and our report dated June 14, 2023, expressed an unqualified opinion.

 

Basis for Opinion

 

The Company’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

Definition and Limitations of Internal Control over Financial Reporting

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/ PANNELL KERR FORSTER OF TEXAS, P.C.

 

Houston, Texas

June 14, 2023

 

 

ITEM 9B. OTHER INFORMATION

 

We are reporting the following information in lieu of reporting on a Current Report on Form 8-K under Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 12, 2023, the Board approved a one-time cash bonus payment to Robert D. Wiley, the Company’s Chief Financial Officer. The Company will pay $129,000 to Mr. Wiley on or prior to June [  ], 2023. This amount represents twenty percent (20%) of the total base salary paid to Mr. Wiley in the three years ended March 31, 2023.

 

In addition, on June 12, 2023, the Board approved, and the Company and Mr. Wiley entered into, a Third Amendment to Employment Agreement (the “Amendment”). Pursuant to the terms of the Amendment, the Company shall pay Mr. Wiley an annual salary of $325,000. All other terms of the Employment Agreement remain in full force and effect. The foregoing description of the Amendment is not complete and is qualified in its entirety by reference to the full text of the Employment Agreement, which is attached to this filing as Exhibit 10.6.

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

44

 

 

PART III

 

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Information responsive to this item is incorporated herein by reference to our definitive proxy statement with respect to our 2023 Annual Meeting of Stockholder to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.

 

ITEM 11. EXECUTIVE COMPENSATION

 

Information responsive to this item is incorporated herein by reference to our definitive proxy statement with respect to our 2023 Annual Meeting of Stockholder to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

Information responsive to this item is incorporated herein by reference to our definitive proxy statement with respect to our 2023 Annual Meeting of Stockholder to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

Information responsive to this item is incorporated herein by reference to our definitive proxy statement with respect to our 2023 Annual Meeting of Stockholder to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Information responsive to this item is incorporated herein by reference to our definitive proxy statement with respect to our 2023 Annual Meeting of Stockholder to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.

 

45

 

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

  (a) Financial Statements and Financial Statement Schedules are set forth under Part II, Item 8 of this report.
     
  (b) Exhibits

 

Other Schedules are omitted because they are not applicable, not required, or because the required information is included in the Consolidated Financial Statements or notes thereto.

 

        Reference   Filed or Furnished

Exhibit

Number

  Exhibit Description   Form   Exhibit  

Filing

Date

  Herewith
2.1#   Agreement and Plan of Merger, dated April 30, 2021, by and among Ammo, Inc., SpeedLight Group I, LLC, Gemini Direct Investments, LLC and Steven F. Urvan (1)   8-K   2.1   5/6/2021    
3.1   Certificate of Incorporation (Amended and Restated) filed with the Delaware Secretary of State on October 24, 2018   8-K   3.1   10/26/2018    
3.2   Bylaws   8-K   3.03   02/09/2017    
3.3   Certificate of Designations with respect to the 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share, dated May 18, 2021   8-A   3.1   5/20/2021    
4.1   Compilation of JSC Agreements dated November 4, 2020   10-Q   4.3   11/13/2020    
4.2   Form of Underwriters’ Warrant Agreement issued December 3, 2020   8-K   4.1   12/4/2020    
4.3   Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.               X
4.4   Promissory Note issued by Ammo, Inc., Firelight Group I, LLC in favor of Hiawatha National Bank, dated October 14, 2021.   10-Q   4.1   2/14/2022    
10.1+   2017 Equity Incentive Plan, as amended   S-8   4.1   3/30/2023    
10.2   First Amended and Restated Factoring and Security Agreement, as amended, by and between Ammo, Inc. and Factors Southwest, LLC   8-K   10.1   3/11/2021    
10.3   Revolving Inventory Loan and Security Agreement, as amended, by and between Ammo, Inc. and Factors Southwest, LLC   8-K   10.2   3/11/2021    
10.4   Exclusive License Agreement between AMMO Technologies Inc. and University of Louisiana at Lafayette, dated November 16, 2017, as amended in 2018 and 2022   10-Q   10.1   2/14/2023    

 

46

 

 

10.5+   Employment Agreement of Fred W. Wagenhals               X
10.6+   Employment Agreement of Robert D. Wiley, as amended         X
10.7+   Employment Agreement of Jared R. Smith, dated December 15, 2022   10-Q   10.4   2/14/2023    
10.8   Lock-Up Agreement, dated April 30, 2021, by and between Ammo, Inc. and Steven F. Urvan   8-K   10.1   5/6/2021    
10.9   Voting Rights Agreement, dated April 30, 2021, by and between Ammo, Inc. and Steven F. Urvan   8-K   10.2   5/6/2021    
10.10   Standstill Agreement, dated April 30, 2021, by and between Ammo, Inc. and Steven F. Urvan   8-K   10.3   5/6/2021    
10.11   Investor Rights Agreement, dated April 30, 2021, by and between Ammo, Inc. and Steven F. Urvan   8-K   10.4   5/6/2021    
10.12   Construction Loan Agreement by and among Ammo, Inc., Firelight Group I, LLC, and Hiawatha National Bank, dated October 14, 2021.   10-Q   10.1   2/14/2022    
10.13   Settlement Agreement, by and among AMMO, Inc., Steven F. Urvan and Susan T. Lokey, dated November 3, 2022   8-K   10.1   11/7/22    
10.14   Amendment to Settlement Agreement, by and among AMMO, Inc., Steven F. Urvan and Susan T. Lokey, dated November 21, 2022   8-K   10.1   11/22/22    
21.1   Subsidiaries of the Company               X
23.1   Consent of Pannell Kerr Forster of Texas, P.C Independent Registered Account Firm Relating to Consolidated Financial Statements of the Company for the year ended March 31, 2023               X
31.1   Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.               X
31.2   Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.               X
32.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.               X
32.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.               X
101.INS   Inline XBRL Instance Document               X
101.SCH   Inline XBRL Taxonomy Extension Schema Document               X
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document               X
101.LAB   Inline XBRL Taxonomy Extension Labels Linkbase Document               X
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document               X
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document               X
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)               X

 

# Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company will furnish supplementally copies of omitted schedules and exhibits to the Securities and Exchange Commission or its staff upon its request.

 

+ Management compensatory plan or contract.

 

* Furnished herewith.

 

47

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AMMO, INC.
     
  By: /s/ Fred W. Wagenhals
Dated: June 14, 2023   Fred W. Wagenhals, Chief Executive Officer
     
  By: /s/ Robert D. Wiley
Dated: June 14, 2023   Robert D. Wiley, Chief Financial Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the following persons on behalf of the Registrant and in the capacities and on the dates indicated have signed this report below.

 

Name   Title   Date
         
/s/ Fred W. Wagenhals  

Chief Executive Officer and

Chairman of the Board of Directors

(Principal Executive Officer)

  June 14, 2023
Fred W. Wagenhals        
         
/s/ Robert D. Wiley   Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)   June 14, 2023
Robert D. Wiley        
         
/s/ Russell W. Wallace Jr.   Director   June 14, 2023
Russell W. Wallace, Jr.        
         
/s/ Richard Childress   Director   June 14, 2023
Richard Childress        
         
/s/ Harry Markley   Director   June 14, 2023
Harry Markley        
         
/s/ Jessica M. Lockett   Director   June 14, 2023
Jessica M. Lockett        
         
  Director  
Steven F. Urvan        
         
/s/ Wayne Walker   Director   June 14, 2023
Wayne Walker        
         
/s/ Christos Tsentas   Director   June 14, 2023
Christos Tsentas        
         
/s/ Randy E. Luth   Director   June 14, 2023
Randy E. Luth        

 

48

 

 

Index to Consolidated Financial Statements

 

Report of Pannell Kerr Forster of Texas, P.C. PCAOB ID: 342 F-2
Consolidated Balance Sheets as of March 31, 2023 and March 31, 2022 F-3
Consolidated Statements of Operations for the years ended March 31, 2023, March 31, 2022, and March 31, 2021 F-4
Consolidated Statements of Stockholders’ Equity for the years ended March 31, 2023, March 31, 2022, and March 31, 2021 F-5
Consolidated Statements of Cash Flows for the years ended March 31, 2023, March 31, 2022, and March 31, 2021 F-6
Notes to Consolidated Financial Statements F-8

 

F-1
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and Board of Directors of

AMMO, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of AMMO, Inc. and Subsidiaries (the “Company”) as of March 31, 2023 and 2022, the related consolidated statements of operations, stockholders’ equity and cash flows for each of the years in the three year period ended March 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2023 and 2022, and the results of its operations and its cash flows for the each of the years in the three year period ended March 31, 2023 in conformity with U. S. Generally Accepted Accounting Principles.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of March 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated June 14, 2023, expressed an adverse opinion.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (i) related to accounts or disclosures that are material to the financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Goodwill Impairment

 

The Company has recorded goodwill of approximately $90.8 million. As described in Note 2 to the financial statements, the Company tests goodwill for impairment annually or more frequently when an event occurs or circumstances change that may indicate that the carrying value of the reporting unit exceeds its fair value. The fair value was determined using the weighting of certain valuation techniques, including both income and market approaches, which include a discounted cashflow analysis, an analysis of similar public company financial information, and an analysis of market transactions. The Company’s fair value estimate in performing this analysis requires management to make various judgments, assumptions, and estimates, the most significant of which include discount rates, projected revenue growth rates, operating margins and guideline public company metrics. We identified goodwill impairment as a critical audit matter primarily because of the judgment involved in reviewing management’s estimates included in the specialist’s reports, as well as the degree of subjectivity in evaluating audit evidence.

 

Our testing procedures to address this critical audit matter included, among others, the following:

 

  evaluating the methodologies and assumptions used by management and its specialist in its analysis of the assessment;
  performing assessments of the specialist’s qualifications and relationship with the Company;
  testing the mathematical accuracy of the specialist’s calculations; and
  evaluating the reasonableness of inputs utilized in the calculation.

 

/s/ PANNELL KERR FORSTER OF TEXAS, P.C.

 

We have served as the Company’s auditor since 2021.

 

Houston, Texas

June 14, 2023

 

F-2
 

 

AMMO, Inc.

CONSOLIDATED BALANCE SHEETS

 

   March 31, 2023   March 31, 2022 
         
ASSETS          
Current Assets:          
Cash and cash equivalents  $39,134,027   $23,281,475 
Accounts receivable, net   29,346,380    43,955,084 
Due from related parties   -    15,000 
Inventories   54,344,819    59,016,152 
Prepaid expenses   5,126,667    3,423,925 
Current portion of restricted cash   500,000    - 
Total Current Assets   128,451,893    129,691,636 
           
Property and Equipment, net   55,963,255    37,637,806 
           
Other Assets:          
Deposits   7,028,947    11,360,322 
Patents, net   5,032,754    5,526,218 
Other intangible assets, net   123,726,810    136,300,387 
Goodwill   90,870,094    90,870,094 
Right of use assets - operating leases   1,261,634    2,791,850 
TOTAL ASSETS  $412,335,387   $414,178,313 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current Liabilities:          
Accounts payable  $18,079,397   $26,817,083 
Factoring liability   -    485,671 
Accrued liabilities   4,353,354    6,178,814 
Inventory credit facility   -    825,675 
Current portion of operating lease liability   470,734    831,429 
Current portion of note payable related party   180,850    684,639 
Current portion of construction note payable   260,429    - 
Insurance premium note payable   2,118,635    - 
Total Current Liabilities   25,463,399    35,823,311 
           
Long-term Liabilities:          
Contingent consideration payable   140,378    204,142 
Notes payable related party, net of current portion   -    181,132 
Construction note payable, net of unamortized issuance costs   10,922,443    38,330 
Operating lease liability, net of current portion   903,490    2,091,351 
Deferred income tax liability   2,309,592    1,536,481 
Total Liabilities   39,739,302    39,874,747 
           
Shareholders’ Equity:          
Series A cumulative perpetual preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of March 31, 2023 and March 31, 2022, respectively   1,400    1,400 
Common stock, $0.001 par value, 200,000,000 shares authorized 118,562,806 and 116,485,747 shares issued and 118,294,478 and 116,485,747 outstanding at March 31, 2023 and March 31, 2022, respectively   118,294    116,487 
Additional paid-in capital   391,940,374    385,426,431 
Accumulated deficit   (18,941,825)   (11,240,752)
Treasury Stock   (522,158)   - 
Total Shareholders’ Equity   372,596,085    374,303,566 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $412,335,387   $414,178,313 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3
 

 

AMMO, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   2023   2022   2021 
   For the Year Ended March 31, 
   2023   2022   2021 
             
Net Revenues               
Ammunition sales(1)  $114,116,044   $161,459,025   $49,620,530 
Marketplace revenue   63,149,673    64,608,516    - 
Casing sales   14,174,084    14,201,625    12,861,800 
Total Revenues   191,439,801    240,269,166    62,482,330 
                
Cost of Revenues   136,031,204    151,505,657    51,095,679 
Gross Profit   55,408,597    88,763,509    11,386,651 
                
Operating Expenses               
Selling and marketing   4,729,540    7,310,216    1,879,128 
Corporate general and administrative   24,980,079    16,986,344    7,191,544 
Employee salaries and related expenses   15,679,135    13,615,439    5,036,721 
Depreciation and amortization expense   13,278,762    13,702,148    1,659,243 
Loss on purchase   -    -    1,000,000 
Total operating expenses   58,667,516    51,614,147    16,766,636 
Income/(Loss) from Operations   (3,258,919)   37,149,362    (5,379,985)
                
Other Expenses               
Other income/(expense)   25,181    21,840    576,785 
Interest expense   (632,062)   (637,797)   (3,009,094)
Total other expense   (606,881)   (615,957)   (2,432,309)
                
Income/(Loss) before Income Taxes   (3,865,800)   36,533,405    (7,812,294)
                
Provision for Income Taxes   730,238    3,285,969    - 
                
Net Income/(Loss)   (4,596,038)   33,247,436    (7,812,294)
                
Preferred Stock Dividend   (3,105,034)   (2,668,649)   - 
                
Net Income/(Loss) Attributable to Common Stock Shareholders  $(7,701,072)  $30,578,787   $(7,812,294)
                
Net Income/(Loss) per share               
Basic  $(0.07)  $0.27   $(0.14)
Diluted  $(0.07)  $0.27   $(0.14)
                
Weighted average number of shares outstanding               
Basic   117,177,885    112,328,680    55,041,502 
Diluted   117,177,885    114,189,720    55,041,502 

 

(1) Included in revenue for the years ended March 31, 2023, 2022, and 2021 is excises taxes of $9,789,896, $14,646,983, and $4,286,258, respectively.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4
 

 

AMMO, Inc.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

                                         
   Preferred Stock   Common Shares   Additional             
   Number   Par Value   Number   Par Value   Paid-In Capital   Accumulated (Deficit)   Treasury Stock   Total 
                                 
Balance as of March 31, 2020         -   $     -    46,204,139   $46,204   $53,219,834   $(34,007,245)   -   $19,258,793 
                                         
Common stock issued for cash   -    -    34,536,143    34,537    138,578,082    -    -    138,612,619 
Common stock issued for convertible notes   -    -    3,145,481    3,145    4,828,061    -    -    4,831,206 
Common stock issued for exercised warrants   -    -    6,521,563    6,522    13,945,814    -    -    13,952,336 
Common stock issued for debt conversion   -    -    1,000,000    1,000    2,099,000    -    -    2,100,000 
Common stock issued for cashless warrant exercise   -    -    732,974    733    (733)   -    -    - 
Common stock issuance costs   -    -    -    -    (13,847,069)   -    -    (13,847,069)
Common stock issued for services   -    -    943,336    943    1,706,557    -    -    1,707,500 
Employee stock awards   -    -    1,016,331    1,016    1,449,343    -    -    1,450,359 
Stock grants   -    -    -    -    278,585    -    -    278,585 
Issuance of warrants for convertible notes   -    -    -    -    1,315,494    -    -    1,315,494 
Common stock repurchase and cancellation   -    -    (1,000,000)   (1,000)   (1,499,000)   -    -    (1,500,000)
Net loss   -    -    -    -    -    (7,812,294)   -    (7,812,294)
                                         
Balance as of March 31, 2021   -   $-    93,099,967   $93,100   $202,073,968   $(41,819,539)  $-   $160,347,529 

 

   Preferred Stock   Common Shares   Additional             
   Number   Par Value   Number   Par Value   Paid-In Capital   Accumulated (Deficit)   Treasury Stock   Total 
                                 
Balance as of March 31, 2021   -   $-    93,099,967   $93,100   $202,073,968   $(41,819,539)   -   $160,347,529 
                                         
Acquisition stock issuances   -    -    20,000,000    20,000    142,671,282    -    -    142,691,282 
Common stock issued for exercised warrants   -    -    431,080    431    943,476    -    -    943,907 
Common stock issued for cashless warrant exercise   -    -    374,584    375    (375)   -    -    - 
Common stock issued for services and equipment   -    -    772,450    773    1,630,928    -    -    1,631,701 
Employee stock awards   -    -    1,807,666    1,808    5,757,192    -    -    5,759,000 
Stock grants   -    -    -    -    252,488    -    -    252,488 
Issuance of Series A Preferred Stock, net of issuance costs   1,400,000    1,400    -    -    31,007,396    -    -    31,008,796 
Warrant issued for services                       1,090,076    -         1,090,076 
Preferred stock dividends declared   -    -    -    -    -    (2,524,087)   -    (2,524,087)
Dividends accumulated on preferred stock   -    -    -    -    -    (144,562)   -    (144,562)
Net income   -    -    -    -    -    33,247,436    -    33,247,436 
                                         
Balance as of March 31, 2022   1,400,000   $1,400    116,485,747   $116,487   $385,426,431   $(11,240,752)  $-   $374,303,566 

 

   Preferred Stock   Common Shares   Additional             
   Number   Par Value   Number   Par Value   Paid-In Capital   Accumulated (Deficit)   Treasury Stock   Total 
                                 
Balance as of March 31, 2022   1,400,000   $1,400    116,485,747   $116,487   $385,426,431   $(11,240,752)  $-   $374,303,566 
                                         
Common stock issued for exercised warrants   -    -    200,003    200    101,306    -    -    101,506 
Common stock issued for cashless warrant exercise   -    -    99,762    99    (99)   -    -    - 
Employee stock awards   -    -    1,777,294    1,776    5,806,003    -    -    5,807,779 
Stock grants   -    -    -    -    179,094    -    -    179,094 
Warrants issued for services   -    -    -    -    427,639    -    -    427,639 
Preferred stock dividends declared   -    -    -    -    -    (638,071)   -    (638,071)
Dividends accumulated on preferred stock   -    -    -    -    -    (144,618)   -    (144,618)
Preferred stock dividend   -    -    -    -    -    (2,322,346)   -    (2,322,346)
Net Loss                            (4,596,038)        (4,596,038)
Treasury shares purchased   -    -    (268,328)   (268)   -    -    (522,158)   (522,426)
                                         
Balance as of March 31, 2023   1,400,000   $1,400    118,294,478   $118,294   $391,940,374   $(18,941,825)  $(522,158)  $372,596,085 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5
 

 

AMMO, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOW

 

   2023   2022   2021 
   For the Year Ended March 31, 
   2023   2022   2021 
             
Cash flows from operating activities:               
Net Income/(Loss)   (4,596,038)   33,247,436    (7,812,294)
Adjustments to reconcile Net Loss to Net Cash provided by (used in) operations:               
Depreciation and amortization   17,519,949    17,339,093    4,876,756 
Debt discount amortization   83,253    38,330    446,466 
Employee stock awards   5,807,779    5,759,000    1,450,359 
Stock grants   179,094    252,488    278,585 
Stock for services   -    4,200    1,707,500 
Contingent consideration payable fair value   (63,764)   (385,750)   (119,731)
Allowance for doubtful accounts   191,299    2,748,250    86,292 
(Gain)/loss on disposal of assets   -    (12,044)   25,400 
Reduction in right of use asset   629,140    720,491    443,739 
Warrant issued for services   213,819    718,045    - 
Deferred income taxes   730,238    1,536,481    - 
Stock issued in lieu of cash payments   -    -    48,000 
Interest on convertible promissory notes   -    -    163,351 
Paycheck protection program note forgiveness   -    -    (1,051,985)
Loss on Jagemann Munition Components   -    -    1,000,000 
Stock and warrants for note conversion   -    -    1,315,494 
Changes in Current Assets and Liabilities               
Accounts receivable   14,417,405    (20,707,052)   (6,075,373)
Due to (from) related parties   15,000    657    150 
Inventories   4,671,333    (43,149,234)   (11,458,845)
Prepaid expenses   2,763,855    1,996,287    (1,331,710)
Deposits   4,306,375    (8,826,504)   (1,616,858)
Accounts payable   (8,694,813)   9,930,191    1,810,417 
Accrued liabilities   (1,970,078)   2,374,686    1,843,166 
Operating lease liability   (647,480)   (732,468)   (444,439)
Net cash provided by (used in) operating activities   35,556,366    2,852,583    (14,415,560)
                
Cash flows from investing activities:               
Gemini acquisition   -    (50,517,840)   - 
Purchase of equipment   (12,541,325)   (19,218,982)   (7,437,265)
Proceeds from disposal of assets   -    59,800    - 
Net cash used in investing activities   (12,541,325)   (69,677,022)   (7,437,265)
                
Cash flow from financing activities:               
Payments on inventory facility, net   (825,675)   (265,422)   1,091,098 
Proceeds from factoring liability   71,348,761    121,488,045    40,309,292 
Payments on factoring liability   (71,834,432)   (122,844,562)   (40,473,083)
Payments on assumed debt from Gemini   -    (50,000,000)   - 
Payments on note payable - related party   (684,921)   (625,147)   (8,783,410)
Payments on insurance premium note payment   (2,134,143)   (2,208,369)   (514,746)
Proceeds from construction note payable   1,000,000    -    - 
Payments on construction note payable   (150,743)   -    - 
Payments on note payable   -    (4,000,000)   - 
Sale of preferred stock   -    35,000,000    - 
Common stock issued for exercised warrants   101,506    943,907    13,952,336 
Common stock issuance costs   -    (3,199,922)   (13,895,069)
Preferred stock dividends paid   (2,960,416)   (2,524,087)     
Common stock repurchase plan   (522,426)   -    - 
Sale of common stock   -    -    138,612,619 
Proceeds from paycheck protection program notes   -    -    1,051,985 
Proceeds from note payable related party issued   -    -    3,500,000 
Proceeds from note payable   -    -    4,000,000 
Proceeds from convertible promissory notes   -    -    1,959,000 
Payments on common stock repurchase and cancellation   -    -    (1,500,000)
Net cash used in financing activities   (6,662,489)   (28,235,557)   139,310,022 
              - 
Net increase/(decrease) in cash   16,352,552    (95,059,996)   117,457,197 
Cash, beginning of period   23,281,475    118,341,471    884,274 
Cash and restricted cash, end of period  $39,634,027   $23,281,475   $118,341,471 
Restricted cash, end of period  $

500,000

  

$

-

  

$

-

 
Cash, end of period 

$

39,134,027

    

23,281,475

    

118,341,471

 

 

(Continued)

 

F-6
 

 

AMMO, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOW

 

   For the Year Ended March 31, 
   2023   2022   2021 
             
Supplemental cash flow disclosures:               
Cash paid during the period for:               
Interest  $665,043   $626,571   $1,186,302 
Income taxes  $1,302,811   $-   $- 
                
Non-cash investing and financing activities:               
Construction note payable  $10,237,032   $387,968   $- 
Insurance premium note payment  $4,252,778   $2,166,852   $226,539 
Operating lease liability  $901,076   $809,451   $897,845 
Dividends accumulated on preferred stock  $144,618   $144,562   $- 
Acquisition stock issuances  $-   $143,400,000   $- 
Warrant issued for services  $-   $1,090,077   $- 
Convertible promissory note  $-   $-   $4,667,855 
Note payable related party  $-   $-   $2,635,797 
Note payable related party conversion  $-   $-   $2,100,000 
Stock subscription receivable  $-   $-   $664,975 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – ORGANIZATION AND BUSINESS ACTIVITY

 

We were formed under the name Retrospettiva, Inc. in November 1990 to manufacture and import textile products, including both finished garments and fabrics. We were inactive until the following series of events in December 2016 and March 2017.

 

On December 15, 2016, the Company’s majority shareholders sold 475,681 (11,891,976 pre-split) of their outstanding shares to Mr. Fred W. Wagenhals (“Mr. Wagenhals”) resulting in a change in control of the Company. Mr. Wagenhals was appointed as sole officer and the sole member of the Company’s Board of Directors.

 

The Company also approved (i) doing business in the name AMMO, Inc., (ii) a change to the Company’s OTC trading symbol to POWW, (iii) an agreement and plan of merger to re-domicile and change the Company’s state of incorporation from California to Delaware, and (iv) a 1-for-25 reverse stock split (“Reverse Split”) of the issued and outstanding shares of the common stock of the Company. As a result of the reverse split, the previous issued and outstanding shares of common stock became 580,052 shares; no shareholder was reversed below 100 shares, and all fractional shares resulting from the reverse split were rounded up to the next whole share. All references to the outstanding stock have been retrospectively adjusted to reflect this split. These transactions were effective as of December 30, 2016.

 

On March 17, 2017, the Company entered into a definitive agreement with AMMO, Inc. a Delaware Corporation (PRIVCO) under which the Company acquired all of the outstanding shares of common stock of (PRIVCO). Under the terms of the Agreement, the Company issued 17,285,800 newly issued shares of common stock of the Company. In connection with this transaction the Company retired 475,681 shares of common stock and issued 500,000 shares of common stock to satisfy an issuance commitment. The acquisition was considered to be a capital transaction. The transaction was the equivalent to the issuance by PRIVCO of 604,371 shares to the Company’s shareholders accompanied by a recapitalization. The weighted average number of outstanding shares has been adjusted for this transaction. (PRIVCO) subsequently changes its name to AMMO Munitions, Inc.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation and warrant-based compensation.

 

Goodwill

 

We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline it is not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2023. As of March 31, 2023, the Company has a goodwill carrying value of $90,870,094, all of which is assigned to the Marketplace segment. However, due to declines in the value of the Company’s common stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2024.

 

Cash and Cash Equivalents

 

For purposes of the consolidated statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

 

Restricted Cash

 

We consider cash to be restricted when withdrawal or general use is legally restricted. Our restricted cash balance is comprised of cash on deposit with banks to secure the Construction Loan Agreement as discussed in Note 11. We report restricted cash in the Consolidated Balance Sheets as current or non-current classification based on the expected duration of the restriction.

 

F-8
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Our accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts.

 

License Agreements

 

We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

 

We were a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants us through February 2022 the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

 

Patents

 

On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to AMMO Technologies Inc. pursuant to an Assignment and First Amendment to Exclusive License Agreement. Assumption Agreement dated to be effective as of August 22, 2017, the Merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.

 

Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $0.01 per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the years ended March 31, 2023, 2022, and 2021, the Company recognized royalty expenses of $99,268, $44,764, and $87,093 respectively under this agreement.

 

F-9
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

In August 2018, we applied for additional patent coverage for the manufacturing methods or application of the Hybrid Luminescence Ammunition Technology on a variety of projectile and ammunition types. The costs of filing this patent were expensed.

 

On October 5, 2018, we completed the acquisition of SW Kenetics Inc. AMMO Technologies, Inc. succeeded all of the assets of SW Kenetics Inc. and assumed all of the liabilities.

 

The primary asset of SW Kenetics Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to AMMO Technologies, Inc. pursuant to Intellectual Property Rights Agreement on September 27, 2018.

 

We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.

 

Other Intangible Assets

 

On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement (See Note 18). The intangible assets acquired include a tradename, customer relationships, and intellectual property.

 

On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company. Whereby SpeedLight Group I, LLC merged with and into Gemini Direct Investments, LLC, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company. At the time of the Merger, Gemini Direct Investments, LLC had nine (9) subsidiaries, all of which are related to Gemini’s ownership of GunBroker.com, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software and domain names.

 

Impairment of Long-Lived Assets

 

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. No impairment expense was recognized for the years ended March 31, 2023, 2022, and 2021.

 

Revenue Recognition

 

We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

 

  Identification of a contract with a customer
  Identification of the performance obligations in the contact
  Determination of the transaction price
  Allocation of the transaction price to the separate performance allocation
  Recognition of revenue when performance obligations are satisfied

 

F-10
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services it transfers to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.

 

For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.

 

For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized as follows:

 

Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

 

Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.

 

Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.

 

Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.

 

Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.

 

Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.

 

For the years ended March 31, 2023, 2022, and 2021, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:

 

   For the Year Ended
March 31, 2023
   For the Year Ended
March 31, 2022
    For the Year Ended
March 31, 2021
 
PERCENTAGES  Revenues   Accounts Receivable   Revenues  

Accounts

Receivable

    Revenues    

Accounts

Receivable

 
                                 
Customers:                                    
                                         
A   12.2%   -    -    -      16.5 %     23.3 %
B   -    -    -    11.8%     -       -  
C   -    -    -    -      -       11.9 %
D   -    -    -    -      -       10.6 %
    12.2%   -    -    11.8%     16.5 %     45.8 %

 

Disaggregated Revenue Information

 

The following table represent a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types; ammunition, ammunition casings, and marketplace fees. The Company notes that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.

 

                 
   For the Year Ended  
   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition Sales  $114,116,044   $161,459,025    $ 49,620,530  
Marketplace Fee Revenue   63,149,673    64,608,516      -  
Ammunition Casings Sales   14,174,084    14,201,625      12,861,800  
Total Sales  $191,439,801   $240,269,166    $ 62,482,330  

 

Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell direct to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our Gunbroker.com online auction marketplace.

 

F-11
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

All sales are recorded upon shipment and, depending on credit worthiness of customer, the payment terms will vary from thirty (30) to sixty (60) days. No refunds are allowed on any product shipped.

 

Each product manufactured by the Company has standard specifications and performance objectives. The Company has an extensive product testing program and, if the Company were given notice of a product defect by a customer, the Company would request the return of the product so that the manufacturing defect could be identified.

 

Advertising Costs

 

We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expenses as they are incurred in cost of revenues. We incurred advertising expenses recognized in selling expenses of $1,068,700, $1,406,043, and $257,866 for the years ended March 31, 2023, 2022, and 2021 respectively. We incurred marketplace advertising expenses of 286,479 and $417,017 in cost of revenues for the years ended March 31, 2023 and 2022. We did not have marketplace advertising expenses in cost of revenues for the year ended March 31, 2021.

 

Fair Value of Financial Instruments

 

We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.

 

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:

 

Level 1 – Quoted prices for identical instruments in active markets;

 

Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

 

Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

F-12
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.

 

We value all common stock issued for services on the date of the agreements, using the price at which shares were being sold to private investors or at the value of the services performed.

 

We valued warrants issued for services at their respective grants dates during the years ended March 31, 2023, 2022, and 2021 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.

 

   March 31, 2023   March 31, 2022   

March 31,

2021

 
                 
Risk free interest rate   3.9%   1.21%-1.74%     0.32%-0.38 %
Expected volatility   77.5%   89.1%-90.7%     88.9%-90.4 %
Expected term   2.5 years    2.5 years      2.5 years  
Expected dividend yield   0%   0%     0 %

 

 

   Quoted
Active
Markets
for
Identified
Assets
   Significant
Other
Observable
Inputs
   Significant
Unobservable
Inputs
   Total 
   (Level 1)   (Level 2)   (Level 3)     
March 31, 2023                    
Warrants issued for services  $-   $427,639   $-   $427,639 
March 31, 2022                    
Warrants issued for services  $-   $1,090,077   $-   $1,090,077 
March 31, 2021                                  
Warrants issued for convertible promissory notes conversion  $-   $1,315,494   $-   $1,315,494 

 

In connection with our acquisition of Gemini, we used the Level 2 inputs in estimating the fair value of the transaction. Please refer to Note 14.

 

Inventories

 

We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence.

 

F-13
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Property and Equipment

 

We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income or expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.

 

We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.

 

Compensated Absences

 

We accrue a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General (“ASC 710”).

 

Research and Development

 

To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.

 

Excise Tax

 

As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an 11% excise tax for all products sold into these channels. During the years ended March 31, 2023, 2022, and 2021, we recognized approximately $9.8 million, $14.6 million, and $4.3 million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of goods sold.

 

Stock-Based Compensation

 

We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”). Which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors. We measure stock compensation based on reference to the closing fair market value of our Common Stock on the date of grant. Stock-based compensation is recognized on a straight line basis over the vesting periods and forfeitures are recognized in the periods they occur.

 

Concentrations of Credit Risk

 

Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of March 31, 2023, our bank account balances exceeded federally insured limits, however, we have not incurred losses related to these deposits.

 

Income Taxes

 

We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.

 

F-14
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Contingencies

 

Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed.

 

On September 24, 2019, the Company received notice that a former employee that had voluntarily terminated filed a complaint against the Company, and certain individuals, with the U.S. Department of Labor (“DOL”). The Complaint in alleges that the individual reported potential violations of SEC rules and regulations by management and that as a result of such disclosures, the individual experienced a hostile work environment; that the Company lacks sufficient internal controls, and that the individual was the victim of retaliation and constructive discharge after being removed as a director by majority vote of the shareholders. The claims were investigated by a newly appointed Special Investigative Committee made up of independent directors represented by special independent legal counsel. The Special Investigative Committee and legal counsel found the material claims were unsubstantiated, including those concerning alleged SEC violations, and recommended enhancements to certain corporate governance charter documents and processes which the Company promptly implemented. The parties participated in a successful mediation at the end of June 2022 and all matters relating to this former employee/claimant were confidentially resolved with the lawsuit dismissed with prejudice.  The settlement was covered by our Employment Practices Liability Policy and did not amount to a material amount.

 

On February 10, 2022, AMMO filed a Texas state court complaint against Expansion Industries pursing eight (8) claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e., Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO has since moved aggressively to further the process, including successfully garnishing a portion of the deposit monies in Expansion bank accounts, filing a Motion for Summary Judgement, continuing to pursue written discovery, and amending the Complaint to add Expansion principal as an individual party. The putative primer manufacturer settled the two related lawsuits in September 2022 by repaying all deposit monies due AMMO, in addition to payment of principally all fees and costs incurred by the Company in pursuit of the resolution. The principal lawsuit and AMMO’s garnishment action adverse the defendant were dismissed with prejudice.

 

Along with countless other suppliers of Remington Outdoors, AMMO was served with an avoidance claim lawsuit by the bankruptcy trustee. AMMO presented substantial “ordinary course” defense evidence to the Trustee and the case was settled for a nominal sum in September 2022, with the lawsuit dismissed with prejudice.

 

AMMO is defending two contract arbitration cases adverse former employees that are presently in discovery, one involving an employee terminated for cause and the second action involving a termination without cause wherein the former employee is seeking contract wages, commissions and allegedly earned common stock. Discovery is ongoing at this time in the employment arbitration matters. While discovery continues, the Company received a favorable ruling on a partial motion for summary judgment in the “for cause” arbitration case wherein the arbitrator ruled the employee had stolen funds and thus granted the Company’s dispositive motion.

 

The Company also received notice in October 2022 that an OSHA whistleblower complaint had been filed with the US Department of Labor by an employee that had been terminated for cause. The regulatory filing was received after AMMO refused to capitulate to the former employee’s demands. AMMO has produced documents and submitted its position statement to OSHA and the matters is currently pending at the agency level.

 

On April 30, 2023, Director and shareholder Steve Urvan filed suit in the Delaware Chancery Court against the Company, certain Directors, former directors, employees, former employees and consultants, seeking rescission of the Company’s acquisition of GunBroker.com and certain affiliated companies. Plaintiff Urvan’s claims include rescission, misrepresentation and fraud. The Company is currently in communications with its insurance carriers as concerns coverage (defense and indemnification), has engaged counsel and formal/legal service of process is being coordinated at this time. The Company and named defendants are in alignment in all respects, reasonably believe at this date that the claims are without merit and the Company has engaged Delaware Chancery Court litigation specialists to defend its interests in all respects in this case. There were no other known contingencies at March 31, 2023 and 2022.

 

F-15
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Recent Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit loss (“CECL”) methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The guidance should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. The guidance is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. We anticipate that this ASC will not have a material effect on the Company’s financial statements.

 

In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires specific disclosures for equity securities subject to contractual sale restrictions. These changes will become effective for the Company on April 1, 2024, with early adoption permitted. We are currently evaluating the potential impact of these changes.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

NOTE 3 – INCOME/(LOSS) PER COMMON SHARE

 

We calculate basic income/(loss) per share using the weighted-average number of shares of common stock outstanding during each reporting period. Diluted loss per share includes potentially dilutive securities, such as outstanding options and warrants. We use the treasury stock method, in the determination of dilutive shares outstanding during each reporting period. We have issued warrants to purchase 2,460,946 shares of common stock. Due to the loss from operations in the year ended March 31, 2023, there are no common shares added to calculate the dilutive loss per share for that period as the effect would be antidilutive. The Company excluded warrants of 2,406,946 for the year ended March 31, 2023 and warrants of 150,000 and equity incentive awards of 20,000 for the year ended March 31, 2022, from the weighted average diluted common shares outstanding because their inclusion would have been antidilutive.

 

   2023     2022     2021 
   For the Year Ended
March 31,
 
   2023   2022     2021 
                 
Numerator:                  
Net income/(loss)  $(4,596,038)  $ 33,247,436     $(7,182,294)
Less: Preferred stock dividends   (3,105,034)    (2,668,648 )    - 
Net income/(loss) attributable to common stockholders  $(7,701,072)  $ 30,578,788     $(7,182,294)
                   
Denominator:                  
Weighted averaged shares of common stock - basic   117,177,885     112,328,680      55,041,502 
Effect of dilutive common stock purchase warrants   -     1,861,040      - 
Effect of dilutive equity incentive awards   -     -      - 
Weighted average shares of common stock - Diluted   117,177,885     114,189,720      55,041,502 
                   
Basic earnings per share:                  
Income/(loss) per share attributable to common stockholders - basic  $(0.07)  $ 0.27     $(0.14)
                   
Diluted earnings per share:                  
Income/(loss) per share attributable to common stockholders - diluted  $(0.07)  $ 0.27     $(0.14)

 

F-16
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – ACCOUNTS RECEIVABLE

 

Our net accounts receivable are summarized as follows:

 

           
   March 31, 2023   March 31, 2022 
Accounts receivable  $32,592,931   $47,010,336 
Less: allowance for doubtful accounts   (3,246,551)   (3,055,252)
Accounts receivable, net  $29,346,380   $43,955,084 

 

The following presents a reconciliation of our allowance for doubtful accounts for the periods presented:

 

March 31, 2021  $148,540 
Increase in allowance   2,903,304 
Write-off of uncollectible amounts   (12,703)
Purchase accounting   16,111 
March 31, 2022   3,055,252 
Increase in allowance   2,160,323 
Write-off of uncollectible amounts   (1,969,024)
March 31, 2023  $3,246,551 

 

NOTE 5 – INVENTORIES

 

At March 31, 2023 and March 31, 2022, the inventory balances are composed of:

 

   March 31, 2023   March 31, 2022 
Finished product  $14,362,514   $6,167,318 
Raw materials   23,898,596    33,924,813 
Work in process   16,083,709    18,924,021 
           
Inventory net  $54,344,819   $59,016,152 

 

NOTE 6 – PROPERTY, PLANT AND EQUIPMENT

 

Property and equipment consisted of the following at March 31, 2023 and March 31, 2022:

 

   March 31, 2023   March 31, 2022 
Leasehold Improvements  $257,009   $257,009 
Building and Improvements   28,623,329    - 
Furniture and Fixtures   384,650    343,014 
Vehicles   153,254    153,254 
Equipment   40,233,186    32,524,850 
Tooling   143,710    143,710 
Construction in Progress   734,781    14,335,371 
Total property and equipment  $70,529,919   $47,757,208 
Less accumulated depreciation   (14,566,664)   (10,119,402)
Net property and equipment   55,963,225    37,637,806 

 

Depreciation Expense for the years ended March 31, 2023, 2022, and 2021 totaled $4,452,908, $4,266,126, and $2,904,968, respectively. Of these totals $3,747,723, $3,101,929, and $2,674,161 were included in cost of goods sold for the years ending March 31, 2023, 2022, and 2021. Additionally, $705,185, $1,164,197, and $230,797 were included in depreciation and amortization expenses in operating expenses.

 

NOTE 7 – FACTORING LIABILITY

 

On July 1, 2019, we entered into a Factoring and Security Agreement with Factors Southwest, LLC (“FSW”). FSW may purchase from time to time the Company’s Accounts Receivables with recourse on an account by account basis. The twenty-four month agreement contains a maximum advance amount of $5,000,000 on 85% of eligible accounts and has an annualized interest rate of the Prime Rate published from time to time by the Wall Street Journal plus 4.5%. The agreement a contains fee of 3% ($150,000) of the Maximum Facility assessed to the Company. Our obligations under this agreement are secured by present and future accounts receivables and related assets, inventory, and equipment. The Company has the right to terminate the agreement, with 30 days written notice, upon obtaining a non-factoring credit facility. This agreement provides the Company with the ability to convert our account receivables into cash. We did not have an outstanding balance on our Factoring liability as of March 31, 2023. As of March 31, 2022, the outstanding balance of the Factoring Liability was $485,671. Interest expense recognized on the Factoring Liability for the year ended March 31, 2023 was $153,646, including $37,500 of amortization of the commitment fee, for the year ended March 31, 2022, $327,746, including $100,000 of amortization of the commitment fee, for the year ended March 31, 2021, $305,747, including $50,000 of amortization of the commitment fee.

 

On June 17, 2021, this agreement was amended which extended the maturity date to June 17, 2024.

 

NOTE 8 – INVENTORY CREDIT FACILITY

 

On June 17, 2020, we entered into a Revolving Inventory Loan and Security Agreement with FSW. FSW will establish a revolving credit line, and make loans from time to time to the Company for the purpose of providing capital. The twenty-four month agreement secured by our inventory, among other assets, contains a maximum loan amount of $1,750,000 on eligible inventory and has an annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%. The agreement contains a fee of 2% of the maximum loan amount ($35,000) assessed to the Company. On July 31, 2020, the Company amended its Revolving Loan and Security Agreement to increase the maximum inventory loan amount to $2,250,000. As of March 31, 2022, the outstanding balance of the Inventory Credit Facility was $825,675 and no outstanding balance remained as of March 31, 2023. Interest expense recognized on the Inventory Credit Facility for the year ended March 31, 2023 was $6,580, for the year ended March 31, 2022 was $40,940, including $8,561 of amortization of the annual fee, and for the year ended March 31, 2021 was $171,414, including $36,439 of amortization of the annual fee.

 

NOTE 9 – LEASES

 

We lease office, manufacturing, and warehouse space in Scottsdale, AZ, Atlanta and Marietta, GA, and Manitowoc, WI under contracts we classify as operating leases. None of our leases are financing leases. The Scottsdale lease does not include a renewal option. In August of 2021 we extended the lease of our Atlanta offices through May of 2027, accordingly we increased our Right of Use Assets and Operating Lease Liabilities by $501,125 at September 30, 2021. In January of 2022, we extended the lease of our second Manitowoc, WI location and increased our Right of Use Assets and Operating Lease Liabilities by $308,326. We terminated our lease agreement in our first Manitowoc, WI location during the year ended March 31, 2023. Accordingly, we decreased our Right of Use Assets and Operating Lease Liabilities by $901,076.

 

As of March 31, 2023 and March 31, 2022, total Right of Use Assets were $1,261,634 and $2,791,850, respectively. As of March 31, 2023 and March 31, 2022, total Operating Lease Liabilities were $1,374,224 and $2,922,780, respectively. The current portion of our Operating Lease Liability on March 31, 2023 and March 31, 2022 is $470,734 and $831,429, respectively, and is reported as a current liability. The remaining $903,490 of the total $1,374,224 for the year ended March 31, 2023 and the $2,091,351 of the total $2,922,780 for the year ended March 31, 2022 of the Operating Lease Liability is presented as a long-term liability net of the current portion.

 

F-17
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Consolidated lease expense for the year ended March 31, 2023 was $881,171 including $861,777 of operating lease expense and $19,394 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2022 was $1,221,473 including $1,177,589 of operating lease expense and $43,884 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2021 was $844,441 including $742,433 of operating lease expense and $102,008 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals.

 

The weighted average remaining lease term and weighted average discount rate for operating leases were 3.3 years and 10.0%, respectively at March 31, 2023 and were 3.5 years and 10.0%, respectively at March 31, 2022.

 

Future minimum lease payments under non-cancellable leases as of March 31, 2023 are as follows:

 

Years Ended March 31,    
2024  $583,768 
2025   387,214 
2026   351,962 
2027   257,508 
2028   43,660 
Thereafter   - 

Total Lease Payments

   1,624,112 
Less: Amount Representing Interest   (249,888)
Present value of lease liabilities  $1,374,224 

 

NOTE 10 – NOTES PAYABLE – RELATED PARTY

 

In connection with the acquisition of the casing division of Jagemann Stamping Company (“JSC”), a $10,400,000 promissory note was executed on March 14, 2020. The promissory note, under which $500,000 was paid on March 25, 2019 using funds raised for the acquisition, had a remaining balance at March 31, 2019 of $9,900,000. On April 30, 2019, the original due date of the note was subsequently extended to April 1, 2020. The note bears interest per annum at approximately 4.6% payable in arrears monthly. In May of 2019, the Company paid $1,500,000 on the balance of the note. The note is secured by all the equipment purchased from JSC. JSC owned at least five percent (5%) of our shares outstanding from March 2019 through March 16, 2021.

 

Post-closing of the transaction, it was made apparent that certain equipment that was agreed to be delivered free and clear by the Seller was not achievable as Seller was not able to purchase equipment that Seller had leased. Accordingly, the remaining value of the promissory note was reduced by $2,596,200. As a result of the change to the purchase price of the transaction, the Company reduced Equipment for a net value of $1,871,306, decreased Other Intangible Assets by $766,068, increased Accounts Receivable by $31,924, and recorded an increase to Deposits for $9,250 worth of equipment that the Company agreed to transfer back to Seller. Consequently, accumulated amortization has decreased by $159,530. Additionally, the Company entered into a lease to gain possession of the assets that were originally to be transferred.

 

On June 26, 2020, the Company, Enlight Group II, LLC (“Enlight”), the Company’s wholly owned subsidiary and JSC entered into a Settlement Agreement pursuant to which the parties mutually agreed to settle all disputes and mutually release each other from liabilities related to the Amended APA occurring prior to June 26, 2020. Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, which was reclassed from accounts payable, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering. Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.

 

As a result of the Settlement Agreement, the Company agreed to forego $1,000,000 in Construction in Progress that the parties had previously agreed to exchange. As a result, the Company recognized a loss in operating expenses for the year ended March 31, 2021.

 

On November 5, 2020, the Company paid $6,000,000 to JSC allocated as follows: (i) payment in full of Note A, representing the balance due from the Company to JSC relating to the acquisition of Jagemann Munition Components in March 2019 and (ii) $592,982 remitted in partial payment of Note B, resulting in the parties’ execution of Amended Note B which has a starting principal balance of $1,687,664 (“Amended Note B”). The Amended Note B principal balance carries a 9% per annum interest rate and is amortized equally over the thirty six (36) month term. As a result of the payment in full of Note A JSC shall release the accompanying security interest in Company assets which secured Note A. Concurrently, upon entry into Amended Note B, JSC and the Company entered into the First Amendment to General Business Security Agreement to reflect a revised list of collateral in which JSC has a security interest. The total interest expense recognized on Note A was $216,160 for the year ended March 31, 2021. The total interest expense recognized on the original Note B was $62,876 for the year ended March 31, 2021.

 

F-18
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company’s balance of Amended Note B was $180,850 at March 31, 2023 and $865,771 at March 31, 2022. The Company recognized $48,665, $110,518, and $60,100 in interest expense on Amended Note B for the years ended March 31, 2023, 2022, and 2021, respectively.

 

On May 3, 2019, the Company entered into a promissory note of $375,000 with a shareholder of the Company. The original interest rate was the applicable LIBOR Rate. The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020. The amended note bears interest at 1.25% per month. The Company made $18,195 in principal payments during the nine months ended December, 2020 and the Note was paid in full in July of 2020. We recognized $10,327 of interest expenses related to the note during the year ended March 31, 2021.

 

In December of 2019, the Company entered into a Promissory Note of $90,000 with Fred Wagenhals, the Company’s Chief Executive Officer and Chairman of the Board of Directors. The Note originally matured on June 12, 2020 and had an interest rate at the applicable LIBOR Rate. The promissory note has since been amended and the amended maturity date is September 18, 2020. The Company made $25,000 in principal payments during the year ended March 31, 2021 and the Note was paid in full in July of 2020. The amended note bears interest at 1.25% per month. We recognized $5,350 of interest expense on the note for the year ended March 31, 2021.

 

On September 23, 2020, the Company and Enlight entered into a promissory note (the “Forest Street Note”) with Forest Street, LLC (“Lender”), an Arizona limited liability company wholly owned by our current Chief Executive Officer, Fred Wagenhals, for the principal sum of $3.5 million, which accrues interest at 12% per annum. The Note has a maturity date of September 23, 2022.

 

Pursuant to the terms of the Forest Street Note, the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.

 

On December 14, 2020, the Company entered into a Debt Conversion Agreement with the Lender Pursuant to the Agreement, the Company and Forest Street agreed to convert $2,100,000 of the Note’s principal into 1,000,000 shares of the Company’s common stock. The share issuance occurred on December 15, 2020. As a result of the Debt Conversion Agreement the remaining balance of the Forest Street Note was $1,400,000. On January 14, 2021, the Company paid the remaining $1,400,000 in principal and accrued interest of the Forest Street Note. The Company recognized $137,666 in interest expense related to the Forest Street Note for the year ended March 31, 2021.

 

On January 22, 2021, the Company repurchased 1,000,000 shares of the Company’s common stock issued to JSC at a price of $1.50 per share pursuant to the Amended APA.

 

F-19
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11 – CONSTRUCTION NOTE PAYABLE

 

On October 14, 2021, we entered into a Construction Loan Agreement (the “Loan Agreement”) with Hiawatha National Bank (“Hiawatha”). The Loan Agreement specifies that Hiawatha may lend up to $11,625,000 to the Borrower to pay a portion of the construction costs of an approximately 160,000 square foot manufacturing facility to be constructed on our property (the “Loan”). The first advance of Loan funds by Hiawatha was made on October 14, 2021 in the amount of $329,843. We received advances of Loan funds approximately every month as our “owner’s equity” was fully funded into the ongoing new plant construction project. The Loan is an advancing term loan and not a revolving loan so any portion of the principal repaid cannot be reborrowed.

 

Additionally, on October 14, 2021, we issued a Promissory Note in favor of Hiawatha (the “Note”) in the amount of up to $11,625,000 with an interest rate of four and one-half percent (4.5%). The maturity date of the Note is October 14, 2026. Under the terms of the Loan Agreement, we are required to make monthly payments of $64,620 which consists of principial and interest until the maturity date, at which time the remaining principial balance of the Loan would become due.

 

We can prepay the Note in whole or in part starting in July 2022 with a prepayment premium of one percent (1%) of the principal being prepaid.

 

The Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Loan Agreement or Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of five percent (5%) of the amount due will be owed with all amounts then owed pursuant to the Note bearing interest at an increased rate.

 

For the year ended March 31, 2023 approximately $11.2 million of Loan funds were advanced including $1.0 million of cash collateral or restricted cash as security for the Loan. We made $150,743 in principal payments for the year ended March 31, 2023. The restricted cash can be released per the terms documented in the Loan Agreement filed with the Commission on Form 10-Q on February 14, 2022. During the year ended March 31, 2023, $500,000 of restricted cash was released to the Company.

 

F-20
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12 – CAPITAL STOCK

 

Our authorized capital consists of 200,000,000 shares of common stock with a par value of $0.001 per share.

 

During the year ended March 31, 2021, we issued 47,895,828 shares of common stock as follows:

 

  34,512,143 shares were sold to investors for $138,564,619
  3,145,481 shares were issued for the conversion of convertible promissory notes for $4,831,206
  6,521,563 shares were issued to investors for exercised warrants valued for $13,952,336
  732,974 shares were issued for cashless exercise of 1,300,069 warrants
  1,000,000 shares were issued pursuant to a debt conversion agreement for $2,100,000
  943,336 shares were issued for services provided to the Company valued at $1,707,500
  1,016,331 shares valued at $1,450,359 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation
  24,000 shares were issued to investors for $48,000 in liquidation damage fees
  1,000,000 shares were repurchased from JSC for a total value of $1,500,000 and subsequently cancelled

 

During the year ended March 31, 2022, we issued 23,385,780 shares of common stock as follows:

 

  20,000,000 shares were issued in connection with our merger of Gemini Direct Investments, LLC valued at $142,691,282
  431,080 shares were issued to investors for exercised warrants valued for $943,907
  374,584 shares were issued for cashless exercise of 443,110 warrants
  772,450 shares valued at $1,631,701 were issued for services and equipment provided to the Company
  1,807,666 shares valued at $5,759,000 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation

 

During the year ended March 31, 2023, we issued 2,077,059 shares of common stock as follows:

 

  200,003 shares were issued to investors for exercised warrants valued for $101,506
  99,762 shares were issued for cashless exercise of 100,000 warrants
  1,777,294 shares valued at $5,807,779 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation

 

At March 31, 2023, 2022, and 2021 outstanding and exercisable stock purchase warrants consisted of the following:

SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2020   8,504,372   $2.10    3.60 
Granted   2,925,204    2.31    2.47 
Exercised   (7,821,631)   2.08    - 
Forfeited or cancelled   -    -    - 
Outstanding at March 31, 2021   3,607,945   $2.31    3.24 
Exercisable at March 31, 2021   3,179,730   $2.27    3.05 

 

SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2021   3,607,945   $2.31    3.24 
Granted   200,000    0.01    3.92 
Exercised   (874,190)   1.76    - 
Forfeited or cancelled   -    -    - 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Exercisable at March 31, 2022   2,933,755   $2.32    2.29 

 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Granted   150,000    0.01    4.5 
Exercised   (300,003)   0.34    - 
Forfeited or cancelled   (322,806)   2.00    - 
Outstanding at March 31, 2023   2,460,946   $2.46    1.59 
Exercisable at March 31, 2023   2,460,946   $2.46    1.59 

 

As of March 31, 2023, we had 2,460,946 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,448,758 shares of our Common Stock at an exercise price of $2.00 per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.

 

NOTE 13 – PREFERRED STOCK

 

On May 18, 2021, the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, voting powers, limitations as to dividends or other distributions, qualifications, terms and conditions of redemption and other terms and conditions of the Series A Preferred Stock.

 

The Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”), as to dividend rights and rights as to the distribution of assets upon the Company’s liquidation, dissolution or winding-up, ranks: (1) senior to all classes or series of Common Stock and to all other capital stock issued by the Company expressly designated as ranking junior to the Series A Preferred Stock; (2) on parity with any future class or series of the Company’s capital stock expressly designated as ranking on parity with the Series A Preferred Stock; (3) junior to any future class or series of the Company’s capital stock expressly designated as ranking senior to the Series A Preferred Stock; and (4) junior to all the Company’s existing and future indebtedness.

 

F-21
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Series A Preferred Stock has no stated maturity and is not subject to mandatory redemption or any sinking fund. In the event of the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of shares for the Series A Preferred Stock are entitled to be paid out of the Company’s assets legally available for distribution to its stockholders (i.e., after satisfaction of all the Company’s liabilities to creditors, if any) an amount equal to $25.00 per share of the Series A Preferred Stock, plus any amount equal to any accumulated and unpaid dividends to the date of payment before any distribution or payment may be made to holders of shares of Common Stock or any other class of or series of the Corporation’s capital stock ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Stock.

 

The Company will pay cumulative cash dividends on the Series A Preferred Stock when, as and if declared by its board of directors (or a duly authorized committee of its board of directors), only out of funds legally available for payment of dividends. Dividends on the Series A Preferred Stock will accrue on the stated amount of $25.00 per share of the Series A Preferred Stock at a rate per annum equal to 8.75% (equivalent to $2.1875 per year), payable quarterly in arrears. Dividends on the Series A Preferred Stock declared by our board of directors (or a duly authorized committee of our board of directors) will be payable quarterly in arrears on March 15, June 15, September 15 and December 15.

 

Generally, the Series A Preferred Stock is not redeemable by the Company prior to May 18, 2026. However, upon a change of control or delisting event (each as defined in the Certificate of Designations), the Company will have a special option to redeem the Series A Preferred Stock for a limited period of time.

 

On May 19, 2021, we entered into an underwriting agreement (the “Underwriting Agreement”) with Alexander Capital, L.P., as representative of several underwriters (collectively, the “Underwriters”), relating to a firm commitment public offering of 1,097,200 newly issued shares of our 8.75% Series A Preferred Stock at a public offering price of $25.00 per share. Under the terms of the Underwriting Agreement, we granted the Underwriters a 45-day option to purchase up to an additional 164,580 shares of Series A Preferred Stock from us. The gross proceeds to us from the sale of 1,097,200 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, was $27,430,000. The closing of the offering took place on May 21, 2021.

 

On May 25, 2021, we entered into an additional underwriting agreement with Alexander Capital, L.P. relating to a firm commitment public offering of 138,220 newly issued shares of our Series A Preferred Stock at a public offering price of $25.00 per share. The closing of the offering took place on May 27, 2021. The gross proceeds to us from the sale of 138,220 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, were $3,455,500. Additionally, the Underwriters exercised its previously announced over-allotment option to purchase 164,580 shares of Series A Preferred Stock pursuant to that certain Underwriting Agreement dated May 19, 2021, by and between us and Alexander Capital, L.P., as representative of the several underwriters identified therein. We closed the exercise of the over-allotment option on May 27, 2021. The gross proceeds from the exercise of the over-allotment option were $4,114,500, before deducting underwriting discounts and commissions.

 

F-22
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Preferred dividends accumulated as of March 31, 2022 were $144,562. On August 27, 2021 the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning May 21, 2021 (the first issuance date of the Series A Preferred Stock) through and including June 30, 2021 payable on September 15, 2021 to holders of record of Series A Preferred Stock on August 31, 2021 equal to $0.241246528 per share. Dividends totaling $337,745 were paid on September 15, 2021. On November 17, 2021, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning July 1, 2021 through and including December 14, 2021 payable on December 15, 2021 to holders of record of Series A Preferred Stock on November 30, 2021 equal to $1.01475694444444 per share. Dividends totaling $1,420,660 were paid on December 15, 2021. On February 18, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning December 15, 2021 through and including March 14, 2022 payable on March 15, 2022 to holders of record of Series A Preferred Stock on February 28, 2022 equal to $0.546875 per share. Dividends totaling $765,642 were paid on March 15, 2022.

 

Preferred dividends accumulated as of March 31, 2023 were $144,618. On February 17, 2023, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning December 15, 2022 through and including March 14, 2023 payable on March 15, 2023 to holders of record of Series A Preferred Stock on February 28, 2023 equal to $0.546875 per share. Dividends totaling $765,625 were paid on March 15, 2023. On November 18, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning September 15, 2022 through and including December 14, 2022 payable on December 15, 2022 to holders of record of Series A Preferred Stock on November 30, 2022 equal to $0.5529514 per share. Dividends totaling $774,132 were paid on December 15, 2022. On August 17, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning June 15, 2022 through and including September 14, 2022 payable on September 15, 2022 to holders of record of Series A Preferred Stock on August 31, 2022 equal to $0.55902778 per share. Dividends totaling $782,639 were paid on September 15, 2022. On May 12, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning March 15, 2022 through and including June 14, 2022 payable on June 15, 2022 to holders of record of Series A Preferred Stock on May 31, 2022 equal to $0.559027777777778 per share. Dividends totaling $782,639 were paid on June 15, 2022.

 

NOTE 14 – ACQUISITIONS

 

Gemini Direct Investments, LLC

 

On April 30, 2021 (the “Effective Date”) we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Sub”), Gemini Direct Investments, LLC, a Nevada limited liability company (“Gemini”), and Steven F. Urvan, an individual (the “Seller”), whereby Sub merged with and into Gemini, with Sub surviving the merger as a wholly owned subsidiary of the Company (the “Merger”). At the time of the Merger, Gemini had nine (9) subsidiaries, all of which are related to Gemini’s ownership of the Gunbroker.com business. Gunbroker.com is an on-line auction marketplace dedicated to firearms, hunting, shooting, and related products. The Merger was completed on the Effective Date.

 

In consideration of the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, on the Effective Date, (i) the Company assumed and repaid an aggregate amount of indebtedness of Gemini and its subsidiaries equal to $50,000,000 (the “Assumed Indebtedness”); and, (ii) the issued and outstanding membership interests in Gemini (the “Membership Interests”), held by the Seller, automatically converted into the right to receive (A) $50,000,000 (the “Cash Consideration”), and (B) 20,000,000 shares of common stock of the Company, $0.001 par value per share (the “Stock Consideration”).

 

In connection with the Merger Agreement, the Company and the Seller agreed that the Stock Consideration consisted of: (a) 14,500,000 shares issued without being held in escrow or requiring prior stockholder approval; (b) 4,000,000 shares issued subject to the Pledge and Escrow Agreement; and (c) 1,500,000 shares that will not be issued prior to the Company obtaining stockholder approval for the issuance (the “Additional Securities”).

 

The total estimated consideration consisted of cash payment of $50,000,000 less $1,350,046 of acquired cash, a working capital adjustment of $2,000,000, debt assumption and repayment upon closing of $50,000,000, contingent consideration of $10,755,000 for 1,500,000 Additional Securities, and 18,500,000 shares of AMMO Inc. Common Stock. The shares were valued at $7.17 per share, the five-day average closing price of the Company’s Common Stock immediately preceding the signing of the binding agreement.

 

Pursuant to the Merger Agreement, the Company completed a Post-Closing Adjustment following the close of the Merger equal to the Closing Working Capital minus the Estimated Working Capital at closing of the Merger. Accordingly, the Company received a cash payment of $129,114 and adjusted the $2,000,000 Estimated Working Capital Adjustment in the fair value of the consideration transferred to $1,870,886.

 

F-23
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

In accordance with the acquisition method of accounting for business combinations, the assets acquired, and the liabilities assumed have been recorded at their respective fair values. The consideration in excess of the fair values of assets acquired, and liabilities assumed are recorded as goodwill, which we expect to be deductible for tax purposes. The goodwill consists largely of the growth and profitability expected from this Merger.

 

The fair value of the consideration transferred was valued as follows:

 

SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED

      
Cash  $48,649,954 
Working capital adjustment   1,870,886 
Contingent consideration   10,755,000 
Common stock   132,645,000 
Assumed debt   50,000,000 
      
Fair value of consideration transferred    $243,920,840 

 

The allocation for the consideration recorded for the acquisition is as follows:

 

SCHEDULE OF ALLOCATION FOR CONSIDERATION

      
Accounts receivable, net  $17,002,362 
Prepaid expenses   478,963 
Equipment   1,051,980 
Deposits   703,389 
Other Intangible assets(1)   146,617,380 
Goodwill(1)   90,870,094 
Right of use assets - operating leases   612,727 
Accounts payable   (12,514,919)
Accrued expenses   (196,780)
Operating lease liability   (704,356)
      
Total Consideration  $243,920,840 

 

(1) Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.

 

We recorded approximately $1.3 million in transaction costs in the year ended March 31, 2022 related to the above acquisition.

 

Unaudited Pro Forma Results of Operations

 

These pro forma results of operations give effect to the acquisition as if it had occurred on April 1, 2021. Material pro forma adjustments include the removal of approximately $1.8 million of interest expenses and debt discount amortization and the addition of approximately $0.9 million of depreciation and amortization expenses.

 

SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS

INCOME STATEMENT DATA 

For the Year Ended

March 31, 2022

 
     
Net revenues  $248,314,587 
Net income  $37,793,924 

 

The unaudited pro forma condensed combined financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations and financial position that would have been achieved had the acquisition been completed and taken place on the dates indicated or the future consolidated results of operations or financial position of the Company.

 

F-24
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 15 – ACCRUED LIABILITIES

 

At March 31, 2023 and March 31, 2022, accrued liabilities were as follows:

 

SCHEDULE OF ACCRUED LIABILITIES

   March 31, 2023   March 31, 2022 
Accrued FAET  $1,808,065   $2,408,318 
Accrued professional fees   736,323    66,000 
Income taxes payable   403,739   1,749,488 
Accrued sales commissions   252,366    932,712 
Unearned revenue   101,593    201,891 
Accrued interest   2,681    4,762 
Accrued payroll   430,344    458,027 
Other accruals   618,243    357,616 
Accrued liabilities  $4,353,354   $6,178,814 

 

NOTE 16– RELATED PARTY TRANSACTIONS

 

On November 3, 2022, AMMO, Inc. (the “Company”) entered into a Settlement Agreement (the “Settlement Agreement”) with Steven F. Urvan and Susan T. Lokey (collectively with each of their respective affiliates and associates, the “Urvan Group”).

 

Pursuant to the Settlement Agreement, the Urvan Group has agreed to withdraw its notice of stockholder nomination of its seven director candidates (the “Urvan Candidates”) and its demand to inspect books and records, pursuant to Section 220 of the General Corporation Law of the State of Delaware, and the Company agreed to immediately increase the size of the Board from seven to nine directors and appoint Christos Tsentas and Wayne Walker (each, a “New Director” and the New Directors together with Mr. Urvan, the “Urvan Group Directors”) to the Board to serve as directors with terms expiring at the 2022 annual meeting of stockholders (the “2022 Annual Meeting”). The Company will include the Urvan Group Directors in its director candidates slate for the 2022 Annual Meeting and any subsequent annual meeting of stockholders of the Company occurring prior to the Termination Date (as defined below). The Company has agreed to not increase the size of the Board above nine directors prior to the Termination Date unless the increase is approved by at least seven directors. Mr. Wagenhals will continue to serve as a director and Chairman of the Board.

 

Unless otherwise mutually agreed to in writing by each party, the Settlement Agreement will remain in effect until the date that is the earlier of (i) 30 days prior to the earlier of (A) the deadline set forth in the notice requirements of Federal “Universal Proxy Rules” promulgated under Rule 14a-19(a) and Rule 14a-19(b) under the Securities Exchange Act of 1934, as amended (the “UPR Deadline”) relating to the Company’s 2023 annual meeting of stockholders (the “2023 Annual Meeting”) and (B) any deadline that may be set forth in the Company’s Amended and Restated Certificate of Incorporation (as amended from time to time, the “Certificate”) or Bylaws (the “Bylaws”) following the execution of the Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2023 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2022 Annual Meeting (such date, the “Termination Date”). However, if the Company notifies Mr. Urvan in writing at least 15 days prior to such Termination Date that the Board irrevocably offers to re-nominate the Urvan Group Directors for election at the 2023 Annual Meeting and Mr. Urvan accepts such offer within 15 days of receipt of such notice, the Termination Date will be automatically extended until the earlier of (i) 30 days prior to the earlier of (A) the UPR Deadline relating to the Company’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”) and (B) any deadline that may be set forth in the Certificate or the Bylaws following execution of the Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2024 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2023 Annual Meeting. Notwithstanding the foregoing, the “Termination Date” shall not occur prior to 20 days after Mr. Urvan’s departure from the Board.

 

Pursuant to the Settlement Agreement, the Company will suspend the previously announced separation of Company into Action Outdoor Sports, Inc. and Outdoor Online, Inc., pending the further evaluation of strategic options by the Board. The Company paid approximately $500,000 of the Urvan Group’s costs, fees and expenses per the terms of the Settlement Agreement. Additionally, the Company issued 125,000 shares of Common Stock for a total value of $437,500 to an employee and issued 110,000 shares of Common Stock for a total value of $385,000 to an independent contractor as a result of termination without cause per the terms of the Settlement Agreement.

 

The foregoing summary of the Settlement Agreement does not purport to be complete and is subject to, and qualified in its entirety, by reference to the full text of the Settlement Agreement, a copy of which was previously filed as Exhibit 10.1 in the Form 8-K filed with the SEC on November 7, 2022, and incorporated herein by reference.

 

During the year ended March 31, 2023, we paid $551,916 in service fees to two independent contractors of which $223,333 were created as a result of termination without cause as a result of our Proxy Settlement Agreement. The two independent contractors 141,419 shares of our common stock for a total value of $494,967 in addition to the issuances described in the foregoing paragraphs. We issued 45,000 shares in the aggregate to its advisory committee members for service for a total value of $129,750. Through our acquisition of Gemini, a related party relationship was created through one of our Members of the Board of Directors by ownership of entities that transacts with Gemini. We recognized $215,300 in Marketplace Revenue for the year ended March 31, 2022 that was attributable to that relationship. There was $182,344 included in our Accounts Receivable at March 31, 2023 as a result of this relationship.

 

During the year ended March 31, 2022, we paid $229,083 in service fees to an independent contractor and 60,000 shares in the aggregate to its advisory committee members for service for a total value of $173,000. Through our acquisition of Gemini, a related party relationship was created through one of our Members of the Board of Directors by ownership of an entity that transacts with Gemini. We recognized $1,042,277 in Marketplace Revenue for the year ended March 31, 2022 that was attributable to that relationship. There was $139,164 included in our Accounts Receivable at March 31, 2022 as a result of this relationship.

 

In connection with the acquisition of the casing division of JSC, a promissory note was executed. On April 30, 2019, the note was subsequently extended to April 1, 2020. The note bears interest per annum at approximately 4.6% payable in arrears monthly. On June 26, 2020, the Company extended the promissory note until August 15, 2021. As of March 31, 2021, we accrued interest of $352,157 related to the note. The was paid in full on November 5, 2020. JSC owned at least five percent (5%) of our shares outstanding from March 2019 through March 16, 2021.

 

In October of 2019, it was made apparent that certain equipment that was agreed to be delivered free and clear by the Seller was not achievable as Seller was not able to purchase equipment that Seller had leased. Accordingly, the remaining value of the promissory note was reduced by $2,596,200. As a result of the change to the purchase price of the transaction, the Company reduced Equipment for a net value of $1,871,306, decreased Other Intangible Assets by $766,068, increased Accounts Receivable by $31,924, and recorded an increase to Deposits for $9,250 worth of equipment that the Company agreed to transfer back to Seller. Consequently, accumulated amortization has decreased by $159,530. Additionally, the Company entered into a lease to gain possession of the assets that were originally to be transferred.

 

Through the Administrative and Management Services Agreement the Company with JSC, the Company purchased approximately incurred $2.0 million in inventory support services, and $170,355 of rent expenses for the year ended March 31, 2023. Through the Administrative and Management Services Agreement the Company with JSC, the Company purchased approximately incurred $1.7 million in inventory support services, and $408,852 of rent expenses for the year ended March 31, 2022. For the year ended March 31, 2021, the Company purchased approximately $3.4 million in inventory support services, and incurred $405,171 of rent expenses for the year ended March 31, 2021.

 

F-25
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On June 26, 2020, the Company and JSC entered into a Settlement Agreement pursuant to which the parties mutually agreed to settle all disputes and mutually release each other from liabilities related to the Amended APA occurring prior to June 26, 2020. Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering. Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.

 

On November 5, 2020, the Company paid $6,000,000 to JSC allocated as follows: (i) payment in full of Note A, representing the balance due from the Company to JSC relating to the acquisition of Jagemann Munition Components in March 2019 and (ii) $592,982 remitted in partial payment of Note B, resulting in the parties’ execution of Amended Note B which has a starting principal balance of $1,687,664 (“Amended Note B”). The Amended Note B principal balance carries a 9% per annum interest rate and is amortized equally over the thirty six (36) month term. As a result of the payment in full of Note A JSC shall release the accompanying security interest in Company assets which secured Note A. Concurrently, upon entry into Amended Note B, JSC and the Company entered into the First Amendment to General Business Security Agreement to reflect a revised list of collateral in which JSC has a security interest. The total interest expense recognized on Note A $216,160 for the year ended March 31, 2021. The total interest expense recognized on the original Note B was $62,876 for the year ended March 31, 2021.

 

The Company’s balance of Amended Note B was $180,850 and $865,771 at March 31, 2023 and 2022, respectively. The Company recognized $48,665, $110,518, and $60,100 in interest expense on Amended Note B for the years ended March 31, 2023, 2022, and 2021, respectively.

 

On January 22, 2021, the Company repurchased 1,000,000 shares of the Company’s common stock issued to JSC at a price of $1.50 per share pursuant to the Amended APA.

 

On May 3, 2019, the Company entered into a promissory note of $375,000 with a shareholder of the Company. The original interest rate was the applicable LIBOR Rate. The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020. The amended note bears interest at 1.25% per month. The Company made $18,195 in principal payments during the nine months ended December, 2020 and the Note was paid in full in July of 2020. We recognized $10,327 of interest expenses related to the note during the year ended March 31, 2021.

 

In December of 2019, the Company entered into a Promissory Note of $90,000 with Fred Wagenhals, the Company’s Chief Executive Officer and Chairman of the Board of Directors. The Note originally matured on June 12, 2020 and had an interest rate at the applicable LIBOR Rate. The promissory note has since been amended and the amended maturity date is September 18, 2020. The Company made $25,000 in principal payments during the year ended March 31, 2021 and the Note was paid in full in July of 2020. The amended note bears interest at 1.25% per month. We recognized $5,350 of interest expense on the note for the year ended March 31, 2021.

 

On September 23, 2020, the Company and Enlight entered into a promissory note (the “Forest Street Note”) with Forest Street, LLC (“Lender”), an Arizona limited liability company wholly owned by our current Chief Executive Officer, Fred Wagenhals, for the principal sum of $3.5 million, which accrues interest at 12% per annum. The Note has a maturity date of September 23, 2022.

 

Pursuant to the terms of the Forest Street Note, the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.

 

On December 14, 2020, the Company entered into a Debt Conversion Agreement with the Lender Pursuant to the Agreement, the Company and Forest Street agreed to convert $2,100,000 of the Note’s principal into 1,000,000 shares of the Company’s common stock. The share issuance occurred on December 15, 2020. As a result of the Debt Conversion Agreement the remaining balance of the Forest Street Note was $1,400,000. On January 14, 2021, the Company paid the remaining $1,400,000 in principal and accrued interest of the Forest Street Note. The Company recognized $137,666 in interest expense related to the Forest Street Note for the year ended March 31, 2021.

 

F-26
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 17 – INCOME TAXES

 

The income tax (provision) benefit for the periods shown consist of the following:

 

   2023   2022    2021  
Current                  
US Federal  $-   $(1,302,811)     -  
US State   -    (446,677)     -  
Total current provision   -    (1,749,488)     -  
Deferred                  
US Federal   (578,679)   (7,727,011)     582,724  
US State   (151,559)   (2,649,261)     137,276  
Total deferred benefit   (730,238)   (10,376,272)     720,000  
Change in valuation allowance   -    8,839,791      (720,000 )
Income tax (provision) benefit  $(730,238)  $(3,285,969)     -  

 

The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision is as follows:

 

   2023   2022    2021  
Computed tax expense  $21%  $21%     21 %
State taxes, net of Federal income tax benefit   6%   7%     5 %
Change in valuation allowance   0%   24%     (10 )%
Employee stock awards   (40)%   4%     (5 )%
Stock grants   (2)%   0%     (1 )%
Stock for services   0%   0%     (6 )%
Other   1%   0%     0 %
Non-deductible meals & entertainment   0 %   0%     0 %
Contingent consideration fair value   1%   1%     0 %
Stock and Warrants on Note Conversion   (5)%   1%     (4 )%
Total provision for income taxes  $(18)%  $9%     0 %

 

The Company’s effective tax rates was (18%) for the year ended March 31, 2023. During the year ended March 31, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to Employee stock awards.

 

F-27
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Significant components of the Company’s deferred tax liabilities and assets are as follows:

 

   2023   2022 
Deferred tax assets          
Net operating loss carryforward  $871,331   $- 
Loss on purchase   826,311    879,319 
Other   -    - 
Total deferred tax assets  $1,697,642   $879,319 
           
Deferred tax liabilities          
Depreciation expense  $(2,906,214)  $(2,208,361)
Other   (1,101,020)   (207,439)
Total deferred tax liabilities  $(4,007,234)  $(2,415,800)
Net deferred tax assets/(liabilities)  $(2,309,592)  $(1,536,481)
Valuation allowance   -    - 
Net deferred tax assets/(liabilities)  $(2,309,592)  $(1,536,481)

 

The Company accounts for uncertain tax positions in accordance with ASC No. 740-10-25. ASC No. 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC No. 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. To the extent that the final tax outcome of these matters is different than the amount recorded, such differences impact income tax expense in the period in which such determination is made. Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. ASC No. 740-10-25 also requires management to evaluate tax positions taken by the Company and recognize a liability if the Company has taken uncertain tax positions that more likely than not would not be sustained upon examination by applicable taxing authorities. The Company has evaluated tax positions taken by the Company and has concluded that as of March 31, 2023 and 2022, there are no uncertain tax positions taken, or expected to be taken, that would require recognition of a liability that would require disclosure in the financial statements.

 

The Company has never had an Internal Revenue Service audit; therefore, the tax periods ended December 31, 2016, December 31, 2017 and March 31, 2018, 2019, 2020, 2021, 2022, and 2023 are subject to audit.

 

F-28
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 18 – GOODWILL AND INTANGIBLE ASSETS

 

During our fiscal year ended March 31, 2022, we recorded $90,870,094 of Goodwill generated from our Merger with Gemini. The balance of Goodwill at March 31, 2023 and 2022 was $90,870,094. We did not have any goodwill prior to the year ended March 31, 2022.

 

Total amortization expense of our intangible assets was $13,072,967, $13,072,967 and $1,971,188 for the years ended March 31, 2023, 2022, and 2021, respectively.

 

Intangible assets consisted of the following:

 

      March 31, 2023 
   Life  Licenses   Patent   Other Intangible Assets 
Licensing Agreement – Jesse James  5  $125,000   $-   $- 
Licensing Agreement – Jeff Rann  5   125,000    -    - 
Streak Visual Ammunition patent  11.2   -    950,000    - 
SWK patent acquisition  15   -    6,124,005    - 
Jagemann Munition Components:                  
Customer Relationships  3   -    -    1,450,613 
Intellectual Property  3   -    -    1,543,548 
Tradename  5   -    -    2,152,076 
GDI Acquisition:                  
Tradename  15   -    -    76,532,389 
Customer List  10   -    -    65,252,802 
Intellectual Property  10   -    -    4,224,442 
Other Intangible Assets  5   -    -    607,747 
       250,000    7,074,005    151,763,617 
                   
Accumulated amortization – Licensing Agreements      (250,000)   -    - 
Accumulated amortization – Patents      -    (2,041,251)   - 
Accumulated amortization – Intangible Assets      -    -    (28,036,807)
      $-   $5,032,754   $123,726,810 

 

      March 31, 2022 
   Life  Licenses   Patent   Other Intangible Assets 
Licensing Agreement – Jesse James  5  $125,000   $-   $- 
Licensing Agreement – Jeff Rann  5   125,000    -    - 
Streak Visual Ammunition patent  11.2   -    950,000    - 
SWK patent acquisition  15   -    6,124,005    - 
Jagemann Munition Components:                  
Customer Relationships  3   -    -    1,450,613 
Intellectual Property  3   -    -    1,543,548 
Tradename  5   -    -    2,152,076 
GDI Acquisition:                  
Tradename  15   -    -    76,532,389 
Customer List  10   -    -    65,252,802 
Intellectual Property  10   -    -    4,224,442 
Other Intangible Assets  5   -    -    607,747 
       250,000    7,074,005    151,763,617 
                   
Accumulated amortization – Licensing Agreements      (250,000)   -    - 
Accumulated amortization – Patents      -    (1,547,787)   - 
Accumulated amortization – Intangible Assets      -    -    (15,463,230)
      $-   $5,526,218   $136,300,387 

 

Annual estimated amortization of intangible assets for the next five fiscal years are as follows:

 

Years Ended March 31,  Estimates for
Fiscal Year
 
2024  $13,102,785 
2025   12,664,775 
2026   12,664,775 
2027   12,553,355 
2028   12,543,226 
Thereafter   65,230,648 
Annual amortization of intangible assets  $128,759,564 

 

F-29
 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 19 – SEGMENTS

 

On April 30, 2021, the Company entered into an agreement and plan of merger with Gemini, which, along with its subsidiaries, engages primarily in the operation of an online marketplace dedicated to firearms, hunting, shooting and related products. As a result, at March 31, 2023, our Chief Executive Officer reviews financial performance based on two operating segments as follows:

 

  Ammunition – which consists of our manufacturing business. The Ammunition segment engages in the design, production and marketing of ammunition, ammunition component and related products.
  Marketplace – which consists of the GunBroker.com Ecommerce marketplace. In its role as an auction site, GunBroker.com supports the lawful sale of firearms, ammunition and hunting/shooting accessories.

 

In the current period, we began the reporting of the separate allocation of certain corporate general and administrative expenses including non-cash stock compensation expense, as such we have updated the prior period disclosure herein. The following tables set forth certain financial information utilized by management to evaluate our operating segments for the annual periods presented:

 

   Ammunition   Marketplace   Corporate
and other
expenses
   Total 
   For the Year Ended March 31, 2023 
   Ammunition   Marketplace   Corporate
and other
expenses
   Total 
                 
Net Revenues  $128,290,128   $63,149,673   $-   $191,439,801 
Cost of Revenues   126,914,265    9,116,939    -    136,031,204 
General and administrative expense   10,378,456    9,707,425    25,302,873    45,388,754 
Depreciation and amortization   578,326    12,700,436    -    13,278,762 
Income/(Loss) from Operations  $(9,580,919)  $31,624,873   $(25,302,873)  $(3,258,919)

 

   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
   For the Year Ended March 31, 2022 
   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
                 
Net Revenues  $175,660,650   $64,608,516   $-   $240,269,166 
Cost of Revenues   142,773,306    8,732,351    -    151,505,657 
General and administrative expense   11,932,721    8,434,308    17,544,970    37,911,999 
Depreciation and amortization   1,579,778    12,122,370    -    13,702,148 
Income/(Loss) from Operations  $19,374,845   $35,319,487   $(17,544,970)  $37,149,362 

 

   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
   For the Year Ended March 31, 2021 
   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
                 
Net Revenues  $62,482,330   $              -   $-   $62,482,330 
Cost of Revenues   51,095,679    -    -    51,095,679 
General and administrative expense   4,269,558    -    10,837,834    15,107,392 
Depreciation and amortization   1,659,243    -    -    1,659,243 
Income/(Loss) from Operations  $5,475,850   $-   $10,834,834   $(5,379,984)

 

Total assets by segment were as follows:

 

   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition  $154,044,607   $160,305,107    $ 179,379,341  
Marketplace   258,290,780    253,873,206      -  
   $412,335,387   $414,178,313    $ 179,379,341  

 

Total capital expenditures by segment were as follows:

   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition  $10,819,177   $17,728,023    $ 7,437,265  
Marketplace   1,722,148    1,490,959      -  
   $12,541,325   $19,218,982    $ 7,437,265  

 

NOTE 20 - SUBSEQUENT EVENT

 

Common Stock Issuances

 

Subsequent to March 31, 2023, we issued 25,111 shares of Common Stock to our employees, independent contractors and Members of our Board of Directors as compensation for a total value of $45,346 or $1.81 per share.

 

 

Note Payable Related Party Repayment

 

Subsequent to March 31, 2023, we repaid the remaining outstanding principal balance on Amended Note B.

 

F-30

EX-4.14 2 ex4-3.htm

 

Exhibit 4.3

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES

 

General

 

As of June 14, 2023, AMMO, Inc. (the “Company”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) our common stock, par value $0.001 per share; and (ii) our 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 per share (the “Series A Preferred Stock”).

 

The following description summarizes the most important terms of our common stock and Series A Preferred Stock. This summary does not purport to be complete and is qualified in its entirety by the provisions of our amended and restated certificate of incorporation, certificate of designations of the Series A Preferred Stock, and bylaws, copies of which have been incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.3 is a part. For a complete description of our capital stock, you should refer to our amended and restated certificate of incorporation, certificate of designations of the Series A Preferred Stock, and bylaws, and to the applicable provisions of Delaware law.

 

Our authorized capital stock consists of 200,000,000 shares of common stock, $0.001 par value per share, and 10,000,000 shares of preferred stock, $0.001 par value per share, of which 1,680,000 have been designated Series A Preferred Stock. The outstanding shares of our common stock and Series A Preferred Stock are fully paid and nonassessable.

 

Common Stock

 

Listing

 

Our common stock trades on the Nasdaq Capital Market under the symbol “POWW.”

 

Dividend Rights

 

Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock will be entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine.

 

Voting Rights

 

Holders of our common stock are entitled to one vote for each share held on all matters properly submitted to a vote of stockholders on which holders of common stock are entitled to vote. We have not provided for cumulative voting for the election of directors in our amended and restated certificate of incorporation. The directors will be elected by a plurality of the outstanding shares entitled to vote on the election of directors.

 

No Preemptive or Similar Rights

 

Our common stock is not entitled to preemptive rights, and is not subject to conversion, redemption or sinking fund provisions.

 

Right to Receive Liquidation Distributions

 

If we become subject to a liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.

 

 
 

 

Preferred Stock

 

Our board of directors is authorized, subject to limitations prescribed by Delaware law, to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series, and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Our board of directors can also increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding) the number of shares of any series of preferred stock, without any further vote or action by our stockholders. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock or other series of preferred stock. The issuance of preferred stock, while providing flexibility in connection with possible financings, acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control of our company and might adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock.

 

Series A Preferred Stock

 

Listing

 

Our Series A Preferred Stock trades on the Nasdaq Capital Market under the symbol “POWWP.”

 

No Maturity, Sinking Fund or Mandatory Redemption

 

The Series A Preferred Stock has no stated maturity and will not be subject to any sinking fund or mandatory redemption. Shares of the Series A Preferred Stock will remain outstanding indefinitely unless we decide to redeem or otherwise repurchase them. We are not required to set aside funds to redeem the Series A Preferred Stock.

 

Ranking

 

The Series A Preferred Stock will rank, with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up:

 

  (1) senior to all classes or series of our common stock and to all other equity securities issued by us other than equity securities referred to in clauses (2) and (3) below;
     
  (2) on a parity with all equity securities issued by us with terms specifically providing that those equity securities rank on a parity with the Series A Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up;
     
  (3) junior to all equity securities issued by us with terms specifically providing that those equity securities rank senior to the Series A Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up (please see the section entitled “Voting Rights” below); and
     
  (4) effectively junior to all of our existing and future indebtedness (including indebtedness convertible to our common stock or preferred stock) and to any indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our existing subsidiaries.

 

Dividends

 

Holders of shares of the Series A Preferred Stock are entitled to receive, when, as and if declared by the Board of Directors, out of funds of the Company legally available for the payment of dividends, cumulative cash dividends at the rate of 8.75% of the $25.00 per share liquidation preference per annum (equivalent to $2.1875 per annum per share). Dividends on the Series A Preferred Stock shall be payable on a quarterly basis on the fifteenth day of each of March, June, September, and December; provided that if any dividend payment date is not a business day, as defined in the certificate of designations, then the dividend that would otherwise have been payable on that dividend payment date may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after that dividend payment date to that next succeeding business day. Any dividend payable on the Series A Preferred Stock, including dividends payable for any partial dividend period, will be computed on the basis of a 360-day year consisting of twelve 30-day months, however, the shares of Series A Preferred Stock offered hereby will be credited as having accrued dividends since May 21, 2021. Dividends will be payable to holders of record as they appear in our stock records for the Series A Preferred Stock at the close of business on the applicable record date, which shall be the last day of the calendar month, whether or not a business day, immediately preceding the month in which the applicable dividend payment date falls. As a result, holders of shares of Series A Preferred Stock will not be entitled to receive dividends on a dividend payment date if such shares were not issued and outstanding on the applicable dividend record date.

 

 
 

 

No dividends on shares of Series A Preferred Stock shall be authorized by our board of directors or paid or set apart for payment by us at any time when the terms and provisions of any agreement of ours, including any agreement relating to our indebtedness, prohibit the authorization, payment or setting apart for payment thereof or provide that the authorization, payment or setting apart for payment thereof would constitute a breach of the agreement or a default under the agreement, or if the authorization, payment or setting apart for payment shall be restricted or prohibited by law. You should review the information appearing above under “Risk Factors—We may not be able to pay dividends on the Series A Preferred Stock” for information as to, among other things, other circumstances under which we may be unable to pay dividends on the Series A Preferred Stock.

 

Notwithstanding the foregoing, dividends on the Series A Preferred Stock will accrue whether or not we have earnings, whether or not there are funds legally available for the payment of those dividends and whether or not those dividends are declared by our board of directors. No interest, or sum in lieu of interest, will be payable in respect of any dividend payment or payments on the Series A Preferred Stock that may be in arrears, and holders of the Series A Preferred Stock will not be entitled to any dividends in excess of full cumulative dividends described above. Any dividend payment made on the Series A Preferred Stock shall first be credited against the earliest accumulated but unpaid dividend due with respect to those shares.

 

Future distributions on our common stock and preferred stock, including the Series A Preferred Stock will be at the discretion of our board of directors and will depend on, among other things, our results of operations, cash flow from operations, financial condition and capital requirements, any debt service requirements and any other factors our board of directors deems relevant. Accordingly, we cannot guarantee that we will be able to make cash distributions on our preferred stock or what the actual distributions will be for any future period.

 

Unless full cumulative dividends on all shares of Series A Preferred Stock have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past dividend periods, no dividends (other than in shares of common stock or in shares of any series of preferred stock that we may issue ranking junior to the Series A Preferred Stock as to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up) shall be declared or paid or set aside for payment upon shares of our common stock or preferred stock that we may issue ranking junior to, or on a parity with, the Series A Preferred Stock as to the payment of dividends or the distribution of assets upon liquidation, dissolution or winding up. Nor shall any other distribution be declared or made upon shares of our common stock or preferred stock that we may issue ranking junior to, or on a parity with, the Series A Preferred Stock as to the payment of dividends or the distribution of assets upon liquidation, dissolution or winding up. Also, any shares of our common stock or preferred stock that we may issue ranking junior to or on a parity with the Series A Preferred Stock as to the payment of dividends or the distribution of assets upon liquidation, dissolution or winding up shall not be redeemed, purchased or otherwise acquired for any consideration (or any moneys paid to or made available for a sinking fund for the redemption of any such shares) by us (except by conversion into or exchange for our other capital stock that we may issue ranking junior to the Series A Preferred Stock as to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up).

 

When dividends are not paid in full (or a sum sufficient for such full payment is not so set apart) upon the Series A Preferred Stock and the shares of any other series of preferred stock that we may issue ranking on a parity as to the payment of dividends with the Series A Preferred Stock, all dividends declared upon the Series A Preferred Stock and any other series of preferred stock that we may issue ranking on a parity as to the payment of dividends with the Series A Preferred Stock shall be declared pro rata so that the amount of dividends declared per share of Series A Preferred Stock and such other series of preferred stock that we may issue shall in all cases bear to each other the same ratio that accrued dividends per share on the Series A Preferred Stock and such other series of preferred stock that we may issue (which shall not include any accrual in respect of unpaid dividends for prior dividend periods if such preferred stock does not have a cumulative dividend) bear to each other. No interest, or sum of money in lieu of interest, shall be payable in respect of any dividend payment or payments on the Series A Preferred Stock that may be in arrears.

 

 
 

 

Liquidation Preference

 

In the event of our voluntary or involuntary liquidation, dissolution or winding up, the holders of shares of Series A Preferred Stock will be entitled to be paid out of the assets we have legally available for distribution to our shareholders, subject to the preferential rights of the holders of any class or series of our capital stock we may issue ranking senior to the Series A Preferred Stock with respect to the distribution of assets upon liquidation, dissolution or winding up, a liquidation preference of $25.00 per share, plus an amount equal to any accumulated and unpaid dividends to, but not including, the date of payment, before any distribution of assets is made to holders of our common stock or any other class or series of our capital stock we may issue that ranks junior to the Series A Preferred Stock as to liquidation rights.

 

In the event that, upon any such voluntary or involuntary liquidation, dissolution or winding up, our available assets are insufficient to pay the amount of the liquidating distributions on all outstanding shares of Series A Preferred Stock and the corresponding amounts payable on all shares of other classes or series of our capital stock that we may issue ranking on a parity with the Series A Preferred Stock in the distribution of assets, then the holders of the Series A Preferred Stock and all other such classes or series of capital stock shall share ratably in any such distribution of assets in proportion to the full liquidating distributions to which they would otherwise be respectively entitled.

 

Holders of Series A Preferred Stock will be entitled to written notice of any such liquidation, dissolution or winding up no fewer than 30 days and no more than 60 days prior to the payment date. After payment of the full amount of the liquidating distributions to which they are entitled, the holders of Series A Preferred Stock will have no right or claim to any of our remaining assets. The consolidation or merger of us with or into any other corporation, trust or entity or of any other entity with or into us, or the sale, lease, transfer or conveyance of all or substantially all of our property or business, shall not be deemed a liquidation, dissolution or winding up of us (although such events may give rise to the special optional redemption to the extent described below).

 

Redemption

 

The Series A Preferred Stock is not redeemable by us prior to May 18, 2026, except as described below under “—Special Optional Redemption.”

 

Optional Redemption. On and after May 18, 2026, we may, at our option, upon not less than 30 nor more than 60 days’ written notice, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25.00 per share, plus any accumulated and unpaid dividends thereon to, but not including, the date fixed for redemption.

 

Special Optional Redemption. Upon the occurrence of a Change of Control, we may, at our option, upon not less than 30 nor more than 60 days’ written notice, redeem the Series A Preferred Stock, in whole or in part, within 120 days after the first date on which such Change of Control occurred, for cash at a redemption price of $25.00 per share, plus any accumulated and unpaid dividends thereon to, but not including, the redemption date.

 

In connection with any redemption of Series A Preferred Stock, we shall pay, in cash, any accumulated and unpaid dividends to, but not including, the redemption date, unless a redemption date falls after a dividend record date and prior to the corresponding dividend payment date, in which case each holder of Series A Preferred Stock at the close of business on such dividend record date shall be entitled to the dividend payable on such shares on the corresponding dividend payment date notwithstanding the redemption of such shares before such dividend payment date. Except as provided above, we will make no payment or allowance for unpaid dividends, whether or not in arrears, on shares of the Series A Preferred Stock to be redeemed.

 

 
 

 

Unless full cumulative dividends on all shares of Series A Preferred Stock have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past dividend periods, no shares of Series A Preferred Stock shall be redeemed unless all outstanding shares of Series A Preferred Stock are simultaneously redeemed and we shall not purchase or otherwise acquire directly or indirectly any shares of Series A Preferred Stock (except by exchanging it for our capital stock ranking junior to the Series A Preferred Stock as to the payment of dividends and distribution of assets upon liquidation, dissolution or winding up); provided, however, that the foregoing shall not prevent the purchase or acquisition by us of shares of Series A Preferred Stock pursuant to a purchase or exchange offer made on the same terms to holders of all outstanding shares of Series A Preferred Stock.

 

Subject to applicable law, we may purchase shares of Series A Preferred Stock in the open market, by tender or by private agreement. Any shares of Series A Preferred Stock that we acquire may be retired and reclassified as authorized but unissued shares of preferred stock, without designation as to class or series, and may thereafter be reissued as any class or series of preferred stock.

 

Voting Rights

 

Holders of the Series A Preferred Stock do not have any voting rights, except as set forth below or as otherwise required by law.

 

On each matter on which holders of Series A Preferred Stock are entitled to vote, each share of Series A Preferred Stock will be entitled to one vote. In instances described below where holders of Series A Preferred Stock vote with holders of any other class or series of our preferred stock as a single class on any matter, the Series A Preferred Stock and the shares of each such other class or series will have one vote for each $25.00 of liquidation preference (excluding accumulated dividends) represented by their respective shares.

 

Whenever dividends on any shares of Series A Preferred Stock are in arrears for four or more consecutive or non-consecutive quarterly dividend periods, the number of directors constituting our board of directors will be automatically increased by two (if not already increased by two by reason of the election of directors by the holders of any other class or series of our preferred stock we may issue upon which like voting rights have been conferred and are exercisable and with which the Series A Preferred Stock is entitled to vote as a class with respect to the election of those two directors) and the holders of Series A Preferred Stock (voting separately as a class with all other classes or series of preferred stock we may issue upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Series A Preferred Stock in the election of those two directors) will be entitled to vote for the election of those two additional directors (the “preferred stock directors”) at a special meeting called by us at the request of the holders of record of at least 25% of the outstanding shares of Series A Preferred Stock or by the holders of any other class or series of preferred stock upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Series A Preferred Stock in the election of those two preferred stock directors (unless the request is received less than 90 days before the date fixed for the next annual or special meeting of shareholders, in which case, such vote will be held at the earlier of the next annual or special meeting of shareholders), and at each subsequent annual meeting until all dividends accumulated on the Series A Preferred Stock for all past dividend periods and the then current dividend period have been fully paid or declared and a sum sufficient for the payment thereof set aside for payment. In that case, the right of holders of the Series A Preferred Stock to elect any directors will cease and, unless there are other classes or series of our preferred stock upon which like voting rights have been conferred and are exercisable, any preferred stock directors elected by holders of the Series A Preferred Stock shall immediately resign and the number of directors constituting the board of directors shall be reduced accordingly. In no event shall the holders of Series A Preferred Stock be entitled under these voting rights to elect a preferred stock director that would cause us to fail to satisfy a requirement relating to director independence of any national securities exchange or quotation system on which any class or series of our capital stock is listed or quoted. For the avoidance of doubt, in no event shall the total number of preferred stock directors elected by holders of the Series A Preferred Stock (voting separately as a class with all other classes or series of preferred stock we may issue upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Series A Preferred Stock in the election of such directors) under these voting rights exceed two.

 

 
 

 

If a special meeting is not called by us within 30 days after request from the holders of Series A Preferred Stock as described above, then the holders of record of at least 25% of the outstanding Series A Preferred Stock may designate a holder to call the meeting at our expense.

 

If, at any time when the voting rights conferred upon the Series A Preferred Stock are exercisable, any vacancy in the office of a preferred stock director shall occur, then such vacancy may be filled only by a written consent of the remaining preferred stock director, or if none remains in office, by vote of the holders of record of the outstanding Series A Preferred Stock and any other classes or series of preferred stock upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Series A Preferred Stock in the election of the preferred stock directors. Any preferred stock director elected or appointed may be removed only by the affirmative vote of holders of the outstanding Series A Preferred Stock and any other classes or series of preferred stock upon which like voting rights have been conferred and are exercisable and which classes or series of preferred stock are entitled to vote as a class with the Series A Preferred Stock in the election of the preferred stock directors, such removal to be effected by the affirmative vote of a majority of the votes entitled to be cast by the holders of the outstanding Series A Preferred Stock and any such other classes or series of preferred stock, and may not be removed by the holders of the common stock.

 

So long as any shares of Series A Preferred Stock remain outstanding, we will not, without the affirmative vote or consent of the holders of at least two-thirds of the votes entitled to be cast by the holders of the Series A Preferred Stock outstanding at the time, given in person or by proxy, either in writing or at a meeting (voting together as a class with all other series of parity preferred stock that we may issue upon which like voting rights have been conferred and are exercisable), (a) authorize or create, or increase the authorized or issued amount of, any class or series of capital stock ranking senior to, or on parity with, the Series A Preferred Stock with respect to payment of dividends or the distribution of assets upon liquidation, dissolution or winding up or reclassify any of our authorized capital stock into such shares, or create, authorize or issue any obligation or security convertible into or evidencing the right to purchase any such shares; or (b) amend, alter, repeal or replace our amended and restated certificate of incorporation, including by way of a merger, consolidation or otherwise in which we may or may not be the surviving entity, so as to materially and adversely affect and deprive holders of Series A Preferred Stock of any right, preference, privilege or voting power of the Series A Preferred Stock (each, an “Event”). An increase in the amount of the authorized preferred stock, including the Series A Preferred Stock, or the creation or issuance of any additional Series A Preferred Stock or other series of preferred stock that we may issue, or any increase in the amount of authorized shares of such series, in each case ranking junior to the Series A Preferred Stock with respect to payment of dividends or the distribution of assets upon liquidation, dissolution or winding up, shall not be deemed an Event and will not require us to obtain two-thirds of the votes entitled to be cast by the holders of the Series A Preferred Stock and all such other similarly affected series, outstanding at the time (voting together as a class).

 

The foregoing voting provisions will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all outstanding shares of Series A Preferred Stock shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been deposited in trust to effect such redemption.

 

Except as expressly stated in the certificate of designations or as may be required by applicable law, the Series A Preferred Stock do not have any relative, participating, optional or other special voting rights or powers and the consent of the holders thereof shall not be required for the taking of any corporate action.

 

Information Rights

 

During any period in which we are not subject to Section 13 or 15(d) of the Exchange Act and any shares of Series A Preferred Stock are outstanding, we will use our best efforts to (i) transmit by mail (or other permissible means under the Exchange Act) to all holders of Series A Preferred Stock, as their names and addresses appear on our record books and without cost to such holders, copies of the Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q that we would have been required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act if we were subject thereto (other than any exhibits that would have been required) and (ii) promptly, upon request, supply copies of such reports to any holders or prospective holder of Series A Preferred Stock. We will use our best effort to mail (or otherwise provide) the information to the holders of the Series A Preferred Stock within 15 days after the respective dates by which a periodic report on Form 10-K or Form 10-Q, as the case may be, in respect of such information would have been required to be filed with the SEC, if we were subject to Section 13 or 15(d) of the Exchange Act, in each case, based on the dates on which we would be required to file such periodic reports if we were a “non-accelerated filer” within the meaning of the Exchange Act.

 

No Conversion Rights

 

The Series A Preferred Stock is not convertible into our common stock or any other security.

 

No Preemptive Rights

 

No holders of the Series A Preferred Stock will, as holders of Series A Preferred Stock, have any preemptive rights to purchase or subscribe for our common stock or any other security.

 

 

 

EX-10.5 3 ex10-5.htm

 

Exhibit 10.5

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “Agreement”) is made and entered into January 3, 2022 effective January 1, 2022, (the “Effective Date”) between AMMO, Inc., a Delaware corporation (the “Company”), and Fred W. Wagenhals (“Employee”). Company and Employee are sometimes referred to individually as “Party” and collectively as “Parties”.

 

RECITALS

 

A. The Company is a public company and its securities are quoted in the over-the-counter market under the ticker symbol “POWW”; and

 

B. The Employee and Company previously entered into an employment agreement dated March 24, 2020 having an effective date April 1, 2020 (“Prior Agreement”);

 

C. The Employee has experience in running public and private companies and the Company desires to hire Employee to serve as its Chief Executive Officer.

 

D. The Company and Employee desire to embody the terms and conditions of Employee’s employment in a written agreement, which will supersede all prior agreements of employment, whether written or oral, between the Company and Employee, including but not limited to the Prior Employment Agreement, pursuant to the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of their mutual covenants and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

ARTICLE I.

EMPLOYMENT DUTIES AND TERM

 

Section 1.1 Employment.

 

(a) The Company shall employ Employee as its Chief Executive Officer. In this capacity, Employee shall perform such duties, assume such responsibilities and devote such time, attention and energy to the business of the Company at such locations as the Company’s officers or Employee’s supervisor shall from time to time require; provided Employee shall not be required to relocate unless both Parties agree.

 

(b) Employee shall not, during the term of Employee’s employment hereunder, be engaged in any other activities if such activities materially interfere with Employee’s duties and responsibilities for the Company.

 

(c) Employee shall perform the following duties: See Exhibit “A” for list of duties

 

 
 

 

Section 1.2 Term. The term of this Agreement shall commence on the date first written above and shall continue, unless sooner terminated, until three (3) years following the Execution Date (the “Initial Term”); provided the Parties may mutually elect to terminate this Agreement at any time upon ninety (90) day written notice. Either Party shall have the right to extend this Agreement for up to three (3) additional one (1) year terms (the “Additional Terms,” and collectively with the Initial Term, the “Term”).

 

ARTICLE II.

COMPENSATION

 

Section 2.1 Compensation. During the Term of Employment, Company shall pay and Employee shall receive the following compensation:

 

(a) Salary. The Company shall pay Employee Four Hundred and Seventy Five Thousand Dollars ($475,000.00) per year during the Term paid in accordance with Company’s normal payroll practices (“Salary”).

 

(b) Stock Compensation. The Aggregate Restricted Share Compensation shall be 600,000 shares during the Initial Term. Employee shall earn 200,000 shares per year during the Term, or 50,000 shares of restricted stock in the Company (the “Shares”) per quarter, which shall be earned and issued on a quarterly basis as is set forth on Exhibit “B” (the Restricted Shares Compensation”). Exhibit C sets forth the stock restrictions of the Shares (the “Share Restrictions”).

 

(i) The Restricted Share Compensation issued pursuant to this Section 2.1, in each case shall not be subject to adjustment in the event of a stock split, stock dividend, recapitalization or similar event. The amounts granted herein are intended to remain unchanged by such events unless expressly agreed upon by Employee and Company.

 

(c) Performance Bonus. In addition, during the Term Employee shall receive a quarterly bonus equal to .25% of the gross sales made by the Company, payable in arrears in cash (“Bonus”). The first quarter in which the Bonus shall be payable is December 31, 2021 (continuing unchanged from Employee’s Prior Employment Agreement. The Bonus shall be calculated at the close of each respective fiscal quarter end and shall payable as soon as practicable thereafter.

 

Section 2.2 Participation in Employee Benefit Plans; Incentive Programs. Employee shall be entitled to participate in any employee benefit plans, the Company may establish or adopt for the benefit of employees of the Company. During the Term the Company shall provide Employee with health and medical insurance benefits with 100% of monthly premiums paid for by Company for the Employee and his/her immediate family.

 

Section 2.3 Time Off. Employee shall be entitled to 4 weeks of paid time off per year, whether because of sickness, vacation or to service Employee’s outside business interest as Employee shall determine (“Time Off”). The timing of vacations shall be scheduled in a manner reasonably acceptable to the Company. Accrued but unused Time Off shall roll over to the next fiscal year and shall not be ‘use it or lose it’ Time Off.

 

2
 

 

Section 2.4 Expenses. The Company shall reimburse Employee’s reasonable and actual out-of-pocket expenses incurred by Employee which are approved in advance by the Company in the performance of his duties and responsibilities under this Agreement.

 

ARTICLE III.

TERMINATION OF EMPLOYMENT

 

Section 3.1 Death & Disability of Employee. In the event of the Employee’s death during the Term of Employment, this Agreement shall terminate immediately. If, during the Term, the Employee shall suffer a “Disability” within the meaning of Section 22(e)(3) of the Internal Revenue Code of 1986, the Company may terminate the Employee’s employment. Section 22(e)(3) provides, in relevant part: “An individual is permanently and totally disabled if he is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months.” In the event the Employee is terminated due to death or Disability, the Employee (or his estate in the event of his death) shall be receive (i) all of Employee’s unpaid Salary and a severance benefit of three (3) months pay, (ii) all Restricted Share Compensation, including the unvested portion, (iii) all reimbursable expenses and benefits owing to Employee through the date of Employee’s death together with any benefits payable under any life insurance program in which Employee is a participant, if applicable, and (iv) Employee’s estate shall be entitled to pro-rata share of the Bonus at the end the respective fiscal year.

 

Section 3.2 Termination With Cause By Company. The Company may terminate this Agreement at any time during the Term for “Cause” upon written notice to Employee, upon which termination shall be effective immediately. For purposes of this Agreement, “Cause” means the following, without limitation:

 

(a)Willful misconduct or willful failure by the Employee to perform his responsibilities to the Company or
(b)The conviction for any major felony involving moral turpitude that reflects adversely upon the standing of the Company in the community.

 

Section 3.3 Termination Without Cause By Company. The Company may terminate this Agreement at any time during the Term without “Cause” upon 60 days written notice to Employee.

 

Section 3.4 Termination By Employee for Good Reason. Employee may terminate this Agreement at any time by providing the Company 30 days’ written notice, with or without “Good Reason.” For purposes hereof, the term “Good Reason” shall exist upon (i) a material diminution in the Employees’ Salary; (ii) a material diminution in the Employee’s authority, duties or responsibilities; (iii) a material change in geographic location at which the Employee performs services; or (iv) any material breach by the Company of this Agreement. “Good Reason Process” means the following series of actions: (i) the Employee reasonably determines in good faith that Good Reason exists, (ii) the Employee notifies the Company or the acquiring or succeeding corporation (if applicable) in writing of the existence of Good Reason within 60 days of the occurrence of the event that gave rise to the existence of Good Reason, (iii) the Employee cooperates in good faith with the Company’s (or the acquiring or succeeding corporations, if applicable) efforts to remedy the conditions that gave rise to the existence of Good Reason for a period of 30 days following such notice (such 30 day period, the “Cure Period”), (iv) notwithstanding such efforts, Good Reason continues to exist and (v) the Employee terminates his employment within 30 days after the end of the Cure Period. For the avoidance of doubt, if the Company or the acquiring or succeeding corporation successfully remedies the conditions that gave rise to the existence of Good Reason during the Cure Period, Good Reason shall be deemed not to have existed. In the event the Employee terminates employment under this Agreement for Good Reason, the Employee shall be eligible to receive the severance benefits set forth in Section 3.6(b).

 

3
 

 

Section 3.5 Termination by the Employee without Good Reason. The Employee may terminate the Employee’s employment with the Company without Good Reason at any time subject to the Employee’s provision of thirty (30) days’ advance written notice to the Company (the “Applicable Notice Period”), provided, however, that the Company may, in its sole discretion, in lieu of all or part of the Applicable Notice Period, pay the Employee an amount equal to the Salary that would otherwise have been payable to the Employee had the Employee remained employed for the duration of the Applicable Notice Period. In such instance, the Employee’s termination will become effective on the date set forth in a written notice of termination to be provided by the Company (the “Early Termination Date”), and the Employee will be paid an amount equal to the base Salary the Employee would have received had the Employee remained employed by the Company between the Early Termination Date and the end of the Applicable Notice Period (the “Early Termination Payment”), with the Early Termination Payment to be made no later than the 30th day following the end of the Applicable Notice Period.

 

Section 3.6 Compensation upon Termination.

 

(a) In the event that the Company terminates the Employee’s employment hereunder due to a Termination for Cause or the Employee voluntarily terminates employment with the Company without Good Reason, the Employee shall be entitled to accrued but unpaid Salary, Restricted Shares Compensation which have vested, reimbursable expenses and benefits owing to Employee through the day on which Employee is terminated.

 

(b) In the event that the Company terminates the Employee’s employment hereunder due to a Termination without Cause or Employee terminates the employment hereunder for Good Reason, Employee shall be entitled to compensation, including base Salary, the Aggregate Restricted Shares Compensation set forth in Section 2.1 (b), the Bonus, and insurance benefits for a period of 12 months from the effective date of termination (the “Severance Period”). The Employee’s reimbursable expenses shall be paid within 15 days of Termination. Except as otherwise contemplated by this Agreement, Employee will not be entitled to any other compensation upon termination of this Agreement.

 

(c) The salary and fringe benefits to be paid are referred to herein as the “Termination Compensation.” Employee shall not be entitled to any Termination Compensation unless, Employee complies with all surviving provisions of any confidentiality agreement that Employee may have signed.

 

(d) If Employee terminates this Agreement by providing appropriate notice, the Company, at its election, Company may (i) require Employee to continue to perform duties hereunder for the full notice period, or (ii) terminate Employee employment at any time during such notice period, provided that any such termination shall not be deemed to be a termination without cause of Employee ‘s employment by the Company. Unless otherwise provided by this Section, all compensation and benefits paid by Company to Employee shall cease upon his last day of employment.

 

4
 

 

Section 3.7 Change in Control. In addition, notwithstanding the foregoing, in the event that Employee’s continuous status as an employee of the Company is terminated by the Company without Cause or Employee terminates the employment with the Company for Good Reason, in either case upon or within twelve (12) months after a Change in Control (“CoC”) as defined below then, subject to Employee’s execution of a standard release of claims in favor of the Company or its successor, (i) Employee shall receive the Salary for the duration of the Term, (ii) 100% of the total number of Restricted Shares Compensation which would be earned over the whole Term shall immediately become vested and issuable (minimum 600,000 shares over Initial Term), and (iii) Employee shall be entitled to the Bonus for the duration of the Term.

 

As used in this Agreement, “Change in Control” shall be deemed to have occurred if any “person” (as such term is used in Sections 13(d) and 14(d)(2) of the Exchange Act) is or becomes the beneficial owner, directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding securities; (ii) a sale of substantially all of the assets of the Company; or (iii) a liquidation of the Company.

 

ARTICLE IV.

RESTRICTIVE COVENANTS

 

Section 4.1 Confidentiality.

 

(a) Employee recognizes and acknowledges that Employee has had and will continue to have access to various trade secrets and/or proprietary information (collectively, the “Confidential Information”) concerning the Company. Employee acknowledges that the Confidential Information has been developed solely through the substantial efforts of the Company over a long period of time, and that such Confidential Information is valuable and unique and constitutes a trade secret of the Company.

 

(b) Employee agrees to keep all Confidential Information of the Company in strict confidence and agrees not to disclose any Confidential Information to any other person, firm, association, company, corporation or other entity for any reason except as such disclosure may be required in connection with his employment hereunder. Employee further agrees not to use any Confidential Information for any purpose except on behalf of the Company.

 

(c) For purposes of this Agreement, “Confidential Information” shall mean any information, process or idea that is not generally known in the industry, that the Company considers confidential and/or that gives the Company a competitive advantage, including, without limitation: (i) books and records relating to operation, finance, accounting, sales, personnel and management, (ii) policies and matters relating particularly to operations such as customer service requirements, costs of providing service and equipment, operating costs, and price matters, and (iii) various trade or business secrets, including business opportunities, marketing or business diversification plans, business development and bidding techniques, methods of processes, financial data and the like. If Employee is unsure whether certain information or material is Confidential Information, Employee shall treat that information or material as confidential unless Employee is informed by the Company, in writing, to the contrary. “Confidential Information” shall not include any information which: (i) is or becomes publicly available through no act or failure of Employee; (ii) was or is rightfully learned by Employee from a source other than the Company before being received from the Company; (iii) becomes independently available to Employee as a matter of right from a third Party having lawful right to make such communication; or (iv) is developed by Employee independently of any Confidential Information.

 

5
 

 

(d) Employee further agrees that upon termination of his employment with the Company, for whatever reason, Employee will surrender to the Company all of the property, notes, manuals, reports, documents and other things in Employee’s possession, including copies or computerized records thereof, which relate directly or indirectly to Confidential Information.

 

Section 4.2. Remedies. If the provisions of this Article are violated, or threatened to be violated, in whole or in part, the Company shall be entitled to a temporary restraining order or a preliminary injunction restraining or enjoining Employee from using or disclosing, in whole or in part, such Confidential Information, without prejudice to any other remedies the Company may have at law or in equity. If Employee violates this Article, Employee agrees that the Company would be irreparably harmed.

 

ARTICLE V.

CONDUCT

 

Section 5.1 No Derogatory Statements. Employee shall not engage in any pattern of conduct that involves the making or publishing of written or oral statements or remarks (including, without limitation, the repetition or distribution of derogatory rumors, allegations, negative reports or comments) which are disparaging, deleterious or damaging to the integrity, reputation or goodwill of the Company, its competitors or its management.

 

ARTICLE VI.

MISCELLANEOUS

 

Section 6.1 Assignment; Binding Effect; Amendment. This Agreement and the rights of the Parties under it may not be assigned (except by operation of law and except that it may be assigned by the Company to an Affiliated Entity) and shall be binding upon and shall inure to the benefit of the Parties and their successors and assigns. This Agreement, upon execution and delivery, constitutes a valid and binding agreement of the Parties enforceable in accordance with its terms and may be modified or amended only by a written instrument executed by all Parties hereto.

 

Section 6.2 Entire Agreement. This Agreement is the final, complete and exclusive statement and expression of the agreement among the Parties hereto with relation to the subject matter of this Agreement, it being understood that there are no oral representations, understandings or agreements covering the same subject matter as this Agreement. This Agreement supersedes, and cannot be varied, contradicted or supplemented by evidence of any prior or contemporaneous discussions, correspondence, or oral or written agreements of any kind.

 

6
 

 

Section 6.3 Counterparts. This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute but one and the same instrument.

 

Section 6.4 Notices. All notices or other communications required or permitted hereunder shall be in writing and may be given by depositing the same in United States mail, addressed to the Party to be notified, postage prepaid and registered or certified with return receipt requested, by nationally recognized overnight courier or by delivering the same in person to such Party.

 

(a)If to Employee, addressed to:

 

Fred Wagenhals

7681 E. Grey Road

Scottsdale, AZ 85260

 

(b)If to the Company, addressed to it at:

 

Ammo, Inc.

Attn: Fred Wagenhals

7681 E. Grey Road

Scottsdale, AZ 85260

 

Notice shall be deemed given and effective the day personally delivered, the day after being sent by overnight courier, subject to signature verification, and three business days after the deposit in the U.S. mail of a writing addressed as above and sent first class mail, certified, return receipt requested, or when actually received , if earlier. Any Party may change the address for notice by notifying the other Parties of such change in accordance with this Section.

 

Section 6.5 Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Arizona, without giving effect to any choice or conflict of law provision or rule (whether of the State of Arizona or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Arizona.

 

Section 6.6 No Waiver. No delay of or omission in the exercise of any right, power or remedy accruing to any Party as a result of any breach or default by any other Party under this Agreement shall impair any such right, power or remedy, nor shall it be construed as a waiver of or acquiescence in any such breach or default, or of or in any similar breach or default occurring later; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver.

 

Section 6.7 Captions. The headings of this Agreement are inserted for convenience only, and shall not constitute a part of this Agreement or be used to construe or interpret any provision hereof.

 

7
 

 

Section 6.8 Severability. In case any prov1s1on of this Agreement shall be invalid, illegal or unenforceable, it shall, to the extent possible, be modified in such manner as to be valid, legal and enforceable but so as most nearly to retain the intent of the Parties. If such modification is not possible, such provision shall be severed from this Agreement. In either case the validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby.

 

Section 6.9 Construction. The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement. Any reference to any federal, state, local or foreign statute shall be deemed to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The word “including” means including, without limitation. The Parties intend that representations, warranties and covenants contained herein shall have independent significance. If any Party has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) that the Party has not breached shall not detract from or mitigate the fact the Party is in breach of the first representation, warranty or covenant.

 

Section 6.10 No Derogatory Statement. The Company shall not engage in any pattern of conduct that involves the making or publishing of written or oral statements or remarks (including, without limitation, the repetition or distribution of derogatory rumors, allegations, negative reports or comments) which are disparaging, deleterious or damaging to the integrity or reputation of Employee.

 

Section 6.11 Indemnification by the Company. The Company shall indemnify, defend and hold Employee harmless from any liabilities, obligations, claims, penalties, fines or losses resulting from any unauthorized or unlawful acts of the Company which contravene any applicable statute, rule, regulation or order of any jurisdiction, foreign or domestic.

 

Section 6.12 Headings. The headings used herein are for convenience only and do not limit the contents of this Agreement.

 

8
 

 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed effective as of the day and year first above written.

 

  AMMO, INC.
   
  /s/ Robert Wiley
  By: Robert Wiley
  Its: Chief Financial Officer
   
  EMPLOYEE
   
  /s/ Fred Wagenhals
  By: Fred Wagenhals
  Its: Chief Employee Officer

 

9
 

 

Supplemental Information For

EMPLOYMENT AGREEMENT

 

Dated January 3, 2022

 

The following is a list of Exhibits to the above referenced Agreement, not attached herewith. Any omitted information will be furnished to the Securities and Exchange Commission upon request.

 

1. Exhibit “A” Roles And Responsibilities Chief Financial Officer For AMMO, INC. (the “Company”)

2. Exhibit “B” The Restricted Shares Compensation

3. Exhibit “C” Share Restrictions

 

10

 

EX-10.6 4 ex10-6.htm

 

Exhibit 10.6

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “Agreement”) is made and entered into January 29, 2021 effective January 29, 2021, (the “Effective Date”) between AMMO, Inc., a Delaware corporation (the “Company”), and Robert D. Wiley (“Employee”). Company and Employee are sometimes referred to individually as “Party” and collectively as “Parties”.

 

RECITALS

 

A. The Company is a public company and its securities are quoted in the over-the-counter market under the ticker symbol “POWW”; and

 

B. The Employee has experience in running public and private companies and the Company desires to hire Employee to serve as its Chief Financial Officer.

 

C. The Company and Employee desire to embody the terms and conditions of Employee’s employment in a written agreement, which will supersede all prior agreements of employment, whether written or oral, between the Company and Employee, pursuant to the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of their mutual covenants and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

ARTICLE I.

EMPLOYMENT DUTIES AND TERM

 

Section 1.1 Employment.

 

(a) The Company shall employ Employee as its Chief Financial Officer. In this capacity, Employee shall perform such duties, assume such responsibilities and devote such time, attention and energy to the business of the Company at such locations as the Company’s officers or Employee’s supervisor shall from time to time require; provided Employee shall not be required to relocate unless both Parties agree.

 

(b) Employee shall not, during the term of Employee’s employment hereunder, be engaged in any other activities if such activities materially interfere with Employee’s duties and responsibilities for the Company.

 

(c) Employee shall perform the following duties: See Exhibit “A” for list of duties

 

Section 1.2 Term. The term of this Agreement shall commence on the date first written above and shall continue, unless sooner terminated, until three (3) years following the Execution Date (the “Initial Term”); provided either Party may mutually elect to terminate this Agreement at any time upon ninety (90) day written notice. Either Party shall have the right to extend this Agreement for up to three (3) additional one (1) year terms (the “Additional Terms,” and collectively with the Initial Term, the “Term”).

 

 
 

 

ARTICLE II.

COMPENSATION

 

Section 2.1 Compensation. During the Term of Employment, Company shall pay and Employee shall receive the following compensation:

 

(a) Salary. The Company shall pay Employee One Hundred and Thirty Thousand Dollars ($165,000.00) per year during the Term paid in accordance with Company’s normal payroll practices (“Salary”). The Salary may be incrementally increased annually upon review of Employee’s performance of duties, at the discretion of the Board of Directors.

 

(b) Stock Compensation. Employee shall earn an aggregate 300,000 shares during the Initial Term, or 100,000 shares of restricted stock in the Company (the “Shares”) per year, which shall be earned and issued on a quarterly basis as is set forth on Exhibit “B” (the Restricted Shares Compensation”). Exhibit C sets forth the stock restrictions of the Shares (the “Share Restrictions”). (the “Shares Delivery Date”). Company and Employee agree that Employee may file a Section 83(b) election with the Internal Revenue Service in a form to be agreed to prior to the Commencement of Employment (the “Shares Grant Date”) and which shall be filed by Employee within thirty (30) days of the Shares Grant Date.

 

(i) The Restricted Share Compensation issued pursuant to this Section 2.1, in each case shall not be subject to adjustment in the event of a stock split, stock dividend, recapitalization or similar event. The amounts granted herein are intended to remain unchanged by such events unless expressly agreed upon by Employee and Company.

 

(c) Performance Bonus. Employee shall be eligible to earn an annual bonus up to 20% of Employee’s Salary to be issued in the sole discretion of the Board of Directors (“Bonus”). The first year in which the Bonus shall be payable is March 31, 2021.

 

Section 2.2 Participation in Employee Benefit Plans; Incentive Programs. Employee shall be entitled to participate in any employee benefit plans, the Company may establish or adopt for the benefit of employees of the Company.

 

Section 2.3 Time Off. Employee shall be entitled to 4 weeks of paid time off per year, whether because of sickness, vacation or to service Employee’s outside business interest as Employee shall determine (“Time Off”). The timing of vacations shall be scheduled in a manner reasonably acceptable to the Company. Accrued but unused Time Off shall roll over to the next fiscal year and shall not be ‘use it or lose it’ Time Off.

 

Section 2.4 Expenses. The Company shall reimburse Employee’s reasonable and actual out-of-pocket expenses incurred by Employee which are approved in advance by the Company in the performance of his duties and responsibilities under this Agreement.

 

2
 

 

ARTICLE III.

TERMINATION OF EMPLOYMENT

 

Section 3.1 Death & Disability of Employee. In the event of the Employee’s death during the Term of Employment, this Agreement shall terminate immediately. If, during the Term, the Employee shall suffer a “Disability” within the meaning of Section 22(e)(3) of the Internal Revenue Code of 1986, the Company may terminate the Employee’s employment. Section 22(e)(3) provides, in relevant part: “An individual is permanently and totally disabled if he is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months.” In the event the Employee is terminated due to death or Disability, the Employee (or his estate in the event of his death) shall be receive (i) all of Employee’s unpaid Salary and a severance benefit of 3 months pay, (ii) all Restricted Share Compensation, including the unvested portion, (iii) all reimbursable expenses and benefits owing to Employee through the date of Employee’s death together with any benefits payable under any life insurance program in which Employee is a participant, if applicable, and (iv) Employee’s estate shall be entitled to pro-rata share of the Bonus at the end the respective fiscal year.

 

Section 3.2 Termination With Cause By Company. The Company may terminate this Agreement at any time during the Term for “Cause” upon written notice to Employee, upon which termination shall be effective immediately. For purposes of this Agreement, “Cause” means the following, without limitation:

 

(a)Willful misconduct or willful failure by the Employee to perform his responsibilities to the Company or
(b)The conviction for any major felony involving moral turpitude that reflects adversely upon the standing of the Company in the community.

 

Section 3.3 Termination Without Cause By Company. The Company may terminate this Agreement at any time during the Term without “Cause” upon 30 days written notice to Employee.

 

Section 3.4 Termination By Employee for Good Reason. Employee may terminate this Agreement at any time by providing the Company 30 days’ written notice, with or without “Good Reason.” For purposes hereof, the term “Good Reason” shall exist upon (i) a material diminution in the Employees’ Salary; (ii) a material diminution in the Employee’s authority, duties or responsibilities; (iii) a material change in geographic location at which the Employee performs services; or (iv) any material breach by the Company of this Agreement. “Good Reason Process” means the following series of actions: (i) the Employee reasonably determines in good faith that Good Reason exists, (ii) the Employee notifies the Company or the acquiring or succeeding corporation (if applicable) in writing of the existence of Good Reason within 60 days of the occurrence of the event that gave rise to the existence of Good Reason, (iii) the Employee cooperates in good faith with the Company’s (or the acquiring or succeeding corporations, if applicable) efforts to remedy the conditions that gave rise to the existence of Good Reason for a period of 30 days following such notice (such 30 day period, the “Cure Period”), (iv) notwithstanding such efforts, Good Reason continues to exist and (v) the Employee terminates his employment within 30 days after the end of the Cure Period. For the avoidance of doubt, if the Company or the acquiring or succeeding corporation successfully remedies the conditions that gave rise to the existence of Good Reason during the Cure Period, Good Reason shall be deemed not to have existed. In the event the Employee terminates employment under this Agreement for Good Reason, the Employee shall be eligible to receive the severance benefits set forth in Section 3.2 (e).

 

3
 

 

Section 3.5 Termination by the Employee without Good Reason. The Employee may terminate the Employee’s employment with the Company without Good Reason at any time subject to the Employee’s provision of thirty (30) days’ advance written notice to the Company (the “Applicable Notice Period”), provided, however, that the Company may, in its sole discretion, in lieu of all or part of the Applicable Notice Period, pay the Employee an amount equal to the Salary that would otherwise have been payable to the Employee had the Employee remained employed for the duration of the Applicable Notice Period. In such instance, the Employee’s termination will become effective on the date set forth in a written notice of termination to be provided by the Company (the “Early Termination Date”), and the Employee will be paid an amount equal to the base Salary the Employee would have received had the Employee remained employed by the Company between the Early Termination Date and the end of the Applicable Notice Period (the “Early Termination Payment”), with the Early Termination Payment to be made no later than the 30th day following the end of the Applicable Notice Period.

 

Section 3.6 Compensation upon Termination.

 

(a) In the event that the Company terminates the Employee’s employment hereunder due to a Termination for Cause or the Employee voluntarily terminates employment with the Company without Good Reason, the Employee shall be entitled to accrued but unpaid Salary, Restricted Shares Compensation which have vested, reimbursable expenses and benefits owing to Employee through the day on which Employee is terminated.

 

(b) In the event that the Company terminates the Employee’s employment hereunder due to a Termination without Cause, Employee shall be entitled to compensation, including base Salary, the aggregate Restricted Shares Compensation set forth in Section 2.1 (b), the Bonus, and insurance benefits for a period of 12 months from the effective date of termination (the “Severance Period”). The Employee’s reimbursable expenses shall be paid within 15 days of Termination. Except as otherwise contemplated by this Agreement, Employee will not be entitled to any other compensation upon termination of this Agreement.

 

(c) The salary and fringe benefits to be paid are referred to herein as the “Termination Compensation.” Employee shall not be entitled to any Termination Compensation unless, Employee complies with all surviving provisions of any confidentiality agreement that Employee may have signed.

 

(d) If Employee terminates this Agreement by providing appropriate notice, the Company, at its election, Company may (i) require Employee to continue to perform duties hereunder for the full notice period, or (ii) terminate Employee employment at any time during such notice period, provided that any such termination shall not be deemed to be a termination without cause of Employee ‘s employment by the Company. Unless otherwise provided by this Section, all compensation and benefits paid by Company to Employee shall cease upon his last day of employment.

 

4
 

 

Section 3.7 Change in Control. In addition, notwithstanding the foregoing, in the event that Employee’s continuous status as an employee of the Company is terminated by the Company without Cause or Employee terminates the employment with the Company for Good Reason (, in either case upon or within twelve (12) months after a Change in Control (“CoC”) as defined below then, subject to Employee’s execution of a standard release of claims in favor of the Company or its successor, (i) Employee shall receive the Salary for the duration of the Term, (ii) 100% of the total number of Restricted Shares Compensation shall immediately become vested and issuable, and (iii) Employee shall be entitled to the Bonus for the duration of the Term.

 

As used in this Agreement, “Change in Control” shall be deemed to have occurred if any “person” (as such term is used in Sections 13(d) and 14(d)(2) of the Exchange Act) is or becomes the beneficial owner, directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding securities; (ii) a sale of substantially all of the assets of the Company; or (iii) a liquidation of the Company.

 

ARTICLE IV.

RESTRICTIVE COVENANTS

 

Section 4.1 Confidentiality.

 

(a) Employee recognizes and acknowledges that Employee has had and will continue to have access to various trade secrets and/or proprietary information (collectively, the “Confidential Information”) concerning the Company. Employee acknowledges that the Confidential Information has been developed solely through the substantial efforts of the Company over a long period of time, and that such Confidential Information is valuable and unique and constitutes a trade secret of the Company.

 

(b) Employee agrees to keep all Confidential Information of the Company in strict confidence and agrees not to disclose any Confidential Information to any other person, firm, association, company, corporation or other entity for any reason except as such disclosure may be required in connection with his employment hereunder. Employee further agrees not to use any Confidential Information for any purpose except on behalf of the Company.

 

(c) For purposes of this Agreement, “Confidential Information” shall mean any information, process or idea that is not generally known in the industry, that the Company considers confidential and/or that gives the Company a competitive advantage, including, without limitation: (i) books and records relating to operation, finance, accounting, sales, personnel and management, (ii) policies and matters relating particularly to operations such as customer service requirements, costs of providing service and equipment, operating costs, and price matters, and (iii) various trade or business secrets, including business opportunities, marketing or business diversification plans, business development and bidding techniques, methods of processes, financial data and the like. If Employee is unsure whether certain information or material is Confidential Information, Employee shall treat that information or material as confidential unless Employee is informed by the Company, in writing, to the contrary. “Confidential Information” shall not include any information which: (i) is or becomes publicly available through no act or failure of Employee; (ii) was or is rightfully learned by Employee from a source other than the Company before being received from the Company; (iii) becomes independently available to Employee as a matter of right from a third Party having lawful right to make such communication; or (iv) is developed by Employee independently of any Confidential Information.

 

5
 

 

(d) Employee further agrees that upon termination of his employment with the Company, for whatever reason, Employee will surrender to the Company all of the property, notes, manuals, reports, documents and other things in Employee’s possession, including copies or computerized records thereof, which relate directly or indirectly to Confidential Information.

 

Section 4.2. Remedies. If the provisions of this Article are violated, or threatened to be violated, in whole or in part, the Company shall be entitled to a temporary restraining order or a preliminary injunction restraining or enjoining Employee from using or disclosing, in whole or in part, such Confidential Information, without prejudice to any other remedies the Company may have at law or in equity. If Employee violates this Article, Employee agrees that the Company would be irreparably harmed.

 

ARTICLE V.

CONDUCT

 

Section 5.1 No Derogatory Statements. Employee shall not engage in any pattern of conduct that involves the making or publishing of written or oral statements or remarks (including, without limitation, the repetition or distribution of derogatory rumors, allegations, negative reports or comments) which are disparaging, deleterious or damaging to the integrity, reputation or goodwill of the Company, its competitors or its management.

 

ARTICLE VI.

MISCELLANEOUS

 

Section 6.1 Assignment; Binding Effect; Amendment. This Agreement and the rights of the Parties under it may not be assigned (except by operation of law and except that it may be assigned by the Company to an Affiliated Entity) and shall be binding upon and shall inure to the benefit of the Parties and their successors and assigns. This Agreement, upon execution and delivery, constitutes a valid and binding agreement of the Parties enforceable in accordance with its terms and may be modified or amended only by a written instrument executed by all Parties hereto.

 

Section 6.2 Entire Agreement. This Agreement is the final, complete and exclusive statement and expression of the agreement among the Parties hereto with relation to the subject matter of this Agreement, it being understood that there are no oral representations, understandings or agreements covering the same subject matter as this Agreement. This Agreement supersedes, and cannot be varied, contradicted or supplemented by evidence of any prior or contemporaneous discussions, correspondence, or oral or written agreements of any kind.

 

Section 6.3 Counterparts. This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute but one and the same instrument.

 

6
 

 

Section 6.4 Notices. All notices or other communications required or permitted hereunder shall be in writing and may be given by depositing the same in United States mail, addressed to the Party to be notified, postage prepaid and registered or certified with return receipt requested, by nationally recognized overnight courier or by delivering the same in person to such Party.

 

(a)If to Employee, addressed to:

 

Robert D. Wiley

7681 E. Grey Road

Scottsdale, AZ 85260

 

(b)If to the Company, addressed to it at:

 

Ammo, Inc.

Attn: Fred Wagenhals

7681 E. Grey Road

Scottsdale, AZ 85260

 

Notice shall be deemed given and effective the day personally delivered, the day after being sent by overnight courier, subject to signature verification, and three business days after the deposit in the U.S. mail of a writing addressed as above and sent first class mail, certified, return receipt requested, or when actually received, if earlier. Any Party may change the address for notice by notifying the other Parties of such change in accordance with this Section.

 

Section 6.5 Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Arizona, without giving effect to any choice or conflict of law provision or rule (whether of the State of Arizona or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Arizona.

 

Section 6.6 No Waiver. No delay of or omission in the exercise of any right, power or remedy accruing to any Party as a result of any breach or default by any other Party under this Agreement shall impair any such right, power or remedy, nor shall it be construed as a waiver of or acquiescence in any such breach or default, or of or in any similar breach or default occurring later; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver.

 

Section 6.7 Captions. The headings of this Agreement are inserted for convenience only, and shall not constitute a part of this Agreement or be used to construe or interpret any provision hereof.

 

Section 6.8 Severability. In case any prov1s1on of this Agreement shall be invalid, illegal or unenforceable, it shall, to the extent possible, be modified in such manner as to be valid, legal and enforceable but so as most nearly to retain the intent of the Parties. If such modification is not possible, such provision shall be severed from this Agreement. In either case the validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby.

 

7
 

 

Section 6.9 Construction. The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement. Any reference to any federal, state, local or foreign statute shall be deemed to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The word “including” means including, without limitation. The Parties intend that representations, warranties and covenants contained herein shall have independent significance. If any Party has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) that the Party has not breached shall not detract from or mitigate the fact the Party is in breach of the first representation, warranty or covenant.

 

Section 6.10 No Derogatory Statement. The Company shall not engage in any pattern of conduct that involves the making or publishing of written or oral statements or remarks (including, without limitation, the repetition or distribution of derogatory rumors, allegations, negative reports or comments) which are disparaging, deleterious or damaging to the integrity or reputation of Employee.

 

Section 6.11 Indemnification by the Company. The Company shall indemnify, defend and hold Employee harmless from any liabilities, obligations, claims, penalties, fines or losses resulting from any unauthorized or unlawful acts of the Company which contravene any applicable statute, rule, regulation or order of any jurisdiction, foreign or domestic.

 

Section 6.12 Headings. The headings used herein are for convenience only and do not limit the contents of this Agreement.

 

8
 

 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed effective as of the day and year first above written.

 

  AMMO, INC.
   
  /s/ Fred Wagenhals 
  By: Fred Wagenhals 
  Its: Chief Executive Officer
   
  EMPLOYEE
   
  /s/ Robert D. Wiley 
  By: Robert D. Wiley 
  Its: Chief Financial Officer

 

9
 

 

Supplemental Information For

EMPLOYMENT AGREEMENT

Dated March 24, 2021

 

The following is a list of Exhibits to the above referenced Agreement, not attached herewith. Any omitted information will be furnished to the Securities and Exchange Commission upon request.

 

1.Exhibit “A” Roles And Responsibilities Chief Financial Officer For AMMO, INC. (the “Company”)
2.Exhibit “B” The Restricted Shares Compensation
3.Exhibit “C” Share Restrictions

 

Page 1 of 3
 

 

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

 

This First Amendment to Employment Agreement (the “Agreement”) is made and entered into effective January 29, 2021, with an effective date as of January 29, 2021 (the “Effective Date”) between AMMO, Inc., a Delaware corporation (the “Company”), and Robert D. Wiley (“Employee”). Company and Employee are sometimes referred to individually as “Party” and collectively as “Parties”.

 

RECITALS

 

A.The Company is in the business of the manufacture and sale of ammunition and ammunition components. The Company is a public company and its securities are quoted in the over-the-counter market;

 

B.The Employee entered into employment agreement with the Company to continue employment as its Chief Financial Officer via that certain Employment Agreement dated January 29, 2021 (“Employment Agreement”); and

 

C.The Company has agreed to increase Employee’s annual salary as set forth in the Employment Agreement as of January 29, 2021 and the Parties therefore desire to modify and amend the Employment Agreement solely as set forth below to implement this compensation increase pursuant to the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of their mutual covenants and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree to amend the Employment Agreement as follows:

 

ARTICLE II.

COMPENSATION

 

1.Section 2.1 of the Employment Agreement is modified solely as it concerns compensation to be paid to Employee commencing April 1, 2021. In this regard, the Company shall pay Employee One Hundred and Eighty-Five Thousand & 00/100 Dollars ($185,000.00) per year, remitted in the same manner and at such time as other key employees of Company receive their compensation.

 

a.Except as specifically addressed above in Section 1 herein, the remaining terms and conditions set forth in Section 2.1 of the Employment Agreement shall remain in full force and effect.

 

2.All other terms and conditions set forth in the Employment Agreement (including all Exhibits thereto) shall remain in full force and effect. In the event of any conflict between the terms of this Amendment and the Employment Agreement, the Employment Agreement shall govern and control.

 

Page 2 of 3
 

 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed effective as of the day and year first above written.

 

  AMMO, INC.
     
  By: /s/ Fred Wagenhals
  Name: Fred Wagenhals
  Its: CEO
     
  EMPLOYEE:
     
    /s/ Robert D. Wiley
    Robert D. Wiley

 

Page 3 of 3
 

 

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT

 

This Second Amendment to Employment Agreement (the “Agreement”) is made and entered into effective September 1, 2021, with an effective date as of September 1, 2021 (the “Effective Date”) between AMMO, Inc., a Delaware corporation (the “Company”), and Robert D. Wiley (“Employee”). Company and Employee are sometimes referred to individually as “Party” and collectively as “Parties”.

 

RECITALS

 

D. The Company is in the business of the manufacture and sale of ammunition and ammunition components. The Company is a public company and its securities are quoted in the over-the-counter market;

 

E. The Employee entered into employment agreement with the Company to continue employment as its Chief Financial Officer via that certain Employment Agreement dated January 29, 2021 (“Employment Agreement”) and the First Amendment to the Employment Agreement; and

 

F. The Company has agreed to increase Employee’s annual salary as set forth in the Employment Agreement as of January 29, 2021 and the First Amendment to the Employment Agreement and the Parties therefore desire to modify and amend the Employment Agreement solely as set forth below to implement this compensation increase pursuant to the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of their mutual covenants and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree to amend the Employment Agreement as follows:

 

ARTICLE II.

COMPENSATION

 

3. Section 2.1 of the Employment Agreement is modified solely as it concerns compensation to be paid to Employee commencing September 1, 2021. In this regard, the Company shall pay Employee Two Hundred and Forty Thousand & 00/100 Dollars ($240,000.00) per year, remitted in the same manner and at such time as other key employees of Company receive their compensation

 

a. Except as specifically addressed above in Section 1 herein, the remaining terms and conditions set forth in Section 2.1 of the Employment Agreement shall remain in full force and effect.

 

4. All other terms and conditions set forth in the Employment Agreement (including all Exhibits thereto) shall remain in full force and effect. In the event of any conflict between the terms of this Amendment and the Employment Agreement, the Employment Agreement shall govern and control.

 

Page 1 of 2
 

 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed effective as of the day and year first above written.

 

  AMMO, INC.
     
  By: /s/ Fred Wagenhals
  Name: Fred Wagenhals
  Its: CEO
     
  EMPLOYEE:
     
    /s/ Robert D. Wiley
    Robert D. Wiley

 

Page 2 of 2
 

 

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT

 

This Third Amendment to Employment Agreement (the “Agreement”) is made and entered into effective June 12, 2023, with an effective date as of June 1, 2023 (the “Effective Date”) between AMMO, Inc., a Delaware corporation (the “Company”), and Robert D. Wiley (“Employee”). Company and Employee are sometimes referred to individually as “Party” and collectively as “Parties”.

 

RECITALS

 

G. The Company is in the business of the manufacture and sale of ammunition and ammunition components. The Company is a public company and its securities are quoted in the over-the-counter market;

 

H. The Employee entered into employment agreement with the Company to continue employment as its Chief Financial Officer via that certain Employment Agreement dated January 29, 2021 (“Employment Agreement”), as amended, and

 

I. The Company has agreed to increase Employee’s annual salary as set forth in the Employment Agreement as of January 29, 2021, as amended, and the Parties therefore desire to modify and amend the Employment Agreement solely as set forth below to implement this compensation increase pursuant to the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of their mutual covenants and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree to amend the Employment Agreement as follows:

 

ARTICLE II.

COMPENSATION

 

5. Section 2.1 of the Employment Agreement is modified solely as it concerns compensation to be paid to Employee commencing June 1, 2023. In this regard, the Company shall pay Employee Three Hundred and Twenty Five Thousand & 00/100 Dollars ($325,000.00) per year, remitted in the same manner and at such time as other key employees of Company receive their compensation

 

a. Except as specifically addressed above in Section 1 herein, the remaining terms and conditions set forth in Section 2.1 of the Employment Agreement shall remain in full force and effect.

 

6. All other terms and conditions set forth in the Employment Agreement (including all Exhibits thereto) shall remain in full force and effect. In the event of any conflict between the terms of this Amendment and the Employment Agreement, the Employment Agreement shall govern and control.

 

Page 1 of 2
 

 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed effective as of the day and year first above written.

 

  AMMO, INC.
     
  By: /s/ Fred Wagenhals
  Name: Fred Wagenhals
  Its: CEO
     
  EMPLOYEE:
     
    /s/ Robert D. Wiley
    Robert D. Wiley

 

Page 2 of 2

EX-21.1 5 ex21-1.htm

 

Exhibit 21.1

SUBSIDIARIES

 

AMMO, Inc., a Delaware corporation, had the subsidiaries shown below as of June 14, 2023. AMMO, Inc. is not a subsidiary of any other entity.

 

Name   Jurisdiction
Ammo Munitions, Inc.   Delaware
Ammo Technologies Inc.   Arizona
Enlight Group II, LLC   Delaware
Firelight Group I, LLC   Delaware
SNI LLC   Arizona
Speedlight Group I, LLC   Delaware
GB Investments, Inc. (wholly owned subsidiary of Speedlight Group I, LLC)   Delaware
IA Tech, LLC (wholly owned subsidiary of GB Investments, Inc.)   Delaware
Cloud Catalyst Technologies, LLC (wholly owned subsidiary of IA Tech, LLC)   Delaware
Enthusiast Commerce, LLC (wholly owned subsidiary of IA Tech, LLC)   Delaware
Outdoors Online, LLC f/k/a GunBroker.com, LLC (wholly owned subsidiary of IA Tech, LLC)   Delaware
S&T Logistics, LLC (wholly owned subsidiary of IA Tech, LLC)   Delaware
Outdoor Liquidators, LLC (wholly owned subsidiary of Enthusiast Commerce, LLC)   Delaware
Outsource Commerce, LLC (wholly owned subsidiary of Enthusiast Commerce, LLC)   Delaware
RightFit Direct, LLC (wholly owned subsidiary of Enthusiast Commerce, LLC)   Delaware

 

 

 

EX-23.1 6 ex23-1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statements of Ammo, Inc. on Form S-8 (No. 333-251677) and Form S-3 (No. 333-252786) of our reports dated June 14, 2023, with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting appearing in the Annual Report on Form 10-K of Ammo, Inc. for the year ended March 31, 2023.

 

/s/ PANNELL KERR FORSTER OF TEXAS, P.C.

 

Houston, Texas

June 14, 2023

 

 

 

EX-31.1 7 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

EXCHANGE ACT RULES 13a-14(a) and 15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF2002

 

I, Fred W. Wagenhals, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of AMMO, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: June 14, 2023 By: /s/ Fred W. Wagenhals
  Name: Fred W. Wagenhals
  Title: Chief Executive Officer (Principal Executive Officer)

 

 

 

EX-31.2 8 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

EXCHANGE ACT RULES 13a-14(a) and 15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF2002

 

I, Robert D. Wiley, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of AMMO, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: June 14, 2023 By: /s/ Robert D. Wiley
  Name: Robert D. Wiley
  Title: Chief Financial Officer (Principal Financial Officer)

 

 

 

EX-32.1 9 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with Annual Report of AMMO, Inc. (the “ Company”) on Form 10-K for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Fred W. Wagenhals, Chief Executive Officer (Principal Executive Officer) of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13a-14(b) or 15d-14(b) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: June 14, 2023 By: /s/ Fred W. Wagenhals
  Name: Fred W. Wagenhals
  Title: Chief Executive Officer (Principal Executive Officer)

 

 

 

EX-32.2 10 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with Annual Report of AMMO, Inc. (the “ Company”) on Form 10-K for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Robert D. Wiley, Chief Financial Officer (Principal Financial Officer) of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13a-14(b) or 15d-14(b) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: June 14, 2023 By: /s/ Robert D. Wiley
  Name: Robert D. Wiley
  Title: Chief Financial Officer (Principal Financial Officer)

 

 

 

GRAPHIC 11 form10-k_001.jpg begin 644 form10-k_001.jpg M_]C_X 02D9)1@ ! 0$ E@"6 #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" +B Y0# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4Z*** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:^<%\67WQ^^/6N>$(KZ MZT_P/X30?;XK25H7U*Y)QL9U.?+']T$9PBN.T'XN>%O$6O?V);ZA):ZRR&1 M-/U*UELYY5'5D295+CW7-59/CEX#A\1WNA-XFLO[2LH)+FYC#$K#&GWR[XV@ MCT)S0!W=%>>>'?V@OA[XI\/ZMK>G>)[273=*.+R60/$8O3*N Q![$#GM5WP3 M\:/!7Q$T&_UG0=?MKO3K XNY9 T)@XSEU< J,=R* .VHKR^Z_::^&5GX?N-: MD\5VITV&Y-H94CD8M*!DA%"[G '=01[UU>F?$GPOK'@T^++37+.3PXL1F?43 M(%B11UW$_=(]#S0!TM%<'HOQP\':]K]AHL&I36^HZA&9K**^L9[47:#O$TJ* MK_\ 2']3U'3[[Q7917>GQ&6YC7<^P X*Y4$%L_PCGVH [;5_ M$6E>'VM%U/4K33C=RB"W%U,L?G2'HB9(W-[#FM&O*]9^,'PJUY?"[:KJ6F:A M+J4L=QI$-U:F2;S&)"2*C)NC/7#$"NR\3^/M%\(W-K:ZA<3->W0+0V=G;2W5 MPZC@OY<2LVT<9;&!GK0!T5%9&B^+-'\1:;<:AIVH07-E;N\4TRMA8W3[ZL3T M*]\]*Y=OCOX(CNK:.;6#:V]U)Y5OJ%S:S164[$X 2X9!$V3TPW- '?T5RGCK MXI>%?AK:P3^)-:M]+6X(6%9,L\A) ^55!)Y(Z"LFZ^/WP_LO&EIX3F\2VJ:] M=$+':[7(W$9",X&U6(Q\I(- 'H-%%% !17 ZI\=/!6CR2&ZU=DLXI?(DU);2 M9[*-P<%6N50Q*0>N6XJ/XS?$2'P;\+]6UBRDN)Y9K&5K*YL+>2X0,8R5] '2_P#"=>'/^$@&A?V]IO\ ;1Z:?]KC\_IG[F=WZ5MLRHN6(4>I M-?/_ ,"?#_A+XG?!_P $V6L:/<:A?Z1##J NKRPGMQ]IR6,B3%5$F2>=K$'O M7K7Q"^'NE?$S1K;2=:C\_3H[R*[DM\D"7RR2$;!'!.,_2@#H_M4/_/6/_OH4 MJ3QR'"2*Q]%(-?)W[2'PX\*:%\3/@U:Z=X;TNPMK[7'BNX;:T2-+A-F=L@ ^ M8>QKW6/X-^#O#OB;3?%&E:3I_AZ[TQ)0\UI"L"/$ZX8.%P.,9R>E 'H%%5;7UU:S0V<[$X CN&01MGMAN:YCX_?'H?"F;0=,M+" M^GOM6OH8/M<=G(\$,98;R&"D.Y&0$7)YH ]FI*Y#4?BQX;T?1[#4;^ZN;)=0 ME,%I:W%C.EW<2#JJ6Y3S6/?A>G-2^#_B5X9^(S:I::1>_:KBP?R+ZQN;>2"> M$D='BD56 /N,4 ;6G>(M*U>\N[2QU*TO;JT(%Q#;SJ[PD] X!RN?>M&OFK]F MC3;31_CA\;;.QMHK.TAU2)8X($"(@V= !P*^DY(UFC:-U#HP*LK#((/44 ,^ MU0]?-3'^\*>KK(N58,/4'-?(^D?#7PHW[:VO:*WAW39-'_L".Y&GR6RM LIQ MEPA&T$^PJ?Q.K?"O]K+P3HG@&>2"PUJ%CK/AVUVB\^33;RTFMKGR_P"\L4B*S#W - '845X3X+_:7MO%7Q0\5Z/)IFLVFF:2 MD4$"?V1<2322'<7>14C+1C& V,XS7H?A+XO>&/'#ZW'HUYH45Y ME=?M*?#:S\+R>(I?%-L-(2Y:T$ZQR,7D7[P1 NYP,]5!'O7<^&?$VE^,M"L] M9T6]CU#3+M!)#<1'Y64_J#['F@#4HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^4?V:[=OA_^T?\ M5_"NK,T.H:E.-3LFF./M,)8G*>N W_CIKZNKB_B#\(_#OQ)DLKG4X)K?5K!M M]EJUA*8+NV;_ &)%YQ['(]J .R=UC1G=@JJ,EF. !ZU\U_&WQ5'>?'KX*0S2 M[_#%S(;5+&:'B;YVPR@]<8YQ[5#J6EVM[^W#I?VFTAD(\- M&7:R C>&.&^H['M7K>C_ DL[74]+U#6M9U3Q9>:5DZ?)K#Q,+9BNTN%C1 S MX_C8%O>L67]G^SF^+"_$(^*O$ UQ$\E8Q)!]G$'_ #QV>5]WGUSWSF@#SWPK MH6G_ /#;WC0?8H=HT"UNPNP8\XO@R8_O8'6M#X26<%E^U3\788(EAAEMK.9X MT&%9R.6(]37::3\ [72?BE=>/D\5^()=:NT$-Q'*]N8)( N]4U-=M]'>20&"5!]U2HB&T+@8VD=* .#_9/T73; MJ\^*,\MI;SW+>)+J!VD0,?+)^YST4^G>N$\$6O@_P'H/QSTKQ3:OO;-4^ ?A#5?AG/X&>TFATB:3[0TTI]E^SU8Z=\3#XYMO%&OQZMY*VGE&2!H?L MZ](=IB)Q[YW=\YH XG]KJ%%UOX0L$4,/%$8! YQL/%;GQA\%^.;?XA6GCKX; MWVG7>MV=A]BOM!U$_+=0%]Z[6R-IR#W&?7M72?%?X#V/Q=U71[W4O$6N:<-) ME%S9V^FR0I'',/\ EI\T;$M]3CVK:U3X91ZAJ4>K0Z_J^G:ZMJMF=2M9(PSQ M@Y.Z-D,1)/.2G';% 'S1\5/C._C#]FWQK)9^'KKPCKEIK$%IXDTU@*/V:-5M6CMVTDZ$)H" -D>V(,C+Z$8'(KJ=#^$ MOA[1]!UK2I[=M837':35KC42))+YV&TM)@ =, !0 ,< 5SFD_L[Z/I>A?\(X MVNZY?>$ V5\/7=RCVZKG(CW[!*8P?X"Y'KF@#P_QQ+J.J?L&^&)]<\R342EC MNDF_UF/. 4YZ@[<- &CW2*&P??OZUZ MO\7O@GI?QD\-6OA_4M4U+2M&A=7-II+11*Y3[F2T;$!>P&!61X\_9SL/B-X7 MT'0-9\5^(7LM'*/$T,ENCRR)_JY)#Y/+*!@8P.Y!/- 'KE>=_M#ZIJ6B_ _Q MI>Z.774H=-D,+1@E@2,$C'?!-=QH]A)I>EVUI->SZC)"@1KJZV^;+C^)MJJN M?H!5B>&.ZADAFC66*12CQN,JRD8(([B@#R3X-Z?HGB;]F70;*.*";2;K1/*E MC(#*24(?=[[LGZUY)\'9-1'[$?BJ"]DEDM[:/4K>Q:0Y_P!&5B$ _P!GKBO9 M-'_9WT?PW:ZAIFBZYKFD^&;]V>?0+>Y3[+\WWU1F0R1JV>0CBMOQI\(=,\6^ M H_!MK?WWAO0%A^SO;:/Y4>^'&/+)=&P/I@GN: *O[.O_)#/ _\ V"H?_0:] M%KC/A=\,X_A7X?AT.TUW5-6TNV18K6'4C"QMU&>%9(U)'/\ $379T ?-O[4O M_)6/@9_V,#_^BZV?VV-8O='^ VH/:-(D$UY;07K1YS]F9_WF<= 0,'ZUO_$+ M]GFT^)7BC3=V,,C+Z$8&"*\(\67FJWWP5_9TGUEI7U%]6LS(TQ^<\?*3[[<5[_I/[/.C MZ9H2^')==US4?"*.&3P_>7"/;JH.5CWA!*T8('R%R/4&MOXK?!S0?B[X6M]" MU5KJQAM9H[BUN--D$4MLZ?=*'! Q]* .<^+'B#PWIOQ%\&VXT(^(_B$?.?1; M99FA6!",2RR/]U4 [E6/H*X/X0KJ.,^@KT;4?V>-"NKOPOJ%IJNM:;KGA\,+?6(;H274ZORXG:16$@8\G(I]M^ MSWX>M?B5<^.8[_6/[:N;98)5:])AH2*9(V57,98$!EQD>XS0!\I:KX5M_&'[;GB&PN;J_LE;PS$5GTV\EM94; M.Z-@3C/0Y'J*L?LXO#\(OBEKWPX\66L+^*;AWO-,\331#S]6M6.=K2GEF4]L M^M>AVW[-=K:_$A_':^-?$S>)9(A ]RSVI1H>/W>SR-N,#' S[YKH/BY\#?#_ M ,9+?2_[6FOM/U#2YQ/9ZIITJZM;OR+VU2(G[8JR;:ZI>/& MEY;OC *21HO(]P<]\TOP\^!>E^ +R.[DUWQ!XHNX1MMI?$.H-=?901@^4N J MG'&<9]Z //O@2?\ C(_XVY/_ "]6W_H)JS\!Y%_X7W\;%W#=_:-NVW/./+ZU MV5Q^SWX;F^*D_CM;K5+?4+E4%W86]V4L[ID^XTJ 9;!YP3C/.*BU_P#9S\-: M]\1Y/&:WVLZ7?W$:Q7UKIE\UO;WZKT$P498>H! />@#RSX-M%>:/^T)-9? M3U0I:O6WD>*5OO2QDP\,1QSD>V>:VO@W\%]/\ @GHUSI.D:SJVH:;-*TZV M^I/$XBD8Y=E*QJ?F/7)(H ]#HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K: MEIMIK-A/8W]M#>6= Z2*>H93P15FB@#FO#_P ,_"/A.^^VZ)X8TC2+ MS:4-Q8V4<+[3U&Y5!Q72T44 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 ?$KP_:Z%;:NEY)?V5R"8?[.MY;J1P M#AB(XU9L*>#QP>N*\X^.7A'4[?7['QEX:N8;C5[=K*RN]&N&"I>1?:U>'#]8 MV$F?FP002.U=5X/\?:#<> 8_$%CITEB\T\\/]G/@S_;/-;S85.<$F0-R#C'/ M ' !T%M\1O#EYX17Q/!JL,VB,/EN4R:=<,\<+F*:.>)X987 !*R1N R'!!PP'!!KQ35O#*>$T^'=E+<6\WG^+S? MZPL3@QQW4R2R(F!T4.RA<]<*>]0^/FU#_A(OCE_8X8*/#5KO\O/-QY./A3H'Q DBFU);R"YC,>;C3[R2VDD5 M'#JCE&&Y:R/%7[._@#QEI&DZ5JNA>9INE*5L[2&[F@CCSR6VHX! M8]V.2_( 49X&20,GI0!T5%>3_ P^+'B/Q/K!L/$GAJWTL7,]REG?:8U$ M6TF.;*J0^&&"N5//2M7P+\5KCQ?X_P#%_AB[\/7&AR^'_(82W-Q'(;A)5+*X M5"0HP/[Q/J!0!Z'17S_KWQ\^)^DZR/*^"TTOAV6_2TMM5FU^".26-Y HD^S[ M"XXRVWK@5O>)OCS?:3K'B>+3?#L&HZ;X7DABU5I-1\J[)D"D&W@\MO, ##EF M3)! S0![%14=O,+BWBE"L@D4,%<889&<$=C7 > _BM<>,/'GC#PS=^'KC0I? M#Y@/F7-Q'(UPDJEE?"$A1@?WB?7% 'H=%?/^M_'OXGZ7K2B/X+S/X=FU".SM MM5FU^".22-Y JRFWV%QQEMO7 KW\9P,\'O0 M%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !16#XL\=>'O MO!/X@UBSTB*>18 MHFNI0F]B0,#/U&3T'4UH76N:=8Z6=2N+^V@TX('-W),JQ;3T.XG&* +U%4KO M6M/T_2FU.YOK>WTY8Q*UW+*JQ!",AMQ.,>]1Z#XDTKQ18B]T;4K35;,L5%Q9 MS+*F1U&5)&: -&BLO2?%.C:]>7EIINJV5_=6;;+F&VG61X6]' .5/UK4H ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "L'QY)I,?@_5O[=LFU'1F@*7ELL!F+Q-\ MK?(.2 #D^@!/:MZDH ^5_P!G/Q$-!^)%WX3\(:\OBSP/-ZV>FVFFB46EK#:B:0RR>3&$WN>K''4GUJ588U;AZ6"39Z/;OJMP/X6E8F.$?4?.WXBOGWXL26.J_$?Q=JUS=IX7^)7A MV>$^%8UC ?5X0@(0H1_I(D;:U9^'KQ_LWB>33(]3GT_RW(CC8[6^?&WA\C&<\5Y-\+?%VAZE^T_\5;6T MUBQN;F:#3Q'#%.K,YBA*R@ 'G82 V.A/->^[1NS@9Z9IBP1HVY8U5O[P49H MX?7&;Q%\5-$TL$FST:W?5+A?X6E4F!G..:6@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \'^/7AO5M%\6: M9XZL;)->L8UM+"\TP &Y11=I(KV^>"S'Y64D9&/2I/&UGX2\2?LP^))]&M8[ MK1UL[V[MX;J !K6?=(S+L(^1D><@8J.]^#VES?#6;P397^H:7IEPLBW%Q;R(]Q/YA) ME+O(K9+EB2<9YXQ0!RWQ LX[_P"#/A"%+T6>K^9IK:4'B$J2W@"F-'0]4/.> M> ,]JYBU\2:CI_P\^+M[=6!T3XB6UJ9-1MK4X@&(2L,]N>Z%0QW'YLJ0>@KU M74/A/8:QX&T[PWJ&IZC=G37CEL]4+QQW<$D9_=NI1 N5''W<$=V.D M1ZH][Y5Q'A7X3:9X6U6TO1?7^IG3X&M-,A MOI%=-/A.,I'A03D #M<9X)U]/" MGBS3-6FB:6&VEW.B\$J00TV"_L9UN+69=R.I_3ZU=H Q?[5U?_H"_P#DRM']JZO_ - 7_P F5K:H MH Q?[5U?_H"_^3*T?VKJ_P#T!?\ R96MJB@#%_M75_\ H"_^3*T?VKJ__0%_ M\F5K:HH Q?[5U?\ Z O_ ),K1_:NK_\ 0%_\F5K:HH Q?[5U?_H"_P#DRM'] MJZO_ - 7_P F5K:HH Q?[5U?_H"_^3*T?VKJ_P#T!?\ R96MJB@#%_M75_\ MH"_^3*T?VKJ__0%_\F5K:HH Q?[5U?\ Z O_ ),K1_:NK_\ 0%_\F5K:HH Q M?[5U?_H"_P#DRM']JZO_ - 7_P F5K:HH Q?[5U?_H"_^3*T?VKJ_P#T!?\ MR96MJB@#%_M75_\ H"_^3*T?VKJ__0%_\F5K:HH Q?[5U?\ Z O_ ),K1_:N MK_\ 0%_\F5K:HH Q?[5U?_H"_P#DRM']JZO_ - 7_P F5K:HH Q?[5U?_H"_ M^3*T?VKJ_P#T!?\ R96MJB@#%_M75_\ H"_^3*T?VKJ__0%_\F5K:HH Q?[5 MU?\ Z O_ ),K1_:NK_\ 0%_\F5K:HH Q?[5U?_H"_P#DRM']JZO_ - 7_P F M5K:HH Q?[5U?_H"_^3*T?VKJ_P#T!?\ R96MJB@#%_M75_\ H"_^3*T?VKJ_ M_0%_\F5K:HH Q?[5U?\ Z O_ ),K5G3[V^N)BMSIWV2/;D/YROD^F!6C10 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !39)%C1G=@J*,ECT ]:=7FWQV\8?\(SX-DM('VWNHDP)@\JG\;?EQ^- M 'D=TTOQE^+P10QL/,V^RVZ'D_C_ %KWOQO\.],\:: -.FC6!X5_T:=!S$P& M!^'J*XC]G3P;_97A^;6YX]MQ?G;#DPT ?+WA+Q5K/P2\53:3J\; MMIS/F:(6Q@FWN@.4/H?53W%>'^!?&VJ_!WQ)-H>N12#3C)B6+KY>>DL?J#Z=_K0!].T M5!8WT&I6D-U:RK/;S*'CD0Y# ]Q4] !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% "5\O>,KR;XN?%B/3K4EK..3[-&0>!&IS(_X\_I7M'Q MD\8?\(CX+N6B;%[>?Z- ,\@DRNO$5RG[R<^1;%NNP?>;\3 M_*@#V>PL8=-LH+2W01P0H(T4=@!@58HHH *XSXF?#6S^(.D[#M@U.$$V]UCD M?[+>JFNSHH ^9OAU\0-1^%.O2^']?CD33_,VNC6\ M<\$BS0R*&21#D,#T(-<5\4OAC:_$#2]\86#5X%/V>X]?]AO8_I7DWPO^)5[\ M.-8?PYXB62.P639^\ZVK9Z_[A_\ KT ?2=%,BF2>-)(W62-QN5E.00>XI] ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%Y?6VGQK M)=7$5M&SK&&E<*"S$!1D]R2 ![U-N&,YXKYW_:0T>2S\6:1XBU[2CK_@F-+: MVFCVF8:?+]J1GF,/\8=/DR 2,>AK;^(FAZ/J'[,VO'3M7N-6TJ*PN;VPNX+R M0?+EVC0L&RRID+M8D?*,CB@#VVD5U9B P)'4 ]*\:\<>+-8T7X:^ M%T!C%K M/B0VNFQ7((!@0P[Y) 3P&"J<'!P3G!QBL&P\66WP\\'_ !+L;+PZF@^,M!TX M7<\ZW)O6OE9&,5P9V57D.=V0P&#F@#Z#5U8D!@2.#@]*=7A%OI5M\-O$WPKG MT@,EQKY:QU9ARU_FV,OG2_WG#KG<><,1T->[T %%%4=2U3^SO+_T6YN=^?\ MCWCW8QZT 7J*Q?\ A)A_T#-1_P"_'_UZ/^$F'_0,U'_OQ_\ 7H VJ*Q?^$F' M_0,U'_OQ_P#7H_X28?\ 0,U'_OQ_]>@#:HK%_P"$F'_0,U'_ +\?_7H_X28? M] S4?^_'_P!>@#:HK%_X28?] S4?^_'_ ->C_A)A_P! S4?^_'_UZ -JBL7_ M (28?] S4?\ OQ_]>C_A)A_T#-1_[\?_ %Z -JBL7_A)A_T#-1_[\?\ UZ/^ M$F'_ $#-1_[\?_7H VJ*Q?\ A)A_T#-1_P"_'_UZ/^$F'_0,U'_OQ_\ 7H V MJ*Q?^$F'_0,U'_OQ_P#7H_X28?\ 0,U'_OQ_]>@#:HK%_P"$F'_0,U'_ +\? M_7H_X28?] S4?^_'_P!>@#:HK%_X28?] S4?^_'_ ->C_A)A_P! S4?^_'_U MZ -JBL7_ (28?] S4?\ OQ_]>C_A)A_T#-1_[\?_ %Z -JBL7_A)A_T#-1_[ M\?\ UZ/^$F'_ $#-1_[\?_7H VJ*Q?\ A)A_T#-1_P"_'_UZ/^$F'_0,U'_O MQ_\ 7H VJ*Q?^$F'_0,U'_OQ_P#7H_X28?\ 0,U'_OQ_]>@#:HK%_P"$F'_0 M,U'_ +\?_7H_X28?] S4?^_'_P!>@#:HK%_X28?] S4?^_'_ ->C_A)A_P! MS4?^_'_UZ -JBL7_ (28?] S4?\ OQ_]>C_A)A_T#-1_[\?_ %Z -JBL7_A) MA_T#-1_[\?\ UZ/^$F'_ $#-1_[\?_7H VJ*Q?\ A)A_T#-1_P"_'_UZ/^$F M'_0,U'_OQ_\ 7H VJ*Q?^$F'_0,U'_OQ_P#7H_X28?\ 0,U'_OQ_]>@#:HK% M_P"$F'_0,U'_ +\?_7H_X28?] S4?^_'_P!>@#:HK%_X28?] S4?^_'_ ->C M_A)A_P! S4?^_'_UZ -JBL7_ (28?] S4?\ OQ_]>C_A)A_T#-1_[\?_ %Z M-JBL7_A)A_T#-1_[\?\ UZ/^$F'_ $#-1_[\?_7H VJ*Q?\ A)A_T#-1_P"_ M'_UZ/^$F'_0,U'_OQ_\ 7H VJ*Q?^$F'_0,U'_OQ_P#7H_X28?\ 0,U'_OQ_ M]>@#:HK%_P"$F'_0,U'_ +\?_7H_X28?] S4?^_'_P!>@#:HK%_X28?] S4? M^_'_ ->N;^(7Q(7PUX5O+E;*\@N9%\J!IH]@WL, YSVZT >0_%75I_B3\3+? M1+ EX+>06D>T\%L_._X?TKZ.T328-!TBTTZV79!;1K&H'L.M> ? #1S;WMWX MBN[*[NSS#;R11;AN)^=L^O:O<_\ A)A_T#-1_P"_'_UZ -JBL7_A)A_T#-1_ M[\?_ %Z/^$F'_0,U'_OQ_P#7H VJ*Q?^$F'_ $#-1_[\?_7H_P"$F'_0,U'_ M +\?_7H VJ\]^+'PKM_'E@;FU"P:U O[J3H)1_<;^A[5U'_"3#_H&:C_ -^/ M_KT?\),/^@9J/_?C_P"O0!X;\)_BE<^"-0/AGQ('ALT?RT>8?-:OG[I_V/Y? M2OHI661592&5AD,#D$5X_P#%KP7!X[M?MMCI=[;ZU"O#M;X691_"W/7T-(>5,) Z;64AO4'(; ''6L^Y^#4]O\'KWP/I6M);R7ZSB[U*\M M/-+F9F:5EC5T"DEC@9P/0UZ?10!YWJ7PMO-:\"Z#I5WK$4>OZ')%<6&KVMGL M2.6(;4)B9VR"ORL-W.3C':WI'PQ1U\17'B.ZCUK4]?MUM+V6&W\B(0*K*L4: M%F('S,>6)RQ]A7=>%_A3=Z9K.BW>LZX=;@\/P-;:1#]F\IH@RA#),VX M^9)L&W< HP3QDYKT6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^;/CEX@G\ M9>.K3PYI^9%M7$(5>0TS=3^ _K7N?CSQ1'X/\*W^J.?GC3;$O]Z0\*/S_E7B MO[/7A>37/$5[XEO@9%MV(C=OXIFY8_@#^M 'NGA7P_!X5\/6.EVXPEO&%)_O M-W/XG-:U%% !1110 4444 %%%% !7EGQB^$5;W$QP8R./+?/Z'\*]\KR3XR_!]?$\4 MFLZ/$%U9!F6%>!<*/_9OYUC_ 7^,#;HO#GB"4K,I\JUNI>#D<>6_OZ'\* / M=**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHK)\5>((/"WA^^U2X/R6\9<#^\W8?B< M4 >%_M#>*)-<\167AJQS(+=@9$7^.9N%7\!_.O:O ?A>+P=X5L-,C'SQINE; M^](>6/YUX7\#O#\_C+QU=^(M0!E2U-?&CX/C6EEU[1(=NHH-UQ;1C'G@?Q#_:_G]:]EHH \4^ M"_Q@_M 1>'M=EVWB?);7,AP9,?P-G^(?K7M=>(?&CX/FZ,OB+08METO[RYMH MA@OCGS%Q_%ZU=^"_Q@&O1Q:%K4NW4T&V"X&K5F8J1/<*O\3'A%_K7N&M:M!H.DW>H7+;8 M+:-I&/T'2OG#X5Z3/\2OB9<:W?JSP02&[DW=-Q/[M/P_I0![?\+_ BO@SP= M963+BZ=?.N&[F1N2/PZ?A76T44 %%%% ',_$?QI!X!\&ZCK,V"\*8AC/\-PG'& M55L\_2OK:&6X98-2Q4^24M5WMZ=>Y\K6S#$O%N.&AS1CH^U_7\#[1AN(KB,/ M%(LJ-R&1@0:DKY F_9]^)W@Z0RZ+>>=@Y#:;?&)OR;;48^)7QA\!Y&HQ7\D$ M?7[?9>8A_P"VF,G\ZY/[(C5_W>O&7X/]3J_M65/_ 'BC*/XK]#[#HKY;T7]L M348=BZQX?MY_[SVDK1$>^&W9_.N^T7]JWP7J6%O!?:4WNA[-17+Z+\4/"?B +]@\06$S-TC:8(_P#WRV#73*RN M,J0P]0:\N=.=-VFFO4].-2%17@[CJ***S+"O!_C-\(7ADE\2>'HV1U/FW5M# MP01SYB8_4?C7O%)UX- 'E'P;^+R>*H(]'U:54UB-<1RMP+E1_P"S>H[UZQ7S M_P#&+X22Z/ M#T%PH_B'OZB@#TR:>.UADFFD6**-2SR.0%50,DDGH*Y_P?\ $?PO\0%O&\-Z M]8ZT+.5H)_LAZ'M5/XO>!YOB5\-?$'AJVO1I]QJ-OY<=PR[E5 M@P8!AW4E<$>A->/_ UG3KCQ@=)\2:)_P (]X]TV?4DA\B,?8[V$RKYHMY0 M/G5&"_*<%<].: /H&QU[3-4OKRRL]0M;N[LR%N8(9E=X2>0'4'*D^]5+?QKX M?N_$DZ)GZG>V+;;JWM+I)9(#DC#JI)7D'KZ57U#XB^%=)\26_A^^\2:39Z]<; M?)TR>]C2YDW=-L9;<<^PKRNQ6?2?VG-/CUSP[;Z9'-H]Q:>'=0TR;S(YHD=& MF2X!52'P4*C!4<\DFN3OOAQXA^&/QUM?&.NVWAWQSH?B#6%B%[<:7'%JFBR. M"(?)E.2T:A0IYR,\ 4 ?45%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110!\\_M$ZA"*[%TATCX!7W@C39=/O=4O8;B%FGE>"UMQ,S,5CP MKML3=A5QR!VH [73?$4FF_#[1+V0/>W]Q9VZ11LV7GF=%P"3ZDY)[#)KS'P' M\0M=\/\ PA^)/B'6;UM7U31M6U-4:3/E_NL!$5?X4![5W]C\/!X@\'>';'Q1 M"]KJ.E1JJG1M4N(@K*GE[ED3RV.5[$<9(YZUS7P]^ L?AOPGXWT/5+J6XA\0 MWMXP(O9IPMO+D)D2'B0 G*MUKJ:7D M[RHUP8#,LL2DD1 ,K+M3"X;ID9KVNO+?#WPZ\17>O>%[GQ1<6$MKX5A=+%K) MG:2\F:/RO/E#*!'A,_("W+9SQBO4J "J6HZQ::3Y8NI?*\S.WY2HS0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P ) MAI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\ M*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ M ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@ MHVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8 M:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_ MPH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"? MK_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H* M-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P ) MAI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\ M*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ M ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@ MHVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8 M:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_ MPH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"? MK_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H* M-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P ) MAI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\ M*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ M ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@ MHVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*@OKN#3;*>ZN" M$AA0R.WH ,F@#P_]H+X@V]UI=MH6GS,_G-YMR0"/E'W5Y]3_ "KIO@]'I7@S MP=!%//LO[H_:+C]VV03T7IV%>7^#[.;XN?%B34+I6:SCD^TR#LL:G]VGXX'Z MU]0;5_NC\J ,C_A,-)_Y^O\ R&W^%'_"8:3_ ,_7_D-O\*V-H]!61XL\4:9X M)\-ZAKNKR_9]-L(C--(%+$ =@!R23@ >IH 3_A,-)_Y^O_(;?X5P?QC^-5AX M)\*2G3IQ-K-T#%:IM(VYZR'(Z#^=1>%?VA--UA;]M;T#5/"@@-PUNVI(C+]CRLPQ%2G#V5!7G+\/,[;]F[P?9MJ^)K'08O"WB7Q7J-PBR2KX3] 37-C<7+&5G5EMT79'1@\+'"4E3COU?=G:_\)AI/_/U_P"0 MV_PI#XNTAN#=9'_7-O\ "M>/$D:MLV[@#M8H MVU[H+QI"5*!L,5P.N #VS7"=HFM6'@7Q%G^T=-L;MC_ !R6GS_] M];F[1Z"NNGB\11_AS:^9RU,+0K?Q()_(^3-:_ M9ITU=SZ/XM5C_#'>6CK_ ./+G^5$-6V_8]>M9V;HJD[ORQFN' MUK]E/P7J6YK,WVE-V$$V]1^#@G]:X#6OV.]1AW-I'B"WN#V2[B:+_P >4MG\ MJ/8Y76^"I*#\U?\ K[P]MF='XZ:FO)V_K[CZ+/BW2)%(-SN4C!'EL0?TKY^^ M*7@VUT'51X@\+7#1Q;_,>&%65K=_[R\?=]NU#_$TOB'4_%6I^*=8#W)M)]0C5%M4G??(%2)%4LQ W.1DXXP.*^;9/B* ML>OC5-.LFT>57\U$MY=PC;OMR.GL:^DO ?[37A;6],A37+H:3JBC;()(V\N0 M_P!X$ @?0UPU(%!TW5K&^SSB"=6/Y YK6VKZ"O- ME&47:2L>C&2DKQ=SSA=+TN37;V\O?%NL:EIMQ,+@:+=!#:Q.""-I$0DV@@': M7*^U6M2M](U+7-2U$^)M9MUOM-.FFSMYW2"'ECY\:A?EF^;[^>P]*O?"K7KS MQ-X/CO=1G6YN_M$\;.$5>%D8*, >@%=AM'H*DH\P\(^'="\-W]IJ&H>)M6\5 M:I9P-:VE]K6UI+>)L;@OEQH"6P,LP+' R:G\/:7I>CW@FO\ Q;K'B*.*8SVD M&J!&6U8Y^Z4B5FP"0-Y8CM7I&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2? M^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%; M&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ M /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]? M^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-) M_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6Q MM'H*-H]!0!C_ /"8:3_S]?\ D-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/ M_P )AI/_ #]?^0V_PH_X3#2?^?K_ ,AM_A6QM'H*-H]!0!C_ /"8:3_S]?\ MD-O\*/\ A,-)_P"?K_R&W^%;&T>@HVCT% &/_P )AI/_ #]?^0V_PJSI^O6. MJ3&*VF\R0+N(V,./Q'O5_:/048 Z"@!:*** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ KQ_P#:,\8?V5X?AT2"3;<7YW2X/2('G\SQ7KLT MR6\+RR,$CC4LS'H !DFOEVV67XR_%XNVYM/\S=[+;H>!^/\ 6@#UOX#^#_\ MA&O!J7 M!=9T_P 4ND>@74/D7;NY0*K$*#N'0AB,'L<5TU>1?M&?$^'P3X1ETN#RY=6U M6-HDCM##TW5GLCY#UKQ=KW_ FLOPIA MOX_%5A'JUT;#40H-[*WRKB9APPZ#V>*C_9'^ ^G>%[>7QC+I<-IOK_7^ M70\[!4_:S>,FK.2T]/Z_SZGS5XQUKQ!#\8OA3>ZOX'UJUU>XUV\DD+SV3B5? MLY14B*SGY43#?-MR,]3Q7:?&?X0Z+=:[=_$;PAK=WHWQ&LYX8FDL;]G2\*LJ MBUGA+%2I4D;1MZYKD/VR/C1?>%/$FB:%HEO;0:I;1F\&JR0))/;E\KMA+ [" M1U8<]JXS]EOXK7+?&1;#Q/IMC=:MJRLBZQ-9QI?+(%R%:4 ,RL!W/85K#)<3 M/"?6TU:U[=;+J:RS"E&O[!WOM?I<^UK77K-]0BTJ:\M4UK[,MR^GB9?-"$X+ M[,YV[LC/2O)OAXTN_V'IW]L_P!K_8+;^U?) M^S?;?*7SO*SNV;\9VYYQG&:R-)^&OA+0->FUS3/#.DZ?K,V[S=0MK*..=]W+ M9<#<<]^:\ ],^:]6\#>)='\+Z?\ !6WNM)UNUFUB*YMKVSE>[7$6 MW;%MQL63>=Q/ ZU]<*NU0!T Q65X?\(Z)X42X31=(L=)6XD,LPLK=(O,';$LW5X8_*8_BF#7SQ\8OV?(O!LIU+2/.?17/S G<;=O0^J^AKZX MJ*ZM8;ZVEM[B)9H)%*O&XR&![&NZECL51^"HU\SBJ8+#5OCII_(^)?"/P0O? M&UG))H6M6G]H0',EG<[HG [,I&A?$#P%J?PD\00Z]H,DBZ=YFZ.1>?))_Y9OZJ:]"TF+P?^T#I MEK/K>GK/J=BI5[7SW0QYZD;6&5/K7L8?.ZCDEBTI1]%?]$>37R:FHMX5N,O5 MV_5G@GPK^/UW\.;B[AEL?[0TNZ97:'S=KQN 64X[@'M2 MFTR7J+>Y'FQ?0'[P_6JJ5,IQ3M:4'W_ILFG3S3#*]XS7;^DCZ CD610R,'4\ MAE.0:=7QP_AWXL_!9R]F]Y)I\9R6M6^TVQ'J4.=OU(%=AX1_:^P4@\3:/M/0 MW.GG^<;'^1_"N:ID]5QY\-)5(^6_W'13S:E?DQ$73EY[?>?2]%/!_]B^%WU>=-MUJ1RF1RL0^[^?6O-?$%Q+\ M8OBXEI S-8+)Y*'LL*'YV_'G\Q7T]:VT=G;16\*A(HE"(H[ # H EHHI* ,C MQ;XHL?!GAZ]UC49!';6J%B,\N>RCW)XKY-\">'M2_:&^*5UK&KAO[+A<2W/] MU8P?D@7Z]_;-7_CEX\O?BUXYM/"7A[-Q8V\_E($/$\W1G/\ LKS^1-?2/PU\ M V?PY\*6ND6H#R*-]Q/CF60_>8_T]J^HC_PE87G?\6IMY+^OZT/FI?\ "IB> M1?PJ>_F_Z_K4Z:"".UACAB18XHU"(BC 4 8 %245R?Q4^(%G\,/ NJ^(;PJ1 M:Q_N8B<&64\(@^I_3-?-TX2JS4(*[9]'*2A%R>R/C[]N+6M*USXF:1I>F0F? M6[.W$-U+$]6OV3_A_>?%GXJ:AXYU\-=6UA.;IGE&1-=N>%1XM\/RV MT;^3?0D3VDXZQS+RI_I7V>/QTLK='"X=WE36KWU>Z]/^!V/ PV'6,52O55E/ M9>G7U/B[P9^TY\1/@GJBZ!XUT^YU.UA^4V^I I=(OJDI^^/KG/8BOK/X8_'; MP?\ %BW7^Q=35;[;E].NL1W"?\!_B^JDBH[/2?#_ ,;/!@M?$^D6][[ M@F7]Y!,O!*M]Y<]01CK7SC\3OV)-7\/W#:O\/M1DNQ$?,2QGD\NYC(Y'ER# M;\<'ZUS>TRW-/XB]C4[KX7_E^'J:\N+P?P/VD.W4^TZ*^%O /[77C7X7ZB-! M\>Z;<:K# =C_ &I3%?1#ZGA_QY/K7UK\.OC#X3^*5D)_#^JQ7$P&9+.0[)X_ M]Y#S^(R/>O)QN58G!>]-7C_,M5_P#NP^-HXC2+L^SW.THHHKQSN"BBB@ HHH MH **** "BBB@"O?V%OJEG-:7<*SVTRE'C<9# U\L?$3PO=_"3Q2)RLB+G!1B.O]:^KZ\J^,7PJU7X@ZEI]SIUS:0K;Q-&ZW+,#R4E64L 01]#7UK7R/XF^'?B#X67FG:G=)! M<1QS+(D]N6:,.IR%;(!&<5]&_#WXA6'Q T@7%N1#>1@"XM6/S1MZCU4]C0!U M=<;XN^$/A/QL';4M'A^TM_R]0#RI<^NY>OXYKLJ*UIU9TIW#.*DH\F*@JD?/?[SQ MIY33B^?#2=-^6WW'A?@_]K3P_JFR'7K.;1ICP9H_WT/UX^8?D:]ET/Q-I7B: MU%QI6HVVH0G^*WD#8^H'0_6N!\8?LX^#/%>^6.R.CW;<^=IYV#/NGW?R KQK M7/V9_&G@NZ-]X7U+[?Y?*M;2&WN!^&<'\#5^QRW%_P *;IR[/;[_ /@F?MLP MPO\ %@JD>ZW^[_@'UM17R+H_[1?CSP#="P\3Z>U^J<&.^B,$^/9@.?J0:]B\ M'_M+>#O%'EQ7-R^B7;<>7?#"9]G'&/KBN2OE.*H+F4>:/=:_\$ZZ&:8:L^5R MY7V>AZQ14-K=P7T"36TT<\+C*R1,&4CV(J:O'V/6W"BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HKPKXV>--:L_B%H7AJ/7;GPII MEZMO);WUK&F^\N#=(CP[W5E&R,[MN/FSSP"*Z/X@ZMXU\.?!76M334[.R\1Z M9#/,UY]C$B31QEMA";\*S*%/.0"3Q0!ZE17+6:ZMXF\%Z,\&J-IMS=VD4MQ? M0QHTPW1@DQAE* ECW4C&>*XGP_\ $'6O"GAGXB77B"Z_MZT\+32"TU,Q+"]X MJQ!RCA0%W*QV%E &>W% 'K]%>0Z/XI\2>%]>\$C7]5&JVWBQ&CDA,4<:V-UY M/G*L)503&0&7#ECG:<]17KU !114%Q?6]GM\^>.'=T\QPN?SH GHJE_;6G_\ M_P!;_P#?U?\ &C^VM/\ ^?ZW_P"_J_XT 7:*I?VUI_\ S_6__?U?\:/[:T__ M )_K?_OZO^- %VBJ7]M:?_S_ %O_ -_5_P :/[:T_P#Y_K?_ +^K_C0!=HJE M_;6G_P#/];_]_5_QH_MK3_\ G^M_^_J_XT 7:*I?VUI__/\ 6_\ W]7_ !H_ MMK3_ /G^M_\ OZO^- %VBJ7]M:?_ ,_UO_W]7_&C^VM/_P"?ZW_[^K_C0!=H MJE_;6G_\_P!;_P#?U?\ &C^VM/\ ^?ZW_P"_J_XT 7:*I?VUI_\ S_6__?U? M\:/[:T__ )_K?_OZO^- %VBJ7]M:?_S_ %O_ -_5_P :/[:T_P#Y_K?_ +^K M_C0!=HJE_;6G_P#/];_]_5_QH_MK3_\ G^M_^_J_XT 7:P/'7C;3?A[X;N-: MU4R_9HV2-8X$+RS2.P5(T7NS,0!]:TO[:T__ )_K?_OZO^-)-6AL["\FBCCNH[D1R0W&\&%T;LP< @GC(YH B^&OQ@B\?B2"[T'4_#>I MI'+<+9WRK)YD*2F(NDD9920PP5SN!/0C!-[XFZXW@K7[O2]8FMK2ZO+/7K9U$_D M_;'1H[I>BNS#>"IPP[#%;_P'UBP7X@?&0F^M\-XD4K^]7D?9X^1S0!WOA;XM M:1XN\=^(/"=I:ZE!J.B1QR7#WEHT$;JY(4Q[L%AD'YL8..":KZI\8M/T7Q9I M6D7FDZI#8ZI=_P!GVFN>4C62&ER.M4?BMKD;^-/ _B[P[XOM-?;%BOG1M&[J1G@@D,,C(K9NOB!X7LGOX[GQ%I4#V$:RW:R M7D:FW1ONM)D_*#V)KR'POJ$_A/X\>($;Q%'XPTC5M%.I&XG\HSV#)( ENKQ@ M*8G5B57&'=8\$>--&OK:Y\.^)M5FLYO",LYD&B32NX\^V!),9 M&#YJXQACC KZW_MK3_\ G^M_^_J_XT 7:*I?VUI__/\ 6_\ W]7_ !H_MK3_ M /G^M_\ OZO^- %VBJ7]M:?_ ,_UO_W]7_&C^VM/_P"?ZW_[^K_C0!=HJE_; M6G_\_P!;_P#?U?\ &C^VM/\ ^?ZW_P"_J_XT 7:*I?VUI_\ S_6__?U?\:/[ M:T__ )_K?_OZO^- %VBJ7]M:?_S_ %O_ -_5_P :/[:T_P#Y_K?_ +^K_C0! M=HJE_;6G_P#/];_]_5_QH_MK3_\ G^M_^_J_XT 7:*I?VUI__/\ 6_\ W]7_ M !H_MK3_ /G^M_\ OZO^- %VBJ7]M:?_ ,_UO_W]7_&C^VM/_P"?ZW_[^K_C M0!=HJE_;6G_\_P!;_P#?U?\ &C^VM/\ ^?ZW_P"_J_XT 7:\]^-WC'_A%?!D MT<,FR^O_ /1X<=0"/F;\!_.NU_MK3_\ G^M_^_J_XU\T_$G6F^)WQ.@TVUN% M%A#(+6*3=A0,_O'S^?Y4 =W^S?X/^PZ/-8T42J. ,>M6O[:T_P#Y_K?_ +^K_C0!=KQ/]I3XL_\ M"&Z#_8.FS;=8U!"'=3S!#T+?4]!7H?C;XC:/X*\-WFK7%W#-Y*?NX8Y 6E<_ M=4#/] MB\1\$/Q?8\3,<1/3"T/CG^"[GJ/[,?PF_P"$;TG_ (2C4X=NIWR8MHW',,)[ M_5OY5[S5%=8TV-0JWMLJJ, "5<#]:7^VM/\ ^?ZW_P"_J_XUYF*Q,\76E5GU M/1PV'AA:2I0Z%VOAC]L#XC77Q&^(FG^ M"+7,%A,L3QQ\B:\%_'9\6>, M;NXN;XS>79PVMK)K/7A%4XJ,=D5%\*WFE_$ ZS MIK1K87\1348&.,R+]R11Z]C775R6D?%CPAKGA+_A)K3Q!9-H@1G>ZDD\L1[3 MA@ZMAE8'@J0"#VJQX1^)'AGQUH-OK6AZQ;WNF7&[RI\E V#@\, >H]*S+(?' MWPN\,?$W3C9^(M)AO@ 1'-C;-%[HXY'\J^2?B-^QKXI\!WQUOP!J4^I10'S$ MA63R;V'']UA@/^&#[5]8^/OBYX0^&/AV37/$FN6]AIL;K&95#2L6;H B!F)^ M@IWAOXL^$?%7@^'Q3I^NVO\ 8,L1F6\NB;=0@ZL1(%*CCN!7K8+-,3@=*7Y5Y#CCYT. M_P"A]S7UKX$^)GAKXE::+WP[JT&H1@ O&IVRQ>SH>5_$5PNM:3\+?VC-)N9; MB..[$#>5'JA@DM9HW+7S3XZ_9F\5?"G4CKW@37_[5@@.]&LY MQ%>Q#T*@_./IU]*]CERS-/A_E^/[!KI8SL;4K6/9.F/^>D? /X8^AKZL\+_$CPOXTTU+_1MQT[K5?>>AA\71Q*]QZ]NITM%4O[:T__ )_K M?_OZO^-']M:?_P _UO\ ]_5_QKRSL+M%4O[:T_\ Y_K?_OZO^-']M:?_ ,_U MO_W]7_&@"S-/':PR332+%%&I9Y'("JH&223T%<_X/^(_A?X@+>-X;UZQUH6< MK03_ &.8/Y; X.<=O0]#VK'^+N@VOQ*^&NO^&;;6[73[C4;?RX[AG#*K!@P# M#/*DK@CT)KR+X ^+-#N/%SZ9XDTZ'P[XZTR?48XF@V_8KR%I5\P02@?.J,J_ M*<$9SB@#Z*L=>TS5+Z\LK/4+6[N[,A;F"&97>$GD!U!RI/O5&U\>>&[[Q%-H M%MK^FSZ[""9=-CNXVN$ ZYC!W#\J\>^#\.AZ#\>/C!;Z>MCIUD[Z=(([;;&A M9K?+L,=R3DGUK7\=^']!\4>,/!&D:4;.S;PY?+K%Q?PLH-M&JLJPAO64MR,] M%R>HH [[Q-XL\'_;E\,:YK6DQ7U^H5-,N[N-)I0>FU"W-NT&O_#>]U.V'BF2-%^WZ M;,JQ[GMVS^\C4!"W&4^;;G''T%\3/%6D:9\)O$6HQ-:ZI!;:3-] "^"_C1X9\6K8VCZI9V&NW)V+I4]PJSNP&3L4G+C )R!7976K65C= M6EK9@,D("*_/[1['Q%^SWJ7@CQ2MYINJP^)U5Y] M1M@6GBG>/S"DK$G='@$ +@#CI7=1_&[PO\ $;XV?";Q3<>(M/MKE;O4+5[! M[Q0ME&8 L>X$_>D8DY//(7M0!]I452_MK3_^?ZW_ ._J_P"-']M:?_S_ %O_ M -_5_P : +M%4O[:T_\ Y_K?_OZO^-']M:?_ ,_UO_W]7_&@!NL:#IOB&U-M MJ=C;W\!_Y9W$81'_K8<_[I.1^!_"O9/[:T M_P#Y_K?_ +^K_C1_;6G_ //];_\ ?U?\:ZZ&+KX9WI3:_+[CEK86AB%:K!/^ MNY\D77PM^*7PBN'NM$GN+FU4[C)IOY$5O^%?VMM5TR06OBC1UN MMAVM-;#RI1CKE#P3],5],?VUI_\ S_6__?U?\:YSQ5X4\%^-(BNL6VG7;D8$ MV]5E'T<$']:]C^U*.(TQM)2\UH_Z^9Y/]FU--B6.K MQ0W37B,#B<+_ !8-+OT^\]/#XW#XG^%.[[=?N.CHJE_; M6G_\_P!;_P#?U?\ &C^VM/\ ^?ZW_P"_J_XUP'<7:*I?VUI__/\ 6_\ W]7_ M !H_MK3_ /G^M_\ OZO^- %VBJ7]M:?_ ,_UO_W]7_&C^VM/_P"?ZW_[^K_C M0!=HJE_;6G_\_P!;_P#?U?\ &C^VM/\ ^?ZW_P"_J_XT 7:*I?VUI_\ S_6_ M_?U?\:EM]0M;MRD%S%,X&2L;ACCUXH L4444 %%%% !1110!Y-\>++4M>DBWUT8O*5H@K$B, LV7"MG QU->P444 %07-C;WFWSX(YMO3S$ M#8_.IZ* */\ 8>G?\^-O_P!^E_PH_L/3O^?&W_[]+_A5ZB@"C_8>G?\ /C;_ M /?I?\*/[#T[_GQM_P#OTO\ A5ZB@"C_ &'IW_/C;_\ ?I?\*/[#T[_GQM_^ M_2_X5>HH H_V'IW_ #XV_P#WZ7_"C^P]._Y\;?\ []+_ (5>HH H_P!AZ=_S MXV__ 'Z7_"C^P]._Y\;?_OTO^%7J* */]AZ=_P ^-O\ ]^E_PH_L/3O^?&W_ M ._2_P"%7J* */\ 8>G?\^-O_P!^E_PH_L/3O^?&W_[]+_A5ZB@"C_8>G?\ M/C;_ /?I?\*/[#T[_GQM_P#OTO\ A5ZB@"C_ &'IW_/C;_\ ?I?\*/[#T[_G MQM_^_2_X5>HH H_V'IW_ #XV_P#WZ7_"C^P]._Y\;?\ []+_ (5>HH H_P!A MZ=_SXV__ 'Z7_"H+[PKHNJ6:3975K,NR2&:W1T<>A!K10!ROA3X5^ M#_ ^GRV6@^&]-TNUE9GD2WME&\DDG<<9/4]>@X'%+H7PK\&>%[V>\T?PIHNE MWFZZ^MVOA/1;;6'+%M0BL(EG) M;ALN%SS]:DTOX8^$-#U.XU'3O"VCV.H7!)FNK>QB220DY)9@N3FJ/C/XLZ'X M%U*.QU$7+3R1^:!#&& &<=R/2L_0/CIX;\1:Q::9;"\2XN7\N,R1 +N]"0: M.EN/ /AF[DOY)_#VES2:A$(;MI+.,FXC&<+)D?,!D\'UHT'P!X9\+69M-&\/ M:7I5L6W&&SM(XESZX4"M^B@#FK'X9^$=+UF?5[/PQH]KJMQGS;V&QB2:3/7+ MAG?\^-O_P!^E_PJ]10!1_L/3O\ GQM_^_2_X4?V'IW_ #XV_P#W MZ7_"KU% %'^P]._Y\;?_ +]+_A1_8>G?\^-O_P!^E_PJ]10!1_L/3O\ GQM_ M^_2_X4?V'IW_ #XV_P#WZ7_"KU% %'^P]._Y\;?_ +]+_A1_8>G?\^-O_P!^ ME_PJ]10!1_L/3O\ GQM_^_2_X4?V'IW_ #XV_P#WZ7_"KU% %'^P]._Y\;?_ M +]+_A1_8>G?\^-O_P!^E_PJ]10!1_L/3O\ GQM_^_2_X4?V'IW_ #XV_P#W MZ7_"KU% %'^P]._Y\;?_ +]+_A1_8>G?\^-O_P!^E_PJ]10!1_L/3O\ GQM_ M^_2_X4?V'IW_ #XV_P#WZ7_"KU% 'G_Q:U73O!O@V[N8[2V6]G'D6P\I<[V[ M_@,FN$_9S\$1W$-[X@OH5F5R;>W65<]/OMS[\5A?&77)_'WQ#M?#^GMYD-M( M+9 O(,K??;\!_(U]#>'-#@\-Z'9:9;C$5M$(Q[XZG\30!)_8>G?\^-O_ -^E M_P *231],C1G>SM411DLT:@ >O2K]> _M/?%@Z'IO_"*:7-C4+Q,W#O#MGI-M9PR+ @#RR1@M(_\ $Q..I->? M_LW_ G'@GP\-9U&';K.HH"%8SUZ698F#Y<)0_AP_%]6>=EV' MFKXJO\<_P78H_P!AZ=_SXV__ 'Z7_"C^P]._Y\;?_OTO^%7J\=_:B^+(^%OP MUN?LDH76]4S:6:YY7(^>3_@(_4BO*P]">)JQHT]Y.QZU6I&C!U);(^7OV@/$ MDOQR^-ECX2\,Q1FRM)_L%MY*@*\I/[V4^RX/X+7J_C;X,R_"'6O#.N>!HK36 MVAGL;#4O#MPRHUU)%'(8Y4E/^KZE$6FN-UMIW MF#)V9_>2_5CQGT%>]^//@?X6^(NI0WVJ17T%RLB/,VGWTUJ+H("JK,(V < , M1D\@' (!->_G5>$'# 4/@I_C+K_7>YYF7TY24L34^*?Y'E?Q:NO#/B?]C_4- M9\.Z6EGIEQ:P26\,L0$D/^E(&4]>0VX<&O:-0\-&\\+QC1TTW3];^RA;2\O+ M(3I"Q498H&4GCMN':J_BCX0>%/%W@VV\*7VG21>';<*L>GV%U+:1;5QM4B)E MRH(!P>,C--UKX/\ AKQ!INA65['J#C0\FPNH]5NH[F+(VG,ZR"1L@ '2V MM '.?&KX!Q?%6#2;C2O$=]X1UC1W>XL;C3DC,)E8 9FC*_O%P.F0.:\HUF/6 M/B-:_!G0?$JVVE_VE>WG]JW%G:J(KR:U3]T55EV[7.7"L"N1T.*]_O/A'X:O M6T4F"]MQI%NMI:K:ZE<0#R1C$<@20>8O'1\UH^*?A[H'C+0X-(U33UDLK>1) M;<0.T#V[K]UXGC*M&P]5(/- ' ?!>\U.\U[QQX7\0K;ZS_PCE_'!::P;6*)[ MB&2(2*LBHH3>F<': .G KU3^Q-/_ .?&W_[]+_A53POX2TKP;IK66DVWD1/( MTTKO(TLLTC?>>21R6=CW9B36Q0!YO\2?V??!7Q0M674M)CM;[&$U"Q413+^( M&&^C U\F>./V8_B%\%M2;7/"5U-K%C"=XN+ 8G11VDAYW#Z9'K7WW17M8/-L M3@UR7YH?RO5?\ \_$8&E7?-M+NMSXR^%G[96GAXM-\?:%;QNIV'5+*V P?62 M+''N5_*OJOPW?>%_&&EQZCHKZ=J=E)TFMPK#Z'T/L>:XWXJ?LV^#/BLDL]Y8 MC3=78$C4[$!)2?\ ;'1_QY]Q7RIXD^"/Q3_9RU236_#%[<7NG1G+7NE@GY1S M^^A.>/P(]Z]3ZOEV::X>7LJG\K^%^C_KT./VN+P?\5<\>ZW_ *_JY]X_V'IW M_/C;_P#?I?\ "C^P]._Y\;?_ +]+_A7R]\*?VY-/U'R=/\?1 M_,]*AB:6(5Z;O^9G>(O ^D>)=%N=-GMA;QS@?OK7]U*C AE96'0@@'TXP9^%_@78^&/&^O\ B9=>U2^N=:55N;6ZBM?(4JNV,H%A!!0<#GGOFN)T MO]C71-/\3#6)O'7C;45:]^W3Z==:HGV.Y?=NQ)$L8!7('''2OH*B@#RK5OV< M_#VI:YK%Y#?:CIVG:VZR:MHUJT7V2]8#!+;HRZ;@ &\MER!S73?\*OT<^(I] M2(\??(.TG/0 5U]% 'E7A[]G/PUHFZ M<)%TS3=2>-X;%7&"$*H&8@<*9&8J.A%>-?$[X-R_#CQUH/BJR#366F3R26;E M%9 SKM,QKK?[#T[_ )\;?_OTO^%?-WC3P1K/P:\11:WH MLTC:=O\ W4_79G_EG(.X/Z_6O MG?\ /C;_ /?I?\*O44 4?[#T[_GQM_\ OTO^%']AZ=_SXV__ 'Z7_"KU% %' M^P]._P"?&W_[]+_A1_8>G8P;&V(]/*7_ J]10!Y[XM^ _@SQ@K-/I,=C9B,MPV(UE&S[K1GQ;'\2OB!\+]UAK>F)*NTI'_:MH&(./O+( M/O8^I%>C_LN>-+?Q):7_ (?U9(KK4(&-S!+,H9GC8_,N3UVD_DWM7?\ QD^# MT_Q:&FQ_VZVEVUGN8PBW\T.QQ\WWAT KDO ?[,,_@7Q9I^MP>*FE:U?S4Q. Q.$ESI0J/71/=;=.OZGD4\-CL/BH\K:I TYN5ENEA,42!EX49+G.0",8ZT >Y45Y/\0/B/XR\)_! M'4O%<.A:;%X@TV.:2ZL[VXD$(6)V4NF%W/N"AE4[>&'/KI>+/B9>Z-X7\(_8 M;>";Q%XHFM[2S24'R(I)(_,DD< Y*(H9MH.3@#(SF@#T:BO%KWXZ:AX/TOQ= MI^OV=O?>*=!FM((%L5:?M9VVS*K,QCR^Y6&6QMSDYQ71^$?&VNVOCZ?P7 MXL-A/JC45P'C[QQJECXJT M#PAX=%K'KVL1SW)O+^)I8+2WB W.T:LI3^.-)U./4+ M>.TUO1M0ETO4(H23&94P0Z9YVNC(P!Z9(YQD@':4444 %%%% !1110 451U3 M7=.T6+S+^^M[-/6:0+G\ZX#7/V@_"VD[DM9)]4E''^CQX7/^\V/TS0!Z;2$A M1DG KYSU7]HS7]7D\C1=,AM2YPO!GD_#M^E4/^$4^)OQ".Z^>\CMWZ_;)/(C M_P"^!_A0![MKGQ*\,^'=PO=8MED7K%$WF/\ ]\KDUYWKW[3.FV^Y-)TR>[;H M)+AA&OUP,D_I5+0_V8T^5]8UAF_O16:8_P#'V_PKT30O@_X3T#:T.DQ7$H_Y M:77[T_7!X'X"@#YC\<>-+[QUK"ZCJ$44$@C$:)"I"[03ZGGK3/ .J6VB^--% MOKN3RK6"Y5Y),9VKZ\5]>WWA71=4:-KS2;&Z:-=B&:W1MJ^@R.!7)>-O@KH/ MBC3MEE:P:/?1@^5-:Q!%)]'4=1^M '>6EY!?VT=Q;2I/!(-R21G*L/4&IJ^7 M-#\4^)_@?KATW48&ET]FRULQRCC^_$W8_P"37T3X4\7Z7XSTQ;[3+@31]'C/ M#QGT8=C0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S M/Q&\6)X-\(WVH[@)POEP*?XI&X7_ !_"NFKYQ^/WB:7Q-XLL_#=@?-2U8*RK M_%.W&/P% %K]G/PJ^I:M?>);P&3RB8H68?>D;EV_SZU]"5B>"_#47A'PS8:7 M%@^1&-[#^)SRQ_.M:YN8K.WEGGD6*&)2[NQP%4#))H Y?XG_ !!M/AMX3N=5 MN"KS_P"KMH,\RR'H/IW/M7SK\!?A_>?%+QG=>,/$.ZYLX)S*3(.+B?J /]E> M/T%9?C'7-2_:+^*EMI>F%ETJ%S';_P!V.('YYF]S_@*^MO"_ANQ\(:#9Z1IT M0BM;6,(O'+'NQ]R>:^HG_P )6%]FOXM3?R7]?UH?-0_X5,3[1_PH;>;-6BBB MOESZ49)(D,;R2,L<: LS,< =237Y\_$#6+[]J3]H2WTG3'?^R8Y3:6S#)6* MW0_O9O;.#^E?0W[8_P 6SX#\ C0;"?R]9UP-%E3\T5O_ ,M&_'[H^IK)_8G^ M$?\ PB_A&7Q=?P;=1UA0ML&',=L#Q]"QY^F*^NRU++L'/,9_$_=A^K_KL>'B MV\57CA8[+67^1]$^']#L_#.B6.DZ?"L%E9PK!%&HP JC%:%%%?)2DY-M[GMI M)*R"BBBD,**** "BBB@ HHHH **** "DI:* /&_BM^ROX,^)WG7:6W]@ZT_/ MV^P4*'/_ $TC^ZWUX/O7R]K'PY^+7[+VI2:IH]S//I ;+W>GYEMG7_IM$?N\ M=R,#L:_06D90ZE6 93P01P:]["9SB,/'V53]Y3[2U^[^K'FU\!2JOGC[LNZ/ MF'X4?MO:'XB\FP\96XT&_;"_;HH(X->(_%?]D/P?\ $+SKS3(_^$:UELGSK-!Y,C?[<73\5Q^-?-MQ MHGQ>_93U)KBU>9]%WY,L&;BPF&?XU_@)]\'T->A]2P&9ZX*?LY_RRV^3_P"' M]$,?)L?$R#PSJC?+YSMNM)#[/U3_@ M7 ]:^B;>XBO((YH)4FAD 9)(V#*P/0@CJ*^=Q6#KX.?)7C9_ULSU:->G7CS4 MWH/Z_6OIVJ^H:?;:M936EW"MQ;3*4>-QD,* .7^'/ MQ(L/B!I?F1$0:A$!]HM2>5/J/53ZUV%?,/CCP/J_P=\11:WHDTAT[?F*;KY> M?^6R?#'X;ZYXFBM%O9;")66%V*IEG5 SD D(N[F'5=*@>!8#%/L6(J68,K*7?'+%Y@+NP&6P1T48]Z /3J*\QT/XB>(KKX\ M:UX+U*PTVWTBWTF/4[*>VE>2>0-*T?[S( 4_*?E /U-<;\3?%'Q\T.]U;4_# MUEX$B\-1SK%8V^K&Z:_FRXC7.PA,NQ&!D8!&>] 'T!16=<7EWI_A^6ZDM_ME M]#;&5K>W&/-D"9*KG.,D8'7K7CWPC^,GB'Q]JVA2FXT/6],U6WFEO+?289(Y M]"D0 B*X9Y&W$DE.5C.5) (Z 'N5%?.OA7]H#Q!\2OCQJ7AKPOJW@Y?#6CW; M6U[97[7"ZQ,(QB22%>(V7=P#S@#)KZ*H **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ KP#]J)=#U2UTRRUW0-9\V&]LY=.U M_1K26:XA9IP)4BDA4M$X4#&[ ;< ,D5[_24 ?/'BR?Q;$/A5XMT[3-0N3X8N MX;BZT^2TDANO),+03$0N Y9<[@N,L%XSD5[I10!\P>*OASKGQ,F\<^.+#2KJ M.66ZTF71M/OHVMI[J.QD,KDQN 4WEF50^#\N2!D5VVBM<^-/C#+X_32-5M-$ MT/09=/MX[VS>WN+JXDD6201Q. Q"K&%R1AF8;20":]IHH \1\075T_CCP'\4 MUT'6$TK^RKFPU"Q:R=[^R6;9)&S6Z;F)#IM8*"1NST%;WP)\,ZAI=KXKU_4[ M26PNO$VM3:I'9W Q+#!M2.(./X6*IN([;@#R#7J%9.L^*]'\/H6U'4K:S_V9 M) &/T'4T :U%>4:[^T;XH?'SQ;XDF-MHE@E MJ6^ZMO$9Y?U&/TH ^D9)$A0N[*B@9+,< 5R.N_%SPIX?W"?5X9I5_P"65M^] M;/I\O _$UXI'\-?B-X\82:I--#"QSG4)RH'T09(_*NNT+]F6PAVOJ^JS73=3 M';*(U^F3DG]* (-<_:YZ%\+_"_AW:;/1[?S%Z2S+YK_ %RV?"^E[7O!<:I*.?WS[4S_NKC M]2:]0HH S]*\/:9HA% '#_#;XN:;X]@6!]MEJZK\]JSW6M7X8?'A+QHM)\3. M(+D'9'?,,*Y])/0^_2@#VZBD5@RAE(92,@CH:6@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH Q/&7B2'PEX:O]4F('DQG8O]YSPH_.O"_@'X;F\4>+[S MQ)?_ +U;5BX9N=T[\Y_ 5<_:,\6/J&J67AJS;S!$1+.J_P 4C<(O]?QKUSX< M>$T\&>$;'3L#SPOF3MC[TCD2%IY=IOWB.3@_ M=B&.Y[_@*]6^,7Q*@^&?A&:]RKZC/F*SA/\ %)CJ?8=37AW[-_PUG\8>()_& MVO!KB&*9G@\[GSYR>7/LO;W^E?0Y;1A1@\?77NQV7=_U_6AX.85IU9K!4/BE MN^R_K^M3U?\ 9_\ A2OPZ\+BZO8Q_;FH*'N#WB7JL8^G?WKU2BBO%KUYXBI* MK4>K/7H488>FJ4%H@JMJ6H6^DZ?;?%3S';@\+_P(_H*Z,#A)8[$1H1Z_@NK)Q%98>DZDNAXO M8PWW[6'[1+2RAQHWF;V':&QC/"_5OUR?2OT'M+6*QM8;:WC$4$*".-%Z*H& M!^%>'_LB_"3_ (5S\.TU.^@\O6];"W$P8?-%%C]W'^7)]S7NU>EG6+A6K*A1 M_AT]%^K.3+Z,J=-U*GQ3U84445\\>H%%%% !1110 4444 %%%% !1110 444 M4 %%%% !4Q!J2B@#YW^+'[&/A7QMYU]X=(\,:JV M6*0INM9&]X_X?JOY&OEWQ;'\4?V>UG\+7>KWNEZ=?*3']DN"T,R@\F-NJ'UQ M@^M?I57G_P 9/@OH?QH\/Q:?JQDMKBVO4'C(]J^JR[.YTI1 MI8SWZ?FKM>G]>AXV*R^,TYT/=GY:7/B7]G/XS>*/#/Q.T6R;5+S4-+U*Y2UN M;.XE:12'. Z@]&!(.1VS7Z-5^<_Q ^&NN_LJ_$K0M:@=-8LHY!/9WDD.U)& MP\3KD[6P3SGN#7WC\./B!I?Q.\(V.OZ3)N@N%^>,GYH9!]Y&]P:Z.(:=.M[/ M&8=+DDK77?S_ *_(QRN4J?/0JOWET.GHHHKXT]\**** *]_86^J6-QD,#7S7XY\"ZM\'?$,6N:'+)_9V_P#=S=?*S_RSD]0?UKZ+?48@/M%J3RI_O+ZJ:[*OF'QWX M$U7X/^((M_V?X;O9FTB778=H6;3X45VEB8A9,*>&PI8[>IQ@$[;6K/X?-)J#75GJMK);VUK<"Y(MTM$E =3LW;U MVC Z&NL^#NI--\>HR* M]QI: /#+'4F/[6M_%M/^SRG3+.235+F?8?++H-D,9/3)9R^/\ IF*[2B@#E-;\3:A/ MJ&NZ!I&EWT>JV^EF[M-2N(,6,DS;E2,29Y<,H)7' (KPSX3^';S_ (3CP?K> MD:+KF@^)/LTD'CC^T;26"WO,1G#EF CFE\X J\9/RELD# KZ>HH \7U#2-%^ M+GB[PSKFG>'M1T?Q!X?U(33:GJ&ERV$.P7S5?.,*67')KVBBB@ HH MHH **** "BBB@ HHHH **** /'?BM\3-?TSQUIWA+P_.O%GASX1:IXCBT;3X]=TZ.9Y[:ZGD$&V) MF!D3"[F#!0R@X^]UKG?VCET?4-/LK/6M$U5C'=6DMCK6EVLDTT+F=1(L;Q M M&^T#&L^!_AKXBL-.OIY?#=U;W-Q82VTD-R8Q$T,V(G 8LNXL!CY@O&%X/$UO8QVGBF)WLELT97LIA'YH@E9F(D)3=\X"\KC'.:]0KQ+3;?4_B# MXD^'4M>L_\(?I/_/L?^_C_P"-?*OQX\!:_=?$ M+4%TCP]J=UIWR.LMO;22(S; #A@#TQ7HY?AXXG$1A-VCN_0X,=7EAZ$IP5WT M]3NO"?[51NKB)M>MK6"U,;%C:9\P,!P &;UJ77?VJD;&_$'@_19=2U+P_J5I C*N^YMGC4DG&-Q'^<5H_">Q\(_$>9+'4O M%G_"+ZN[;8[>ZM0T,OH%EW@9]B![9KZBID6&Y95E4?*GT5[?IW_#&UG_T,LW_ ("+_P#% M5X_U?*_^?[^[_@'H_6,S_P"?*^__ ()J:/IOP;T%U\_7+74YEYWW,Y=?R4 ? MGFNYT_XM?#G281%9:UI=I$/X(5V#]!7G,/['.E*F)?$-VS^JP*!^6:D_X8[T M;_H/WO\ WZ2CV&5?\_I?=_P ]MFG_/J/W_\ !/1IOCQX"MV ;Q):DGGY5=OY M"H_^&@/ '_0QP?\ ?N3_ .)K@H?V/?#Z@^;K>HN>VQ47^AJ3_AC_ ,-?]!G5 M/SC_ /B:/8Y3_P _)?=_P ]KFG_/N/W_ /!.TF_:(^'UOC=XBC.?[D$K?R6H MO^&D/AW_ -# /_ 6;_XBN4A_9 \+*3YNJZLX[;7C7_V0U+_PR%X/_P"@CK/_ M '_C_P#C=/V>4?SS_#_(/:9K_)#\?\SHY?VE/A[&N5UQI3_=2UES^JBH?^&G M/A__ -!2;_P%D_PK%A_9&\'1MEKW5Y1_=:=,?HE3?\,F^"_^>NI_^!"__$TN M7*%]J?X?Y!S9J_LP_'_,TI/VGO "(6&I7#G^ZMJ^3^8J#_AJ;P)_S\7G_@,? M\:KQ_LH>"4<,S:E(!_"UP,'\EJQ_PRSX$_Y][S_P)/\ A1;*%UG^ 7S5](?B M(W[4_@55)$]ZQ]!;'G]:K?\ #6/@K_GGJ?\ X#K_ /%5:'[+/@0$$VUX1Z?: M3_A5G_AF/X?_ /0+F_\ J3_ !HOE"Z3_ +9J^L/Q.?UO]K+PPND7G]F07\F MH>4P@66$*F_'&3NZ9K4_9W^+3>.O#K6&L7J2Z_:.0QD(5YXSR' [XZ''M7'? M$3]E-KZ_M3X/^PZ=9K&1,+V>5G=\\$<-QBN+O_V5_'.BVKWMK<6%Y/#\RQ6< M[K*?]TLJC/XUZ"H956P_)3GRR??=?\ X76S.E7YZD.9+MLS[%W#UHW#UKXW\ M(?&C4?!5^=*\9:/-?QQG:YD+1747Z@-^//O7T7X+U3P3X^L_M&BSIZV/YWNX>M>6_$_X)V7BY9=0 MTKR['5\98=(YS_M>A]_SKN?^$/TG_GV/_?Q_\:/^$/TG_GV/_?Q_\:\P]$\" M\#?%76?AGJ1T+Q%!-+81-M,U>!7^D^(/@SKZBZA^U6# MMPM&X>M>?^!=4\*>/M/\ZQB,=R@_?6DDK>9&?SY' MN*Z?_A#])_Y]C_W\?_&@#9W#UHW#UK&_X0_2?^?8_P#?Q_\ &C_A#])_Y]C_ M -_'_P : -G3+!:VZ&221C@*H&37#?#/X9V.A>$;. M.]@WWTR^=.P=A\QY X/8<5XA^T=XNM+K68O!WAV)G=)%%VT3LQDE/W8ASV[^ M]=^"PDL965..W5]D<.,Q4<)2=1[]%W9AWEQJG[2GQ96*+S(-)B.%]+>V!Y8_ M[3?S/M7V!HND6?A[2;33;")8+.UC$44:]@*\\^$/P6T_P1X4ACOX1-J]R!+= MRAF&">B#!Z+7;_\ "'Z3_P ^Q_[^/_C75F6+C6DJ-'2G#1?YG-EV%E1BZU;6 MI/5_Y&SN'K1N'K6-_P (?I/_ #['_OX_^-'_ A^D_\ /L?^_C_XUXQZY)XI M\2V/@_P[J.M:C*L5E8PM-(Q.. .GU)P/QKX/^$GAV^_:8^/MWX@UE&;2X)A? M7:MRJQJ?W, _(<>Q]:[#]M3QO96M[8^!=#1C-E;C4/+=F+$_ZN+&>IZ_E7N/ M[/?P-L?A[\.;*#4;;?K5Z!=7K[F!#L.$X/11@5]?A_\ A*RYXE_Q*ND?)=_Z M\CPJO^VXI4E\$-7Z_P!?J>QJ%C554*JJ,!1P *7)X]*-_)IMOYJP&9U4DL%!8C)"C=D\= :X_X.R>(=>NO^)]' MI>O:3>3W@BU/25E@6V,3@+&078.C!CM;(/RG(/6@#W?]P?$SX=Z5\4O!][X?U5 M1Y4ZYBF !:"0?==?<'\QD5\3_"GQUK?[*_Q:O?#?B(.-%FF$=ZBY*[3]RYC_ M Z^H^@KZ%\4_$/2[GQ]-X-\-76@Z7=VLJV]UJWB"[;RQ<, 1;00"1&GDP03 MAE"Y Y/%+^TE^S[IWCGP'/J5FL5KXATF!ITN"2$E106>-LDX'!(YX-?195CJ M=/FP>*UI3_!]_P"O4\K&X>4K5Z/QQ_%=CW>TO(+^UAN;>9)X)D#QR(2YFXXA5ED41C/*DJV>G&17 ML^LQ?&W2]?T^9](\ V^@ZAJD=K!:-)>OJ"PNQ)#$,(S(L:LQPV.?\ KH_^-'_"'Z3_ ,^Q M_P"_C_XUQG0;.X>M&X>M8W_"'Z3_ ,^Q_P"_C_XT?\(?I/\ S['_ +^/_C0! MI7UE;:G9S6MW$EQ;S+M>.09#"OFSQYX#U3X1:_%KN@S2?V=OS'(.3"3_ ,LW M]5-?0/\ PA^D_P#/L?\ OX_^-,N/ ^BW4+PS60EB<;61I&((_.@#(^&OQ,L? MB!IN5*V^IPJ/M%J3T_VE]5KL]P]:^7_B1\-K_P"&.KIJ^D-(^E%\I(,DPG^X M_J/>O4_AGKGASX@Z9D6PM]3A ^T6OFM_WTO/*G]* /3=P]:-P]:QO^$/TG_G MV/\ W\?_ !H_X0_2?^?8_P#?Q_\ &@#9W#UHW#UK&_X0_2?^?8_]_'_QH_X0 M_2?^?8_]_'_QH V=P]:-P]:QO^$/TG_GV/\ W\?_ !H_X0_2?^?8_P#?Q_\ M&@#9W#UHW#UK&_X0_2?^?8_]_'_QH_X0_2?^?8_]_'_QH V=P]:-P]:QO^$/ MTG_GV/\ W\?_ !H_X0_2?^?8_P#?Q_\ &@#9W#UHW#UK&_X0_2?^?8_]_'_Q MH_X0_2?^?8_]_'_QH V=P]:,BL;_ (0_2?\ GV/_ '\?_&K6GZ#8Z7,9;:'R MY"NTG>QX_$^U &A1110 4444 %%%% "4M%% !1110 4444 %%%% !1110 44 M44 %%%>=_$SX]>$?A3J.GZ;K-UM'Y>GZ=:R74ZQM((_-9$!*ID]^3@A M03Q0!Z)17":Y\-=0\2V'] \'1^*;_4%M]$DABFCN"C$R"3'EA4 W,S;E 4#))QB@#YACN()%*O%*H96!Z@@]17S)\8?V)](\1>?J?@J5-$U Y8Z?)G[+(?]GO& M?S'L*]UT;XJ>%M=\+ZCXAM]52'2M-,BW\EY&]L]HR#+K+'(%9"!@X8 X(]:7 MP+\4/#GQ&%V-#O)99K389[:ZM9;69%<;D/S'M M7U[\+/CMX2^+EFK:-?B+4 ,RZ;=82X3U^7/S#W7(J7XQW/@>/PU%;>.;>.\L MKR86]M:K;27%Q+*03B%(U,A8 $_(,@ FODWQ3^R[<3:;;>-OA#K4FN:2^9H8 M5"2I!!4@,",8)KZ'VN7YMI67LJO=?"_7^OF>5R8K _![\.W5'W M?17Q/\*_VSM;\(W2Z'\0[*>]CA;RFOA'LNX2./WB'&['X'ZU]>^$O&FB>.M) MCU/0=2@U.S?_ ):0MDJ?1AU4^Q&:\3&Y;B, _P!['W>C6S/1P^+I8E>X]>W4 MVZ***\L[ HHHH **** "BBN2^*'Q"M_ACX0GUN>U>]?SHK6"VC<)YLTKA(U+ M'A06898]!0!UM%>9?"KXF^(/%A:S\2>'8=,U!H;BYAFTVY\^VE2.X,)3+!66 M0$#@C!'(/86/AC\7)/'TWB^/4-"F\-R>'+\V4T=U<)*Q 0/O.S*CY2. 3]: M/1:*\FT#X[-JEYH%[=Z)]A\*>)+HV6CZK]I+RR2981F6'8/+63:=A#-G(R%S M3+SX^K;27FKIHPD\#6.I?V3=:Y]I(E2;>$:18=GS0J[!2^\'(.%.* .X\9_# MOP_X^LS!K6GQW) PDX&V6/\ W6'(^G2OG'QG^S7XE\#WAU;P=?37\4)WJL3^ M7=Q_3'#_ (<^U?5EW=PV-K-.KAM2 MTSP\T?@Q4D:/5[RYV3W6T':\-N%),;'HSLA(Y (Q7IX7,:^$T@[Q[/8\[%9? M0Q6LU:7=;GCO@/\ :HU30YQIGC.RDNA&=C74:;+B/_?0X!_#!^M?1OA?QCHW MC/3UO-&U"&^A/7RV^9/9EZ@_6OFOQ7KGBSXC^)-&T_Q3\"6TBQU2]6S@\0+X MA@-S#&V2)6B1"_"C<5;IWK/\3_ ?QK\*M0;6/"UY/?V\?(FLGR8#,?@?LJG;[+_K^D>;SX[+_ (U[6'?[2_K^F?7M4M8T6R\0:?+8ZA;I M=6L@PT<@S^(]#[U\[?#W]K$QLEAXQM"K*=AU"U3!';YX_P"J_E7T-H?B#3?$ MVGQWNEWL-]:OTDA<,/H?0^QKR,5@:^#=JL=._0]7#8VABU>E+7MU/GCQQ\+- M:^&.I#7?#MQ/+8Q-N$D?^M@'HX_B7W_.O1?A?\;+/Q MW45\^_#?XY7.B3+HOBOS#'&WEK>2 ^9$>F)!U(]^M>^V]S%>01SP2+-#(-R2 M1D%6'J#0!+1110 4444 %%%% !1110!5U34H-(TZYO;EPD%O&TCL3C@#-?-/ MP]TZ?XJ?%2;5KU=]K#)]KE5AQ@'$:?R_*NY_:/\ &/\ 9^CV^@028FO#YD^. MHB7H/Q/\JU?A?I=G\+_AG+K&K,MLTL?VRYD;J%Q\B_7&/Q-.,7)I+=B;45=[ M%CXZ?%./X:^%6^SNK:S>@Q6D>>5]9"/0?SKR[]F'X6R:A=MXWUI&E)=C8B;D MNY/S3']^'2HB&EQT@MP?EC'^TW^-?8UC8P:9906E MK$L-M"@CCC48"J!@"OIL1)99AOJL/XD]9/LNW]?J?.8=/,L1]9G_ X?"N[[ M_P!?H6****^8/I KF?B1XZLOAOX)U7Q#?D>59PEDC[R2'A$'N3BNFKX>_;-^ M)=QXV\;V'@#1"UQ%8RJ)XX_^6MV_"I_P$'\S7K97@GCL3&F_A6K]%_5CBQF( M^K47/KT]3+_9?\"WOQJ^,&H>-?$"_:;2QN/MD[/R)+EN8T^BCG\!7WK7"?!/ MX9V_PG^'>F:%& UTJ^;=RC_EI,W+GZ \#Z5W=:9MC5C<2W#X(Z1]%_F3@X VQM"PYWE3A?ESD5Z]XBL[WQ#X1 MUCX:_9]3_M&;PR8_[>DAQ9R2O&T6WS<\ON&XC'0YKTZB@#\WOC3\(;FXTOPI MXD\.^%-8\/:OX?MTC\11&P>WAMGB4()8I,!9-[( M-*BU@A-2\+Z>Q2RML$JCU5$Y]#(?6OIBXMXKRWE@GC6:"52CQN,JRD8 M(([@BO@3XP?#_6?V7?BK8^*/#+.NBSS&6S;DJF>7MI/;'3U'N*^JP/L\TH/! M57:HM8OO96M]R_JQXN)YL'46(A\#T:^>Y^@%%W)^>"4?>1OI^HP:ZZOF:E.5*;IS5FCV(R4XJ47=,****S*"BBB@""^L8-2M M);6ZB6>WE4H\;C(8'M7S9X^^'^J?"77(M>T&63^S@^4D')@)_@?U4^M?350W MEG!J%K+;7,2SP2J4>-QD,#V- ''_ S^)UE\0-.Q\MOJD*CS[4G_ ,>7U7^5 M=M7S)\0OA[J?PGUR+7M!ED73A)NCD7DP$_P/ZJ>GZ5[)\,?B=9_$#3<';;ZK M"O[^VS_X\OJI_2@#MZ*2EH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY<_:@\"ZGIOC;2_B-X1O8 M;_7;:?2]/U'PW.ZJ+R,7JR6VU_\ EDWF@C)&",^G/U'7G?Q*^ OA/XJ7T-[J M\-[;W\?DJ]UIM[+:R31QR"18Y-C#>H8'&>5R2I!YH \H\=>*- \;_L2^-=7\ M/Z7)I%I-I]\TVGW'S/;W1E8SKG)!_>%SD<8/;H(/B%O_ +,_9C^T[?[)_M73 M_-W=/.^QGR<_\"SCWQ7M&J?!/P=JWP]M_ \FE-;>%8$\M=-L;J:V1EYRKF-U M+@Y)(8G).3DU:D^$WABX\!P>#KFPDO- @55AANKJ666+::O)Q_L[=WMC->[73G_ (;6TX:< MJ +X.D.ILN.8OM \G/\ P+.,]B:]-T?X2^$]#\*:CX<@TB.;2-2>22^BO)'N M'NW?[[2R2%F=CQRQ)X'I4'AGX-^$O".FZO9:=ITH35HQ#>S7-W-<3S1A-BH9 M9'9PJJ2 <#/% 'G7CIF;]L#X7&Z*&S.B:I]BST^T83?CMG9^F:/V5F=]2^+ M1MD5-#_X3&[^R*O3S-J>?CVW_KFO0+GX(^#;KP?HOADZ4\6EZ*0=-,-W-'<6 MA&>8YU<2*<$@D-R#@UTGA/PGI/@?P_::)H=E'I^F6JE8H(R3C))))))8DDDD MDDDDF@#DOBI\!_"7Q:9&>/S'O7Z 4C*&4@C(/!!KV\%FU?!KV;]^GUB]O M^!^1YV(P-.N^=>[+NCYA^#W[;&C>)/(TSQI$FAZB<(+^/)M93_M=XS]N-EM\"?Z M/,W^W&.F?5?R-?.5CX@^*_[)NM+9W<4DFBL^!!,3+8SCN8V_@/TP?45Z;P." MS1<^ ER3_D?Z/^OD?H517CWPA_:>\(_%98K03_V+ MKK Z=>.!O;_ *9OT?Z<'VKV&OF:^'JX:;IUHV9Z].K"M'FINZ"BBBNQZI>>%].UQ?%O@RTM9[J'4MNXZ=)]J=5MFN!\LVY/WF3\PZGK M5KX-:QI/C7Q'\>-)TG6+.[N]0U.1H5M[A68QM;)'Y@P?NA_EW=,C%?1%CI]K MI=N+>SMH;2 %F$4$816?F)XHT75+)]8L<$3:?%9L?,DE_N!MHV$_?W#&:HWBR6OP1\1_"3#_\)O>Z MW<6MMIS?ZV:&:[\Y;H?],@C$F3[H*D$U]:X/P#;^&]7 M^*OP^U;X:&*UB33)HO$T-DK*@C$2K%'=#_GNL@ ?Y^#VKZ';((H_A-S/G+#W$:D'_?KO*3 &>*6@#S[ MXA? _P ,?$17ENK3[%J1'%]: ))G_:'1OQY]Z^>M;^%OQ ^!^H/JNA74UU8H M>;"WWA?XC_ +/M^]Y8 MRRR:7NRT]MF6VD'_ $T0_=/N0/8UW_5L%F&N&ER3_E>WR?\ 7H(?*M/$48T2^/R^?DM;N?KU3\>/>O5/$? MAC1O'^BB"\2.[MI!OAN(F!*Y'#(P_P#U&O$Q&%K867+6C8]G#XFCB8\U*5RQ MX8\5:9XPTQ+[3+E9XF^\O1D/]UAV-:]?+FN>%_$_P/UP:CIT[2Z>S86Y49C= M?[DJ]C_D5[5\.?BQIGCZW6($6>JJN9+1VZ^I0]Q^HKD.H[FBBO!M-_:.U?6O M$=W V/45\T?&?]I:63PB MT]EI4:>$-2O7TY-7^UYN&5'V/+Y&SB(N-H;?NX/RXH ?H4$WQB^+CW4PW6*R M>?. HQ_"O\_I7"77 MQTN_A-X;\1:?I.D02:JRQK=7%IRQM;=?"N[[G@X^53%5(X.EL_B M?9=CU;X2?#>V^&?ATVO?2XEO)P/OR$=/H.@KMJ**\.K4G6FZDW=L]JG3C M1@J<%9(****R-#@OC=\3;?X3_#O4M23GSKIN7?_ ("#^9K'_:<\<7OQM^,6G^#/#[&Y ML[&?[% (SE9+ACB23W"C(SZ U]I?#GP-8_#?P7I?AZP4"&SB"LX',DAY9S[D MY-?83_X2LM4/^7M;?RC_ %^;['A1_P!MQ?-]BG^+.EHHHKX\]T**** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YSX@^ M ]+^)7A.^T#5XO,M;I,!P/FB]LYDN;2XC6 M6*:,Y5U(R"#7E/[2/P-M_C'X/9K5$C\1Z>K26,YXW]S"Q]&[>A_&O"OV1/CE M/X2UAOAUXID>V@:9H[![G@VTV<- V>@)Z>AX[U]=BH1SC#?7*2_>P^-=UW_K M]#Q*,G@*WU>?P2^%]O(^U****^./="BBB@ HHHH AO+.#4+66VN8EGMY5*/& MXR&![&OFOX@?#O5/A3KD>OZ!+(-.63F?P-?350W5K#?6TMO M<1+-!*I1XW&0P/4$4 ?&_P 6?C /&.M: GB"[U/1O"8BMUN'T^ZDMH8[T7D9 M:2>2,AEC\K.TD@!L]\&O3/BI)X@\*_#WPW^5J-[8L M'-N(I(]C2,HV%@A#.%)R>:\Y_:'^#_B?P5=#4_"UM::IX>EEA9K6[$O!Q\/ZCIS^*/"^IW>H2:)>,\-C+%<[@T<+ M .R+&'PAVG'/'- 'J'PE:?Q=\&[^YL/%M]/IVH27$FE7\IXJ;P1X M!UCP7X>\6W4-MIS:[K]]+J1TN*X=+&WE=%0HLOE[B#MW,VP98GY15#X0^"_' M'P[^!Z>&I(M"7Q-IT$D6GRK_OM6U[5M(L;*U>5'TJ^ELV@902928V!D/3"ME>.G-<39_#7Q9\6/A+X,M_ M%7C'Q!X5U6"W$]_/X?N1:7=Q(1A/,<*0 %R64#EC[4[XN>'_ (R^)+S0X_"R M>"CIEK&D]]!KQM(;RZL[F/>X24'RS M&R960,00,'.>H%:6@?$ZTU34;[3]3TN_\-7UI:?;WAU01#=;Y(,H:-W7 (P0 M2"/2@#LZ*XGPO\5M-\4:I:60LK[3?[0@:ZTR:^1$34(5QEXL,2.&!VN%;!SC M&:[:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6L:+8>(-.F ML-3LX+^RF&V2WN(PZ,/<&KM%--Q=T)J^C/D3XO?L0I(TVJ_#^Y^SS [_ .R+ MF3Y<_P#3*0\CZ-^8KB?A_P#M0^.O@OJH\.>.;"ZU.SMR$:&]REY OJKG[Z^F M>O8BOO&N4^(/PO\ #7Q0THV/B'3(KQ0#Y<^-LT)]4< MTAW^TOG_ $_,\BI@.27M,++EE^#(_AU\6/#'Q3TL7OA[4X[HJ,RVS?+/#[.A MY'UZ>]=?7PG\1/V4_&GPCU0^(O =_=ZG:VYWHUH2E[ /=1_K!]/RKJ_A'^VZ MT,D6D?$*U,;J?+_M:WCP0>G[V,=/.10RL/0@]:]O#YK5IQ]E77M(=G_F>-B,KI5)>THODGW7^ M1X[X&_:,\*_$"U_LS78X](NYEV/#=D-;RY[!SQ^#8_&N=^(GP5N_#LW]O>$G MEDMHSYWD0L3+#WW(1]Y?U^M:?Q$_97T;Q!YMYXZS);N/^F;C[OX'ZBNIX'"XY]SLCO3\J2'T?^ZWOTKR#Q9XFT MCP3\89->^&NI?9?$%]&%U#P;)"9&U&9KI4<>1]Z!BN9-ZX4@!CD5T-YJ7@WX MS W&DRQ^&_%3C+Z?=L$ANF]%;IN/X$^G>K7@/XE7GP\UT6'B73O-\E?L_P!H MDB'VJW3.=H;JR9YQGZ5X-:A5P\N2K&S///2E='KWQ*9];OO#/AA<@: MG>">[4=/LT(WNI_WCM%'?%<>G2>+Q:;[#'[K4@3DQFW<8 M=CN&=JDC(Y%>P:7JEGK=C%>V-Q'=6T@RDL9R#46M:MI^@VOV[4'6"%65/-9" MQ!8X X&>IK V.4\*^)(_!V@^"?#?BK4F?Q+J-IY,?F(S&=XH@TA9@N 0O)+8 MR(-+M->\0:CX:T37O[2\$1:F]S*&C#&PMEF\R2+S@=K;GR%0+N^;VK[ MC^.WB\>&_![VT#@7VH$P1GNJ8^=A^''XU\@K!>>+-9M="TF+S9+B545$'#MZ MGV'6O2R_!O&5>5Z16K?D>=CL6L)2YEK)Z)>9QNNHOQE^*/B36-1O[;P_K6EQ MQR:):NH)O40?N;1$ZS;B-I Y&2>*_2CPW)/+X=TM[JT73[IK6)I;1>D#E!N0 M>RG(_"L;X<_#VP^'GA:STJV1))8QOFN"OS22'[S9_E[5U=1C*\:U1JG\"V_K M^M+%X.C*E33J?$]_Z_K6X4445P'<%>3?M+_%A?A3\-;NXMY NLZAFTL5SR'( M^9_HHY_*O5V98U+,0JJ,EB< "OSZ^+'B"_\ VFOC]:Z#H[LVEPS?8;5A]U(U M/[Z8_7!Y]A7O9/@XXK$<]7^'#67RZ?UT/-Q^(=&ERP^*6B/1/V'?A.TTE[\0 M-4C+NQ:VT\R#)))_>R_B>,_6OL.LOPOX=LO"/A[3]%TZ(0V5C"L$2#T Z_CU M_&M2N/,<9+'8F59[=/)=#?"X=8:DJ:^?J%%%%>:=84444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?)7[8WP$> M]C?Q_P"';=A>0 '4X(!@NHZ3C'\2]_;GUKZUIDL23Q/'(BR1N"K(PR&!X((] M*[\#C*F!KJM3^:[KL]>^U\"_';X8ZM^S?\ $NQ\8^%"T&C37'FVK+DK;R'EX'_V6&<> MH..HK[$^$'Q2TWXN^"[37+ B.4_N[JUSEH)@/F4^W<'N"*]7-<'32CCL+_"G M_P"2OL<6"Q$KO#UOCC^*[G;4445\V>L%%%% !1110!#=6L-];2V]Q$LT$JE' MC<9# ]017S9\1?AUJ7PLUN/7] DE73EDW)(G+6[?W6]5/_UC7TS45S;17EO) M!/<,BE7C<9# ]010!Q/PO^*5G\0-/\M]MMJ\*_OK?/#?[:>H_E7=U\I?%3 MPH?A?XR@DT6[FMHYXS<0&-BKP\D%0>X_H:C\$_$3Q-=>,-%@FUN\FAENXXWC MDD)5E+ $$'VH ^L:*** "BBB@ HHHH **** "BBB@ HHHH **** "N&^+GAG M1?%N@V>G:IJ4FD7ANEETN^A<)+#=HK,I0G@G ;@\$9%=S5'6M#T[Q)ILNGZK M8V^HV,HQ);W48D1OJ#0!\V:#\1GA^#GBK2/$^D:;KLFCZ+9))?)N+>92( MTF[H\8RS 'HT7QSX,L]4;Q9%J?A:2^TS5G8RW4*+\OV5WR=R M'=F/_@77K7T+X=\%:#X2T(:-H^DVFGZ7MVFUAB 1P1@[A_$2.I.2:D\.^$-# M\(PS0Z'H]CI$4S;Y$L;=(0[>I"@9- 'D=[J-OXJ\0?!)-$E2KD#)/UK5H M*HZEI?\ :/E_Z5O:**Z*&(JX::J49.O>!_BI^RUJH(/45\U_&']BO0_%7GZEX/D MC\/ZFV6-FP)M)3[#K&?IQ[5],L?@\S7)F$>6?\Z_5?U\CQWAJ^#]["N\?Y7^ MG]?>>^+X<$BAEU;4&4C((N,@_I3O^$9/_04U'_O_ /\ UJ^%O#/Q<^)_[,>L M)H?B&RGN]*4X6PU!BT94'K!-S@>PR/:OKKX4_M >$?BY;JNEWOV75 N9-,N\ M).OK@=''N/QQ7FXW**^$7M8^_3_F6WS[?EYG7A\=3KOD?NR[,Z__ (1D_P#0 M4U'_ +__ /UJ/^$9/_04U'_O_P#_ %JVJ*\,]$Q?^$9/_04U'_O_ /\ UJ/^ M$9/_ $%-1_[_ /\ ]:MJB@#%_P"$9/\ T%-1_P"__P#]:C_A&3_T%-1_[_\ M_P!:MJB@#%_X1D_]!34?^_\ _P#6H_X1D_\ 04U'_O\ _P#UJVJ* ,7_ (1D M_P#04U'_ +__ /UJ/^$9/_04U'_O_P#_ %JVJ* ,7_A&3_T%-1_[_P#_ -:C M_A&3_P!!34?^_P#_ /6K:HH Q?\ A&3_ -!34?\ O_\ _6JKJ7@>TUBSDM+^ MZN[RUD&'AGD#J?P(KI**:;3NA-)JS/G3Q]^R7:7$;W7A2]:UN!EOL=XV8V]E M8#*_CG\*\6UZZ\4>$;J/2O%=I=2"$;(?M1)95_Z9RE9NO>'=,\4: M>]EJMC#?VK=8YD!Q[CT/N*]ZCFLG'V6+C[2'GNOG_7J>)6RN*E[7"2]G+RV^ M[^O0^-O WQ,O/#MT/[/O9DMW;,MGYA0/]/0^]>YZWK.E^.OACJ]]INJ7LMS; M0B9[&XF!9&4@X(QR/0BN.^(G[)K1^9>^#[K/\7]G73<_1)/Z-^=>'W$VL^$= M2?3]6MI[2X3Y7BF!5P/7/<5I/+:.*BZF G?^Z]U_7],SCF%7#-4\="W]Y;?U M_5CJ?B_XZ.N:L!!YXZM_*O$_A?H5KXL^*>E0W0^T:>UVI=6SAP 2!],BONY5"*%4 M!548 P!1BZD<%AHX.E\4K.;]>G]?JPPM.6,Q#QE7X8W45^IC?\ ",G_ *"F MH_\ ?_\ ^M1_PC)_Z"FH_P#?_P#^M6U17SA] 8O_ C)_P"@IJ/_ '__ /K4 M?\(R?^@IJ/\ W_\ _K5M5#>7D.GV<]U<2+#;PHTDDC=%4#))_ 4]]$!\[_M: M>//^%9^ _P"SK'5[YM:UG,$2M/G9#_RT<_AP/K7/_L8_!7^S_"\OC*_>XM+W M4QY=EY3;2MN#][I_$?T%>07+WW[6/[1(1-XT7S-H/:&QC/)^K_KN]J_033M/ MM])L+>RM(EAMK>-8HHU& J@8 KZ['?\ "7@8X&/QS]Z?Z+^OU/"P_P#MF)>( M?PQTC_F9W_",G_H*:C_W_P#_ *U'_",G_H*:C_W_ /\ ZU;5%?('NF+_ ,(R M?^@IJ/\ W_\ _K4?\(R?^@IJ/_?_ /\ K5M44 8O_",G_H*:C_W_ /\ ZU'_ M C)_P"@IJ/_ '__ /K5M44 8O\ PC)_Z"FH_P#?_P#^M1_PC)_Z"FH_]_\ M_P"M6U10!B_\(R?^@IJ/_?\ _P#K4?\ ",G_ *"FH_\ ?_\ ^M6U10!B_P#" M,G_H*:C_ -__ /ZU'_",G_H*:C_W_P#_ *U;5% &+_PC)_Z"FH_]_P#_ .M1 M_P (R?\ H*:C_P!__P#ZU;5% &+_ ,(R?^@IJ/\ W_\ _K4?\(R?^@IJ/_?_ M /\ K5M44 8O_",G_H*:C_W_ /\ ZU'_ C)_P"@IJ/_ '__ /K5M44 8O\ MPC)_Z"FH_P#?_P#^M1_PC)_Z"FH_]_\ _P"M6U10!B_\(R?^@IJ/_?\ _P#K M4?\ ",G_ *"FH_\ ?_\ ^M6U10!B_P#",G_H*:C_ -__ /ZU'_",G_H*:C_W M_P#_ *U;5% &+_PC)_Z"FH_]_P#_ .M1_P (R?\ H*:C_P!__P#ZU;5% &+_ M ,(R?^@IJ/\ W_\ _K4?\(R?^@IJ/_?_ /\ K5M44 8O_",G_H*:C_W_ /\ MZU'_ C)_P"@IJ/_ '__ /K5M44 8O\ PC)_Z"FH_P#?_P#^M1_PC)_Z"FH_ M]_\ _P"M6U10!QGB[X6Z;XX\.WFBZO=WUU972;65Y0=I[,..H/-?$&CWVO\ M[)_QAFTK4IKHZ-,ZBX-NQ475L2=LR?[2_P!"*_1*O*_VA?@G:?&7P;);QJD. MO68:73[H\8;',;'^ZW3V.#7T&58Z%!RPV(UI3T?EY_U^AYF-P\JB56EI..WG MY'7:/8VGB#2[34M/UR^NK*ZC6:&:.XRKJ1D$<5<_X1D_]!34?^__ /\ 6KX[ M_90^-5U\.?$DWP\\5L]I9R7#16YN#@V=SG!C.>BL?R/UK[>KCS' SR^NZ;U3 MU3[HWPN)CB:?.M^J[,Q?^$9/_04U'_O_ /\ UJ/^$9/_ $%-1_[_ /\ ]:MJ MBO+.PQ?^$9/_ $%-1_[_ /\ ]:C_ (1D_P#04U'_ +__ /UJVJ* ,7_A&3_T M%-1_[_\ _P!:C_A&3_T%-1_[_P#_ -:MJB@#QWXH_!C5O&&I65QIVHQND41C M?^T)6+9R3QA3QS7-^'?V=_$&FZ]I]W<:A8K!!.DCF"1_,P#GY3-M)ETS7 M-.M]3LI!S%.F<'U!Z@^XYKY$^*_[%>J^'+AM;^'=Y-AP?K7VG17J8+,L3@)7I2TZI[,X\1A*6)7OK7OU/A'P?^V5XW^'UIDV]Q$P[2G_ #Y^5;&8.MR-N4%Y;K^O,_3NBOF;X,_MHZ+XL\C3/&*QZ#JK85; MU3_HLQ]R?]6?KQ[BOI:&9+B))8G62-QN5T.0P/0@U\)BL'7P4_9UXV?X/T9] M)1Q%/$1YJ;N/HHHKB.@**** "BBB@ HHHH **** "BBB@ KYS_:+^$_BKQQX MML[S0M+^VVJVP223SXTPP)XPS ]*^C**Z\+B)82JJT$FUW.7$X>.*I.E-M)] MCY1^#OP3\;>%_B%I.H:GI'V73X7+2R?:8FQP<61CC"J,U\#_#K1[[]J/\ :$N-8U1& M;28Y1=W*MG$=NAQ%"/3/'ZU]+DN&A*I+&5_X=+7U?1?UY'DYA6DHJA3^*>GR MZGT1^QU\(SX!\ _V[?P>7K.N*LI#KAHH/^6:?C]X_6OH&FQQK#&L:*$10%55 M& .@%.KQ<7B9XRO*O/=G?1I1H4U3CT"BBBN0W"BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@#Y7_;%^ 1\06,GCKP_;9U2T3_ (F-O$.9XE'$HQ_$HZ^WTK>_9)^/P^(F M@KX9UJXSXCTZ+]W*YYNX!P&]V7@'\#ZU]$LH=2K ,K#!!&0:^#OVBOA/J7P$ M^(%GXY\)%K729KGSHFC!Q9SGDQG_ &&YQ[9%?78"K#,\/_9V(=I+X'^G]?HC MP\3"6#J_6J2T?Q+]3[RHK@/@K\6M/^,7@FVUBUVPWJ8BOK3.3!,!R/\ =/4' MT-=_7RU6E.A-TZBLUN>S"<:D5.+NF%%%%9%A1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17F?Q$^.%KX(\26G MA^QT+4O$^LR&!KBVT[RU%M%+)Y:,S2,JEF.=J@Y..W6JGB_]HC2?#.A:'J=A MX9\4^+/[6$C)9Z#I33W,"H=KM+&Q4H _R\]Z /5Z1E#J58!E/!!'!KS#P7\= MX/'7A.?6=/\ !_B:"ZCO)+%-&OK6*WO))(P&?Y7D"H ".79:Z3X=_$G3?B1I M]]-96]YI]YI]TUE?Z;J$0CN+690"4< D'@@@J2"#P: /)/C-^QWX=\>^?J7A MLQ^'-;;+%$3_ $6=O]I!]TGU7\C7@'AWXD_$_P#96UQ-&UNTEN-'W<6-XQ:" M1<\M!+_#^''J*^TO'7Q,'@F.XE3PYK6OP6> &WYZ"OH\+G M$XP^KXR/M*?9[KT?]>J/*K8",I>UH/DGY;?,D^$OQ]\*?%^T4:7>?9=45Z30?B+:SW,<+>4VHK'MN82.,2IQNQZCGZUO6RBGB M8.OEDN==8_:7^?\ 6YG3QTJ,O9XN/*^_1_U_5C[5HK*\,^*M)\9:3#J>B:A! MJ5C*,K-;ON'T/H?8\UJU\O*+BW&2LSV$U)704445(PHHHH **** "O'OB)\; M-8T;Q]#X2\*Z%::MJ,#6CW\FHWAMHT2=V6-(\*Q9SM/)&T<9SFO8:^:?VG/^ M$0C\3:+J,NO_ /"#^-]/N[46VMR *LL#%F(V-\MPJD,9H [CQ/\8O& M/]AZ#>^"OAE>^*KN_C>6[M+G4H;#["%8IAG;J> M-?%OA6/PQJ%M>O86VCRZK'(MS,&"(!<;0@#-D9Y P>:V-#^(VN77P!M_%&M: M>VG>(+FS(%ND31DS,Q2)PC?,N[*OM/(!I_BG1_A]X9^'.A^'/B)_9$FE.%@! MUE%,#W.TLS;F&%8L6(.0*/&GAHZCXJ\)1^#[QI"(;./5(M0$ MD6 1()(P%P?2JWQ1^(&N>!=)O=4TOPVFMV6FQ?:+XS7GV9S'W$ V,)'QGY25 M'09R:Y'X56>C? 3X?^)+B>^N+3P!:ZBTVE?:/-G-O;N5&U/E+F,NQV]>#Z56 M_:"UOP3XTTG4/"=YXEN],\6V5LNHZ9:64\L,\LQ4M 4C^[,M1\40Z%\2H=&%I<:/]C^V-JJ,%:2);9'5RPDZ,IPI//%;GP_BF^!7P;U_Q M-XN81ZM?7=SKE]#D$K+*WR0Y'!( 4<>_7&:N$)5)*$5=LF4E%.3V1Y?^W)\6 M#%;V?@'39299]MSJ(CY.W/[N+ZD\X],5ZW^R_P#"8?"SX:VPNHPNM:IB[O6[ MJ2/DC_X"OZDU\Q_LY^"[[X\_&J^\7Z^AGL;*X^W7);E7F)S%%] #]%%??E? M59K..!P]/+*;U6L_-OI_7D>-@HO$598N?I'T_K]0HHHKY(]L**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ K(\6>%=-\;>';[1-6MUN;"\C,A!P0?45KT M549.#4HNS0FE)69^>EC=>(?V/?C4\$WF76BS$!P.%O;0GAAVWK^A!'0U]]^' M]>L/%&BV>K:9<+=6%W$LL,R'AE(_G[5POQY^#=C\9O!VS+I]VP_U M+M*\%:2V MI:Q="UM@ZQKA2[R.QPJ(B@LS$] 36Q7"_%[P2WC;0K&.TU1=(UK3[M;_3;A MU#IYZ*WRLF1N4J6! YQSVH U/ OQ$T7XAZ6+S29I RHCRVMU$T-Q"'&5WQL M0".AZ'L33M#^(>@^)-6N[#2[UKY[0,9KB&&1K92IPR^?M\LL#U4-G@\<5\YW MOCR^NO@OJ&F-I[^'/%45EI-C?7D$OF(VGS2;$G1A@CY6DR#@C/XUO>/?^$C\ M 6/B7P1IEXVJZ'<>$KJ]L0+>.*33VBPA1?*5V>&_B1X>\6: MA)9:9?--<*AE02021K/&" 9(F90)4!(&Y"1R.>:Z:O#]8,/]O? H:.(\Y?:8 M>GV3[$=_3^'[GMG%>X4 %%%4=2M;RY\O[)>_8]N=W[H/N].M %ZBL7^R]8_Z M#7_DLM']EZQ_T&O_ "66@#:HK%_LO6/^@U_Y++1_9>L?]!K_ ,EEH VJ*Q?[ M+UC_ *#7_DLM']EZQ_T&O_)9: -JBL7^R]8_Z#7_ )++1_9>L?\ 0:_\EEH MVJ*Q?[+UC_H-?^2RT?V7K'_0:_\ )9: -JBL7^R]8_Z#7_DLM']EZQ_T&O\ MR66@#:HK%_LO6/\ H-?^2RT?V7K'_0:_\EEH VJ*Q?[+UC_H-?\ DLM']EZQ M_P!!K_R66@#:HK%_LO6/^@U_Y++1_9>L?]!K_P EEH VJ*Q?[+UC_H-?^2RT M?V7K'_0:_P#)9: -JBL7^R]8_P"@U_Y++1_9>L?]!K_R66@#Q/\ : \+VTWB MZP\2^%]?MM)\,?@_I?Q":S;Q+;Z=K;VDBR M0->:?&Y0@YP">V1R.A[UMS>%+FXL$L9;VWDLD"A;9K&,QJ%QM 7IQ@8^E '. M/XJTCX(?"VPO?%.HV]C/M!E:ZF6+SKN4EV0,Q ^^Q&3P /:LKX0^*O!=CH7B M/68?%>BZE=SW/]I:]JEI>(]I#+( J(90=@"JJJ!GMG S72^*OA=8^.HH(_$D M&EZ_';L6A34]+AN!&2,$J&!P:KZ;\'=&T70[O1-/T[1;'1KP[KG3[?1X$@F/ MJZ 8;H.H[4 97QE^+/AOP[:)X8N/%.CZ'JNM0$+/J%[%"L%NW#S?.1G@D*.Y M/H":J7WQ9\!?#'X8Z!#HFO:3;6%S#]AT.2\O$AAEV#;YGF/@%!@DMT/;.:U] M?^!/AKQ7J#7^MZ)X?UB^9%C-S?:);S2%5&%7&M>ALHM3T3P_ MJ,5C#]GM8[K1+>1;>,?P("/E7V% %OX)?\(Q#X%AM?"FKVVO64$TGVC4K-Q) M%<73MOF<..#EG)X) Z=JH_%K]GWPG\7K5FU*T^QZL%Q%JEJ LR^F[LX]C^&* MZ#P_X&/A+2X]-T.:ST;3HR2EI8:?'#$N3DX5< 9K2_LO6/\ H-?^2RUM1K5, M/-5*4K-=C.I3A5CRS5T?"6O_ ]^*'[*>N/J^CW4L^C;N;ZT4O;2KV6>+^$_ M7\#7T)\&?VP?#GQ \C3?$/E^'-=;"CS&_P!&G;_8<_=/LWYFO9IM%U.YA>*; M5DEB<%61[1"K ]017SI\5OV)++Q"MSJ7A:^ATW4VRYLGBV6TI]L$[#]!CV%? M41Q^$S-*GF$>6?2:_7^ON/'>&KX-\V%=X_RO]/Z^\^IPP8 @Y!Z&EK\^/#'Q ML^)G[.^J)X;\1Q74FGQ' L[X!F5/6&0YROH,D?2OK7X8_%+3?BUIPN-!\5*U MRJYFL)K9$N(?JN>1[C(]Z\O'937P2]I\4'M);?\ .S#XVGB/=VEV9ZE16+_ M &7K'_0:_P#)9:/[+UC_ *#7_DLM>*>@;5%8O]EZQ_T&O_)9:/[+UC_H-?\ MDLM &U5:\TVTU'R?M=K#<^3()8_.C#[''1AD<$>M9W]EZQ_T&O\ R66C^R]8 M_P"@U_Y++0!LD ]1FDDC25<.BN/1AFL?^R]8_P"@U_Y++1_9>L?]!K_R66@# M8*JR[2 5],<4C0HSARBEAT8CD5D?V7K'_0:_\EEH_LO6/^@U_P"2RT ;!C5F M#%5+#HV.17Q1^VM\4)O%'B>P^'VC,TZ6LJO=QQ'_ %MRW$?PKY>_9)^&.H_$KQUJ'CO59V*6 M,[2)<31[_.NVY)Y[*#_(5]5DU*&'A/,JR]V&WG+^OS\CQL?.564<)3WEOY(^ MJ_@/\+X?A-\.=.T<*IOW7[1>RXY>9AEOP'0?2O0ZQ?[+UC_H-?\ DLM']EZQ M_P!!K_R66OFZU6=>I*K-W;=SUJ<(TXJ$=D;5%8O]EZQ_T&O_ "66C^R]8_Z# M7_DLM8EFU16+_9>L?]!K_P EEH_LO6/^@U_Y++0!M45B_P!EZQ_T&O\ R66C M^R]8_P"@U_Y++0!M45B_V7K'_0:_\EEH_LO6/^@U_P"2RT ;5%8O]EZQ_P!! MK_R66C^R]8_Z#7_DLM &U16+_9>L?]!K_P EEH_LO6/^@U_Y++0!M45B_P!E MZQ_T&O\ R66C^R]8_P"@U_Y++0!M45B_V7K'_0:_\EEH_LO6/^@U_P"2RT ; M5%8O]EZQ_P!!K_R66C^R]8_Z#7_DLM &U16+_9>L?]!K_P EEH_LO6/^@U_Y M++0!M45B_P!EZQ_T&O\ R66C^R]8_P"@U_Y++0!M45B_V7K'_0:_\EEH_LO6 M/^@U_P"2RT ;5%8O]EZQ_P!!K_R66C^R]8_Z#7_DLM &U16+_9>L?]!K_P E MEH_LO6/^@U_Y++0!M45B_P!EZQ_T&O\ R66C^R]8_P"@U_Y++0!M45B_V7K' M_0:_\EEH_LO6/^@U_P"2RT ;5%8O]EZQ_P!!K_R66C^R]8_Z#7_DLM &U16+ M_9>L?]!K_P EEH_LO6/^@U_Y++0!M45B_P!EZQ_T&O\ R66C^R]8_P"@U_Y+ M+0!M5\R_M@? $^,M)?QEH-MNUNQC_P!,AC'-U H^][LH_,?2OH#^R]8_Z#7_ M )++1_9>K_\ 0:'_ ("K7;@\74P5:->ENOQ78YZ]"&(ING/J>!?LA?'[_A-- M(3P?KMSG7;"/_19I3S=0CMGNZ]_4<^M?2]?!_P"TA\&-5^"OBRT\>>&9VCL9 M;H3&2WCV?8[C.>@XV-S[=17TA\#?BAP45B_V7K'_0:_ M\EEH_LO6/^@U_P"2RU\R>N;5%8O]EZQ_T&O_ "66C^R]8_Z#7_DLM &U16+_ M &7K'_0:_P#)9:/[+UC_ *#7_DLM &U16+_9>L?]!K_R66C^R]8_Z#7_ )++ M0!M45B_V7K'_ $&O_)9:/[+UC_H-?^2RT ;5%8O]EZQ_T&O_ "66K.GV=_;S M%KK4/M<>W 3R0F#ZY% &C1110 4444 %%%% !6/XH\)Z;XPT\6>IPNZ(_F1R M0RO#+$^"-R2(0RG!(R#T)%;%% '%^%_@_P"%O"?AJ\T.VT[[7:7T2PWLE^[7 M$MVH7:!([$D@#H.@[ 5?\+?#O0?!ZSC3K20O-&L#S7EQ)=2&)<[8]\K,P09. M%S@9Z5TM% '+^&?AKX=\(ZC)?:78&"X:,PH7FDD6",G)CB5F(B3(!VH .!QQ M74444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110!SWC;P#H'Q$T=],\0:;#J-JW MW?,'SQG^\C#E3[BOCGXG?LE>*_A?J7_"1_#^^N]1M;=O,1+=BE];?3'^L'TY M]J^YZ*]; YGB,"[4W>+WB]F<6(P=+$J\E9]UN?'GP=_;:>"2+1OB' 4=#Y?] MKP1X*D(^74K1 "Q_Z:+T(?! MK]JSPM\41#87KKX?\0, /LERX\N5O^F3G@_[IP?K7M]?,XC#5L+/V=:-F>O2 MK0K1YZ;N@HHHKF-@HHHH ***\O\ VBOBLGPF^&U]J$3@:M= VM@G?S6'WOHH MY_"MZ%&>(JQI4UK)V,ZE2-*#G+9'R]^U=X_O/BY\5M/\#Z QN;;3YQ:HD?*S M7;<,W'4*./SK[&^%OP_L_ACX%TOP]9 %;6,>;(/^6LIY=S]37R]^Q!\*GU+4 MK[X@ZJAEV,]O8M)R7D)_>R_KC/KFOLROHLZK0HJ&747[M/?SEU/*R^G*HY8J MIO+;R04445\L>R%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M!F^(_#UAXLT.]TC5+=;JPO(C%-$W<'^1'4'L17P-=0^(?V._C2KQ&2[T6;E< M\+>VA/*GL'7]"/0U^A=>?_&WX1Z?\8_!=QI-R%AOX\RV-X1S#+CC_@)Z$>GT M%>[E6/CA9NC75Z4])+]3S<;AG6BJE/2<=O\ (ZOPMXGT[QEX?L=:TFX6ZL+R M,2Q2+Z'L?0@\$=B*U:^#OV;_ (M:A\"O'M[X&\7;[/2IKDPR"8\6=QT#@_W& MXSVZ'UK[P5@ZAE(92,@CH:PS+ 2P%;EWB]8ONC3"8E8FG?:2W7F+1117DG<% M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !5>^L+;5+.6TO+>*ZM9E*20S('1P>Q!X M-6**=[:H#Y-^,G[$EIJ#3:MX!E6PNOOMI,[_ +IC_P!,WZH?8\>XKS[X>?M- M>.?@?JP\->.+"[U*PMR$:"\RMW OJCG[Z^@.1Z$5]YUR7Q$^%GAKXI:2;#Q# MIL=V #Y5PORS0GU1QR/IT]17TV'SA5(?5\PC[2'?[2^?]/S/'JX#EE[7"OEE M^#'?#WXH>&OBAI(O_#VI1WB@#S("=LT)]'0\C^7I75U\%?$+]FGQU\"]7/B7 MP3?W>HZ?;G>MQ996Z@7TD0??7U(R/4"O1O@W^VU9ZH8=)\>Q+IUYG8NK0+^Y M<_\ 31>J'W''THQ&3\\/K&7R]I#M]I?+^GY#I8_EE[+%+EE^#/J^BH+&^MM2 MM(KJTGCNK:50T+/P MUH;F73K6?[!:,OW>#^^F/MP<$^GO7TI^UE\6O^%:_#B6SLIMFMZR&M;;:?FC M3'[R3\ <#W-<#^P[\)/[*T6Y\_P#7F>'C&\56CA([;R]/Z_0^E?!_A:Q\$^&--T+38_+L[&%88QCK M@?'[_A(]/B\#:_<'^UK-"-/GE/,\2_\ +,Y_C4?F![5] M2U\/_M5_!6[^&?BB'XB>$P]I8R7"S3BWa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end EX-101.SCH 12 poww-20230331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Operations (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Consolidated Statements of Cash Flow link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - ORGANIZATION AND BUSINESS ACTIVITY link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - INCOME/(LOSS) PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - FACTORING LIABILITY link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - INVENTORY CREDIT FACILITY link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - NOTES PAYABLE – RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - CONSTRUCTION NOTE PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SEGMENTS link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUBSEQUENT EVENT link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INCOME/(LOSS) PER COMMON SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - CAPITAL STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SEGMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - ORGANIZATION AND BUSINESS ACTIVITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF CONCENTRATION OF RISKS (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - INCOME/(LOSS) PER COMMON SHARE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - FACTORING LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - INVENTORY CREDIT FACILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - NOTES PAYABLE – RELATED PARTY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - CONSTRUCTION NOTE PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - CAPITAL STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF ALLOCATION FOR CONSIDERATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - ACQUISITIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SCHEDULE OF ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF INCOME TAX PROVISION BENEFIT (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - SCHEDULE OF RECONCILIATION OF INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - SCHEDULE OF TOTAL ASSETS SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - SCHEDULE OF CAPITAL EXPENDITURE SEGMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - SUBSEQUENT EVENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 13 poww-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 14 poww-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 15 poww-20230331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.001 par value 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value Product and Service [Axis] Ammunition Sales [Member] Marketplace Revenue [Member] Casing Sales [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Treasury Stock, Common [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Definitive Agreement [Member] Legal Entity [Axis] PRIVCO [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] Exclusive License Agreement [Member] Income Statement Location [Axis] Selling and Marketing Expense [Member] Cost of Sales [Member] Statistical Measurement [Axis] Maximum [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] Customer A [Member] Accounts Receivable [Member] Customer B [Member] Customer C [Member] Customer D [Member] Customers [Member] Marketplace Fee Revenue [Member] Ammunition Casings Sales [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Debt Instrument [Axis] Convertible Promissory Note [Member] Minimum [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Term [Member] Measurement Input, Expected Dividend Rate [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Antidilutive Securities [Axis] Warrant [Member] Equity incentive awards [Member] Long-Lived Tangible Asset [Axis] Leasehold Improvements [Member] Building Improvements [Member] Furniture and Fixtures [Member] Vehicles [Member] Equipment [Member] Tooling [Member] Construction in Progress [Member] Operating Expense [Member] Factoring and Security Agreement [Member] Credit Facility [Axis] Prime Rate [Member] Revolving Inventory Loan and Security Agreement [Member] Inventory [Axis] Eligible Inventory [Member] Inventory Credit Facility [Member] Lease Agreement [Member] Jagemann Stamping Company [Member] Promissory Note [Member] Scenario [Axis] Post Closing Transaction Note Reduction [Member] Decreased Equipment Net [Member] Reduction in Other Intangible Assets [Member] Increased Accounts Receivable [Member] Increase to Deposits [Member] Decreased Accumulated Amortization [Member] Settlement Agreement [Member] Inventory and Services [Member] Note B [Member] Amended Note B [Member] Related and Nonrelated Party Status [Axis] Related Party [Member] Note A [Member] Title of Individual [Axis] Shareholder [Member] Fred Wagenhals [Member] Forest Street, LLC [Member] Debt Conversion Agreement [Member] Forest Street Note [Member] Amended APA [Member] Construction Loan Agreement [Member] Related Party, Type [Axis] Hiawatha National Bank [Member] Related Party Transaction [Axis] First Advance [Member] New Issuance of Shares [Member] Investor [Member] Convertible Notes Payable [Member] Investors [Member] Shares Issued for Services [Member] Employees, Board of Directors, Advisory Committee [Member] Liquidation Damage Fees [Member] Gemini Direct Investments LLC [Member] Warrant One [Member] Award Date [Axis] Until April 2025 [Member] Warrant Two [Member] Until August 2024 [Member] Warrant Three [Member] Until September 2024 [Member] Warrant Four [Member] Until November 2025 [Member] Warrant Five [Member] Until February 2024 [Member] Series A Preferred Stock [Member] Underwriting Agreement [Member] Underwriters [Member] Sale of Stock [Axis] Over-Allotment Option [Member] August 27, 2021 [Member] February 17. 2023 [Member] Merger Agreement [Member] Business Acquisition [Axis] Without Being Held in Escrow or Requiring Prior Stockholder Approval [Member] Pledge and Escrow Agreement [Member] Will Not Be Issued Prior to The Stockholder Approval [Member] Two Independent Contractors [Member] Proxy Settlement Agreement [Member] Foregoing [Member] Advisory Committee [Member] Board Of Directors [Member] Independent Contractor [Member] Administrative and Management Services [Member] Seller Note [Member] Award Type [Axis] Monthly Payments [Member] Ninety Percent [Member] Hundred Percent [Member] Jesse James [Member] Licensing Agreements [Member] Jeff Rann [Member] Streak Visual Ammunition Patent [Member] SWK Patent Acquisition [Member] Customer Relationships [Member] Intellectual Property [Member] Tradename [Member] GDI Acquisition [Member] Customer Lists [Member] Other Intangible Assets [Member] Ammunition [Member] Marketplace [Member] Corporate and Other Expenses [Member] Segments [Axis] Subsequent Event Type [Axis] Subsequent Event [Member] Members of Board of Directors [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated By Reference ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current Assets: Cash and cash equivalents Accounts receivable, net Due from related parties Other Receivable, after Allowance for Credit Loss, Current, Related and Nonrelated Party Status [Extensible Enumeration] Inventories Prepaid expenses Current portion of restricted cash Total Current Assets Property and Equipment, net Other Assets: Deposits Patents, net Other intangible assets, net Goodwill Right of use assets - operating leases TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities: Accounts payable Factoring liability Accrued liabilities Inventory credit facility Current portion of operating lease liability Current portion of note payable related party Notes Payable, Current, Related and Nonrelated Party Status [Extensible Enumeration] Current portion of construction note payable Insurance premium note payable Total Current Liabilities Long-term Liabilities: Contingent consideration payable Notes payable related party, net of current portion Notes Payable, Noncurrent, Related and Nonrelated Party Status [Extensible Enumeration] Construction note payable, net of unamortized issuance costs Operating lease liability, net of current portion Deferred income tax liability Total Liabilities Shareholders’ Equity: Series A cumulative perpetual preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of March 31, 2023 and March 31, 2022, respectively Common stock, $0.001 par value, 200,000,000 shares authorized 118,562,806 and 116,485,747 shares issued and 118,294,478 and 116,485,747 outstanding at March 31, 2023 and March 31, 2022, respectively Additional paid-in capital Accumulated deficit Treasury Stock Total Shareholders’ Equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Preferred stock, dividend rate, percentage Preferred stock, stated value per share Preferred stock, par value per share Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par or stated value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Net Revenues Total Revenues Cost of Revenues Gross Profit Operating Expenses Selling and marketing Corporate general and administrative Employee salaries and related expenses Depreciation and amortization expense Loss on purchase Total operating expenses Income/(Loss) from Operations Other Expenses Other income/(expense) Interest expense Total other expense Income/(Loss) before Income Taxes Provision for Income Taxes Net Income/(Loss) Preferred Stock Dividend Net Income/(Loss) Attributable to Common Stock Shareholders Net Income/(Loss) per share Basic Diluted Weighted average number of shares outstanding Basic Diluted Income Statement [Abstract] Excises taxes Balance Balance, shares Issuance of Series A Preferred Stock, net of issuance costs Issuance of Series A Preferred Stock, net of issuance costs, shares Common stock issued for convertible notes Common stock issued for convertible notes, shares Common stock issued for exercised warrants Common stock issued for exercised warrants, shares Common stock issued for debt conversion Common stock issued for debt conversion, shares Common stock issued for cashless warrant exercise Common stock issued for cashless warrant exercise, shares Common stock issuance costs Common stock issued for services Common stock issued for services, shares Employee stock awards Employee stock awards, shares Stock grants Issuance of warrants for convertible notes Common stock repurchase and cancellation Common stock repurchase and cancellation, shares Net (Income) Loss Acquisition stock issuances Acquisition stock issuances, shares Common stock issued for services and equipment Common stock issued for services and equipment, shares Warrants issued for services Preferred stock dividends declared Dividends accumulated on preferred stock Preferred stock dividend Treasury shares purchased Treasury shares purchased, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Income/(Loss) Adjustments to reconcile Net Loss to Net Cash provided by (used in) operations: Depreciation and amortization Debt discount amortization Employee stock awards Stock grants Stock for services Contingent consideration payable fair value Allowance for doubtful accounts (Gain)/loss on disposal of assets Reduction in right of use asset Warrant issued for services Deferred income taxes Stock issued in lieu of cash payments Interest on convertible promissory notes Paycheck protection program note forgiveness Loss on Jagemann Munition Components Stock and warrants for note conversion Changes in Current Assets and Liabilities Accounts receivable Due to (from) related parties Inventories Prepaid expenses Deposits Accounts payable Accrued liabilities Operating lease liability Net cash provided by (used in) operating activities Cash flows from investing activities: Gemini acquisition Purchase of equipment Proceeds from disposal of assets Net cash used in investing activities Cash flow from financing activities: Payments on inventory facility, net Proceeds from factoring liability Payments on factoring liability Payments on assumed debt from Gemini Payments on note payable - related party Payments on insurance premium note payment Proceeds from construction note payable Payments on construction note payable Payments on note payable Sale of preferred stock Common stock issued for exercised warrants Common stock issuance costs Preferred stock dividends paid Common stock repurchase plan Sale of common stock Proceeds from paycheck protection program notes Proceeds from note payable related party issued Proceeds from note payable Proceeds from convertible promissory notes Payments on common stock repurchase and cancellation Net cash used in financing activities Net increase/(decrease) in cash Cash, beginning of period Cash and restricted cash, end of period Restricted cash, end of period Cash, end of period Supplemental cash flow disclosures: Cash paid during the period for: Interest Income taxes Non-cash investing and financing activities: Construction note payable Insurance premium note payment Operating lease liability Dividends accumulated on preferred stock Acquisition stock issuances Warrant issued for services Convertible promissory note Note payable related party Note payable related party conversion Stock subscription receivable Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND BUSINESS ACTIVITY Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share [Abstract] INCOME/(LOSS) PER COMMON SHARE Credit Loss [Abstract] ACCOUNTS RECEIVABLE Inventory Disclosure [Abstract] INVENTORIES Property, Plant and Equipment [Abstract] PROPERTY, PLANT AND EQUIPMENT Factoring Liability FACTORING LIABILITY Inventory Credit Facility INVENTORY CREDIT FACILITY Leases [Abstract] LEASES Debt Disclosure [Abstract] NOTES PAYABLE – RELATED PARTY Construction Note Payable CONSTRUCTION NOTE PAYABLE Equity [Abstract] CAPITAL STOCK PREFERRED STOCK Business Combination and Asset Acquisition [Abstract] ACQUISITIONS Payables and Accruals [Abstract] ACCRUED LIABILITIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Income Tax Disclosure [Abstract] INCOME TAXES Goodwill and Intangible Assets Disclosure [Abstract] GOODWILL AND INTANGIBLE ASSETS Segment Reporting [Abstract] SEGMENTS Subsequent Events [Abstract] SUBSEQUENT EVENT Principles of Consolidation Use of Estimates Goodwill Cash and Cash Equivalents Restricted Cash Accounts Receivable and Allowance for Doubtful Accounts License Agreements Patents Other Intangible Assets Impairment of Long-Lived Assets Revenue Recognition Advertising Costs Fair Value of Financial Instruments Inventories Property and Equipment Compensated Absences Research and Development Excise Tax Stock-Based Compensation Concentrations of Credit Risk Income Taxes Contingencies Recent Accounting Pronouncements SCHEDULE OF CONCENTRATION OF RISKS SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED SCHEDULE OF ALLOCATION FOR CONSIDERATION SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS SCHEDULE OF ACCRUED LIABILITIES SCHEDULE OF INCOME TAX PROVISION BENEFIT SCHEDULE OF RECONCILIATION OF INCOME TAX SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET SCHEDULE OF OPERATING SEGMENTS SCHEDULE OF TOTAL ASSETS SEGMENTS SCHEDULE OF CAPITAL EXPENDITURE SEGMENT Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Number of shares sold Number of shares issued for pre-split Reverse stock split Number of shares issued, post reverse split Number of common stock shares issued Number of shares retired Number of shares issued to satisfy issuance commitment Shares equivalent to issuance recapitalization Schedule of Product Information [Table] Product Information [Line Items] Concentration Risk, Percentage Total Sales Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Fair value assumptions, measurement input, percentages Fair value assumptions, measurement input, percentages Platform Operator, Crypto-Asset [Table] Platform Operator, Crypto-Asset [Line Items] Warrants issued for services Warrants issued for convertible promissory notes conversion Share price Royalty expenses Impairment expense Advertising expenses Excise tax percentage Excise tax amount Cash FDIC insured amount Income tax examination, description Net income/(loss) Less: Preferred stock dividends Net income/(loss) attributable to common stockholders Weighted averaged shares of common stock - basic Effect of dilutive common stock purchase warrants Effect of dilutive equity incentive awards Weighted average shares of common stock - Diluted Income/(loss) per share attributable to common stockholders - basic Income/(loss) per share attributable to common stockholders - diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Warrants to purchase shares Weighted average number of shares outstanding, diluted Accounts receivable Less: allowance for doubtful accounts Accounts receivable, net Allowance for doubtful accounts receivable, beginning balance Increase in allowance Write-off of uncollectible amounts Purchase accounting Allowance for doubtful accounts receivable, ending balance Finished product Raw materials Work in process Inventory net Total property and equipment Less accumulated depreciation Net property and equipment Impaired Assets to be Disposed of by Method Other than Sale [Table] Impaired Assets to be Disposed of by Method Other than Sale [Line Items] Depreciation expense Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Interest Rate During Period Line of Credit Facility, Commitment Fee Percentage Line of Credit Facility, Commitment Fee Amount Factoring liability Interest expenses on factoring liability Amortization of commitment fee Maturity date Line of Credit Facility, Interest Rate Description Inventory credit facility Interest expense on factoring liability Amortization of annual fee 2024 2025 2026 2027 2028 Thereafter Total Lease Payments Less: Amount Representing Interest Present value of lease liabilities Operating lease, liability Right use of asset Operating lease liability, current Operating lease liability non-current Consolidated lease expense Operating Lease, Expense Other Lease Operating Expenses. Weighted average remaining lease term Weighted average discount rate for operating leases Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Payment of note payable related party Debt description Post-closing changes to the purchase price of transaction Principal payments Debt instrument maturity date Debt monthly payments Stock repurchased during period, shares Proceeds from advances for construction Promissory note Debt interest rate Interest expenses Debt instrument maturity date description Debt conversion, converted Instrument, amount Debt conversion, converted instrument, shares issued Shares issued, price per share Debt face amount Area of land Proceeds from notes payable Debt maturity date Debt periodic payment Prepayment premium of note amount, percentage Debt default, description Cash collateral or restricted cash Debt instrument principal payment Restricted cash Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of shares, outstanding beginning Weighted average exercise price, outstanding beginning Weighted average life remaining years, outstanding beginning Number of shares, granted Weighted average exercise price, granted Weighted average life remaining years, outstanding granted Number of shares, exercised Weighted average exercise price, exercised Number of shares, forfeited or cancelled Weighted average exercise price, forfeited or cancelled Number of shares, outstanding ending Weighted average exercise price, outstanding ending Weighted average life remaining years, outstanding ending Number of shares, exercisable Weighted average exercise price, exercisable Weighted average life remaining years, exercisable Number of shares, forfeited or cancelled Common stock, par value Common stock issued new shares, shares Number of shares issued for merger, shares Number of shares issued for conversion of notes, shares Number of shares issued for conversion of notes, value Stock issued during period shares warrants exercised, shares Stock issued during period value warrants exercised, value Shares issued cashless exercise of warrants Cashless exercise of warrants Number of shares issued for services, shares Number of shares issued for services, value Shares issued for employees benefit, shares Shares issued for employees benefit, value Common stock issued for liquidation damage fees, shares Common stock issued for liquidation damage fees, value Shares repurchased Stock repurchased and cancelled Number of shares issued for merger, value Warrants outstanding Issuance of warrants, description Warrants issued to purchase common stock Warrants exercise price Schedule of Stock by Class [Table] Class of Stock [Line Items] Share price Dividend rate Preferred stock dividend rate per annum Dividend payment terms Proceeds from offering Accumulated preferred dividends Cash Working capital adjustment Contingent consideration Common stock Assumed debt Fair value of consideration transferred   Accounts receivable, net Prepaid expenses Equipment Deposits Other Intangible assets Right of use assets - operating leases Accounts payable Accrued expenses Operating lease liability Total Consideration Net revenues Net income Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Business acquisition, amount Business acquisition, shares Business acquisition, share price Company received a cash payment Business acquisition, cash acquired Estimated working capital adjustment Contingent consideration payable, net of current portion Contingent consideration, amount Shares issued prior stockholder Business combination additional securities of common stock Working capital adjustments Consideration transferred Transaction cost Business acquisitions pro form a interest and debt expense Business acquisitions pro form a depreciation and amortization Accrued FAET Accrued professional fees Income taxes payable Accrued sales commissions Unearned revenue Accrued interest Accrued payroll Other accruals Accrued liabilities Costs, fees and expenses Common stock shares issued, value Service paid Shares for service Revenues Accounts receivable Debt instrument, description Accrued interest Inventory purchased during period Rent paid Proceeds from Notes payable Option grant to repurchase Share price per share Debt instrument term Shares repurchase Debt principal and accrued interest US Federal US State Total current provision US Federal US State Total deferred benefit Change in valuation allowance Income tax (provision) benefit Computed tax expense State taxes, net of Federal income tax benefit Change in valuation allowance Employee stock awards Stock grants Stock for services Other Non-deductible meals & entertainment Contingent consideration fair value Stock and Warrants on Note Conversion Total provision for income taxes Net operating loss carryforward Loss on purchase Other Total deferred tax assets Depreciation expense Other Total deferred tax liabilities Net deferred tax assets/(liabilities) Valuation allowance Net deferred tax assets/(liabilities) Effective Income Tax Rate Reconciliation, Percent Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Licensing agreement, life Intangible assets, Gross Accumulated amortization Intangible assets, net 2024 2025 2026 2027 2028 Thereafter Annual amortization of intangible assets Amortization of intangible assets Revenue from External Customers by Products and Services [Table] Revenue from External Customer [Line Items] Cost of Revenues General and administrative expense Depreciation and amortization Income/(Loss) from Operations Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Total assets Payment to acquire property and plant equipment Subsequent Event [Table] Subsequent Event [Line Items] Number of stock issued as compensation Number of stock issued as compensation, value 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value Common Stock, $0.001 par value License Agreements [Policy Text Block] Exclusive License Agreement [Member]. Factoring liability current. Inventory credit facility current. Preferred stock, stated value per share. Customer A [Member] Customers [Member] Customer B [Member] Convertible Promissory Note [Member] Schedule Of Stockholders Equity Warrants Or Rights [Table Text Block] Loss on subsidiaries Warrants issued for services. Stock and warrants issued for convertible promissory notes. Excise Tax [Policy Text Block] Excise tax percentage. Excise tax amount. Warrants [Member] Equity incentive awards [Member] Incremental common shares attributable to dilutive effect of conversion of effect of dilutive equity incentive awards. Stock issued during period value for exercised warrants. Stock issued during period shares for exercised warrants. Stock issued during period value for cashless warrant exercise. Stock issued during period shares for cashless warrant exercise. Adjustments to additional paid in capital warrant issued for services. Stock grants. Factoring Liability [Text Block] Revolving Inventory Loan and Security Agreement [Member] Eligible Inventory [Member] Factoring and Security Agreement [Member] Factoring liability. Interest expenses on factoring liability. Amortization of commitment fee. Stock Issued During Period Value Common Stock Issued for Debt Conversion. Common stock issued for exercised warrants shares Stock issued during period shares common stock issued for debt conversion Common stock issued for cashless warrant exercise shares Inventory Credit Facility [Text Block] Inventory credit facility. Inventory Credit Facility [Member] Interest expense on factoring liability. Amortization of annual fee. Stock issued during period value issued for service and equipment. Stock issued during period shares issued for service and equipment. Lease Agreement [Member]. Stock issued during period value new issues one. Stock issued during period shares new issues one Stock grants. Contingent consideration fair value. Other Lease Operating Expenses. Reduction in right of use asset. Warrant issued for services Stock issued in lieu of cash payments Interest on convertible promissory notes Paycheck protection program note forgiveness Stock and warrants for note conversion Payments on inventor facility. Proceeds from factoring liablity. Payments on factoring liability. Repayments from insurance premium note payment. Payments on construction note payable. Proceeds from long term debt Amount of cash inflow from construction note payable. Cash Paid During The Period For: Construction note payable. Insurance premium note payment. Dividends accumulated on preferred stock. Operating lease liabilities. Acquisition Stock Issuances. Non cash warrant issued for services. Convertible promissory note. Note Payable Related Party Conversion. Notes payable related party non cash investing activities. Stock subscription receivable. The cash outflow to reacquire common stock and cancellation Tooling [Member] Definitive Agreement [Member] PRIVCO [Member] Number of shares issued to satisfy issuance commitment. Shares equivalent to issuance recapitalization. Notes Payable Related Party [Text Block]. Jagemann Stamping Company [Member] Promissory Note [Member] Post-closing changes to the purchase price of transaction. Post Closing Transaction Note Reduction [Member] Decreased Equipment Net [Member] Increased Accounts Receivable [Member] Reduction in Other Intangible Assets [Member] Increase to Deposits [Member] Decreased Accumulated Amortization [Member] Settlement Agreement [Member] Inventory and Services [Member] Note B [Member] Amended Note B [Member] Note A [Member] Shareholder [Member] Fred Wagenhals [Member] Forest Street, LLC [Member] Debt Conversion Agreement [Member] Forest Street Note [Member] Amended APA [Member] New Issuance of Shares [Member] Construction Note Payable Disclosure [Text Block] Construction Loan Agreement [Member] Hiawatha National Bank [Member] First Advance [Member] Prepayment premium percentage. Shares issued cashless exercise of warrants. Warrants exercise. Gemini Direct Investments LLC [Member] Shares issued warrants exercise. Investors [Member] Shares issued warrants exercise, value. Shares issued cashless exercise of warrants shares. Shares Issued for Services [Member] Employees, Board of Directors, Advisory Committee [Member] Effective income tax rate stock for services. Effective income tax rate rent expense. Effective income tax rate stock and warrants on note conversion. Share based compensation arrangement by share based payment award non option equity instruments exercisable. Share based compensation arrangement by share based payment award non option equity instruments Outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments exercised weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments forfeitures and expirations weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term beginning. Effective income tax rate reconciliation warrants issued for services Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted. Share based compensation arrangement by share based payment award non option equity instruments Outstanding weighted average remaining contractual term ending. Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average remaining contractual term. Deferred tax assets: Loss on purchase. Deferred tax asset. Deferred tax liabilities: Depreciation expense. Issuance of warrants, description. Warrant One [Member] Until April 2025 [Member] Warrant Two [Member] Until August 2024 [Member] Deferred tax liabilities amortization expense. Deferred tax assets liabilities gross. Deferred tax asset liabilities net. Warrant Three [Member] Until September 2024 [Member] Warrant Four [Member] Until November 2025 [Member] Warrant Five [Member] Until February 2024 [Member] Underwriting Agreement [Member] Underwriters [Member] Jesse James [Member]. Jeff Rann [Member]. Streak Visual Ammunition Patent [Member]. SWK Patent Acquisition [Member] Tradename [Member] GDI Acquisition [Member]. Merger Agreement [Member]. Without Being Held in Escrow or Requiring Prior Stockholder Approval [Member] Pledge and Escrow Agreement [Member] Will Not Be Issued Prior to The Stockholder Approval [Member] Business combinations contingent consideration liability. Business combination contingent consideration shares issued prior stockholder. Business combination additional securities of common stock. Working capital adjustments. Working capital adjustment. Business combination recognized identifiable assets acquired and liabilities assumed common stock. Business combination recognized identifiable assets acquired and liabilities assumed deposits. Other intangible assets. Business combination recognized identifiable assets acquired and liabilities assumed right-of-use assets operating leases. Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued liabilities. Business acquisitions pro forma interest and debt expense. Business acquisitions pro forma depreciation and amortization. Operating income percentage. Ammunition Sales [Member] Marketplace Revenue [Member] Accrued FAET. Unearned revenue. Ammunition [Member] Marketplace [Member] Corporate and Other Expenses [Member] Schedule Of Total Assets [Table Text Block] Independent Contractor [Member] Schedule of Capital Expenditure [Table Text Block] Advisory Committee Members [Member] Employees [Member] Members of Board of Directors [Member] Proxy Settlement Agreement [Member] Inventory purchased during period. Administrative and Management Services [Member] Seller Note [Member] Monthly Payments [Member] Ninety Percent [Member] Hundred Percent [Member] Option grant to repurchase. Foregoing [Member] Advisory Committee [Member] Preferred stock dividends. Two Independent Contractors [Member] August 27, 2021 [Member] February 17. 2023 [Member] Purchase accounting. Net property and equipment. Income/(Loss) from Operations. Net income loss. Preferred stock dividends income statement impact. Net income loss available to common stockholders basic. Assets, Current Liabilities, Current Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses [Default Label] Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Preferred Stock Dividends, Income Statement Impact Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Dividends, Preferred Stock, Stock Dividends, Stock Stock Issued During Period, Shares, Treasury Stock Reissued Employee Benefit and Share-Based Payment Arrangement, Noncash StockGrants ContingentConsiderationFairValue Gain (Loss) on Disposition of Assets PaycheckProtectionProgramNoteForgiveness Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Businesses and Interest in Affiliates Net Cash Provided by (Used in) Investing Activities PaymentsOnInventorFacility PaymentsOnFactoringLiability Repayments of Other Debt Repayments of Related Party Debt RepaymentsFromInsurancePremiumNotePayment PaymentsOnConstructionNotePayable Proceeds from Warrant Exercises Payments of Stock Issuance Costs Payments of Ordinary Dividends, Preferred Stock and Preference Stock Payments for Repurchase of Common Stock PaymentsOnCommonStockRepurchaseAndCancellation Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Restricted Cash and Cash Equivalents Restricted Cash [Default Label] Warrants Until April 2023, August 2024, February 2026 [Member] DividendsAccumulatedOnPreferredStock Factoring Liability [Text Block] NonCashWarrantIssuedForServices Goodwill and Intangible Assets, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Warrants and Rights Outstanding, Term WarrantsIssuedForServices PreferredStockDividendsIncomeStatementImpact1 NetIncomeLossAvailableToCommonStockholdersBasic1 Accounts Receivable, Allowance for Credit Loss, Current Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss, Writeoff Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment PropertyPlantAndEquipmentNet1 FactoringLiability Inventory credit facility [Default Label] Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetsOperatingLeases Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Interest Payable Current Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Deferred Federal, State and Local, Tax Expense (Benefit) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Percent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent Effective income tax rate stock for services Deferred tax assets: Loss on purchase Deferred Tax Assets, Other Deferred Tax Assets, Gross Deferred tax liabilities: Depreciation expense DeferredTaxLiabilitiesAmortizationExpense Deferred Tax Liabilities, Gross DeferredTaxAssetsLiabilitiesGross Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Asset, Expected Amortization, Year One Finite-Lived Intangible Asset, Expected Amortization, Year Two Finite-Lived Intangible Asset, Expected Amortization, Year Three Finite-Lived Intangible Asset, Expected Amortization, Year Four Finite-Lived Intangible Asset, Expected Amortization, Year Five Finite-Lived Intangible Asset, Expected Amortization, after Year Five Cost of Goods and Services Sold OperatingIncomeLoss1 EX-101.PRE 16 poww-20230331_pre.xml XBRL PRESENTATION FILE XML 17 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
12 Months Ended
Mar. 31, 2023
Jun. 09, 2023
Sep. 30, 2022
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Mar. 31, 2023    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Current Fiscal Year End Date --03-31    
Entity File Number 001-13101    
Entity Registrant Name AMMO, Inc.    
Entity Central Index Key 0001015383    
Entity Tax Identification Number 83-1950534    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 7681 E Gray Road    
Entity Address, City or Town Scottsdale    
Entity Address, State or Province AZ    
Entity Address, Postal Zip Code 85260    
City Area Code (480)    
Local Phone Number 947-0001    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 258,196,798
Entity Common Stock, Shares Outstanding   117,580,758  
Documents Incorporated By Reference Part III incorporates information by reference from the definitive proxy statement for the registrant’s 2023 Annual Meeting of Stockholders to be filed within 120 days after the end of the registrant’s fiscal year.    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 342    
Auditor Name PANNELL KERR FORSTER OF TEXAS, P.C    
Auditor Location Houston, Texas    
Common Stock, $0.001 par value      
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol POWW    
Security Exchange Name NASDAQ    
8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value      
Title of 12(b) Security 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value    
Trading Symbol POWWP    
Security Exchange Name NASDAQ    
XML 18 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Current Assets:    
Cash and cash equivalents $ 39,134,027 $ 23,281,475
Accounts receivable, net 29,346,380 43,955,084
Due from related parties $ 15,000
Other Receivable, after Allowance for Credit Loss, Current, Related and Nonrelated Party Status [Extensible Enumeration] Related Party [Member] Related Party [Member]
Inventories $ 54,344,819 $ 59,016,152
Prepaid expenses 5,126,667 3,423,925
Current portion of restricted cash 500,000
Total Current Assets 128,451,893 129,691,636
Property and Equipment, net 55,963,255 37,637,806
Other Assets:    
Deposits 7,028,947 11,360,322
Patents, net 5,032,754 5,526,218
Other intangible assets, net 123,726,810 136,300,387
Goodwill 90,870,094 90,870,094
Right of use assets - operating leases 1,261,634 2,791,850
TOTAL ASSETS 412,335,387 414,178,313
Current Liabilities:    
Accounts payable 18,079,397 26,817,083
Factoring liability 485,671
Accrued liabilities 4,353,354 6,178,814
Inventory credit facility 825,675
Current portion of operating lease liability 470,734 831,429
Current portion of note payable related party $ 180,850 $ 684,639
Notes Payable, Current, Related and Nonrelated Party Status [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of construction note payable $ 260,429
Insurance premium note payable 2,118,635
Total Current Liabilities 25,463,399 35,823,311
Long-term Liabilities:    
Contingent consideration payable 140,378 204,142
Notes payable related party, net of current portion $ 181,132
Notes Payable, Noncurrent, Related and Nonrelated Party Status [Extensible Enumeration] Related Party [Member] Related Party [Member]
Construction note payable, net of unamortized issuance costs $ 10,922,443 $ 38,330
Operating lease liability, net of current portion 903,490 2,091,351
Deferred income tax liability 2,309,592 1,536,481
Total Liabilities 39,739,302 39,874,747
Shareholders’ Equity:    
Series A cumulative perpetual preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of March 31, 2023 and March 31, 2022, respectively 1,400 1,400
Common stock, $0.001 par value, 200,000,000 shares authorized 118,562,806 and 116,485,747 shares issued and 118,294,478 and 116,485,747 outstanding at March 31, 2023 and March 31, 2022, respectively 118,294 116,487
Additional paid-in capital 391,940,374 385,426,431
Accumulated deficit (18,941,825) (11,240,752)
Treasury Stock (522,158)
Total Shareholders’ Equity 372,596,085 374,303,566
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 412,335,387 $ 414,178,313
XML 19 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, dividend rate, percentage 8.75% 8.75%
Preferred stock, stated value per share $ 25.00 $ 25.00
Preferred stock, par value per share $ 0.001 $ 0.001
Preferred stock, shares issued 1,400,000 1,400,000
Preferred stock, shares outstanding 1,400,000 1,400,000
Common stock, par or stated value per share $ 0.001 $ 0.001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 118,562,806 116,485,747
Common stock, shares outstanding 118,294,478 116,485,747
XML 20 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Net Revenues      
Total Revenues $ 191,439,801 $ 240,269,166 $ 62,482,330
Cost of Revenues 136,031,204 151,505,657 51,095,679
Gross Profit 55,408,597 88,763,509 11,386,651
Operating Expenses      
Selling and marketing 4,729,540 7,310,216 1,879,128
Corporate general and administrative 24,980,079 16,986,344 7,191,544
Employee salaries and related expenses 15,679,135 13,615,439 5,036,721
Depreciation and amortization expense 13,278,762 13,702,148 1,659,243
Loss on purchase 1,000,000
Total operating expenses 58,667,516 51,614,147 16,766,636
Income/(Loss) from Operations (3,258,919) 37,149,362 (5,379,985)
Other Expenses      
Other income/(expense) 25,181 21,840 576,785
Interest expense (632,062) (637,797) (3,009,094)
Total other expense (606,881) (615,957) (2,432,309)
Income/(Loss) before Income Taxes (3,865,800) 36,533,405 (7,812,294)
Provision for Income Taxes 730,238 3,285,969
Net Income/(Loss) (4,596,038) 33,247,436 (7,812,294)
Preferred Stock Dividend (3,105,034) (2,668,649)
Net Income/(Loss) Attributable to Common Stock Shareholders $ (7,701,072) $ 30,578,787 $ (7,812,294)
Net Income/(Loss) per share      
Basic $ (0.07) $ 0.27 $ (0.14)
Diluted $ (0.07) $ 0.27 $ (0.14)
Weighted average number of shares outstanding      
Basic 117,177,885 112,328,680 55,041,502
Diluted 117,177,885 114,189,720 55,041,502
Ammunition Sales [Member]      
Net Revenues      
Total Revenues [1] $ 114,116,044 $ 161,459,025 $ 49,620,530
Marketplace Revenue [Member]      
Net Revenues      
Total Revenues 63,149,673 64,608,516
Casing Sales [Member]      
Net Revenues      
Total Revenues $ 14,174,084 $ 14,201,625 $ 12,861,800
[1] Included in revenue for the years ended March 31, 2023, 2022, and 2021 is excises taxes of $9,789,896, $14,646,983, and $4,286,258, respectively.
XML 21 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations (Parenthetical) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]      
Excises taxes $ 9,789,896 $ 14,646,983 $ 4,286,258
XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Total
Balance at Mar. 31, 2020 $ 46,204 $ 53,219,834 $ (34,007,245) $ 19,258,793
Balance, shares at Mar. 31, 2020 46,204,139        
Issuance of Series A Preferred Stock, net of issuance costs $ 34,537 138,578,082 138,612,619
Issuance of Series A Preferred Stock, net of issuance costs, shares   34,536,143        
Common stock issued for convertible notes $ 3,145 4,828,061 4,831,206
Common stock issued for convertible notes, shares   3,145,481        
Common stock issued for exercised warrants $ 6,522 13,945,814 13,952,336
Common stock issued for exercised warrants, shares   6,521,563        
Common stock issued for debt conversion $ 1,000 2,099,000 2,100,000
Common stock issued for debt conversion, shares   1,000,000        
Common stock issued for cashless warrant exercise $ 733 (733)
Common stock issued for cashless warrant exercise, shares   732,974        
Common stock issuance costs (13,847,069) (13,847,069)
Common stock issued for services $ 943 1,706,557 1,707,500
Common stock issued for services, shares   943,336        
Employee stock awards $ 1,016 1,449,343 1,450,359
Employee stock awards, shares   1,016,331        
Stock grants 278,585 278,585
Issuance of warrants for convertible notes 1,315,494 1,315,494
Common stock repurchase and cancellation $ (1,000) (1,499,000) (1,500,000)
Common stock repurchase and cancellation, shares   (1,000,000)        
Net (Income) Loss (7,812,294) (7,812,294)
Balance at Mar. 31, 2021 $ 93,100 202,073,968 (41,819,539) 160,347,529
Balance, shares at Mar. 31, 2021 93,099,967        
Issuance of Series A Preferred Stock, net of issuance costs $ 1,400 31,007,396 31,008,796
Issuance of Series A Preferred Stock, net of issuance costs, shares 1,400,000          
Common stock issued for exercised warrants $ 431 943,476 943,907
Common stock issued for exercised warrants, shares   431,080        
Common stock issued for cashless warrant exercise $ 375 (375)
Common stock issued for cashless warrant exercise, shares   374,584        
Common stock issued for services, shares           772,450
Employee stock awards $ 1,808 5,757,192 $ 5,759,000
Employee stock awards, shares   1,807,666        
Stock grants 252,488 252,488
Net (Income) Loss 33,247,436 33,247,436
Acquisition stock issuances $ 20,000 142,671,282 142,691,282
Acquisition stock issuances, shares   20,000,000        
Common stock issued for services and equipment $ 773 1,630,928 1,631,701
Common stock issued for services and equipment, shares   772,450        
Warrants issued for services     1,090,076   1,090,076
Preferred stock dividends declared (2,524,087) (2,524,087)
Dividends accumulated on preferred stock (144,562) (144,562)
Balance at Mar. 31, 2022 $ 1,400 $ 116,487 385,426,431 (11,240,752) 374,303,566
Balance, shares at Mar. 31, 2022 1,400,000 116,485,747        
Common stock issued for exercised warrants $ 200 101,306 101,506
Common stock issued for exercised warrants, shares   200,003        
Common stock issued for cashless warrant exercise $ 99 (99)
Common stock issued for cashless warrant exercise, shares   99,762        
Employee stock awards $ 1,776 5,806,003 5,807,779
Employee stock awards, shares   1,777,294        
Stock grants 179,094 179,094
Net (Income) Loss       (4,596,038)   (4,596,038)
Warrants issued for services 427,639 427,639
Preferred stock dividends declared (638,071) (638,071)
Dividends accumulated on preferred stock (144,618) (144,618)
Preferred stock dividend (2,322,346) (2,322,346)
Treasury shares purchased (268) (522,158) $ (522,426)
Treasury shares purchased, shares           (268,328)
Balance at Mar. 31, 2023 $ 1,400 $ 118,294 $ 391,940,374 $ (18,941,825) $ (522,158) $ 372,596,085
Balance, shares at Mar. 31, 2023 1,400,000 118,294,478        
XML 23 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flow - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:      
Net Income/(Loss) $ (4,596,038) $ 33,247,436 $ (7,812,294)
Adjustments to reconcile Net Loss to Net Cash provided by (used in) operations:      
Depreciation and amortization 17,519,949 17,339,093 4,876,756
Debt discount amortization 83,253 38,330 446,466
Employee stock awards 5,807,779 5,759,000 1,450,359
Stock grants 179,094 252,488 278,585
Stock for services 4,200 1,707,500
Contingent consideration payable fair value (63,764) (385,750) (119,731)
Allowance for doubtful accounts 191,299 2,748,250 86,292
(Gain)/loss on disposal of assets (12,044) 25,400
Reduction in right of use asset 629,140 720,491 443,739
Warrant issued for services 213,819 718,045
Deferred income taxes 730,238 1,536,481
Stock issued in lieu of cash payments 48,000
Interest on convertible promissory notes 163,351
Paycheck protection program note forgiveness (1,051,985)
Loss on Jagemann Munition Components 1,000,000
Stock and warrants for note conversion 1,315,494
Changes in Current Assets and Liabilities      
Accounts receivable 14,417,405 (20,707,052) (6,075,373)
Due to (from) related parties 15,000 657 150
Inventories 4,671,333 (43,149,234) (11,458,845)
Prepaid expenses 2,763,855 1,996,287 (1,331,710)
Deposits 4,306,375 (8,826,504) (1,616,858)
Accounts payable (8,694,813) 9,930,191 1,810,417
Accrued liabilities (1,970,078) 2,374,686 1,843,166
Operating lease liability (647,480) (732,468) (444,439)
Net cash provided by (used in) operating activities 35,556,366 2,852,583 (14,415,560)
Cash flows from investing activities:      
Gemini acquisition (50,517,840)
Purchase of equipment (12,541,325) (19,218,982) (7,437,265)
Proceeds from disposal of assets 59,800
Net cash used in investing activities (12,541,325) (69,677,022) (7,437,265)
Cash flow from financing activities:      
Payments on inventory facility, net (825,675) (265,422) 1,091,098
Proceeds from factoring liability 71,348,761 121,488,045 40,309,292
Payments on factoring liability (71,834,432) (122,844,562) (40,473,083)
Payments on assumed debt from Gemini (50,000,000)
Payments on note payable - related party (684,921) (625,147) (8,783,410)
Payments on insurance premium note payment (2,134,143) (2,208,369) (514,746)
Proceeds from construction note payable 1,000,000
Payments on construction note payable (150,743)
Payments on note payable (4,000,000)
Sale of preferred stock 35,000,000
Common stock issued for exercised warrants 101,506 943,907 13,952,336
Common stock issuance costs (3,199,922) (13,895,069)
Preferred stock dividends paid (2,960,416) (2,524,087)  
Common stock repurchase plan (522,426)
Sale of common stock 138,612,619
Proceeds from paycheck protection program notes 1,051,985
Proceeds from note payable related party issued 3,500,000
Proceeds from note payable 4,000,000
Proceeds from convertible promissory notes 1,959,000
Payments on common stock repurchase and cancellation (1,500,000)
Net cash used in financing activities (6,662,489) (28,235,557) 139,310,022
Net increase/(decrease) in cash 16,352,552 (95,059,996) 117,457,197
Cash, beginning of period 23,281,475 118,341,471 884,274
Cash and restricted cash, end of period 39,634,027 23,281,475 118,341,471
Restricted cash, end of period 500,000
Cash, end of period 39,134,027 23,281,475 118,341,471
Cash paid during the period for:      
Interest 665,043 626,571 1,186,302
Income taxes 1,302,811
Non-cash investing and financing activities:      
Construction note payable 10,237,032 387,968
Insurance premium note payment 4,252,778 2,166,852 226,539
Operating lease liability 901,076 809,451 897,845
Dividends accumulated on preferred stock 144,618 144,562
Acquisition stock issuances 143,400,000
Warrant issued for services 1,090,077
Convertible promissory note 4,667,855
Note payable related party 2,635,797
Note payable related party conversion 2,100,000
Stock subscription receivable $ 664,975
XML 24 R8.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND BUSINESS ACTIVITY
12 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BUSINESS ACTIVITY

NOTE 1 – ORGANIZATION AND BUSINESS ACTIVITY

 

We were formed under the name Retrospettiva, Inc. in November 1990 to manufacture and import textile products, including both finished garments and fabrics. We were inactive until the following series of events in December 2016 and March 2017.

 

On December 15, 2016, the Company’s majority shareholders sold 475,681 (11,891,976 pre-split) of their outstanding shares to Mr. Fred W. Wagenhals (“Mr. Wagenhals”) resulting in a change in control of the Company. Mr. Wagenhals was appointed as sole officer and the sole member of the Company’s Board of Directors.

 

The Company also approved (i) doing business in the name AMMO, Inc., (ii) a change to the Company’s OTC trading symbol to POWW, (iii) an agreement and plan of merger to re-domicile and change the Company’s state of incorporation from California to Delaware, and (iv) a 1-for-25 reverse stock split (“Reverse Split”) of the issued and outstanding shares of the common stock of the Company. As a result of the reverse split, the previous issued and outstanding shares of common stock became 580,052 shares; no shareholder was reversed below 100 shares, and all fractional shares resulting from the reverse split were rounded up to the next whole share. All references to the outstanding stock have been retrospectively adjusted to reflect this split. These transactions were effective as of December 30, 2016.

 

On March 17, 2017, the Company entered into a definitive agreement with AMMO, Inc. a Delaware Corporation (PRIVCO) under which the Company acquired all of the outstanding shares of common stock of (PRIVCO). Under the terms of the Agreement, the Company issued 17,285,800 newly issued shares of common stock of the Company. In connection with this transaction the Company retired 475,681 shares of common stock and issued 500,000 shares of common stock to satisfy an issuance commitment. The acquisition was considered to be a capital transaction. The transaction was the equivalent to the issuance by PRIVCO of 604,371 shares to the Company’s shareholders accompanied by a recapitalization. The weighted average number of outstanding shares has been adjusted for this transaction. (PRIVCO) subsequently changes its name to AMMO Munitions, Inc.

 

XML 25 R9.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation and warrant-based compensation.

 

Goodwill

 

We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline it is not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2023. As of March 31, 2023, the Company has a goodwill carrying value of $90,870,094, all of which is assigned to the Marketplace segment. However, due to declines in the value of the Company’s common stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2024.

 

Cash and Cash Equivalents

 

For purposes of the consolidated statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

 

Restricted Cash

 

We consider cash to be restricted when withdrawal or general use is legally restricted. Our restricted cash balance is comprised of cash on deposit with banks to secure the Construction Loan Agreement as discussed in Note 11. We report restricted cash in the Consolidated Balance Sheets as current or non-current classification based on the expected duration of the restriction.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Our accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts.

 

License Agreements

 

We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

 

We were a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants us through February 2022 the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

 

Patents

 

On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to AMMO Technologies Inc. pursuant to an Assignment and First Amendment to Exclusive License Agreement. Assumption Agreement dated to be effective as of August 22, 2017, the Merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.

 

Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $0.01 per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the years ended March 31, 2023, 2022, and 2021, the Company recognized royalty expenses of $99,268, $44,764, and $87,093 respectively under this agreement.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

In August 2018, we applied for additional patent coverage for the manufacturing methods or application of the Hybrid Luminescence Ammunition Technology on a variety of projectile and ammunition types. The costs of filing this patent were expensed.

 

On October 5, 2018, we completed the acquisition of SW Kenetics Inc. AMMO Technologies, Inc. succeeded all of the assets of SW Kenetics Inc. and assumed all of the liabilities.

 

The primary asset of SW Kenetics Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to AMMO Technologies, Inc. pursuant to Intellectual Property Rights Agreement on September 27, 2018.

 

We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.

 

Other Intangible Assets

 

On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement (See Note 18). The intangible assets acquired include a tradename, customer relationships, and intellectual property.

 

On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company. Whereby SpeedLight Group I, LLC merged with and into Gemini Direct Investments, LLC, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company. At the time of the Merger, Gemini Direct Investments, LLC had nine (9) subsidiaries, all of which are related to Gemini’s ownership of GunBroker.com, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software and domain names.

 

Impairment of Long-Lived Assets

 

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. No impairment expense was recognized for the years ended March 31, 2023, 2022, and 2021.

 

Revenue Recognition

 

We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

 

  Identification of a contract with a customer
  Identification of the performance obligations in the contact
  Determination of the transaction price
  Allocation of the transaction price to the separate performance allocation
  Recognition of revenue when performance obligations are satisfied

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services it transfers to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.

 

For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.

 

For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized as follows:

 

Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

 

Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.

 

Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.

 

Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.

 

Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.

 

Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.

 

For the years ended March 31, 2023, 2022, and 2021, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:

 

   For the Year Ended
March 31, 2023
   For the Year Ended
March 31, 2022
    For the Year Ended
March 31, 2021
 
PERCENTAGES  Revenues   Accounts Receivable   Revenues  

Accounts

Receivable

    Revenues    

Accounts

Receivable

 
                                 
Customers:                                    
                                         
A   12.2%   -    -    -      16.5 %     23.3 %
B   -    -    -    11.8%     -       -  
C   -    -    -    -      -       11.9 %
D   -    -    -    -      -       10.6 %
    12.2%   -    -    11.8%     16.5 %     45.8 %

 

Disaggregated Revenue Information

 

The following table represent a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types; ammunition, ammunition casings, and marketplace fees. The Company notes that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.

 

                 
   For the Year Ended  
   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition Sales  $114,116,044   $161,459,025    $ 49,620,530  
Marketplace Fee Revenue   63,149,673    64,608,516      -  
Ammunition Casings Sales   14,174,084    14,201,625      12,861,800  
Total Sales  $191,439,801   $240,269,166    $ 62,482,330  

 

Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell direct to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our Gunbroker.com online auction marketplace.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

All sales are recorded upon shipment and, depending on credit worthiness of customer, the payment terms will vary from thirty (30) to sixty (60) days. No refunds are allowed on any product shipped.

 

Each product manufactured by the Company has standard specifications and performance objectives. The Company has an extensive product testing program and, if the Company were given notice of a product defect by a customer, the Company would request the return of the product so that the manufacturing defect could be identified.

 

Advertising Costs

 

We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expenses as they are incurred in cost of revenues. We incurred advertising expenses recognized in selling expenses of $1,068,700, $1,406,043, and $257,866 for the years ended March 31, 2023, 2022, and 2021 respectively. We incurred marketplace advertising expenses of 286,479 and $417,017 in cost of revenues for the years ended March 31, 2023 and 2022. We did not have marketplace advertising expenses in cost of revenues for the year ended March 31, 2021.

 

Fair Value of Financial Instruments

 

We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.

 

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:

 

Level 1 – Quoted prices for identical instruments in active markets;

 

Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

 

Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.

 

We value all common stock issued for services on the date of the agreements, using the price at which shares were being sold to private investors or at the value of the services performed.

 

We valued warrants issued for services at their respective grants dates during the years ended March 31, 2023, 2022, and 2021 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.

 

   March 31, 2023   March 31, 2022   

March 31,

2021

 
                 
Risk free interest rate   3.9%   1.21%-1.74%     0.32%-0.38 %
Expected volatility   77.5%   89.1%-90.7%     88.9%-90.4 %
Expected term   2.5 years    2.5 years      2.5 years  
Expected dividend yield   0%   0%     0 %

 

 

   Quoted
Active
Markets
for
Identified
Assets
   Significant
Other
Observable
Inputs
   Significant
Unobservable
Inputs
   Total 
   (Level 1)   (Level 2)   (Level 3)     
March 31, 2023                    
Warrants issued for services  $-   $427,639   $-   $427,639 
March 31, 2022                    
Warrants issued for services  $-   $1,090,077   $-   $1,090,077 
March 31, 2021                                  
Warrants issued for convertible promissory notes conversion  $-   $1,315,494   $-   $1,315,494 

 

In connection with our acquisition of Gemini, we used the Level 2 inputs in estimating the fair value of the transaction. Please refer to Note 14.

 

Inventories

 

We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Property and Equipment

 

We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income or expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.

 

We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.

 

Compensated Absences

 

We accrue a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General (“ASC 710”).

 

Research and Development

 

To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.

 

Excise Tax

 

As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an 11% excise tax for all products sold into these channels. During the years ended March 31, 2023, 2022, and 2021, we recognized approximately $9.8 million, $14.6 million, and $4.3 million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of goods sold.

 

Stock-Based Compensation

 

We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”). Which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors. We measure stock compensation based on reference to the closing fair market value of our Common Stock on the date of grant. Stock-based compensation is recognized on a straight line basis over the vesting periods and forfeitures are recognized in the periods they occur.

 

Concentrations of Credit Risk

 

Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of March 31, 2023, our bank account balances exceeded federally insured limits, however, we have not incurred losses related to these deposits.

 

Income Taxes

 

We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Contingencies

 

Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed.

 

On September 24, 2019, the Company received notice that a former employee that had voluntarily terminated filed a complaint against the Company, and certain individuals, with the U.S. Department of Labor (“DOL”). The Complaint in alleges that the individual reported potential violations of SEC rules and regulations by management and that as a result of such disclosures, the individual experienced a hostile work environment; that the Company lacks sufficient internal controls, and that the individual was the victim of retaliation and constructive discharge after being removed as a director by majority vote of the shareholders. The claims were investigated by a newly appointed Special Investigative Committee made up of independent directors represented by special independent legal counsel. The Special Investigative Committee and legal counsel found the material claims were unsubstantiated, including those concerning alleged SEC violations, and recommended enhancements to certain corporate governance charter documents and processes which the Company promptly implemented. The parties participated in a successful mediation at the end of June 2022 and all matters relating to this former employee/claimant were confidentially resolved with the lawsuit dismissed with prejudice.  The settlement was covered by our Employment Practices Liability Policy and did not amount to a material amount.

 

On February 10, 2022, AMMO filed a Texas state court complaint against Expansion Industries pursing eight (8) claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e., Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO has since moved aggressively to further the process, including successfully garnishing a portion of the deposit monies in Expansion bank accounts, filing a Motion for Summary Judgement, continuing to pursue written discovery, and amending the Complaint to add Expansion principal as an individual party. The putative primer manufacturer settled the two related lawsuits in September 2022 by repaying all deposit monies due AMMO, in addition to payment of principally all fees and costs incurred by the Company in pursuit of the resolution. The principal lawsuit and AMMO’s garnishment action adverse the defendant were dismissed with prejudice.

 

Along with countless other suppliers of Remington Outdoors, AMMO was served with an avoidance claim lawsuit by the bankruptcy trustee. AMMO presented substantial “ordinary course” defense evidence to the Trustee and the case was settled for a nominal sum in September 2022, with the lawsuit dismissed with prejudice.

 

AMMO is defending two contract arbitration cases adverse former employees that are presently in discovery, one involving an employee terminated for cause and the second action involving a termination without cause wherein the former employee is seeking contract wages, commissions and allegedly earned common stock. Discovery is ongoing at this time in the employment arbitration matters. While discovery continues, the Company received a favorable ruling on a partial motion for summary judgment in the “for cause” arbitration case wherein the arbitrator ruled the employee had stolen funds and thus granted the Company’s dispositive motion.

 

The Company also received notice in October 2022 that an OSHA whistleblower complaint had been filed with the US Department of Labor by an employee that had been terminated for cause. The regulatory filing was received after AMMO refused to capitulate to the former employee’s demands. AMMO has produced documents and submitted its position statement to OSHA and the matters is currently pending at the agency level.

 

On April 30, 2023, Director and shareholder Steve Urvan filed suit in the Delaware Chancery Court against the Company, certain Directors, former directors, employees, former employees and consultants, seeking rescission of the Company’s acquisition of GunBroker.com and certain affiliated companies. Plaintiff Urvan’s claims include rescission, misrepresentation and fraud. The Company is currently in communications with its insurance carriers as concerns coverage (defense and indemnification), has engaged counsel and formal/legal service of process is being coordinated at this time. The Company and named defendants are in alignment in all respects, reasonably believe at this date that the claims are without merit and the Company has engaged Delaware Chancery Court litigation specialists to defend its interests in all respects in this case. There were no other known contingencies at March 31, 2023 and 2022.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Recent Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit loss (“CECL”) methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The guidance should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. The guidance is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. We anticipate that this ASC will not have a material effect on the Company’s financial statements.

 

In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires specific disclosures for equity securities subject to contractual sale restrictions. These changes will become effective for the Company on April 1, 2024, with early adoption permitted. We are currently evaluating the potential impact of these changes.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

XML 26 R10.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME/(LOSS) PER COMMON SHARE
12 Months Ended
Mar. 31, 2023
Net Income/(Loss) per share  
INCOME/(LOSS) PER COMMON SHARE

NOTE 3 – INCOME/(LOSS) PER COMMON SHARE

 

We calculate basic income/(loss) per share using the weighted-average number of shares of common stock outstanding during each reporting period. Diluted loss per share includes potentially dilutive securities, such as outstanding options and warrants. We use the treasury stock method, in the determination of dilutive shares outstanding during each reporting period. We have issued warrants to purchase 2,460,946 shares of common stock. Due to the loss from operations in the year ended March 31, 2023, there are no common shares added to calculate the dilutive loss per share for that period as the effect would be antidilutive. The Company excluded warrants of 2,406,946 for the year ended March 31, 2023 and warrants of 150,000 and equity incentive awards of 20,000 for the year ended March 31, 2022, from the weighted average diluted common shares outstanding because their inclusion would have been antidilutive.

 

   2023     2022     2021 
   For the Year Ended
March 31,
 
   2023   2022     2021 
                 
Numerator:                  
Net income/(loss)  $(4,596,038)  $ 33,247,436     $(7,182,294)
Less: Preferred stock dividends   (3,105,034)    (2,668,648 )    - 
Net income/(loss) attributable to common stockholders  $(7,701,072)  $ 30,578,788     $(7,182,294)
                   
Denominator:                  
Weighted averaged shares of common stock - basic   117,177,885     112,328,680      55,041,502 
Effect of dilutive common stock purchase warrants   -     1,861,040      - 
Effect of dilutive equity incentive awards   -     -      - 
Weighted average shares of common stock - Diluted   117,177,885     114,189,720      55,041,502 
                   
Basic earnings per share:                  
Income/(loss) per share attributable to common stockholders - basic  $(0.07)  $ 0.27     $(0.14)
                   
Diluted earnings per share:                  
Income/(loss) per share attributable to common stockholders - diluted  $(0.07)  $ 0.27     $(0.14)

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 27 R11.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE
12 Months Ended
Mar. 31, 2023
Credit Loss [Abstract]  
ACCOUNTS RECEIVABLE

NOTE 4 – ACCOUNTS RECEIVABLE

 

Our net accounts receivable are summarized as follows:

 

           
   March 31, 2023   March 31, 2022 
Accounts receivable  $32,592,931   $47,010,336 
Less: allowance for doubtful accounts   (3,246,551)   (3,055,252)
Accounts receivable, net  $29,346,380   $43,955,084 

 

The following presents a reconciliation of our allowance for doubtful accounts for the periods presented:

 

March 31, 2021  $148,540 
Increase in allowance   2,903,304 
Write-off of uncollectible amounts   (12,703)
Purchase accounting   16,111 
March 31, 2022   3,055,252 
Increase in allowance   2,160,323 
Write-off of uncollectible amounts   (1,969,024)
March 31, 2023  $3,246,551 

 

XML 28 R12.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES
12 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
INVENTORIES

NOTE 5 – INVENTORIES

 

At March 31, 2023 and March 31, 2022, the inventory balances are composed of:

 

   March 31, 2023   March 31, 2022 
Finished product  $14,362,514   $6,167,318 
Raw materials   23,898,596    33,924,813 
Work in process   16,083,709    18,924,021 
           
Inventory net  $54,344,819   $59,016,152 

 

XML 29 R13.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY, PLANT AND EQUIPMENT
12 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT

NOTE 6 – PROPERTY, PLANT AND EQUIPMENT

 

Property and equipment consisted of the following at March 31, 2023 and March 31, 2022:

 

   March 31, 2023   March 31, 2022 
Leasehold Improvements  $257,009   $257,009 
Building and Improvements   28,623,329    - 
Furniture and Fixtures   384,650    343,014 
Vehicles   153,254    153,254 
Equipment   40,233,186    32,524,850 
Tooling   143,710    143,710 
Construction in Progress   734,781    14,335,371 
Total property and equipment  $70,529,919   $47,757,208 
Less accumulated depreciation   (14,566,664)   (10,119,402)
Net property and equipment   55,963,225    37,637,806 

 

Depreciation Expense for the years ended March 31, 2023, 2022, and 2021 totaled $4,452,908, $4,266,126, and $2,904,968, respectively. Of these totals $3,747,723, $3,101,929, and $2,674,161 were included in cost of goods sold for the years ending March 31, 2023, 2022, and 2021. Additionally, $705,185, $1,164,197, and $230,797 were included in depreciation and amortization expenses in operating expenses.

 

XML 30 R14.htm IDEA: XBRL DOCUMENT v3.23.1
FACTORING LIABILITY
12 Months Ended
Mar. 31, 2023
Factoring Liability  
FACTORING LIABILITY

NOTE 7 – FACTORING LIABILITY

 

On July 1, 2019, we entered into a Factoring and Security Agreement with Factors Southwest, LLC (“FSW”). FSW may purchase from time to time the Company’s Accounts Receivables with recourse on an account by account basis. The twenty-four month agreement contains a maximum advance amount of $5,000,000 on 85% of eligible accounts and has an annualized interest rate of the Prime Rate published from time to time by the Wall Street Journal plus 4.5%. The agreement a contains fee of 3% ($150,000) of the Maximum Facility assessed to the Company. Our obligations under this agreement are secured by present and future accounts receivables and related assets, inventory, and equipment. The Company has the right to terminate the agreement, with 30 days written notice, upon obtaining a non-factoring credit facility. This agreement provides the Company with the ability to convert our account receivables into cash. We did not have an outstanding balance on our Factoring liability as of March 31, 2023. As of March 31, 2022, the outstanding balance of the Factoring Liability was $485,671. Interest expense recognized on the Factoring Liability for the year ended March 31, 2023 was $153,646, including $37,500 of amortization of the commitment fee, for the year ended March 31, 2022, $327,746, including $100,000 of amortization of the commitment fee, for the year ended March 31, 2021, $305,747, including $50,000 of amortization of the commitment fee.

 

On June 17, 2021, this agreement was amended which extended the maturity date to June 17, 2024.

 

XML 31 R15.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY CREDIT FACILITY
12 Months Ended
Mar. 31, 2023
Inventory Credit Facility  
INVENTORY CREDIT FACILITY

NOTE 8 – INVENTORY CREDIT FACILITY

 

On June 17, 2020, we entered into a Revolving Inventory Loan and Security Agreement with FSW. FSW will establish a revolving credit line, and make loans from time to time to the Company for the purpose of providing capital. The twenty-four month agreement secured by our inventory, among other assets, contains a maximum loan amount of $1,750,000 on eligible inventory and has an annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%. The agreement contains a fee of 2% of the maximum loan amount ($35,000) assessed to the Company. On July 31, 2020, the Company amended its Revolving Loan and Security Agreement to increase the maximum inventory loan amount to $2,250,000. As of March 31, 2022, the outstanding balance of the Inventory Credit Facility was $825,675 and no outstanding balance remained as of March 31, 2023. Interest expense recognized on the Inventory Credit Facility for the year ended March 31, 2023 was $6,580, for the year ended March 31, 2022 was $40,940, including $8,561 of amortization of the annual fee, and for the year ended March 31, 2021 was $171,414, including $36,439 of amortization of the annual fee.

 

XML 32 R16.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES
12 Months Ended
Mar. 31, 2023
Leases [Abstract]  
LEASES

NOTE 9 – LEASES

 

We lease office, manufacturing, and warehouse space in Scottsdale, AZ, Atlanta and Marietta, GA, and Manitowoc, WI under contracts we classify as operating leases. None of our leases are financing leases. The Scottsdale lease does not include a renewal option. In August of 2021 we extended the lease of our Atlanta offices through May of 2027, accordingly we increased our Right of Use Assets and Operating Lease Liabilities by $501,125 at September 30, 2021. In January of 2022, we extended the lease of our second Manitowoc, WI location and increased our Right of Use Assets and Operating Lease Liabilities by $308,326. We terminated our lease agreement in our first Manitowoc, WI location during the year ended March 31, 2023. Accordingly, we decreased our Right of Use Assets and Operating Lease Liabilities by $901,076.

 

As of March 31, 2023 and March 31, 2022, total Right of Use Assets were $1,261,634 and $2,791,850, respectively. As of March 31, 2023 and March 31, 2022, total Operating Lease Liabilities were $1,374,224 and $2,922,780, respectively. The current portion of our Operating Lease Liability on March 31, 2023 and March 31, 2022 is $470,734 and $831,429, respectively, and is reported as a current liability. The remaining $903,490 of the total $1,374,224 for the year ended March 31, 2023 and the $2,091,351 of the total $2,922,780 for the year ended March 31, 2022 of the Operating Lease Liability is presented as a long-term liability net of the current portion.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Consolidated lease expense for the year ended March 31, 2023 was $881,171 including $861,777 of operating lease expense and $19,394 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2022 was $1,221,473 including $1,177,589 of operating lease expense and $43,884 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2021 was $844,441 including $742,433 of operating lease expense and $102,008 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals.

 

The weighted average remaining lease term and weighted average discount rate for operating leases were 3.3 years and 10.0%, respectively at March 31, 2023 and were 3.5 years and 10.0%, respectively at March 31, 2022.

 

Future minimum lease payments under non-cancellable leases as of March 31, 2023 are as follows:

 

Years Ended March 31,    
2024  $583,768 
2025   387,214 
2026   351,962 
2027   257,508 
2028   43,660 
Thereafter   - 

Total Lease Payments

   1,624,112 
Less: Amount Representing Interest   (249,888)
Present value of lease liabilities  $1,374,224 

 

XML 33 R17.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE – RELATED PARTY
12 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
NOTES PAYABLE – RELATED PARTY

NOTE 10 – NOTES PAYABLE – RELATED PARTY

 

In connection with the acquisition of the casing division of Jagemann Stamping Company (“JSC”), a $10,400,000 promissory note was executed on March 14, 2020. The promissory note, under which $500,000 was paid on March 25, 2019 using funds raised for the acquisition, had a remaining balance at March 31, 2019 of $9,900,000. On April 30, 2019, the original due date of the note was subsequently extended to April 1, 2020. The note bears interest per annum at approximately 4.6% payable in arrears monthly. In May of 2019, the Company paid $1,500,000 on the balance of the note. The note is secured by all the equipment purchased from JSC. JSC owned at least five percent (5%) of our shares outstanding from March 2019 through March 16, 2021.

 

Post-closing of the transaction, it was made apparent that certain equipment that was agreed to be delivered free and clear by the Seller was not achievable as Seller was not able to purchase equipment that Seller had leased. Accordingly, the remaining value of the promissory note was reduced by $2,596,200. As a result of the change to the purchase price of the transaction, the Company reduced Equipment for a net value of $1,871,306, decreased Other Intangible Assets by $766,068, increased Accounts Receivable by $31,924, and recorded an increase to Deposits for $9,250 worth of equipment that the Company agreed to transfer back to Seller. Consequently, accumulated amortization has decreased by $159,530. Additionally, the Company entered into a lease to gain possession of the assets that were originally to be transferred.

 

On June 26, 2020, the Company, Enlight Group II, LLC (“Enlight”), the Company’s wholly owned subsidiary and JSC entered into a Settlement Agreement pursuant to which the parties mutually agreed to settle all disputes and mutually release each other from liabilities related to the Amended APA occurring prior to June 26, 2020. Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, which was reclassed from accounts payable, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering. Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.

 

As a result of the Settlement Agreement, the Company agreed to forego $1,000,000 in Construction in Progress that the parties had previously agreed to exchange. As a result, the Company recognized a loss in operating expenses for the year ended March 31, 2021.

 

On November 5, 2020, the Company paid $6,000,000 to JSC allocated as follows: (i) payment in full of Note A, representing the balance due from the Company to JSC relating to the acquisition of Jagemann Munition Components in March 2019 and (ii) $592,982 remitted in partial payment of Note B, resulting in the parties’ execution of Amended Note B which has a starting principal balance of $1,687,664 (“Amended Note B”). The Amended Note B principal balance carries a 9% per annum interest rate and is amortized equally over the thirty six (36) month term. As a result of the payment in full of Note A JSC shall release the accompanying security interest in Company assets which secured Note A. Concurrently, upon entry into Amended Note B, JSC and the Company entered into the First Amendment to General Business Security Agreement to reflect a revised list of collateral in which JSC has a security interest. The total interest expense recognized on Note A was $216,160 for the year ended March 31, 2021. The total interest expense recognized on the original Note B was $62,876 for the year ended March 31, 2021.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company’s balance of Amended Note B was $180,850 at March 31, 2023 and $865,771 at March 31, 2022. The Company recognized $48,665, $110,518, and $60,100 in interest expense on Amended Note B for the years ended March 31, 2023, 2022, and 2021, respectively.

 

On May 3, 2019, the Company entered into a promissory note of $375,000 with a shareholder of the Company. The original interest rate was the applicable LIBOR Rate. The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020. The amended note bears interest at 1.25% per month. The Company made $18,195 in principal payments during the nine months ended December, 2020 and the Note was paid in full in July of 2020. We recognized $10,327 of interest expenses related to the note during the year ended March 31, 2021.

 

In December of 2019, the Company entered into a Promissory Note of $90,000 with Fred Wagenhals, the Company’s Chief Executive Officer and Chairman of the Board of Directors. The Note originally matured on June 12, 2020 and had an interest rate at the applicable LIBOR Rate. The promissory note has since been amended and the amended maturity date is September 18, 2020. The Company made $25,000 in principal payments during the year ended March 31, 2021 and the Note was paid in full in July of 2020. The amended note bears interest at 1.25% per month. We recognized $5,350 of interest expense on the note for the year ended March 31, 2021.

 

On September 23, 2020, the Company and Enlight entered into a promissory note (the “Forest Street Note”) with Forest Street, LLC (“Lender”), an Arizona limited liability company wholly owned by our current Chief Executive Officer, Fred Wagenhals, for the principal sum of $3.5 million, which accrues interest at 12% per annum. The Note has a maturity date of September 23, 2022.

 

Pursuant to the terms of the Forest Street Note, the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.

 

On December 14, 2020, the Company entered into a Debt Conversion Agreement with the Lender Pursuant to the Agreement, the Company and Forest Street agreed to convert $2,100,000 of the Note’s principal into 1,000,000 shares of the Company’s common stock. The share issuance occurred on December 15, 2020. As a result of the Debt Conversion Agreement the remaining balance of the Forest Street Note was $1,400,000. On January 14, 2021, the Company paid the remaining $1,400,000 in principal and accrued interest of the Forest Street Note. The Company recognized $137,666 in interest expense related to the Forest Street Note for the year ended March 31, 2021.

 

On January 22, 2021, the Company repurchased 1,000,000 shares of the Company’s common stock issued to JSC at a price of $1.50 per share pursuant to the Amended APA.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 34 R18.htm IDEA: XBRL DOCUMENT v3.23.1
CONSTRUCTION NOTE PAYABLE
12 Months Ended
Mar. 31, 2023
Construction Note Payable  
CONSTRUCTION NOTE PAYABLE

NOTE 11 – CONSTRUCTION NOTE PAYABLE

 

On October 14, 2021, we entered into a Construction Loan Agreement (the “Loan Agreement”) with Hiawatha National Bank (“Hiawatha”). The Loan Agreement specifies that Hiawatha may lend up to $11,625,000 to the Borrower to pay a portion of the construction costs of an approximately 160,000 square foot manufacturing facility to be constructed on our property (the “Loan”). The first advance of Loan funds by Hiawatha was made on October 14, 2021 in the amount of $329,843. We received advances of Loan funds approximately every month as our “owner’s equity” was fully funded into the ongoing new plant construction project. The Loan is an advancing term loan and not a revolving loan so any portion of the principal repaid cannot be reborrowed.

 

Additionally, on October 14, 2021, we issued a Promissory Note in favor of Hiawatha (the “Note”) in the amount of up to $11,625,000 with an interest rate of four and one-half percent (4.5%). The maturity date of the Note is October 14, 2026. Under the terms of the Loan Agreement, we are required to make monthly payments of $64,620 which consists of principial and interest until the maturity date, at which time the remaining principial balance of the Loan would become due.

 

We can prepay the Note in whole or in part starting in July 2022 with a prepayment premium of one percent (1%) of the principal being prepaid.

 

The Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Loan Agreement or Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of five percent (5%) of the amount due will be owed with all amounts then owed pursuant to the Note bearing interest at an increased rate.

 

For the year ended March 31, 2023 approximately $11.2 million of Loan funds were advanced including $1.0 million of cash collateral or restricted cash as security for the Loan. We made $150,743 in principal payments for the year ended March 31, 2023. The restricted cash can be released per the terms documented in the Loan Agreement filed with the Commission on Form 10-Q on February 14, 2022. During the year ended March 31, 2023, $500,000 of restricted cash was released to the Company.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 35 R19.htm IDEA: XBRL DOCUMENT v3.23.1
CAPITAL STOCK
12 Months Ended
Mar. 31, 2023
Equity [Abstract]  
CAPITAL STOCK

NOTE 12 – CAPITAL STOCK

 

Our authorized capital consists of 200,000,000 shares of common stock with a par value of $0.001 per share.

 

During the year ended March 31, 2021, we issued 47,895,828 shares of common stock as follows:

 

  34,512,143 shares were sold to investors for $138,564,619
  3,145,481 shares were issued for the conversion of convertible promissory notes for $4,831,206
  6,521,563 shares were issued to investors for exercised warrants valued for $13,952,336
  732,974 shares were issued for cashless exercise of 1,300,069 warrants
  1,000,000 shares were issued pursuant to a debt conversion agreement for $2,100,000
  943,336 shares were issued for services provided to the Company valued at $1,707,500
  1,016,331 shares valued at $1,450,359 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation
  24,000 shares were issued to investors for $48,000 in liquidation damage fees
  1,000,000 shares were repurchased from JSC for a total value of $1,500,000 and subsequently cancelled

 

During the year ended March 31, 2022, we issued 23,385,780 shares of common stock as follows:

 

  20,000,000 shares were issued in connection with our merger of Gemini Direct Investments, LLC valued at $142,691,282
  431,080 shares were issued to investors for exercised warrants valued for $943,907
  374,584 shares were issued for cashless exercise of 443,110 warrants
  772,450 shares valued at $1,631,701 were issued for services and equipment provided to the Company
  1,807,666 shares valued at $5,759,000 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation

 

During the year ended March 31, 2023, we issued 2,077,059 shares of common stock as follows:

 

  200,003 shares were issued to investors for exercised warrants valued for $101,506
  99,762 shares were issued for cashless exercise of 100,000 warrants
  1,777,294 shares valued at $5,807,779 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation

 

At March 31, 2023, 2022, and 2021 outstanding and exercisable stock purchase warrants consisted of the following:

SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2020   8,504,372   $2.10    3.60 
Granted   2,925,204    2.31    2.47 
Exercised   (7,821,631)   2.08    - 
Forfeited or cancelled   -    -    - 
Outstanding at March 31, 2021   3,607,945   $2.31    3.24 
Exercisable at March 31, 2021   3,179,730   $2.27    3.05 

 

SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2021   3,607,945   $2.31    3.24 
Granted   200,000    0.01    3.92 
Exercised   (874,190)   1.76    - 
Forfeited or cancelled   -    -    - 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Exercisable at March 31, 2022   2,933,755   $2.32    2.29 

 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Granted   150,000    0.01    4.5 
Exercised   (300,003)   0.34    - 
Forfeited or cancelled   (322,806)   2.00    - 
Outstanding at March 31, 2023   2,460,946   $2.46    1.59 
Exercisable at March 31, 2023   2,460,946   $2.46    1.59 

 

As of March 31, 2023, we had 2,460,946 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,448,758 shares of our Common Stock at an exercise price of $2.00 per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.

 

XML 36 R20.htm IDEA: XBRL DOCUMENT v3.23.1
PREFERRED STOCK
12 Months Ended
Mar. 31, 2023
Equity [Abstract]  
PREFERRED STOCK

NOTE 13 – PREFERRED STOCK

 

On May 18, 2021, the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, voting powers, limitations as to dividends or other distributions, qualifications, terms and conditions of redemption and other terms and conditions of the Series A Preferred Stock.

 

The Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”), as to dividend rights and rights as to the distribution of assets upon the Company’s liquidation, dissolution or winding-up, ranks: (1) senior to all classes or series of Common Stock and to all other capital stock issued by the Company expressly designated as ranking junior to the Series A Preferred Stock; (2) on parity with any future class or series of the Company’s capital stock expressly designated as ranking on parity with the Series A Preferred Stock; (3) junior to any future class or series of the Company’s capital stock expressly designated as ranking senior to the Series A Preferred Stock; and (4) junior to all the Company’s existing and future indebtedness.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Series A Preferred Stock has no stated maturity and is not subject to mandatory redemption or any sinking fund. In the event of the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of shares for the Series A Preferred Stock are entitled to be paid out of the Company’s assets legally available for distribution to its stockholders (i.e., after satisfaction of all the Company’s liabilities to creditors, if any) an amount equal to $25.00 per share of the Series A Preferred Stock, plus any amount equal to any accumulated and unpaid dividends to the date of payment before any distribution or payment may be made to holders of shares of Common Stock or any other class of or series of the Corporation’s capital stock ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Stock.

 

The Company will pay cumulative cash dividends on the Series A Preferred Stock when, as and if declared by its board of directors (or a duly authorized committee of its board of directors), only out of funds legally available for payment of dividends. Dividends on the Series A Preferred Stock will accrue on the stated amount of $25.00 per share of the Series A Preferred Stock at a rate per annum equal to 8.75% (equivalent to $2.1875 per year), payable quarterly in arrears. Dividends on the Series A Preferred Stock declared by our board of directors (or a duly authorized committee of our board of directors) will be payable quarterly in arrears on March 15, June 15, September 15 and December 15.

 

Generally, the Series A Preferred Stock is not redeemable by the Company prior to May 18, 2026. However, upon a change of control or delisting event (each as defined in the Certificate of Designations), the Company will have a special option to redeem the Series A Preferred Stock for a limited period of time.

 

On May 19, 2021, we entered into an underwriting agreement (the “Underwriting Agreement”) with Alexander Capital, L.P., as representative of several underwriters (collectively, the “Underwriters”), relating to a firm commitment public offering of 1,097,200 newly issued shares of our 8.75% Series A Preferred Stock at a public offering price of $25.00 per share. Under the terms of the Underwriting Agreement, we granted the Underwriters a 45-day option to purchase up to an additional 164,580 shares of Series A Preferred Stock from us. The gross proceeds to us from the sale of 1,097,200 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, was $27,430,000. The closing of the offering took place on May 21, 2021.

 

On May 25, 2021, we entered into an additional underwriting agreement with Alexander Capital, L.P. relating to a firm commitment public offering of 138,220 newly issued shares of our Series A Preferred Stock at a public offering price of $25.00 per share. The closing of the offering took place on May 27, 2021. The gross proceeds to us from the sale of 138,220 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, were $3,455,500. Additionally, the Underwriters exercised its previously announced over-allotment option to purchase 164,580 shares of Series A Preferred Stock pursuant to that certain Underwriting Agreement dated May 19, 2021, by and between us and Alexander Capital, L.P., as representative of the several underwriters identified therein. We closed the exercise of the over-allotment option on May 27, 2021. The gross proceeds from the exercise of the over-allotment option were $4,114,500, before deducting underwriting discounts and commissions.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Preferred dividends accumulated as of March 31, 2022 were $144,562. On August 27, 2021 the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning May 21, 2021 (the first issuance date of the Series A Preferred Stock) through and including June 30, 2021 payable on September 15, 2021 to holders of record of Series A Preferred Stock on August 31, 2021 equal to $0.241246528 per share. Dividends totaling $337,745 were paid on September 15, 2021. On November 17, 2021, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning July 1, 2021 through and including December 14, 2021 payable on December 15, 2021 to holders of record of Series A Preferred Stock on November 30, 2021 equal to $1.01475694444444 per share. Dividends totaling $1,420,660 were paid on December 15, 2021. On February 18, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning December 15, 2021 through and including March 14, 2022 payable on March 15, 2022 to holders of record of Series A Preferred Stock on February 28, 2022 equal to $0.546875 per share. Dividends totaling $765,642 were paid on March 15, 2022.

 

Preferred dividends accumulated as of March 31, 2023 were $144,618. On February 17, 2023, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning December 15, 2022 through and including March 14, 2023 payable on March 15, 2023 to holders of record of Series A Preferred Stock on February 28, 2023 equal to $0.546875 per share. Dividends totaling $765,625 were paid on March 15, 2023. On November 18, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning September 15, 2022 through and including December 14, 2022 payable on December 15, 2022 to holders of record of Series A Preferred Stock on November 30, 2022 equal to $0.5529514 per share. Dividends totaling $774,132 were paid on December 15, 2022. On August 17, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning June 15, 2022 through and including September 14, 2022 payable on September 15, 2022 to holders of record of Series A Preferred Stock on August 31, 2022 equal to $0.55902778 per share. Dividends totaling $782,639 were paid on September 15, 2022. On May 12, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning March 15, 2022 through and including June 14, 2022 payable on June 15, 2022 to holders of record of Series A Preferred Stock on May 31, 2022 equal to $0.559027777777778 per share. Dividends totaling $782,639 were paid on June 15, 2022.

 

XML 37 R21.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS
12 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS

NOTE 14 – ACQUISITIONS

 

Gemini Direct Investments, LLC

 

On April 30, 2021 (the “Effective Date”) we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Sub”), Gemini Direct Investments, LLC, a Nevada limited liability company (“Gemini”), and Steven F. Urvan, an individual (the “Seller”), whereby Sub merged with and into Gemini, with Sub surviving the merger as a wholly owned subsidiary of the Company (the “Merger”). At the time of the Merger, Gemini had nine (9) subsidiaries, all of which are related to Gemini’s ownership of the Gunbroker.com business. Gunbroker.com is an on-line auction marketplace dedicated to firearms, hunting, shooting, and related products. The Merger was completed on the Effective Date.

 

In consideration of the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, on the Effective Date, (i) the Company assumed and repaid an aggregate amount of indebtedness of Gemini and its subsidiaries equal to $50,000,000 (the “Assumed Indebtedness”); and, (ii) the issued and outstanding membership interests in Gemini (the “Membership Interests”), held by the Seller, automatically converted into the right to receive (A) $50,000,000 (the “Cash Consideration”), and (B) 20,000,000 shares of common stock of the Company, $0.001 par value per share (the “Stock Consideration”).

 

In connection with the Merger Agreement, the Company and the Seller agreed that the Stock Consideration consisted of: (a) 14,500,000 shares issued without being held in escrow or requiring prior stockholder approval; (b) 4,000,000 shares issued subject to the Pledge and Escrow Agreement; and (c) 1,500,000 shares that will not be issued prior to the Company obtaining stockholder approval for the issuance (the “Additional Securities”).

 

The total estimated consideration consisted of cash payment of $50,000,000 less $1,350,046 of acquired cash, a working capital adjustment of $2,000,000, debt assumption and repayment upon closing of $50,000,000, contingent consideration of $10,755,000 for 1,500,000 Additional Securities, and 18,500,000 shares of AMMO Inc. Common Stock. The shares were valued at $7.17 per share, the five-day average closing price of the Company’s Common Stock immediately preceding the signing of the binding agreement.

 

Pursuant to the Merger Agreement, the Company completed a Post-Closing Adjustment following the close of the Merger equal to the Closing Working Capital minus the Estimated Working Capital at closing of the Merger. Accordingly, the Company received a cash payment of $129,114 and adjusted the $2,000,000 Estimated Working Capital Adjustment in the fair value of the consideration transferred to $1,870,886.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

In accordance with the acquisition method of accounting for business combinations, the assets acquired, and the liabilities assumed have been recorded at their respective fair values. The consideration in excess of the fair values of assets acquired, and liabilities assumed are recorded as goodwill, which we expect to be deductible for tax purposes. The goodwill consists largely of the growth and profitability expected from this Merger.

 

The fair value of the consideration transferred was valued as follows:

 

SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED

      
Cash  $48,649,954 
Working capital adjustment   1,870,886 
Contingent consideration   10,755,000 
Common stock   132,645,000 
Assumed debt   50,000,000 
      
Fair value of consideration transferred    $243,920,840 

 

The allocation for the consideration recorded for the acquisition is as follows:

 

SCHEDULE OF ALLOCATION FOR CONSIDERATION

      
Accounts receivable, net  $17,002,362 
Prepaid expenses   478,963 
Equipment   1,051,980 
Deposits   703,389 
Other Intangible assets(1)   146,617,380 
Goodwill(1)   90,870,094 
Right of use assets - operating leases   612,727 
Accounts payable   (12,514,919)
Accrued expenses   (196,780)
Operating lease liability   (704,356)
      
Total Consideration  $243,920,840 

 

(1) Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.

 

We recorded approximately $1.3 million in transaction costs in the year ended March 31, 2022 related to the above acquisition.

 

Unaudited Pro Forma Results of Operations

 

These pro forma results of operations give effect to the acquisition as if it had occurred on April 1, 2021. Material pro forma adjustments include the removal of approximately $1.8 million of interest expenses and debt discount amortization and the addition of approximately $0.9 million of depreciation and amortization expenses.

 

SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS

INCOME STATEMENT DATA 

For the Year Ended

March 31, 2022

 
     
Net revenues  $248,314,587 
Net income  $37,793,924 

 

The unaudited pro forma condensed combined financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations and financial position that would have been achieved had the acquisition been completed and taken place on the dates indicated or the future consolidated results of operations or financial position of the Company.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 38 R22.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED LIABILITIES
12 Months Ended
Mar. 31, 2023
Payables and Accruals [Abstract]  
ACCRUED LIABILITIES

NOTE 15 – ACCRUED LIABILITIES

 

At March 31, 2023 and March 31, 2022, accrued liabilities were as follows:

 

SCHEDULE OF ACCRUED LIABILITIES

   March 31, 2023   March 31, 2022 
Accrued FAET  $1,808,065   $2,408,318 
Accrued professional fees   736,323    66,000 
Income taxes payable   403,739   1,749,488 
Accrued sales commissions   252,366    932,712 
Unearned revenue   101,593    201,891 
Accrued interest   2,681    4,762 
Accrued payroll   430,344    458,027 
Other accruals   618,243    357,616 
Accrued liabilities  $4,353,354   $6,178,814 

 

XML 39 R23.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 16– RELATED PARTY TRANSACTIONS

 

On November 3, 2022, AMMO, Inc. (the “Company”) entered into a Settlement Agreement (the “Settlement Agreement”) with Steven F. Urvan and Susan T. Lokey (collectively with each of their respective affiliates and associates, the “Urvan Group”).

 

Pursuant to the Settlement Agreement, the Urvan Group has agreed to withdraw its notice of stockholder nomination of its seven director candidates (the “Urvan Candidates”) and its demand to inspect books and records, pursuant to Section 220 of the General Corporation Law of the State of Delaware, and the Company agreed to immediately increase the size of the Board from seven to nine directors and appoint Christos Tsentas and Wayne Walker (each, a “New Director” and the New Directors together with Mr. Urvan, the “Urvan Group Directors”) to the Board to serve as directors with terms expiring at the 2022 annual meeting of stockholders (the “2022 Annual Meeting”). The Company will include the Urvan Group Directors in its director candidates slate for the 2022 Annual Meeting and any subsequent annual meeting of stockholders of the Company occurring prior to the Termination Date (as defined below). The Company has agreed to not increase the size of the Board above nine directors prior to the Termination Date unless the increase is approved by at least seven directors. Mr. Wagenhals will continue to serve as a director and Chairman of the Board.

 

Unless otherwise mutually agreed to in writing by each party, the Settlement Agreement will remain in effect until the date that is the earlier of (i) 30 days prior to the earlier of (A) the deadline set forth in the notice requirements of Federal “Universal Proxy Rules” promulgated under Rule 14a-19(a) and Rule 14a-19(b) under the Securities Exchange Act of 1934, as amended (the “UPR Deadline”) relating to the Company’s 2023 annual meeting of stockholders (the “2023 Annual Meeting”) and (B) any deadline that may be set forth in the Company’s Amended and Restated Certificate of Incorporation (as amended from time to time, the “Certificate”) or Bylaws (the “Bylaws”) following the execution of the Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2023 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2022 Annual Meeting (such date, the “Termination Date”). However, if the Company notifies Mr. Urvan in writing at least 15 days prior to such Termination Date that the Board irrevocably offers to re-nominate the Urvan Group Directors for election at the 2023 Annual Meeting and Mr. Urvan accepts such offer within 15 days of receipt of such notice, the Termination Date will be automatically extended until the earlier of (i) 30 days prior to the earlier of (A) the UPR Deadline relating to the Company’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”) and (B) any deadline that may be set forth in the Certificate or the Bylaws following execution of the Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2024 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2023 Annual Meeting. Notwithstanding the foregoing, the “Termination Date” shall not occur prior to 20 days after Mr. Urvan’s departure from the Board.

 

Pursuant to the Settlement Agreement, the Company will suspend the previously announced separation of Company into Action Outdoor Sports, Inc. and Outdoor Online, Inc., pending the further evaluation of strategic options by the Board. The Company paid approximately $500,000 of the Urvan Group’s costs, fees and expenses per the terms of the Settlement Agreement. Additionally, the Company issued 125,000 shares of Common Stock for a total value of $437,500 to an employee and issued 110,000 shares of Common Stock for a total value of $385,000 to an independent contractor as a result of termination without cause per the terms of the Settlement Agreement.

 

The foregoing summary of the Settlement Agreement does not purport to be complete and is subject to, and qualified in its entirety, by reference to the full text of the Settlement Agreement, a copy of which was previously filed as Exhibit 10.1 in the Form 8-K filed with the SEC on November 7, 2022, and incorporated herein by reference.

 

During the year ended March 31, 2023, we paid $551,916 in service fees to two independent contractors of which $223,333 were created as a result of termination without cause as a result of our Proxy Settlement Agreement. The two independent contractors 141,419 shares of our common stock for a total value of $494,967 in addition to the issuances described in the foregoing paragraphs. We issued 45,000 shares in the aggregate to its advisory committee members for service for a total value of $129,750. Through our acquisition of Gemini, a related party relationship was created through one of our Members of the Board of Directors by ownership of entities that transacts with Gemini. We recognized $215,300 in Marketplace Revenue for the year ended March 31, 2022 that was attributable to that relationship. There was $182,344 included in our Accounts Receivable at March 31, 2023 as a result of this relationship.

 

During the year ended March 31, 2022, we paid $229,083 in service fees to an independent contractor and 60,000 shares in the aggregate to its advisory committee members for service for a total value of $173,000. Through our acquisition of Gemini, a related party relationship was created through one of our Members of the Board of Directors by ownership of an entity that transacts with Gemini. We recognized $1,042,277 in Marketplace Revenue for the year ended March 31, 2022 that was attributable to that relationship. There was $139,164 included in our Accounts Receivable at March 31, 2022 as a result of this relationship.

 

In connection with the acquisition of the casing division of JSC, a promissory note was executed. On April 30, 2019, the note was subsequently extended to April 1, 2020. The note bears interest per annum at approximately 4.6% payable in arrears monthly. On June 26, 2020, the Company extended the promissory note until August 15, 2021. As of March 31, 2021, we accrued interest of $352,157 related to the note. The was paid in full on November 5, 2020. JSC owned at least five percent (5%) of our shares outstanding from March 2019 through March 16, 2021.

 

In October of 2019, it was made apparent that certain equipment that was agreed to be delivered free and clear by the Seller was not achievable as Seller was not able to purchase equipment that Seller had leased. Accordingly, the remaining value of the promissory note was reduced by $2,596,200. As a result of the change to the purchase price of the transaction, the Company reduced Equipment for a net value of $1,871,306, decreased Other Intangible Assets by $766,068, increased Accounts Receivable by $31,924, and recorded an increase to Deposits for $9,250 worth of equipment that the Company agreed to transfer back to Seller. Consequently, accumulated amortization has decreased by $159,530. Additionally, the Company entered into a lease to gain possession of the assets that were originally to be transferred.

 

Through the Administrative and Management Services Agreement the Company with JSC, the Company purchased approximately incurred $2.0 million in inventory support services, and $170,355 of rent expenses for the year ended March 31, 2023. Through the Administrative and Management Services Agreement the Company with JSC, the Company purchased approximately incurred $1.7 million in inventory support services, and $408,852 of rent expenses for the year ended March 31, 2022. For the year ended March 31, 2021, the Company purchased approximately $3.4 million in inventory support services, and incurred $405,171 of rent expenses for the year ended March 31, 2021.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On June 26, 2020, the Company and JSC entered into a Settlement Agreement pursuant to which the parties mutually agreed to settle all disputes and mutually release each other from liabilities related to the Amended APA occurring prior to June 26, 2020. Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering. Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.

 

On November 5, 2020, the Company paid $6,000,000 to JSC allocated as follows: (i) payment in full of Note A, representing the balance due from the Company to JSC relating to the acquisition of Jagemann Munition Components in March 2019 and (ii) $592,982 remitted in partial payment of Note B, resulting in the parties’ execution of Amended Note B which has a starting principal balance of $1,687,664 (“Amended Note B”). The Amended Note B principal balance carries a 9% per annum interest rate and is amortized equally over the thirty six (36) month term. As a result of the payment in full of Note A JSC shall release the accompanying security interest in Company assets which secured Note A. Concurrently, upon entry into Amended Note B, JSC and the Company entered into the First Amendment to General Business Security Agreement to reflect a revised list of collateral in which JSC has a security interest. The total interest expense recognized on Note A $216,160 for the year ended March 31, 2021. The total interest expense recognized on the original Note B was $62,876 for the year ended March 31, 2021.

 

The Company’s balance of Amended Note B was $180,850 and $865,771 at March 31, 2023 and 2022, respectively. The Company recognized $48,665, $110,518, and $60,100 in interest expense on Amended Note B for the years ended March 31, 2023, 2022, and 2021, respectively.

 

On January 22, 2021, the Company repurchased 1,000,000 shares of the Company’s common stock issued to JSC at a price of $1.50 per share pursuant to the Amended APA.

 

On May 3, 2019, the Company entered into a promissory note of $375,000 with a shareholder of the Company. The original interest rate was the applicable LIBOR Rate. The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020. The amended note bears interest at 1.25% per month. The Company made $18,195 in principal payments during the nine months ended December, 2020 and the Note was paid in full in July of 2020. We recognized $10,327 of interest expenses related to the note during the year ended March 31, 2021.

 

In December of 2019, the Company entered into a Promissory Note of $90,000 with Fred Wagenhals, the Company’s Chief Executive Officer and Chairman of the Board of Directors. The Note originally matured on June 12, 2020 and had an interest rate at the applicable LIBOR Rate. The promissory note has since been amended and the amended maturity date is September 18, 2020. The Company made $25,000 in principal payments during the year ended March 31, 2021 and the Note was paid in full in July of 2020. The amended note bears interest at 1.25% per month. We recognized $5,350 of interest expense on the note for the year ended March 31, 2021.

 

On September 23, 2020, the Company and Enlight entered into a promissory note (the “Forest Street Note”) with Forest Street, LLC (“Lender”), an Arizona limited liability company wholly owned by our current Chief Executive Officer, Fred Wagenhals, for the principal sum of $3.5 million, which accrues interest at 12% per annum. The Note has a maturity date of September 23, 2022.

 

Pursuant to the terms of the Forest Street Note, the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.

 

On December 14, 2020, the Company entered into a Debt Conversion Agreement with the Lender Pursuant to the Agreement, the Company and Forest Street agreed to convert $2,100,000 of the Note’s principal into 1,000,000 shares of the Company’s common stock. The share issuance occurred on December 15, 2020. As a result of the Debt Conversion Agreement the remaining balance of the Forest Street Note was $1,400,000. On January 14, 2021, the Company paid the remaining $1,400,000 in principal and accrued interest of the Forest Street Note. The Company recognized $137,666 in interest expense related to the Forest Street Note for the year ended March 31, 2021.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 40 R24.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 17 – INCOME TAXES

 

The income tax (provision) benefit for the periods shown consist of the following:

 

   2023   2022    2021  
Current                  
US Federal  $-   $(1,302,811)     -  
US State   -    (446,677)     -  
Total current provision   -    (1,749,488)     -  
Deferred                  
US Federal   (578,679)   (7,727,011)     582,724  
US State   (151,559)   (2,649,261)     137,276  
Total deferred benefit   (730,238)   (10,376,272)     720,000  
Change in valuation allowance   -    8,839,791      (720,000 )
Income tax (provision) benefit  $(730,238)  $(3,285,969)     -  

 

The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision is as follows:

 

   2023   2022    2021  
Computed tax expense  $21%  $21%     21 %
State taxes, net of Federal income tax benefit   6%   7%     5 %
Change in valuation allowance   0%   24%     (10 )%
Employee stock awards   (40)%   4%     (5 )%
Stock grants   (2)%   0%     (1 )%
Stock for services   0%   0%     (6 )%
Other   1%   0%     0 %
Non-deductible meals & entertainment   0 %   0%     0 %
Contingent consideration fair value   1%   1%     0 %
Stock and Warrants on Note Conversion   (5)%   1%     (4 )%
Total provision for income taxes  $(18)%  $9%     0 %

 

The Company’s effective tax rates was (18%) for the year ended March 31, 2023. During the year ended March 31, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to Employee stock awards.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Significant components of the Company’s deferred tax liabilities and assets are as follows:

 

   2023   2022 
Deferred tax assets          
Net operating loss carryforward  $871,331   $- 
Loss on purchase   826,311    879,319 
Other   -    - 
Total deferred tax assets  $1,697,642   $879,319 
           
Deferred tax liabilities          
Depreciation expense  $(2,906,214)  $(2,208,361)
Other   (1,101,020)   (207,439)
Total deferred tax liabilities  $(4,007,234)  $(2,415,800)
Net deferred tax assets/(liabilities)  $(2,309,592)  $(1,536,481)
Valuation allowance   -    - 
Net deferred tax assets/(liabilities)  $(2,309,592)  $(1,536,481)

 

The Company accounts for uncertain tax positions in accordance with ASC No. 740-10-25. ASC No. 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC No. 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. To the extent that the final tax outcome of these matters is different than the amount recorded, such differences impact income tax expense in the period in which such determination is made. Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. ASC No. 740-10-25 also requires management to evaluate tax positions taken by the Company and recognize a liability if the Company has taken uncertain tax positions that more likely than not would not be sustained upon examination by applicable taxing authorities. The Company has evaluated tax positions taken by the Company and has concluded that as of March 31, 2023 and 2022, there are no uncertain tax positions taken, or expected to be taken, that would require recognition of a liability that would require disclosure in the financial statements.

 

The Company has never had an Internal Revenue Service audit; therefore, the tax periods ended December 31, 2016, December 31, 2017 and March 31, 2018, 2019, 2020, 2021, 2022, and 2023 are subject to audit.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 41 R25.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLE ASSETS
12 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS

NOTE 18 – GOODWILL AND INTANGIBLE ASSETS

 

During our fiscal year ended March 31, 2022, we recorded $90,870,094 of Goodwill generated from our Merger with Gemini. The balance of Goodwill at March 31, 2023 and 2022 was $90,870,094. We did not have any goodwill prior to the year ended March 31, 2022.

 

Total amortization expense of our intangible assets was $13,072,967, $13,072,967 and $1,971,188 for the years ended March 31, 2023, 2022, and 2021, respectively.

 

Intangible assets consisted of the following:

 

      March 31, 2023 
   Life  Licenses   Patent   Other Intangible Assets 
Licensing Agreement – Jesse James  5  $125,000   $-   $- 
Licensing Agreement – Jeff Rann  5   125,000    -    - 
Streak Visual Ammunition patent  11.2   -    950,000    - 
SWK patent acquisition  15   -    6,124,005    - 
Jagemann Munition Components:                  
Customer Relationships  3   -    -    1,450,613 
Intellectual Property  3   -    -    1,543,548 
Tradename  5   -    -    2,152,076 
GDI Acquisition:                  
Tradename  15   -    -    76,532,389 
Customer List  10   -    -    65,252,802 
Intellectual Property  10   -    -    4,224,442 
Other Intangible Assets  5   -    -    607,747 
       250,000    7,074,005    151,763,617 
                   
Accumulated amortization – Licensing Agreements      (250,000)   -    - 
Accumulated amortization – Patents      -    (2,041,251)   - 
Accumulated amortization – Intangible Assets      -    -    (28,036,807)
      $-   $5,032,754   $123,726,810 

 

      March 31, 2022 
   Life  Licenses   Patent   Other Intangible Assets 
Licensing Agreement – Jesse James  5  $125,000   $-   $- 
Licensing Agreement – Jeff Rann  5   125,000    -    - 
Streak Visual Ammunition patent  11.2   -    950,000    - 
SWK patent acquisition  15   -    6,124,005    - 
Jagemann Munition Components:                  
Customer Relationships  3   -    -    1,450,613 
Intellectual Property  3   -    -    1,543,548 
Tradename  5   -    -    2,152,076 
GDI Acquisition:                  
Tradename  15   -    -    76,532,389 
Customer List  10   -    -    65,252,802 
Intellectual Property  10   -    -    4,224,442 
Other Intangible Assets  5   -    -    607,747 
       250,000    7,074,005    151,763,617 
                   
Accumulated amortization – Licensing Agreements      (250,000)   -    - 
Accumulated amortization – Patents      -    (1,547,787)   - 
Accumulated amortization – Intangible Assets      -    -    (15,463,230)
      $-   $5,526,218   $136,300,387 

 

Annual estimated amortization of intangible assets for the next five fiscal years are as follows:

 

Years Ended March 31,  Estimates for
Fiscal Year
 
2024  $13,102,785 
2025   12,664,775 
2026   12,664,775 
2027   12,553,355 
2028   12,543,226 
Thereafter   65,230,648 
Annual amortization of intangible assets  $128,759,564 

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 42 R26.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENTS
12 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
SEGMENTS

NOTE 19 – SEGMENTS

 

On April 30, 2021, the Company entered into an agreement and plan of merger with Gemini, which, along with its subsidiaries, engages primarily in the operation of an online marketplace dedicated to firearms, hunting, shooting and related products. As a result, at March 31, 2023, our Chief Executive Officer reviews financial performance based on two operating segments as follows:

 

  Ammunition – which consists of our manufacturing business. The Ammunition segment engages in the design, production and marketing of ammunition, ammunition component and related products.
  Marketplace – which consists of the GunBroker.com Ecommerce marketplace. In its role as an auction site, GunBroker.com supports the lawful sale of firearms, ammunition and hunting/shooting accessories.

 

In the current period, we began the reporting of the separate allocation of certain corporate general and administrative expenses including non-cash stock compensation expense, as such we have updated the prior period disclosure herein. The following tables set forth certain financial information utilized by management to evaluate our operating segments for the annual periods presented:

 

   Ammunition   Marketplace   Corporate
and other
expenses
   Total 
   For the Year Ended March 31, 2023 
   Ammunition   Marketplace   Corporate
and other
expenses
   Total 
                 
Net Revenues  $128,290,128   $63,149,673   $-   $191,439,801 
Cost of Revenues   126,914,265    9,116,939    -    136,031,204 
General and administrative expense   10,378,456    9,707,425    25,302,873    45,388,754 
Depreciation and amortization   578,326    12,700,436    -    13,278,762 
Income/(Loss) from Operations  $(9,580,919)  $31,624,873   $(25,302,873)  $(3,258,919)

 

   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
   For the Year Ended March 31, 2022 
   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
                 
Net Revenues  $175,660,650   $64,608,516   $-   $240,269,166 
Cost of Revenues   142,773,306    8,732,351    -    151,505,657 
General and administrative expense   11,932,721    8,434,308    17,544,970    37,911,999 
Depreciation and amortization   1,579,778    12,122,370    -    13,702,148 
Income/(Loss) from Operations  $19,374,845   $35,319,487   $(17,544,970)  $37,149,362 

 

   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
   For the Year Ended March 31, 2021 
   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
                 
Net Revenues  $62,482,330   $              -   $-   $62,482,330 
Cost of Revenues   51,095,679    -    -    51,095,679 
General and administrative expense   4,269,558    -    10,837,834    15,107,392 
Depreciation and amortization   1,659,243    -    -    1,659,243 
Income/(Loss) from Operations  $5,475,850   $-   $10,834,834   $(5,379,984)

 

Total assets by segment were as follows:

 

   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition  $154,044,607   $160,305,107    $ 179,379,341  
Marketplace   258,290,780    253,873,206      -  
   $412,335,387   $414,178,313    $ 179,379,341  

 

Total capital expenditures by segment were as follows:

   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition  $10,819,177   $17,728,023    $ 7,437,265  
Marketplace   1,722,148    1,490,959      -  
   $12,541,325   $19,218,982    $ 7,437,265  

 

XML 43 R27.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENT
12 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENT

NOTE 20 - SUBSEQUENT EVENT

 

Common Stock Issuances

 

Subsequent to March 31, 2023, we issued 25,111 shares of Common Stock to our employees, independent contractors and Members of our Board of Directors as compensation for a total value of $45,346 or $1.81 per share.

 

 

Note Payable Related Party Repayment

 

Subsequent to March 31, 2023, we repaid the remaining outstanding principal balance on Amended Note B.

XML 44 R28.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation and warrant-based compensation.

 

Goodwill

Goodwill

 

We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline it is not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2023. As of March 31, 2023, the Company has a goodwill carrying value of $90,870,094, all of which is assigned to the Marketplace segment. However, due to declines in the value of the Company’s common stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2024.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

For purposes of the consolidated statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

 

Restricted Cash

Restricted Cash

 

We consider cash to be restricted when withdrawal or general use is legally restricted. Our restricted cash balance is comprised of cash on deposit with banks to secure the Construction Loan Agreement as discussed in Note 11. We report restricted cash in the Consolidated Balance Sheets as current or non-current classification based on the expected duration of the restriction.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

 

Our accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts.

 

License Agreements

License Agreements

 

We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

 

We were a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants us through February 2022 the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

 

Patents

Patents

 

On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to AMMO Technologies Inc. pursuant to an Assignment and First Amendment to Exclusive License Agreement. Assumption Agreement dated to be effective as of August 22, 2017, the Merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.

 

Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $0.01 per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the years ended March 31, 2023, 2022, and 2021, the Company recognized royalty expenses of $99,268, $44,764, and $87,093 respectively under this agreement.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

In August 2018, we applied for additional patent coverage for the manufacturing methods or application of the Hybrid Luminescence Ammunition Technology on a variety of projectile and ammunition types. The costs of filing this patent were expensed.

 

On October 5, 2018, we completed the acquisition of SW Kenetics Inc. AMMO Technologies, Inc. succeeded all of the assets of SW Kenetics Inc. and assumed all of the liabilities.

 

The primary asset of SW Kenetics Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to AMMO Technologies, Inc. pursuant to Intellectual Property Rights Agreement on September 27, 2018.

 

We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.

 

Other Intangible Assets

Other Intangible Assets

 

On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement (See Note 18). The intangible assets acquired include a tradename, customer relationships, and intellectual property.

 

On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company. Whereby SpeedLight Group I, LLC merged with and into Gemini Direct Investments, LLC, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company. At the time of the Merger, Gemini Direct Investments, LLC had nine (9) subsidiaries, all of which are related to Gemini’s ownership of GunBroker.com, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software and domain names.

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. No impairment expense was recognized for the years ended March 31, 2023, 2022, and 2021.

 

Revenue Recognition

Revenue Recognition

 

We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

 

  Identification of a contract with a customer
  Identification of the performance obligations in the contact
  Determination of the transaction price
  Allocation of the transaction price to the separate performance allocation
  Recognition of revenue when performance obligations are satisfied

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services it transfers to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.

 

For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.

 

For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized as follows:

 

Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

 

Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.

 

Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.

 

Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.

 

Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.

 

Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.

 

For the years ended March 31, 2023, 2022, and 2021, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:

 

   For the Year Ended
March 31, 2023
   For the Year Ended
March 31, 2022
    For the Year Ended
March 31, 2021
 
PERCENTAGES  Revenues   Accounts Receivable   Revenues  

Accounts

Receivable

    Revenues    

Accounts

Receivable

 
                                 
Customers:                                    
                                         
A   12.2%   -    -    -      16.5 %     23.3 %
B   -    -    -    11.8%     -       -  
C   -    -    -    -      -       11.9 %
D   -    -    -    -      -       10.6 %
    12.2%   -    -    11.8%     16.5 %     45.8 %

 

Disaggregated Revenue Information

 

The following table represent a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types; ammunition, ammunition casings, and marketplace fees. The Company notes that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.

 

                 
   For the Year Ended  
   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition Sales  $114,116,044   $161,459,025    $ 49,620,530  
Marketplace Fee Revenue   63,149,673    64,608,516      -  
Ammunition Casings Sales   14,174,084    14,201,625      12,861,800  
Total Sales  $191,439,801   $240,269,166    $ 62,482,330  

 

Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell direct to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our Gunbroker.com online auction marketplace.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

All sales are recorded upon shipment and, depending on credit worthiness of customer, the payment terms will vary from thirty (30) to sixty (60) days. No refunds are allowed on any product shipped.

 

Each product manufactured by the Company has standard specifications and performance objectives. The Company has an extensive product testing program and, if the Company were given notice of a product defect by a customer, the Company would request the return of the product so that the manufacturing defect could be identified.

 

Advertising Costs

Advertising Costs

 

We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expenses as they are incurred in cost of revenues. We incurred advertising expenses recognized in selling expenses of $1,068,700, $1,406,043, and $257,866 for the years ended March 31, 2023, 2022, and 2021 respectively. We incurred marketplace advertising expenses of 286,479 and $417,017 in cost of revenues for the years ended March 31, 2023 and 2022. We did not have marketplace advertising expenses in cost of revenues for the year ended March 31, 2021.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.

 

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:

 

Level 1 – Quoted prices for identical instruments in active markets;

 

Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

 

Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.

 

We value all common stock issued for services on the date of the agreements, using the price at which shares were being sold to private investors or at the value of the services performed.

 

We valued warrants issued for services at their respective grants dates during the years ended March 31, 2023, 2022, and 2021 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.

 

   March 31, 2023   March 31, 2022   

March 31,

2021

 
                 
Risk free interest rate   3.9%   1.21%-1.74%     0.32%-0.38 %
Expected volatility   77.5%   89.1%-90.7%     88.9%-90.4 %
Expected term   2.5 years    2.5 years      2.5 years  
Expected dividend yield   0%   0%     0 %

 

 

   Quoted
Active
Markets
for
Identified
Assets
   Significant
Other
Observable
Inputs
   Significant
Unobservable
Inputs
   Total 
   (Level 1)   (Level 2)   (Level 3)     
March 31, 2023                    
Warrants issued for services  $-   $427,639   $-   $427,639 
March 31, 2022                    
Warrants issued for services  $-   $1,090,077   $-   $1,090,077 
March 31, 2021                                  
Warrants issued for convertible promissory notes conversion  $-   $1,315,494   $-   $1,315,494 

 

In connection with our acquisition of Gemini, we used the Level 2 inputs in estimating the fair value of the transaction. Please refer to Note 14.

 

Inventories

Inventories

 

We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Property and Equipment

Property and Equipment

 

We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income or expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.

 

We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.

 

Compensated Absences

Compensated Absences

 

We accrue a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General (“ASC 710”).

 

Research and Development

Research and Development

 

To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.

 

Excise Tax

Excise Tax

 

As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an 11% excise tax for all products sold into these channels. During the years ended March 31, 2023, 2022, and 2021, we recognized approximately $9.8 million, $14.6 million, and $4.3 million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of goods sold.

 

Stock-Based Compensation

Stock-Based Compensation

 

We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”). Which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors. We measure stock compensation based on reference to the closing fair market value of our Common Stock on the date of grant. Stock-based compensation is recognized on a straight line basis over the vesting periods and forfeitures are recognized in the periods they occur.

 

Concentrations of Credit Risk

Concentrations of Credit Risk

 

Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of March 31, 2023, our bank account balances exceeded federally insured limits, however, we have not incurred losses related to these deposits.

 

Income Taxes

Income Taxes

 

We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Contingencies

Contingencies

 

Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed.

 

On September 24, 2019, the Company received notice that a former employee that had voluntarily terminated filed a complaint against the Company, and certain individuals, with the U.S. Department of Labor (“DOL”). The Complaint in alleges that the individual reported potential violations of SEC rules and regulations by management and that as a result of such disclosures, the individual experienced a hostile work environment; that the Company lacks sufficient internal controls, and that the individual was the victim of retaliation and constructive discharge after being removed as a director by majority vote of the shareholders. The claims were investigated by a newly appointed Special Investigative Committee made up of independent directors represented by special independent legal counsel. The Special Investigative Committee and legal counsel found the material claims were unsubstantiated, including those concerning alleged SEC violations, and recommended enhancements to certain corporate governance charter documents and processes which the Company promptly implemented. The parties participated in a successful mediation at the end of June 2022 and all matters relating to this former employee/claimant were confidentially resolved with the lawsuit dismissed with prejudice.  The settlement was covered by our Employment Practices Liability Policy and did not amount to a material amount.

 

On February 10, 2022, AMMO filed a Texas state court complaint against Expansion Industries pursing eight (8) claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e., Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO has since moved aggressively to further the process, including successfully garnishing a portion of the deposit monies in Expansion bank accounts, filing a Motion for Summary Judgement, continuing to pursue written discovery, and amending the Complaint to add Expansion principal as an individual party. The putative primer manufacturer settled the two related lawsuits in September 2022 by repaying all deposit monies due AMMO, in addition to payment of principally all fees and costs incurred by the Company in pursuit of the resolution. The principal lawsuit and AMMO’s garnishment action adverse the defendant were dismissed with prejudice.

 

Along with countless other suppliers of Remington Outdoors, AMMO was served with an avoidance claim lawsuit by the bankruptcy trustee. AMMO presented substantial “ordinary course” defense evidence to the Trustee and the case was settled for a nominal sum in September 2022, with the lawsuit dismissed with prejudice.

 

AMMO is defending two contract arbitration cases adverse former employees that are presently in discovery, one involving an employee terminated for cause and the second action involving a termination without cause wherein the former employee is seeking contract wages, commissions and allegedly earned common stock. Discovery is ongoing at this time in the employment arbitration matters. While discovery continues, the Company received a favorable ruling on a partial motion for summary judgment in the “for cause” arbitration case wherein the arbitrator ruled the employee had stolen funds and thus granted the Company’s dispositive motion.

 

The Company also received notice in October 2022 that an OSHA whistleblower complaint had been filed with the US Department of Labor by an employee that had been terminated for cause. The regulatory filing was received after AMMO refused to capitulate to the former employee’s demands. AMMO has produced documents and submitted its position statement to OSHA and the matters is currently pending at the agency level.

 

On April 30, 2023, Director and shareholder Steve Urvan filed suit in the Delaware Chancery Court against the Company, certain Directors, former directors, employees, former employees and consultants, seeking rescission of the Company’s acquisition of GunBroker.com and certain affiliated companies. Plaintiff Urvan’s claims include rescission, misrepresentation and fraud. The Company is currently in communications with its insurance carriers as concerns coverage (defense and indemnification), has engaged counsel and formal/legal service of process is being coordinated at this time. The Company and named defendants are in alignment in all respects, reasonably believe at this date that the claims are without merit and the Company has engaged Delaware Chancery Court litigation specialists to defend its interests in all respects in this case. There were no other known contingencies at March 31, 2023 and 2022.

 

 

AMMO, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit loss (“CECL”) methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The guidance should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. The guidance is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. We anticipate that this ASC will not have a material effect on the Company’s financial statements.

 

In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires specific disclosures for equity securities subject to contractual sale restrictions. These changes will become effective for the Company on April 1, 2024, with early adoption permitted. We are currently evaluating the potential impact of these changes.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

XML 45 R29.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
SCHEDULE OF CONCENTRATION OF RISKS

For the years ended March 31, 2023, 2022, and 2021, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:

 

   For the Year Ended
March 31, 2023
   For the Year Ended
March 31, 2022
    For the Year Ended
March 31, 2021
 
PERCENTAGES  Revenues   Accounts Receivable   Revenues  

Accounts

Receivable

    Revenues    

Accounts

Receivable

 
                                 
Customers:                                    
                                         
A   12.2%   -    -    -      16.5 %     23.3 %
B   -    -    -    11.8%     -       -  
C   -    -    -    -      -       11.9 %
D   -    -    -    -      -       10.6 %
    12.2%   -    -    11.8%     16.5 %     45.8 %
SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT

 

                 
   For the Year Ended  
   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition Sales  $114,116,044   $161,459,025    $ 49,620,530  
Marketplace Fee Revenue   63,149,673    64,608,516      -  
Ammunition Casings Sales   14,174,084    14,201,625      12,861,800  
Total Sales  $191,439,801   $240,269,166    $ 62,482,330  
SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES

 

   March 31, 2023   March 31, 2022   

March 31,

2021

 
                 
Risk free interest rate   3.9%   1.21%-1.74%     0.32%-0.38 %
Expected volatility   77.5%   89.1%-90.7%     88.9%-90.4 %
Expected term   2.5 years    2.5 years      2.5 years  
Expected dividend yield   0%   0%     0 %
SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS

 

   Quoted
Active
Markets
for
Identified
Assets
   Significant
Other
Observable
Inputs
   Significant
Unobservable
Inputs
   Total 
   (Level 1)   (Level 2)   (Level 3)     
March 31, 2023                    
Warrants issued for services  $-   $427,639   $-   $427,639 
March 31, 2022                    
Warrants issued for services  $-   $1,090,077   $-   $1,090,077 
March 31, 2021                                  
Warrants issued for convertible promissory notes conversion  $-   $1,315,494   $-   $1,315,494 
XML 46 R30.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME/(LOSS) PER COMMON SHARE (Tables)
12 Months Ended
Mar. 31, 2023
Net Income/(Loss) per share  
SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE

 

   2023     2022     2021 
   For the Year Ended
March 31,
 
   2023   2022     2021 
                 
Numerator:                  
Net income/(loss)  $(4,596,038)  $ 33,247,436     $(7,182,294)
Less: Preferred stock dividends   (3,105,034)    (2,668,648 )    - 
Net income/(loss) attributable to common stockholders  $(7,701,072)  $ 30,578,788     $(7,182,294)
                   
Denominator:                  
Weighted averaged shares of common stock - basic   117,177,885     112,328,680      55,041,502 
Effect of dilutive common stock purchase warrants   -     1,861,040      - 
Effect of dilutive equity incentive awards   -     -      - 
Weighted average shares of common stock - Diluted   117,177,885     114,189,720      55,041,502 
                   
Basic earnings per share:                  
Income/(loss) per share attributable to common stockholders - basic  $(0.07)  $ 0.27     $(0.14)
                   
Diluted earnings per share:                  
Income/(loss) per share attributable to common stockholders - diluted  $(0.07)  $ 0.27     $(0.14)
XML 47 R31.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE (Tables)
12 Months Ended
Mar. 31, 2023
Credit Loss [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLE

Our net accounts receivable are summarized as follows:

 

           
   March 31, 2023   March 31, 2022 
Accounts receivable  $32,592,931   $47,010,336 
Less: allowance for doubtful accounts   (3,246,551)   (3,055,252)
Accounts receivable, net  $29,346,380   $43,955,084 

 

The following presents a reconciliation of our allowance for doubtful accounts for the periods presented:

 

March 31, 2021  $148,540 
Increase in allowance   2,903,304 
Write-off of uncollectible amounts   (12,703)
Purchase accounting   16,111 
March 31, 2022   3,055,252 
Increase in allowance   2,160,323 
Write-off of uncollectible amounts   (1,969,024)
March 31, 2023  $3,246,551 
XML 48 R32.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES (Tables)
12 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

At March 31, 2023 and March 31, 2022, the inventory balances are composed of:

 

   March 31, 2023   March 31, 2022 
Finished product  $14,362,514   $6,167,318 
Raw materials   23,898,596    33,924,813 
Work in process   16,083,709    18,924,021 
           
Inventory net  $54,344,819   $59,016,152 
XML 49 R33.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY, PLANT AND EQUIPMENT (Tables)
12 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at March 31, 2023 and March 31, 2022:

 

   March 31, 2023   March 31, 2022 
Leasehold Improvements  $257,009   $257,009 
Building and Improvements   28,623,329    - 
Furniture and Fixtures   384,650    343,014 
Vehicles   153,254    153,254 
Equipment   40,233,186    32,524,850 
Tooling   143,710    143,710 
Construction in Progress   734,781    14,335,371 
Total property and equipment  $70,529,919   $47,757,208 
Less accumulated depreciation   (14,566,664)   (10,119,402)
Net property and equipment   55,963,225    37,637,806 
XML 50 R34.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Tables)
12 Months Ended
Mar. 31, 2023
Leases [Abstract]  
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES

Future minimum lease payments under non-cancellable leases as of March 31, 2023 are as follows:

 

Years Ended March 31,    
2024  $583,768 
2025   387,214 
2026   351,962 
2027   257,508 
2028   43,660 
Thereafter   - 

Total Lease Payments

   1,624,112 
Less: Amount Representing Interest   (249,888)
Present value of lease liabilities  $1,374,224 
XML 51 R35.htm IDEA: XBRL DOCUMENT v3.23.1
CAPITAL STOCK (Tables)
12 Months Ended
Mar. 31, 2023
Equity [Abstract]  
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS

At March 31, 2023, 2022, and 2021 outstanding and exercisable stock purchase warrants consisted of the following:

SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2020   8,504,372   $2.10    3.60 
Granted   2,925,204    2.31    2.47 
Exercised   (7,821,631)   2.08    - 
Forfeited or cancelled   -    -    - 
Outstanding at March 31, 2021   3,607,945   $2.31    3.24 
Exercisable at March 31, 2021   3,179,730   $2.27    3.05 

 

SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2021   3,607,945   $2.31    3.24 
Granted   200,000    0.01    3.92 
Exercised   (874,190)   1.76    - 
Forfeited or cancelled   -    -    - 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Exercisable at March 31, 2022   2,933,755   $2.32    2.29 

 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Granted   150,000    0.01    4.5 
Exercised   (300,003)   0.34    - 
Forfeited or cancelled   (322,806)   2.00    - 
Outstanding at March 31, 2023   2,460,946   $2.46    1.59 
Exercisable at March 31, 2023   2,460,946   $2.46    1.59 

 

As of March 31, 2023, we had 2,460,946 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,448,758 shares of our Common Stock at an exercise price of $2.00 per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.

 

XML 52 R36.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS (Tables)
12 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED

The fair value of the consideration transferred was valued as follows:

 

SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED

      
Cash  $48,649,954 
Working capital adjustment   1,870,886 
Contingent consideration   10,755,000 
Common stock   132,645,000 
Assumed debt   50,000,000 
      
Fair value of consideration transferred    $243,920,840 
SCHEDULE OF ALLOCATION FOR CONSIDERATION

The allocation for the consideration recorded for the acquisition is as follows:

 

SCHEDULE OF ALLOCATION FOR CONSIDERATION

      
Accounts receivable, net  $17,002,362 
Prepaid expenses   478,963 
Equipment   1,051,980 
Deposits   703,389 
Other Intangible assets(1)   146,617,380 
Goodwill(1)   90,870,094 
Right of use assets - operating leases   612,727 
Accounts payable   (12,514,919)
Accrued expenses   (196,780)
Operating lease liability   (704,356)
      
Total Consideration  $243,920,840 

 

(1) Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.
SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS

SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS

INCOME STATEMENT DATA 

For the Year Ended

March 31, 2022

 
     
Net revenues  $248,314,587 
Net income  $37,793,924 
XML 53 R37.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED LIABILITIES (Tables)
12 Months Ended
Mar. 31, 2023
Payables and Accruals [Abstract]  
SCHEDULE OF ACCRUED LIABILITIES

At March 31, 2023 and March 31, 2022, accrued liabilities were as follows:

 

SCHEDULE OF ACCRUED LIABILITIES

   March 31, 2023   March 31, 2022 
Accrued FAET  $1,808,065   $2,408,318 
Accrued professional fees   736,323    66,000 
Income taxes payable   403,739   1,749,488 
Accrued sales commissions   252,366    932,712 
Unearned revenue   101,593    201,891 
Accrued interest   2,681    4,762 
Accrued payroll   430,344    458,027 
Other accruals   618,243    357,616 
Accrued liabilities  $4,353,354   $6,178,814 
XML 54 R38.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF INCOME TAX PROVISION BENEFIT

The income tax (provision) benefit for the periods shown consist of the following:

 

   2023   2022    2021  
Current                  
US Federal  $-   $(1,302,811)     -  
US State   -    (446,677)     -  
Total current provision   -    (1,749,488)     -  
Deferred                  
US Federal   (578,679)   (7,727,011)     582,724  
US State   (151,559)   (2,649,261)     137,276  
Total deferred benefit   (730,238)   (10,376,272)     720,000  
Change in valuation allowance   -    8,839,791      (720,000 )
Income tax (provision) benefit  $(730,238)  $(3,285,969)     -  
SCHEDULE OF RECONCILIATION OF INCOME TAX

The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision is as follows:

 

   2023   2022    2021  
Computed tax expense  $21%  $21%     21 %
State taxes, net of Federal income tax benefit   6%   7%     5 %
Change in valuation allowance   0%   24%     (10 )%
Employee stock awards   (40)%   4%     (5 )%
Stock grants   (2)%   0%     (1 )%
Stock for services   0%   0%     (6 )%
Other   1%   0%     0 %
Non-deductible meals & entertainment   0 %   0%     0 %
Contingent consideration fair value   1%   1%     0 %
Stock and Warrants on Note Conversion   (5)%   1%     (4 )%
Total provision for income taxes  $(18)%  $9%     0 %
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

Significant components of the Company’s deferred tax liabilities and assets are as follows:

 

   2023   2022 
Deferred tax assets          
Net operating loss carryforward  $871,331   $- 
Loss on purchase   826,311    879,319 
Other   -    - 
Total deferred tax assets  $1,697,642   $879,319 
           
Deferred tax liabilities          
Depreciation expense  $(2,906,214)  $(2,208,361)
Other   (1,101,020)   (207,439)
Total deferred tax liabilities  $(4,007,234)  $(2,415,800)
Net deferred tax assets/(liabilities)  $(2,309,592)  $(1,536,481)
Valuation allowance   -    - 
Net deferred tax assets/(liabilities)  $(2,309,592)  $(1,536,481)
XML 55 R39.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
12 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

Intangible assets consisted of the following:

 

      March 31, 2023 
   Life  Licenses   Patent   Other Intangible Assets 
Licensing Agreement – Jesse James  5  $125,000   $-   $- 
Licensing Agreement – Jeff Rann  5   125,000    -    - 
Streak Visual Ammunition patent  11.2   -    950,000    - 
SWK patent acquisition  15   -    6,124,005    - 
Jagemann Munition Components:                  
Customer Relationships  3   -    -    1,450,613 
Intellectual Property  3   -    -    1,543,548 
Tradename  5   -    -    2,152,076 
GDI Acquisition:                  
Tradename  15   -    -    76,532,389 
Customer List  10   -    -    65,252,802 
Intellectual Property  10   -    -    4,224,442 
Other Intangible Assets  5   -    -    607,747 
       250,000    7,074,005    151,763,617 
                   
Accumulated amortization – Licensing Agreements      (250,000)   -    - 
Accumulated amortization – Patents      -    (2,041,251)   - 
Accumulated amortization – Intangible Assets      -    -    (28,036,807)
      $-   $5,032,754   $123,726,810 

 

      March 31, 2022 
   Life  Licenses   Patent   Other Intangible Assets 
Licensing Agreement – Jesse James  5  $125,000   $-   $- 
Licensing Agreement – Jeff Rann  5   125,000    -    - 
Streak Visual Ammunition patent  11.2   -    950,000    - 
SWK patent acquisition  15   -    6,124,005    - 
Jagemann Munition Components:                  
Customer Relationships  3   -    -    1,450,613 
Intellectual Property  3   -    -    1,543,548 
Tradename  5   -    -    2,152,076 
GDI Acquisition:                  
Tradename  15   -    -    76,532,389 
Customer List  10   -    -    65,252,802 
Intellectual Property  10   -    -    4,224,442 
Other Intangible Assets  5   -    -    607,747 
       250,000    7,074,005    151,763,617 
                   
Accumulated amortization – Licensing Agreements      (250,000)   -    - 
Accumulated amortization – Patents      -    (1,547,787)   - 
Accumulated amortization – Intangible Assets      -    -    (15,463,230)
      $-   $5,526,218   $136,300,387 

SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET

Annual estimated amortization of intangible assets for the next five fiscal years are as follows:

 

Years Ended March 31,  Estimates for
Fiscal Year
 
2024  $13,102,785 
2025   12,664,775 
2026   12,664,775 
2027   12,553,355 
2028   12,543,226 
Thereafter   65,230,648 
Annual amortization of intangible assets  $128,759,564 
XML 56 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENTS (Tables)
12 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
SCHEDULE OF OPERATING SEGMENTS

   Ammunition   Marketplace   Corporate
and other
expenses
   Total 
   For the Year Ended March 31, 2023 
   Ammunition   Marketplace   Corporate
and other
expenses
   Total 
                 
Net Revenues  $128,290,128   $63,149,673   $-   $191,439,801 
Cost of Revenues   126,914,265    9,116,939    -    136,031,204 
General and administrative expense   10,378,456    9,707,425    25,302,873    45,388,754 
Depreciation and amortization   578,326    12,700,436    -    13,278,762 
Income/(Loss) from Operations  $(9,580,919)  $31,624,873   $(25,302,873)  $(3,258,919)

 

   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
   For the Year Ended March 31, 2022 
   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
                 
Net Revenues  $175,660,650   $64,608,516   $-   $240,269,166 
Cost of Revenues   142,773,306    8,732,351    -    151,505,657 
General and administrative expense   11,932,721    8,434,308    17,544,970    37,911,999 
Depreciation and amortization   1,579,778    12,122,370    -    13,702,148 
Income/(Loss) from Operations  $19,374,845   $35,319,487   $(17,544,970)  $37,149,362 

 

   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
   For the Year Ended March 31, 2021 
   Ammunition   Marketplace  

Corporate

and other

expenses

   Total 
                 
Net Revenues  $62,482,330   $              -   $-   $62,482,330 
Cost of Revenues   51,095,679    -    -    51,095,679 
General and administrative expense   4,269,558    -    10,837,834    15,107,392 
Depreciation and amortization   1,659,243    -    -    1,659,243 
Income/(Loss) from Operations  $5,475,850   $-   $10,834,834   $(5,379,984)
SCHEDULE OF TOTAL ASSETS SEGMENTS

Total assets by segment were as follows:

 

   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition  $154,044,607   $160,305,107    $ 179,379,341  
Marketplace   258,290,780    253,873,206      -  
   $412,335,387   $414,178,313    $ 179,379,341  
SCHEDULE OF CAPITAL EXPENDITURE SEGMENT

Total capital expenditures by segment were as follows:

   March 31, 2023   March 31, 2022    March 31, 2021  
Ammunition  $10,819,177   $17,728,023    $ 7,437,265  
Marketplace   1,722,148    1,490,959      -  
   $12,541,325   $19,218,982    $ 7,437,265  
XML 57 R41.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND BUSINESS ACTIVITY (Details Narrative) - shares
Mar. 17, 2017
Dec. 15, 2016
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Number of shares sold   475,681
Number of shares issued for pre-split   11,891,976
Reverse stock split   1-for-25 reverse stock split (“Reverse Split”) of the issued and outstanding shares of the common stock of the Company. As a result of the reverse split, the previous issued and outstanding shares of common stock became 580,052 shares; no shareholder was reversed below 100 shares, and all fractional shares resulting from the reverse split were rounded up to the next whole share
Number of shares issued, post reverse split   580,052
Definitive Agreement [Member] | PRIVCO [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Number of common stock shares issued 17,285,800  
Number of shares retired 475,681  
Number of shares issued to satisfy issuance commitment 500,000  
Shares equivalent to issuance recapitalization 604,371  
XML 58 R42.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF CONCENTRATION OF RISKS (Details) - Customer Concentration Risk [Member]
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Revenue Benchmark [Member] | Customer A [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 12.20% 16.50%
Revenue Benchmark [Member] | Customer B [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage  
Revenue Benchmark [Member] | Customer C [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage  
Revenue Benchmark [Member] | Customer D [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage  
Revenue Benchmark [Member] | Customers [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 12.20% 16.50%
Accounts Receivable [Member] | Customer A [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 23.30%
Accounts Receivable [Member] | Customer B [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 11.80%
Accounts Receivable [Member] | Customer C [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage   11.90%
Accounts Receivable [Member] | Customer D [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage   10.60%
Accounts Receivable [Member] | Customers [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 11.80% 45.80%
XML 59 R43.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Product Information [Line Items]      
Total Sales $ 191,439,801 $ 240,269,166 $ 62,482,330
Ammunition Sales [Member]      
Product Information [Line Items]      
Total Sales [1] 114,116,044 161,459,025 49,620,530
Marketplace Fee Revenue [Member]      
Product Information [Line Items]      
Total Sales 63,149,673 64,608,516
Ammunition Casings Sales [Member]      
Product Information [Line Items]      
Total Sales $ 14,174,084 $ 14,201,625 $ 12,861,800
[1] Included in revenue for the years ended March 31, 2023, 2022, and 2021 is excises taxes of $9,789,896, $14,646,983, and $4,286,258, respectively.
XML 60 R44.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details)
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Measurement Input, Risk Free Interest Rate [Member] | Convertible Promissory Note [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages 3.9    
Measurement Input, Risk Free Interest Rate [Member] | Convertible Promissory Note [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages   1.21 0.32
Measurement Input, Risk Free Interest Rate [Member] | Convertible Promissory Note [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages   1.74 0.38
Measurement Input, Price Volatility [Member] | Convertible Promissory Note [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages 77.5    
Measurement Input, Price Volatility [Member] | Convertible Promissory Note [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages   89.1 88.9
Measurement Input, Price Volatility [Member] | Convertible Promissory Note [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages   90.7 90.4
Measurement Input, Expected Term [Member] | Convertible Promissory Note [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages 2 years 6 months 2 years 6 months 2 years 6 months
Measurement Input, Expected Dividend Rate [Member]      
Property, Plant and Equipment [Line Items]      
Fair value assumptions, measurement input, percentages 0 0 0
XML 61 R45.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Platform Operator, Crypto-Asset [Line Items]      
Warrants issued for services $ 427,639 $ 1,090,077  
Warrants issued for convertible promissory notes conversion     $ 1,315,494
Fair Value, Inputs, Level 1 [Member]      
Platform Operator, Crypto-Asset [Line Items]      
Warrants issued for services  
Warrants issued for convertible promissory notes conversion    
Fair Value, Inputs, Level 2 [Member]      
Platform Operator, Crypto-Asset [Line Items]      
Warrants issued for services 427,639 1,090,077  
Warrants issued for convertible promissory notes conversion     1,315,494
Fair Value, Inputs, Level 3 [Member]      
Platform Operator, Crypto-Asset [Line Items]      
Warrants issued for services  
Warrants issued for convertible promissory notes conversion    
XML 62 R46.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Apr. 30, 2021
[1]
Property, Plant and Equipment [Line Items]        
Goodwill $ 90,870,094 $ 90,870,094   $ 90,870,094
Impairment expense $ 0 0 $ 0  
Excise tax percentage 11.00%      
Excise tax amount $ 9,800,000 14,600,000 4,300,000  
Income tax examination, description We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized.      
Maximum [Member]        
Property, Plant and Equipment [Line Items]        
Cash FDIC insured amount $ 250,000      
Selling and Marketing Expense [Member]        
Property, Plant and Equipment [Line Items]        
Advertising expenses 1,068,700 1,406,043 257,866  
Cost of Sales [Member]        
Property, Plant and Equipment [Line Items]        
Advertising expenses $ 286,479 417,017    
Patents [Member] | Exclusive License Agreement [Member]        
Property, Plant and Equipment [Line Items]        
Share price $ 0.01      
Royalty expenses $ 99,268 $ 44,764 $ 87,093  
[1] Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.
XML 63 R47.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Net Income/(Loss) per share      
Net income/(loss) $ (4,596,038) $ 33,247,436 $ (7,182,294)
Less: Preferred stock dividends (3,105,034) (2,668,648)
Net income/(loss) attributable to common stockholders $ (7,701,072) $ 30,578,788 $ (7,182,294)
Weighted averaged shares of common stock - basic 117,177,885 112,328,680 55,041,502
Effect of dilutive common stock purchase warrants 1,861,040
Effect of dilutive equity incentive awards
Weighted average shares of common stock - Diluted 117,177,885 114,189,720 55,041,502
Income/(loss) per share attributable to common stockholders - basic $ (0.07) $ 0.27 $ (0.14)
Income/(loss) per share attributable to common stockholders - diluted $ (0.07) $ 0.27 $ (0.14)
XML 64 R48.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME/(LOSS) PER COMMON SHARE (Details Narrative) - shares
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Weighted average number of shares outstanding, diluted 117,177,885 114,189,720 55,041,502
Warrant [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Warrants to purchase shares 2,460,946    
Weighted average number of shares outstanding, diluted 2,406,946 150,000  
Equity incentive awards [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Weighted average number of shares outstanding, diluted   20,000  
XML 65 R49.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Credit Loss [Abstract]    
Accounts receivable $ 32,592,931 $ 47,010,336
Less: allowance for doubtful accounts (3,246,551) (3,055,252)
Accounts receivable, net 29,346,380 43,955,084
Allowance for doubtful accounts receivable, beginning balance 3,055,252 148,540
Increase in allowance 2,160,323 2,903,304
Write-off of uncollectible amounts (1,969,024) (12,703)
Purchase accounting   16,111
Allowance for doubtful accounts receivable, ending balance $ 3,246,551 $ 3,055,252
XML 66 R50.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INVENTORIES (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Inventory Disclosure [Abstract]    
Finished product $ 14,362,514 $ 6,167,318
Raw materials 23,898,596 33,924,813
Work in process 16,083,709 18,924,021
Inventory net $ 54,344,819 $ 59,016,152
XML 67 R51.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 70,529,919 $ 47,757,208
Less accumulated depreciation (14,566,664) (10,119,402)
Net property and equipment 55,963,225 37,637,806
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 257,009 257,009
Building Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 28,623,329
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 384,650 343,014
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 153,254 153,254
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 40,233,186 32,524,850
Tooling [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 143,710 143,710
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 734,781 $ 14,335,371
XML 68 R52.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY, PLANT AND EQUIPMENT (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]      
Depreciation expense $ 4,452,908 $ 4,266,126 $ 2,904,968
Cost of Sales [Member]      
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]      
Depreciation expense 3,747,723 3,101,929 2,674,161
Operating Expense [Member]      
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]      
Depreciation expense $ 705,185 $ 1,164,197 $ 230,797
XML 69 R53.htm IDEA: XBRL DOCUMENT v3.23.1
FACTORING LIABILITY (Details Narrative) - USD ($)
12 Months Ended
Jun. 17, 2021
Jul. 01, 2019
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Factoring liability       $ 485,671  
Interest expenses on factoring liability     $ 153,646 327,746 $ 305,747
Amortization of commitment fee     $ 37,500 $ 100,000 $ 50,000
Maturity date Jun. 17, 2024        
Factoring and Security Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity   $ 5,000,000      
Line of Credit Facility, Interest Rate During Period   85.00%      
Line of Credit Facility, Commitment Fee Percentage   3.00%      
Line of Credit Facility, Commitment Fee Amount   $ 150,000      
Factoring and Security Agreement [Member] | Prime Rate [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Line of Credit Facility, Interest Rate During Period   4.50%      
XML 70 R54.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY CREDIT FACILITY (Details Narrative) - USD ($)
12 Months Ended
Jun. 17, 2020
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Jul. 31, 2020
Inventory Credit Facility [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Inventory credit facility   $ 825,675      
Interest expense on factoring liability   $ 6,580 $ 40,940 $ 171,414  
Amortization of annual fee     $ 8,561 $ 36,439  
Revolving Inventory Loan and Security Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity $ 35,000       $ 2,250,000
Line of Credit Facility, Interest Rate Description an annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%.        
Line of Credit Facility, Commitment Fee Percentage 2.00%        
Revolving Inventory Loan and Security Agreement [Member] | Eligible Inventory [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity $ 1,750,000        
XML 71 R55.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Jan. 31, 2022
Sep. 30, 2021
Leases [Abstract]        
2024 $ 583,768      
2025 387,214      
2026 351,962      
2027 257,508      
2028 43,660      
Thereafter      
Total Lease Payments 1,624,112      
Less: Amount Representing Interest (249,888)      
Present value of lease liabilities $ 1,374,224 $ 2,922,780 $ 308,326 $ 501,125
XML 72 R56.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Jan. 31, 2022
Sep. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Operating lease, liability $ 1,374,224 $ 2,922,780   $ 308,326 $ 501,125
Right use of asset 1,261,634 2,791,850   308,326 $ 501,125
Operating lease liability, current 470,734 831,429      
Operating lease liability non-current 903,490 2,091,351      
Consolidated lease expense 881,171 1,221,473 $ 844,441    
Operating Lease, Expense 861,777 1,177,589 742,433    
Other Lease Operating Expenses. $ 19,394 $ 43,884 $ 102,008    
Weighted average remaining lease term 3 years 3 months 18 days 3 years 6 months      
Weighted average discount rate for operating leases 10.00% 10.00%      
Lease Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Operating lease, liability       901,076  
Right use of asset       $ 901,076  
XML 73 R57.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE – RELATED PARTY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 17, 2021
Jan. 22, 2021
Jan. 14, 2021
Dec. 14, 2020
Nov. 05, 2020
Sep. 23, 2020
Jun. 26, 2020
Apr. 14, 2020
Mar. 14, 2020
Oct. 31, 2019
May 03, 2019
Apr. 30, 2019
Mar. 31, 2019
Mar. 25, 2019
May 31, 2019
Apr. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2019
Short-Term Debt [Line Items]                                            
Payment of note payable related party                                     $ 4,000,000  
Debt description                       The note bears interest per annum at approximately 4.6% payable in arrears monthly.       The note bears interest per annum at approximately 4.6% payable in arrears monthly            
Principal payments                                     150,743      
Debt instrument maturity date Jun. 17, 2024                                          
Settlement Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Payment of note payable related party         $ 6,000,000                                  
Debt description             Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering.                              
Principal payments             $ 1,269,977                              
Debt instrument maturity date             Aug. 15, 2021                              
Proceeds from advances for construction             $ 1,000,000                              
Post Closing Transaction Note Reduction [Member]                                            
Short-Term Debt [Line Items]                                            
Post-closing changes to the purchase price of transaction                 $ 2,596,200 $ 2,596,200                        
Decreased Equipment Net [Member]                                            
Short-Term Debt [Line Items]                                            
Post-closing changes to the purchase price of transaction                 1,871,306 1,871,306                        
Reduction in Other Intangible Assets [Member]                                            
Short-Term Debt [Line Items]                                            
Post-closing changes to the purchase price of transaction                 766,068 766,068                        
Increased Accounts Receivable [Member]                                            
Short-Term Debt [Line Items]                                            
Post-closing changes to the purchase price of transaction                 31,924 31,924                        
Increase to Deposits [Member]                                            
Short-Term Debt [Line Items]                                            
Post-closing changes to the purchase price of transaction                 9,250 9,250                        
Decreased Accumulated Amortization [Member]                                            
Short-Term Debt [Line Items]                                            
Post-closing changes to the purchase price of transaction                 $ 159,530 $ 159,530                        
Inventory and Services [Member] | Settlement Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Payment of note payable related party             2,635,797                              
Promissory Note [Member]                                            
Short-Term Debt [Line Items]                                            
Debt instrument maturity date description                     the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020                      
Promissory Note [Member] | Shareholder [Member]                                            
Short-Term Debt [Line Items]                                            
Principal payments                                   $ 18,195        
Promissory note                     $ 375,000                      
Debt interest rate                     1.25%                      
Interest expenses                                         10,327  
Debt instrument maturity date description                     The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020.                      
Promissory Note [Member] | Fred Wagenhals [Member]                                            
Short-Term Debt [Line Items]                                            
Principal payments                                         $ 25,000  
Debt instrument maturity date                                 Sep. 18, 2020       Sep. 18, 2020  
Promissory note                                           $ 90,000
Debt interest rate                                         1.25% 125.00%
Interest expenses                                         $ 5,350  
Promissory Note [Member] | Settlement Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Payment of note payable related party             $ 5,803,800                              
Note B [Member] | Settlement Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Payment of note payable related party         592,982                                  
Interest expenses                                         62,876  
Amended Note B [Member]                                            
Short-Term Debt [Line Items]                                            
Interest expenses                                     48,665 110,518 60,100  
Amended Note B [Member] | Related Party [Member]                                            
Short-Term Debt [Line Items]                                            
Promissory note                                     $ 180,850 $ 865,771    
Amended Note B [Member] | Settlement Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Promissory note         $ 1,687,664                                  
Debt interest rate         9.00%                                  
Amended Note B [Member] | Settlement Agreement [Member] | Related Party [Member]                                            
Short-Term Debt [Line Items]                                            
Promissory note         $ 1,687,664                                  
Note A [Member] | Settlement Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Interest expenses                                         216,160  
Jagemann Stamping Company [Member]                                            
Short-Term Debt [Line Items]                                            
Debt description             Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.                              
Debt monthly payments             $ 204,295                              
Debt interest rate                                       4.60%    
Jagemann Stamping Company [Member] | Settlement Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Debt description             upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.                              
Debt instrument maturity date             Apr. 01, 2021                              
Stock repurchased during period, shares             1,000,000                              
Shares issued, price per share             $ 1.50                              
Jagemann Stamping Company [Member] | Amended APA [Member]                                            
Short-Term Debt [Line Items]                                            
Stock repurchased during period, shares   1,000,000                                        
Shares issued, price per share   $ 1.50                                        
Jagemann Stamping Company [Member] | Promissory Note [Member]                                            
Short-Term Debt [Line Items]                                            
Payment of note payable related party               $ 10,400,000         $ 9,900,000 $ 500,000 $ 1,500,000              
Forest Street, LLC [Member] | Promissory Note [Member]                                            
Short-Term Debt [Line Items]                                            
Debt instrument maturity date           Sep. 23, 2022                                
Promissory note           $ 3,500,000                                
Debt interest rate           12.00%                                
Debt instrument maturity date description           the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.                                
Forest Street, LLC [Member] | Forest Street Note [Member] | Debt Conversion Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Payment of note payable related party     $ 1,400,000 $ 1,400,000                                    
Debt monthly payments     $ 1,400,000                                      
Interest expenses                                         $ 137,666  
Debt conversion, converted Instrument, amount       $ 2,100,000                                    
Forest Street, LLC [Member] | Forest Street Note [Member] | Debt Conversion Agreement [Member] | Common Stock [Member]                                            
Short-Term Debt [Line Items]                                            
Debt conversion, converted instrument, shares issued       1,000,000                                    
XML 74 R58.htm IDEA: XBRL DOCUMENT v3.23.1
CONSTRUCTION NOTE PAYABLE (Details Narrative)
12 Months Ended
Oct. 14, 2021
USD ($)
ft²
Jun. 17, 2021
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from notes payable     $ 4,000,000
Debt maturity date   Jun. 17, 2024      
Debt instrument principal payment     150,743    
Restricted cash     500,000  
Hiawatha National Bank [Member] | Promissory Note [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Debt interest rate 4.50%        
Debt maturity date Oct. 14, 2026        
Hiawatha National Bank [Member] | Maximum [Member] | Promissory Note [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Debt face amount $ 11,625,000        
Debt periodic payment $ 64,620        
Construction Loan Agreement [Member] | Hiawatha National Bank [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Area of land | ft² 160,000        
Proceeds from notes payable     11,200,000    
Prepayment premium of note amount, percentage 1.00%        
Debt default, description The Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Loan Agreement or Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of five percent (5%) of the amount due will be owed with all amounts then owed pursuant to the Note bearing interest at an increased rate.        
Cash collateral or restricted cash     $ 1,000,000.0    
Construction Loan Agreement [Member] | Hiawatha National Bank [Member] | First Advance [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from notes payable $ 329,843        
Construction Loan Agreement [Member] | Hiawatha National Bank [Member] | Maximum [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Debt face amount $ 11,625,000        
XML 75 R59.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS (Details) - Warrant [Member] - $ / shares
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Number of shares, outstanding beginning 2,933,755 3,607,945 8,504,372
Weighted average exercise price, outstanding beginning $ 2.32 $ 2.31 $ 2.10
Weighted average life remaining years, outstanding beginning 2 years 3 months 14 days 3 years 2 months 26 days 3 years 7 months 6 days
Number of shares, granted 150,000 200,000 2,925,204
Weighted average exercise price, granted $ 0.01 $ 0.01 $ 2.31
Weighted average life remaining years, outstanding granted 4 years 6 months 3 years 11 months 1 day 2 years 5 months 19 days
Number of shares, exercised (300,003) (874,190) (7,821,631)
Weighted average exercise price, exercised $ 0.34 $ 1.76 $ 2.08
Number of shares, forfeited or cancelled 322,806
Weighted average exercise price, forfeited or cancelled $ 2.00
Number of shares, outstanding ending 2,460,946 2,933,755 3,607,945
Weighted average exercise price, outstanding ending $ 2.46 $ 2.32 $ 2.31
Weighted average life remaining years, outstanding ending 1 year 7 months 2 days 2 years 3 months 14 days 3 years 2 months 26 days
Number of shares, exercisable 2,460,946 2,933,755 3,179,730
Weighted average exercise price, exercisable $ 2.46 $ 2.32 $ 2.27
Weighted average life remaining years, exercisable 1 year 7 months 2 days 2 years 3 months 14 days 3 years 18 days
Number of shares, forfeited or cancelled (322,806)
XML 76 R60.htm IDEA: XBRL DOCUMENT v3.23.1
CAPITAL STOCK (Details Narrative) - USD ($)
12 Months Ended
Dec. 15, 2016
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock, shares authorized   200,000,000 200,000,000  
Common stock, par value   $ 0.001 $ 0.001  
Number of shares sold 475,681      
Number of shares issued for services, shares     772,450  
Number of shares issued for services, value       $ 1,707,500
Stock repurchased and cancelled       $ 1,500,000
Number of shares issued for merger, value     $ 142,691,282  
Debt Conversion Agreement [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares issued for conversion of notes, shares       1,000,000
Number of shares issued for conversion of notes, value       $ 2,100,000
Shares Issued for Services [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares issued for services, shares       943,336
Number of shares issued for services, value     $ 1,631,701 $ 1,707,500
Amended APA [Member] | Jagemann Stamping Company [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares repurchased       1,000,000
Warrant [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares issued cashless exercise of warrants   99,762 374,584 732,974
Cashless exercise of warrants   100,000 443,110 1,300,069
Warrants outstanding   2,460,946    
Issuance of warrants, description   Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,448,758 shares of our Common Stock at an exercise price of $2.00 per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.    
Warrant One [Member] | Until April 2025 [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants issued to purchase common stock   911    
Warrants exercise price   $ 1.65    
Warrant Two [Member] | Until August 2024 [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants issued to purchase common stock   1,448,758    
Warrants exercise price   $ 2.00    
Warrant Three [Member] | Until September 2024 [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants issued to purchase common stock   474,966    
Warrants exercise price   $ 2.40    
Warrant Four [Member] | Until November 2025 [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants issued to purchase common stock   386,311    
Warrants exercise price   $ 2.63    
Warrant Five [Member] | Until February 2024 [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants issued to purchase common stock   150,000    
Warrants exercise price   $ 6.72    
Investor [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares sold       34,512,143
Number of shares issued for merger, shares       138,564,619
Investor [Member] | Liquidation Damage Fees [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock issued for liquidation damage fees, shares       24,000
Common stock issued for liquidation damage fees, value       $ 48,000
Convertible Notes Payable [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares issued for conversion of notes, shares       3,145,481
Number of shares issued for conversion of notes, value       $ 4,831,206
Investors [Member] | Warrant [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Stock issued during period shares warrants exercised, shares   200,003 431,080 6,521,563
Stock issued during period value warrants exercised, value   $ 101,506 $ 943,907  
Warrant [Member] | Warrant [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Stock issued during period value warrants exercised, value       $ 13,952,336
Employees, Board of Directors, Advisory Committee [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares issued for employees benefit, shares   1,777,294 1,807,666 1,016,331
Shares issued for employees benefit, value   $ 5,807,779 $ 5,759,000 $ 1,450,359
Gemini Direct Investments LLC [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares issued for merger, shares     20,000,000  
Number of shares issued for merger, value     $ 142,691,282  
New Issuance of Shares [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock issued new shares, shares   2,077,059 23,385,780 47,895,828
XML 77 R61.htm IDEA: XBRL DOCUMENT v3.23.1
PREFERRED STOCK (Details Narrative) - USD ($)
12 Months Ended
Mar. 15, 2023
Feb. 17, 2023
Dec. 15, 2022
Nov. 18, 2022
Sep. 15, 2022
Aug. 17, 2022
Jun. 15, 2022
May 12, 2022
Mar. 15, 2022
Feb. 18, 2022
Dec. 15, 2021
Nov. 17, 2021
Sep. 15, 2021
Aug. 27, 2021
May 25, 2021
May 19, 2021
May 18, 2021
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Class of Stock [Line Items]                                        
Dividend rate                                   8.75% 8.75%  
Proceeds from offering                                     $ 31,008,796 $ 138,612,619
Accumulated preferred dividends                                   $ 144,618 144,562  
Series A Preferred Stock [Member]                                        
Class of Stock [Line Items]                                        
Share price                                 $ 25.00      
Dividend rate                                 8.75%      
Preferred stock dividend rate per annum   $ 0.546875   $ 0.5529514   $ 0.55902778   $ 0.559027777777778   $ 0.546875   $ 1.01475694444444   $ 0.241246528     $ 2.1875      
Dividend payment terms                                 payable quarterly in arrears on March 15, June 15, September 15 and December 15.      
Accumulated preferred dividends $ 765,625   $ 774,132   $ 782,639   $ 782,639   $ 765,642   $ 1,420,660   $ 337,745              
Series A Preferred Stock [Member] | August 27, 2021 [Member]                                        
Class of Stock [Line Items]                                        
Accumulated preferred dividends                                     $ 144,562  
Series A Preferred Stock [Member] | February 17. 2023 [Member]                                        
Class of Stock [Line Items]                                        
Accumulated preferred dividends                                   $ 144,618    
Series A Preferred Stock [Member] | Underwriting Agreement [Member]                                        
Class of Stock [Line Items]                                        
Share price                             $ 25.00 $ 25.00        
Number of common stock shares issued                             138,220 1,097,200        
Proceeds from offering                             $ 3,455,500 $ 27,430,000        
Series A Preferred Stock [Member] | Underwriting Agreement [Member] | Over-Allotment Option [Member]                                        
Class of Stock [Line Items]                                        
Number of common stock shares issued                             164,580          
Proceeds from offering                             $ 4,114,500          
Series A Preferred Stock [Member] | Underwriting Agreement [Member] | Underwriters [Member]                                        
Class of Stock [Line Items]                                        
Number of common stock shares issued                               164,580        
XML 78 R62.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED (Details)
Apr. 30, 2021
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Cash $ 48,649,954
Working capital adjustment 1,870,886
Contingent consideration 10,755,000
Common stock 132,645,000
Assumed debt 50,000,000
Fair value of consideration transferred   $ 243,920,840
XML 79 R63.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ALLOCATION FOR CONSIDERATION (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Apr. 30, 2021
Business Combination and Asset Acquisition [Abstract]      
Accounts receivable, net     $ 17,002,362
Prepaid expenses     478,963
Equipment     1,051,980
Deposits     703,389
Other Intangible assets [1]     146,617,380
Goodwill $ 90,870,094 $ 90,870,094 90,870,094 [1]
Right of use assets - operating leases     612,727
Accounts payable     (12,514,919)
Accrued expenses     (196,780)
Operating lease liability     (704,356)
Total Consideration     $ 243,920,840
[1] Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.
XML 80 R64.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS (Details)
12 Months Ended
Mar. 31, 2022
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Net revenues $ 248,314,587
Net income $ 37,793,924
XML 81 R65.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS (Details Narrative) - USD ($)
12 Months Ended
Apr. 30, 2021
Apr. 01, 2021
Mar. 31, 2022
Mar. 31, 2023
Business Acquisition [Line Items]        
Contingent consideration payable, net of current portion     $ 204,142 $ 140,378
Contingent consideration, amount $ 10,755,000      
Working capital adjustments $ 2,000,000      
Transaction cost     $ 1,300,000  
Business acquisitions pro form a interest and debt expense   $ 1,800,000    
Business acquisitions pro form a depreciation and amortization   $ 900,000    
Gemini Direct Investments LLC [Member]        
Business Acquisition [Line Items]        
Business acquisition, share price $ 7.17      
Company received a cash payment $ 50,000,000      
Business acquisition, cash acquired 1,350,046      
Estimated working capital adjustment 2,000,000      
Contingent consideration payable, net of current portion 50,000,000      
Contingent consideration, amount $ 10,755,000      
Shares issued prior stockholder 1,500,000      
Business combination additional securities of common stock 18,500,000      
Merger Agreement [Member] | Gemini Direct Investments LLC [Member]        
Business Acquisition [Line Items]        
Business acquisition, amount $ 50,000,000      
Business acquisition, shares 20,000,000      
Business acquisition, share price $ 0.001      
Company received a cash payment $ 129,114      
Consideration transferred $ 1,870,886      
Without Being Held in Escrow or Requiring Prior Stockholder Approval [Member]        
Business Acquisition [Line Items]        
Issuance of Series A Preferred Stock, net of issuance costs, shares 14,500,000      
Pledge and Escrow Agreement [Member]        
Business Acquisition [Line Items]        
Issuance of Series A Preferred Stock, net of issuance costs, shares 4,000,000      
Will Not Be Issued Prior to The Stockholder Approval [Member]        
Business Acquisition [Line Items]        
Issuance of Series A Preferred Stock, net of issuance costs, shares 1,500,000      
XML 82 R66.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ACCRUED LIABILITIES (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Payables and Accruals [Abstract]    
Accrued FAET $ 1,808,065 $ 2,408,318
Accrued professional fees 736,323 66,000
Income taxes payable 403,739 1,749,488
Accrued sales commissions 252,366 932,712
Unearned revenue 101,593 201,891
Accrued interest 2,681 4,762
Accrued payroll 430,344 458,027
Other accruals 618,243 357,616
Accrued liabilities $ 4,353,354 $ 6,178,814
XML 83 R67.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 03, 2022
Jun. 17, 2021
Jan. 22, 2021
Jan. 14, 2021
Dec. 14, 2020
Nov. 05, 2020
Sep. 23, 2020
Jun. 26, 2020
Apr. 14, 2020
Mar. 14, 2020
Oct. 31, 2019
May 03, 2019
Apr. 30, 2019
Mar. 31, 2019
Mar. 25, 2019
May 31, 2019
Apr. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2019
Common stock shares issued, value                                         $ 31,008,796 $ 138,612,619  
Service paid                                           1,707,500  
Shares for service                                         772,450    
Revenues                                       $ 191,439,801 $ 240,269,166 62,482,330  
Accounts receivable                                       29,346,380 43,955,084    
Debt instrument, description                         The note bears interest per annum at approximately 4.6% payable in arrears monthly.       The note bears interest per annum at approximately 4.6% payable in arrears monthly            
Accrued interest                                           352,157  
Rent paid                                       881,171 1,221,473 844,441  
Principal payments                                       150,743      
Payment of note payable related party                                       4,000,000  
Debt maturity date   Jun. 17, 2024                                          
Proceeds from Notes payable                                       4,000,000  
Amended Note B [Member]                                              
Interest expenses                                       48,665 $ 110,518 60,100  
Promissory Note [Member]                                              
Debt instrument maturity date description                       the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020                      
Post Closing Transaction Note Reduction [Member]                                              
Post-closing changes to the purchase price of transaction                   $ 2,596,200 $ 2,596,200                        
Decreased Equipment Net [Member]                                              
Post-closing changes to the purchase price of transaction                   1,871,306 1,871,306                        
Reduction in Other Intangible Assets [Member]                                              
Post-closing changes to the purchase price of transaction                   766,068 766,068                        
Increased Accounts Receivable [Member]                                              
Post-closing changes to the purchase price of transaction                   31,924 31,924                        
Increase to Deposits [Member]                                              
Post-closing changes to the purchase price of transaction                   9,250 9,250                        
Decreased Accumulated Amortization [Member]                                              
Post-closing changes to the purchase price of transaction                   $ 159,530 $ 159,530                        
Jagemann Stamping Company [Member]                                              
Debt instrument, description               Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.                              
Debt interest rate                                         4.60%    
Debt principal and accrued interest               $ 204,295                              
Jagemann Stamping Company [Member] | Promissory Note [Member]                                              
Payment of note payable related party                 $ 10,400,000         $ 9,900,000 $ 500,000 $ 1,500,000              
Forest Street, LLC [Member] | Promissory Note [Member]                                              
Debt interest rate             12.00%                                
Debt maturity date             Sep. 23, 2022                                
Promissory note             $ 3,500,000                                
Debt instrument maturity date description             the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.                                
Related Party [Member]                                              
Accounts receivable                                       182,344 $ 139,164    
Related Party [Member] | Amended Note B [Member]                                              
Promissory note                                       180,850 865,771    
Marketplace Revenue [Member]                                              
Revenues                                       63,149,673 64,608,516  
Board Of Directors [Member] | Marketplace Revenue [Member]                                              
Revenues                                       215,300 1,042,277    
Two Independent Contractors [Member]                                              
Service paid                                       $ 551,916      
Shares for service                                       141,419      
Foregoing [Member]                                              
Service paid                                       $ 494,967      
Advisory Committee [Member]                                              
Service paid                                       $ 129,750 173,000    
Shares for service                                       45,000      
Independent Contractor [Member]                                              
Service paid                                         $ 229,083    
Shares for service                                         60,000    
Shareholder [Member] | Promissory Note [Member]                                              
Debt interest rate                       1.25%                      
Principal payments                                     $ 18,195        
Promissory note                       $ 375,000                      
Interest expenses                                           $ 10,327  
Debt instrument maturity date description                       The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020.                      
Fred Wagenhals [Member] | Promissory Note [Member]                                              
Debt interest rate                                           1.25% 125.00%
Principal payments                                           $ 25,000  
Debt maturity date                                   Sep. 18, 2020       Sep. 18, 2020  
Promissory note                                             $ 90,000
Interest expenses                                           $ 5,350  
Common Stock [Member]                                              
Issuance of Series A Preferred Stock, net of issuance costs, shares                                           34,536,143  
Common stock shares issued, value                                         $ 34,537  
Service paid                                           $ 943  
Shares for service                                           943,336  
Settlement Agreement [Member]                                              
Costs, fees and expenses $ 500,000                                            
Issuance of Series A Preferred Stock, net of issuance costs, shares 110,000                                            
Common stock shares issued, value $ 385,000                                            
Debt instrument, description               Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering.                              
Principal payments               $ 1,269,977                              
Payment of note payable related party           $ 6,000,000                                  
Debt maturity date               Aug. 15, 2021                              
Settlement Agreement [Member] | Maximum [Member]                                              
Option grant to repurchase               1,000,000                              
Settlement Agreement [Member] | Monthly Payments [Member]                                              
Principal payments               $ 204,295                              
Settlement Agreement [Member] | Ninety Percent [Member]                                              
Proceeds from Notes payable               10,000,000                              
Settlement Agreement [Member] | Hundred Percent [Member]                                              
Proceeds from Notes payable               10,000,000                              
Settlement Agreement [Member] | Seller Note [Member]                                              
Payment of note payable related party               5,803,800                              
Settlement Agreement [Member] | Note B [Member]                                              
Payment of note payable related party           $ 592,982                                  
Interest expenses                                           $ 62,876  
Settlement Agreement [Member] | Amended Note B [Member]                                              
Debt interest rate           9.00%                                  
Promissory note           $ 1,687,664                                  
Debt instrument term           36 months                                  
Settlement Agreement [Member] | Note A [Member]                                              
Interest expenses                                           216,160  
Settlement Agreement [Member] | Promissory Note [Member]                                              
Payment of note payable related party               5,803,800                              
Settlement Agreement [Member] | Inventory and Services [Member]                                              
Payment of note payable related party               $ 2,635,797                              
Settlement Agreement [Member] | Jagemann Stamping Company [Member]                                              
Debt instrument, description               upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.                              
Debt maturity date               Apr. 01, 2021                              
Share price per share               $ 1.50                              
Shares repurchase               1,000,000                              
Settlement Agreement [Member] | Related Party [Member] | Amended Note B [Member]                                              
Promissory note           $ 1,687,664                                  
Settlement Agreement [Member] | Common Stock [Member]                                              
Issuance of Series A Preferred Stock, net of issuance costs, shares 125,000                                            
Common stock shares issued, value $ 437,500                                            
Proxy Settlement Agreement [Member] | Two Independent Contractors [Member]                                              
Service paid                                       $ 223,333      
Administrative and Management Services [Member]                                              
Inventory purchased during period                                       2,000,000.0 1,700,000 3,400,000  
Rent paid                                       $ 170,355 $ 408,852 405,171  
Amended APA [Member] | Jagemann Stamping Company [Member]                                              
Share price per share     $ 1.50                                        
Shares repurchase     1,000,000                                        
Debt Conversion Agreement [Member] | Forest Street, LLC [Member] | Forest Street Note [Member]                                              
Payment of note payable related party       $ 1,400,000 $ 1,400,000                                    
Interest expenses                                           $ 137,666  
Debt conversion, converted Instrument, amount         $ 2,100,000                                    
Debt principal and accrued interest       $ 1,400,000                                      
Debt Conversion Agreement [Member] | Common Stock [Member] | Forest Street, LLC [Member] | Forest Street Note [Member]                                              
Debt conversion, converted instrument, shares issued         1,000,000                                    
XML 84 R68.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INCOME TAX PROVISION BENEFIT (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]      
US Federal $ (1,302,811)
US State (446,677)
Total current provision (1,749,488)
US Federal (578,679) (7,727,011) 582,724
US State (151,559) (2,649,261) 137,276
Total deferred benefit (730,238) (10,376,272) 720,000
Change in valuation allowance 8,839,791 (720,000)
Income tax (provision) benefit $ (730,238) $ (3,285,969)
XML 85 R69.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF RECONCILIATION OF INCOME TAX (Details)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]      
Computed tax expense 21.00% 21.00% 21.00%
State taxes, net of Federal income tax benefit 6.00% 7.00% 5.00%
Change in valuation allowance 0.00% 24.00% (10.00%)
Employee stock awards (40.00%) 4.00% (5.00%)
Stock grants (2.00%) 0.00% (1.00%)
Stock for services 0.00% 0.00% (6.00%)
Other 1.00% 0.00% 0.00%
Non-deductible meals & entertainment 0.00% 0.00% 0.00%
Contingent consideration fair value 1.00% 1.00% 0.00%
Stock and Warrants on Note Conversion (5.00%) 1.00% (4.00%)
Total provision for income taxes (18.00%) 9.00% 0.00%
XML 86 R70.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carryforward $ 871,331
Loss on purchase 826,311 879,319
Other
Total deferred tax assets 1,697,642 879,319
Depreciation expense (2,906,214) (2,208,361)
Other (1,101,020) (207,439)
Total deferred tax liabilities (4,007,234) (2,415,800)
Net deferred tax assets/(liabilities) (2,309,592) (1,536,481)
Valuation allowance
Net deferred tax assets/(liabilities) $ (2,309,592) $ (1,536,481)
XML 87 R71.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details Narrative)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]      
Effective Income Tax Rate Reconciliation, Percent (18.00%) 9.00% 0.00%
XML 88 R72.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, net $ 128,759,564  
Licensing Agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, Gross 250,000 $ 250,000
Accumulated amortization (250,000) (250,000)
Intangible assets, net
Streak Visual Ammunition Patent [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 11 years 2 months 12 days 11 years 2 months 12 days
Intangible assets, Gross $ 950,000 $ 950,000
SWK Patent Acquisition [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 15 years 15 years
Intangible assets, Gross $ 6,124,005 $ 6,124,005
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 3 years 3 years
Intangible assets, Gross $ 1,450,613 $ 1,450,613
Intellectual Property [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 3 years 3 years
Intangible assets, Gross $ 1,543,548 $ 1,543,548
Intellectual Property [Member] | GDI Acquisition [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 10 years 10 years
Intangible assets, Gross $ 4,224,442 $ 4,224,442
Tradename [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 5 years 5 years
Intangible assets, Gross $ 2,152,076 $ 2,152,076
Tradename [Member] | GDI Acquisition [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 15 years 15 years
Intangible assets, Gross $ 76,532,389 $ 76,532,389
Customer Lists [Member] | GDI Acquisition [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 10 years 10 years
Intangible assets, Gross $ 65,252,802 $ 65,252,802
Other Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, Gross 151,763,617 151,763,617
Accumulated amortization (28,036,807) (15,463,230)
Intangible assets, net $ 123,726,810 $ 136,300,387
Other Intangible Assets [Member] | GDI Acquisition [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 5 years 5 years
Intangible assets, Gross $ 607,747 $ 607,747
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, Gross 7,074,005 7,074,005
Accumulated amortization (2,041,251) (1,547,787)
Intangible assets, net $ 5,032,754 $ 5,526,218
Jesse James [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 5 years 5 years
Jesse James [Member] | Licensing Agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, Gross $ 125,000 $ 125,000
Jeff Rann [Member]    
Finite-Lived Intangible Assets [Line Items]    
Licensing agreement, life 5 years 5 years
Jeff Rann [Member] | Licensing Agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, Gross $ 125,000 $ 125,000
XML 89 R73.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET (Details)
Mar. 31, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2024 $ 13,102,785
2025 12,664,775
2026 12,664,775
2027 12,553,355
2028 12,543,226
Thereafter 65,230,648
Annual amortization of intangible assets $ 128,759,564
XML 90 R74.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLE ASSETS (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Apr. 30, 2021
[1]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Goodwill $ 90,870,094 $ 90,870,094   $ 90,870,094
Amortization of intangible assets $ 13,072,967 13,072,967 $ 1,971,188  
Merger Agreement [Member] | Gemini Direct Investments LLC [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Goodwill   $ 90,870,094    
[1] Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.
XML 91 R75.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OPERATING SEGMENTS (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Revenue from External Customer [Line Items]      
Total Revenues $ 191,439,801 $ 240,269,166 $ 62,482,330
Cost of Revenues 136,031,204 151,505,657 51,095,679
General and administrative expense 45,388,754 37,911,999 15,107,392
Depreciation and amortization 13,278,762 13,702,148 1,659,243
Income/(Loss) from Operations (3,258,919) 37,149,362 (5,379,985)
Income/(Loss) from Operations     (5,379,984)
Ammunition [Member]      
Revenue from External Customer [Line Items]      
Total Revenues 128,290,128 175,660,650 62,482,330
Cost of Revenues 126,914,265 142,773,306 51,095,679
General and administrative expense 10,378,456 11,932,721 4,269,558
Depreciation and amortization 578,326 1,579,778 1,659,243
Income/(Loss) from Operations (9,580,919) 19,374,845  
Income/(Loss) from Operations     5,475,850
Marketplace [Member]      
Revenue from External Customer [Line Items]      
Total Revenues 63,149,673 64,608,516
Cost of Revenues 9,116,939 8,732,351
General and administrative expense 9,707,425 8,434,308
Depreciation and amortization 12,700,436 12,122,370
Income/(Loss) from Operations 31,624,873 35,319,487  
Income/(Loss) from Operations    
Corporate and Other Expenses [Member]      
Revenue from External Customer [Line Items]      
Total Revenues
Cost of Revenues
General and administrative expense 25,302,873 17,544,970 10,837,834
Depreciation and amortization
Income/(Loss) from Operations $ (25,302,873) $ (17,544,970)  
Income/(Loss) from Operations     $ 10,834,834
XML 92 R76.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF TOTAL ASSETS SEGMENTS (Details) - USD ($)
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]      
Total assets $ 412,335,387 $ 414,178,313 $ 179,379,341
Ammunition [Member]      
Segment Reporting Information [Line Items]      
Total assets 154,044,607 160,305,107 179,379,341
Marketplace [Member]      
Segment Reporting Information [Line Items]      
Total assets $ 258,290,780 $ 253,873,206
XML 93 R77.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF CAPITAL EXPENDITURE SEGMENT (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]      
Payment to acquire property and plant equipment $ 12,541,325 $ 19,218,982 $ 7,437,265
Ammunition [Member]      
Segment Reporting Information [Line Items]      
Payment to acquire property and plant equipment 10,819,177 17,728,023 7,437,265
Marketplace [Member]      
Segment Reporting Information [Line Items]      
Payment to acquire property and plant equipment $ 1,722,148 $ 1,490,959
XML 94 R78.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENT (Details Narrative) - Subsequent Event [Member] - Members of Board of Directors [Member]
Apr. 01, 2023
USD ($)
$ / shares
shares
Subsequent Event [Line Items]  
Number of stock issued as compensation | shares 25,111
Number of stock issued as compensation, value | $ $ 45,346
Share price | $ / shares $ 1.81
XML 95 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001015383 2022-04-01 2023-03-31 0001015383 POWW:CommonStock0.001ParValueMember 2022-04-01 2023-03-31 0001015383 POWW:Sec8.75SeriesCumulativeRedeemablePerpetualPreferredStock0.001ParValueMember 2022-04-01 2023-03-31 0001015383 2022-09-30 0001015383 2023-06-09 0001015383 2023-03-31 0001015383 2022-03-31 0001015383 2021-04-01 2022-03-31 0001015383 2020-04-01 2021-03-31 0001015383 POWW:AmmunitionSalesMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionSalesMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionSalesMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceRevenueMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceRevenueMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceRevenueMember 2020-04-01 2021-03-31 0001015383 POWW:CasingSalesMember 2022-04-01 2023-03-31 0001015383 POWW:CasingSalesMember 2021-04-01 2022-03-31 0001015383 POWW:CasingSalesMember 2020-04-01 2021-03-31 0001015383 us-gaap:PreferredStockMember 2020-03-31 0001015383 us-gaap:CommonStockMember 2020-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001015383 us-gaap:RetainedEarningsMember 2020-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2020-03-31 0001015383 2020-03-31 0001015383 us-gaap:PreferredStockMember 2021-03-31 0001015383 us-gaap:CommonStockMember 2021-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001015383 us-gaap:RetainedEarningsMember 2021-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2021-03-31 0001015383 2021-03-31 0001015383 us-gaap:PreferredStockMember 2022-03-31 0001015383 us-gaap:CommonStockMember 2022-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001015383 us-gaap:RetainedEarningsMember 2022-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2022-03-31 0001015383 us-gaap:PreferredStockMember 2020-04-01 2021-03-31 0001015383 us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2021-03-31 0001015383 us-gaap:RetainedEarningsMember 2020-04-01 2021-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2020-04-01 2021-03-31 0001015383 us-gaap:PreferredStockMember 2021-04-01 2022-03-31 0001015383 us-gaap:CommonStockMember 2021-04-01 2022-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2022-03-31 0001015383 us-gaap:RetainedEarningsMember 2021-04-01 2022-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2021-04-01 2022-03-31 0001015383 us-gaap:PreferredStockMember 2022-04-01 2023-03-31 0001015383 us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2023-03-31 0001015383 us-gaap:RetainedEarningsMember 2022-04-01 2023-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2022-04-01 2023-03-31 0001015383 us-gaap:PreferredStockMember 2023-03-31 0001015383 us-gaap:CommonStockMember 2023-03-31 0001015383 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001015383 us-gaap:RetainedEarningsMember 2023-03-31 0001015383 us-gaap:TreasuryStockCommonMember 2023-03-31 0001015383 2016-12-13 2016-12-15 0001015383 POWW:DefinitiveAgreementMember POWW:PRIVCOMember 2017-03-15 2017-03-17 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2023-03-31 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2022-04-01 2023-03-31 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2021-04-01 2022-03-31 0001015383 us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember 2020-04-01 2021-03-31 0001015383 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2023-03-31 0001015383 us-gaap:SellingAndMarketingExpenseMember 2021-04-01 2022-03-31 0001015383 us-gaap:SellingAndMarketingExpenseMember 2020-04-01 2021-03-31 0001015383 us-gaap:CostOfSalesMember 2022-04-01 2023-03-31 0001015383 us-gaap:CostOfSalesMember 2021-04-01 2022-03-31 0001015383 srt:MaximumMember 2023-03-31 0001015383 POWW:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001015383 POWW:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001015383 POWW:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001015383 POWW:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0001015383 POWW:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001015383 POWW:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001015383 POWW:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceFeeRevenueMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceFeeRevenueMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceFeeRevenueMember 2020-04-01 2021-03-31 0001015383 POWW:AmmunitionCasingsSalesMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionCasingsSalesMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionCasingsSalesMember 2020-04-01 2021-03-31 0001015383 POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0001015383 srt:MinimumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001015383 srt:MaximumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001015383 srt:MinimumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-03-31 0001015383 srt:MaximumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-03-31 0001015383 POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001015383 srt:MinimumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001015383 srt:MaximumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001015383 srt:MinimumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputPriceVolatilityMember 2021-03-31 0001015383 srt:MaximumMember POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputPriceVolatilityMember 2021-03-31 0001015383 POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputExpectedTermMember 2023-03-31 0001015383 POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputExpectedTermMember 2022-03-31 0001015383 POWW:ConvertiblePromissoryNoteMember us-gaap:MeasurementInputExpectedTermMember 2021-03-31 0001015383 us-gaap:MeasurementInputExpectedDividendRateMember 2023-03-31 0001015383 us-gaap:MeasurementInputExpectedDividendRateMember 2022-03-31 0001015383 us-gaap:MeasurementInputExpectedDividendRateMember 2021-03-31 0001015383 us-gaap:FairValueInputsLevel1Member 2022-04-01 2023-03-31 0001015383 us-gaap:FairValueInputsLevel2Member 2022-04-01 2023-03-31 0001015383 us-gaap:FairValueInputsLevel3Member 2022-04-01 2023-03-31 0001015383 us-gaap:FairValueInputsLevel1Member 2021-04-01 2022-03-31 0001015383 us-gaap:FairValueInputsLevel2Member 2021-04-01 2022-03-31 0001015383 us-gaap:FairValueInputsLevel3Member 2021-04-01 2022-03-31 0001015383 us-gaap:FairValueInputsLevel1Member 2020-04-01 2021-03-31 0001015383 us-gaap:FairValueInputsLevel2Member 2020-04-01 2021-03-31 0001015383 us-gaap:FairValueInputsLevel3Member 2020-04-01 2021-03-31 0001015383 us-gaap:WarrantMember 2023-03-31 0001015383 us-gaap:WarrantMember 2022-04-01 2023-03-31 0001015383 us-gaap:WarrantMember 2021-04-01 2022-03-31 0001015383 POWW:EquityIncentiveAwardsMember 2021-04-01 2022-03-31 0001015383 us-gaap:LeaseholdImprovementsMember 2023-03-31 0001015383 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001015383 us-gaap:BuildingImprovementsMember 2023-03-31 0001015383 us-gaap:BuildingImprovementsMember 2022-03-31 0001015383 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001015383 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001015383 us-gaap:VehiclesMember 2023-03-31 0001015383 us-gaap:VehiclesMember 2022-03-31 0001015383 us-gaap:EquipmentMember 2023-03-31 0001015383 us-gaap:EquipmentMember 2022-03-31 0001015383 POWW:ToolingMember 2023-03-31 0001015383 POWW:ToolingMember 2022-03-31 0001015383 us-gaap:ConstructionInProgressMember 2023-03-31 0001015383 us-gaap:ConstructionInProgressMember 2022-03-31 0001015383 us-gaap:CostOfSalesMember 2020-04-01 2021-03-31 0001015383 us-gaap:OperatingExpenseMember 2022-04-01 2023-03-31 0001015383 us-gaap:OperatingExpenseMember 2021-04-01 2022-03-31 0001015383 us-gaap:OperatingExpenseMember 2020-04-01 2021-03-31 0001015383 POWW:FactoringAndSecurityAgreementMember 2019-07-01 0001015383 POWW:FactoringAndSecurityAgreementMember 2019-06-28 2019-07-01 0001015383 us-gaap:PrimeRateMember POWW:FactoringAndSecurityAgreementMember 2019-06-28 2019-07-01 0001015383 2021-06-16 2021-06-17 0001015383 POWW:EligibleInventoryMember POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-06-17 0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-06-15 2020-06-17 0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-06-17 0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-07-31 0001015383 POWW:InventoryCreditFacilityMember 2023-03-31 0001015383 POWW:InventoryCreditFacilityMember 2022-04-01 2023-03-31 0001015383 POWW:InventoryCreditFacilityMember 2021-04-01 2022-03-31 0001015383 POWW:InventoryCreditFacilityMember 2020-04-01 2021-03-31 0001015383 2021-09-30 0001015383 2022-01-31 0001015383 POWW:LeaseAgreementMember 2022-01-31 0001015383 POWW:PromissoryNoteMember POWW:JagemannStampingCompanyMember 2020-04-13 2020-04-14 0001015383 POWW:PromissoryNoteMember POWW:JagemannStampingCompanyMember 2019-03-24 2019-03-25 0001015383 POWW:PromissoryNoteMember POWW:JagemannStampingCompanyMember 2019-03-30 2019-03-31 0001015383 2019-04-01 2019-04-30 0001015383 POWW:PromissoryNoteMember POWW:JagemannStampingCompanyMember 2019-05-01 2019-05-31 0001015383 POWW:PostClosingTransactionNoteReductionMember 2020-03-13 2020-03-14 0001015383 POWW:DecreasedEquipmentMember 2020-03-13 2020-03-14 0001015383 POWW:OtherIntangibleAssetReductionMember 2020-03-13 2020-03-14 0001015383 POWW:IncreasedAccountsReceivableMember 2020-03-13 2020-03-14 0001015383 POWW:IncreaseToDepositsMember 2020-03-13 2020-03-14 0001015383 POWW:DecreasedAccumulatedDepreciationMember 2020-03-13 2020-03-14 0001015383 POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:PromissoryNoteMember POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:InventoryAndServicesMember POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:JagemannStampingCompanyMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:JagemannStampingCompanyMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember 2020-11-03 2020-11-05 0001015383 POWW:NoteBMember POWW:SettlementAgreementMember 2020-11-03 2020-11-05 0001015383 POWW:AmendedNoteBMember us-gaap:RelatedPartyMember POWW:SettlementAgreementMember 2020-11-05 0001015383 POWW:AmendedNoteBMember POWW:SettlementAgreementMember 2020-11-05 0001015383 POWW:NoteAMember POWW:SettlementAgreementMember 2020-04-01 2021-03-31 0001015383 POWW:NoteBMember POWW:SettlementAgreementMember 2020-04-01 2021-03-31 0001015383 POWW:AmendedNoteBMember us-gaap:RelatedPartyMember 2023-03-31 0001015383 POWW:AmendedNoteBMember us-gaap:RelatedPartyMember 2022-03-31 0001015383 POWW:AmendedNoteBMember 2022-04-01 2023-03-31 0001015383 POWW:AmendedNoteBMember 2021-04-01 2022-03-31 0001015383 POWW:AmendedNoteBMember 2020-04-01 2021-03-31 0001015383 POWW:ShareholderMember POWW:PromissoryNoteMember 2019-05-03 0001015383 POWW:PromissoryNoteMember 2019-05-02 2019-05-03 0001015383 POWW:ShareholderMember POWW:PromissoryNoteMember 2020-04-01 2020-12-31 0001015383 POWW:ShareholderMember POWW:PromissoryNoteMember 2020-04-01 2021-03-31 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2019-12-31 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2019-01-01 2019-03-31 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2020-04-01 2021-03-31 0001015383 POWW:PromissoryNoteMember POWW:ForestStreetLLCMember 2020-09-23 0001015383 POWW:PromissoryNoteMember POWW:ForestStreetLLCMember 2020-09-22 2020-09-23 0001015383 POWW:ForestStreetNoteMember POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember 2020-12-13 2020-12-14 0001015383 POWW:ForestStreetNoteMember us-gaap:CommonStockMember POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember 2020-12-13 2020-12-14 0001015383 POWW:ForestStreetNoteMember POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember 2020-04-01 2021-03-31 0001015383 POWW:AmendedAPAMember POWW:JagemannStampingCompanyMember 2021-01-19 2021-01-22 0001015383 POWW:AmendedAPAMember POWW:JagemannStampingCompanyMember 2021-01-22 0001015383 srt:MaximumMember POWW:HiawathaNationalBankMember POWW:ConstructionLoanAgreementMember 2021-10-14 0001015383 POWW:HiawathaNationalBankMember POWW:ConstructionLoanAgreementMember 2021-10-14 0001015383 POWW:FirstAdvanceMember POWW:HiawathaNationalBankMember POWW:ConstructionLoanAgreementMember 2021-10-13 2021-10-14 0001015383 srt:MaximumMember POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember 2021-10-14 0001015383 POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember 2021-10-14 0001015383 POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember 2021-10-13 2021-10-14 0001015383 srt:MaximumMember POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember 2021-10-13 2021-10-14 0001015383 POWW:HiawathaNationalBankMember POWW:ConstructionLoanAgreementMember 2021-10-13 2021-10-14 0001015383 POWW:HiawathaNationalBankMember POWW:ConstructionLoanAgreementMember 2022-04-01 2023-03-31 0001015383 POWW:HiawathaNationalBankMember POWW:ConstructionLoanAgreementMember 2023-03-31 0001015383 POWW:NewIssuanceOfSharesMember 2020-04-01 2021-03-31 0001015383 us-gaap:InvestorMember 2020-04-01 2021-03-31 0001015383 us-gaap:ConvertibleNotesPayableMember 2020-04-01 2021-03-31 0001015383 POWW:InvestorsMember us-gaap:WarrantMember 2020-04-01 2021-03-31 0001015383 us-gaap:WarrantMember us-gaap:WarrantMember 2020-04-01 2021-03-31 0001015383 us-gaap:WarrantMember 2020-04-01 2021-03-31 0001015383 POWW:DebtConversionAgreementMember 2020-04-01 2021-03-31 0001015383 POWW:SharesIssuedForServicesMember 2020-04-01 2021-03-31 0001015383 POWW:EmployeesMembersBoardOfDirectorsMember 2020-04-01 2021-03-31 0001015383 us-gaap:InvestorMember POWW:LiquidationDamageFeesMember 2020-04-01 2021-03-31 0001015383 POWW:AmendedAPAMember POWW:JagemannStampingCompanyMember 2020-04-01 2021-03-31 0001015383 POWW:NewIssuanceOfSharesMember 2021-04-01 2022-03-31 0001015383 POWW:GeminiDirectInvestmentsLLCMember 2021-04-01 2022-03-31 0001015383 POWW:InvestorsMember us-gaap:WarrantMember 2021-04-01 2022-03-31 0001015383 us-gaap:WarrantMember 2021-04-01 2022-03-31 0001015383 POWW:SharesIssuedForServicesMember 2021-04-01 2022-03-31 0001015383 POWW:EmployeesMembersBoardOfDirectorsMember 2021-04-01 2022-03-31 0001015383 POWW:NewIssuanceOfSharesMember 2022-04-01 2023-03-31 0001015383 POWW:InvestorsMember us-gaap:WarrantMember 2022-04-01 2023-03-31 0001015383 us-gaap:WarrantMember 2022-04-01 2023-03-31 0001015383 POWW:EmployeesMembersBoardOfDirectorsMember 2022-04-01 2023-03-31 0001015383 us-gaap:WarrantMember 2023-03-31 0001015383 POWW:UntilAprilTwoThousandTwentyFiveMember POWW:WarrantOneMember 2023-03-31 0001015383 POWW:UntilAugustTwoThousandTwentyFourMember POWW:WarrantTwoMember 2023-03-31 0001015383 POWW:UntilSeptemberTwoThousandTwentyFourMember POWW:WarrantThreeMember 2023-03-31 0001015383 POWW:UntilNovemberTwoThousandTwentyFiveMember POWW:WarrantFourMember 2023-03-31 0001015383 POWW:UntilFebrauryTwoThousandTwentyFourMember POWW:WarrantFiveMember 2023-03-31 0001015383 us-gaap:WarrantMember 2020-03-31 0001015383 us-gaap:WarrantMember 2021-03-31 0001015383 us-gaap:WarrantMember 2022-03-31 0001015383 us-gaap:SeriesAPreferredStockMember 2021-05-18 0001015383 us-gaap:SeriesAPreferredStockMember 2021-05-17 2021-05-18 0001015383 us-gaap:SeriesAPreferredStockMember POWW:UnderwritingAgreementMember 2021-05-19 2021-05-19 0001015383 us-gaap:SeriesAPreferredStockMember POWW:UnderwritingAgreementMember 2021-05-19 0001015383 POWW:UnderwritersMember us-gaap:SeriesAPreferredStockMember POWW:UnderwritingAgreementMember 2021-05-19 2021-05-19 0001015383 us-gaap:SeriesAPreferredStockMember POWW:UnderwritingAgreementMember 2021-05-24 2021-05-25 0001015383 us-gaap:SeriesAPreferredStockMember POWW:UnderwritingAgreementMember 2021-05-25 0001015383 us-gaap:SeriesAPreferredStockMember us-gaap:OverAllotmentOptionMember POWW:UnderwritingAgreementMember 2021-05-24 2021-05-25 0001015383 POWW:AugustTwentySevenTwoThousandTwentyOneMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2022-03-31 0001015383 us-gaap:SeriesAPreferredStockMember 2021-08-26 2021-08-27 0001015383 us-gaap:SeriesAPreferredStockMember 2021-09-15 2021-09-15 0001015383 us-gaap:SeriesAPreferredStockMember 2021-11-17 2021-11-17 0001015383 us-gaap:SeriesAPreferredStockMember 2021-12-15 2021-12-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-02-17 2022-02-18 0001015383 us-gaap:SeriesAPreferredStockMember 2022-03-15 2022-03-15 0001015383 POWW:FebruarySeventeenTwoThousandTwentyThreeMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2023-03-31 0001015383 us-gaap:SeriesAPreferredStockMember 2023-02-17 2023-02-17 0001015383 us-gaap:SeriesAPreferredStockMember 2023-03-14 2023-03-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-11-17 2022-11-18 0001015383 us-gaap:SeriesAPreferredStockMember 2022-12-14 2022-12-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-08-16 2022-08-17 0001015383 us-gaap:SeriesAPreferredStockMember 2022-09-14 2022-09-15 0001015383 us-gaap:SeriesAPreferredStockMember 2022-05-11 2022-05-12 0001015383 us-gaap:SeriesAPreferredStockMember 2022-06-14 2022-06-15 0001015383 POWW:GeminiDirectInvestmentsLLCMember POWW:MergerAgreementMember 2021-04-30 0001015383 POWW:GeminiDirectInvestmentsLLCMember POWW:MergerAgreementMember 2021-04-29 2021-04-30 0001015383 POWW:WithoutBeingHeldInEscrowOrRequiringPriorStockholderApprovalMember 2021-04-29 2021-04-30 0001015383 POWW:PledgeAndEscrowAgreementMember 2021-04-29 2021-04-30 0001015383 POWW:WillNotBeIssuedPriorToTheStockholderApprovalMember 2021-04-29 2021-04-30 0001015383 POWW:GeminiDirectInvestmentsLLCMember 2021-04-29 2021-04-30 0001015383 POWW:GeminiDirectInvestmentsLLCMember 2021-04-30 0001015383 2021-04-29 2021-04-30 0001015383 2021-04-01 2021-04-01 0001015383 2021-04-30 0001015383 POWW:SettlementAgreementMember 2022-11-02 2022-11-03 0001015383 us-gaap:CommonStockMember POWW:SettlementAgreementMember 2022-11-02 2022-11-03 0001015383 POWW:TwoIndependentContractorsMember 2022-04-01 2023-03-31 0001015383 POWW:TwoIndependentContractorsMember POWW:ProxySettlementAgreementMember 2022-04-01 2023-03-31 0001015383 POWW:ForegoingMember 2022-04-01 2023-03-31 0001015383 POWW:AdvisoryCommitteeMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceRevenueMember POWW:BoardOfDirectorsMember 2022-04-01 2023-03-31 0001015383 us-gaap:RelatedPartyMember 2023-03-31 0001015383 POWW:IndependentContractorMember 2021-04-01 2022-03-31 0001015383 POWW:AdvisoryCommitteeMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceRevenueMember POWW:BoardOfDirectorsMember 2021-04-01 2022-03-31 0001015383 us-gaap:RelatedPartyMember 2022-03-31 0001015383 2019-04-29 2019-04-30 0001015383 POWW:JagemannStampingCompanyMember 2022-03-31 0001015383 POWW:PostClosingTransactionNoteReductionMember 2019-10-29 2019-10-31 0001015383 POWW:DecreasedEquipmentMember 2019-10-29 2019-10-31 0001015383 POWW:OtherIntangibleAssetReductionMember 2019-10-29 2019-10-31 0001015383 POWW:IncreasedAccountsReceivableMember 2019-10-29 2019-10-31 0001015383 POWW:IncreaseToDepositsMember 2019-10-29 2019-10-31 0001015383 POWW:DecreasedAccumulatedDepreciationMember 2019-10-29 2019-10-31 0001015383 POWW:AdministrativeAndManagementServicesAgreementMember 2022-04-01 2023-03-31 0001015383 POWW:AdministrativeAndManagementServicesAgreementMember 2021-04-01 2022-03-31 0001015383 POWW:AdministrativeAndManagementServicesAgreementMember 2020-04-01 2021-03-31 0001015383 POWW:SellerNoteMember POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:MonthlyPaymentsMember POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:NinetyPercentMember POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:HundredPercentMember POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 srt:MaximumMember POWW:SettlementAgreementMember 2020-06-25 2020-06-26 0001015383 POWW:SettlementAgreementMember POWW:JagemannStampingCompanyMember 2020-06-26 0001015383 POWW:AmendedNoteBMember POWW:SettlementAgreementMember 2020-11-03 2020-11-05 0001015383 POWW:ShareholderMember POWW:PromissoryNoteMember 2019-05-02 2019-05-03 0001015383 POWW:FredWagenhalsMember POWW:PromissoryNoteMember 2021-03-31 0001015383 POWW:ForestStreetNoteMember POWW:DebtConversionAgreementMember POWW:ForestStreetLLCMember 2021-01-13 2021-01-14 0001015383 POWW:MergerAgreementMember POWW:GeminiDirectInvestmentsLLCMember 2022-03-31 0001015383 POWW:JesseJamesMember 2023-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JesseJamesMember 2023-03-31 0001015383 POWW:JeffRannMember 2023-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JeffRannMember 2023-03-31 0001015383 POWW:StreakVisualAmmunitionPatentMember 2023-03-31 0001015383 POWW:SWKPatentAcquisitionMember 2023-03-31 0001015383 us-gaap:CustomerRelationshipsMember 2023-03-31 0001015383 us-gaap:IntellectualPropertyMember 2023-03-31 0001015383 POWW:TradenameMember 2023-03-31 0001015383 POWW:GDIAcquisitionMember POWW:TradenameMember 2023-03-31 0001015383 POWW:GDIAcquisitionMember us-gaap:CustomerListsMember 2023-03-31 0001015383 POWW:GDIAcquisitionMember us-gaap:IntellectualPropertyMember 2023-03-31 0001015383 POWW:GDIAcquisitionMember us-gaap:OtherIntangibleAssetsMember 2023-03-31 0001015383 us-gaap:LicensingAgreementsMember 2023-03-31 0001015383 us-gaap:PatentsMember 2023-03-31 0001015383 us-gaap:OtherIntangibleAssetsMember 2023-03-31 0001015383 POWW:JesseJamesMember 2022-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JesseJamesMember 2022-03-31 0001015383 POWW:JeffRannMember 2022-03-31 0001015383 us-gaap:LicensingAgreementsMember POWW:JeffRannMember 2022-03-31 0001015383 POWW:StreakVisualAmmunitionPatentMember 2022-03-31 0001015383 POWW:SWKPatentAcquisitionMember 2022-03-31 0001015383 us-gaap:CustomerRelationshipsMember 2022-03-31 0001015383 us-gaap:IntellectualPropertyMember 2022-03-31 0001015383 POWW:TradenameMember 2022-03-31 0001015383 POWW:GDIAcquisitionMember POWW:TradenameMember 2022-03-31 0001015383 POWW:GDIAcquisitionMember us-gaap:CustomerListsMember 2022-03-31 0001015383 POWW:GDIAcquisitionMember us-gaap:IntellectualPropertyMember 2022-03-31 0001015383 POWW:GDIAcquisitionMember us-gaap:OtherIntangibleAssetsMember 2022-03-31 0001015383 us-gaap:LicensingAgreementsMember 2022-03-31 0001015383 us-gaap:PatentsMember 2022-03-31 0001015383 us-gaap:OtherIntangibleAssetsMember 2022-03-31 0001015383 POWW:AmmunitionMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceMember 2022-04-01 2023-03-31 0001015383 POWW:CorporateAndOtherExpensesMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceMember 2021-04-01 2022-03-31 0001015383 POWW:CorporateAndOtherExpensesMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceMember 2020-04-01 2021-03-31 0001015383 POWW:CorporateAndOtherExpensesMember 2020-04-01 2021-03-31 0001015383 POWW:AmmunitionMember 2023-03-31 0001015383 POWW:AmmunitionMember 2022-03-31 0001015383 POWW:AmmunitionMember 2021-03-31 0001015383 POWW:MarketplaceMember 2023-03-31 0001015383 POWW:MarketplaceMember 2022-03-31 0001015383 POWW:MarketplaceMember 2021-03-31 0001015383 POWW:AmmunitionMember 2022-04-01 2023-03-31 0001015383 POWW:AmmunitionMember 2021-04-01 2022-03-31 0001015383 POWW:AmmunitionMember 2020-04-01 2021-03-31 0001015383 POWW:MarketplaceMember 2022-04-01 2023-03-31 0001015383 POWW:MarketplaceMember 2021-04-01 2022-03-31 0001015383 POWW:MarketplaceMember 2020-04-01 2021-03-31 0001015383 POWW:MembersOfBoardOfDirectorsMember us-gaap:SubsequentEventMember 2023-04-01 2023-04-01 0001015383 POWW:MembersOfBoardOfDirectorsMember us-gaap:SubsequentEventMember 2023-04-01 iso4217:USD shares iso4217:USD shares pure utr:sqft 0001015383 false FY http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember 10-K true 2023-03-31 --03-31 2023 false AMMO, Inc. DE 001-13101 83-1950534 7681 E Gray Road Scottsdale AZ 85260 (480) 947-0001 Common Stock, $0.001 par value POWW NASDAQ 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value POWWP NASDAQ No No Yes Yes Accelerated Filer false false true false false 258196798 117580758 Part III incorporates information by reference from the definitive proxy statement for the registrant’s 2023 Annual Meeting of Stockholders to be filed within 120 days after the end of the registrant’s fiscal year. 342 PANNELL KERR FORSTER OF TEXAS, P.C Houston, Texas 39134027 23281475 29346380 43955084 15000 54344819 59016152 5126667 3423925 500000 128451893 129691636 55963255 37637806 7028947 11360322 5032754 5526218 123726810 136300387 90870094 90870094 1261634 2791850 412335387 414178313 18079397 26817083 485671 4353354 6178814 825675 470734 831429 180850 684639 260429 2118635 25463399 35823311 140378 204142 181132 10922443 38330 903490 2091351 2309592 1536481 39739302 39874747 0.0875 0.0875 25.00 25.00 0.001 0.001 1400000 1400000 1400000 1400000 1400 1400 0.001 0.001 200000000 200000000 118562806 116485747 118294478 116485747 118294 116487 391940374 385426431 -18941825 -11240752 522158 372596085 374303566 412335387 414178313 114116044 161459025 49620530 63149673 64608516 14174084 14201625 12861800 191439801 240269166 62482330 136031204 151505657 51095679 55408597 88763509 11386651 4729540 7310216 1879128 24980079 16986344 7191544 15679135 13615439 5036721 13278762 13702148 1659243 1000000 58667516 51614147 16766636 -3258919 37149362 -5379985 25181 21840 576785 -632062 -637797 -3009094 -606881 -615957 -2432309 -3865800 36533405 -7812294 730238 3285969 -4596038 33247436 -7812294 3105034 2668649 -7701072 30578787 -7812294 -0.07 0.27 -0.14 -0.07 0.27 -0.14 117177885 112328680 55041502 117177885 114189720 55041502 9789896 14646983 4286258 46204139 46204 53219834 -34007245 19258793 34536143 34537 138578082 138612619 3145481 3145 4828061 4831206 6521563 6522 13945814 13952336 1000000 1000 2099000 2100000 732974 733 -733 13847069 13847069 943336 943 1706557 1707500 1016331 1016 1449343 1450359 278585 278585 1315494 1315494 1000000 1000 1499000 1500000 -7812294 -7812294 93099967 93100 202073968 -41819539 160347529 93099967 93100 202073968 -41819539 160347529 20000000 20000 142671282 142691282 431080 431 943476 943907 374584 375 -375 772450 773 1630928 1631701 1807666 1808 5757192 5759000 252488 252488 1400000 1400 31007396 31008796 1090076 1090076 2524087 2524087 144562 144562 33247436 33247436 1400000 1400 116485747 116487 385426431 -11240752 374303566 1400000 1400 116485747 116487 385426431 -11240752 374303566 1400000 1400 116485747 116487 385426431 -11240752 374303566 200003 200 101306 101506 99762 99 -99 1777294 1776 5806003 5807779 179094 179094 427639 427639 638071 638071 144618 144618 2322346 2322346 -4596038 -4596038 -4596038 -4596038 268328 -268 -522158 -522426 1400000 1400 118294478 118294 391940374 -18941825 -522158 372596085 1400000 1400 118294478 118294 391940374 -18941825 -522158 372596085 -4596038 33247436 -7812294 17519949 17339093 4876756 83253 38330 446466 5807779 5759000 1450359 179094 252488 278585 4200 1707500 63764 385750 119731 191299 2748250 86292 12044 -25400 629140 720491 443739 213819 718045 730238 1536481 48000 163351 1051985 1000000 1315494 -14417405 20707052 6075373 15000 657 150 -4671333 43149234 11458845 -2763855 -1996287 1331710 -4306375 8826504 1616858 -8694813 9930191 1810417 -1970078 2374686 1843166 -647480 -732468 -444439 35556366 2852583 -14415560 50517840 12541325 19218982 7437265 59800 -12541325 -69677022 -7437265 825675 265422 -1091098 71348761 121488045 40309292 71834432 122844562 40473083 50000000 684921 625147 8783410 2134143 2208369 514746 1000000 150743 4000000 35000000 101506 943907 13952336 3199922 13895069 2960416 2524087 522426 138612619 1051985 3500000 4000000 1959000 1500000 -6662489 -28235557 139310022 16352552 -95059996 117457197 23281475 118341471 884274 39634027 23281475 118341471 500000 39134027 23281475 118341471 665043 626571 1186302 1302811 10237032 387968 4252778 2166852 226539 901076 809451 897845 -144618 -144562 -143400000 1090077 4667855 2635797 2100000 664975 <p id="xdx_80B_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_znjfMJWIgSea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82A_zssSB7SKVKNi">ORGANIZATION AND BUSINESS ACTIVITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We were formed under the name Retrospettiva, Inc. in November 1990 to manufacture and import textile products, including both finished garments and fabrics. We were inactive until the following series of events in December 2016 and March 2017.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 15, 2016, the Company’s majority shareholders sold <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20161213__20161215_zitAIBH7SVR2" title="Number of shares sold">475,681</span> (<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_c20161213__20161215_zHQ5eISo8r6l" title="Number of shares issued for pre-split">11,891,976</span> pre-split) of their outstanding shares to Mr. Fred W. Wagenhals (“Mr. Wagenhals”) resulting in a change in control of the Company. Mr. Wagenhals was appointed as sole officer and the sole member of the Company’s Board of Directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also approved (i) doing business in the name AMMO, Inc., (ii) a change to the Company’s OTC trading symbol to POWW, (iii) an agreement and plan of merger to re-domicile and change the Company’s state of incorporation from California to Delaware, and (iv) a <span id="xdx_904_eus-gaap--StockholdersEquityReverseStockSplit_c20161213__20161215_zlyj9qZQi616" title="Reverse stock split">1-for-25 reverse stock split (“Reverse Split”) of the issued and outstanding shares of the common stock of the Company. As a result of the reverse split, the previous issued and outstanding shares of common stock became <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20161213__20161215_zW5TtGKuY8zh" title="Number of shares issued, post reverse split">580,052</span> shares; no shareholder was reversed below 100 shares, and all fractional shares resulting from the reverse split were rounded up to the next whole share</span>. All references to the outstanding stock have been retrospectively adjusted to reflect this split. These transactions were effective as of December 30, 2016.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2017, the Company entered into a definitive agreement with AMMO, Inc. a Delaware Corporation (PRIVCO) under which the Company acquired all of the outstanding shares of common stock of (PRIVCO). Under the terms of the Agreement, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20170315__20170317__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__dei--LegalEntityAxis__custom--PRIVCOMember_zqfO9pSnlnI2" title="Number of common stock shares issued">17,285,800</span> newly issued shares of common stock of the Company. In connection with this transaction the Company retired <span id="xdx_90E_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20170315__20170317__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__dei--LegalEntityAxis__custom--PRIVCOMember_z9BpWyHTGVVa" title="Number of shares retired">475,681</span> shares of common stock and issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_c20170315__20170317__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__dei--LegalEntityAxis__custom--PRIVCOMember_zQTd7yAGepy4" title="Number of shares issued to satisfy issuance commitment">500,000</span> shares of common stock to satisfy an issuance commitment. The acquisition was considered to be a capital transaction. The transaction was the equivalent to the issuance by PRIVCO of <span id="xdx_90A_ecustom--SharesEquivalentToIssuanceRecapitalization_c20170315__20170317__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAgreementMember__dei--LegalEntityAxis__custom--PRIVCOMember_zYIYuqh0m0Sb" title="Shares equivalent to issuance recapitalization">604,371</span> shares to the Company’s shareholders accompanied by a recapitalization. The weighted average number of outstanding shares has been adjusted for this transaction. (PRIVCO) subsequently changes its name to AMMO Munitions, Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 475681 11891976 1-for-25 reverse stock split (“Reverse Split”) of the issued and outstanding shares of the common stock of the Company. As a result of the reverse split, the previous issued and outstanding shares of common stock became 580,052 shares; no shareholder was reversed below 100 shares, and all fractional shares resulting from the reverse split were rounded up to the next whole share 580052 17285800 475681 500000 604371 <p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_z8GdjHLB0Gv5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - <span id="xdx_826_zXIKdwW8V3X2">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zzZ6wJfEK25h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zCYtY9DRBxYl">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--UseOfEstimates_zaFNntgU8cQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z2RRrHXiSTTh">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with <span style="background-color: white">accounting principles generally accepted in the United States of America (“</span>U.S. GAAP”) requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation and warrant-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zrIXdICzAZXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_866_z5ZleJhjEg01" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline it is not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2023. As of March 31, 2023, the Company has a goodwill carrying value of $<span id="xdx_900_eus-gaap--Goodwill_iI_c20230331_zbZ7fxBILRUi" title="Goodwill">90,870,094</span>, all of which is assigned to the Marketplace segment. However, due to declines in the value of the Company’s common stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zosGTv3eqJPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zhwqOV4wZgrb">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the consolidated statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zAMDFdEeb2ul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_863_z5Bfn0UGqVa4">Restricted Cash</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We consider cash to be restricted when withdrawal or general use is legally restricted. Our restricted cash balance is comprised of cash on deposit with banks to secure the Construction <span style="background-color: white">Loan Agreement</span> as discussed in Note <span style="background-color: white">11</span>. We report restricted cash in the Consolidated Balance Sheets as current or non-current classification based on the expected duration of the restriction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zkm8xgjt7Fzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zyzzN1Sl35H4">Accounts Receivable and Allowance for Doubtful Accounts</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--LicenseAgreementsPolicyTextBlock_zpk20DXwd33j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zq4YdOMjZgw4">License Agreements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We were a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants us through February 2022 the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zWsaVBi4VWZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z4Gir1nIEVj">Patents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to AMMO Technologies Inc. pursuant to an Assignment and First Amendment to Exclusive License Agreement. Assumption Agreement dated to be effective as of August 22, 2017, the Merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $<span id="xdx_904_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zZvS3LCUM6wb" title="Share price">0.01</span> per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the years ended March 31, 2023, 2022, and 2021, the Company recognized royalty expenses of $<span id="xdx_90C_eus-gaap--RoyaltyExpense_c20220401__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zIXjz4YWWqgh" title="Royalty expenses">99,268</span>, $<span id="xdx_908_eus-gaap--RoyaltyExpense_c20210401__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zhTfr5VBeqOi" title="Royalty expenses">44,764</span>, and $<span id="xdx_906_eus-gaap--RoyaltyExpense_c20200401__20210331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zenBhpGXK8he" title="Royalty expenses">87,093</span> respectively under this agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2018, we applied for additional patent coverage for the manufacturing methods or application of the Hybrid Luminescence Ammunition Technology on a variety of projectile and ammunition types. The costs of filing this patent were expensed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 5, 2018, we completed the acquisition of SW Kenetics Inc. AMMO Technologies, Inc. succeeded all of the assets of SW Kenetics Inc. and assumed all of the liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The primary asset of SW Kenetics Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to AMMO Technologies, Inc. pursuant to Intellectual Property Rights Agreement on September 27, 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zRJFEhX2bQv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zpescrLQbXGl">Other Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement (See Note 18). The intangible assets acquired include a tradename, customer relationships, and intellectual property.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company. Whereby SpeedLight Group I, LLC merged with and into Gemini Direct Investments, LLC, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company. At the time of the Merger, Gemini Direct Investments, LLC had nine (9) subsidiaries, all of which are related to Gemini’s ownership of GunBroker.com, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software and domain names.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z31jIohzkTN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zTKY4F29gus5">Impairment of Long-Lived Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. <span id="xdx_90B_eus-gaap--AssetImpairmentCharges_do_c20220401__20230331_z579DXkMKPH" title="Impairment expense"><span id="xdx_904_eus-gaap--AssetImpairmentCharges_do_c20210401__20220331_zYmvn814gfd1" title="Impairment expense"><span id="xdx_902_eus-gaap--AssetImpairmentCharges_do_c20200401__20210331_zR4NPwFRP9A" title="Impairment expense">No</span></span></span> impairment expense was recognized for the years ended March 31, 2023, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zs3eg4pzd6og" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z5FcuF2Gh4Vb">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification of a contract with a customer</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification of the performance obligations in the contact</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determination of the transaction price</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of the transaction price to the separate performance allocation</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognition of revenue when performance obligations are satisfied</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services it transfers to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zGKiGzbZvpxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended March 31, 2023, 2022, and 2021, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zdqUiCb04gx8" style="display: none">SCHEDULE OF CONCENTRATION OF RISKS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended<br/> March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended<br/> March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Year Ended<br/> March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">PERCENTAGES</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivable</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Revenues</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>Accounts</b></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>Receivable</b></p> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right">     </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 46%">A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zATm7IHH8ITd" style="width: 5%; text-align: right">12.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zbo7IXXG9Mcc" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEONOdI9s1Pg" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zOCrpxR535E1" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zyUNlGzRXug" style="text-align: right; width: 5%">16.5</td> <td style="width: 1%">%</td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td> <td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zhlCYM1AyNS7" style="text-align: right; width: 5%">23.3</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zy3EZ1zQwiTa" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zuvt1YmA6wge" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zfSCj9ZAQPdg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zilMjhYJfGAi" style="text-align: right">11.8</td><td style="text-align: left">%</td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zbwmxCevapBh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1086">-</span></td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zjM5Uu4uuxDk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zB2PaS1054Ji" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zoVmyxIX2f7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1089">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zmZQ3iF8NbHc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zFEHua7oxXtc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></td><td style="text-align: left"> </td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zdVtc1MPE4R7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></span></td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zGGrEaPWpwC6" style="text-align: right">11.9</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zdmCg04dDVg6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zxnMqitfzD73" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zpdwEZ0OF3F9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zYGs6Fg9kFb6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1097">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zkPZubA6jTF1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zuqLxJGaVll5" style="border-bottom: Black 1.5pt solid; text-align: right">10.6</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zBfmYnu6Yz6l" style="border-bottom: Black 1.5pt solid; text-align: right">12.2</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zY2ivWSc2xn1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1101">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zyIwlCNLH7Ud" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1102">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zahKdc9oMoxi" style="border-bottom: Black 1.5pt solid; text-align: right">11.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zwRdKgmHzhy2" style="border-bottom: Black 1.5pt solid; text-align: right">16.5</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zCZM48FFZyYa" style="border-bottom: Black 1.5pt solid; text-align: right">45.8</td> <td style="padding-bottom: 1.5pt">%</td></tr> </table> <p id="xdx_8A4_zuw54968nd44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disaggregated Revenue Information</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represent a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types; ammunition, ammunition casings, and marketplace fees. The Company notes that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zQESnuF35MM4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zAXib1SJrlzl" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220401__20230331_z3s55NisIyY6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210401__20220331_zCmpQbLbubzc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td id="xdx_492_20200401__20210331_zzqTsZuurx3c" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AmmunitionSalesMember_zv4Gdqe5ckI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: bold; text-align: left">Ammunition Sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">114,116,044</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">161,459,025</td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 14%">49,620,530</td> <td style="width: 1%"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MarketplaceFeeRevenueMember_zLzbz0FXVwV9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Marketplace Fee Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,149,673</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,608,516</td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AmmunitionCasingsSalesMember_ztryvUTPJN58" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Ammunition Casings Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,174,084</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,201,625</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">12,861,800</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwF71nCqpjc" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Total Sales</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">191,439,801</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">240,269,166</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td style="text-align: right">62,482,330</td> <td> </td></tr> </table> <p id="xdx_8A0_zOOIMVBRVFia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell direct to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our Gunbroker.com online auction marketplace.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All sales are recorded upon shipment and, depending on credit worthiness of customer, the payment terms will vary from thirty (30) to sixty (60) days. No refunds are allowed on any product shipped.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each product manufactured by the Company has standard specifications and performance objectives. The Company has an extensive product testing program and, if the Company were given notice of a product defect by a customer, the Company would request the return of the product so that the manufacturing defect could be identified.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--AdvertisingCostsPolicyTextBlock_zsfMw1rtr2Pj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zR5AcM1h4ekj">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expenses as they are incurred in cost of revenues. We incurred advertising expenses recognized in selling expenses of $<span id="xdx_908_eus-gaap--AdvertisingExpense_c20220401__20230331__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_znXPxYuZzdId" title="Advertising expenses">1,068,700</span>, $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20210401__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z0XQuWnUw3i8" title="Advertising expenses">1,406,043</span>, and $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20200401__20210331__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zB0L0hQv0kVh" title="Advertising expenses">257,866</span> for the years ended March 31, 2023, 2022, and 2021 respectively. We incurred marketplace advertising expenses of <span id="xdx_90F_eus-gaap--AdvertisingExpense_c20220401__20230331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zt9W37UJwzHa" title="Advertising expenses">286,479</span> and $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20210401__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zLNGluTDTOO2" title="Advertising expenses">417,017</span> in cost of revenues for the years ended March 31, 2023 and 2022. We did not have marketplace advertising expenses in cost of revenues for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zKoer4idb4d8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zvLF33sFPKH2">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices for identical instruments in active markets;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We value all common stock issued for services on the date of the agreements, using the price at which shares were being sold to private investors or at the value of the services performed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 34.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We valued warrants issued for services at their respective grants dates during the years ended March 31, 2023, 2022, and 2021 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.</span></p> <p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOmWg1FYe6sf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 34.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zn1X3BBHMVL9" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>March 31,</b></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>2021</b></p></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Risk free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zLe4pmZsmudh" title="Fair value assumptions, measurement input, percentages">3.9</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zpuVTmJnd4e1" title="Fair value assumptions, measurement input, percentages">1.21</span>%-<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zCNh7Z2RiBM9" title="Fair value assumptions, measurement input, percentages">1.74</span></span></td><td style="width: 1%; text-align: left">%</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 14%"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zXWi3IYZ88ve" title="Fair value assumptions, measurement input, percentages">0.32</span>%-<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_ztlto5DJtin" title="Fair value assumptions, measurement input, percentages">0.38</span></td> <td style="text-align: left; width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zpmkB3QOsVDh" title="Fair value assumptions, measurement input, percentages">77.5</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zwW122s2xomi" title="Fair value assumptions, measurement input, percentages">89.1</span>%-<span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zb3RBYhO3PG9" title="Fair value assumptions, measurement input, percentages">90.7</span></span></td><td style="text-align: left">%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zYFn0gWXWUF8" title="Fair value assumptions, measurement input, percentages">88.9</span>%-<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z5C5ZItYh2f" title="Fair value assumptions, measurement input, percentages">90.4</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zr5D3prb549g" title="Fair value assumptions, measurement input, percentages">2.5</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zzxOxg8Yubs1" title="Fair value assumptions, measurement input, percentages">2.5</span> years</span></td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zn2IQoCLZfh4" title="Fair value assumptions, measurement input, percentages">2.5</span> years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zASChOxtA3Od" title="Fair value assumptions, measurement input, percentages">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zt6gwFNADomd" title="Fair value assumptions, measurement input, percentages">0</span></td><td style="text-align: left">%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zilzVEdb4pc4" title="Fair value assumptions, measurement input, percentages">0</span></td> <td style="text-align: left">%</td></tr> </table> <p id="xdx_8AE_zeYW1NkfAIa6" style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89B_ecustom--ScheduleOfStockholdersEquityWarrantsOrRightsTableTextBlock_zc5RAE6RF51e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zk1SJM288zF5" style="display: none">SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted <br/> Active<br/> Markets <br/> for<br/> Identified<br/> Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">(Level 1)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Level 2)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Level 3)</td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Warrants issued for services</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT1xyXp1wjj1" style="width: 11%; text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1175">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRvtPowVTFq6" style="width: 11%; text-align: right" title="Warrants issued for services">427,639</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWPLAh8J9Jaa" style="width: 11%; text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--WarrantsIssuedForServices_c20220401__20230331_zKNDUzYHPWU7" style="width: 11%; text-align: right" title="Warrants issued for services">427,639</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">March 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued for services</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdKpWPD6abyi" style="text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1183">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zO1CvqdndZTa" style="text-align: right" title="Warrants issued for services"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090,077</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZ6WNVdF3GS7" style="text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WarrantsIssuedForServices_c20210401__20220331_zRGuqWLijluf" style="text-align: right" title="Warrants issued for services">1,090,077</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">      </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">          </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued for convertible promissory notes conversion</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1AqbQQUibF" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="-sec-ix-hidden: xdx2ixbrl1191">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRyQZirti5dk" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="background-color: white">1,315,494</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpasGYdiI2bh" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331_zQQvO0ugp1m1" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="background-color: white">1,315,494</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_zYuW8xC341kh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with our acquisition of Gemini, we used the Level 2 inputs in estimating the fair value of the transaction. Please refer to Note 14.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_zCHosbJaiTl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zvceze7Iwnjc">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z5Y1DqEJsnn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zHhi9AFVcj41">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income or expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--CompensatedAbsencesPolicy_zCwrKtwn3MX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zW5W9JuWhfwk">Compensated Absences</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We accrue a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General (“ASC 710”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zlozuQOdVi1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z1d7aPchJyC4">Research and Development</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ExciseTaxPolicyTextBlock_z64KmcSxoXT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zzboR0ctQxEd">Excise Tax</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an <span id="xdx_90E_ecustom--ExciseTaxPercentage_iI_pid_dp_uPure_c20230331_zFaX71Kk7zIi" title="Excise tax percentage">11</span>% excise tax for all products sold into these channels. During the years ended March 31, 2023, 2022, and 2021, we recognized approximately $<span id="xdx_908_ecustom--ExciseTaxAmount_pn5n6_c20220401__20230331_zyrVZJ1gsiF9" title="Excise tax amount">9.8</span> million, $<span id="xdx_90C_ecustom--ExciseTaxAmount_pn5n6_c20210401__20220331_z6vbnKSzdVR6" title="Excise tax amount">14.6</span> million, and $<span id="xdx_90C_ecustom--ExciseTaxAmount_pn5n6_c20200401__20210331_zWrpOmv9gsL4" title="Excise tax amount">4.3</span> million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of goods sold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zBAKZGfpo3jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zO1qWTiwdjI6">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”). Which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors. We measure stock compensation based on reference to the closing fair market value of our Common Stock on the date of grant. Stock-based compensation is recognized on a straight line basis over the vesting periods and forfeitures are recognized in the periods they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zGPah4jPE8u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zpZLjOnZBz6e">Concentrations of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20230331__srt--RangeAxis__srt--MaximumMember_zyT7LQF6FHv2" title="Cash FDIC insured amount">250,000</span>. As of March 31, 2023, our bank account balances exceeded federally insured limits, however, we have not incurred losses related to these deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_z8xke6J7HV7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zjDSQarPltU6">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. <span id="xdx_90C_eus-gaap--IncomeTaxExaminationDescription_c20220401__20230331_ztViNe0Njig3" title="Income tax examination, description">We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized.</span> We reflect changes in recognition or measurement in the period in which the change in judgment occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zYAq4eZ6ohH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zxAnRi7NsxQ1">Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 24, 2019, the Company received notice that a former employee that had voluntarily terminated filed a complaint against the Company, and certain individuals, with the U.S. Department of Labor (“DOL”). The Complaint in alleges that the individual reported potential violations of SEC rules and regulations by management and that as a result of such disclosures, the individual experienced a hostile work environment; that the Company lacks sufficient internal controls, and that the individual was the victim of retaliation and constructive discharge after being removed as a director by majority vote of the shareholders. The claims were investigated by a newly appointed Special Investigative Committee made up of independent directors represented by special independent legal counsel. The Special Investigative Committee and legal counsel found the material claims were unsubstantiated, including those concerning alleged SEC violations, and recommended enhancements to certain corporate governance charter documents and processes which the Company promptly implemented. The parties participated in a successful mediation at the end of June 2022 and all matters relating to this former employee/claimant were confidentially resolved with the lawsuit dismissed with prejudice.  The settlement was covered by our Employment Practices Liability Policy and did not amount to a material amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, AMMO filed a Texas state court complaint against Expansion Industries pursing eight (8) claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e., Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO has since moved aggressively to further the process, including successfully garnishing a portion of the deposit monies in Expansion bank accounts, filing a Motion for Summary Judgement, continuing to pursue written discovery, and amending the Complaint to add Expansion principal as an individual party. The putative primer manufacturer settled the two related lawsuits in September 2022 by repaying all deposit monies due AMMO, in addition to payment of principally all fees and costs incurred by the Company in pursuit of the resolution. The principal lawsuit and AMMO’s garnishment action adverse the defendant were dismissed with prejudice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Along with countless other suppliers of Remington Outdoors, AMMO was served with an avoidance claim lawsuit by the bankruptcy trustee. AMMO presented substantial “ordinary course” defense evidence to the Trustee and the case was settled for a nominal sum in September 2022, with the lawsuit dismissed with prejudice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMMO is defending two contract arbitration cases adverse former employees that are presently in discovery, one involving an employee terminated for cause and the second action involving a termination without cause wherein the former employee is seeking contract wages, commissions and allegedly earned common stock. Discovery is ongoing at this time in the employment arbitration matters. While discovery continues, the Company received a favorable ruling on a partial motion for summary judgment in the “for cause” arbitration case wherein the arbitrator ruled the employee had stolen funds and thus granted the Company’s dispositive motion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also received notice in October 2022 that an OSHA whistleblower complaint had been filed with the US Department of Labor by an employee that had been terminated for cause. The regulatory filing was received after AMMO refused to capitulate to the former employee’s demands. AMMO has produced documents and submitted its position statement to OSHA and the matters is currently pending at the agency level.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2023, Director and shareholder Steve Urvan filed suit in the Delaware Chancery Court against the Company, certain Directors, former directors, employees, former employees and consultants, seeking rescission of the Company’s acquisition of GunBroker.com and certain affiliated companies. Plaintiff Urvan’s claims include rescission, misrepresentation and fraud. The Company is currently in communications with its insurance carriers as concerns coverage (defense and indemnification), has engaged counsel and formal/legal service of process is being coordinated at this time. The Company and named defendants are in alignment in all respects, reasonably believe at this date that the claims are without merit and the Company has engaged Delaware Chancery Court litigation specialists to defend its interests in all respects in this case. There were no other known contingencies at March 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6D2koRRnqz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zeebepUi9Da1">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit loss (“CECL”) methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The guidance should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. The guidance is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. We anticipate that this ASC will not have a material effect on the Company’s financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires specific disclosures for equity securities subject to contractual sale restrictions. These changes will become effective for the Company on April 1, 2024, with early adoption permitted. We are currently evaluating the potential impact of these changes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</span></p> <p id="xdx_855_znQX6mZKgsHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zzZ6wJfEK25h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zCYtY9DRBxYl">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--UseOfEstimates_zaFNntgU8cQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z2RRrHXiSTTh">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with <span style="background-color: white">accounting principles generally accepted in the United States of America (“</span>U.S. GAAP”) requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation and warrant-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zrIXdICzAZXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_866_z5ZleJhjEg01" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline it is not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2023. As of March 31, 2023, the Company has a goodwill carrying value of $<span id="xdx_900_eus-gaap--Goodwill_iI_c20230331_zbZ7fxBILRUi" title="Goodwill">90,870,094</span>, all of which is assigned to the Marketplace segment. However, due to declines in the value of the Company’s common stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 90870094 <p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zosGTv3eqJPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zhwqOV4wZgrb">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the consolidated statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zAMDFdEeb2ul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_863_z5Bfn0UGqVa4">Restricted Cash</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We consider cash to be restricted when withdrawal or general use is legally restricted. Our restricted cash balance is comprised of cash on deposit with banks to secure the Construction <span style="background-color: white">Loan Agreement</span> as discussed in Note <span style="background-color: white">11</span>. We report restricted cash in the Consolidated Balance Sheets as current or non-current classification based on the expected duration of the restriction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zkm8xgjt7Fzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zyzzN1Sl35H4">Accounts Receivable and Allowance for Doubtful Accounts</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--LicenseAgreementsPolicyTextBlock_zpk20DXwd33j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zq4YdOMjZgw4">License Agreements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We were a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants us through February 2022 the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zWsaVBi4VWZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z4Gir1nIEVj">Patents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to AMMO Technologies Inc. pursuant to an Assignment and First Amendment to Exclusive License Agreement. Assumption Agreement dated to be effective as of August 22, 2017, the Merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $<span id="xdx_904_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zZvS3LCUM6wb" title="Share price">0.01</span> per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the years ended March 31, 2023, 2022, and 2021, the Company recognized royalty expenses of $<span id="xdx_90C_eus-gaap--RoyaltyExpense_c20220401__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zIXjz4YWWqgh" title="Royalty expenses">99,268</span>, $<span id="xdx_908_eus-gaap--RoyaltyExpense_c20210401__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zhTfr5VBeqOi" title="Royalty expenses">44,764</span>, and $<span id="xdx_906_eus-gaap--RoyaltyExpense_c20200401__20210331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember__us-gaap--TypeOfArrangementAxis__custom--ExclusiveLicenseAgreementMember_zenBhpGXK8he" title="Royalty expenses">87,093</span> respectively under this agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2018, we applied for additional patent coverage for the manufacturing methods or application of the Hybrid Luminescence Ammunition Technology on a variety of projectile and ammunition types. The costs of filing this patent were expensed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 5, 2018, we completed the acquisition of SW Kenetics Inc. AMMO Technologies, Inc. succeeded all of the assets of SW Kenetics Inc. and assumed all of the liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The primary asset of SW Kenetics Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to AMMO Technologies, Inc. pursuant to Intellectual Property Rights Agreement on September 27, 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.01 99268 44764 87093 <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zRJFEhX2bQv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zpescrLQbXGl">Other Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement (See Note 18). The intangible assets acquired include a tradename, customer relationships, and intellectual property.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company. Whereby SpeedLight Group I, LLC merged with and into Gemini Direct Investments, LLC, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company. At the time of the Merger, Gemini Direct Investments, LLC had nine (9) subsidiaries, all of which are related to Gemini’s ownership of GunBroker.com, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software and domain names.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z31jIohzkTN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zTKY4F29gus5">Impairment of Long-Lived Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. <span id="xdx_90B_eus-gaap--AssetImpairmentCharges_do_c20220401__20230331_z579DXkMKPH" title="Impairment expense"><span id="xdx_904_eus-gaap--AssetImpairmentCharges_do_c20210401__20220331_zYmvn814gfd1" title="Impairment expense"><span id="xdx_902_eus-gaap--AssetImpairmentCharges_do_c20200401__20210331_zR4NPwFRP9A" title="Impairment expense">No</span></span></span> impairment expense was recognized for the years ended March 31, 2023, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 0 <p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zs3eg4pzd6og" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z5FcuF2Gh4Vb">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification of a contract with a customer</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification of the performance obligations in the contact</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determination of the transaction price</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of the transaction price to the separate performance allocation</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognition of revenue when performance obligations are satisfied</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services it transfers to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zGKiGzbZvpxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended March 31, 2023, 2022, and 2021, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zdqUiCb04gx8" style="display: none">SCHEDULE OF CONCENTRATION OF RISKS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended<br/> March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended<br/> March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Year Ended<br/> March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">PERCENTAGES</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivable</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Revenues</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>Accounts</b></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>Receivable</b></p> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right">     </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 46%">A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zATm7IHH8ITd" style="width: 5%; text-align: right">12.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zbo7IXXG9Mcc" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEONOdI9s1Pg" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zOCrpxR535E1" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zyUNlGzRXug" style="text-align: right; width: 5%">16.5</td> <td style="width: 1%">%</td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td> <td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zhlCYM1AyNS7" style="text-align: right; width: 5%">23.3</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zy3EZ1zQwiTa" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zuvt1YmA6wge" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zfSCj9ZAQPdg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zilMjhYJfGAi" style="text-align: right">11.8</td><td style="text-align: left">%</td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zbwmxCevapBh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1086">-</span></td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zjM5Uu4uuxDk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zB2PaS1054Ji" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zoVmyxIX2f7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1089">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zmZQ3iF8NbHc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zFEHua7oxXtc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></td><td style="text-align: left"> </td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zdVtc1MPE4R7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></span></td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zGGrEaPWpwC6" style="text-align: right">11.9</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zdmCg04dDVg6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zxnMqitfzD73" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zpdwEZ0OF3F9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zYGs6Fg9kFb6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1097">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zkPZubA6jTF1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zuqLxJGaVll5" style="border-bottom: Black 1.5pt solid; text-align: right">10.6</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zBfmYnu6Yz6l" style="border-bottom: Black 1.5pt solid; text-align: right">12.2</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zY2ivWSc2xn1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1101">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zyIwlCNLH7Ud" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1102">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zahKdc9oMoxi" style="border-bottom: Black 1.5pt solid; text-align: right">11.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zwRdKgmHzhy2" style="border-bottom: Black 1.5pt solid; text-align: right">16.5</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zCZM48FFZyYa" style="border-bottom: Black 1.5pt solid; text-align: right">45.8</td> <td style="padding-bottom: 1.5pt">%</td></tr> </table> <p id="xdx_8A4_zuw54968nd44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disaggregated Revenue Information</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represent a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types; ammunition, ammunition casings, and marketplace fees. The Company notes that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zQESnuF35MM4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zAXib1SJrlzl" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220401__20230331_z3s55NisIyY6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210401__20220331_zCmpQbLbubzc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td id="xdx_492_20200401__20210331_zzqTsZuurx3c" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AmmunitionSalesMember_zv4Gdqe5ckI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: bold; text-align: left">Ammunition Sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">114,116,044</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">161,459,025</td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 14%">49,620,530</td> <td style="width: 1%"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MarketplaceFeeRevenueMember_zLzbz0FXVwV9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Marketplace Fee Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,149,673</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,608,516</td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AmmunitionCasingsSalesMember_ztryvUTPJN58" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Ammunition Casings Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,174,084</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,201,625</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">12,861,800</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwF71nCqpjc" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Total Sales</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">191,439,801</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">240,269,166</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td style="text-align: right">62,482,330</td> <td> </td></tr> </table> <p id="xdx_8A0_zOOIMVBRVFia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell direct to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our Gunbroker.com online auction marketplace.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All sales are recorded upon shipment and, depending on credit worthiness of customer, the payment terms will vary from thirty (30) to sixty (60) days. No refunds are allowed on any product shipped.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each product manufactured by the Company has standard specifications and performance objectives. The Company has an extensive product testing program and, if the Company were given notice of a product defect by a customer, the Company would request the return of the product so that the manufacturing defect could be identified.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zGKiGzbZvpxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended March 31, 2023, 2022, and 2021, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zdqUiCb04gx8" style="display: none">SCHEDULE OF CONCENTRATION OF RISKS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended<br/> March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended<br/> March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For the Year Ended<br/> March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">PERCENTAGES</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivable</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Revenues</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>Accounts</b></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>Receivable</b></p> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right">     </td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 46%">A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zATm7IHH8ITd" style="width: 5%; text-align: right">12.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zbo7IXXG9Mcc" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEONOdI9s1Pg" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zOCrpxR535E1" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerAMember_zyUNlGzRXug" style="text-align: right; width: 5%">16.5</td> <td style="width: 1%">%</td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td> <td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerAMember_zhlCYM1AyNS7" style="text-align: right; width: 5%">23.3</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zy3EZ1zQwiTa" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zuvt1YmA6wge" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zfSCj9ZAQPdg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zilMjhYJfGAi" style="text-align: right">11.8</td><td style="text-align: left">%</td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerBMember_zbwmxCevapBh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1086">-</span></td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerBMember_zjM5Uu4uuxDk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zB2PaS1054Ji" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zoVmyxIX2f7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1089">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zmZQ3iF8NbHc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zFEHua7oxXtc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></td><td style="text-align: left"> </td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerCMember_zdVtc1MPE4R7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></span></td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerCMember_zGGrEaPWpwC6" style="text-align: right">11.9</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zdmCg04dDVg6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zxnMqitfzD73" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zpdwEZ0OF3F9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zYGs6Fg9kFb6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1097">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerDMember_zkPZubA6jTF1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerDMember_zuqLxJGaVll5" style="border-bottom: Black 1.5pt solid; text-align: right">10.6</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zBfmYnu6Yz6l" style="border-bottom: Black 1.5pt solid; text-align: right">12.2</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zY2ivWSc2xn1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1101">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zyIwlCNLH7Ud" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1102">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zahKdc9oMoxi" style="border-bottom: Black 1.5pt solid; text-align: right">11.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zwRdKgmHzhy2" style="border-bottom: Black 1.5pt solid; text-align: right">16.5</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200401__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zCZM48FFZyYa" style="border-bottom: Black 1.5pt solid; text-align: right">45.8</td> <td style="padding-bottom: 1.5pt">%</td></tr> </table> 0.122 0.165 0.233 0.118 0.119 0.106 0.122 0.118 0.165 0.458 <p id="xdx_89E_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zQESnuF35MM4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zAXib1SJrlzl" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220401__20230331_z3s55NisIyY6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210401__20220331_zCmpQbLbubzc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td id="xdx_492_20200401__20210331_zzqTsZuurx3c" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AmmunitionSalesMember_zv4Gdqe5ckI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: bold; text-align: left">Ammunition Sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">114,116,044</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">161,459,025</td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 14%">49,620,530</td> <td style="width: 1%"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MarketplaceFeeRevenueMember_zLzbz0FXVwV9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Marketplace Fee Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,149,673</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,608,516</td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--AmmunitionCasingsSalesMember_ztryvUTPJN58" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Ammunition Casings Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,174,084</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,201,625</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">12,861,800</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwF71nCqpjc" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Total Sales</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">191,439,801</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">240,269,166</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td style="text-align: right">62,482,330</td> <td> </td></tr> </table> 114116044 161459025 49620530 63149673 64608516 14174084 14201625 12861800 191439801 240269166 62482330 <p id="xdx_848_eus-gaap--AdvertisingCostsPolicyTextBlock_zsfMw1rtr2Pj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zR5AcM1h4ekj">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expenses as they are incurred in cost of revenues. We incurred advertising expenses recognized in selling expenses of $<span id="xdx_908_eus-gaap--AdvertisingExpense_c20220401__20230331__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_znXPxYuZzdId" title="Advertising expenses">1,068,700</span>, $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20210401__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z0XQuWnUw3i8" title="Advertising expenses">1,406,043</span>, and $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20200401__20210331__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zB0L0hQv0kVh" title="Advertising expenses">257,866</span> for the years ended March 31, 2023, 2022, and 2021 respectively. We incurred marketplace advertising expenses of <span id="xdx_90F_eus-gaap--AdvertisingExpense_c20220401__20230331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zt9W37UJwzHa" title="Advertising expenses">286,479</span> and $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20210401__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zLNGluTDTOO2" title="Advertising expenses">417,017</span> in cost of revenues for the years ended March 31, 2023 and 2022. We did not have marketplace advertising expenses in cost of revenues for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1068700 1406043 257866 286479 417017 <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zKoer4idb4d8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zvLF33sFPKH2">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices for identical instruments in active markets;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We value all common stock issued for services on the date of the agreements, using the price at which shares were being sold to private investors or at the value of the services performed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 34.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We valued warrants issued for services at their respective grants dates during the years ended March 31, 2023, 2022, and 2021 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.</span></p> <p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOmWg1FYe6sf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 34.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zn1X3BBHMVL9" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>March 31,</b></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>2021</b></p></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Risk free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zLe4pmZsmudh" title="Fair value assumptions, measurement input, percentages">3.9</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zpuVTmJnd4e1" title="Fair value assumptions, measurement input, percentages">1.21</span>%-<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zCNh7Z2RiBM9" title="Fair value assumptions, measurement input, percentages">1.74</span></span></td><td style="width: 1%; text-align: left">%</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 14%"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zXWi3IYZ88ve" title="Fair value assumptions, measurement input, percentages">0.32</span>%-<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_ztlto5DJtin" title="Fair value assumptions, measurement input, percentages">0.38</span></td> <td style="text-align: left; width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zpmkB3QOsVDh" title="Fair value assumptions, measurement input, percentages">77.5</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zwW122s2xomi" title="Fair value assumptions, measurement input, percentages">89.1</span>%-<span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zb3RBYhO3PG9" title="Fair value assumptions, measurement input, percentages">90.7</span></span></td><td style="text-align: left">%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zYFn0gWXWUF8" title="Fair value assumptions, measurement input, percentages">88.9</span>%-<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z5C5ZItYh2f" title="Fair value assumptions, measurement input, percentages">90.4</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zr5D3prb549g" title="Fair value assumptions, measurement input, percentages">2.5</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zzxOxg8Yubs1" title="Fair value assumptions, measurement input, percentages">2.5</span> years</span></td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zn2IQoCLZfh4" title="Fair value assumptions, measurement input, percentages">2.5</span> years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zASChOxtA3Od" title="Fair value assumptions, measurement input, percentages">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zt6gwFNADomd" title="Fair value assumptions, measurement input, percentages">0</span></td><td style="text-align: left">%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zilzVEdb4pc4" title="Fair value assumptions, measurement input, percentages">0</span></td> <td style="text-align: left">%</td></tr> </table> <p id="xdx_8AE_zeYW1NkfAIa6" style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89B_ecustom--ScheduleOfStockholdersEquityWarrantsOrRightsTableTextBlock_zc5RAE6RF51e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zk1SJM288zF5" style="display: none">SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted <br/> Active<br/> Markets <br/> for<br/> Identified<br/> Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">(Level 1)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Level 2)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Level 3)</td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Warrants issued for services</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT1xyXp1wjj1" style="width: 11%; text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1175">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRvtPowVTFq6" style="width: 11%; text-align: right" title="Warrants issued for services">427,639</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWPLAh8J9Jaa" style="width: 11%; text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--WarrantsIssuedForServices_c20220401__20230331_zKNDUzYHPWU7" style="width: 11%; text-align: right" title="Warrants issued for services">427,639</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">March 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued for services</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdKpWPD6abyi" style="text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1183">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zO1CvqdndZTa" style="text-align: right" title="Warrants issued for services"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090,077</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZ6WNVdF3GS7" style="text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WarrantsIssuedForServices_c20210401__20220331_zRGuqWLijluf" style="text-align: right" title="Warrants issued for services">1,090,077</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">      </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">          </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued for convertible promissory notes conversion</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1AqbQQUibF" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="-sec-ix-hidden: xdx2ixbrl1191">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRyQZirti5dk" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="background-color: white">1,315,494</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpasGYdiI2bh" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331_zQQvO0ugp1m1" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="background-color: white">1,315,494</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_zYuW8xC341kh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with our acquisition of Gemini, we used the Level 2 inputs in estimating the fair value of the transaction. Please refer to Note 14.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOmWg1FYe6sf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 34.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zn1X3BBHMVL9" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>March 31,</b></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><b>2021</b></p></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Risk free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zLe4pmZsmudh" title="Fair value assumptions, measurement input, percentages">3.9</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zpuVTmJnd4e1" title="Fair value assumptions, measurement input, percentages">1.21</span>%-<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zCNh7Z2RiBM9" title="Fair value assumptions, measurement input, percentages">1.74</span></span></td><td style="width: 1%; text-align: left">%</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 14%"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zXWi3IYZ88ve" title="Fair value assumptions, measurement input, percentages">0.32</span>%-<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_ztlto5DJtin" title="Fair value assumptions, measurement input, percentages">0.38</span></td> <td style="text-align: left; width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zpmkB3QOsVDh" title="Fair value assumptions, measurement input, percentages">77.5</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zwW122s2xomi" title="Fair value assumptions, measurement input, percentages">89.1</span>%-<span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zb3RBYhO3PG9" title="Fair value assumptions, measurement input, percentages">90.7</span></span></td><td style="text-align: left">%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zYFn0gWXWUF8" title="Fair value assumptions, measurement input, percentages">88.9</span>%-<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z5C5ZItYh2f" title="Fair value assumptions, measurement input, percentages">90.4</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zr5D3prb549g" title="Fair value assumptions, measurement input, percentages">2.5</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zzxOxg8Yubs1" title="Fair value assumptions, measurement input, percentages">2.5</span> years</span></td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zn2IQoCLZfh4" title="Fair value assumptions, measurement input, percentages">2.5</span> years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zASChOxtA3Od" title="Fair value assumptions, measurement input, percentages">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zt6gwFNADomd" title="Fair value assumptions, measurement input, percentages">0</span></td><td style="text-align: left">%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20210331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zilzVEdb4pc4" title="Fair value assumptions, measurement input, percentages">0</span></td> <td style="text-align: left">%</td></tr> </table> 3.9 1.21 1.74 0.32 0.38 77.5 89.1 90.7 88.9 90.4 P2Y6M P2Y6M P2Y6M 0 0 0 <p id="xdx_89B_ecustom--ScheduleOfStockholdersEquityWarrantsOrRightsTableTextBlock_zc5RAE6RF51e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zk1SJM288zF5" style="display: none">SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted <br/> Active<br/> Markets <br/> for<br/> Identified<br/> Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">(Level 1)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Level 2)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Level 3)</td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Warrants issued for services</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT1xyXp1wjj1" style="width: 11%; text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1175">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRvtPowVTFq6" style="width: 11%; text-align: right" title="Warrants issued for services">427,639</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--WarrantsIssuedForServices_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWPLAh8J9Jaa" style="width: 11%; text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--WarrantsIssuedForServices_c20220401__20230331_zKNDUzYHPWU7" style="width: 11%; text-align: right" title="Warrants issued for services">427,639</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">March 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants issued for services"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued for services</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdKpWPD6abyi" style="text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1183">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zO1CvqdndZTa" style="text-align: right" title="Warrants issued for services"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090,077</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--WarrantsIssuedForServices_c20210401__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZ6WNVdF3GS7" style="text-align: right" title="Warrants issued for services"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WarrantsIssuedForServices_c20210401__20220331_zRGuqWLijluf" style="text-align: right" title="Warrants issued for services">1,090,077</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">      </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">          </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued for convertible promissory notes conversion</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1AqbQQUibF" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="-sec-ix-hidden: xdx2ixbrl1191">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRyQZirti5dk" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="background-color: white">1,315,494</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpasGYdiI2bh" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--StockAndWarrantsIssuedForConvertiblePromissoryNotes_c20200401__20210331_zQQvO0ugp1m1" style="text-align: right" title="Warrants issued for convertible promissory notes conversion"><span style="background-color: white">1,315,494</span></td><td style="text-align: left"> </td></tr> </table> 427639 427639 1090077 1090077 1315494 1315494 <p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_zCHosbJaiTl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zvceze7Iwnjc">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z5Y1DqEJsnn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zHhi9AFVcj41">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income or expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--CompensatedAbsencesPolicy_zCwrKtwn3MX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zW5W9JuWhfwk">Compensated Absences</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We accrue a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General (“ASC 710”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zlozuQOdVi1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z1d7aPchJyC4">Research and Development</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ExciseTaxPolicyTextBlock_z64KmcSxoXT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zzboR0ctQxEd">Excise Tax</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an <span id="xdx_90E_ecustom--ExciseTaxPercentage_iI_pid_dp_uPure_c20230331_zFaX71Kk7zIi" title="Excise tax percentage">11</span>% excise tax for all products sold into these channels. During the years ended March 31, 2023, 2022, and 2021, we recognized approximately $<span id="xdx_908_ecustom--ExciseTaxAmount_pn5n6_c20220401__20230331_zyrVZJ1gsiF9" title="Excise tax amount">9.8</span> million, $<span id="xdx_90C_ecustom--ExciseTaxAmount_pn5n6_c20210401__20220331_z6vbnKSzdVR6" title="Excise tax amount">14.6</span> million, and $<span id="xdx_90C_ecustom--ExciseTaxAmount_pn5n6_c20200401__20210331_zWrpOmv9gsL4" title="Excise tax amount">4.3</span> million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of goods sold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0.11 9800000 14600000 4300000 <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zBAKZGfpo3jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zO1qWTiwdjI6">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”). Which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors. We measure stock compensation based on reference to the closing fair market value of our Common Stock on the date of grant. Stock-based compensation is recognized on a straight line basis over the vesting periods and forfeitures are recognized in the periods they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zGPah4jPE8u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zpZLjOnZBz6e">Concentrations of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20230331__srt--RangeAxis__srt--MaximumMember_zyT7LQF6FHv2" title="Cash FDIC insured amount">250,000</span>. As of March 31, 2023, our bank account balances exceeded federally insured limits, however, we have not incurred losses related to these deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_z8xke6J7HV7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zjDSQarPltU6">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. <span id="xdx_90C_eus-gaap--IncomeTaxExaminationDescription_c20220401__20230331_ztViNe0Njig3" title="Income tax examination, description">We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized.</span> We reflect changes in recognition or measurement in the period in which the change in judgment occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. <p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zYAq4eZ6ohH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zxAnRi7NsxQ1">Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 24, 2019, the Company received notice that a former employee that had voluntarily terminated filed a complaint against the Company, and certain individuals, with the U.S. Department of Labor (“DOL”). The Complaint in alleges that the individual reported potential violations of SEC rules and regulations by management and that as a result of such disclosures, the individual experienced a hostile work environment; that the Company lacks sufficient internal controls, and that the individual was the victim of retaliation and constructive discharge after being removed as a director by majority vote of the shareholders. The claims were investigated by a newly appointed Special Investigative Committee made up of independent directors represented by special independent legal counsel. The Special Investigative Committee and legal counsel found the material claims were unsubstantiated, including those concerning alleged SEC violations, and recommended enhancements to certain corporate governance charter documents and processes which the Company promptly implemented. The parties participated in a successful mediation at the end of June 2022 and all matters relating to this former employee/claimant were confidentially resolved with the lawsuit dismissed with prejudice.  The settlement was covered by our Employment Practices Liability Policy and did not amount to a material amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, AMMO filed a Texas state court complaint against Expansion Industries pursing eight (8) claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e., Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO has since moved aggressively to further the process, including successfully garnishing a portion of the deposit monies in Expansion bank accounts, filing a Motion for Summary Judgement, continuing to pursue written discovery, and amending the Complaint to add Expansion principal as an individual party. The putative primer manufacturer settled the two related lawsuits in September 2022 by repaying all deposit monies due AMMO, in addition to payment of principally all fees and costs incurred by the Company in pursuit of the resolution. The principal lawsuit and AMMO’s garnishment action adverse the defendant were dismissed with prejudice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Along with countless other suppliers of Remington Outdoors, AMMO was served with an avoidance claim lawsuit by the bankruptcy trustee. AMMO presented substantial “ordinary course” defense evidence to the Trustee and the case was settled for a nominal sum in September 2022, with the lawsuit dismissed with prejudice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMMO is defending two contract arbitration cases adverse former employees that are presently in discovery, one involving an employee terminated for cause and the second action involving a termination without cause wherein the former employee is seeking contract wages, commissions and allegedly earned common stock. Discovery is ongoing at this time in the employment arbitration matters. While discovery continues, the Company received a favorable ruling on a partial motion for summary judgment in the “for cause” arbitration case wherein the arbitrator ruled the employee had stolen funds and thus granted the Company’s dispositive motion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also received notice in October 2022 that an OSHA whistleblower complaint had been filed with the US Department of Labor by an employee that had been terminated for cause. The regulatory filing was received after AMMO refused to capitulate to the former employee’s demands. AMMO has produced documents and submitted its position statement to OSHA and the matters is currently pending at the agency level.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2023, Director and shareholder Steve Urvan filed suit in the Delaware Chancery Court against the Company, certain Directors, former directors, employees, former employees and consultants, seeking rescission of the Company’s acquisition of GunBroker.com and certain affiliated companies. Plaintiff Urvan’s claims include rescission, misrepresentation and fraud. The Company is currently in communications with its insurance carriers as concerns coverage (defense and indemnification), has engaged counsel and formal/legal service of process is being coordinated at this time. The Company and named defendants are in alignment in all respects, reasonably believe at this date that the claims are without merit and the Company has engaged Delaware Chancery Court litigation specialists to defend its interests in all respects in this case. There were no other known contingencies at March 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6D2koRRnqz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zeebepUi9Da1">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit loss (“CECL”) methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The guidance should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. The guidance is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. We anticipate that this ASC will not have a material effect on the Company’s financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires specific disclosures for equity securities subject to contractual sale restrictions. These changes will become effective for the Company on April 1, 2024, with early adoption permitted. We are currently evaluating the potential impact of these changes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</span></p> <p id="xdx_801_eus-gaap--EarningsPerShareTextBlock_zmds0LyzXTa5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_821_zj2LTQEScnse">INCOME/(LOSS) PER COMMON SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We calculate basic income/(loss) per share using the weighted-average number of shares of common stock outstanding during each reporting period. Diluted loss per share includes potentially dilutive securities, such as outstanding options and warrants. We use the treasury stock method, in the determination of dilutive shares outstanding during each reporting period. We have issued warrants to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zljZ3o4D8vAa" title="Warrants to purchase shares">2,460,946</span> shares of common stock. Due to the loss from operations in the year ended March 31, 2023, there are no common shares added to calculate the dilutive loss per share for that period as the effect would be antidilutive. The Company excluded warrants of <span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220401__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zCbSMo9WjnO5" title="Weighted average number of shares outstanding, diluted">2,406,946</span> for the year ended March 31, 2023 and warrants of <span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zue1FubLrFo8" title="Weighted average number of shares outstanding, diluted">150,000</span> and equity incentive awards of <span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityIncentiveAwardsMember_zOJpnwG4Cxgd" title="Weighted average number of shares outstanding, diluted">20,000</span> for the year ended March 31, 2022, from the weighted average diluted common shares outstanding because their inclusion would have been antidilutive.</span></p> <p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ztXB0E6gfLV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zT5c4H4DHmQ8" style="display: none">SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220401__20230331_zlag61oC6qOc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td> </td> <td id="xdx_49F_20210401__20220331_zO6VZfiCabId" style="text-align: right">2022</td> <td> </td> <td> </td> <td colspan="2" id="xdx_494_20200401__20210331_zVSVONUVhnxg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended <br/> March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--NetIncomeLoss1_maNILATznMm_zgZXlfxNtXZ7" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Net income/(loss)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(4,596,038</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 14%">33,247,436</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(7,182,294</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--PreferredStockDividendsIncomeStatementImpact1_iN_di_msNILATznMm_zEbzuvkOybf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,105,034</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(2,668,648</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--NetIncomeLossAvailableToCommonStockholdersBasic1_iT_mtNILATznMm_zK6U97Ikm868" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net income/(loss) attributable to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,701,072</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">30,578,788</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,182,294</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zWEe8Uxwy6ck" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted averaged shares of common stock - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">117,177,885</td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right">112,328,680</td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,041,502</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Effect of dilutive common stock purchase warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1259">-</span></td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right">1,861,040</td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of dilutive equity incentive awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1263">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1265">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_z28tuQcD8Bki" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares of common stock - Diluted</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">117,177,885</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">114,189,720</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,041,502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Basic earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_pid_zjESHBfLys97" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income/(loss) per share attributable to common stockholders - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.14</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Diluted earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareDiluted_pid_zvCPEQBTNIwe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income/(loss) per share attributable to common stockholders - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.14</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A6_z540DU1NN0jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2460946 2406946 150000 20000 <p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ztXB0E6gfLV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zT5c4H4DHmQ8" style="display: none">SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220401__20230331_zlag61oC6qOc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td> </td> <td id="xdx_49F_20210401__20220331_zO6VZfiCabId" style="text-align: right">2022</td> <td> </td> <td> </td> <td colspan="2" id="xdx_494_20200401__20210331_zVSVONUVhnxg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended <br/> March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--NetIncomeLoss1_maNILATznMm_zgZXlfxNtXZ7" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Net income/(loss)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(4,596,038</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 14%">33,247,436</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(7,182,294</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--PreferredStockDividendsIncomeStatementImpact1_iN_di_msNILATznMm_zEbzuvkOybf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,105,034</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(2,668,648</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--NetIncomeLossAvailableToCommonStockholdersBasic1_iT_mtNILATznMm_zK6U97Ikm868" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net income/(loss) attributable to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,701,072</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">30,578,788</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,182,294</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zWEe8Uxwy6ck" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted averaged shares of common stock - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">117,177,885</td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right">112,328,680</td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,041,502</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Effect of dilutive common stock purchase warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1259">-</span></td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right">1,861,040</td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of dilutive equity incentive awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1263">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1265">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_z28tuQcD8Bki" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares of common stock - Diluted</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">117,177,885</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">114,189,720</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,041,502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Basic earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_pid_zjESHBfLys97" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income/(loss) per share attributable to common stockholders - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.14</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Diluted earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareDiluted_pid_zvCPEQBTNIwe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income/(loss) per share attributable to common stockholders - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.14</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -4596038 33247436 -7182294 3105034 2668648 -7701072 30578788 -7182294 117177885 112328680 55041502 1861040 117177885 114189720 55041502 -0.07 0.27 -0.14 -0.07 0.27 -0.14 <p id="xdx_80C_eus-gaap--AccountsAndNontradeReceivableTextBlock_zesNhkAbOS1h" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_823_zlo0pFWkYM8b">ACCOUNTS RECEIVABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zKaQvkzxjlRk" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our net accounts receivable are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span id="xdx_8B7_zNML6GuMCuY4" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_497_20230331_zk1wLATTP2b3" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_495_20220331_z8yvwln2634b" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsReceivableGrossCurrent_iI_maARNCz5f8_zOq5KAm9bSMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">32,592,931</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47,010,336</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_msARNCz5f8_zcIOAATWAmFg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,246,551</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,055,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_iTI_mtARNCz5f8_zewGsaz1KR0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,346,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">43,955,084</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following presents a reconciliation of our allowance for doubtful accounts for the periods presented:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%">March 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20210401__20220331_z59EVINNfv7a" style="width: 18%; text-align: right" title="Allowance for doubtful accounts receivable">148,540</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Increase in allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_c20210401__20220331_z7xjahJbr9jd" style="text-align: right" title="Increase in allowance">2,903,304</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Write-off of uncollectible amounts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_c20210401__20220331_zQQORYqWMRp8" style="text-align: right" title="Write-off of uncollectible amounts">(12,703</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Purchase accounting</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsReceivablePurchaseAccounting_c20210401__20220331_zbjyYGGinMRk" style="text-align: right" title="Purchase accounting">16,111</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20220401__20230331_zG6lAvCx5Rdl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Allowance for doubtful accounts receivable, beginning balance">3,055,252</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Increase in allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_c20220401__20230331_zUKyGBCaLq05" style="text-align: right" title="Increase in allowance">2,160,323</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Write-off of uncollectible amounts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_c20220401__20230331_zQye9oWcwbsa" style="text-align: right" title="Write-off of uncollectible amounts">(1,969,024</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20220401__20230331_zdmQgF3ewplj" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for doubtful accounts receivable, ending balance">3,246,551</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_znLg0pA4aqJj" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zKaQvkzxjlRk" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our net accounts receivable are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span id="xdx_8B7_zNML6GuMCuY4" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_497_20230331_zk1wLATTP2b3" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_495_20220331_z8yvwln2634b" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsReceivableGrossCurrent_iI_maARNCz5f8_zOq5KAm9bSMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">32,592,931</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47,010,336</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_msARNCz5f8_zcIOAATWAmFg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,246,551</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,055,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_iTI_mtARNCz5f8_zewGsaz1KR0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,346,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">43,955,084</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following presents a reconciliation of our allowance for doubtful accounts for the periods presented:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%">March 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20210401__20220331_z59EVINNfv7a" style="width: 18%; text-align: right" title="Allowance for doubtful accounts receivable">148,540</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Increase in allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_c20210401__20220331_z7xjahJbr9jd" style="text-align: right" title="Increase in allowance">2,903,304</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Write-off of uncollectible amounts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_c20210401__20220331_zQQORYqWMRp8" style="text-align: right" title="Write-off of uncollectible amounts">(12,703</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Purchase accounting</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsReceivablePurchaseAccounting_c20210401__20220331_zbjyYGGinMRk" style="text-align: right" title="Purchase accounting">16,111</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20220401__20230331_zG6lAvCx5Rdl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Allowance for doubtful accounts receivable, beginning balance">3,055,252</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Increase in allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_c20220401__20230331_zUKyGBCaLq05" style="text-align: right" title="Increase in allowance">2,160,323</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Write-off of uncollectible amounts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_c20220401__20230331_zQye9oWcwbsa" style="text-align: right" title="Write-off of uncollectible amounts">(1,969,024</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20220401__20230331_zdmQgF3ewplj" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for doubtful accounts receivable, ending balance">3,246,551</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 32592931 47010336 3246551 3055252 29346380 43955084 148540 2903304 12703 16111 3055252 2160323 1969024 3246551 <p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zTHceafkNcPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_828_zAcR2B8WXEt7">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z4qeOopVZzo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and March 31, 2022, the inventory balances are composed of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_z35pz1962PXk" style="display: none">SCHEDULE OF INVENTORIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230331_zidIMcMqVBA3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220331_zMDGSFD142ud" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzqZW_zy7gqKlfG3z9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished product</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,362,514</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,167,318</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzqZW_z1xGvVblMYE7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,898,596</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,924,813</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzqZW_zIU4m5nSJLLd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Work in process</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,083,709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,924,021</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryNet_iTI_pp0p0_mtINzqZW_znCN3GeF8pMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,344,819</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,016,152</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_z0ad2ARwyUh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z4qeOopVZzo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and March 31, 2022, the inventory balances are composed of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_z35pz1962PXk" style="display: none">SCHEDULE OF INVENTORIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230331_zidIMcMqVBA3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220331_zMDGSFD142ud" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzqZW_zy7gqKlfG3z9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished product</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,362,514</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,167,318</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzqZW_z1xGvVblMYE7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,898,596</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,924,813</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzqZW_zIU4m5nSJLLd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Work in process</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,083,709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,924,021</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryNet_iTI_pp0p0_mtINzqZW_znCN3GeF8pMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,344,819</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,016,152</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 14362514 6167318 23898596 33924813 16083709 18924021 54344819 59016152 <p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zC1SkWYaauy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_829_zdvsSQBBDhcc">PROPERTY, PLANT AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zM2TKtXOm0E9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following at March 31, 2023 and March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zJSkhuyD7dFg" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zY0L1PYP7kmf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220331_zw3I9xC4BxUg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zcEbgYk3NMH3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Leasehold Improvements</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">257,009</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">257,009</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zaWcqCbAyR21" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Building and Improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,623,329</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1332">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0QG6qhkwXIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and Fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">384,650</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">343,014</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zb3HVMnf4jW9" style="vertical-align: bottom; background-color: White"> <td>Vehicles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,254</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,254</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zFMjzQGY22l4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,233,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,524,850</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingMember_zoZLqcf80nq2" style="vertical-align: bottom; background-color: White"> <td>Tooling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,710</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_z8hRV6Q7Zlqj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Construction in Progress</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">734,781</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,335,371</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzEOT_z8EiebZClKhc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total property and equipment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">70,529,919</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">47,757,208</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzEOT_zjzd4vOhhhzk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14,566,664</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,119,402</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--PropertyPlantAndEquipmentNet1_iTI_pp0p0_mtPPAENzEOT_zavT7Z6lYTa9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net property and equipment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,963,225</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">37,637,806</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zxNE970i58ed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation Expense for the years ended March 31, 2023, 2022, and 2021 totaled $<span id="xdx_90F_eus-gaap--Depreciation_c20220401__20230331_zGGMvAEy1Hei" title="Depreciation">4,452,908</span>, $<span id="xdx_901_eus-gaap--Depreciation_c20210401__20220331_zkZ5En6TFIye" title="Depreciation">4,266,126</span>, and $<span id="xdx_90D_eus-gaap--Depreciation_c20200401__20210331_zwQFTDnIm3db" title="Depreciation">2,904,968</span>, respectively. Of these totals $<span id="xdx_90D_eus-gaap--Depreciation_pp0p0_c20220401__20230331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zWSdsVese6a1" title="Depreciation expense">3,747,723</span>, $<span id="xdx_907_eus-gaap--Depreciation_c20210401__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zKyUNsVuL2Q4" title="Depreciation expense">3,101,929</span>, and $<span id="xdx_900_eus-gaap--Depreciation_c20200401__20210331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zG6j5UqKlBIe" title="Depreciation expense">2,674,161</span> were included in cost of goods sold for the years ending March 31, 2023, 2022, and 2021. Additionally, $<span id="xdx_90D_eus-gaap--Depreciation_pp0p0_c20220401__20230331__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingExpenseMember_ztBUxgVtNiB4" title="Depreciation expense">705,185</span>, $<span id="xdx_90F_eus-gaap--Depreciation_c20210401__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingExpenseMember_z5bA2gTcoIQ6" title="Depreciation expense">1,164,197</span>, and $<span id="xdx_906_eus-gaap--Depreciation_c20200401__20210331__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingExpenseMember_zp3Te9s6QU4g" title="Depreciation expense">230,797</span> were included in depreciation and amortization expenses in operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zM2TKtXOm0E9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following at March 31, 2023 and March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zJSkhuyD7dFg" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zY0L1PYP7kmf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220331_zw3I9xC4BxUg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zcEbgYk3NMH3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Leasehold Improvements</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">257,009</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">257,009</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zaWcqCbAyR21" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Building and Improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,623,329</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1332">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0QG6qhkwXIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and Fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">384,650</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">343,014</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zb3HVMnf4jW9" style="vertical-align: bottom; background-color: White"> <td>Vehicles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,254</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,254</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zFMjzQGY22l4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,233,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,524,850</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingMember_zoZLqcf80nq2" style="vertical-align: bottom; background-color: White"> <td>Tooling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,710</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_z8hRV6Q7Zlqj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Construction in Progress</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">734,781</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,335,371</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzEOT_z8EiebZClKhc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total property and equipment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">70,529,919</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">47,757,208</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzEOT_zjzd4vOhhhzk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14,566,664</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,119,402</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--PropertyPlantAndEquipmentNet1_iTI_pp0p0_mtPPAENzEOT_zavT7Z6lYTa9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net property and equipment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,963,225</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">37,637,806</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 257009 257009 28623329 384650 343014 153254 153254 40233186 32524850 143710 143710 734781 14335371 70529919 47757208 14566664 10119402 55963225 37637806 4452908 4266126 2904968 3747723 3101929 2674161 705185 1164197 230797 <p id="xdx_801_ecustom--FactoringLiabilityTextBlock_zg6wid1vlJm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_825_zQ1VpG9RHkd9">FACTORING LIABILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2019, we entered into a Factoring and Security Agreement with Factors Southwest, LLC (“FSW”). FSW may purchase from time to time the Company’s Accounts Receivables with recourse on an account by account basis. The twenty-four month agreement contains a maximum advance amount of $<span id="xdx_905_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pp0p0_c20190701__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember_zb1hLPJoC2Lc">5,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on <span id="xdx_90A_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20190628__20190701__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember_ztDF8uXAc6Nf">85</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of eligible accounts and has an annualized interest rate of the Prime Rate published from time to time by the Wall Street Journal plus <span id="xdx_90B_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20190628__20190701__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--PrimeRateMember_zWkE3hayqxJ">4.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. The agreement a contains fee of <span id="xdx_906_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_pid_dp_uPure_c20190628__20190701__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember_zrTYej2749N">3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% ($<span id="xdx_90E_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_pp0p0_c20190628__20190701__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember_zoajnBZGRrH8">150,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) of the Maximum Facility assessed to the Company. Our obligations under this agreement are secured by present and future accounts receivables and related assets, inventory, and equipment. The Company has the right to terminate the agreement, with 30 days written notice, upon obtaining a non-factoring credit facility. This agreement provides the Company with the ability to convert our account receivables into cash. We did not have an outstanding balance on our Factoring liability as of March 31, 2023. As of March 31, 2022, the outstanding balance of the Factoring Liability was $<span id="xdx_903_ecustom--FactoringLiability_c20210401__20220331_zVbOmgSsPyd4" title="Factoring liability">485,671</span>. Interest expense recognized on the Factoring Liability for the year ended March 31, 2023 was $</span><span id="xdx_904_ecustom--InterestExpensesOnFactoringLiability_c20220401__20230331_zvfcec041pG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Interest expenses on factoring liability">153,646</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, including $<span id="xdx_900_ecustom--AmortizationOfCommitmentFee_c20220401__20230331_zGVsH3yKRLq2" title="Amortization of commitment fee">37,500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of amortization of the commitment fee, for the year ended March 31, 2022, $<span id="xdx_907_ecustom--InterestExpensesOnFactoringLiability_c20210401__20220331_zgWd3METX9cl" title="Interest expenses on factoring liability">327,746</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, including $<span id="xdx_900_ecustom--AmortizationOfCommitmentFee_c20210401__20220331_zP0R93XvrHX3" title="Amortization of commitment fee">100,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of amortization of the commitment fee, <span style="background-color: white">for the year ended March 31, 2021, $<span id="xdx_90D_ecustom--InterestExpensesOnFactoringLiability_c20200401__20210331_zTdGtj4i9mVd" title="Interest expenses on factoring liability">305,747</span>, including $<span id="xdx_903_ecustom--AmortizationOfCommitmentFee_c20200401__20210331_zWqUMLUppXg2" title="Amortization of commitment fee">50,000</span> of amortization of the commitment fee.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 17, 2021, this agreement was amended which extended the maturity date to <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20210616__20210617_zQeod9NoTVCl" title="Maturity date">June 17, 2024</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5000000 0.85 0.045 0.03 150000 485671 153646 37500 327746 100000 305747 50000 2024-06-17 <p id="xdx_805_ecustom--InventoryCreditFacilityTextBlock_zTzptNIH3ti3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_82A_zJRAzkrmb8H8">INVENTORY CREDIT FACILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 17, 2020, we entered into a Revolving Inventory Loan and Security Agreement with FSW. FSW will establish a revolving credit line, and make loans from time to time to the Company for the purpose of providing capital. The twenty-four month agreement secured by our inventory, among other assets, contains a maximum loan amount of $<span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pp0p0_c20200617__us-gaap--TypeOfArrangementAxis__custom--RevolvingInventoryLoanAndSecurityAgreementMember__us-gaap--PublicUtilitiesInventoryAxis__custom--EligibleInventoryMember_zqXNAeIY4Phe">1,750,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on eligible inventory and has <span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20200615__20200617__us-gaap--TypeOfArrangementAxis__custom--RevolvingInventoryLoanAndSecurityAgreementMember_zYqWpOWQtnVb">an annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The agreement contains a fee of <span id="xdx_909_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_pid_dp_uPure_c20200615__20200617__us-gaap--TypeOfArrangementAxis__custom--RevolvingInventoryLoanAndSecurityAgreementMember_zFYwFiYD4Pqa">2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the maximum loan amount ($<span id="xdx_904_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200617__us-gaap--TypeOfArrangementAxis__custom--RevolvingInventoryLoanAndSecurityAgreementMember_zQLMAZny3AC4">35,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) assessed to the Company. On July 31, 2020, the Company amended its Revolving Loan and Security Agreement to increase the maximum inventory loan amount to $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200731__us-gaap--TypeOfArrangementAxis__custom--RevolvingInventoryLoanAndSecurityAgreementMember_z3O22pgfoqIf">2,250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. As of March 31, 2022, the outstanding balance of the Inventory Credit Facility was $<span id="xdx_904_ecustom--InventoryCreditFacility_iI_c20230331__us-gaap--CreditFacilityAxis__custom--InventoryCreditFacilityMember_zKTwPqRIDil" title="Inventory credit facility">825,675 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and no outstanding balance remained as of March 31, 2023</span>. Interest expense recognized on the Inventory Credit Facility for the year ended March 31, 2023 was $<span id="xdx_90F_ecustom--InterestExpenseOnFactoringLiability_c20220401__20230331__us-gaap--CreditFacilityAxis__custom--InventoryCreditFacilityMember_zf6GpN9YN2W6" title="Interest expense on factoring liability">6,580</span>, for the year ended March 31, 2022 was $<span id="xdx_909_ecustom--InterestExpenseOnFactoringLiability_c20210401__20220331__us-gaap--CreditFacilityAxis__custom--InventoryCreditFacilityMember_zUVtkpZ0KDb4" title="Interest expense on factoring liability">40,940</span>, including $<span id="xdx_907_ecustom--AmortizationOfAnnualFee_c20210401__20220331__us-gaap--CreditFacilityAxis__custom--InventoryCreditFacilityMember_zPJpTBauhJgi" title="Amortization of annual fee">8,561 </span>of amortization of the annual fee, and <span style="background-color: white">for the year ended March 31, 2021 was $<span id="xdx_90D_ecustom--InterestExpenseOnFactoringLiability_c20200401__20210331__us-gaap--CreditFacilityAxis__custom--InventoryCreditFacilityMember_z3la75673LVg" title="Interest expense on factoring liability">171,414</span>, including $<span id="xdx_906_ecustom--AmortizationOfAnnualFee_c20200401__20210331__us-gaap--CreditFacilityAxis__custom--InventoryCreditFacilityMember_zavaqM2Ip9d1" title="Amortization of annual fee">36,439</span> of amortization of the annual fee.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1750000 an annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%. 0.02 35000 2250000 825675 6580 40940 8561 171414 36439 <p id="xdx_80B_eus-gaap--LesseeOperatingLeasesTextBlock_zGQpY3dM8eY6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_827_zFUez4tnQYvd">LEASES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We lease office, manufacturing, and warehouse space in Scottsdale, AZ, Atlanta and Marietta, GA, and Manitowoc, WI under contracts we classify as operating leases. None of our leases are financing leases. The Scottsdale lease does not include a renewal option. In August of 2021 we extended the lease of our Atlanta offices through May of 2027, accordingly we increased our Right of Use Assets and Operating Lease Liabilities by $<span id="xdx_90E_eus-gaap--OperatingLeaseLiability_iI_c20210930_zS5EbYigdOX2" title="Operating lease liabilities"><span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20210930_zd4zPWY1qnRd" title="Rigjht of use assets">501,125</span></span> at September 30, 2021. In January of 2022, we extended the lease of our second Manitowoc, WI location and increased our Right of Use Assets and Operating Lease Liabilities by $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20220131_zK2eAvInDi18" title="Operating lease liabilities"><span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220131_zjE8akOeLc19" title="Rigjht of use assets">308,326</span></span>. We terminated our lease agreement in our first Manitowoc, WI location during the year ended March 31, 2023. Accordingly, we decreased our Right of Use Assets and Operating Lease Liabilities by $<span id="xdx_908_eus-gaap--OperatingLeaseLiability_iI_c20220131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_z0WmVUJXdqn7" title="Operating lease liabilities"><span id="xdx_906_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zvGcqZNx6CHh" title="Rigjht of use assets">901,076</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023 and March 31, 2022, total Right of Use Assets were $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pid_c20230331_zVyKHqTldhJa" title="Right use of asset">1,261,634</span> and $<span id="xdx_90C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pid_c20220331_z6kIQHTw397g" title="Right use of asset">2,791,850</span>, respectively. As of March 31, 2023 and March 31, 2022, total Operating Lease Liabilities were $<span id="xdx_906_eus-gaap--OperatingLeaseLiability_iI_c20230331_zbqOoF7NGb27" title="Operating lease liability">1,374,224</span> and $<span id="xdx_903_eus-gaap--OperatingLeaseLiability_iI_c20220331_zQ217XSlYyK3" title="Operating lease liability">2,922,780</span>, respectively. The current portion of our Operating Lease Liability on March 31, 2023 and March 31, 2022 is $<span id="xdx_909_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20230331_zlI0D9kJvts7" title="Operating lease liability, current">470,734</span> and $<span id="xdx_905_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20220331_z0ylAua2qDq3" title="Operating lease liability, current">831,429</span>, respectively, and is reported as a current liability. The remaining $<span id="xdx_909_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20230331_zaI1rb2nMbg7" title="Operating lease liability non-current">903,490</span> of the total $<span id="xdx_902_eus-gaap--OperatingLeaseLiability_iI_c20230331_zPV1LzswqrFd" title="Operating lease, liability">1,374,224</span> for the year ended March 31, 2023 and the $<span id="xdx_90A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20220331_zDyXDIttlE8c" title="Operating lease liability non-current">2,091,351</span> of the total $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20220331_z5sHP18tQJS3" title="Operating lease, liability">2,922,780</span> for the year ended March 31, 2022 of the Operating Lease Liability is presented as a long-term liability net of the current portion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated lease expense for the year ended March 31, 2023 was $<span id="xdx_906_eus-gaap--PaymentsForRent_pp0p0_c20220401__20230331_z1K3Pi1l99jk" title="Consolidated lease expense">881,171</span> including $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_pp0p0_c20220401__20230331_z8XdrWq3L8f5" title="Operating lease expense">861,777</span> of operating lease expense and $<span id="xdx_904_ecustom--OtherLeaseOperatingExpenses_pp0p0_c20220401__20230331_zaKNE4NXzUUk" title="[custom:OtherLeaseOperatingExpenses]">19,394</span> of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2022 was $<span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20210401__20220331_zR8eAaTU7vYa" title="Consolidated lease expense">1,221,473</span> including $<span id="xdx_90F_eus-gaap--OperatingLeaseExpense_pp0p0_c20210401__20220331_zaOxwGr90Ya" title="Operating Lease, Expense">1,177,589</span> of operating lease expense and $<span id="xdx_904_ecustom--OtherLeaseOperatingExpenses_c20210401__20220331_zABVviVQjtG3" title="Other Lease Operating Expenses.">43,884</span> of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2021 was $<span id="xdx_900_eus-gaap--PaymentsForRent_c20200401__20210331_zAUVODcv7ku8" title="Consolidated lease expense">844,441</span> including $<span id="xdx_90F_eus-gaap--OperatingLeaseExpense_c20200401__20210331_ztsZH8XeBNh2" title="Operating Lease, Expense">742,433</span> of operating lease expense and $<span id="xdx_90B_ecustom--OtherLeaseOperatingExpenses_c20200401__20210331_z1Ij1dQoChoa" title="Other Lease Operating Expenses.">102,008</span> of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining lease term and weighted average discount rate for operating leases were <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331_zLf6asqJbFZ2" title="Weighted average remaining lease term">3.3</span> years and <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zrgyq9YgBSO6" title="Weighted average discount rate for operating leases">10.0</span>%, respectively at March 31, 2023 and were <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220331_zCTvUGEZgpq6" title="Weighted average remaining lease term">3.5</span> years and <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220331_z6w3UgU7Fjz" title="Weighted average discount rate for operating leases">10.0</span>%, respectively at March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zV5oBvSL2o61" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments under non-cancellable leases as of March 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_ziEO0hhUwUQ5" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Years Ended March 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230331_zfDLDpZvH5ui"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzWWX_zFDRiDrgw2Ve" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: center">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">583,768</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzWWX_z6pgsXGCqXR9" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">387,214</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzWWX_zVG3LSSqXSr9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">351,962</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzWWX_zYP8PrFrbyi2" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">257,508</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzWWX_zA5dwWZVo0Y7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,660</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzWWX_zwQyZ5V24cQl" style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzWWX_zj5D5F3Zxsx7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Lease Payments</span></p></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,624,112</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zbK2i8Mlsbt" style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt">Less: Amount Representing Interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(249,888</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,374,224</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zoRQ1yoPla5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 501125 501125 308326 308326 901076 901076 1261634 2791850 1374224 2922780 470734 831429 903490 1374224 2091351 2922780 881171 861777 19394 1221473 1177589 43884 844441 742433 102008 P3Y3M18D 0.100 P3Y6M 0.100 <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zV5oBvSL2o61" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments under non-cancellable leases as of March 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_ziEO0hhUwUQ5" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Years Ended March 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230331_zfDLDpZvH5ui"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzWWX_zFDRiDrgw2Ve" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: center">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">583,768</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzWWX_z6pgsXGCqXR9" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">387,214</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzWWX_zVG3LSSqXSr9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">351,962</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzWWX_zYP8PrFrbyi2" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">257,508</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzWWX_zA5dwWZVo0Y7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,660</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzWWX_zwQyZ5V24cQl" style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzWWX_zj5D5F3Zxsx7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Lease Payments</span></p></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,624,112</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zbK2i8Mlsbt" style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt">Less: Amount Representing Interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(249,888</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,374,224</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 583768 387214 351962 257508 43660 1624112 249888 1374224 <p id="xdx_801_eus-gaap--DebtDisclosureTextBlock_zjDf4WfTZoW2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_826_zHFtUGX7jBH7">NOTES PAYABLE – RELATED PARTY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the acquisition of the casing division of Jagemann Stamping Company (“JSC”), a $<span id="xdx_907_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20200413__20200414__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zvfmH9xznsEf" title="Payment of note payable related party">10,400,000</span> promissory note was executed on March 14, 2020. The promissory note, under which $<span id="xdx_901_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20190324__20190325__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zRlLFtvpSYa7" title="Payment of note payable related party">500,000</span> was paid on March 25, 2019 using funds raised for the acquisition, had a remaining balance at March 31, 2019 of $<span id="xdx_909_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20190330__20190331__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zaISu9aUkdg9" title="Payment of note payable related party">9,900,000</span>. On April 30, 2019, the original due date of the note was subsequently extended to April 1, 2020. <span id="xdx_907_eus-gaap--DebtInstrumentDescription_c20190401__20190430_zfbO2WzYMxR8" title="Debt instrument, description">The note bears interest per annum at approximately 4.6% payable in arrears monthly</span>. In May of 2019, the Company paid $<span id="xdx_906_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20190501__20190531__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zjb1MXJpescg" title="Repayments of notes payable">1,500,000</span> on the balance of the note. The note is secured by all the equipment purchased from JSC. JSC owned at least five percent (5%) of our shares outstanding from March 2019 through March 16, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-closing of the transaction, it was made apparent that certain equipment that was agreed to be delivered free and clear by the Seller was not achievable as Seller was not able to purchase equipment that Seller had leased. Accordingly, the remaining value of the promissory note was reduced by $<span id="xdx_90F_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20200313__20200314__srt--StatementScenarioAxis__custom--PostClosingTransactionNoteReductionMember_zWT0XgQMwewa" title="Post-closing changes to the purchase price of transaction">2,596,200</span>. As a result of the change to the purchase price of the transaction, the Company reduced Equipment for a net value of $<span id="xdx_902_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20200313__20200314__srt--StatementScenarioAxis__custom--DecreasedEquipmentMember_zvRFQKCf0TK7" title="Post-closing changes to the purchase price of transaction">1,871,306</span>, decreased Other Intangible Assets by $<span id="xdx_906_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20200313__20200314__srt--StatementScenarioAxis__custom--OtherIntangibleAssetReductionMember_zOPfg1j7DH9e" title="Post-closing changes to the purchase price of transaction">766,068</span>, increased Accounts Receivable by $<span id="xdx_905_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20200313__20200314__srt--StatementScenarioAxis__custom--IncreasedAccountsReceivableMember_zT3mDlSEAqWe" title="Post-closing changes to the purchase price of transaction">31,924</span>, and recorded an increase to Deposits for $<span id="xdx_903_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20200313__20200314__srt--StatementScenarioAxis__custom--IncreaseToDepositsMember_z4WzCOstdbZ1" title="Post-closing changes to the purchase price of transaction">9,250</span> worth of equipment that the Company agreed to transfer back to Seller. Consequently, accumulated amortization has decreased by $<span id="xdx_90F_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20200313__20200314__srt--StatementScenarioAxis__custom--DecreasedAccumulatedDepreciationMember_zdSZwmpa6Luk" title="Post-closing changes to the purchase price of transaction">159,530</span>. Additionally, the Company entered into a lease to gain possession of the assets that were originally to be transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 26, 2020, the Company, Enlight Group II, LLC (“Enlight”), the Company’s wholly owned subsidiary and JSC entered into a Settlement Agreement pursuant to which the parties mutually agreed to settle all disputes and mutually release each other from liabilities related to the Amended APA occurring prior to June 26, 2020. Pursuant to the Settlement Agreement, the Company shall pay JSC $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zdee9E2KV70b" title="Principal payments">1,269,977</span> and shall provide JSC with: (i) two new promissory notes, a note of $<span id="xdx_909_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zdNFXLElJ0l7" title="Payment of note payable related party">5,803,800</span> related to the Seller Note and note of $<span id="xdx_900_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--StatementScenarioAxis__custom--InventoryAndServicesMember_zMHbRdAps1le" title="Payment of note payable related party">2,635,797</span> for inventory and services, which was reclassed from accounts payable, both with a maturity date of <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zAWeMECSmuMc" title="Debt instrument maturity date">August 15, 2021</span>, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20200625__20200626__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember_pp0p0" title="Debt monthly payments">204,295</span> to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering. Pursuant to such provision, the Company: (a) <span id="xdx_90F_eus-gaap--DebtInstrumentDescription_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember_zLXHo8IFPo7f" title="Debt description">upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to <span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodShares_c20200625__20200626__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zRCMfZTsdAu8" title="Stock repurchased during period, shares">1,000,000</span> of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20200625__20200626__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zUxf4dWb0c36" title="Debt instrument maturity date">April 1, 2021</span> so long as there are no defaults under the Settlement Agreement.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Settlement Agreement, the Company agreed to forego $<span id="xdx_90D_eus-gaap--ProceedsFromAdvancesForConstruction_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_z5OFSzJMUac8" title="Proceeds from advances for construction">1,000,000</span> in Construction in Progress that the parties had previously agreed to exchange. As a result, the Company recognized a loss in operating expenses for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 5, 2020, the Company paid $<span id="xdx_903_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20201103__20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zYrbWoAbhUu6" title="Payment of note payable related party">6,000,000</span> to JSC allocated as follows: (i) payment in full of Note A, representing the balance due from the Company to JSC relating to the acquisition of Jagemann Munition Components in March 2019 and (ii) $<span id="xdx_90B_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20201103__20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--NoteBMember_zQCu4sWqsayh" title="Payment of note payable related party">592,982</span> remitted in partial payment of Note B, resulting in the parties’ execution of Amended Note B which has a starting principal balance of $<span id="xdx_908_eus-gaap--NotesPayable_iI_pp0p0_c20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z5a0aW92zRne" title="Notes payable related party">1,687,664</span> (“Amended Note B”). The Amended Note B principal balance carries a <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zIr7o8J4lNCh" title="Debt interest rate">9</span>% per annum interest rate and is amortized equally over the thirty six (36) month term. As a result of the payment in full of Note A JSC shall release the accompanying security interest in Company assets which secured Note A. Concurrently, upon entry into Amended Note B, JSC and the Company entered into the First Amendment to General Business Security Agreement to reflect a revised list of collateral in which JSC has a security interest. The total interest expense recognized on Note A was $<span id="xdx_907_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--NoteAMember_zewnNxU2H2V7" title="Interest expenses">216,160</span> for the year ended March 31, 2021. The total interest expense recognized on the original Note B was $<span id="xdx_903_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--NoteBMember_zMlnOwzTZv69" title="Interest expenses">62,876</span> for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s balance of Amended Note B was $<span id="xdx_90D_eus-gaap--NotesPayable_iI_c20230331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zj4IqyMJXyb1" title="Notes payable related party">180,850</span> at March 31, 2023 and $<span id="xdx_900_eus-gaap--NotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zZrtwDAEqWfe" title="Notes payable related party">865,771</span> at March 31, 2022. The Company recognized $<span id="xdx_902_eus-gaap--InterestExpenseDebt_c20220401__20230331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zKkAbUQHy1Ma" title="Interest expenses">48,665</span>, $<span id="xdx_90E_eus-gaap--InterestExpenseDebt_c20210401__20220331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zXe4zFl6oo68" title="Interest expenses">110,518</span>, and $<span id="xdx_901_eus-gaap--InterestExpenseDebt_c20200401__20210331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zLm8zwjMrkS9" title="Interest expenses">60,100</span> in interest expense on Amended Note B for the years ended March 31, 2023, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 3, 2019, the Company entered into a promissory note of $<span id="xdx_90F_eus-gaap--NotesPayable_iI_pp0p0_c20190503__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_zPQ0GMYBy797" title="Promissory note">375,000</span> with a shareholder of the Company. The original interest rate was the applicable LIBOR Rate. The promissory note was amended and <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDateDescription_c20190502__20190503__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zCErgrazOyga" title="Debt instrument maturity date description">the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020</span>. The amended note bears interest at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190503__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_z3PyghQglkMf" title="Debt interest rate">1.25</span>% per month. The Company made $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20200401__20201231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_zRIkzBJtbuX7" title="Principal payments">18,195</span> in principal payments during the nine months ended December, 2020 and the Note was paid in full in July of 2020. We recognized $<span id="xdx_90E_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_zF3ikRGW6Uja" title="Interest expenses">10,327</span> of interest expenses related to the note during the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December of 2019, the Company entered into a Promissory Note of $<span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zxKvp4qYR0Z6" title="Promissory note">90,000</span> with Fred Wagenhals, the Company’s Chief Executive Officer and Chairman of the Board of Directors. The Note originally matured on June 12, 2020 and had an interest rate at the applicable LIBOR Rate. The promissory note has since been amended and the amended maturity date is <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20190101__20190331__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zpzsmADsaDCd" title="Debt instrument maturity date">September 18, 2020</span>. The Company made $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20200401__20210331__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z94Vuuy8DIwb" title="Principal payments">25,000</span> in principal payments during the year ended March 31, 2021 and the Note was paid in full in July of 2020. The amended note bears interest at <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_uPure_c20191231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember_zzwg7t6RIfM9" title="Debt interest rate">1.25</span>% per month. We recognized $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zCBSv527TPIh" title="Interest expenses">5,350</span> of interest expense on the note for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 23, 2020, the Company and Enlight entered into a promissory note (the “Forest Street Note”) with Forest Street, LLC (“Lender”), an Arizona limited liability company wholly owned by our current Chief Executive Officer, Fred Wagenhals, for the principal sum of $<span id="xdx_903_eus-gaap--NotesPayable_iI_pn5n6_c20200923__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zHLWxGNC8kOk" title="Promissory note">3.5</span> million, which accrues interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200923__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z37tYZ3qb1ai" title="Debt interest rate">12</span>% per annum. The Note has a maturity date of September 23, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the Forest Street Note, <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDateDescription_c20200922__20200923__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zR3wrRtDubi5" title="Debt instrument maturity date description">the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 14, 2020, the Company entered into a Debt Conversion Agreement with the Lender Pursuant to the Agreement, the Company and Forest Street agreed to convert $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20201213__20201214__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_z1cRZxS8pdm6" title="Debt conversion, converted Instrument, amount">2,100,000</span> of the Note’s principal into <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20201213__20201214__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7nvkTzdBhng" title="Debt conversion, converted instrument, shares issued">1,000,000</span> shares of the Company’s common stock. The share issuance occurred on December 15, 2020. As a result of the Debt Conversion Agreement the remaining balance of the Forest Street Note was $<span id="xdx_90B_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20201213__20201214__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_zFRrFJgDoSoc" title="Payment of note payable related party">1,400,000</span>. On January 14, 2021, the Company paid the remaining $<span id="xdx_90B_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20201213__20201214__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_zk5kOK9r1hv2" title="Payment of note payable related party">1,400,000</span> in principal and accrued interest of the Forest Street Note. The Company recognized $<span id="xdx_907_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_zlbIylHlESj8" title="Interest expenses">137,666</span> in interest expense related to the Forest Street Note for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 22, 2021, the Company repurchased <span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodShares_c20210119__20210122__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--AmendedAPAMember_zgD3WuHnoe5b">1,000,000</span> shares of the Company’s common stock issued to JSC at a price of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210122__us-gaap--TypeOfArrangementAxis__custom--AmendedAPAMember__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember_zDw5YEHuWmod" title="Shares issued, price per share">1.50</span> per share pursuant to the Amended APA.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 10400000 500000 9900000 The note bears interest per annum at approximately 4.6% payable in arrears monthly 1500000 2596200 1871306 766068 31924 9250 159530 1269977 5803800 2635797 2021-08-15 204295 upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement. 1000000 2021-04-01 1000000 6000000 592982 1687664 0.09 216160 62876 180850 865771 48665 110518 60100 375000 the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020 0.0125 18195 10327 90000 2020-09-18 25000 1.25 5350 3500000 0.12 the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon. 2100000 1000000 1400000 1400000 137666 1000000 1.50 <p id="xdx_80E_ecustom--ConstructionNotePayableDisclosureTextBlock_zNWChOF96vf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE 11 – <span id="xdx_827_zzaUJRgHaIP9">CONSTRUCTION NOTE PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On October 14, 2021, we entered into a Construction Loan Agreement (the “Loan Agreement”) with Hiawatha National Bank (“Hiawatha”). The Loan Agreement specifies that Hiawatha may lend up to $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20211014__us-gaap--TypeOfArrangementAxis__custom--ConstructionLoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember__srt--RangeAxis__srt--MaximumMember_zfNnGGQhPu8" title="Debt face amount">11,625,000</span> to the Borrower to pay a portion of the construction costs of an approximately <span id="xdx_900_eus-gaap--AreaOfLand_iI_usqft_c20211014__us-gaap--TypeOfArrangementAxis__custom--ConstructionLoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember_zkUuxIAmbg8g" title="Area of land">160,000</span> square foot manufacturing facility to be constructed on our property (the “Loan”). The first advance of Loan funds by Hiawatha was made on October 14, 2021 in the amount of $<span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20211013__20211014__us-gaap--TypeOfArrangementAxis__custom--ConstructionLoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember__us-gaap--RelatedPartyTransactionAxis__custom--FirstAdvanceMember_zrtu6kLfhjec" title="Proceeds from notes payable">329,843</span>. We <span style="background-color: white">received </span> advances of Loan funds approximately every month as our “owner’s equity” <span style="background-color: white">was </span> fully funded into the ongoing new plant construction project. The Loan is an advancing term loan and not a revolving loan so any portion of the principal repaid cannot be reborrowed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Additionally, on October 14, 2021, we issued a Promissory Note in favor of Hiawatha (the “Note”) in the amount of up to $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20211014__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember__srt--RangeAxis__srt--MaximumMember_zCPTPTYhfyu6" title="Debt face amount">11,625,000</span> with an interest rate of four and one-half percent (<span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211014__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember_z27ir8uXWJX1" title="Debt interest rate">4.5</span>%). The maturity date of the Note is <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20211013__20211014__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember_zs9Rphlimbve" title="Debt maturity date">October 14, 2026</span>. Under the terms of the Loan Agreement, we are required to make monthly payments of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPayment_c20211013__20211014__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember__srt--RangeAxis__srt--MaximumMember_zsqML1KOytwa" title="Debt periodic payment">64,620</span> which consists of principial and interest until the maturity date, at which time the remaining principial balance of the Loan would become due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We can prepay the Note in whole or in part starting in July 2022 with a prepayment premium of one percent (<span id="xdx_90B_ecustom--PrepaymentPremiumPercentage_iI_pid_dp_uPure_c20211014__us-gaap--TypeOfArrangementAxis__custom--ConstructionLoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember_z8CR66YjxYVf" title="Prepayment premium of note amount, percentage">1</span>%) of the principal being prepaid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span id="xdx_90C_eus-gaap--DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_c20211013__20211014__us-gaap--TypeOfArrangementAxis__custom--ConstructionLoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember_zxwUHm4wYD3g" title="Debt default, description">The Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Loan Agreement or Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of five percent (5%) of the amount due will be owed with all amounts then owed pursuant to the Note bearing interest at an increased rate.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">For the year ended March 31, 2023 approximately $<span id="xdx_906_eus-gaap--ProceedsFromNotesPayable_pn5n6_c20220401__20230331__us-gaap--TypeOfArrangementAxis__custom--ConstructionLoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember_ziHsxjcN7XPh" title="Proceeds from notes payable">11.2</span> million of Loan funds were advanced including $<span id="xdx_901_eus-gaap--CashCollateralForBorrowedSecurities_iI_pn5n6_c20230331__us-gaap--TypeOfArrangementAxis__custom--ConstructionLoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HiawathaNationalBankMember_zQJD66DvccW1" title="Cash collateral or restricted cash">1.0</span> million of cash collateral or restricted cash as security for the Loan. We made $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20220401__20230331_z5ICJICBkeD2" title="Debt instrument principal payment">150,743</span> in principal payments for the year ended March 31, 2023. The restricted cash can be released per the terms documented in the Loan Agreement filed with the Commission on Form 10-Q on February 14, 2022. During the year ended March 31, 2023, $<span id="xdx_906_eus-gaap--RestrictedCashCurrent_iI_c20230331_zF5aBAMFOSCb" title="Restricted cash">500,000</span> of restricted cash was released to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11625000 160000 329843 11625000 0.045 2026-10-14 64620 0.01 The Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Loan Agreement or Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of five percent (5%) of the amount due will be owed with all amounts then owed pursuant to the Note bearing interest at an increased rate. 11200000 1000000.0 150743 500000 <p id="xdx_801_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zPGv88w0IaX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 – <span id="xdx_823_za5DzhFaJdp1">CAPITAL STOCK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our authorized capital consists of <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230331_zMCyQE6ZOJ83" title="Common stock, shares authorized">200,000,000</span> shares of common stock with a par value of $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230331_zZURouHUZad2" title="Common stock, par value">0.001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">During the year ended March 31, 2021, we issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200401__20210331__srt--StatementScenarioAxis__custom--NewIssuanceOfSharesMember_zCLRMMZpmnmf" title="Common stock issued new shares, shares">47,895,828</span> shares of common stock as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20200401__20210331__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zIyMgx1Msgb3" title="Number of shares sold">34,512,143</span> shares were sold to investors for $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200401__20210331__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zO4kuQPOYUr9" title="Number of shares issued for merger, shares">138,564,619</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20200401__20210331__srt--TitleOfIndividualAxis__us-gaap--ConvertibleNotesPayableMember_zx4m4mF4wbM1" title="Number of shares issued for conversion of notes, shares">3,145,481</span> shares were issued for the conversion of convertible promissory notes for $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_pid_c20200401__20210331__srt--TitleOfIndividualAxis__us-gaap--ConvertibleNotesPayableMember_zH5j4RfhREZk" title="Number of shares issued for conversion of notes, value">4,831,206</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20200401__20210331__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSwK9QdGRGJe" title="Stock issued during period shares warrants exercised, shares">6,521,563</span> shares were issued to investors for exercised warrants valued for $<span id="xdx_90E_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pid_c20200401__20210331__srt--TitleOfIndividualAxis__us-gaap--WarrantMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfmTN8MjHh4k" title="Stock issued during period value warrants exercised, value">13,952,336</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--SharesIssuedCashlessExerciseOfWarrantsShares_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0ZqcWV8Uqpi" title="Shares issued cashless exercise of warrants, shares">732,974</span> shares were issued for cashless exercise of <span id="xdx_90D_ecustom--SharesIssuedCashlessExerciseOfWarrants_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zm98RHyRSu06" title="Shares issued cashless exercise of warrants, shares">1,300,069</span> warrants </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zT3Xx0Cc4TGk" title="Number of shares issued for conversion of notes, shares">1,000,000</span> shares were issued pursuant to a debt conversion agreement for $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_pid_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zf8q7jT6zs2e" title="Number of shares issued for conversion of notes, value">2,100,000</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--SharesIssuedForServicesMember_z0cLD0OmU67c" title="Common stock issued for services, shares">943,336</span> shares were issued for services provided to the Company valued at $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pid_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--SharesIssuedForServicesMember_zqwmeUY4e3Eh" title="Common stock issued for services">1,707,500</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20200401__20210331__srt--TitleOfIndividualAxis__custom--EmployeesMembersBoardOfDirectorsMember_z3ItSwzjeAEh" title="Shares issued for employees benefit, shares">1,016,331</span> shares valued at $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pid_c20200401__20210331__srt--TitleOfIndividualAxis__custom--EmployeesMembersBoardOfDirectorsMember_z4k9Jp4ZoNw8" title="Shares issued for employees benefit, value">1,450,359</span> were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20200401__20210331__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LiquidationDamageFeesMember_zQFXCPM8Vh4l" title="Common stock issued for liquidation damage fees, shares">24,000</span> shares were issued to investors for $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueOther_pid_c20200401__20210331__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LiquidationDamageFeesMember_zF3TXwxxL3Nl" title="Common stock issued for liquidation damage fees, value">48,000</span> in liquidation damage fees</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span title="Option grant to repurchase"><span id="xdx_900_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20200401__20210331__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--AmendedAPAMember_zqfDI8EMrwLb" title="Shares repurchased">1,000,000</span></span> shares were repurchased from JSC for a total value of $<span id="xdx_903_eus-gaap--StockRepurchasedAndRetiredDuringPeriodValue_c20200401__20210331_zjt9cb2i0Uoi" title="Stock repurchased and cancelled">1,500,000</span> and subsequently cancelled</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended March 31, 2022, we issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210401__20220331__srt--StatementScenarioAxis__custom--NewIssuanceOfSharesMember_z161c7eqExGi" title="Common stock issued new shares, shares">23,385,780</span> shares of common stock as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20210401__20220331__srt--TitleOfIndividualAxis__custom--GeminiDirectInvestmentsLLCMember_z6k2D38uNL63" title="Number of shares issued for merger, shares">20,000,000</span> shares were issued in connection with our merger of Gemini Direct Investments, LLC valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20210401__20220331__srt--TitleOfIndividualAxis__custom--GeminiDirectInvestmentsLLCMember_zelwPjRKYSf2" title="Number of shares issued for merger, value">142,691,282</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zPaDS1cFyL3d" title="Stock issued during period shares warrants exercised, shares">431,080</span> shares were issued to investors for exercised warrants valued for $<span id="xdx_90A_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zLj0XZvYiBUl" title="Stock issued during period value warrants exercised, value">943,907</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharesIssuedCashlessExerciseOfWarrantsShares_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8jwjBrw7xK">374,584</span> shares were issued for cashless exercise of <span id="xdx_900_ecustom--SharesIssuedCashlessExerciseOfWarrants_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvb8fxBniQKc">443,110</span> warrants</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20210401__20220331_zT96snHbolOf" title="Number of shares issued for services, shares">772,450</span> shares valued at $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--SharesIssuedForServicesMember_zFT1Ayiu07C7" title="Number of shares issued for services, value">1,631,701</span> were issued for services and equipment provided to the Company</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20210401__20220331__srt--TitleOfIndividualAxis__custom--EmployeesMembersBoardOfDirectorsMember_zv8tJC8COPbg" title="Shares issued for employees benefit, shares">1,807,666</span> shares valued at $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20210401__20220331__srt--TitleOfIndividualAxis__custom--EmployeesMembersBoardOfDirectorsMember_z4JBR6zqRWA7" title="Shares issued for employees benefit, value">5,759,000</span> were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended March 31, 2023, we issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220401__20230331__srt--StatementScenarioAxis__custom--NewIssuanceOfSharesMember_zco1wdlFbO1">2,077,059</span> shares of common stock as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zVWfmD5O3V2a" title="Stock issued during period shares warrants exercised, shares">200,003</span> shares were issued to investors for exercised warrants valued for $<span id="xdx_904_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z4ro10ixJsJ6" title="Stock issued during period value warrants exercised, value">101,506</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharesIssuedCashlessExerciseOfWarrantsShares_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3XUFgV7zAc5" title="Shares issued cashless exercise of warrants">99,762</span> shares were issued for cashless exercise of <span id="xdx_90D_ecustom--SharesIssuedCashlessExerciseOfWarrants_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI8liuRnebR3" title="Cashless exercise of warrants">100,000</span> warrants</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20220401__20230331__srt--TitleOfIndividualAxis__custom--EmployeesMembersBoardOfDirectorsMember_zMriPJShotwd" title="Shares issued for employees benefit, shares">1,777,294</span> shares valued at $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20220401__20230331__srt--TitleOfIndividualAxis__custom--EmployeesMembersBoardOfDirectorsMember_zuv3Cslnvsrd" title="Shares issued for employees benefit, value">5,807,779</span> were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zf4Zi9j3Ru0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023, 2022, and 2021 outstanding and exercisable stock purchase warrants consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zJBUiXUxxl9">SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Averaged<br/> Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average Life<br/> Remaining (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Outstanding at March 31, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7p7VXFEZBJh" style="width: 14%; text-align: right" title="Number of shares, outstanding beginning">8,504,372</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhHgPEOiuAPk" style="width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">2.10</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIvR8DGVOFq5" title="Weighted average life remaining years, outstanding beginning">3.60</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbZakuleEa76" style="text-align: right" title="Number of shares, granted">2,925,204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQ46Jyi7DLga" style="text-align: right" title="Weighted average exercise price, granted">2.31</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI5PLeeCCni4" title="Weighted average life remaining years, outstanding granted">2.47</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zr1SgGYz2ks2" style="text-align: right" title="Number of shares, exercised">(7,821,631</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMGLa6CkmCba" style="text-align: right" title="Weighted average exercise price, exercised">2.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziYjffat4OJb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1724">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXNfGF3jubA9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1726">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFkh7UI1FQA5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding ending">3,607,945</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmjE0HZBmOGc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, outstanding ending">2.31</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDwE6suYw0Q6" title="Weighted average life remaining years, outstanding ending">3.24</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercisable at March 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFsQ4ZHykMec" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, exercisable">3,179,730</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iI_pid_c20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zq1algJHgZcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, exercisable">2.27</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjU2obrBxAVl" title="Weighted average life remaining years, exercisable">3.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/> Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Averaged<br/> Exercise Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted<br/> Average Life<br/> Remaining (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Outstanding at March 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbUIg33SPCLi" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares, outstanding beginning">3,607,945</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0fUmqscepB5" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">2.31</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8FvnR6Uc46l" title="Weighted average life remaining years, outstanding beginning">3.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBadyUok03z8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, granted">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHZxdCy17f2c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted">0.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztoJ5zE4QLD5" title="Weighted average life remaining years, outstanding granted">3.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUisSO8kscYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercised">(874,190</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBmQuDPxlSBb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised">1.76</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrCeGYtDQYqa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1756">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdHr0Y0h3q6h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Outstanding at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zA3IbtqzgZKe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, outstanding ending">2,933,755</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zStGvXVuIOzd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zETdy7sPkI63" title="Weighted average life remaining years, outstanding ending">2.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercisable at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpdKLBEh3Fbi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercisable">2,933,755</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5nh9ZzF1a7k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3c93mf6mlG" title="Weighted average life remaining years, exercisable">2.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/> Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Averaged<br/> Exercise Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted<br/> Average Life<br/> Remaining (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Outstanding at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCjpe6aD8uFh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares, outstanding beginning">2,933,755</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXXmRoT7wpya" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrnLo7z6CJzb" title="Weighted average life remaining years, outstanding beginning">2.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGG3XjJWjrti" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, granted">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQvfzjmNq6Rg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted">0.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzYilccGIH14" title="Weighted average life remaining years, outstanding granted">4.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zffLnc3smSj3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercised">(300,003</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKawHhbucoSk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised">0.34</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQOhSaiNIci4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, forfeited or cancelled">(322,806</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zX1cWwr37Ybi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited or cancelled">2.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zydmdoebIx9i" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, outstanding ending">2,460,946</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5B3JmTXw7N6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending">2.46</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztciX9VCpXAl" title="Weighted average life remaining years, outstanding ending">1.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercisable at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWURXm2tVcC6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercisable">2,460,946</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoQSJxVo7Hnl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable">2.46</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrnGgLHRwIn6" title="Weighted average life remaining years, exercisable">1.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, we had <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcasPOlXU7h" title="Warrants outstanding">2,460,946</span> warrants outstanding. <span id="xdx_900_ecustom--IssuanceOfWarrantsDescription_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zc0F5bbnadV2" title="Issuance of warrants, description">Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember__us-gaap--AwardDateAxis__custom--UntilAprilTwoThousandTwentyFiveMember_zu6Pn6eC5pEg" title="Warrants issued to purchase common stock">911</span> shares of Common Stock at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember__us-gaap--AwardDateAxis__custom--UntilAprilTwoThousandTwentyFiveMember_zaVYwJnGgBP1" title="Warrants exercise price">1.65</span> per share until April 2025; (2) warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--AwardDateAxis__custom--UntilAugustTwoThousandTwentyFourMember_zGy0yQfnlPq7" title="Warrants issued to purchase common stock">1,448,758</span> shares of our Common Stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--AwardDateAxis__custom--UntilAugustTwoThousandTwentyFourMember_znXthp5u4Qhk" title="Warrants exercise price">2.00</span> per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember__us-gaap--AwardDateAxis__custom--UntilSeptemberTwoThousandTwentyFourMember_zrtMzAmQjXPc" title="Warrants issued to purchase common stock">474,966</span> shares of Common Stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember__us-gaap--AwardDateAxis__custom--UntilSeptemberTwoThousandTwentyFourMember_zUIrSUhTeKYc" title="Warrants exercise price">2.40</span> until September 2024; (4) warrants to purchase <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFourMember__us-gaap--AwardDateAxis__custom--UntilNovemberTwoThousandTwentyFiveMember_zNfsLXMNhkl3" title="Warrants issued to purchase common stock">386,311</span> shares of Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFourMember__us-gaap--AwardDateAxis__custom--UntilNovemberTwoThousandTwentyFiveMember_zrTFQFP0Gr11" title="Warrants exercise price">2.63</span> until November 2025, and (5) warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFiveMember__us-gaap--AwardDateAxis__custom--UntilFebrauryTwoThousandTwentyFourMember_zsPq4Ds7dXWf" title="Warrants issued to purchase common stock">150,000</span> shares of Common Stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFiveMember__us-gaap--AwardDateAxis__custom--UntilFebrauryTwoThousandTwentyFourMember_zxXAZBgk0wAh" title="Warrants exercise price">6.72</span> until February 2024.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 200000000 0.001 47895828 34512143 138564619 3145481 4831206 6521563 13952336 732974 1300069 1000000 2100000 943336 1707500 1016331 1450359 24000 48000 1000000 1500000 23385780 20000000 142691282 431080 943907 374584 443110 772450 1631701 1807666 5759000 2077059 200003 101506 99762 100000 1777294 5807779 <p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zf4Zi9j3Ru0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023, 2022, and 2021 outstanding and exercisable stock purchase warrants consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zJBUiXUxxl9">SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Averaged<br/> Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average Life<br/> Remaining (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Outstanding at March 31, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7p7VXFEZBJh" style="width: 14%; text-align: right" title="Number of shares, outstanding beginning">8,504,372</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhHgPEOiuAPk" style="width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">2.10</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIvR8DGVOFq5" title="Weighted average life remaining years, outstanding beginning">3.60</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbZakuleEa76" style="text-align: right" title="Number of shares, granted">2,925,204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQ46Jyi7DLga" style="text-align: right" title="Weighted average exercise price, granted">2.31</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI5PLeeCCni4" title="Weighted average life remaining years, outstanding granted">2.47</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zr1SgGYz2ks2" style="text-align: right" title="Number of shares, exercised">(7,821,631</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMGLa6CkmCba" style="text-align: right" title="Weighted average exercise price, exercised">2.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziYjffat4OJb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1724">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXNfGF3jubA9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1726">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFkh7UI1FQA5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding ending">3,607,945</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmjE0HZBmOGc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, outstanding ending">2.31</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDwE6suYw0Q6" title="Weighted average life remaining years, outstanding ending">3.24</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercisable at March 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFsQ4ZHykMec" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, exercisable">3,179,730</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iI_pid_c20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zq1algJHgZcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, exercisable">2.27</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjU2obrBxAVl" title="Weighted average life remaining years, exercisable">3.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/> Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Averaged<br/> Exercise Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted<br/> Average Life<br/> Remaining (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Outstanding at March 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbUIg33SPCLi" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares, outstanding beginning">3,607,945</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0fUmqscepB5" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">2.31</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8FvnR6Uc46l" title="Weighted average life remaining years, outstanding beginning">3.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBadyUok03z8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, granted">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHZxdCy17f2c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted">0.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztoJ5zE4QLD5" title="Weighted average life remaining years, outstanding granted">3.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUisSO8kscYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercised">(874,190</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBmQuDPxlSBb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised">1.76</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrCeGYtDQYqa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1756">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdHr0Y0h3q6h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Outstanding at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zA3IbtqzgZKe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, outstanding ending">2,933,755</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zStGvXVuIOzd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zETdy7sPkI63" title="Weighted average life remaining years, outstanding ending">2.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercisable at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpdKLBEh3Fbi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercisable">2,933,755</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5nh9ZzF1a7k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3c93mf6mlG" title="Weighted average life remaining years, exercisable">2.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/> Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Averaged<br/> Exercise Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted<br/> Average Life<br/> Remaining (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Outstanding at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCjpe6aD8uFh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares, outstanding beginning">2,933,755</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXXmRoT7wpya" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrnLo7z6CJzb" title="Weighted average life remaining years, outstanding beginning">2.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGG3XjJWjrti" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, granted">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQvfzjmNq6Rg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted">0.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzYilccGIH14" title="Weighted average life remaining years, outstanding granted">4.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zffLnc3smSj3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercised">(300,003</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKawHhbucoSk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised">0.34</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQOhSaiNIci4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, forfeited or cancelled">(322,806</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zX1cWwr37Ybi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited or cancelled">2.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zydmdoebIx9i" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, outstanding ending">2,460,946</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5B3JmTXw7N6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending">2.46</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztciX9VCpXAl" title="Weighted average life remaining years, outstanding ending">1.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Exercisable at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWURXm2tVcC6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, exercisable">2,460,946</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoQSJxVo7Hnl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable">2.46</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrnGgLHRwIn6" title="Weighted average life remaining years, exercisable">1.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, we had <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcasPOlXU7h" title="Warrants outstanding">2,460,946</span> warrants outstanding. <span id="xdx_900_ecustom--IssuanceOfWarrantsDescription_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zc0F5bbnadV2" title="Issuance of warrants, description">Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember__us-gaap--AwardDateAxis__custom--UntilAprilTwoThousandTwentyFiveMember_zu6Pn6eC5pEg" title="Warrants issued to purchase common stock">911</span> shares of Common Stock at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember__us-gaap--AwardDateAxis__custom--UntilAprilTwoThousandTwentyFiveMember_zaVYwJnGgBP1" title="Warrants exercise price">1.65</span> per share until April 2025; (2) warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--AwardDateAxis__custom--UntilAugustTwoThousandTwentyFourMember_zGy0yQfnlPq7" title="Warrants issued to purchase common stock">1,448,758</span> shares of our Common Stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--AwardDateAxis__custom--UntilAugustTwoThousandTwentyFourMember_znXthp5u4Qhk" title="Warrants exercise price">2.00</span> per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember__us-gaap--AwardDateAxis__custom--UntilSeptemberTwoThousandTwentyFourMember_zrtMzAmQjXPc" title="Warrants issued to purchase common stock">474,966</span> shares of Common Stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember__us-gaap--AwardDateAxis__custom--UntilSeptemberTwoThousandTwentyFourMember_zUIrSUhTeKYc" title="Warrants exercise price">2.40</span> until September 2024; (4) warrants to purchase <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFourMember__us-gaap--AwardDateAxis__custom--UntilNovemberTwoThousandTwentyFiveMember_zNfsLXMNhkl3" title="Warrants issued to purchase common stock">386,311</span> shares of Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFourMember__us-gaap--AwardDateAxis__custom--UntilNovemberTwoThousandTwentyFiveMember_zrTFQFP0Gr11" title="Warrants exercise price">2.63</span> until November 2025, and (5) warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFiveMember__us-gaap--AwardDateAxis__custom--UntilFebrauryTwoThousandTwentyFourMember_zsPq4Ds7dXWf" title="Warrants issued to purchase common stock">150,000</span> shares of Common Stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--WarrantFiveMember__us-gaap--AwardDateAxis__custom--UntilFebrauryTwoThousandTwentyFourMember_zxXAZBgk0wAh" title="Warrants exercise price">6.72</span> until February 2024.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8504372 2.10 P3Y7M6D 2925204 2.31 P2Y5M19D 7821631 2.08 3607945 2.31 P3Y2M26D 3179730 2.27 P3Y18D 3607945 2.31 P3Y2M26D 200000 0.01 P3Y11M1D 874190 1.76 2933755 2.32 P2Y3M14D 2933755 2.32 P2Y3M14D 2933755 2.32 P2Y3M14D 150000 0.01 P4Y6M 300003 0.34 322806 2.00 2460946 2.46 P1Y7M2D 2460946 2.46 P1Y7M2D 2460946 Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,448,758 shares of our Common Stock at an exercise price of $2.00 per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024. 911 1.65 1448758 2.00 474966 2.40 386311 2.63 150000 6.72 <p id="xdx_80B_eus-gaap--PreferredStockTextBlock_zwYponQEj3eh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_827_zbpLLqnxxUri">PREFERRED STOCK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 18, 2021, the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, voting powers, limitations as to dividends or other distributions, qualifications, terms and conditions of redemption and other terms and conditions of the Series A Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”), as to dividend rights and rights as to the distribution of assets upon the Company’s liquidation, dissolution or winding-up, ranks: (1) senior to all classes or series of Common Stock and to all other capital stock issued by the Company expressly designated as ranking junior to the Series A Preferred Stock; (2) on parity with any future class or series of the Company’s capital stock expressly designated as ranking on parity with the Series A Preferred Stock; (3) junior to any future class or series of the Company’s capital stock expressly designated as ranking senior to the Series A Preferred Stock; and (4) junior to all the Company’s existing and future indebtedness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A Preferred Stock has no stated maturity and is not subject to mandatory redemption or any sinking fund. In the event of the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of shares for the Series A Preferred Stock are entitled to be paid out of the Company’s assets legally available for distribution to its stockholders (<i>i.e.</i>, after satisfaction of all the Company’s liabilities to creditors, if any) an amount equal to $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20210518__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zisTRD0iNSGg" title="Share price">25.00</span> per share of the Series A Preferred Stock, plus any amount equal to any accumulated and unpaid dividends to the date of payment before any distribution or payment may be made to holders of shares of Common Stock or any other class of or series of the Corporation’s capital stock ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will pay cumulative cash dividends on the Series A Preferred Stock when, as and if declared by its board of directors (or a duly authorized committee of its board of directors), only out of funds legally available for payment of dividends. Dividends on the Series A Preferred Stock will accrue on the stated amount of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20210518__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z0eTdUztJPXa" title="Share price">25.00</span> per share of the Series A Preferred Stock at a rate per annum equal to <span id="xdx_902_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20210517__20210518__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zGnqFUWU6zb9" title="Dividend rate">8.75</span>% (equivalent to $<span id="xdx_90E_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20210517__20210518__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zwBZqYeoZ4bg" title="Preferred stock dividend rate per annum">2.1875</span> per year), payable quarterly in arrears. Dividends on the Series A Preferred Stock declared by our board of directors (or a duly authorized committee of our board of directors) will be <span id="xdx_905_eus-gaap--PreferredStockDividendPaymentTerms_c20210517__20210518__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zqGiulVXCDTf" title="Dividend payment terms">payable quarterly in arrears on March 15, June 15, September 15 and December 15.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Series A Preferred Stock is not redeemable by the Company prior to May 18, 2026. However, upon a change of control or delisting event (each as defined in the Certificate of Designations), the Company will have a special option to redeem the Series A Preferred Stock for a limited period of time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 19, 2021, we entered into an underwriting agreement (the “Underwriting Agreement”) with Alexander Capital, L.P., as representative of several underwriters (collectively, the “Underwriters”), relating to a firm commitment public offering of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210519__20210519__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zwI0oxAVvJua" title="Number of common stock shares issued">1,097,200</span> newly issued shares of our 8.75% Series A Preferred Stock at a public offering price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20210519__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zwpM0yqaUZI4" title="Share price">25.00</span> per share. Under the terms of the Underwriting Agreement, we granted the Underwriters a 45-day option to purchase up to an additional <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210519__20210519__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zxPu7lwmBHi4" title="Number of common stock shares issued">164,580</span> shares of Series A Preferred Stock from us. The gross proceeds to us from the sale of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210519__20210519__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z71GzhTBGvha" title="Number of common stock shares issued">1,097,200</span> shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, was $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210519__20210519__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zT2Oq7D3FR66" title="Proceeds from offering">27,430,000</span>. The closing of the offering took place on May 21, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 25, 2021, we entered into an additional underwriting agreement with Alexander Capital, L.P. relating to a firm commitment public offering of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210524__20210525__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z67gjs7j2hic" title="Number of common stock shares issued">138,220</span> newly issued shares of our Series A Preferred Stock at a public offering price of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210525__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zztr4TUiNeTf" title="Share price">25.00</span> per share. The closing of the offering took place on May 27, 2021. The gross proceeds to us from the sale of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210524__20210525__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zlUrLmFrX9Y7" title="Number of common stock shares issued">138,220</span> shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, were $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210524__20210525__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zp9SnGwZNNka" title="Proceeds from offering">3,455,500</span>. Additionally, the Underwriters exercised its previously announced over-allotment option to purchase <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210524__20210525__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZcjS9XjSfJ3" title="Number of common stock shares issued">164,580</span> shares of Series A Preferred Stock pursuant to that certain Underwriting Agreement dated May 19, 2021, by and between us and Alexander Capital, L.P., as representative of the several underwriters identified therein. We closed the exercise of the over-allotment option on May 27, 2021. The gross proceeds from the exercise of the over-allotment option were $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210524__20210525__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpQp5sZQ17Yi" title="Proceeds from offering">4,114,500</span>, before deducting underwriting discounts and commissions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred dividends accumulated as of March 31, 2022 were $<span id="xdx_90F_eus-gaap--DividendsPreferredStock_pp0p0_c20210401__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--AwardDateAxis__custom--AugustTwentySevenTwoThousandTwentyOneMember_z9idXhmuhIwd" title="Accumulated preferred dividends">144,562</span>. On August 27, 2021 the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning May 21, 2021 (the first issuance date of the Series A Preferred Stock) through and including June 30, 2021 payable on September 15, 2021 to holders of record of Series A Preferred Stock on August 31, 2021 equal to $<span id="xdx_901_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20210826__20210827__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdg9FDsMCmN6" title="Preferred stock dividend rate per annum">0.241246528</span> per share. Dividends totaling $<span id="xdx_906_eus-gaap--DividendsPreferredStock_pp0p0_c20210915__20210915__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zAUXiu5UGpb4" title="Accumulated preferred dividends">337,745</span> were paid on September 15, 2021. On November 17, 2021, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning July 1, 2021 through and including December 14, 2021 payable on December 15, 2021 to holders of record of Series A Preferred Stock on November 30, 2021 equal to $<span id="xdx_90B_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20211117__20211117__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zaUDTSco96F8" title="Preferred stock dividend rate per annum">1.01475694444444</span> per share. Dividends totaling $<span id="xdx_901_eus-gaap--DividendsPreferredStock_pp0p0_c20211215__20211215__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zREzFgog5Fbc" title="Accumulated preferred dividends">1,420,660</span> were paid on December 15, 2021. On February 18, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning December 15, 2021 through and including March 14, 2022 payable on March 15, 2022 to holders of record of Series A Preferred Stock on February 28, 2022 equal to $<span id="xdx_90B_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20220217__20220218__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zeOx5JRCV6s" title="Preferred stock dividend rate per annum">0.546875</span> per share. Dividends totaling $<span id="xdx_902_eus-gaap--DividendsPreferredStock_pp0p0_c20220315__20220315__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zXhenSJqQQec" title="Accumulated preferred dividends">765,642</span> were paid on March 15, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Preferred dividends accumulated as of March 31, <span style="background-color: white">2023 </span> were $<span id="xdx_907_eus-gaap--DividendsPreferredStock_pp0p0_c20220401__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThousandTwentyThreeMember_z4fzxRYP1FEf" title="Accumulated preferred dividends">144,618</span>. On February 17<span style="background-color: white">, </span> 2023, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning December 15, 2022 through and including March 14, 2023 payable on March 15, 2023 to holders of record of Series A Preferred Stock on February 28, 2023 equal to $<span id="xdx_902_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20230217__20230217__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zwyChXMaEBoe" title="Preferred stock dividend rate per annum">0.546875</span> per share. <span style="background-color: white">Dividends totaling $<span id="xdx_90A_eus-gaap--DividendsPreferredStock_pp0p0_c20230314__20230315__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zaet54ZwfKr2" title="Accumulated preferred dividends">765,625</span> were paid on March 15, 2023. </span> On November 18, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning September 15, 2022 through and including December 14, 2022 payable on December 15, 2022 to holders of record of Series A Preferred Stock on November 30, 2022 equal to $<span id="xdx_904_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20221117__20221118__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zrGW5AVuIfEk" title="Preferred stock dividend rate per annum">0.5529514</span> per share. Dividends totaling $<span id="xdx_90A_eus-gaap--DividendsPreferredStock_pp0p0_c20221214__20221215__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zJtNIlqt7ick" title="Accumulated preferred dividends">774,132</span> were paid on December 15, 2022. On August 17, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning June 15, 2022 through and including September 14, 2022 payable on September 15, 2022 to holders of record of Series A Preferred Stock on August 31, 2022 equal to $<span id="xdx_90F_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20220816__20220817__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYSoOabpF8zl" title="Preferred stock dividend rate per annum">0.55902778</span> per share. Dividends totaling $<span id="xdx_907_eus-gaap--DividendsPreferredStock_pp0p0_c20220914__20220915__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8NTT6W1fkcl" title="Accumulated preferred dividends">782,639</span> were paid on September 15, 2022. On May 12, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning March 15, 2022 through and including June 14, 2022 payable on June 15, 2022 to holders of record of Series A Preferred Stock on May 31, 2022 equal to $<span id="xdx_90B_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20220511__20220512__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zLaf8WrK49G2" title="Preferred stock dividend rate per annum">0.559027777777778</span> per share. Dividends totaling $<span id="xdx_907_eus-gaap--DividendsPreferredStock_pp0p0_c20220614__20220615__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zlnN7hIAmGo" title="Accumulated preferred dividends">782,639</span> were paid on June 15, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 25.00 25.00 0.0875 2.1875 payable quarterly in arrears on March 15, June 15, September 15 and December 15. 1097200 25.00 164580 1097200 27430000 138220 25.00 138220 3455500 164580 4114500 144562 0.241246528 337745 1.01475694444444 1420660 0.546875 765642 144618 0.546875 765625 0.5529514 774132 0.55902778 782639 0.559027777777778 782639 <p id="xdx_802_eus-gaap--BusinessCombinationDisclosureTextBlock_zSPo0GeTFBLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 – <span id="xdx_821_zrr9Qhj2geJ9">ACQUISITIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gemini Direct Investments, LLC</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2021 (the “Effective Date”) we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Sub”), Gemini Direct Investments, LLC, a Nevada limited liability company (“Gemini”), and Steven F. Urvan, an individual (the “Seller”), whereby Sub merged with and into Gemini, with Sub surviving the merger as a wholly owned subsidiary of the Company (the “Merger”). At the time of the Merger, Gemini had nine (9) subsidiaries, all of which are related to Gemini’s ownership of the Gunbroker.com business. Gunbroker.com is an on-line auction marketplace dedicated to firearms, hunting, shooting, and related products. The Merger was completed on the Effective Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In consideration of the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, on the Effective Date, (i) the Company assumed and repaid an aggregate amount of indebtedness of Gemini and its subsidiaries equal to $<span id="xdx_90D_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20210430__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zJlJ0mF8M9ia" title="Business acquisition, amount">50,000,000</span> (the “Assumed Indebtedness”); and, (ii) the issued and outstanding membership interests in Gemini (the “Membership Interests”), held by the Seller, automatically converted into the right to receive (A) $<span id="xdx_90C_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20210430__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zzZMSpql9zq1" title="Business acquisition, amount">50,000,000</span> (the “Cash Consideration”), and (B) <span id="xdx_90C_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20210429__20210430__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_z0JmTyZ95N56" title="Business acquisition, shares">20,000,000</span> shares of common stock of the Company, $<span id="xdx_90E_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20210430__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zRKiY9V9gBlb" title="Business acquisition, share price">0.001</span> par value per share (the “Stock Consideration”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Merger Agreement, the Company and the Seller agreed that the Stock Consideration consisted of: (a) <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210429__20210430__us-gaap--TypeOfArrangementAxis__custom--WithoutBeingHeldInEscrowOrRequiringPriorStockholderApprovalMember_zySaYGhiUnHc" title="Common stock issued for cash, shares">14,500,000</span> shares issued without being held in escrow or requiring prior stockholder approval; (b) <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210429__20210430__us-gaap--TypeOfArrangementAxis__custom--PledgeAndEscrowAgreementMember_zwRDQ7BZVgG2" title="Common stock issued for cash, shares">4,000,000</span> shares issued subject to the Pledge and Escrow Agreement; and (c) <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210429__20210430__us-gaap--TypeOfArrangementAxis__custom--WillNotBeIssuedPriorToTheStockholderApprovalMember_zq0ni7oDP5Gb" title="Common stock issued for cash, shares">1,500,000</span> shares that will not be issued prior to the Company obtaining stockholder approval for the issuance (the “Additional Securities”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total estimated consideration consisted of cash payment of $<span id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20210429__20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zi1ZScqHpA9k" title="Business combination, cash payment">50,000,000</span> less $<span id="xdx_908_eus-gaap--CashAcquiredFromAcquisition_c20210429__20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_z3Ghh1hSBXqc" title="Business acquisition, cash acquired">1,350,046</span> of acquired cash, a working capital adjustment of $<span id="xdx_907_ecustom--BusinessCombinationsContingentConsiderationLiability_iI_c20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_z01p6l98r5Nf" title="Estimated working capital adjustment">2,000,000</span>, debt assumption and repayment upon closing of $<span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityNoncurrent_iI_c20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zGCgBgyNMuS" title="Contingent consideration payable, net of current portion">50,000,000</span>, contingent consideration of $<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_iI_c20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zOstI9l59DW" title="Contingent consideration, amount">10,755,000</span> for <span id="xdx_90D_ecustom--BusinessCombinationContingentConsiderationSharesIssuedPriorStockholder_pid_c20210429__20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zgv0LMQorzK7" title="Shares issued prior stockholder">1,500,000</span> Additional Securities, and <span id="xdx_908_ecustom--BusinessCombinationAdditionalSecuritiesOfCommonStock_pid_c20210429__20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zXN2UlZACRDc" title="Business combination additional securities of common stock">18,500,000</span> shares of AMMO Inc. Common Stock. The shares were valued at $<span id="xdx_90C_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20210430__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zDoxM3lvarc1" title="Business acquisition, share price">7.17</span> per share, the five-day average closing price of the Company’s Common Stock immediately preceding the signing of the binding agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Merger Agreement, the Company completed a Post-Closing Adjustment following the close of the Merger equal to the Closing Working Capital minus the Estimated Working Capital at closing of the Merger. Accordingly, the Company received a cash payment of $<span id="xdx_907_eus-gaap--PaymentsToAcquireBusinessesGross_c20210429__20210430__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zNJ6meKhbHqc" title="Company received a cash payment">129,114</span> and adjusted the $<span id="xdx_900_ecustom--WorkingCapitalAdjustments_c20210429__20210430_zNVGzKEqKzEh" title="Working capital adjustments">2,000,000</span> Estimated Working Capital Adjustment in the fair value of the consideration transferred to $<span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210429__20210430__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GeminiDirectInvestmentsLLCMember_zKZbRIuX0nT8" title="Consideration transferred">1,870,886</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the acquisition method of accounting for business combinations, the assets acquired, and the liabilities assumed have been recorded at their respective fair values. The consideration in excess of the fair values of assets acquired, and liabilities assumed are recorded as goodwill, which we expect to be deductible for tax purposes. The goodwill consists largely of the growth and profitability expected from this Merger.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_ziVnTbl1zU6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the consideration transferred was valued as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 40pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_znfxsQnm43b8">SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_498_20210430_zesFfyoA6OD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzcno_zIQZPvzxbJ2g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">48,649,954</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessCombinationWorkingCapitalAdjustment_iI_msBCRIAzcno_zp44jGNfRC2b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Working capital adjustment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,870,886</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_iI_msBCRIAzcno_z3Hto2tR6DS2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contingent consideration</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,755,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommonStock_iI_msBCRIAzcno_zRsM4fIuL2k6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Common stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">132,645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_msBCRIAzcno_zH2HYjlmZYq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Assumed debt</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">50,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zrDyvdkU8kZ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of consideration transferred</span><span style="font-family: Times New Roman, Times, Serif"> </span></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">243,920,840</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zaWG5v0i5WWk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zij2SrJqb7p8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allocation for the consideration recorded for the acquisition is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 40pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zjWSFByxKChf">SCHEDULE OF ALLOCATION FOR CONSIDERATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49B_20210430_z9jhshtRLO73" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzEp6_zKsqHR2fa7C3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Accounts receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">17,002,362</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzEp6_zvjOWgJnd1B3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">478,963</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzEp6_zoEM6kkxSoad" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,051,980</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits_iI_maBCRIAzEp6_zPP2BAXiVQg2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">703,389</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherIntangibleAssets_iI_maBCRIAzEp6_zq15TBPYdeE6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Intangible assets<sup id="xdx_F41_zpy85b3jvSIh">(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">146,617,380</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--Goodwill_iI_maBCRIAzEp6_zYUZGSjCPru2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill<sup id="xdx_F4B_zpyaFbjdwKth">(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">90,870,094</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetsOperatingLeases_iI_maBCRIAzEp6_zQws636cCDj1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use assets - operating leases</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">612,727</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzEp6_zU7XtiijjFC3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(12,514,919</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_iNI_di_msBCRIAzEp6_zjw6s2hMBTag" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(196,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iNI_di_msBCRIAzEp6_zEslztBu49H2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Operating lease liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(704,356</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzEp6_zoPh2MxPsRjl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Consideration</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">243,920,840</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F03_zCeLelLfn5xa">(1) </sup></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_ztXuiShjxiGb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business. </span></td></tr> </table> <p id="xdx_8AB_zru4vgzPwvHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recorded approximately $<span id="xdx_90D_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_pn5n6_c20210401__20220331_z5Fs4zDcDnHd" title="Transaction cost">1.3</span> million in transaction costs in the year ended March 31, 2022 related to the above acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unaudited Pro Forma Results of Operations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These pro forma results of operations give effect to the acquisition as if it had occurred on April 1, 2021. Material pro forma adjustments include the removal of approximately $<span id="xdx_90A_ecustom--BusinessAcquisitionsProFormaInterestAndDebtExpense_pn5n6_c20210401__20210401_zS6HkeAkfZ89" title="Business acquisitions pro form a interest and debt expense">1.8</span> million of interest expenses and debt discount amortization and the addition of approximately $<span id="xdx_905_ecustom--BusinessAcquisitionsProFormaDepreciationAndAmortization_pn5n6_c20210401__20210401_z9sW6myBtwnb" title="Business acquisitions pro form a depreciation and amortization">0.9</span> million of depreciation and amortization expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zta8S8sWfLDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zS3Y2mJ3bVWd">SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">INCOME STATEMENT DATA</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210401__20220331_zeohWR0l1yka" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaRevenue_zcb9fDakoQ2h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Net revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">248,314,587</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_z7tL5ThTM2s4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net income</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37,793,924</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zkdt1xKR0JVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited pro forma condensed combined financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations and financial position that would have been achieved had the acquisition been completed and taken place on the dates indicated or the future consolidated results of operations or financial position of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 50000000 50000000 20000000 0.001 14500000 4000000 1500000 50000000 1350046 2000000 50000000 10755000 1500000 18500000 7.17 129114 2000000 1870886 <p id="xdx_890_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_ziVnTbl1zU6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the consideration transferred was valued as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 40pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_znfxsQnm43b8">SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_498_20210430_zesFfyoA6OD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzcno_zIQZPvzxbJ2g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">48,649,954</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessCombinationWorkingCapitalAdjustment_iI_msBCRIAzcno_zp44jGNfRC2b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Working capital adjustment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,870,886</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_iI_msBCRIAzcno_z3Hto2tR6DS2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contingent consideration</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,755,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommonStock_iI_msBCRIAzcno_zRsM4fIuL2k6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Common stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">132,645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_msBCRIAzcno_zH2HYjlmZYq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Assumed debt</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">50,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zrDyvdkU8kZ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of consideration transferred</span><span style="font-family: Times New Roman, Times, Serif"> </span></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">243,920,840</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 48649954 1870886 10755000 132645000 50000000 243920840 <p id="xdx_890_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zij2SrJqb7p8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allocation for the consideration recorded for the acquisition is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 40pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zjWSFByxKChf">SCHEDULE OF ALLOCATION FOR CONSIDERATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49B_20210430_z9jhshtRLO73" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzEp6_zKsqHR2fa7C3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Accounts receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">17,002,362</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzEp6_zvjOWgJnd1B3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">478,963</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzEp6_zoEM6kkxSoad" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,051,980</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits_iI_maBCRIAzEp6_zPP2BAXiVQg2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">703,389</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherIntangibleAssets_iI_maBCRIAzEp6_zq15TBPYdeE6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Intangible assets<sup id="xdx_F41_zpy85b3jvSIh">(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">146,617,380</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--Goodwill_iI_maBCRIAzEp6_zYUZGSjCPru2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill<sup id="xdx_F4B_zpyaFbjdwKth">(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">90,870,094</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetsOperatingLeases_iI_maBCRIAzEp6_zQws636cCDj1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use assets - operating leases</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">612,727</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzEp6_zU7XtiijjFC3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(12,514,919</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_iNI_di_msBCRIAzEp6_zjw6s2hMBTag" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(196,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iNI_di_msBCRIAzEp6_zEslztBu49H2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Operating lease liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(704,356</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzEp6_zoPh2MxPsRjl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Consideration</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">243,920,840</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F03_zCeLelLfn5xa">(1) </sup></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_ztXuiShjxiGb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business. </span></td></tr> </table> 17002362 478963 1051980 703389 146617380 90870094 612727 12514919 196780 704356 243920840 1300000 1800000 900000 <p id="xdx_896_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zta8S8sWfLDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zS3Y2mJ3bVWd">SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">INCOME STATEMENT DATA</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210401__20220331_zeohWR0l1yka" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaRevenue_zcb9fDakoQ2h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Net revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">248,314,587</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_z7tL5ThTM2s4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net income</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37,793,924</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> 248314587 37793924 <p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zyVpwbzXWld8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 – <span id="xdx_822_zjtkS8ifr5ej">ACCRUED LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zKOILsMETWge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and March 31, 2022, accrued liabilities were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zBMKwkOSvXu3">SCHEDULE OF ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230331_z5IcG7ZPo0Ml" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220331_zmZad0W2znYd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_ecustom--AccruedFaet_iI_pp0p0_maALCzKUB_zPFNLNhTiINc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Accrued FAET</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,808,065</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">2,408,318</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzKUB_zEm8y7m08WIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued professional fees</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">736,323</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--IncomeTaxesPayable_iI_maALCzKUB_zjOPbUj2US5k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">403,739</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,749,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maALCzKUB_z2ivy5LVqgI4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued sales commissions</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">252,366</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">932,712</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccruedUnearnedRevenueCurrent_iI_maALCzKUB_zJSei96J21Dl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Unearned revenue</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">101,593</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">201,891</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_pp0p0_maALCzKUB_z1N2Fbt0wXWf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,681</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,762</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maALCzKUB_zUoOr7FzoKX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">430,344</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">458,027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzKUB_zlY1fyuamY93" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accruals</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">618,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">357,616</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzKUB_z0XfizP19KYc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,353,354</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,178,814</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zpRW8XMCQl29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zKOILsMETWge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and March 31, 2022, accrued liabilities were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zBMKwkOSvXu3">SCHEDULE OF ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230331_z5IcG7ZPo0Ml" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220331_zmZad0W2znYd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_ecustom--AccruedFaet_iI_pp0p0_maALCzKUB_zPFNLNhTiINc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Accrued FAET</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,808,065</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">2,408,318</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzKUB_zEm8y7m08WIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued professional fees</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">736,323</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--IncomeTaxesPayable_iI_maALCzKUB_zjOPbUj2US5k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">403,739</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,749,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maALCzKUB_z2ivy5LVqgI4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued sales commissions</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">252,366</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">932,712</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccruedUnearnedRevenueCurrent_iI_maALCzKUB_zJSei96J21Dl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Unearned revenue</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">101,593</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">201,891</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_pp0p0_maALCzKUB_z1N2Fbt0wXWf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,681</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,762</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maALCzKUB_zUoOr7FzoKX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">430,344</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">458,027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzKUB_zlY1fyuamY93" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accruals</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">618,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">357,616</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzKUB_z0XfizP19KYc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,353,354</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,178,814</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1808065 2408318 736323 66000 403739 1749488 252366 932712 101593 201891 2681 4762 430344 458027 618243 357616 4353354 6178814 <p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zBLVMkH7r0ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16– <span id="xdx_82E_zfqAv4JYxYj9">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 3, 2022, AMMO, Inc. (the “Company”) entered into a Settlement Agreement (the “Settlement Agreement”) with Steven F. Urvan and Susan T. Lokey (collectively with each of their respective affiliates and associates, the “Urvan Group”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Settlement Agreement, the Urvan Group has agreed to withdraw its notice of stockholder nomination of its seven director candidates (the “Urvan Candidates”) and its demand to inspect books and records, pursuant to Section 220 of the General Corporation Law of the State of Delaware, and the Company agreed to immediately increase the size of the Board from seven to nine directors and appoint Christos Tsentas and Wayne Walker (each, a “New Director” and the New Directors together with Mr. Urvan, the “Urvan Group Directors”) to the Board to serve as directors with terms expiring at the 2022 annual meeting of stockholders (the “2022 Annual Meeting”). The Company will include the Urvan Group Directors in its director candidates slate for the 2022 Annual Meeting and any subsequent annual meeting of stockholders of the Company occurring prior to the Termination Date (as defined below). The Company has agreed to not increase the size of the Board above nine directors prior to the Termination Date unless the increase is approved by at least seven directors. Mr. Wagenhals will continue to serve as a director and Chairman of the Board.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise mutually agreed to in writing by each party, the Settlement Agreement will remain in effect until the date that is the earlier of (i) 30 days prior to the earlier of (A) the deadline set forth in the notice requirements of Federal “Universal Proxy Rules” promulgated under Rule 14a-19(a) and Rule 14a-19(b) under the Securities Exchange Act of 1934, as amended (the “UPR Deadline”) relating to the Company’s 2023 annual meeting of stockholders (the “2023 Annual Meeting”) and (B) any deadline that may be set forth in the Company’s Amended and Restated Certificate of Incorporation (as amended from time to time, the “Certificate”) or Bylaws (the “Bylaws”) following the execution of the Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2023 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2022 Annual Meeting (such date, the “Termination Date”). However, if the Company notifies Mr. Urvan in writing at least 15 days prior to such Termination Date that the Board irrevocably offers to re-nominate the Urvan Group Directors for election at the 2023 Annual Meeting and Mr. Urvan accepts such offer within 15 days of receipt of such notice, the Termination Date will be automatically extended until the earlier of (i) 30 days prior to the earlier of (A) the UPR Deadline relating to the Company’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”) and (B) any deadline that may be set forth in the Certificate or the Bylaws following execution of the Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2024 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2023 Annual Meeting. Notwithstanding the foregoing, the “Termination Date” shall not occur prior to 20 days after Mr. Urvan’s departure from the Board.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Settlement Agreement, the Company will suspend the previously announced separation of Company into Action Outdoor Sports, Inc. and Outdoor Online, Inc., pending the further evaluation of strategic options by the Board. The Company paid approximately $<span id="xdx_903_eus-gaap--CostsAndExpenses_c20221102__20221103__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zTgvqRYtDwUi" title="Costs, fees and expenses">500,000</span> of the Urvan Group’s costs, fees and expenses per the terms of the Settlement Agreement. Additionally, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221102__20221103__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQA1vlIzGcji" title="Common stock shares issued">125,000</span> shares of Common Stock for a total value of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221102__20221103__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWtudgk6RHra" title="Common stock shares issued, value">437,500</span> to an employee and issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221102__20221103__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zksa5ky8wzmd" title="Common stock shares issued">110,000</span> shares of Common Stock for a total value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221102__20221103__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zFfLjpnHDiRg" title="Common stock shares issued, value">385,000</span> to an independent contractor as a result of termination without cause per the terms of the Settlement Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing summary of the Settlement Agreement does not purport to be complete and is subject to, and qualified in its entirety, by reference to the full text of the Settlement Agreement, a copy of which was previously filed as Exhibit 10.1 in the Form 8-K filed with the SEC on November 7, 2022, and incorporated herein by reference.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended March 31, 2023, we paid $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220401__20230331__srt--TitleOfIndividualAxis__custom--TwoIndependentContractorsMember_zms5Qt0EhrZ2">551,916 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in service fees to two independent contractors of which $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220401__20230331__srt--TitleOfIndividualAxis__custom--TwoIndependentContractorsMember__us-gaap--TypeOfArrangementAxis__custom--ProxySettlementAgreementMember_zux8sY7D91Oa">223,333 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">were created as a result of termination without cause as a result of our Proxy Settlement Agreement. The two independent contractors <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220401__20230331__srt--TitleOfIndividualAxis__custom--TwoIndependentContractorsMember_zcQu7CTRBRl7">141,419 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock for a total value of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220401__20230331__srt--TitleOfIndividualAxis__custom--ForegoingMember_zWhMVyjfTd6f">494,967 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in addition to the issuances described in the foregoing paragraphs. We issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220401__20230331__srt--TitleOfIndividualAxis__custom--AdvisoryCommitteeMember_z6JSgKcryUel">45,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in the aggregate to its advisory committee members for service for a total value of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220401__20230331__srt--TitleOfIndividualAxis__custom--AdvisoryCommitteeMember_zr26GzFk9yr8">129,750</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Through our acquisition of Gemini, a related party relationship was created through one of our Members of the Board of Directors by ownership of entities that transacts with Gemini. We recognized $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BoardOfDirectorsMember__srt--ProductOrServiceAxis__custom--MarketplaceRevenueMember_zdyK6FFVozgj" title="Revenue">215,300</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in Marketplace Revenue for the year ended March 31, 2022 that was attributable to that relationship. There was $<span id="xdx_909_eus-gaap--AccountsReceivableNetCurrent_iI_c20230331__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z7Q2h4bi30V1" title="Accounts receivable">182,344</span> included in our Accounts Receivable at March 31, 2023 as a result of this relationship.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended March 31, 2022, we paid $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20210401__20220331__srt--TitleOfIndividualAxis__custom--IndependentContractorMember_zegla7oYILO1" title="Service paid">229,083</span> in service fees to an independent contractor and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210401__20220331__srt--TitleOfIndividualAxis__custom--IndependentContractorMember_zCPXmNqRXtna" title="Shares for service">60,000</span> shares in the aggregate to its advisory committee members for service for a total value of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20210401__20220331__srt--TitleOfIndividualAxis__custom--AdvisoryCommitteeMember_zAyaKencRYXe" title="Service paid">173,000</span>. Through our acquisition of Gemini, a related party relationship was created through one of our Members of the Board of Directors by ownership of an entity that transacts with Gemini. We recognized $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BoardOfDirectorsMember__srt--ProductOrServiceAxis__custom--MarketplaceRevenueMember_zNVGl9uIDXB7" title="Revenues">1,042,277</span> in Marketplace Revenue for the year ended March 31, 2022 that was attributable to that relationship. There was $<span id="xdx_904_eus-gaap--AccountsReceivableNetCurrent_iI_c20220331__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zFccZ3cN806k" title="Accounts receivable">139,164</span> included in our Accounts Receivable at March 31, 2022 as a result of this relationship.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the acquisition of the casing division of JSC, a promissory note was executed. On April 30, 2019, the note was subsequently extended to April 1, 2020. <span id="xdx_90F_eus-gaap--DebtInstrumentDescription_c20190429__20190430_z4qrqNJH8MW1" title="Debt instrument, description">The note bears interest per annum at approximately <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220331__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember_ztx1M8T3u4m5" title="Interest rate">4.6</span>% payable in arrears monthly.</span> On June 26, 2020, the Company extended the promissory note until August 15, 2021. As of March 31, 2021, we accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210331_z34e1mt9tRAl" title="Accrued interest">352,157</span> related to the note. The was paid in full on November 5, 2020. JSC owned at least five percent (5%) of our shares outstanding from March 2019 through March 16, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October of 2019, it was made apparent that certain equipment that was agreed to be delivered free and clear by the Seller was not achievable as Seller was not able to purchase equipment that Seller had leased. Accordingly, the remaining value of the promissory note was reduced by $<span id="xdx_90F_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20191029__20191031__srt--StatementScenarioAxis__custom--PostClosingTransactionNoteReductionMember_zDXqkOliy7J7" title="Post-closing changes to the purchase price of transaction">2,596,200</span>. As a result of the change to the purchase price of the transaction, the Company reduced Equipment for a net value of $<span id="xdx_90D_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20191029__20191031__srt--StatementScenarioAxis__custom--DecreasedEquipmentMember_zCz8sKELl4W9" title="Post-closing changes to the purchase price of transaction">1,871,306</span>, decreased Other Intangible Assets by $<span id="xdx_901_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20191029__20191031__srt--StatementScenarioAxis__custom--OtherIntangibleAssetReductionMember_zgVeRKNckC36" title="Post-closing changes to the purchase price of transaction">766,068</span>, increased Accounts Receivable by $<span id="xdx_906_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20191029__20191031__srt--StatementScenarioAxis__custom--IncreasedAccountsReceivableMember_zUd1UNHVG3zl" title="Post-closing changes to the purchase price of transaction">31,924</span>, and recorded an increase to Deposits for $<span id="xdx_90B_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20191029__20191031__srt--StatementScenarioAxis__custom--IncreaseToDepositsMember_zkoEEw6UAkBe" title="Post-closing changes to the purchase price of transaction">9,250</span> worth of equipment that the Company agreed to transfer back to Seller. Consequently, accumulated amortization has decreased by $<span id="xdx_908_ecustom--ChangesToPurchasePriceOfTransaction_pp0p0_c20191029__20191031__srt--StatementScenarioAxis__custom--DecreasedAccumulatedDepreciationMember_zr9Ahu0EyB1k" title="Post-closing changes to the purchase price of transaction">159,530</span>. Additionally, the Company entered into a lease to gain possession of the assets that were originally to be transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through the Administrative and Management Services Agreement the Company with JSC, the Company purchased approximately incurred $<span id="xdx_908_ecustom--InventoryPurchasedDuringPeriod_pn5n6_c20220401__20230331__us-gaap--TypeOfArrangementAxis__custom--AdministrativeAndManagementServicesAgreementMember_zezyPtXwzX3e" title="Inventory purchased during period">2.0</span> million in inventory support services, and $<span id="xdx_90D_eus-gaap--PaymentsForRent_pp0p0_c20220401__20230331__us-gaap--TypeOfArrangementAxis__custom--AdministrativeAndManagementServicesAgreementMember_z74sXmw3dOba" title="Rent paid">170,355</span> of rent expenses for the year ended March 31, 2023. Through the Administrative and Management Services Agreement the Company with JSC, the Company purchased approximately incurred $<span id="xdx_90C_ecustom--InventoryPurchasedDuringPeriod_pn5n6_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--AdministrativeAndManagementServicesAgreementMember_zKu7PDyUgx2h" title="Inventory purchased during period">1.7</span> million in inventory support services, and $<span id="xdx_904_eus-gaap--PaymentsForRent_pp0p0_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--AdministrativeAndManagementServicesAgreementMember_z9nLefbons97" title="Rent paid">408,852</span> of rent expenses for the year ended March 31, 2022. For the year ended March 31, 2021, the Company purchased approximately $<span id="xdx_90B_ecustom--InventoryPurchasedDuringPeriod_pn5n6_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--AdministrativeAndManagementServicesAgreementMember_zUFH5xohtdl7" title="Inventory purchased during period">3.4</span> million in inventory support services, and incurred $<span id="xdx_90F_eus-gaap--PaymentsForRent_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--AdministrativeAndManagementServicesAgreementMember_z2xqCgYRODDe" title="Rent paid">405,171</span> of rent expenses for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 26, 2020, the Company and JSC entered into a Settlement Agreement pursuant to which the parties mutually agreed to settle all disputes and mutually release each other from liabilities related to the Amended APA occurring prior to June 26, 2020. <span id="xdx_90F_eus-gaap--DebtInstrumentDescription_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zcKiveR0dHr4" title="Debt instrument, description">Pursuant to the Settlement Agreement, the Company shall pay JSC $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_z3SH27o4dCQi" title="Principal payments">1,269,977</span> and shall provide JSC with: (i) two new promissory notes, a note of $<span id="xdx_908_eus-gaap--RepaymentsOfNotesPayable_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SellerNoteMember_pp0p0" title="Payment of note payable related party">5,803,800</span> related to the Seller Note and note of $<span id="xdx_908_eus-gaap--RepaymentsOfNotesPayable_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--StatementScenarioAxis__custom--InventoryAndServicesMember_pp0p0" title="Payment of note payable related party">2,635,797</span> for inventory and services, both with a maturity date of <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember" title="Debt maturity date">August 15, 2021</span>, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--AwardTypeAxis__custom--MonthlyPaymentsMember_zgEa0Bw9wgj5" title="Principal payments">204,295</span> to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering.</span> <span id="xdx_906_eus-gaap--DebtInstrumentDescription_c20200625__20200626__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember_zqWRaeh4OnA2" title="Debt instrument, description">Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $<span id="xdx_908_eus-gaap--ProceedsFromNotesPayable_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--AwardTypeAxis__custom--NinetyPercentMember_pp0p0" title="Proceeds from Notes payable">10,000,000</span> would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $<span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_pp0p0_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--AwardTypeAxis__custom--HundredPercentMember_zgQiDZ5s5iLc" title="Proceeds from Notes payable">10,000,000</span> would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to <span id="xdx_90F_ecustom--OptionGrantToRepurchase_c20200625__20200626__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--RangeAxis__srt--MaximumMember_zDvWfbb6IJrl" title="Option grant to repurchase">1,000,000</span> of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20200626__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zZNOONyaQmR9" title="Share price per share">1.50</span> per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 5, 2020, the Company paid $<span id="xdx_907_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20201103__20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zKpOXOCwTLRa" title="Payment of note payable related party">6,000,000</span> to JSC allocated as follows: (i) payment in full of Note A, representing the balance due from the Company to JSC relating to the acquisition of Jagemann Munition Components in March 2019 and (ii) $<span id="xdx_90C_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20201103__20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--NoteBMember_zTjr8mMkGIU5" title="Payment of note payable related party">592,982</span> remitted in partial payment of Note B, resulting in the parties’ execution of Amended Note B which has a starting principal balance of $<span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zunZEGjXCKc1" title="Notes payable related party">1,687,664</span> (“Amended Note B”). The Amended Note B principal balance carries a <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zuOK5nv2VOU2" title="Debt interest rate">9</span>% per annum interest rate and is amortized equally over the thirty six (<span id="xdx_90E_eus-gaap--DebtInstrumentTerm_pp0p0_dtM_c20201103__20201105__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zswqOV03dW5a" title="Debt instrument term">36</span>) month term. As a result of the payment in full of Note A JSC shall release the accompanying security interest in Company assets which secured Note A. Concurrently, upon entry into Amended Note B, JSC and the Company entered into the First Amendment to General Business Security Agreement to reflect a revised list of collateral in which JSC has a security interest. The total interest expense recognized on Note A $<span id="xdx_902_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--NoteAMember_z8LXR2U8qsil" title="Interest expenses">216,160</span> for the year ended March 31, 2021. The total interest expense recognized on the original Note B was $<span id="xdx_907_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--NoteBMember_zkh4D5HR0hXe" title="Interest expenses">62,876</span> for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s balance of Amended Note B was $<span id="xdx_907_eus-gaap--NotesPayable_iI_pp0p0_c20230331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zy0Hu3gR9s9d" title="Notes payable related party">180,850</span> and $<span id="xdx_902_eus-gaap--NotesPayable_iI_pp0p0_c20220331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zcN4LxDjygk2" title="Notes payable related party">865,771</span> at March 31, 2023 and 2022, respectively. The Company recognized $<span id="xdx_901_eus-gaap--InterestExpenseDebt_pp0p0_c20220401__20230331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zjtPRck1DSS2" title="Interest expenses">48,665</span>, $<span id="xdx_90A_eus-gaap--InterestExpenseDebt_pp0p0_c20210401__20220331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zEjKl27dmiZc" title="Interest expenses">110,518</span>, and $<span id="xdx_902_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--DebtInstrumentAxis__custom--AmendedNoteBMember_zgj1t8ZtVU9e" title="Interest expenses">60,100</span> in interest expense on Amended Note B for the years ended March 31, 2023, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 22, 2021, the Company repurchased <span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodShares_c20210119__20210122__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--AmendedAPAMember_zS1NH8NyfdT3" title="Shares repurchase">1,000,000</span> shares of the Company’s common stock issued to JSC at a price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210122__dei--LegalEntityAxis__custom--JagemannStampingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--AmendedAPAMember_zjTYdTfnCNue" title="Share price per share">1.50</span> per share pursuant to the Amended APA.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 3, 2019, the Company entered into a promissory note of $<span id="xdx_908_eus-gaap--NotesPayable_iI_pp0p0_c20190503__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_z2rdSa7b7HM3" title="Notes payable">375,000</span> with a shareholder of the Company. The original interest rate was the applicable LIBOR Rate. <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDateDescription_pp0p0_c20190502__20190503__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_zgix69kOENb8" title="Maturity date description">The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020.</span> The amended note bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20190503__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_zrbZTGREUang" title="Debt interest rate">1.25</span>% per month. The Company made $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20200401__20201231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_zayPGWclGG68" title="Principal payments">18,195</span> in principal payments during the nine months ended December, 2020 and the Note was paid in full in July of 2020. We recognized $<span id="xdx_902_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ShareholderMember_zJdxy5XaGnni" title="Interest expenses">10,327</span> of interest expenses related to the note during the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December of 2019, the Company entered into a Promissory Note of $<span id="xdx_90A_eus-gaap--NotesPayable_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z5nsGuAxp4ce" title="Notes payable">90,000</span> with Fred Wagenhals, the Company’s Chief Executive Officer and Chairman of the Board of Directors. The Note originally matured on June 12, 2020 and had an interest rate at the applicable LIBOR Rate. The promissory note has since been amended and the amended maturity date is <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20200401__20210331__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z68OVoSUF24a" title="Debt maturity date">September 18, 2020</span>. The Company made $<span id="xdx_90B_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20200401__20210331__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zftD2akGkvnb" title="Principal payments">25,000</span> in principal payments during the year ended March 31, 2021 and the Note was paid in full in July of 2020. The amended note bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210331__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zcKelOc414L" title="Debt interest rate">1.25</span>% per month. We recognized $<span id="xdx_909_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__srt--TitleOfIndividualAxis__custom--FredWagenhalsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zfID2j05uJ8j" title="Interest expenses">5,350</span> of interest expense on the note for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 23, 2020, the Company and Enlight entered into a promissory note (the “Forest Street Note”) with Forest Street, LLC (“Lender”), an Arizona limited liability company wholly owned by our current Chief Executive Officer, Fred Wagenhals, for the principal sum of $<span id="xdx_90B_eus-gaap--NotesPayable_iI_pn5n6_c20200923__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zPbrcpCarYc1" title="Promissory note">3.5</span> million, which accrues interest at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200923__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z7SutXAzxgRa" title="Debt interest rate">12</span>% per annum. The Note has a maturity date of <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20200922__20200923__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z2jRXd7vD4oh" title="Debt maturity date">September 23, 2022</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the Forest Street Note, <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDateDescription_c20200922__20200923__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zaR99mtVhzg8" title="Debt instrument maturity date description">the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 14, 2020, the Company entered into a Debt Conversion Agreement with the Lender Pursuant to the Agreement, the Company and Forest Street agreed to convert $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20201213__20201214__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_zF1H9C9ltnU6" title="Debt conversion, converted Instrument, amount">2,100,000</span> of the Note’s principal into <span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20201213__20201214__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1DeRviSV6z3" title="Debt conversion, converted instrument, shares issued">1,000,000</span> shares of the Company’s common stock. The share issuance occurred on December 15, 2020. As a result of the Debt Conversion Agreement the remaining balance of the Forest Street Note was $<span id="xdx_90C_eus-gaap--RepaymentsOfNotesPayable_pp0p0_c20210113__20210114__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_zmAynq2hQmXj" title="Payment of note payable related party">1,400,000</span>. On January 14, 2021, the Company paid the remaining $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20210113__20210114__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_z79zlyL2KFX9" title="Debt principal and accrued interest">1,400,000</span> in principal and accrued interest of the Forest Street Note. The Company recognized $<span id="xdx_90D_eus-gaap--InterestExpenseDebt_pp0p0_c20200401__20210331__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember__dei--LegalEntityAxis__custom--ForestStreetLLCMember__us-gaap--DebtInstrumentAxis__custom--ForestStreetNoteMember_zPWw2arVsUc3" title="Interest expenses">137,666</span> in interest expense related to the Forest Street Note for the year ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 500000 125000 437500 110000 385000 551916 223333 141419 494967 45000 129750 215300 182344 229083 60000 173000 1042277 139164 The note bears interest per annum at approximately 4.6% payable in arrears monthly. 0.046 352157 2596200 1871306 766068 31924 9250 159530 2000000.0 170355 1700000 408852 3400000 405171 Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering. 1269977 5803800 2635797 2021-08-15 204295 Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s common stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement. 10000000 10000000 1000000 1.50 6000000 592982 1687664 0.09 P36M 216160 62876 180850 865771 48665 110518 60100 1000000 1.50 375000 The promissory note was amended and the note’s original a maturity date of August 3, 2019 was extended to September 18, 2020. 0.0125 18195 10327 90000 2020-09-18 25000 0.0125 5350 3500000 0.12 2022-09-23 the Company and Enlight (collectively, the borrower pursuant to the note) shall pay Lender; (i) on a monthly basis, beginning October 23, 2020, all accrued interest (only), (ii) on a quarterly basis, a monitoring fee of 1% of the principal amount and then accrued interest; and (iii) on the maturity date, the remaining outstanding principal balance of the Loan, together with all unpaid accrued interest thereon. 2100000 1000000 1400000 1400000 137666 <p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zWVRFvCtFwt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 – <span id="xdx_820_zorq0Hju2RAa">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z7oQdcIsPoej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The income tax (provision) benefit for the periods shown consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/><span id="xdx_8B0_ze8Pk7nIsQQ7" style="display: none">SCHEDULE OF INCOME TAX PROVISION BENEFIT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220401__20230331_zIF2F2UGSf4l" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210401__20220331_zKo1iDiivJq3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20200401__20210331_zryUZL5I8lt2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>2021</b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_maCITEBz7bx_zIM9r9VSK15j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 46%; text-align: left">US Federal</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2168">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(1,302,811</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 14%"><span style="-sec-ix-hidden: xdx2ixbrl2170">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBz7bx_zfgcU72xqg9e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">US State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(446,677</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2174">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBz7bx_zIXbRFnKMRaf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current provision</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,749,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2178">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Deferred</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzKFK_zNY6wfArqhK3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">US Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(578,679</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,727,011</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">582,724</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzKFK_zBJc7tOiVRCc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">US State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(151,559</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,649,261</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">137,276</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_pp0p0_mtDITEBzKFK_zcOcpMFHV2m1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total deferred benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(730,238</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(10,376,272</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">720,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2192">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,839,791</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(720,000</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iN_di_zdCr54olzu0i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax (provision) benefit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(730,238</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,285,969</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2198">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8A2_z685AQzxSejj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zOJjHVFFYVM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation of income tax expense computed at the U.S. federal statutory rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20220401__20230331_zjOayjWUmE8c" title="Income tax expense rate"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210401__20220331_z4MGnreavIT" title="Income tax expense rate">21%</span></span> to the income tax provision is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_z7LappkIk9Ac" style="display: none">SCHEDULE OF RECONCILIATION OF INCOME TAX</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220401__20230331_znQXLWvPd3Cg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20210401__20220331_zxibZH50xg1b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200401__20210331_znQ1fPoM9341" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>2021</b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zQbYPrxJ4U24" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left">Computed tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">21</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">21</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 14%">21</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">%</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zznjC5zq3uM6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State taxes, net of Federal income tax benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zqosUdt7xfI8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(10</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_pid_dp_uPure_zVqEN7DBHhq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Employee stock awards</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_ztdmpGSbkhJg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock grants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateStockForServices_pid_dp_uPure_z1SaoYmu2mgc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock for services</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateOther_pid_dp_uPure_zsYenQqeWvzg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_zaw6PCIhW1yg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-deductible meals &amp; entertainment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> %</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxContingencies_pid_dp_uPure_zH6ky6n7dUEk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Contingent consideration fair value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_40B_ecustom--EffectiveIncomeTaxRateStockAndWarrantsOnNoteConversion_pid_dp_uPure_zshDRZIc79r2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Stock and Warrants on Note Conversion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">)%</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zzdLyRtR77Y2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total provision for income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(18</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">%</td></tr> </table> <p id="xdx_8A9_z4AeT4Rj90Vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s effective tax rates was <span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220401__20230331_zGxVJHMs5gth">(18%) </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year ended March 31, 2023. During the year ended March 31, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to Employee stock awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zbE8Q7be1YL9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant components of the Company’s deferred tax liabilities and assets are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zryK8mn2pYO4" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230331_znHUwXsIqef2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220331_zVybenyLDhTg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> </tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zeEgoXgKHsLi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforward</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">871,331</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2254">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr id="xdx_407_ecustom--DeferredTaxAssetsLossOnPurchase_iI_pp0p0_maDTAznlb_zxijg8wcNms6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Loss on purchase</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">826,311</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">879,319</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> </tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAznlb_zEX00eD4rXs4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2260">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAznlb_z9TVaPukqvOf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,697,642</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">879,319</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> </tr> <tr id="xdx_404_ecustom--DeferredTaxLiabilitiesDepreciationExpenses_iNI_pp0p0_di_maDTLzUGz_zCjPlE1c99fc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Depreciation expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,906,214</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,208,361</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> </tr> <tr id="xdx_405_ecustom--DeferredTaxLiabilitiesAmortizationExpense_iNI_pp0p0_di_maDTLzUGz_zIft29dvPC7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,101,020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(207,439</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> </tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDTLzUGz_zmdzwXli50We" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total deferred tax liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,007,234</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,415,800</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> </tr> <tr id="xdx_405_ecustom--DeferredTaxAssetsLiabilitiesGross_iNI_pp0p0_di_zLkvHZnaYxK1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net deferred tax assets/(liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,309,592</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,536,481</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> </tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zzDHBIzsNXfd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2277">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> </tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_zpRHd6QCHiB9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Net deferred tax assets/(liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,309,592</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,536,481</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> </tr> </table> <p id="xdx_8A2_z5pj2qXhgaPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for uncertain tax positions in accordance with ASC No. 740-10-25. ASC No. 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC No. 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. To the extent that the final tax outcome of these matters is different than the amount recorded, such differences impact income tax expense in the period in which such determination is made. Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. ASC No. 740-10-25 also requires management to evaluate tax positions taken by the Company and recognize a liability if the Company has taken uncertain tax positions that more likely than not would not be sustained upon examination by applicable taxing authorities. The Company has evaluated tax positions taken by the Company and has concluded that as of March 31, 2023 and 2022, there are no uncertain tax positions taken, or expected to be taken, that would require recognition of a liability that would require disclosure in the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has never had an Internal Revenue Service audit; therefore, the tax periods ended December 31, 2016, December 31, 2017 and March 31, 2018, 2019, 2020, 2021, 2022, and 2023 are subject to audit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z7oQdcIsPoej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The income tax (provision) benefit for the periods shown consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/><span id="xdx_8B0_ze8Pk7nIsQQ7" style="display: none">SCHEDULE OF INCOME TAX PROVISION BENEFIT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220401__20230331_zIF2F2UGSf4l" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210401__20220331_zKo1iDiivJq3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20200401__20210331_zryUZL5I8lt2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>2021</b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_maCITEBz7bx_zIM9r9VSK15j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 46%; text-align: left">US Federal</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2168">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(1,302,811</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 14%"><span style="-sec-ix-hidden: xdx2ixbrl2170">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBz7bx_zfgcU72xqg9e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">US State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(446,677</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2174">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBz7bx_zIXbRFnKMRaf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current provision</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,749,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2178">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Deferred</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzKFK_zNY6wfArqhK3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">US Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(578,679</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,727,011</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">582,724</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzKFK_zBJc7tOiVRCc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">US State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(151,559</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,649,261</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">137,276</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_pp0p0_mtDITEBzKFK_zcOcpMFHV2m1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total deferred benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(730,238</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(10,376,272</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">720,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2192">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,839,791</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(720,000</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iN_di_zdCr54olzu0i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax (provision) benefit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(730,238</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,285,969</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2198">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> </table> -1302811 -446677 -1749488 -578679 -7727011 582724 -151559 -2649261 137276 -730238 -10376272 720000 8839791 -720000 730238 3285969 <p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zOJjHVFFYVM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation of income tax expense computed at the U.S. federal statutory rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20220401__20230331_zjOayjWUmE8c" title="Income tax expense rate"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210401__20220331_z4MGnreavIT" title="Income tax expense rate">21%</span></span> to the income tax provision is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_z7LappkIk9Ac" style="display: none">SCHEDULE OF RECONCILIATION OF INCOME TAX</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220401__20230331_znQXLWvPd3Cg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20210401__20220331_zxibZH50xg1b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200401__20210331_znQ1fPoM9341" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>2021</b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zQbYPrxJ4U24" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left">Computed tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">21</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">21</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 14%">21</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">%</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zznjC5zq3uM6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State taxes, net of Federal income tax benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zqosUdt7xfI8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(10</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_pid_dp_uPure_zVqEN7DBHhq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Employee stock awards</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_ztdmpGSbkhJg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock grants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateStockForServices_pid_dp_uPure_z1SaoYmu2mgc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock for services</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6</td> <td style="font: 10pt Times New Roman, Times, Serif">)%</td></tr> <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateOther_pid_dp_uPure_zsYenQqeWvzg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_zaw6PCIhW1yg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-deductible meals &amp; entertainment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> %</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxContingencies_pid_dp_uPure_zH6ky6n7dUEk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Contingent consideration fair value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_40B_ecustom--EffectiveIncomeTaxRateStockAndWarrantsOnNoteConversion_pid_dp_uPure_zshDRZIc79r2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Stock and Warrants on Note Conversion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">)%</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zzdLyRtR77Y2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total provision for income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(18</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">%</td></tr> </table> 0.21 0.21 0.21 0.21 0.21 0.06 0.07 0.05 0 0.24 -0.10 -0.40 0.04 -0.05 -0.02 0 -0.01 0 0 -0.06 0.01 0 0 0 0 0 0.01 0.01 0 -0.05 0.01 -0.04 -0.18 0.09 0 -0.18 <p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zbE8Q7be1YL9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant components of the Company’s deferred tax liabilities and assets are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zryK8mn2pYO4" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230331_znHUwXsIqef2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220331_zVybenyLDhTg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> </tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zeEgoXgKHsLi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforward</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">871,331</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2254">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr id="xdx_407_ecustom--DeferredTaxAssetsLossOnPurchase_iI_pp0p0_maDTAznlb_zxijg8wcNms6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Loss on purchase</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">826,311</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">879,319</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> </tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAznlb_zEX00eD4rXs4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2260">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAznlb_z9TVaPukqvOf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,697,642</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">879,319</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> </tr> <tr id="xdx_404_ecustom--DeferredTaxLiabilitiesDepreciationExpenses_iNI_pp0p0_di_maDTLzUGz_zCjPlE1c99fc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Depreciation expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,906,214</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,208,361</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> </tr> <tr id="xdx_405_ecustom--DeferredTaxLiabilitiesAmortizationExpense_iNI_pp0p0_di_maDTLzUGz_zIft29dvPC7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,101,020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(207,439</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> </tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDTLzUGz_zmdzwXli50We" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total deferred tax liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,007,234</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,415,800</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> </tr> <tr id="xdx_405_ecustom--DeferredTaxAssetsLiabilitiesGross_iNI_pp0p0_di_zLkvHZnaYxK1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net deferred tax assets/(liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,309,592</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,536,481</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> </tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zzDHBIzsNXfd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2277">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> </tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_zpRHd6QCHiB9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Net deferred tax assets/(liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,309,592</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,536,481</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> </tr> </table> 871331 826311 879319 1697642 879319 2906214 2208361 1101020 207439 4007234 2415800 2309592 1536481 2309592 1536481 <p id="xdx_808_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zUtbXF6hV7Q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18 – <span style="background-color: white"><span id="xdx_82B_z4TmpCJhf7mg">GOODWILL AND INTANGIBLE ASSETS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During our fiscal year ended March 31, 2022, we recorded $<span id="xdx_908_eus-gaap--Goodwill_iI_c20220331__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--GeminiDirectInvestmentsLLCMember_z82YgX3qtyPa" title="Goodwill">90,870,094</span> of Goodwill generated from our Merger with Gemini. The balance of Goodwill at March 31<span style="background-color: white">,</span> 2023 and 2022 was $<span id="xdx_90C_eus-gaap--Goodwill_iI_c20230331_zQyzNIAGbRy5" title="Goodwill"><span id="xdx_905_eus-gaap--Goodwill_iI_c20220331_znd6rsInmXG4" title="Goodwill">90,870,094</span></span>. We did not have any goodwill prior to the year ended March 31, 2022<span style="background-color: white">.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total amortization expense of our intangible assets was $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20220401__20230331_zMBEa3szJPz4" title="Amortization of intangible assets">13,072,967</span>, $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20210401__20220331_zs8r6diNqUZ9" title="Amortization of intangible assets">13,072,967</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20200401__20210331_zFOfZLhOLGBg" title="Amortization of intangible assets">1,971,188</span> for the years ended March 31, 2023, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zUahL2c1r4Ib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zbMwdADHw3l6" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Licenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Patent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other Intangible Assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Licensing Agreement – Jesse James</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__dei--LegalEntityAxis__custom--JesseJamesMember_zqqi3OO7VxAh" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JesseJamesMember_zC328jeJzPBf" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensing Agreement – Jeff Rann</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__dei--LegalEntityAxis__custom--JeffRannMember_zW0NvP6t9tSl" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JeffRannMember_z5YS3bx3Smhe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Streak Visual Ammunition patent</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_zmEV0t520di9" title="Licensing agreement, life">11.2</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_zdXdBTq4sVF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">950,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">SWK patent acquisition</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_zIiiX3xLHTGa" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_zIQM5McM1ZB5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">6,124,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagemann Munition Components:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer Relationships</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z0zXqCcyzmw9" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zYY8NM0ZeKz6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,450,613</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_z8UPD1lDiTQl" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zlWefGE33cx3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,543,548</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_zzNHy4zGXkO3" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_zViTlRIvMZMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">2,152,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">GDI Acquisition:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zGzHq9naZp67" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_zW4QBkXQZKec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">76,532,389</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer List</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zomH4FHBAEe9" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zEaKYikI7b7k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">65,252,802</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_z9jFm41E6PPl" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_znEuGVnn8nob" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">4,224,442</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_z6Pz2Dui6dud" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zJnjDkdeBtmj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">607,747</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zmKCJDCAer2e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zeoBmXbwSRs8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">7,074,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zWChqNUEsjta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">151,763,617</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Licensing Agreements</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zF1fqpNftiV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Patents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z0wuJsIBg3Vg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(2,041,251</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accumulated amortization – Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zPHIKJxgTpT7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(28,036,807</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zkU83a8NUOod" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net"><span style="-sec-ix-hidden: xdx2ixbrl2355">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z8h14MAeLij1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">5,032,754</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXNtfk3Hkqdf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">123,726,810</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Licenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Patent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other Intangible Assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Licensing Agreement – Jesse James</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__dei--LegalEntityAxis__custom--JesseJamesMember_z6M8ZA99QlX3" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JesseJamesMember_pp0p0_zrgRTu1XPRv2" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensing Agreement – Jeff Rann</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__dei--LegalEntityAxis__custom--JeffRannMember_zQ8OJDAaqmE9" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JeffRannMember_pp0p0_zwXHxuRevN4d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Streak Visual Ammunition patent</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_zTyfS37U6XWa" title="Licensing agreement, life">11.2</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_pp0p0_zrKdqEqoDar5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">950,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">SWK patent acquisition</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_zhPqPrP2p7w4" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_pp0p0_zyGYwervECZh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">6,124,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagemann Munition Components:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer Relationships</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1FCpMNpQO9j" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0_z87q0Fr9nJgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,450,613</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zJEtMSgl65Gk" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0_z8CI3OQm2veb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,543,548</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_z41Cem8fQD3d" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_pp0p0_zlHQAuDuQue3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">2,152,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">GDI Acquisition:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_z09NXtvyHxC1" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_pp0p0_zkdvMkhlvo4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">76,532,389</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer List</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zlqDaHI3PbD8" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_pp0p0_zc9iZgSNccQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">65,252,802</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zLgUsOibxQia" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0_zBGV1v68tf4j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">4,224,442</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_znJSZX4K7wC7" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0_zuCvxWDoDxQ6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">607,747</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pp0p0_zPvoBsC11ny6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0_zG6yuMVdke2j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">7,074,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0_zN5mmhJRvpFf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">151,763,617</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Licensing Agreements</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zvKGie89yZK2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Patents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZtmJHFm9u27" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(1,547,787</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accumulated amortization – Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zPdd94nW2pWb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(15,463,230</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pp0p0_zgtCmtDMumr3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net"><span style="-sec-ix-hidden: xdx2ixbrl2417">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0_zIpPE9suGcAa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">5,526,218</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0_z8mTAtsJMop1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">136,300,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_8A2_zhaHKBaFHIJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zEXGk7mZtGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual estimated amortization of intangible assets for the next five fiscal years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zPA3qLA3IgJa" style="display: none">SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zDgICgqhYNIl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Estimates for<br/> Fiscal Year</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzd7A_zpTUcC6zR7B5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">13,102,785</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzd7A_z2Fiq9NLcg66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,664,775</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzd7A_zuIJpPuBIew5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,664,775</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzd7A_zDMcN5vMLFpc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2027</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,553,355</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzd7A_zisr3qpr6t07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2028</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,543,226</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzd7A_z09dQZFKwaWk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">65,230,648</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzd7A_zhQBOXtShRXk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual amortization of intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">128,759,564</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_z4wqdhLpaUca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMMO, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 90870094 90870094 90870094 13072967 13072967 1971188 <p id="xdx_899_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zUahL2c1r4Ib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zbMwdADHw3l6" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Licenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Patent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other Intangible Assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Licensing Agreement – Jesse James</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__dei--LegalEntityAxis__custom--JesseJamesMember_zqqi3OO7VxAh" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JesseJamesMember_zC328jeJzPBf" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensing Agreement – Jeff Rann</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__dei--LegalEntityAxis__custom--JeffRannMember_zW0NvP6t9tSl" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JeffRannMember_z5YS3bx3Smhe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Streak Visual Ammunition patent</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_zmEV0t520di9" title="Licensing agreement, life">11.2</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_zdXdBTq4sVF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">950,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">SWK patent acquisition</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_zIiiX3xLHTGa" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_zIQM5McM1ZB5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">6,124,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagemann Munition Components:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer Relationships</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z0zXqCcyzmw9" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zYY8NM0ZeKz6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,450,613</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_z8UPD1lDiTQl" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zlWefGE33cx3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,543,548</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_zzNHy4zGXkO3" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_zViTlRIvMZMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">2,152,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">GDI Acquisition:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zGzHq9naZp67" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_zW4QBkXQZKec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">76,532,389</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer List</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zomH4FHBAEe9" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zEaKYikI7b7k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">65,252,802</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_z9jFm41E6PPl" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_znEuGVnn8nob" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">4,224,442</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_z6Pz2Dui6dud" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zJnjDkdeBtmj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">607,747</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zmKCJDCAer2e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zeoBmXbwSRs8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">7,074,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zWChqNUEsjta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">151,763,617</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Licensing Agreements</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zF1fqpNftiV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Patents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z0wuJsIBg3Vg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(2,041,251</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accumulated amortization – Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zPHIKJxgTpT7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(28,036,807</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zkU83a8NUOod" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net"><span style="-sec-ix-hidden: xdx2ixbrl2355">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z8h14MAeLij1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">5,032,754</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXNtfk3Hkqdf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">123,726,810</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Licenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Patent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other Intangible Assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Licensing Agreement – Jesse James</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__dei--LegalEntityAxis__custom--JesseJamesMember_z6M8ZA99QlX3" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JesseJamesMember_pp0p0_zrgRTu1XPRv2" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensing Agreement – Jeff Rann</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__dei--LegalEntityAxis__custom--JeffRannMember_zQ8OJDAaqmE9" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember__dei--LegalEntityAxis__custom--JeffRannMember_pp0p0_zwXHxuRevN4d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">125,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Streak Visual Ammunition patent</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_zTyfS37U6XWa" title="Licensing agreement, life">11.2</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--StreakVisualAmmunitionPatentMember_pp0p0_zrKdqEqoDar5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">950,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">SWK patent acquisition</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_zhPqPrP2p7w4" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SWKPatentAcquisitionMember_pp0p0_zyGYwervECZh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">6,124,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagemann Munition Components:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer Relationships</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1FCpMNpQO9j" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0_z87q0Fr9nJgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,450,613</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zJEtMSgl65Gk" title="Licensing agreement, life">3</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0_z8CI3OQm2veb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">1,543,548</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_z41Cem8fQD3d" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_pp0p0_zlHQAuDuQue3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">2,152,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">GDI Acquisition:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Tradename</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_z09NXtvyHxC1" title="Licensing agreement, life">15</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradenameMember_pp0p0_zkdvMkhlvo4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">76,532,389</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer List</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zlqDaHI3PbD8" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_pp0p0_zc9iZgSNccQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">65,252,802</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_zLgUsOibxQia" title="Licensing agreement, life">10</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0_zBGV1v68tf4j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">4,224,442</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember_znJSZX4K7wC7" title="Licensing agreement, life">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--BusinessAcquisitionAxis__custom--GDIAcquisitionMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0_zuCvxWDoDxQ6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">607,747</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pp0p0_zPvoBsC11ny6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0_zG6yuMVdke2j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">7,074,005</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0_zN5mmhJRvpFf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Gross">151,763,617</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Licensing Agreements</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zvKGie89yZK2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated amortization – Patents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZtmJHFm9u27" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(1,547,787</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accumulated amortization – Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zPdd94nW2pWb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(15,463,230</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pp0p0_zgtCmtDMumr3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net"><span style="-sec-ix-hidden: xdx2ixbrl2417">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0_zIpPE9suGcAa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">5,526,218</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0_z8mTAtsJMop1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">136,300,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> P5Y 125000 P5Y 125000 P11Y2M12D 950000 P15Y 6124005 P3Y 1450613 P3Y 1543548 P5Y 2152076 P15Y 76532389 P10Y 65252802 P10Y 4224442 P5Y 607747 250000 7074005 151763617 250000 2041251 28036807 5032754 123726810 P5Y 125000 P5Y 125000 P11Y2M12D 950000 P15Y 6124005 P3Y 1450613 P3Y 1543548 P5Y 2152076 P15Y 76532389 P10Y 65252802 P10Y 4224442 P5Y 607747 250000 7074005 151763617 250000 1547787 15463230 5526218 136300387 <p id="xdx_894_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zEXGk7mZtGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual estimated amortization of intangible assets for the next five fiscal years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zPA3qLA3IgJa" style="display: none">SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zDgICgqhYNIl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Estimates for<br/> Fiscal Year</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzd7A_zpTUcC6zR7B5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">13,102,785</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzd7A_z2Fiq9NLcg66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,664,775</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzd7A_zuIJpPuBIew5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,664,775</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzd7A_zDMcN5vMLFpc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2027</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,553,355</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzd7A_zisr3qpr6t07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2028</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,543,226</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzd7A_z09dQZFKwaWk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">65,230,648</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzd7A_zhQBOXtShRXk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual amortization of intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">128,759,564</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 13102785 12664775 12664775 12553355 12543226 65230648 128759564 <p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_zhaynC3oeyLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19 – <span id="xdx_82C_zUZ5rpzhhu8a">SEGMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2021, the Company entered into an agreement and plan of merger with Gemini, which, along with its subsidiaries, engages primarily in the operation of an online marketplace dedicated to firearms, hunting, shooting and related products. As a result, at March 31, 2023, our Chief Executive Officer reviews financial performance based on two operating segments as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ammunition – which consists of our manufacturing business. The Ammunition segment engages in the design, production and marketing of ammunition, ammunition component and related products.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketplace – which consists of the GunBroker.com Ecommerce marketplace. In its role as an auction site, GunBroker.com supports the lawful sale of firearms, ammunition and hunting/shooting accessories.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the current period, we began the reporting of the separate allocation of certain corporate general and administrative expenses including non-cash stock compensation expense, as such we have updated the prior period disclosure herein. The following tables set forth certain financial information utilized by management to evaluate our operating segments for the annual periods presented:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zBizCWJcK6cc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z0Cb3RrXiPye" style="display: none">SCHEDULE OF OPERATING SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220401__20230331__srt--ProductOrServiceAxis__custom--AmmunitionMember_zTXbrBMCdXBj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220401__20230331__srt--ProductOrServiceAxis__custom--MarketplaceMember_z3et21LGVryf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220401__20230331__srt--ProductOrServiceAxis__custom--CorporateAndOtherExpensesMember_zJh44wJEUCIg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Corporate<br/> and other<br/> expenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220401__20230331_zRC2aj9mfUNf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Year Ended March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Corporate<br/> and other<br/> expenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maOILz9xp_zXhcZ8Gogki8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Net Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">128,290,128</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">63,149,673</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2445">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">191,439,801</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfGoodsAndServicesSold_msOILz9xp_zWlnj7WaFxB9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Cost of Revenues</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">126,914,265</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,116,939</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">136,031,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILz9xp_zzLqURtIklQf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,378,456</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,707,425</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,302,873</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45,388,754</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_msOILz9xp_z01WGgLXf5w" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">578,326</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,700,436</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2460">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,278,762</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_iT_mtOILz9xp_zSxv9WFXiN5j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Income/(Loss) from Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(9,580,919</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">31,624,873</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(25,302,873</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,258,919</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210401__20220331__srt--ProductOrServiceAxis__custom--AmmunitionMember_zN4FIl36My17" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210401__20220331__srt--ProductOrServiceAxis__custom--MarketplaceMember_zXfhbLL4bfDe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210401__20220331__srt--ProductOrServiceAxis__custom--CorporateAndOtherExpensesMember_zMRcjdG5LRY4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210401__20220331_zGGSAjEBAFG6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Year Ended March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maOILz9xp_zYTgGoYexMh8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Net Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">175,660,650</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">64,608,516</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">240,269,166</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfGoodsAndServicesSold_msOILz9xp_zUmJCP6Krwf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Cost of Revenues</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">142,773,306</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,732,351</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,505,657</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILz9xp_z0SRMWNeWHK5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11,932,721</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,434,308</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,544,970</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37,911,999</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_msOILz9xp_zmN8xdKp7P72" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,579,778</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,122,370</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,702,148</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_iT_mtOILz9xp_zUuxDWyL1szg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Income/(Loss) from Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">19,374,845</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">35,319,487</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(17,544,970</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">37,149,362</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20200401__20210331__srt--ProductOrServiceAxis__custom--AmmunitionMember_zyyaIOTK1Bj5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20200401__20210331__srt--ProductOrServiceAxis__custom--MarketplaceMember_ztibl3e2pJy8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20200401__20210331__srt--ProductOrServiceAxis__custom--CorporateAndOtherExpensesMember_zneFHqqgsKnl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20200401__20210331_zSfcm1skm1r9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Year Ended March 31, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maOILz9xp_zdICzqsiBIx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Net Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">62,482,330</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">              <span style="-sec-ix-hidden: xdx2ixbrl2494">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2495">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">62,482,330</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfGoodsAndServicesSold_msOILz9xp_zXEr0SK14x6k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Cost of Revenues</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51,095,679</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2500">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51,095,679</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILz9xp_zlSiBBjfD0N4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,269,558</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,837,834</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,107,392</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_msOILz9xp_zengXRDQchP1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,659,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2510">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,659,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--OperatingIncomeLoss1_iT_mtOILz9xp_zFHgIkybiAPh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Income/(Loss) from Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,475,850</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">10,834,834</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,379,984</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A2_zRvjRdor0On9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"> </p> <p id="xdx_893_ecustom--ScheduleOfTotalAssetsTableTextBlock_zOG6ulSbMqbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total assets by segment were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zPZJLGMvecai" style="display: none">SCHEDULE OF TOTAL ASSETS SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Ammunition</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20230331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zoPWOsXRs0Lb" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">154,044,607</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_c20220331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zRZinTL9IVe2" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">160,305,107</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_987_eus-gaap--Assets_iI_c20210331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zBlkXAjZNkTh" style="text-align: right; width: 14%" title="Total assets">179,379,341</td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Marketplace</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--Assets_iI_c20230331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zlcVfeORJiW2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">258,290,780</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--Assets_iI_c20220331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zWoau0zRoLyl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">253,873,206</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_989_eus-gaap--Assets_iI_c20210331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zZ0cZDLnLO34" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl2530">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20230331_zUVuBIEh1rM6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">412,335,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20220331_zxO81eFr6a1g" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">414,178,313</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_98E_eus-gaap--Assets_iI_c20210331_z39hJSI8tQQf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">179,379,341</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <p id="xdx_8A2_z5j4J1zueWCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfCapitalExpenditureTableTextBlock_zfSHRnT3pytc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total capital expenditures by segment were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_ziBM1H88kU48" style="display: none">SCHEDULE OF CAPITAL EXPENDITURE SEGMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Ammunition</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220401__20230331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zhFYGEQbvHd6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Payment to acquire property and plant equipment">10,819,177</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20210401__20220331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zzUul6Zfaqb6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Payment to acquire property and plant equipment">17,728,023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_989_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20200401__20210331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zc1Y0VhKZADf" style="text-align: right; width: 14%" title="Payment to acquire property and plant equipment">7,437,265</td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Marketplace</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220401__20230331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zdW8LNTU6YAc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">1,722,148</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20210401__20220331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zDgDzsiXu0fh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">1,490,959</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98C_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20200401__20210331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zRcEXuWmcyN7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payment to acquire property and plant equipment"><span style="-sec-ix-hidden: xdx2ixbrl2550">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220401__20230331_z0OkqodukNo9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">12,541,325</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20210401__20220331_zPXNcshTCpRd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">19,218,982</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_988_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20200401__20210331_zzjIxpClVmt" style="border-bottom: Black 2.5pt double; text-align: right" title="Payment to acquire property and plant equipment">7,437,265</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <p id="xdx_8AA_z9sZxdfbGPOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zBizCWJcK6cc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z0Cb3RrXiPye" style="display: none">SCHEDULE OF OPERATING SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220401__20230331__srt--ProductOrServiceAxis__custom--AmmunitionMember_zTXbrBMCdXBj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220401__20230331__srt--ProductOrServiceAxis__custom--MarketplaceMember_z3et21LGVryf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220401__20230331__srt--ProductOrServiceAxis__custom--CorporateAndOtherExpensesMember_zJh44wJEUCIg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Corporate<br/> and other<br/> expenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220401__20230331_zRC2aj9mfUNf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Year Ended March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Corporate<br/> and other<br/> expenses</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maOILz9xp_zXhcZ8Gogki8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Net Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">128,290,128</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">63,149,673</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2445">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">191,439,801</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfGoodsAndServicesSold_msOILz9xp_zWlnj7WaFxB9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Cost of Revenues</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">126,914,265</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,116,939</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">136,031,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILz9xp_zzLqURtIklQf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,378,456</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,707,425</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,302,873</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45,388,754</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_msOILz9xp_z01WGgLXf5w" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">578,326</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,700,436</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2460">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,278,762</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_iT_mtOILz9xp_zSxv9WFXiN5j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Income/(Loss) from Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(9,580,919</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">31,624,873</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(25,302,873</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,258,919</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210401__20220331__srt--ProductOrServiceAxis__custom--AmmunitionMember_zN4FIl36My17" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210401__20220331__srt--ProductOrServiceAxis__custom--MarketplaceMember_zXfhbLL4bfDe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210401__20220331__srt--ProductOrServiceAxis__custom--CorporateAndOtherExpensesMember_zMRcjdG5LRY4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210401__20220331_zGGSAjEBAFG6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Year Ended March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maOILz9xp_zYTgGoYexMh8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Net Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">175,660,650</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">64,608,516</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">240,269,166</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfGoodsAndServicesSold_msOILz9xp_zUmJCP6Krwf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Cost of Revenues</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">142,773,306</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,732,351</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,505,657</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILz9xp_z0SRMWNeWHK5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11,932,721</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,434,308</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,544,970</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37,911,999</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_msOILz9xp_zmN8xdKp7P72" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,579,778</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,122,370</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,702,148</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_iT_mtOILz9xp_zUuxDWyL1szg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Income/(Loss) from Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">19,374,845</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">35,319,487</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(17,544,970</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">37,149,362</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20200401__20210331__srt--ProductOrServiceAxis__custom--AmmunitionMember_zyyaIOTK1Bj5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20200401__20210331__srt--ProductOrServiceAxis__custom--MarketplaceMember_ztibl3e2pJy8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20200401__20210331__srt--ProductOrServiceAxis__custom--CorporateAndOtherExpensesMember_zneFHqqgsKnl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20200401__20210331_zSfcm1skm1r9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Year Ended March 31, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ammunition</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Marketplace</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maOILz9xp_zdICzqsiBIx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Net Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">62,482,330</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">              <span style="-sec-ix-hidden: xdx2ixbrl2494">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2495">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">62,482,330</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfGoodsAndServicesSold_msOILz9xp_zXEr0SK14x6k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Cost of Revenues</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51,095,679</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2500">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51,095,679</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILz9xp_zlSiBBjfD0N4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,269,558</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,837,834</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,107,392</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_msOILz9xp_zengXRDQchP1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,659,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2510">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,659,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--OperatingIncomeLoss1_iT_mtOILz9xp_zFHgIkybiAPh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Income/(Loss) from Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,475,850</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">10,834,834</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,379,984</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 128290128 63149673 191439801 126914265 9116939 136031204 10378456 9707425 25302873 45388754 578326 12700436 13278762 -9580919 31624873 -25302873 -3258919 175660650 64608516 240269166 142773306 8732351 151505657 11932721 8434308 17544970 37911999 1579778 12122370 13702148 19374845 35319487 -17544970 37149362 62482330 62482330 51095679 51095679 4269558 10837834 15107392 1659243 1659243 5475850 10834834 -5379984 <p id="xdx_893_ecustom--ScheduleOfTotalAssetsTableTextBlock_zOG6ulSbMqbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total assets by segment were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zPZJLGMvecai" style="display: none">SCHEDULE OF TOTAL ASSETS SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Ammunition</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_c20230331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zoPWOsXRs0Lb" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">154,044,607</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_c20220331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zRZinTL9IVe2" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">160,305,107</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_987_eus-gaap--Assets_iI_c20210331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zBlkXAjZNkTh" style="text-align: right; width: 14%" title="Total assets">179,379,341</td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Marketplace</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--Assets_iI_c20230331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zlcVfeORJiW2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">258,290,780</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--Assets_iI_c20220331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zWoau0zRoLyl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">253,873,206</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_989_eus-gaap--Assets_iI_c20210331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zZ0cZDLnLO34" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl2530">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20230331_zUVuBIEh1rM6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">412,335,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20220331_zxO81eFr6a1g" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">414,178,313</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_98E_eus-gaap--Assets_iI_c20210331_z39hJSI8tQQf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">179,379,341</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> 154044607 160305107 179379341 258290780 253873206 412335387 414178313 179379341 <p id="xdx_89B_ecustom--ScheduleOfCapitalExpenditureTableTextBlock_zfSHRnT3pytc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total capital expenditures by segment were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_ziBM1H88kU48" style="display: none">SCHEDULE OF CAPITAL EXPENDITURE SEGMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2021</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Ammunition</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220401__20230331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zhFYGEQbvHd6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Payment to acquire property and plant equipment">10,819,177</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20210401__20220331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zzUul6Zfaqb6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Payment to acquire property and plant equipment">17,728,023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_989_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20200401__20210331__us-gaap--StatementBusinessSegmentsAxis__custom--AmmunitionMember_zc1Y0VhKZADf" style="text-align: right; width: 14%" title="Payment to acquire property and plant equipment">7,437,265</td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Marketplace</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220401__20230331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zdW8LNTU6YAc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">1,722,148</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20210401__20220331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zDgDzsiXu0fh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">1,490,959</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98C_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20200401__20210331__us-gaap--StatementBusinessSegmentsAxis__custom--MarketplaceMember_zRcEXuWmcyN7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payment to acquire property and plant equipment"><span style="-sec-ix-hidden: xdx2ixbrl2550">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220401__20230331_z0OkqodukNo9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">12,541,325</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20210401__20220331_zPXNcshTCpRd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment to acquire property and plant equipment">19,218,982</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_988_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20200401__20210331_zzjIxpClVmt" style="border-bottom: Black 2.5pt double; text-align: right" title="Payment to acquire property and plant equipment">7,437,265</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> 10819177 17728023 7437265 1722148 1490959 12541325 19218982 7437265 <p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_z3w08ScyCDLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 20 - <span id="xdx_820_zc4vC7d0TvCk">SUBSEQUENT EVENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock Issuances</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to March 31, 2023, we issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_c20230401__20230401__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MembersOfBoardOfDirectorsMember_zPVDn1E2wh0f" title="Number of stock issued as compensation">25,111</span> shares of Common Stock to our employees, independent contractors and Members of our Board of Directors as compensation for a total value of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_c20230401__20230401__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MembersOfBoardOfDirectorsMember_zMd3UcRDgH61" title="Number of stock issued as compensation, value">45,346</span> or $<span id="xdx_905_eus-gaap--SharePrice_iI_c20230401__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MembersOfBoardOfDirectorsMember_z3HdNa2WCRPa" title="Share price">1.81</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Note Payable Related Party Repayment</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Subsequent to March 31, 2023, we repaid the remaining outstanding principal balance on Amended Note B.</p> 25111 45346 1.81 Included in revenue for the years ended March 31, 2023, 2022, and 2021 is excises taxes of $9,789,896, $14,646,983, and $4,286,258, respectively. Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business. EXCEL 96 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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


]>]K(F$,<^_T51E0V?@H!0VI,K5DN_OX="/ M-9CP7-I?M*]K>[Z#DDHJ7AS VD%!6?TE;X=S. %@_ X 'P#8^JZ%K,L)420, M!-\C8:HUFUG85BU:FZ/,_"FQ$GJ7:IP*X_']=+)ZF*+Y'5H]1:O)['DZ08OE M'-W-EX\16D[CU<-S;+;GB^DR>I[-GV)T-0%%:"ZO U=I$X;*30Z"HUH0OR/8 MP>B1,Y5)-&4II'\2N-I]TP(^MC#"%QD?B6@AK_,9X3;&:!5/T-7'ZPN\7G,T MGN7MO<,[JJ3.2(G&O%A31NI;Q%(42:FG)4I>*RJIS7Z/UE()?<-^G#N06L8[ M+V.F[E:6)(&AH\=*@MB!$W[ZT.FUOUQHPF^:\"^QAT_:J8 =L KD.6\UVK=H M,\"[$/L#K^-W!_W W9T1[C;"W?\*4Y;P L[)=O^1]?K]&^\&^W^INB=7NP"Q MM0,L4<(KINI;WF2;-R*J1^-W>?W Z'NRI4RB'#8:VF[UM0E1#VT=*%[:05ES MI3G#7U!+ P04 " #SBTXR(8U;07!VY93PC4FWR M55\4G))E62A+^X'GC?H92?+>]+3<=\6GIVPCTR2G5QR)3981_NVW9[V9_P:'0UV@/.// MA-Z+K=](7\H-8U_TQGQYUO-TC6A*8ZD11/VYHQ-K#>TU,77![=^/ M]%_+BU<7I(>6])9L4OF!W;^E]065%8Q9*LK_T7UU[EB= M'&^$9%E=6-4@2_+J+WFHA=@JX \.% CJ L%3"X1U@7"WP.A @4%=8/#4",.Z M0'GI_>K:2^$B(LGTE+-[Q/79BJ9_E.J7I95>2:YOE(7DZFBBRLGI[.*/3_/% M_./\]_<+]"JBDB2I0.\)YT1G\#7Z&7U:1.C5CZ]/^U+%TZ7Z<+1^[B MET1'KXH'EN+XZ<5#AQAAD[JPY(T.\,XW0NT1 LWBKYM$).6#]_F=VH?FDF;B M+TL5SRMD:$?J5NF-*$A,SWJJV1&4W]'>]*J'N^21?T5RBF*D6=4GULZ1R4Y!OY":E1RA7'0"[58\WY_JL@G%]W)8N M9Z2NZ8*$115L4,)T;W0W#;R!/U#/Q=UV(O9/\P=>.)XTIQD2#QN)A\^2^ B1 MC&UR:9-RN%\3;SP<>IYG5OG"&;JK3) P# 0S)!\UDH^=)VLY3H((SI ??B* DEU2% ME8CD2S7RO)&(/JC1N:"V7#AC=J74MB:R=2,T^V&IKQL3_>&3"Y(W=6 M'9*&H6BFZJT?]IVV3KF"K"#Y-Z1:+9K<4=5-J-&J6&O?I5LOJ^;A7N,^]*P# M57?LSKJ#NETHFJE[ZW=]M^&UW^VE].4>OCOW4VM?48?&.%&I/QCM2@]J7$%I M&(IF2M_Z8-]MA+&024:DNM?O#_HSJ_;#/>WM_LP=O[/VH'88BF9JWQIBW^V( M(>=YZE##)[1#H(X9E(:A:&9"6M/LNUWSY[&[.,_D7/=]7NH%U]&R@M J5A M*)J9OM95!R_@J@-05PU*BT!I&(IF9J=UU<%S7/7AOKW&/<'7.$TB!95DY./']P:[JH#X:E(:A:*;JK8\. MONNCM\RSU$N?MY0?F#0*]A>6_*5JU;]5@UDX3)X\GZ?0_A'&%9C/K :M3=]>N<&U"C#D4S7YULC7KH M-NI7*5VN:/DR0=WP[7MVZ_N3H%8O6AVR7AJR07**6WJJAW/%85Y=6W8]6&9$7Y<=0- MDY)EY<\U):IMU">HX[>,R<<-':#Y@F_Z'U!+ P04 " #SB M*$:7M:@4(88P"4O*JR#OU\\>5=Z76R-XQ1X5T-NRI.KUC@FY'P0H>'OPQ)_7 MQCT(\_Z&/K,9,_/-H[*]L,VRY"6K-)<54&PU"(;H=H1J01WQ%V=[?=0&SLI" MRA^N,UT. NB(F&"%<2FH_=NQ$1/"9;(Z!IL.[ZF>,W3"41KTH MNU#.I*5,KBJGIFZ^6^*2UT7UEC/I,. 8DR0Y0^V&]0A.$?:3IBUI^B[IO&)4 M5195L1VKMMY:IMTB013WSK]W-PQ#E/60'S!K ;.K2LDKP^RR-#[ K#MRDJ$S MO&Y0E"87JM=KX7K7+1OZJJ00/K9>=U@"212=T7G"X@SBU,^'X'_G#'R7\)M9 M,V5/[6:W]9XAL+M.48:C\\_KB2-QFJ#D N+148BN*J+@=,$%-]R_ZQRR1">5 MC F)STOI"4Q0FF4H.B,-C\YO=WFR!]XSKS00;&65\":U7E5S'VDZ1F[J(WTA MC;T@U,VUO<,QY0+L^Y64YJWC;@GMK3#_!5!+ P04 " #SB$P2",A4GN MV;TJ:[ M7:\$V ^O$(]^_9[E?Q2/:5H*?\YGB^+?'Q_+/+H/6*^[>WNK3>^VIOOB9%^B6; MQ=.[\O'?'Z\_"G?I?;*:E5[V74DW>S2HO4DV*];_7_B^6;;S49BLBC*;;U:N MMF ^73S_;_+GYI[86Z%[^<8*O;%2[?N\)@L\+@ MO2M<;5:X>N\*P\T*PX,5WKQ;KSY' MN[M]N+N'C_?;SZCM ]X]?,3?7F7[D'??_9AWMP]Z]]V/>G?[L'=?/>YO/7>[ MVP>^^^Y'OKM]Z+N'C_W;HVP?_.ZK1_^M57K;1[_WZM&_>FN5[:/?>__O^LLO M^[M_VWO;1[_W[M_WWO;1[ZT?_<_/?[S6?_E&29G\]FN>?1?R>OG*JV^L_WRN MUZ_^X$T7]9]ZO\RKGTZK]??OU<5J/7QN?)9B3W>:3>&R-U!3-;E(^% M("[NTKLCZ_OMZ_=/K1^TKW]S:OWPQ/;W6H#/U=W^5N\<65U^SUTW>'-UI7UU/UU6^]Y_>N^Z^VK MFTG[ZD;[ZO:D_"3TN_7JW9LCJYNG1G_:/&>/KFV]8]?[G3=7M]^QZRW;[KQC M]=[@S=7=T[O>,KCW]W;=_WN['KSC]^UY]:-/FO#=H_?Z1U:/WK_ZL;]T\?M7 M/_:W9OSN?3^\ZQI_M_LOF=E?>_TWO"_9?%Y-4JITGOPA%(])GA;"M"A6Z=V% M\"V9K=(CF_A[*UE/Z'XNELDD_??':L96I/FW].-O__I']ZKSR[%@(+$1B8DD M)I&83&(*B:DDII&83F(&B9DD9I&836(.B;DDYI&83V(!B84D%CUCEVNL/@;W M[;=^M].Y'MY<_?KYVWXY>#@S"+R3''$-9(QJN79+QJ348O_98N5FEQ+ ];USPW M#TEL1&(BB4DD)I.80F(JB6DDII.806(FB5DD9I.80V(NB7DDYI-80&+AU>OC ME#?=R_[-=:?;3+'H]9*]RT[OZJ9[=7CL\^I5+%[U+J][_?[A+ _:DT:6#5^R M;-B:9;>32;9:E(60IY-T^BWY.CLZS6M%SHTU$AN1F$AB$HG))*:0F$IB&HGI M)&:0F$EB%HG9).:0F$MB'HGY)!:06#A\%4&]F_[E5?_Z((*BUPM6X3<8=*XO M#T*-W+PQA#6"[_HE^*Y;@V^4?BV%Z:(H\]4\7907PEU:3/+ILCYM_U@"MFKG M)B")C4A,)#&)Q&024TA,)3&-Q'02,TC,)#&K_3<]>$R%15:FPME.GL2;C\=/5/89D\U2^'JQ6$),_7Z\[K M\Z9G3Y^.)2>Y1PZ)N23F_?^^KX\%+KE# 8F%)!:16$QB8PAK!/?-2W#?G)JQ MYJOT[N6Y=2RL6X5SPYK$1B0FDIA$8C*)*22FDIA&8CJ)&21FDIA%8C:).23F MDIA'8CZ)!206DEA$8O'-J_EQ?]#K#H8'1W*A,1NYV.V\!&/]Z=_6]R47Y9OG ML+:O>VXFHMH(U414DU!-1C4%U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 MU<*-MA]&U]?=[O#PG[EL']P3/<8>%G].P#'U&XTXVWO _[=UGAS M\NEB,ETFL_IH07W,]N@)..W(V3E':B-4$U%-0C49U1144U%-0S4=U0Q4,U'- M0C4;U1Q4%E_S#GR%%C5!M36C,R>[O([+5'YG-0 M"MG]\U'Y[6'V/)TE97I7?9V7QXZP_][NGIVBI#9"-1'5)%2344U!-175-%33 M4#4=RPTVUOV''R;)*F=X5PGV=SP:KFHL5V,GHT5-'&'50;H9J(:A*JR:BFH)J* M:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%KX5[3CTT\(BKNORW>.SF/'U!W1 MC,Q=_4ZWO7_G=I[6]=SKL!1^%_ZWF#:B*J2:@FHYJ":BJJ::BFHYJ!:B:J6:AF MHYJ#:BZJ>:CFHUJ :F'W=1G/Y?75U>#P5*(C/4#=SJ![??@6YY%NGT[W]0SR M/]'LT]U5^W3;NWVY9#4+-4X5. MU0FUVV?G+5HHA&HBJDFH)J.:@FHJJFFHIJ.:@6KFB=_:ZPU\* M(50=UV[N#G*SZ;?XR MRXKIXD$(\F11)),ZH9_GQUYZMWK^LG6FC)8+H=H(U414DU!-1C4%U514TU!- M1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M1K4QI35BM[]]KZC43K)TRH9[P3QOU?3Y?H8LY66K9/3=O+L M<$3;CU!-1#4)U6144U!-134-U714,U#-1#4+U6Q4MA MM]^Y.IRJOFH%J!:B&H1JL6H-J:T9N;N2I1Z)TJ4 MT)DJ6K&$:B-4$U%-0C49U1144U%-0S6]][K$97AUU;FZ/IRHOF\Y$]TZ"]5L M5'-0S44U#]5\5 M0+42U"-5B5!M36C,S=RU*O?86)76Q?1/U=C+)5HMJ5NJE MDW3Z;=V#WSI!14N54&V$:B*J2:@FHYJ":BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ M>:CFHUJ :B&J1:@6H]J8TIIANRM5ZK67*K$35+1\"=5&J":BFH1J,JHIJ*:B MFH9J>N]U0TR_>U-?LZ$Y/WW78B:Z;1:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:@V MIK1F8NXJFGKM%4W;Z6F=DJ-T627GJ;=-T9XF5!NAFHAJ$JK)J*:@FHIJ&JKI MJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J#:FM&;&[GJ:>NV-+^RL%.UM M0K41JHFH)J&:C&H*JJFHIJ&:OM'VIYLWO<&KCYZ^9RD3W3(+U6Q4=.;R>3U7SU?*GPVWF6E]/_FYSL M1VK7STY(M!\)U414DU!-1C4%U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 MU4)4BU M1K4QI342M[_K1^K_?^Q':A_KW/Q%M1&JB:@FH9J,:@JJJ:BFH9K> M?UU[U!W<#/J'<]1W+F>B6V>AFHUJ#JJYJ.:AFH]J :J%J!:A6HQJ8TIK9N:N M':G?WHZD)0_I/%DL!+],YLLZ.+]D\V6R>&J=G+:C9X:CFHUJ :B&J1:@6H]J8TII!V]L%;7L_ MTL%E;BY.7=FFG3L[8M$*)%0344U"-1G5%%133SSAG%5>K))%61\!*5:31V&9 M9]^F1?5TNU@?$=F\SOM9^#'Y25@ML\7ZN]O#)]F]D"P$^_X^S3=?SM*BJ!:I MOOM#MW/1Z:S_^_ ]6\WNA*^ID'V=31_6;W%4XRV3I[56KY/F]=J+:NO*)V&9 MYI.Z@//'F\X_?UH?A:F6>AFEVL))FM[5%Y,1BO1;M>"3\.-P;\GJOX60/#SD M:3W4AVQ5%F6RN*O7_9K,DL7FR$ZU9'TEBN*7:A_NA!^_OFO_YEF>OMH_X>W] MRQ;IA\?5XBZOOO6R6]W.FULKG-K:3T*P>UC6%\EYR*O'K^*K;K7JEV_GZZCS"K7,K)*60[ Z;_=#]-.C4._P\S(?R,<]6#X_";;7$3.BN MK]_3%8I,F&75?B;U4R:M[MAJ46&157_T[I/5K"SVAO+3LIREZUK6V^JN6M_Z M=/1%(%K2A6H&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&IC2FN^"-S5?54W MW_$BL*S^(A:ED%>I4UDS,75E7O[VL M:YV8U=1B,9DNZXN+5O.Y9#+)ZTG+-D>/1BA:RX5J(U0344U"-1G5%%13-UKC MPD"=R][-H/G;I*&CZJAFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:@VIK1F MAN[*N_KMY5VGW^,7_D=P\FP^+8HL?WJ^BF_KV_]HIQ>JC5!-1#4)U6144U!- M134-U714,U#-1#4+U6Q4 MR=/Z+:[ZK= Z7I?)T[HZ,T^?/Q>V3/+RZ6C6HOU=J#9"-1'5)%2344U!-175 MM(W6.".\<]FI_S5GQCHZKH%J)JI9J&8?N8=O;H[J MC5!-1#4)U6144U!-134-U714,U#-1#4+U6Q4?:-T6 MJNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL6H-J:T1I9>[NJV+D_4;>T. M[M9O:1X+TG;AW"!%M1&JB:@FH9J,:LKEZ\JH_K%WFU1T6 W5=%0S4,U$-0O5 M;%1S4,U%-0_5?%0+4"U$M0C58E0;4UHS,'==6Y?M75L'%2#->>BI/I!V^^PH M12NW4$U$-0G59%133CQ?]MH;UA]\$JLE'AY+X<=)-INEDW+Z+9T]/9=Y?,WR MZNF8YG7/Z4OK1_V#^I793W55PVRV;JTPZEZ'_!?AQ^E/'[*%D CS;%$^SIZ$ MKTDQ+2Z$K^G#=+&HSQ&W)V7VM1+K27$U)^Y<"+5Q^.$KX<=L,7OZZ:("IS\) M:_&_5TE>_7!GK@>9EMFZ:>,^7==(=/^YZ:?XL/?AKGE]9>GUKCY79QR,M:GS MF&Y&JG>O\2OT?%?DZ3R9KO=@OW!C-\I!]8:1)8N+#V7VD-9%%<+W:?FXWM'5 M8IE,7W_8[+G.(EL<:ZA0T6>'AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J): MA&HQJHTIK?F*I[=[Q=/>0>5MSFYVZK.;6\_^:H?.?GF#UIVAFHAJ$JK)J*:@ MFHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J#:FM&:X[LJDJIMM MX7H[F=3SI:*:\4S2Z;?ZXT1'D[55.3M926V$:B*J2:@FHYJ":BJJ::BFHYJ! M:B:J6:AFHYJ#:BZJ>:CFHUJ :N%&V[^@:/>ZU[^\;+[Q%FV6:WP>K'_3O3I8 M+D:W;DQIS33<%45=MA=%'9]J"O_S4F6[_@#2[^V34+0U"M5&J":BFH1J,JHI MJ*:BFH9J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:J-*:T9N[MNJ=PPGHZ^6NKP;#8?=P HHV/%%:,PEW#4^7[0U/9I+_D9;+ M636"X-47KUFU]UVTJOFH%J!:N-'V9X]7_>[ES=6P M?SC//++DY54U(>T>7A/GKVRA<#0!_Q.-3Y>[QJ?+]L:GW[,DOQ/L>V$TS=-) MF>7%_EN=9T]!T68H5!NAFHAJ$JK)J*:@FHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ M'JKYJ!:@6HAJ$:K%J#:FM&8 [PJD+MM[@EJGH&AM%*J-4$U$-0G59%134$U% M-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"W<:/L3RUYWT#^LN(F.+-?M7/9Z MP^'A_!,M?J*T1@8.=L5/@_;BI^![)JB+NW19GUB[*(4OV:+,D^9L]%@^MK/G MYB.JC5!-1#4)U6144U!-134-U714,U#-1#4+U6Q4DMAZX;47.CDQ2&Z&:B&H2JLFHIJ":BFH:JNFH9J":B6H6JMFH MYJ":BVH>JOFH%J!:B&H1JL6H-J:T9K#NZH@&[75$)P_ MJOFH%J!:N-$:Y>^]F^&KCK[-!9M%D*U$:J)J":AFHQJ"JJIJ*:AFHYJ!JJ9J&:AFHUJ#JJYJ.:AFH]J M :J%J!9MM/V#O;W>3>>Z?W@0%ZT?HK1&6%[MZH>NVNN'WG<0MQTY-S)1;81J M(JI)J":CFH)J*JIIJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%&ZW1&=]Y M_;8G.NB8TIJ)N6L1NCK1(E0GYF,VNTOS_;KXO6MWKB^.W790MWV$L^,4+1I" M-1'5)%2344U!-175-%334U2M[V.:)1^+87IHDPKO!3RY/C5L=N1LX,5K2-"-1'5)%2344U!-175 M-%334Z7<^=;J]0?.EOH6.:J.:@VHNJGFHYJ-:@&HAJD6H%J/: MF-*:D;FK(ZINMD6FDT\7D^DRF0G+Y&F>+LJCUUEI1\Z.3%(;H9J(:A*JR:BF MH)J*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6;+3&QTNNNS<'KZE"=- (U6)4 M&U-:,S%W/4-7[3U#>\=P%]D;,TRT:@C51J@FHIJ$:C*J*:BFHIJ&:CJJ&:AF M7KVN?ND/7W^^P$)'M5'-0347U3Q4\U$M0+40U2)4BU%M3&G-O-Q5#5VU5PVI MV^.QZ9_+=%$06_@F!JT&9B[YJ"K]N:@S;N819FO MZ@.RPCPI5_FT?!+NDC(5[M)BDD^7Y31;' U2M%8(U4:H)J*:A&HRJBFHIJ*: MAFHZJAFH9I[XK0T>4V'9/#0D?$\*(9G7G^6^$Y+%G5!6R]0_^-<_KGO=X2^% MD.73A^DBF0G)P6]Y=B_Q62E%=_ M!N+D(5T\)K/B+Y\6C%8EH=H(U414DU!-1C4%U514TU!-1S4#U4Q4LU#-1C4' MU5Q4\U#-1[4 U4)4BU M1K4QI36#=]>H=-7>J/3.TX+1$B54&Z&:B&H2JLFH MIJ":BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL4;[=0I\N/- M_K'J3WN+-;-PUWMTU=Y[],[S?='V(U0;H9J(:A*JR:BFH)J*:AJJZ:AFH)J) M:A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ5='NI1>G\LWI@9M).9P5WXT;"\_6L\> M&^_.'$O,=N3OZ]]+"31S0E1+4*U^._>56-J;1JEA,RY[N[ALKS!ZUZ=EVHVS Q-M,$(U$=4D5)-134$U M%=4T5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LWVG[$#?J'5S4=4V,V M\W+77U3=;,O++]E\GBT$O\PF?[2>-]ONG)V9I#9"-1'5)%2344U!-175-%33 M4*/M7W6F?SGH7W4O^XBO:,+1^'Q=E53'YV%5$K7US>S<524-VTM7JEEIZU6\VU<_.R;1-B14 M$U%-0C49U1144U%-0S4=U0Q4,U'-0C4;U1Q4*,-FGG9[U\=1N9_HC9HN*L-&K;7 M!OEI6<[2=07O[4.>/M]J/<4(;1!"M1&JB:@FH9J,:@JJJ:BFH9J.:@:JF:AF MH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:F-*:V;LKHYHV%Y'].7Y9*'[M)J;U@W9 MK9]Z>5T74;=%'/9%?&D?\NS@1.N&4$U"-1G5%%1344U#-1W5#%0S4L?%QO MR]M7#OW0':RO"]J]J#:WVMZ'=)'FR4SXNBJJ.ZTH*FWRO%ZRO6<*X2&O[KSI MXF&]K\END9>K)TT7POHN2?,BJR]<6NU]=;M:HAIW[V[]]&'[2&QWV'J^;_;O M^FDA9%]GTX?M_3)/_DB%ZA5W^3A[>KD\1?6#,IG5F_1#KW-YT;L9U(]MM7F? M!+7:EKN[:?W'Y&(WAO"8?$O7=\NBND/JNZYZ7FVTYX>RJ%:HED]*89+-Z]?T MU3TLI/?WZ:3:O\9N5 LL[E:3:BL28;FJMG4R>ZH>R8=I4=\==]5.WZ=YM6W' M+KVJH4]\'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*U&-7&E-9\_;9KUZIN MML;INZX6U(Z<_:J-U$:H)J*:A&HRJBFHIFZT_8-BW>IU5O4RJWE43$.'U5'- M0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BU%M3&G-S-RU9EVWMV8YFZE&-2%: M3^JJY$R^SE)A.P%<)M5TZ6B,HKU8J#9"-1'5)%23-]I^5%UUCIQFJ*##JJBF MH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:F-*:\;HKA;KNKT6ZWV7 MW6M'SLY,M <+U414DU!-1C4%U=033[/;U<,GH3Y2OCY4?C1+T>HK5#-0S40U M"]5L5'-0S44U#]5\5 M0+42U"-5B5!M36C-+=S59UZ=JLEH^R2S\CV F?T[G MJWGKAYO;AS@[:=$J+50344U"-1G5%%1344U#-1W5#%0S4^>6O3[/[?F^=?TWRK?J*>OF-%%G>YIHZ]P5+>9"M1&JB:@F MH9J,:@JJJ:BFH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:F-*:^;O MKICKNKV8ZYUG_I*5*E]0;81J(JI)J":CFH)JZO7KTK9>Y[)W,SBO5UZMONX:EV[:&Y=.35[WNW9;)ZYH 1.JC5!- M1#4)U6144U!-134-U714,U#-1#4+U6Q4P:(% M3:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:@VIK1FC.X*FF[^7D'3>NKZ M>_OD%>UG0K41JHFH)J&:C&H*JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH! MJH6H%J%:C&IC2FNF[JZ?Z::]G^FO3U[1JB94&Z&:B&H2JLD;;?^CI8.;WLUU M[Z"H'QU5134-U714,U#-1#4+U6Q4+(MJ-LQ,3;6!"-1'5)%2344U!-175-%334V^H;=]7T\ST'?='^)50;H9J(:A*JR:BFH)J*:AJJZ:AFH)J):A:J MV:CFH)J+:AZJ^:@6H%J(:A&JQ:@VIK1&^G8[NYJF^G9;_JZO+#?=SEKS-ZXL M=T(Y-UM9;L1R(LM)+"=ON6YO[X5=YU/GYN! +SNLRG(:R^DL9["R_DL%[!6K)$6KE%A.8SF=Y0R6,UG.8CF;Y1R644EE-93F,YG>4,EC-9SF(YF^40RU=[N=S>ZO27^R5.P.>',-KFQ'(BRTDL)[.+[>B^?V8JB_,?U%VZ)8 M;L1R(LM)+">SG,)RZI;;_T!3[ZH_&-X,7TU_T4(HEC-8SF0YB^5LEG-8SF4Y MC^5\E@M8+F2YB.5BEAMCW$&^WNSEZ]_KD=*2AW2>+!:"7R;SY73Q('S)YLMD M\71B!HQV2K'54EM-83FY M@.5"EHM8+F:Y,<8U$[J[US35?5?35+'Y4.^%<)<6DWRZ+*?9XFCVMGMG9R_* MC5A.9#F)Y6264UA./?7$6RVSA5 ^IA\FLZRH7_EE]T*R$.S[^S3??#E+BZ): MI/KN#]W.1:>S_D_XGJUF=\+75,B^SJ8/Z\,T958?N:FU]3IIOCZ@4PU8/@G+ M-)_4KSI_O.G\\Z?Z^_52+Z,L\VR2IG?%ARP7BK1^+^9)^'&XMV3UWT)('JH7 MK_500K8JBS)9W-7K?DUFR6*2;I>LSULL?EF_C_/CUY^$[?X);^_?/,O35_OW MX>W]RQ:I\+A:W.7UD:GM;G4[?WUK/PE!=7/[DOM[4@@/>;*H1OQ0;5.V_AM0 MCYVGRU4^>4R*M-JK^AO=EP=CHQ6/2?64V'ZU ?_UC^M>=_A+(4RR^;R2BC*; M_"%,BV+UO$N:_T6H]J9ZM.J5MI6RM\ZMD)1"4CTTTTGZH2)_Z'X:=.H=?AZF M6CK/5@^/PFVUQ*S:%J'7Z76%(A-F6;6?2?V42:O%ZD476?7W[#Y9SRG,5R-LLY+.>RG,=R/LL%+!>R7,1R,[@!=]> M'UJWO0]M_8)OGI2K?%IEW=U;U:+MRODO\]A*-)0364YB.9GE%)933SW=JI#^ M) B=*J77,7T\9=FN-)0S6,YD.8OE;)9S6,YE.8_E?)8+6"YDN8CE8I8;8]Q! MRO;V4K:]6,M?SU364YC=S.5XT+)E:2@W8CF1Y226DUE.83EUR]WLG4A038P/ M3R) !]59SF YD^4LEK-9SF$YE^4\EO-9+F"YD.4BEHM9;HQQ!UFZUXI6W3Z9 MI<7>4K=M9_WN5I>3 .LL9+&>R MG,5R-LLY+.>RG,=R/LL%+!>R7,1R,X@2_^._6) M[W_QBH\GMN'\*&8;T5!.9#F)Y6264UA.93F-Y726,UC.9#F+Y6R67D+?>. MJU>A ZLLI[&^7YY-4_?5)JNW36[;Y#.5&+">RG,1R,LLI+*>RG,9R.LL9+&>R MG,5R-LLY+.>RG,=R/LL%+!>R7,1R,X@E/?JT;KM]6AJ4:RVGTKQTWR: M%L*MX.3I?9K7'W)9A_&%L$C7#2W3[<*3K"B+B\V'3HY']/#U>WR]P:NW^+Z< MV+[SPY5DEE-83F4YC>5TEC-8SF0YB^5LEG-8SF4YC^5\E@M8+F2Y MB.5BEAMCW$'X[I6?==O+S[[L?RQS\PG.YT]G7@C?DMGJC:/-K_NL+OO#P9%H M92O-4$YD.8GE9)936$YE.8WE=)8S6,YD.8OE;)9S6,YE.8_E?)8+6"YDN8CE M8I8;8]Q!M.[UGG7;>\^A+MBCS9%)F M^8D&\/;1SS\"S?:?H9S(R^FW=-V!:":+NMR[GM=N,O;$ MI+9]B/.#EFV<0CF1Y226DUE.83F5Y326TUG.8#F3Y2R6LUG.83F7Y3R6\UDN M8+F0Y2*6BUENC'$'<=S;B^/V]JG=526WE1EWPMWJN? XS:?9&S-=MHD*Y48L M)[*\=: M;Z)C2W:'1Y:,CRW9OSRRY!C;F8-$W.N0JFZW):)7ST/?/L;;NO+YR4=R(Y83 M64YB.9GE%)9364YC.9WE#)8S6Y5[_5>Y=]D9=(?=5[$'[PG,IR&LOI+&>PG,ER%LO9+.>PG,MR'LOY+!>P7,AR M$4,EC-9SF(YF^46OZYS)=%&_T"K2SGLUS G72\7^D4JF_5ZG4;Z]46A]# MGKP<0[[8W*XGH.JB*/-5/4>]$))YMEJ41V.V?8"S8Q;E1BPGLIRTY1J5)MVC M4U9T8(7E5);36$YG.8/E3):S6,YF.8?E7);S6,YGN8#E0I:+6"YFN3'&'>3L M7NE2O[UT:9VSRWRZF$R7R6Q=NI1,)OFJRMGI9C9[/%W9HB64&[&<:P7 M'5AF.87E5);36$YG.8/E3):S6,YF.8?E7);S6,YGN8#E0I:+6"YFN3'&':1K M;R]=VSN4WG4FU-&+QN)G2+5OZ?F!S18SH9S(4TEM-9SF YD^4LEK-9SF$YE^4\ MEO-9+F"YD.4BEHM9;HQQSW'[N7BLYJNCI$Q^^W6>Y@_IEW0V*ZH$72W*>I"] M[PIY>E^G\<^WO8^?7WW?[?[L=8]\/^S^'*^__WG'__;K,GE(S21_J/)9F*7W MU5"=3\,J._+IP^/+%V6VK%X(?!2^9F69S=&PO=V]R M:W-H965T\;*R'6%Z;)DQ44F)_3-1#Y9$%9@87LLJ7)UPQP6H**W'0L*S +G!%CT"O' M[MB@1S/2OAC;):",^)+!CN^UD9(RI_2;ZDS3OF&IC""'1"@*+/^V M,((\5TPRC^\UJ=',J8#[[6?VJU*\%#/''$8T_SM+Q:IO1 9*88$WN;BGNT]0 M"_(57T)S7OZB714;R!F3#1>TJ,&R7V2D^L=/M1%[ #MX >#4 *<-\%X N#7 M?2W JP%>Z4PEI?1AC 4>]!C=(::B)9MJE&:6:"D_(VK=9X+)IYG$B<%L]&DR M?OP\0;=7:'HSNKV>H(?+?]#=_>V7Z6QZ>X.&DYO)U?0!G8Q!X"SGI^@,/<[& MZ.3C:<\4,@/%8R;U;,-J-N>%V6P'75,B5AQ-2 KI(8$I4V_R=Y[S'SJ=C->8 MG2/7_A,YEN-J$AJ]'NYHX./7P^T.-6ZS&F[)%[S -R4)+0 ]X"=XQ>CJ&=6Q<<'7.(&^(<\%#FP+QN"/#W9@_:5SZW>2C7\3 MV8&37N.DU\4^>)RA*TB!X5SG62=6GQG2V57Q>"6/.F&W@S/;M9S(EIMANV_% M^R<\<,%O7/!_Y<),8 $Z#SJ1;_"@XO'W/?"\( C#E@7OG^_ @J"Q(.BTX($* MG,N3E#$@ JT9W6;JFZ5SI)/H#8X$QX[8H1=[4=2RY/T3'E@2-I:$[W@WPN/L M_3 *PO@P^9$F+@R=T#K:^\>!?N2$CM>$'8B(&A'1_][:D68!?-OWVQ(T<4[@ MQ4[0EG <:+M2:Z"7$#<2XE=L35FD@-R<*9H#@44F=()BC=?RG'%;&VJDB;,M M-PRDW2U%QY&A+!4M2Z_(MGZ6$U:GIM$*DR6@C* MSC>XJNUR65UBDFC7JIOO M#6]=3;0O*8K<.(S;BZD)/.L4OU=+V9WBZ\^WD)_OD^:D.>U:V)K0^^7*Z@)= M)_+C(&[+Z\SQ#:>*N5=5%L"6977.44(W1%0%6C/:W NR[JW-3Y4-X.R6OU) M4UTK9/VTS A'.2PDI74>RD5A5:5>=01=E[7KG I9"9?-E;S= %,!\OF"4O'< M41,T]Z7!#U!+ P04 " #SBN-TA/V9)32-3R#^IX^"AS9)4L8 M)[O7,XG[V<#SN/D&Z]2XFSAMO9>[X[!<9.4W69T(Z95">K5"GA55 MH%6 _$P8IG^^(K<0@J QB?+CHB4N@<$J4B:)/9-;3K\BT6PU<$[^JHK-H)Y9 M<;]4W*_?N@UE:T!Q9$?C+KY:+VIP/ MGVI.YZ"4.*BEFB=IS'\#$,SJP2NA>RI":9)63]/JFCS*%0^,6U-5W,#?:Q(\ M+ 4/&TZQUKD6E"FCSGITRSLK<]BX]WX#M]ND\:K4>'6!1BS B$YF40!&I5?- MA[79Q*_WI-5OTN0ZAZK J>5Z4!L0QIO>,9ZP:NHTFE74U-N<.GY4SKBUCM]S M]C?6&%LL)Y0G%5FN("CKGN,%B*)W('2/8=16SVO,8X7+WIQ4&BA;[O!\ (Q5BW-5#8#)K++?]E'SD8!89TV)I MUN(LN<*&*7O<8!,,0AO@^Q7'TU0,] )E6SWY'U!+ P04 " #SBO&=D)"]B 22U@5::]=+6Q;J;H/)ABPZL2<;9;MOS\[85->3+I] M^0)Q,O/X>6;LF>EMA?RB5I1J\%3P4O6]E=;K*]]7^8H61%V*-2W-EX60!=%F M*9>^6DM*YI53P7T,8>07A)5>VJO>W2: V14'DUVO*Q;;O(>_Y MQ3U;KK1]X:>]-5G2"=4/ZSMI5GZ#,F<%+143)9!TT?<&Z&J(L'6H+#XPNE5[ MS\!*F0GQQ2[&\[X'+2/*::XM!#%_CW1(.;=(AL=_.U"OV=,Z[C\_H]]4XHV8 M&5%T*/A'-M>KOM?UP)PNR(;K>[%]2W>".A8O%UQ5OV!;VT;&.-\H+8J=LV%0 ML++^)T^[0.PYH/", ]XYX) M7(]OQ]/Q: (N,JH)X^HU> ,>)AFX>/6ZYVM#Q,+Y^6[3ZWI3?&;3?XB\! 'Z M"V"( X?[\.7N^-#=-_*;&. F!KC"B\[@C?!3&EI MCMF_+H$U8N!&M'?O2JU)3ON>N5R*RD?JI7_^@2+XMTON;P([$!\TXH,V]/2= M*16F*$BB6;D$1KL".9'RJZD06R+G+NTU8%@!VC+QF'9C% 2HYS_NJVK=UZT* MM @*&T%AJZ!;*\$4B/5&YBMSP5T*:H3.O@(A8@<,L3@*4-&8'!#L-P4XK MP?=Z1:6+5:O;BP)6T_YUG -=4:,K:M4U%9IP6T*IE'0.M+E.1"FJE4MK=!): M%"5Q%.*C%)S:M:4@;JC&K50S:J3GC%2=A#Z9GN@^)_')[F]P B.,PB.:+D,, MNT&$W$2[#='NSYV5[NF&"$$$,3QBYC#$, Z#,Q%,&F+)CR:;,S)CG&E&G1E/ M3HF$$,8X.(ZEPQ"'J-.%T$T9P6^]#GZWUCG.IW^Q1]W=SJ"#4P"33G)\7EV6 MJ!-$8??,24![G1JULO] ^*8^L82;Z8N4N?/,MJ/\0!GY#4"'2K_U8]3:\7XA M3_BD-9W+D\/2G2=_;[BRDZV9/I:L5(#3A7&%E[')M:R'Q7JAQ;J:MV9"F^FM M>ER9 9M*:V"^+X30SPL[PC4C>_H_4$L#!!0 ( /.)SE:+J6H_>0( *,& M 9 >&PO=V]R:W-H965T0#1]RD;C,>YQYTCPF M.RX>90F@T%-%F1QYI5+UT/=E5D*%98_7P/1.P46%E9Z*M2]K 3BWH(KZ41 , M_ H3YJ6)75N(-.$;10F#A4!R4U58_)T Y;N1%WK[A259E\HL^&E2XS7<@_I6 M+X2>^2U+3BI@DG"&!!0C;QP.9WT3;P.^$]C)@S$RE:PX?S23FWSD!28AH) I MPX#U:PM3H-00Z33^-)Q>>Z0!'H[W[)]M[;J6%98PY?0'R54Y\JX]E$.!-U0M M^>X+-/5<&;Z,4VF?:.=BKP(/91NI>-6 =0858>Z-GQH=#@#AX @@:@#12T#_ M""!N /&Y@'X#L%+[KA2KPPPKG":"[Y PT9K-#*R8%JW+)\Q\]GLE]"[1.)7> MW$V_WL[1P_CG_!Y=S$!A0B6ZPT)@\T'>)[[2IYA8/VL8)XXQ.L(81NB6,U5* M-&FV.TSW$2G62\Q:*'XO 214$4=R0T/1\>=*Q MY1L<4YQEO +T@)_0C,B,_J(B_"Z%P1ON]I@ZI"A^V^,O6[3H!=\3/SMH4!=46V(*]L_ M:-\*Q-K:H$09WS#ENJ1=;9UV; WFQ?I$.[ SS/\TSK[U3[PF3"(*A:8,>A^N M/"2<);J)XK4UB157VG+LL-2W" @3H/<+SM5^8@YH[Z7T'U!+ P04 " #S MB3UY\GZ-F%R/T@S'Y')^C+Y (]^_7W MTWXN+ULX]Z>;2[Q:7X+LN<0'/WV!*'Z.B$-H@_OYX>Y$=^_+9+<9DVW&I,3C M>_#>!'&0BY,K.7IFZ#+._?@NN T%&F>9R#/TUY6T1Y>YB+*_FW)=@]-F\*+I M7F9+?RK.>K*K,I'>B][HMU\P=_YHRMP2F%8'NJT#A=!'E=3],O7G*!9Y4\IK M'+?$*::%^Q$F X\-&7=/^_?5?, K'IF/N\W'!?.Y"J;%[!+?H?%=*H2<:HJ[ M^4%$MR)MO),@G.F=M 2F9HW$ M*F.:,$?^VQG0O#;T=\RT0+UMH!X8Z'@Z746KT,_E_?*C),V#?_QB46L*U*L% M>M(8:;N=%NI@&^K TBP!XC3?>=0T@OX_CI;H<)OH$$Q4OA;^=_0UR%9^B,91 MM))-51"-:WF;XAR<24!DTPZR!*85 3N*#CA=SB4;=$NEL(6FUZ)"C?"!*XK_ MM*(\1V$P%XV9PU@8HT?AIQDB*$KB?)$A3-#,?VR:G,[M8.E9*WJ$0=9A-(MN MH*KSX[!I"\6G,$RHS-H1QJ) -Q[AJ>L&BAL1D&\8->,&2OO1[#*'8[K3C <8ZN$J M^D)@FB##%6$AEQ6$]CI-EB+-'\%>A &-Q0U+:'KZ%9FG6YW'KM#3A=)#%$TB M,$TRZL46+* 7C_'4,U+$A\!JCU$ONO468RYE[F"W%]L-]7 5-R$P*8![$?V+ MWEY<'LQ@X6L9#\TN)!NB& [AG;8IR)^,:V$)3:^%HD\$ID]F;0IC80?HTV-< M]9P4)2+& M+^1AW4^L\EQ'5=LMNH[89ZN(JU$)@O?$[]F8C]2, =:%7QL86F M;P,H6D,[E7RH5"\69J$7)IP4+^ EYC*>>D:)!U)Z<0^LR#<&,.![? MW>=I-]3#K6Q*P1RAWG^&BR.,;SP8?651N/,TKH8+C;G0=8Z@$KAD(/%'BN@JRRO6K:HU8U M'UMH>DD4P:&=:C[4JN9C"TVOA6)/U*+FTX(%$=BC7/53!8H>N?94'[6-HQ.1VQ@=*//0P0&4\Q<+M?%/=N0KN(F;JN\<^ IB0V0?IB*>H0/\.ZF:9,IY=1QZ&!?C17Q M<&'BT39'&"[H\-6,6Z8+%<95',?U.IT^K)(;6VAZ+12Y<6'UQFA!;\$"./U9M%E]7X@YE'AL]_QSDR$CG. ]&TBL M$%,LA76Z-\2LLA);:'HM%"MA%O>&6K" ME?@83STCQ2T8O*HW#6G).XW/\<.7,;[-72@H3-$3-NQTR%O=F+*%II_F5^R' MVU->>,,QFO+\^^Z!_E8[/5C%7#BLNKP7\SFZ\6/XAQ(,8GI_;*'I*2N"PCO5 M6;A5G<46FEX+Q7ZXQ1,V+5C ]'R,IYZ1HD<@_ M4$L#!!0 ( /.)SE:DVZ[^LP( $' 9 >&PO=V]R:W-H965TY I H>><%;+KK)1:7[BNG*T@ M)_*,EUVGY;PL/-+E2ID%-^VLR1)&H";K!Z%G;NTRISD4DO(""5ATG:QU MT6N;_7;#5PJEW!LCD\F4\RG<.> !\2X)T V[@KD(VR3Q1).X*72)C=VLT,;*I6 MK8.CA?E31DKHMU3K5#JZO+GJ3VZOT/T7E V'D^P697?WC^/!]VP\N!^:Y<%P MG VO!SV]*1N-KL;HK ^*4"8_=ERE0S!&[FR'ZU4X? !W1\0Y\EN?$/:PCR:C M/CI[_\K&U1G4:> Z#6Q]HP.^UYS/2\H8(L4<#0I%BB6=,D"9E* DZE,Y8UQN M!* ?V50JH3^>W15Q2_F6(*Y$*NR0RZCJX "6(+3OKA72OR/A_)P:]S\(^Y MI_I(@J:8*E5@5:;&MFG+;WDX3L*.NVW@!34O.,4+FWB5*MSGX2@*XO@ +ZQY MX2E>U,0+_Y,7U;SH%"]NXD4-O##T_? +ZYY\2E>TL2+FWB!C\UI-/&2FI<< MY8U7H-OP0H%HHB9OJ%&(?2\*DF9JNZ:VCU*SHM@076NE?P%02P,$% @ \XG.5A2-J#8& M! "! !D !X;"]W;W)K&ULQ5=;CZ)(%'[? M7U%A-YN9I+>Y*2BK)MA CXE]2=NS\]#IAU*.0@8HIZK4F)\[:@J6T208G9-UI")+TM"4\Q% MDZY4MJ: PQR4)JJA:9::XCA31H/<]DA' [+A29S!(T5LDZ:8?AM#0G9#15?V MAJ=X%7%I4$>#-5[!#/C']2,5+;5B">,4,A:3#%%8#A57=P)=DX#7DE2I^I3 P_<]>Y /7@QF MCAG^&LIQ % M\X C!)@G (Z9P!F"3 O!71*0.=20+<$=$\!YAF 50*L7/M" MK%QI#W,\&E"R0U1Z"S;YDJ8;>>$A+LX2>KD+Y"='"E/ MFNVHK_5L3>MW!NKV4-I+';W&6-XJVP6]'DG2K23I-DKBIH3R^&^*, MBZDE<7> M3V_>C_);(C:?O*B4'7OM]XM4:UQ;4I7PR_(/'[X5! "R+* M)L;EB?%,<0@93H%=H9O\+BZ6T!,D^9'"HG@M[).,B[)(;(T;G*!'*DH^RK]= MYWG,"J ML]M.8-?9>T[0J[&[?2?HU]EU;5_EJM\5*FID<55?Q1E#"2R%6MJU++8A>*3<="+PY2;]E*R$D>(G6<78^6DFY.1V/L_E*1$'V-MF( M6+VS3-(HD.HP?1QGFU0$BV)0M!YC")UQ%(3Q:')6G+M-)V?)5J[#6-RF(-M& M49#^3]R%CRN9GQA/SC;!H[@7\LOF-E5'XUIE$48BSL(D!JE8 MGH\NT*E/2#Z@B/@C%,_9SFN06WE(DF_YP=7B? 3S&8FUF,M<(E#_GL14K->Y MDIK'WY7HJ+YF/G#W]:OZN\*\,O,09&*:K/\,%W)U/G)'8"&6P78M[Y+G#Z(R MQ'*]>;+.BK_@N8QEZHKS;2:3J!JLCJ,P+O\'+U4B=@8@9\\ 7 W W0%TSP!2 M#2"'#J#5 %IDIK12Y,$/9# Y2Y-GD.;12BU_422S&*WLAW&^[O^&:IR< MW$\_S/PO'V?@YAVXN9W=77R^^O0>W,_>7\\^?;X';WPA@W"=_0I.P)=['[SY M^=>SL537S4>/Y]4U+LMKX#W70!A<)[%<96 6+\2B+3!6$ZYGC5]G?8F-BM=! M^A80]!O $!/-A*:'#\>:X?[APY'!#:G7@!1ZSAZ]._$DXJT RS2)P.Q%BC0. MUF!:++Y(P=>/*AY<21%E?^F27XH3O7A>-TZS33 7YR-5&#*1/HG1Y)>?D -_ MUR7.IIAO2:R55%HGE9K4)Y\3J9)8I3;3Y:T<3XOQ>7E\FB /4>*Y4"WJTVY2 M^I&80NQXR'':D7X_TL'4Q83 .K#EAM5NF-'--,DD2)9&/Z4"V_5#'$@0AK3C M1Q/)$(/,8;SCIQ_)$/28PSV]'Z?VXQC]O!>Q2-7Z!/$"! M5U\),ID'> H!X M43TM$SJ'3F\VE!'7Y:QKL!](N(>0YWD=?_U E0G(B8?U_GCMCQO]^4+=TO,P M*'M;;C)*4AG^6YS06>.:QNT=E5 M/%=5:?SF8Y*IKE"4K)N-2 MCVMO2[JBS%M-^(.&(>J2; E^CR-3Z M>B[36_-J:YY=:T:YH977IICO[4L1U:<(P887H#%)%U&TC!#H.=@J0)-;=]U* A,D+208V_DFB;4G1"L<.ZIC2A%'.N9MI% M&4VHN?>C!LV0FJ:[$>JK'F,N7L\-L"& MS,0VF "0AK6X2W#/G([>N,=Y%P!T@28"0 V\(3.]#6Z4J,]9)QYS81\"-)%J MY3A5J]RU9YSCL;6F 3QD)KSA.3#J#:[;-M5\U(=%1CESV;[ZU= B,N.B^J[\ M35)ZT\#DMR%/;.2O@V"BDMCUH;XY.Q[I M5FI-H,L))JS;8\V3.L)OPX/8S(/'<0;NTYS'(:>X"U.:0)<22F"W$YNG>40& M&GS$9GP<3"%8QY(<0DJZ'**-1!@3WL5C\QR/L-^ )C:#YN FC?L\2%#.\OW/ MNR:2$>2IT*Y]XQR/+7(-B&(SB [/@5%O:,.PJN8?HV:\E1KFQ6;FG2;I)E%9 M$\7'Z$:N5.N=E44D,Y*-67=P.FVJ^;;4VCEM&!KS'TDVV"I16U7S;:FU,]M@ M-S9C]P%D+ GY%H3:V6H(&YM_^#V(BXY 57V^+ GY%H3:CRL;;B9F M;CZ.JTB?D#$C$/=[JR82<4:IUT,+721T"7?)GA^Z20/+Q S+@]')K#?@#K$E MY%L0:B>O(6]B)N_!T%'I[3XY/=EW=VA"]]T>1X#W=ZLPV7FN;Z;OX5FP^RS? M[L-\TG]>KCYJM/]1&^]L1U%]_+'8UI.!>;*-9;G'HSY;;QVZ*#;,=,Y?HE._ MW #4R)3[D:Z#]#&,,[ 62R4)WW)5 =)RBT]Y()--L>GE(9$*)HJ7*Q$L1)H' MJ/>722)?#_(+U!NM)O\!4$L#!!0 ( /.)SE84? "E 0, ,X, 9 M>&PO=V]R:W-H965TIO#P63=R/)$WYX M=C$.[J_&Z.8<36XFHRLT"L/Q)$3A^/OU^(=L' 4@2!3SS^@KN@\#=/3Q\T 7 M8K;U/T)%21&A',0O,FU@FWG;/4L MV_BV:6'L8*\WT#>[EC0A;;/G81/7D<%SI-GK8_FSS0I9*\:NBK%;BQDER3J- MBM5P#U2+.A(K.:I6WGJOBE= M!=O938)C&[;M&OOI:D"Z!C8<95[WCO&R^O2TR[%@H[$:I[V*T_[;XI7_]F+QG(\JV_T/&,O M7DU(^8K#EN'NQ:MU1LWUHJ92]9W-H]KIRW0MHY2C&!92V3CNR02S8O=<= 3- M\OWDE JY.\V;*_G! 4P!Y/T%I>*IH[:HU2>,_Q]02P,$% @ \XG.5LRZ M_AM7 P W T !D !X;"]W;W)K&ULM5=M;YLP M$/XK%INF5MH*& *A2R*E(=LBM5O4M-ND:1_SO*;OD:0*!_29SROK$6(CLU33Y?0T+X"M M3)XQ( L-2F(36Y9G)B1*C4%/CTW9H$ R M6JV%&C 'O8RL8 ;B.ILRV3-+ED640,HCFB(&R[XQM$]#VU( ;?$S@AW?:R.5 MR@VEMZHS6?0-2T4$,P/:> > "@ \![C, IP X+P6X!<#5RN2I:!U"(LB@Q^@.,64MV51# MBZG1,OTH5=]])IB*60 BL:<%\[.AH\?PC_#C8P7A)T@Q_Z(L(6=FH!&+X?C&GCX=6^\T32!U'=SIF=M]T6H, VQW@RZN M&H9/#7W7\;'W2%C)M5/FVFG,=9@DFS3*%\L%)#? :A=*(\EK%TJ;9&%+9!7Q MO%(\[PV+SVM3TS;)PI;(*IKZI:;^6Q=?[J"S7U-6UPYLWS\HOAI#W\==_5^H M%-]3P\;BZY:Y=AMSE3^#6Q RHSDT5E\CRVM72IMD84MD%?6"4KW@#:LO:%/3 M-LG"EL@JFMK6X^'.>NOZ*SQ4?FH^QK;;/:B_.D,WL().<%!_S3'7:X+JY##W MCKT)L)6^/G TIYM4Y$?(++;8/E5XF\(VBF#]&PO=V]R:W-H965TSV[F02BUHS6N*=!%5S3N3/&3*Q MFWJAM]^XIYM"VPT_B2NRP13ULKJ39N5W*CGE6"HJ2I"XGGH7X?EL;.V=P0/% MG3J8@\UD)<2C75SG4R^P0,@PTU:!F&&+E\B8%3(83ZVFUX6TCH?SO?J5R]WD MLB(*+P7[1G-=3+TS#W)['[A&T^#C 33+DO[%K;P(.L5EKPUMD0<%HV M(WENZW#@,'K)(6H=(L?=!'*4SU$3RA3<$BF)+=D)O(.T7BE\JK'4L-C:[_<;Y"N4 M/\Q9,U,@UC 31.9V,J?2E%V8W;UA[&N#:X/Z68LV:]"B%] N*CF (#R%*(B& ML$SG<'QT D?@@RJ(1-4.?PK[)O^N"%%7A,A%FKQ4A'^R^VPLX%HC5[W@C=RP M7\[VT;FJ2(93SS2*0KE%+WG[)IP$'U^!'7:PP]?4D]O:UM,6V5R.[!&H4C7F M0!1D@IM>5<1=]U^]Y6GPFP!C%\!V[3:)QF$8QOZVAVO4<8W^ ] = M]9$U(48'9*/Q<#3I)QMW9.-7R5);"*@DS5S<[@+U 31*'PX PL'9WY7Q#_K- M/ETW1&YHJ8#AVK@%@_=&13;/0;/0HG(MN!+:-+2;%N8%16D-S/E:"+U?V*[N MWN3D-U!+ P04 " #SB6QE* )>=ECNE@OWZ^ M."24^DKH/C1, Y78]^3N>7P^.[$Z*N2&T]LEI=):)SPMQO92RORCXQ3S)4U( M<9GE-%5(G(F$2-45"Z?(!251 4X)=[Q>+W 2PE)[,DI7R74B"VN>K5(YMEV_ MMEGZ\B52UN"#;>EXTRRB8_O^_-W/52:OWECZ>O;^[*QW?W&U;S\O@0O;,0;M M/PY:WGO9Z[U5@<[K#N8>U0,_6ALDH M)U)2D5ZK3GES:7P"657[;I,KA0M!-J[7MQN'\J)(9IF(J&@V;WMKFHPXC4&. M8(LE7&66.P!*F26J$3&RR%)2:MAZ5 T5=DXYOX6GS(_X4>QUO#.SY;Z2UDTE MJ&KJ,+H#\7>CZ=@[8;W>B^):.7O(Y.>5&DY:]J%_H6F[+ M:1WCFKW_F@]H7M"4"L)W1:O:;Z&X>L=Y#>+LN\@0*M'H'[[9(/^R^QNI,TG&1@U=[%ATCTCT%D=XIB/1/0>0)O&M4 M9\2NB^SF4]&ISCD[AZE'1ZG::L&1=6Q_AR,R;TBMV8IQR=*JMV111-,G)RH5 M7I(9IX_CJ_LC&I,5EW&]3G9<7%THBN M:32MNF(Q*YN6:BC6Z@,.^\AU^3$CF(_&S A@& ^F //17AC/OS2>(3H>C6': MAD9DB/H,41_M94*FY1?C,?N$ZF,>:1CZ?A!@&9U.C0JF6-Z" /[,T3!MX('Q M --QN<9G&Z^0Y^L F]/G*@0;*5Z)V$CQ7 -BSAMXA*%YMC$>\,!F :L=X#?S M0$V9?7P?9A73AJU@' E##(%:--=H$"#9">!KGA]LE?A^&)H1P,P*?!]#8#7B M"*8 -&"([Y?/P;WGD;-]3CG-O\@F?P!02P,$% @ \XG.5I>*NQS M$P( L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ M0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'2B3-S1DB^*0*5 S7NBP=+.&:"P /8:?/7]PY%Z6(I.WU9]"0#,OJT M)?FY>CCA\.Y5O48;E1MMFGSJE0[]8YUGGUM M_CNN-]E+WN3W>9&W_UR-NK^+;,1V>9GO\F_9]FIT.6+-8_7UIJKS;U79IH7< MU%517(TF^P/KK&[SS=%NJ2'C]+[I]K3I?90JD*N1?:E.^)#73=N]HSM_JAA? M,O7F_=9S6\WSHLWJ6=IFB[IZ?LK+S_HTZEN,P=?HXG!XW0?Q??U_PE@]/.2; M;%9MGG=9V>[C6&>%!BR;Q_RI&;$RW657([=ZR6K]?=0'B.W^N[4*"D2J?I^K M [78=GB4*&53%?E6??J67:=%6FXRUH6P 8 & FB<#9!=K%( .44@IP-"2@VA M_Z%AU0,+GWJ7VD0@S3-"WAD TD(@K;-!RK;: $@;@;3/!NFFS2. =!!(AQ8R MC!8\$'_Q6(0!X\&,72=2!)Z4C+NQ6 /(MPCD6UI(F2R7/+IEX9Q)L0C$7+@\ MB!6A&R9!+ #D.P3R'2VD"-QPZ=U=^*&4;]C*BYC:7JJHRAL>>7 >O\0F\DM: MRN\QDRSR7$^L^;7?0T,=0RP9$:R]( XCX4F(A%EE0JR5512J"QG?_LI6?G?' MJ0'B_9&(U5*10DC,*A-BKQ/X?N=/D40\V A] 3'I?3B'B6F M H-8!=);:*OW># 9&,0RD,FU5+F&0F+>NI]N&-C\;Q#/_V@RWBL0#^/-$G5=5;Z@*EQ7Q3+:,ZL=$6PQFIA'3&*/0,R9D'RQB+Q%5Y)$.DF$F)A' M3&*/0,PY%Q%;M#8F(4L8@NA94)_\16SD$5LH1,K M#H<+WK KK9;F(4L\E[83U8?]K 0$[.0-:"%YDFL!,F6(A#+9,ET/08QT27W M099*X'6NZU0_.@-330L3D'7.Y9->D6UA K+.M8!R?%MB K(&%%"8Q%)5/C,] MY+LYZ1,4D(4)R"(6T*O>P.N[$SX*@@G()A;0J_6?UZ 0$Q.0/6 9!!+W?5$D M81ED8P*R!RR#N.^'[KY4FX=1QPDQ,0'9 Y9!2< 3Y2 ]'46A)EURB(D)R"86 M4+^!=32_0TQ,0#9U&=3/B)$U0AM]ZHO80C]?(^QB"S$Q"]G4RSA'U9INP.F; M:/OC;$Q"SD#&BA.-29Y_?;8$!-]^IC\88+^0PZO)B6(B5G(Z2PT[M[_B)Q^'G*1__!5!+ P04 " #S MB@0#75P" A+@ &@ 'AL+U]R96QS+W=O[;<@;V03WH2<09 MH0)Q^4>?4,'3KW)LQD-['O:';EA\G([G85WMQ['[4=?#9E].S?#0=N5\N;)M M^U,S7I;]KNZ:S7NS*[4LEU'W]S.JYZ?[F8O7SZ[\S\1VNSULRL]V\_M4SN,_ M!M=_VOY]V)'E;5_W+6ZKJN8,$@F3^ M((4@G3_((,CF#W((\OF# H)B_J ,07G^H!4$K>8/>H2@Q_F#TA)E7!(D3; F MT#HAUXG ZX1@)P*Q$Y*=",Q.B'8B4#LAVXG [81P)P*Y$]*=".Q.B'@OJ+01Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'H+ MZBT$>BOJK01Z*^JM!'HKZJT$>NMDLX1 ;T6]E4!O1;V50&]%O95 ;T6]E4!O M1;V50&]%O95 ;T.]C4!O0[V-0&]#O8U ;T.]C4!OFVQV$^AMJ+<1Z&VHMQ'H M;:BW$>AMJ+<1Z&VHMQ'H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3Z.V3CY4$ M>COJ[01Z.^KM!'H[ZNT$>COJ[01Z!^H=!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$ M>@?J'01ZQ^1G$P*] _4. KT#]0X"O0/U#@*],^J="?3.J'W!W*SZGSX[J*U*=J<7/<.&6M*Q="WS4NEW7V.+9_I2R?$^IRE7?$TLI<]^/YJFW5+[SNQRO;]\W,_S2&Q^G'_'?\[XM?X'^Q @ M?4B0/A1('QJD#P/2AP7IXPM('U]!^N KE$901.4HI'(44SD*JAQ%58["*D=Q ME:/ RE%D%2BR"A19!8JL D56@2*K0)%5H,@J4&05*+(*%%DEBJP215:)(JM$ MD56BR"I19)4HLDH4626*K!)%5H4BJT*15:'(JE!D52BR*A19%8JL"D56A2*K M0I%5H\BJ4635*+)J%%DUBJP:15:-(JM&D56CR*I19#4HLAH460V*K 9%5H,B MJT&1U:#(:E!D-2BR&A19+8JL%D56BR*K19'5HLAJ462U*+):%%GM_Y3UI_?[ M3XZ?G_7@NO$EG\U_>K[^#5!+ 0(4 Q0 ( /.)SE8'04UB@0 +$ 0 M " 0 !D;V-0&UL4$L! A0#% @ M\XG.5D)B _7O *P( !$ ( !KP &1O8U!R;W!S+V-O M&UL4$L! A0#% @ \XG.5IE&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5H5=>1'7" $R< !@ M ("!ZQ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ \XG.5HF.&PO=V]R:W-H965T&UL4$L! A0#% @ M\XG.5GIBXO.U @ U 4 !D ("!''X 'AL+W=OE)PN@$ #*"0 &0 @('K MC0 >&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5E!:&::K! $ H !D M ("!X9H 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ \XG.5F'W]WP5"0 TA0 !D ("!7*P 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG. M5NPHL=N$" U!, !D ("!+\< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5D0Y-=&* @ @P4 M !D ("!==P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5NMQ,!)] P +@@ !D M ("!$A0! 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ \XG.5@:B6G=1 P !0< !D ("!%QX! 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5MTZ M_)>D! G0H !D ("!&2D! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5I+\9[.Q! A@T !D M ("!]C8! 'AL+W=O.P$ >&PO M=V]R:W-H965T&UL4$L! A0#% @ \XG.5H@JST8)!0 >"H !D ("! M?T4! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ \XG.5MUOV('] P J!< !D ("!/%0! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5E2RD"F"! DQD !D M ("!IFT! 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ \XG.5N6N9'?X! ]AT !D ("!#7L! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M\XG.5FS*'##V)P =@ # !D ("!98D! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5A[ZN1L9#0 M$'P !D ("!Q[X! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5KW2F\.(! 61, !D M ("!O-L! 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ \XG.5HD$QOA- P (0H !D ("!A^H! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG. M5C\E@B(6! 8@\ !D ("!&B<" 'AL+W=O&PO=V]R:W-H965T0( *,& 9 " @1$O @!X;"]W;W)K M&UL4$L! A0#% @ \XG.5CJF>YJ0!P 43T M !D ("!P3$" 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \XG.5EAY\<0Z!@ ="4 !D M ("!KT " 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ \XG.5FWK4R-V @ GP4 !D ("!YDT" 'AL+W=O M&PO@0#75P" A+@ M&@ @ &76P( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"% ,4 " #SB XML 97 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 98 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 99 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 364 468 1 true 136 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://ammoinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://ammoinc.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://ammoinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://ammoinc.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Operations (Parenthetical) Sheet http://ammoinc.com/role/StatementsOfOperationsParenthetical Consolidated Statements of Operations (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://ammoinc.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 00000007 - Statement - Consolidated Statements of Cash Flow Sheet http://ammoinc.com/role/StatementsOfCashFlow Consolidated Statements of Cash Flow Statements 7 false false R8.htm 00000008 - Disclosure - ORGANIZATION AND BUSINESS ACTIVITY Sheet http://ammoinc.com/role/OrganizationAndBusinessActivity ORGANIZATION AND BUSINESS ACTIVITY Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://ammoinc.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - INCOME/(LOSS) PER COMMON SHARE Sheet http://ammoinc.com/role/IncomelossPerCommonShare INCOME/(LOSS) PER COMMON SHARE Notes 10 false false R11.htm 00000011 - Disclosure - ACCOUNTS RECEIVABLE Sheet http://ammoinc.com/role/AccountsReceivable ACCOUNTS RECEIVABLE Notes 11 false false R12.htm 00000012 - Disclosure - INVENTORIES Sheet http://ammoinc.com/role/Inventories INVENTORIES Notes 12 false false R13.htm 00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT Sheet http://ammoinc.com/role/PropertyPlantAndEquipment PROPERTY, PLANT AND EQUIPMENT Notes 13 false false R14.htm 00000014 - Disclosure - FACTORING LIABILITY Sheet http://ammoinc.com/role/FactoringLiability FACTORING LIABILITY Notes 14 false false R15.htm 00000015 - Disclosure - INVENTORY CREDIT FACILITY Sheet http://ammoinc.com/role/InventoryCreditFacility INVENTORY CREDIT FACILITY Notes 15 false false R16.htm 00000016 - Disclosure - LEASES Sheet http://ammoinc.com/role/Leases LEASES Notes 16 false false R17.htm 00000017 - Disclosure - NOTES PAYABLE ??? RELATED PARTY Notes http://ammoinc.com/role/NotesPayableRelatedParty NOTES PAYABLE ??? RELATED PARTY Notes 17 false false R18.htm 00000018 - Disclosure - CONSTRUCTION NOTE PAYABLE Sheet http://ammoinc.com/role/ConstructionNotePayable CONSTRUCTION NOTE PAYABLE Notes 18 false false R19.htm 00000019 - Disclosure - CAPITAL STOCK Sheet http://ammoinc.com/role/CapitalStock CAPITAL STOCK Notes 19 false false R20.htm 00000020 - Disclosure - PREFERRED STOCK Sheet http://ammoinc.com/role/PreferredStock PREFERRED STOCK Notes 20 false false R21.htm 00000021 - Disclosure - ACQUISITIONS Sheet http://ammoinc.com/role/Acquisitions ACQUISITIONS Notes 21 false false R22.htm 00000022 - Disclosure - ACCRUED LIABILITIES Sheet http://ammoinc.com/role/AccruedLiabilities ACCRUED LIABILITIES Notes 22 false false R23.htm 00000023 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://ammoinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 23 false false R24.htm 00000024 - Disclosure - INCOME TAXES Sheet http://ammoinc.com/role/IncomeTaxes INCOME TAXES Notes 24 false false R25.htm 00000025 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://ammoinc.com/role/GoodwillAndIntangibleAssets GOODWILL AND INTANGIBLE ASSETS Notes 25 false false R26.htm 00000026 - Disclosure - SEGMENTS Sheet http://ammoinc.com/role/Segments SEGMENTS Notes 26 false false R27.htm 00000027 - Disclosure - SUBSEQUENT EVENT Sheet http://ammoinc.com/role/SubsequentEvent SUBSEQUENT EVENT Notes 27 false false R28.htm 00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 28 false false R29.htm 00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://ammoinc.com/role/SummaryOfSignificantAccountingPolicies 29 false false R30.htm 00000030 - Disclosure - INCOME/(LOSS) PER COMMON SHARE (Tables) Sheet http://ammoinc.com/role/IncomelossPerCommonShareTables INCOME/(LOSS) PER COMMON SHARE (Tables) Tables http://ammoinc.com/role/IncomelossPerCommonShare 30 false false R31.htm 00000031 - Disclosure - ACCOUNTS RECEIVABLE (Tables) Sheet http://ammoinc.com/role/AccountsReceivableTables ACCOUNTS RECEIVABLE (Tables) Tables http://ammoinc.com/role/AccountsReceivable 31 false false R32.htm 00000032 - Disclosure - INVENTORIES (Tables) Sheet http://ammoinc.com/role/InventoriesTables INVENTORIES (Tables) Tables http://ammoinc.com/role/Inventories 32 false false R33.htm 00000033 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) Sheet http://ammoinc.com/role/PropertyPlantAndEquipmentTables PROPERTY, PLANT AND EQUIPMENT (Tables) Tables http://ammoinc.com/role/PropertyPlantAndEquipment 33 false false R34.htm 00000034 - Disclosure - LEASES (Tables) Sheet http://ammoinc.com/role/LeasesTables LEASES (Tables) Tables http://ammoinc.com/role/Leases 34 false false R35.htm 00000035 - Disclosure - CAPITAL STOCK (Tables) Sheet http://ammoinc.com/role/CapitalStockTables CAPITAL STOCK (Tables) Tables http://ammoinc.com/role/CapitalStock 35 false false R36.htm 00000036 - Disclosure - ACQUISITIONS (Tables) Sheet http://ammoinc.com/role/AcquisitionsTables ACQUISITIONS (Tables) Tables http://ammoinc.com/role/Acquisitions 36 false false R37.htm 00000037 - Disclosure - ACCRUED LIABILITIES (Tables) Sheet http://ammoinc.com/role/AccruedLiabilitiesTables ACCRUED LIABILITIES (Tables) Tables http://ammoinc.com/role/AccruedLiabilities 37 false false R38.htm 00000038 - Disclosure - INCOME TAXES (Tables) Sheet http://ammoinc.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://ammoinc.com/role/IncomeTaxes 38 false false R39.htm 00000039 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://ammoinc.com/role/GoodwillAndIntangibleAssetsTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://ammoinc.com/role/GoodwillAndIntangibleAssets 39 false false R40.htm 00000040 - Disclosure - SEGMENTS (Tables) Sheet http://ammoinc.com/role/SegmentsTables SEGMENTS (Tables) Tables http://ammoinc.com/role/Segments 40 false false R41.htm 00000041 - Disclosure - ORGANIZATION AND BUSINESS ACTIVITY (Details Narrative) Sheet http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative ORGANIZATION AND BUSINESS ACTIVITY (Details Narrative) Details http://ammoinc.com/role/OrganizationAndBusinessActivity 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF CONCENTRATION OF RISKS (Details) Sheet http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails SCHEDULE OF CONCENTRATION OF RISKS (Details) Details 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details) Sheet http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details) Details 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details) Sheet http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details) Details 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details) Sheet http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details) Details 45 false false R46.htm 00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesTables 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE (Details) Sheet http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE (Details) Details 47 false false R48.htm 00000048 - Disclosure - INCOME/(LOSS) PER COMMON SHARE (Details Narrative) Sheet http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative INCOME/(LOSS) PER COMMON SHARE (Details Narrative) Details http://ammoinc.com/role/IncomelossPerCommonShareTables 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Sheet http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Details 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://ammoinc.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 51 false false R52.htm 00000052 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details Narrative) Sheet http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative PROPERTY, PLANT AND EQUIPMENT (Details Narrative) Details http://ammoinc.com/role/PropertyPlantAndEquipmentTables 52 false false R53.htm 00000053 - Disclosure - FACTORING LIABILITY (Details Narrative) Sheet http://ammoinc.com/role/FactoringLiabilityDetailsNarrative FACTORING LIABILITY (Details Narrative) Details http://ammoinc.com/role/FactoringLiability 53 false false R54.htm 00000054 - Disclosure - INVENTORY CREDIT FACILITY (Details Narrative) Sheet http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative INVENTORY CREDIT FACILITY (Details Narrative) Details http://ammoinc.com/role/InventoryCreditFacility 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) Sheet http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) Details 55 false false R56.htm 00000056 - Disclosure - LEASES (Details Narrative) Sheet http://ammoinc.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://ammoinc.com/role/LeasesTables 56 false false R57.htm 00000057 - Disclosure - NOTES PAYABLE ??? RELATED PARTY (Details Narrative) Notes http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative NOTES PAYABLE ??? RELATED PARTY (Details Narrative) Details http://ammoinc.com/role/NotesPayableRelatedParty 57 false false R58.htm 00000058 - Disclosure - CONSTRUCTION NOTE PAYABLE (Details Narrative) Sheet http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative CONSTRUCTION NOTE PAYABLE (Details Narrative) Details http://ammoinc.com/role/ConstructionNotePayable 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS (Details) Sheet http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS (Details) Details 59 false false R60.htm 00000060 - Disclosure - CAPITAL STOCK (Details Narrative) Sheet http://ammoinc.com/role/CapitalStockDetailsNarrative CAPITAL STOCK (Details Narrative) Details http://ammoinc.com/role/CapitalStockTables 60 false false R61.htm 00000061 - Disclosure - PREFERRED STOCK (Details Narrative) Sheet http://ammoinc.com/role/PreferredStockDetailsNarrative PREFERRED STOCK (Details Narrative) Details http://ammoinc.com/role/PreferredStock 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED (Details) Sheet http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED (Details) Details 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF ALLOCATION FOR CONSIDERATION (Details) Sheet http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails SCHEDULE OF ALLOCATION FOR CONSIDERATION (Details) Details 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS (Details) Sheet http://ammoinc.com/role/ScheduleOfUnauditedProFormaResultsOfOperationsDetails SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS (Details) Details 64 false false R65.htm 00000065 - Disclosure - ACQUISITIONS (Details Narrative) Sheet http://ammoinc.com/role/AcquisitionsDetailsNarrative ACQUISITIONS (Details Narrative) Details http://ammoinc.com/role/AcquisitionsTables 65 false false R66.htm 00000066 - Disclosure - SCHEDULE OF ACCRUED LIABILITIES (Details) Sheet http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails SCHEDULE OF ACCRUED LIABILITIES (Details) Details 66 false false R67.htm 00000067 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://ammoinc.com/role/RelatedPartyTransactions 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF INCOME TAX PROVISION BENEFIT (Details) Sheet http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails SCHEDULE OF INCOME TAX PROVISION BENEFIT (Details) Details 68 false false R69.htm 00000069 - Disclosure - SCHEDULE OF RECONCILIATION OF INCOME TAX (Details) Sheet http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails SCHEDULE OF RECONCILIATION OF INCOME TAX (Details) Details 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 70 false false R71.htm 00000071 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://ammoinc.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://ammoinc.com/role/IncomeTaxesTables 71 false false R72.htm 00000072 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 72 false false R73.htm 00000073 - Disclosure - SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET (Details) Sheet http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET (Details) Details 73 false false R74.htm 00000074 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details Narrative) Sheet http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative GOODWILL AND INTANGIBLE ASSETS (Details Narrative) Details http://ammoinc.com/role/GoodwillAndIntangibleAssetsTables 74 false false R75.htm 00000075 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details) Sheet http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails SCHEDULE OF OPERATING SEGMENTS (Details) Details 75 false false R76.htm 00000076 - Disclosure - SCHEDULE OF TOTAL ASSETS SEGMENTS (Details) Sheet http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails SCHEDULE OF TOTAL ASSETS SEGMENTS (Details) Details 76 false false R77.htm 00000077 - Disclosure - SCHEDULE OF CAPITAL EXPENDITURE SEGMENT (Details) Sheet http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails SCHEDULE OF CAPITAL EXPENDITURE SEGMENT (Details) Details 77 false false R78.htm 00000078 - Disclosure - SUBSEQUENT EVENT (Details Narrative) Sheet http://ammoinc.com/role/SubsequentEventDetailsNarrative SUBSEQUENT EVENT (Details Narrative) Details http://ammoinc.com/role/SubsequentEvent 78 false false All Reports Book All Reports form10-k.htm ex10-5.htm ex10-6.htm ex21-1.htm ex23-1.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm ex4-3.htm poww-20230331.xsd poww-20230331_cal.xml poww-20230331_def.xml poww-20230331_lab.xml poww-20230331_pre.xml form10-k_001.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 101 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 29, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1196, "http://xbrl.sec.gov/dei/2023": 41 }, "contextCount": 364, "dts": { "calculationLink": { "local": [ "poww-20230331_cal.xml" ] }, "definitionLink": { "local": [ "poww-20230331_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "poww-20230331_lab.xml" ] }, "presentationLink": { "local": [ "poww-20230331_pre.xml" ] }, "schema": { "local": [ "poww-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 754, "entityCount": 1, "hidden": { "http://ammoinc.com/20230331": 91, "http://fasb.org/us-gaap/2023": 181, "http://xbrl.sec.gov/dei/2023": 3, "total": 275 }, "keyCustom": 107, "keyStandard": 361, "memberCustom": 90, "memberStandard": 40, "nsprefix": "POWW", "nsuri": "http://ammoinc.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ammoinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - INCOME/(LOSS) PER COMMON SHARE", "menuCat": "Notes", "order": "10", "role": "http://ammoinc.com/role/IncomelossPerCommonShare", "shortName": "INCOME/(LOSS) PER COMMON SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - ACCOUNTS RECEIVABLE", "menuCat": "Notes", "order": "11", "role": "http://ammoinc.com/role/AccountsReceivable", "shortName": "ACCOUNTS RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INVENTORIES", "menuCat": "Notes", "order": "12", "role": "http://ammoinc.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT", "menuCat": "Notes", "order": "13", "role": "http://ammoinc.com/role/PropertyPlantAndEquipment", "shortName": "PROPERTY, PLANT AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "POWW:FactoringLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - FACTORING LIABILITY", "menuCat": "Notes", "order": "14", "role": "http://ammoinc.com/role/FactoringLiability", "shortName": "FACTORING LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "POWW:FactoringLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "POWW:InventoryCreditFacilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - INVENTORY CREDIT FACILITY", "menuCat": "Notes", "order": "15", "role": "http://ammoinc.com/role/InventoryCreditFacility", "shortName": "INVENTORY CREDIT FACILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "POWW:InventoryCreditFacilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - LEASES", "menuCat": "Notes", "order": "16", "role": "http://ammoinc.com/role/Leases", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - NOTES PAYABLE \u2013 RELATED PARTY", "menuCat": "Notes", "order": "17", "role": "http://ammoinc.com/role/NotesPayableRelatedParty", "shortName": "NOTES PAYABLE \u2013 RELATED PARTY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "POWW:ConstructionNotePayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - CONSTRUCTION NOTE PAYABLE", "menuCat": "Notes", "order": "18", "role": "http://ammoinc.com/role/ConstructionNotePayable", "shortName": "CONSTRUCTION NOTE PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "POWW:ConstructionNotePayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - CAPITAL STOCK", "menuCat": "Notes", "order": "19", "role": "http://ammoinc.com/role/CapitalStock", "shortName": "CAPITAL STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://ammoinc.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - PREFERRED STOCK", "menuCat": "Notes", "order": "20", "role": "http://ammoinc.com/role/PreferredStock", "shortName": "PREFERRED STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - ACQUISITIONS", "menuCat": "Notes", "order": "21", "role": "http://ammoinc.com/role/Acquisitions", "shortName": "ACQUISITIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - ACCRUED LIABILITIES", "menuCat": "Notes", "order": "22", "role": "http://ammoinc.com/role/AccruedLiabilities", "shortName": "ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "23", "role": "http://ammoinc.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "24", "role": "http://ammoinc.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "menuCat": "Notes", "order": "25", "role": "http://ammoinc.com/role/GoodwillAndIntangibleAssets", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SEGMENTS", "menuCat": "Notes", "order": "26", "role": "http://ammoinc.com/role/Segments", "shortName": "SEGMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SUBSEQUENT EVENT", "menuCat": "Notes", "order": "27", "role": "http://ammoinc.com/role/SubsequentEvent", "shortName": "SUBSEQUENT EVENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "28", "role": "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "29", "role": "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockDividendRatePercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://ammoinc.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "lang": null, "name": "POWW:PreferredStockStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - INCOME/(LOSS) PER COMMON SHARE (Tables)", "menuCat": "Tables", "order": "30", "role": "http://ammoinc.com/role/IncomelossPerCommonShareTables", "shortName": "INCOME/(LOSS) PER COMMON SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - ACCOUNTS RECEIVABLE (Tables)", "menuCat": "Tables", "order": "31", "role": "http://ammoinc.com/role/AccountsReceivableTables", "shortName": "ACCOUNTS RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - INVENTORIES (Tables)", "menuCat": "Tables", "order": "32", "role": "http://ammoinc.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "33", "role": "http://ammoinc.com/role/PropertyPlantAndEquipmentTables", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://ammoinc.com/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - CAPITAL STOCK (Tables)", "menuCat": "Tables", "order": "35", "role": "http://ammoinc.com/role/CapitalStockTables", "shortName": "CAPITAL STOCK (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - ACQUISITIONS (Tables)", "menuCat": "Tables", "order": "36", "role": "http://ammoinc.com/role/AcquisitionsTables", "shortName": "ACQUISITIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - ACCRUED LIABILITIES (Tables)", "menuCat": "Tables", "order": "37", "role": "http://ammoinc.com/role/AccruedLiabilitiesTables", "shortName": "ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "38", "role": "http://ammoinc.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "39", "role": "http://ammoinc.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://ammoinc.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SEGMENTS (Tables)", "menuCat": "Tables", "order": "40", "role": "http://ammoinc.com/role/SegmentsTables", "shortName": "SEGMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2016-12-132016-12-15", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - ORGANIZATION AND BUSINESS ACTIVITY (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative", "shortName": "ORGANIZATION AND BUSINESS ACTIVITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2016-12-132016-12-15", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockSplits", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-012023-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF CONCENTRATION OF RISKS (Details)", "menuCat": "Details", "order": "42", "role": "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails", "shortName": "SCHEDULE OF CONCENTRATION OF RISKS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-012023-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerAMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details)", "menuCat": "Details", "order": "43", "role": "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails", "shortName": "SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-012023-03-31_custom_MarketplaceFeeRevenueMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ConvertiblePromissoryNoteMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details)", "menuCat": "Details", "order": "44", "role": "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails", "shortName": "SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ConvertiblePromissoryNoteMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "POWW:ScheduleOfStockholdersEquityWarrantsOrRightsTableTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:WarrantsIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details)", "menuCat": "Details", "order": "45", "role": "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails", "shortName": "SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "POWW:ScheduleOfStockholdersEquityWarrantsOrRightsTableTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:WarrantsIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:NetIncomeLoss1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE (Details)", "menuCat": "Details", "order": "47", "role": "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails", "shortName": "SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:NetIncomeLoss1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - INCOME/(LOSS) PER COMMON SHARE (Details Narrative)", "menuCat": "Details", "order": "48", "role": "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative", "shortName": "INCOME/(LOSS) PER COMMON SHARE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "menuCat": "Details", "order": "49", "role": "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ExciseAndSalesTaxes", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Operations (Parenthetical)", "menuCat": "Statements", "order": "5", "role": "http://ammoinc.com/role/StatementsOfOperationsParenthetical", "shortName": "Consolidated Statements of Operations (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ExciseAndSalesTaxes", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "menuCat": "Details", "order": "50", "role": "http://ammoinc.com/role/ScheduleOfInventoriesDetails", "shortName": "SCHEDULE OF INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "menuCat": "Details", "order": "51", "role": "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "POWW:FactoringLiabilityTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:FactoringLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - FACTORING LIABILITY (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "shortName": "FACTORING LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "POWW:FactoringLiabilityTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:FactoringLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "p", "POWW:InventoryCreditFacilityTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31_custom_InventoryCreditFacilityMember", "decimals": "0", "first": true, "lang": null, "name": "POWW:InventoryCreditFacility", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - INVENTORY CREDIT FACILITY (Details Narrative)", "menuCat": "Details", "order": "54", "role": "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative", "shortName": "INVENTORY CREDIT FACILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "POWW:InventoryCreditFacilityTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31_custom_InventoryCreditFacilityMember", "decimals": "0", "first": true, "lang": null, "name": "POWW:InventoryCreditFacility", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details)", "menuCat": "Details", "order": "55", "role": "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - LEASES (Details Narrative)", "menuCat": "Details", "order": "56", "role": "http://ammoinc.com/role/LeasesDetailsNarrative", "shortName": "LEASES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:OperatingLeaseLiability", "span", "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-01-31", "decimals": "0", "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfNotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - NOTES PAYABLE \u2013 RELATED PARTY (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "shortName": "NOTES PAYABLE \u2013 RELATED PARTY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-06-252020-06-26_custom_SettlementAgreementMember", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromAdvancesForConstruction", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-04-012021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromNotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - CONSTRUCTION NOTE PAYABLE (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "shortName": "CONSTRUCTION NOTE PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "POWW:ConstructionNotePayableDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-10-14_custom_PromissoryNoteMember_custom_HiawathaNationalBankMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-03-31_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS (Details)", "menuCat": "Details", "order": "59", "role": "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails", "shortName": "SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-03-31_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-03-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "6", "role": "http://ammoinc.com/role/StatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-03-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - CAPITAL STOCK (Details Narrative)", "menuCat": "Details", "order": "60", "role": "http://ammoinc.com/role/CapitalStockDetailsNarrative", "shortName": "CAPITAL STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-04-012021-03-31_custom_DebtConversionAgreementMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockDividendRatePercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - PREFERRED STOCK (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://ammoinc.com/role/PreferredStockDetailsNarrative", "shortName": "PREFERRED STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-05-18_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED (Details)", "menuCat": "Details", "order": "62", "role": "http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails", "shortName": "SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF ALLOCATION FOR CONSIDERATION (Details)", "menuCat": "Details", "order": "63", "role": "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails", "shortName": "SCHEDULE OF ALLOCATION FOR CONSIDERATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS (Details)", "menuCat": "Details", "order": "64", "role": "http://ammoinc.com/role/ScheduleOfUnauditedProFormaResultsOfOperationsDetails", "shortName": "SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - ACQUISITIONS (Details Narrative)", "menuCat": "Details", "order": "65", "role": "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "shortName": "ACQUISITIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-292021-04-30", "decimals": "0", "lang": null, "name": "POWW:WorkingCapitalAdjustments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:AccruedFaet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SCHEDULE OF ACCRUED LIABILITIES (Details)", "menuCat": "Details", "order": "66", "role": "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails", "shortName": "SCHEDULE OF ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "POWW:AccruedFaet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "67", "role": "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "lang": null, "name": "us-gaap:InterestPayableCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF INCOME TAX PROVISION BENEFIT (Details)", "menuCat": "Details", "order": "68", "role": "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails", "shortName": "SCHEDULE OF INCOME TAX PROVISION BENEFIT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-04-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - SCHEDULE OF RECONCILIATION OF INCOME TAX (Details)", "menuCat": "Details", "order": "69", "role": "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails", "shortName": "SCHEDULE OF RECONCILIATION OF INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - Consolidated Statements of Cash Flow", "menuCat": "Statements", "order": "7", "role": "http://ammoinc.com/role/StatementsOfCashFlow", "shortName": "Consolidated Statements of Cash Flow", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "menuCat": "Details", "order": "70", "role": "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "71", "role": "http://ammoinc.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "72", "role": "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31_us-gaap_LicensingAgreementsMember", "decimals": "0", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET (Details)", "menuCat": "Details", "order": "73", "role": "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails", "shortName": "SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "74", "role": "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details)", "menuCat": "Details", "order": "75", "role": "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "shortName": "SCHEDULE OF OPERATING SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - SCHEDULE OF TOTAL ASSETS SEGMENTS (Details)", "menuCat": "Details", "order": "76", "role": "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails", "shortName": "SCHEDULE OF TOTAL ASSETS SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "POWW:ScheduleOfTotalAssetsTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - SCHEDULE OF CAPITAL EXPENDITURE SEGMENT (Details)", "menuCat": "Details", "order": "77", "role": "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "shortName": "SCHEDULE OF CAPITAL EXPENDITURE SEGMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "POWW:ScheduleOfCapitalExpenditureTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-012023-03-31_custom_AmmunitionMember248214328", "decimals": "0", "lang": null, "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-04-012023-04-01_us-gaap_SubsequentEventMember_custom_MembersOfBoardOfDirectorsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - SUBSEQUENT EVENT (Details Narrative)", "menuCat": "Details", "order": "78", "role": "http://ammoinc.com/role/SubsequentEventDetailsNarrative", "shortName": "SUBSEQUENT EVENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-04-012023-04-01_us-gaap_SubsequentEventMember_custom_MembersOfBoardOfDirectorsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - ORGANIZATION AND BUSINESS ACTIVITY", "menuCat": "Notes", "order": "8", "role": "http://ammoinc.com/role/OrganizationAndBusinessActivity", "shortName": "ORGANIZATION AND BUSINESS ACTIVITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://ammoinc.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 136, "tag": { "POWW_AccruedFaet": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued FAET.", "label": "Accrued FAET" } } }, "localname": "AccruedFaet", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "POWW_AccruedUnearnedRevenueCurrent": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unearned revenue.", "label": "Unearned revenue" } } }, "localname": "AccruedUnearnedRevenueCurrent", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "POWW_AcquisitionStockIssuances": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Acquisition Stock Issuances.", "label": "Factoring Liability [Text Block]", "negatedLabel": "Acquisition stock issuances" } } }, "localname": "AcquisitionStockIssuances", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital warrant issued for services.", "label": "Warrants issued for services" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "POWW_AdjustmentsToAdditionalPaidInStockGrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock grants.", "label": "Stock grants" } } }, "localname": "AdjustmentsToAdditionalPaidInStockGrants", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "POWW_AdministrativeAndManagementServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Administrative and Management Services [Member]", "label": "Administrative and Management Services [Member]" } } }, "localname": "AdministrativeAndManagementServicesAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_AdvisoryCommitteeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory Committee [Member]", "label": "Advisory Committee [Member]" } } }, "localname": "AdvisoryCommitteeMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_AllowanceForDoubtfulAccountsReceivablePurchaseAccounting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchase accounting.", "label": "Purchase accounting" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePurchaseAccounting", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "POWW_AmendedAPAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended APA [Member]", "label": "Amended APA [Member]" } } }, "localname": "AmendedAPAMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_AmendedNoteBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Note B [Member]", "label": "Amended Note B [Member]" } } }, "localname": "AmendedNoteBMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_AmmunitionCasingsSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ammunition Casings Sales [Member]" } } }, "localname": "AmmunitionCasingsSalesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails" ], "xbrltype": "domainItemType" }, "POWW_AmmunitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ammunition [Member]", "label": "Ammunition [Member]" } } }, "localname": "AmmunitionMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails" ], "xbrltype": "domainItemType" }, "POWW_AmmunitionSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ammunition Sales [Member]", "label": "Ammunition Sales [Member]" } } }, "localname": "AmmunitionSalesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "POWW_AmortizationOfAnnualFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of annual fee.", "label": "Amortization of annual fee" } } }, "localname": "AmortizationOfAnnualFee", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_AmortizationOfCommitmentFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of commitment fee.", "label": "Amortization of commitment fee" } } }, "localname": "AmortizationOfCommitmentFee", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_AugustTwentySevenTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "August 27, 2021 [Member]", "label": "August 27, 2021 [Member]" } } }, "localname": "AugustTwentySevenTwoThousandTwentyOneMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Board Of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_BusinessAcquisitionsProFormaDepreciationAndAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma depreciation and amortization.", "label": "Business acquisitions pro form a depreciation and amortization" } } }, "localname": "BusinessAcquisitionsProFormaDepreciationAndAmortization", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessAcquisitionsProFormaInterestAndDebtExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma interest and debt expense.", "label": "Business acquisitions pro form a interest and debt expense" } } }, "localname": "BusinessAcquisitionsProFormaInterestAndDebtExpense", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessCombinationAdditionalSecuritiesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination additional securities of common stock.", "label": "Business combination additional securities of common stock" } } }, "localname": "BusinessCombinationAdditionalSecuritiesOfCommonStock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "POWW_BusinessCombinationContingentConsiderationSharesIssuedPriorStockholder": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination contingent consideration shares issued prior stockholder.", "label": "Shares issued prior stockholder" } } }, "localname": "BusinessCombinationContingentConsiderationSharesIssuedPriorStockholder", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "POWW_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed common stock.", "label": "Common stock" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommonStock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued liabilities.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities", "negatedLabel": "Accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed deposits.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits", "verboseLabel": "Deposits" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherIntangibleAssets": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other intangible assets.", "label": "Other Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherIntangibleAssets", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetsOperatingLeases": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed right-of-use assets operating leases.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetsOperatingLeases", "verboseLabel": "Right of use assets - operating leases" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetsOperatingLeases", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessCombinationWorkingCapitalAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital adjustment.", "label": "Working capital adjustment" } } }, "localname": "BusinessCombinationWorkingCapitalAdjustment", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "POWW_BusinessCombinationsContingentConsiderationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combinations contingent consideration liability.", "label": "Estimated working capital adjustment" } } }, "localname": "BusinessCombinationsContingentConsiderationLiability", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_CashPaidDuringThePeriodFor": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Paid During The Period For:", "label": "Cash paid during the period for:" } } }, "localname": "CashPaidDuringThePeriodFor", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "POWW_CasingSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Casing Sales [Member]" } } }, "localname": "CasingSalesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "POWW_ChangesToPurchasePriceOfTransaction": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Post-closing changes to the purchase price of transaction.", "label": "Post-closing changes to the purchase price of transaction" } } }, "localname": "ChangesToPurchasePriceOfTransaction", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_CommonStock0.001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, $0.001 par value", "label": "Common Stock, $0.001 par value" } } }, "localname": "CommonStock0.001ParValueMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "domainItemType" }, "POWW_ConstructionLoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Construction Loan Agreement [Member]", "label": "Construction Loan Agreement [Member]" } } }, "localname": "ConstructionLoanAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_ConstructionNotePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Construction note payable.", "label": "Construction note payable" } } }, "localname": "ConstructionNotePayable", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_ConstructionNotePayableDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Construction Note Payable Disclosure [Text Block]", "label": "CONSTRUCTION NOTE PAYABLE" } } }, "localname": "ConstructionNotePayableDisclosureTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayable" ], "xbrltype": "textBlockItemType" }, "POWW_ContingentConsiderationFairValue": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingent consideration fair value.", "label": "ContingentConsiderationFairValue", "negatedLabel": "Contingent consideration payable fair value" } } }, "localname": "ContingentConsiderationFairValue", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_ConvertiblePromissoryNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible promissory note.", "label": "Convertible promissory note" } } }, "localname": "ConvertiblePromissoryNote", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_ConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Promissory Note [Member]", "label": "Convertible Promissory Note [Member]" } } }, "localname": "ConvertiblePromissoryNoteMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "POWW_CorporateAndOtherExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate and Other Expenses [Member]", "label": "Corporate and Other Expenses [Member]" } } }, "localname": "CorporateAndOtherExpensesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "POWW_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A [Member]", "label": "Customer A [Member]" } } }, "localname": "CustomerAMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "POWW_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer B [Member]", "label": "Customer B [Member]" } } }, "localname": "CustomerBMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "POWW_CustomerCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer C [Member]" } } }, "localname": "CustomerCMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "POWW_CustomerDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer D [Member]" } } }, "localname": "CustomerDMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "POWW_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customers [Member]", "label": "Customers [Member]" } } }, "localname": "CustomerMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "POWW_DebtConversionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Conversion Agreement [Member]", "label": "Debt Conversion Agreement [Member]" } } }, "localname": "DebtConversionAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_DecreasedAccumulatedDepreciationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Decreased Accumulated Amortization [Member]", "label": "Decreased Accumulated Amortization [Member]" } } }, "localname": "DecreasedAccumulatedDepreciationMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_DecreasedEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Decreased Equipment Net [Member]", "label": "Decreased Equipment Net [Member]" } } }, "localname": "DecreasedEquipmentMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_DeferredTaxAssetsLiabilitiesGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets liabilities gross.", "label": "DeferredTaxAssetsLiabilitiesGross", "negatedLabel": "Net deferred tax assets/(liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesGross", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "POWW_DeferredTaxAssetsLossOnPurchase": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets: Loss on purchase.", "label": "Deferred tax assets: Loss on purchase", "verboseLabel": "Loss on purchase" } } }, "localname": "DeferredTaxAssetsLossOnPurchase", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "POWW_DeferredTaxLiabilitiesAmortizationExpense": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities amortization expense.", "label": "DeferredTaxLiabilitiesAmortizationExpense", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesAmortizationExpense", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "POWW_DeferredTaxLiabilitiesDepreciationExpenses": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities: Depreciation expense.", "label": "Deferred tax liabilities: Depreciation expense", "negatedLabel": "Depreciation expense" } } }, "localname": "DeferredTaxLiabilitiesDepreciationExpenses", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "POWW_DefinitiveAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Definitive Agreement [Member]", "label": "Definitive Agreement [Member]" } } }, "localname": "DefinitiveAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_DisclosureConstructionNotePayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Construction Note Payable" } } }, "localname": "DisclosureConstructionNotePayableAbstract", "nsuri": "http://ammoinc.com/20230331", "xbrltype": "stringItemType" }, "POWW_DisclosureFactoringLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Factoring Liability" } } }, "localname": "DisclosureFactoringLiabilityAbstract", "nsuri": "http://ammoinc.com/20230331", "xbrltype": "stringItemType" }, "POWW_DisclosureInventoryCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Credit Facility" } } }, "localname": "DisclosureInventoryCreditFacilityAbstract", "nsuri": "http://ammoinc.com/20230331", "xbrltype": "stringItemType" }, "POWW_DividendsAccumulatedOnPreferredStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends accumulated on preferred stock.", "label": "DividendsAccumulatedOnPreferredStock", "negatedLabel": "Dividends accumulated on preferred stock" } } }, "localname": "DividendsAccumulatedOnPreferredStock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_EffectiveIncomeTaxRateOther": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other" } } }, "localname": "EffectiveIncomeTaxRateOther", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "POWW_EffectiveIncomeTaxRateStockAndWarrantsOnNoteConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate stock and warrants on note conversion.", "label": "Stock and Warrants on Note Conversion" } } }, "localname": "EffectiveIncomeTaxRateStockAndWarrantsOnNoteConversion", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "POWW_EffectiveIncomeTaxRateStockForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate stock for services.", "label": "Effective income tax rate stock for services", "verboseLabel": "Stock for services" } } }, "localname": "EffectiveIncomeTaxRateStockForServices", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "POWW_EligibleInventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eligible Inventory [Member]", "label": "Eligible Inventory [Member]" } } }, "localname": "EligibleInventoryMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_EmployeesMembersBoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees, Board of Directors, Advisory Committee [Member]", "label": "Employees, Board of Directors, Advisory Committee [Member]" } } }, "localname": "EmployeesMembersBoardOfDirectorsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_EquityIncentiveAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity incentive awards [Member]", "label": "Equity incentive awards [Member]" } } }, "localname": "EquityIncentiveAwardsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_ExciseTaxAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Excise tax amount.", "label": "Excise tax amount" } } }, "localname": "ExciseTaxAmount", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_ExciseTaxPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Excise tax percentage.", "label": "Excise tax percentage" } } }, "localname": "ExciseTaxPercentage", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "POWW_ExciseTaxPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Excise Tax [Policy Text Block]", "label": "Excise Tax" } } }, "localname": "ExciseTaxPolicyTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "POWW_ExclusiveLicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exclusive License Agreement [Member].", "label": "Exclusive License Agreement [Member]" } } }, "localname": "ExclusiveLicenseAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_FactoringAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring and Security Agreement [Member]", "label": "Factoring and Security Agreement [Member]" } } }, "localname": "FactoringAndSecurityAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_FactoringLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Factoring liability.", "label": "FactoringLiability", "verboseLabel": "Factoring liability" } } }, "localname": "FactoringLiability", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_FactoringLiabilityCurrent": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Factoring liability current.", "label": "Factoring liability" } } }, "localname": "FactoringLiabilityCurrent", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "POWW_FactoringLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring Liability [Text Block]", "label": "FACTORING LIABILITY" } } }, "localname": "FactoringLiabilityTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/FactoringLiability" ], "xbrltype": "textBlockItemType" }, "POWW_FebruarySeventeenTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 17. 2023 [Member]", "label": "February 17. 2023 [Member]" } } }, "localname": "FebruarySeventeenTwoThousandTwentyThreeMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_FirstAdvanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Advance [Member]", "label": "First Advance [Member]" } } }, "localname": "FirstAdvanceMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_ForegoingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foregoing [Member]", "label": "Foregoing [Member]" } } }, "localname": "ForegoingMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_ForestStreetLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forest Street, LLC [Member]", "label": "Forest Street, LLC [Member]" } } }, "localname": "ForestStreetLLCMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_ForestStreetNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forest Street Note [Member]", "label": "Forest Street Note [Member]" } } }, "localname": "ForestStreetNoteMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_FredWagenhalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fred Wagenhals [Member]", "label": "Fred Wagenhals [Member]" } } }, "localname": "FredWagenhalsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_GDIAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GDI Acquisition [Member].", "label": "GDI Acquisition [Member]" } } }, "localname": "GDIAcquisitionMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "POWW_GeminiDirectInvestmentsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gemini Direct Investments LLC [Member]", "label": "Gemini Direct Investments LLC [Member]" } } }, "localname": "GeminiDirectInvestmentsLLCMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_HiawathaNationalBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hiawatha National Bank [Member]", "label": "Hiawatha National Bank [Member]" } } }, "localname": "HiawathaNationalBankMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_HundredPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hundred Percent [Member]", "label": "Hundred Percent [Member]" } } }, "localname": "HundredPercentMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_IncomeTaxesPayable": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income taxes payable" } } }, "localname": "IncomeTaxesPayable", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "POWW_IncreaseToDepositsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase to Deposits [Member]", "label": "Increase to Deposits [Member]" } } }, "localname": "IncreaseToDepositsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_IncreasedAccountsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increased Accounts Receivable [Member]", "label": "Increased Accounts Receivable [Member]" } } }, "localname": "IncreasedAccountsReceivableMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_IndependentContractorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Independent Contractor [Member]", "label": "Independent Contractor [Member]" } } }, "localname": "IndependentContractorMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_InsurancePremiumNotePayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Insurance premium note payment.", "label": "Insurance premium note payment" } } }, "localname": "InsurancePremiumNotePayment", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_InterestExpenseOnFactoringLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expense on factoring liability.", "label": "Interest expense on factoring liability" } } }, "localname": "InterestExpenseOnFactoringLiability", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_InterestExpensesOnFactoringLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expenses on factoring liability.", "label": "Interest expenses on factoring liability" } } }, "localname": "InterestExpensesOnFactoringLiability", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_InterestOnConvertiblePromissoryNotes": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest on convertible promissory notes", "label": "Interest on convertible promissory notes" } } }, "localname": "InterestOnConvertiblePromissoryNotes", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_InventoryAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory and Services [Member]", "label": "Inventory and Services [Member]" } } }, "localname": "InventoryAndServicesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_InventoryCreditFacility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory credit facility.", "label": "Inventory credit facility [Default Label]", "verboseLabel": "Inventory credit facility" } } }, "localname": "InventoryCreditFacility", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_InventoryCreditFacilityCurrent": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory credit facility current.", "label": "Inventory credit facility" } } }, "localname": "InventoryCreditFacilityCurrent", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "POWW_InventoryCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory Credit Facility [Member]", "label": "Inventory Credit Facility [Member]" } } }, "localname": "InventoryCreditFacilityMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_InventoryCreditFacilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory Credit Facility [Text Block]", "label": "INVENTORY CREDIT FACILITY" } } }, "localname": "InventoryCreditFacilityTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacility" ], "xbrltype": "textBlockItemType" }, "POWW_InventoryPurchasedDuringPeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory purchased during period.", "label": "Inventory purchased during period" } } }, "localname": "InventoryPurchasedDuringPeriod", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_InvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investors [Member]", "label": "Investors [Member]" } } }, "localname": "InvestorsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_IssuanceOfWarrantsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of warrants, description.", "label": "Issuance of warrants, description" } } }, "localname": "IssuanceOfWarrantsDescription", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "POWW_JagemannStampingCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jagemann Stamping Company [Member]", "label": "Jagemann Stamping Company [Member]" } } }, "localname": "JagemannStampingCompanyMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_JeffRannMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jeff Rann [Member].", "label": "Jeff Rann [Member]" } } }, "localname": "JeffRannMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "POWW_JesseJamesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jesse James [Member].", "label": "Jesse James [Member]" } } }, "localname": "JesseJamesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "POWW_LeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Agreement [Member].", "label": "Lease Agreement [Member]" } } }, "localname": "LeaseAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_LicenseAgreementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License Agreements [Policy Text Block]", "label": "License Agreements" } } }, "localname": "LicenseAgreementsPolicyTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "POWW_LiquidationDamageFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidation Damage Fees [Member]" } } }, "localname": "LiquidationDamageFeesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_LossOnSubsidiaries": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ammoinc.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on subsidiaries", "label": "Loss on purchase", "verboseLabel": "Loss on Jagemann Munition Components" } } }, "localname": "LossOnSubsidiaries", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "POWW_MarketplaceFeeRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketplace Fee Revenue [Member]" } } }, "localname": "MarketplaceFeeRevenueMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails" ], "xbrltype": "domainItemType" }, "POWW_MarketplaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketplace [Member]", "label": "Marketplace [Member]" } } }, "localname": "MarketplaceMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails" ], "xbrltype": "domainItemType" }, "POWW_MarketplaceRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketplace Revenue [Member]", "label": "Marketplace Revenue [Member]" } } }, "localname": "MarketplaceRevenueMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "POWW_MembersOfBoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Members of Board of Directors [Member]", "label": "Members of Board of Directors [Member]" } } }, "localname": "MembersOfBoardOfDirectorsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_MergerAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger Agreement [Member].", "label": "Merger Agreement [Member]" } } }, "localname": "MergerAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_MonthlyPaymentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Monthly Payments [Member]", "label": "Monthly Payments [Member]" } } }, "localname": "MonthlyPaymentsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_NetIncomeLoss1": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails": { "order": 1.0, "parentTag": "POWW_NetIncomeLossAvailableToCommonStockholdersBasic1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income loss.", "label": "Net income/(loss)" } } }, "localname": "NetIncomeLoss1", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "POWW_NetIncomeLossAvailableToCommonStockholdersBasic1": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income loss available to common stockholders basic.", "label": "NetIncomeLossAvailableToCommonStockholdersBasic1", "totalLabel": "Net income/(loss) attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic1", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "POWW_NewIssuanceOfSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Issuance of Shares [Member]", "label": "New Issuance of Shares [Member]" } } }, "localname": "NewIssuanceOfSharesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_NinetyPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ninety Percent [Member]", "label": "Ninety Percent [Member]" } } }, "localname": "NinetyPercentMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_NonCashWarrantIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "NonCashWarrantIssuedForServices", "verboseLabel": "Warrant issued for services" } } }, "localname": "NonCashWarrantIssuedForServices", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_NoteAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note A [Member]", "label": "Note A [Member]" } } }, "localname": "NoteAMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_NoteBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note B [Member]", "label": "Note B [Member]" } } }, "localname": "NoteBMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_NotePayableRelatedPartyConversion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Note Payable Related Party Conversion.", "label": "Note payable related party conversion" } } }, "localname": "NotePayableRelatedPartyConversion", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_NotePayableRelatedPartyNonCashInvestingActivities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notes payable related party non cash investing activities.", "label": "Note payable related party" } } }, "localname": "NotePayableRelatedPartyNonCashInvestingActivities", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_OperatingIncomeLoss1": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income/(Loss) from Operations.", "label": "OperatingIncomeLoss1", "totalLabel": "Income/(Loss) from Operations" } } }, "localname": "OperatingIncomeLoss1", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "POWW_OperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease liabilities.", "label": "Warrants Until April 2023, August 2024, February 2026 [Member]", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilities", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_OptionGrantToRepurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option grant to repurchase.", "label": "Option grant to repurchase" } } }, "localname": "OptionGrantToRepurchase", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "POWW_OtherIntangibleAssetReductionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reduction in Other Intangible Assets [Member]", "label": "Reduction in Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetReductionMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_OtherLeaseOperatingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Lease Operating Expenses.", "label": "Other Lease Operating Expenses." } } }, "localname": "OtherLeaseOperatingExpenses", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_PRIVCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PRIVCO [Member]", "label": "PRIVCO [Member]" } } }, "localname": "PRIVCOMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_PaycheckProtectionProgramNoteForgiveness": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Paycheck protection program note forgiveness", "label": "PaycheckProtectionProgramNoteForgiveness", "negatedLabel": "Paycheck protection program note forgiveness" } } }, "localname": "PaycheckProtectionProgramNoteForgiveness", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_PaymentsOnCommonStockRepurchaseAndCancellation": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock and cancellation", "label": "PaymentsOnCommonStockRepurchaseAndCancellation", "negatedLabel": "Payments on common stock repurchase and cancellation" } } }, "localname": "PaymentsOnCommonStockRepurchaseAndCancellation", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_PaymentsOnConstructionNotePayable": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments on construction note payable.", "label": "PaymentsOnConstructionNotePayable", "negatedLabel": "Payments on construction note payable" } } }, "localname": "PaymentsOnConstructionNotePayable", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_PaymentsOnFactoringLiability": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments on factoring liability.", "label": "PaymentsOnFactoringLiability", "negatedLabel": "Payments on factoring liability" } } }, "localname": "PaymentsOnFactoringLiability", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_PaymentsOnInventorFacility": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments on inventor facility.", "label": "PaymentsOnInventorFacility", "negatedLabel": "Payments on inventory facility, net" } } }, "localname": "PaymentsOnInventorFacility", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_PledgeAndEscrowAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pledge and Escrow Agreement [Member]", "label": "Pledge and Escrow Agreement [Member]" } } }, "localname": "PledgeAndEscrowAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_PostClosingTransactionNoteReductionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post Closing Transaction Note Reduction [Member]", "label": "Post Closing Transaction Note Reduction [Member]" } } }, "localname": "PostClosingTransactionNoteReductionMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_PreferredStockDividendsIncomeStatementImpact1": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails": { "order": 2.0, "parentTag": "POWW_NetIncomeLossAvailableToCommonStockholdersBasic1", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Preferred stock dividends income statement impact.", "label": "PreferredStockDividendsIncomeStatementImpact1", "negatedLabel": "Less: Preferred stock dividends" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact1", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "POWW_PreferredStockStatedValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock, stated value per share.", "label": "Preferred stock, stated value per share" } } }, "localname": "PreferredStockStatedValuePerShare", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "POWW_PrepaymentPremiumPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayment premium percentage.", "label": "Prepayment premium of note amount, percentage" } } }, "localname": "PrepaymentPremiumPercentage", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "POWW_ProceedsFromConstructionNotePayable": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from construction note payable.", "label": "Proceeds from construction note payable" } } }, "localname": "ProceedsFromConstructionNotePayable", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_ProceedsFromFactoringLiablity": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from factoring liablity.", "label": "Proceeds from factoring liability" } } }, "localname": "ProceedsFromFactoringLiablity", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_ProceedsFromLongTermDebt": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from long term debt", "label": "Proceeds from paycheck protection program notes" } } }, "localname": "ProceedsFromLongTermDebt", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Note [Member]", "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_PropertyPlantAndEquipmentNet1": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net property and equipment.", "label": "PropertyPlantAndEquipmentNet1", "totalLabel": "Net property and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet1", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "POWW_ProxySettlementAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proxy Settlement Agreement [Member]", "label": "Proxy Settlement Agreement [Member]" } } }, "localname": "ProxySettlementAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_ReductionInRightOfUseAsset": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reduction in right of use asset.", "label": "Reduction in right of use asset" } } }, "localname": "ReductionInRightOfUseAsset", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_RepaymentsFromInsurancePremiumNotePayment": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayments from insurance premium note payment.", "label": "RepaymentsFromInsurancePremiumNotePayment", "negatedLabel": "Payments on insurance premium note payment" } } }, "localname": "RepaymentsFromInsurancePremiumNotePayment", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_RevolvingInventoryLoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Inventory Loan and Security Agreement [Member]", "label": "Revolving Inventory Loan and Security Agreement [Member]" } } }, "localname": "RevolvingInventoryLoanAndSecurityAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_SWKPatentAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SWK Patent Acquisition [Member]", "label": "SWK Patent Acquisition [Member]" } } }, "localname": "SWKPatentAcquisitionMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "POWW_ScheduleOfCapitalExpenditureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Capital Expenditure [Table Text Block]", "label": "SCHEDULE OF CAPITAL EXPENDITURE SEGMENT" } } }, "localname": "ScheduleOfCapitalExpenditureTableTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SegmentsTables" ], "xbrltype": "textBlockItemType" }, "POWW_ScheduleOfStockholdersEquityWarrantsOrRightsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Stockholders Equity Warrants Or Rights [Table Text Block]", "label": "SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS" } } }, "localname": "ScheduleOfStockholdersEquityWarrantsOrRightsTableTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "POWW_ScheduleOfTotalAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Total Assets [Table Text Block]", "label": "SCHEDULE OF TOTAL ASSETS SEGMENTS" } } }, "localname": "ScheduleOfTotalAssetsTableTextBlock", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/SegmentsTables" ], "xbrltype": "textBlockItemType" }, "POWW_Sec8.75SeriesCumulativeRedeemablePerpetualPreferredStock0.001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value", "label": "8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value" } } }, "localname": "Sec8.75SeriesCumulativeRedeemablePerpetualPreferredStock0.001ParValueMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "domainItemType" }, "POWW_SellerNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seller Note [Member]", "label": "Seller Note [Member]" } } }, "localname": "SellerNoteMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_SettlementAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Settlement Agreement [Member]", "label": "Settlement Agreement [Member]" } } }, "localname": "SettlementAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable.", "label": "Number of shares, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average exercise price.", "label": "Weighted average exercise price, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "perShareItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average remaining contractual term.", "label": "Weighted average life remaining years, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "durationItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercised weighted average exercise price.", "label": "Weighted average exercise price, exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "perShareItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments forfeitures and expirations weighted average exercise price.", "label": "Weighted average exercise price, forfeited or cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "perShareItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price.", "label": "Weighted average exercise price, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "perShareItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments Outstanding weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted average exercise price, outstanding ending", "periodStartLabel": "Weighted average exercise price, outstanding beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "perShareItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term beginning.", "label": "Weighted average life remaining years, outstanding beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "durationItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments Outstanding weighted average remaining contractual term ending.", "label": "Weighted average life remaining years, outstanding ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "durationItemType" }, "POWW_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted.", "label": "Weighted average life remaining years, outstanding granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "durationItemType" }, "POWW_ShareholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholder [Member]", "label": "Shareholder [Member]" } } }, "localname": "ShareholderMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_SharesEquivalentToIssuanceRecapitalization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares equivalent to issuance recapitalization.", "label": "Shares equivalent to issuance recapitalization" } } }, "localname": "SharesEquivalentToIssuanceRecapitalization", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "POWW_SharesIssuedCashlessExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued cashless exercise of warrants.", "label": "Cashless exercise of warrants" } } }, "localname": "SharesIssuedCashlessExerciseOfWarrants", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "POWW_SharesIssuedCashlessExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued cashless exercise of warrants shares.", "label": "Shares issued cashless exercise of warrants" } } }, "localname": "SharesIssuedCashlessExerciseOfWarrantsShares", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "POWW_SharesIssuedForServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Issued for Services [Member]", "label": "Shares Issued for Services [Member]" } } }, "localname": "SharesIssuedForServicesMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_StockAndWarrantsForNoteConversion": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock and warrants for note conversion", "label": "Stock and warrants for note conversion" } } }, "localname": "StockAndWarrantsForNoteConversion", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_StockAndWarrantsIssuedForConvertiblePromissoryNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock and warrants issued for convertible promissory notes.", "label": "Warrants issued for convertible promissory notes conversion" } } }, "localname": "StockAndWarrantsIssuedForConvertiblePromissoryNotes", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "monetaryItemType" }, "POWW_StockGrants": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock grants.", "label": "StockGrants", "verboseLabel": "Stock grants" } } }, "localname": "StockGrants", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_StockIssuedDuringPeriodSharesCommonStockIssuedForDebtConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares common stock issued for debt conversion", "label": "Common stock issued for debt conversion, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonStockIssuedForDebtConversion", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "POWW_StockIssuedDuringPeriodSharesForCashlessWarrantExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares for cashless warrant exercise.", "label": "Common stock issued for cashless warrant exercise, shares" } } }, "localname": "StockIssuedDuringPeriodSharesForCashlessWarrantExercise", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "POWW_StockIssuedDuringPeriodSharesForExercisedWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares for exercised warrants.", "label": "Common stock issued for exercised warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesForExercisedWarrants", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "POWW_StockIssuedDuringPeriodSharesIssuedForServiceandEquipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares issued for service and equipment.", "label": "Common stock issued for services and equipment, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServiceandEquipment", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "POWW_StockIssuedDuringPeriodSharesWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued warrants exercise.", "label": "Stock issued during period shares warrants exercised, shares" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "POWW_StockIssuedDuringPeriodValueCommonStockIssuedForDebtConversion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period Value Common Stock Issued for Debt Conversion.", "label": "Common stock issued for debt conversion" } } }, "localname": "StockIssuedDuringPeriodValueCommonStockIssuedForDebtConversion", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "POWW_StockIssuedDuringPeriodValueForCashlessWarrantExercise": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value for cashless warrant exercise.", "label": "Common stock issued for cashless warrant exercise" } } }, "localname": "StockIssuedDuringPeriodValueForCashlessWarrantExercise", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "POWW_StockIssuedDuringPeriodValueForExercisedWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value for exercised warrants.", "label": "Common stock issued for exercised warrants" } } }, "localname": "StockIssuedDuringPeriodValueForExercisedWarrants", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "POWW_StockIssuedDuringPeriodValueIssuedForServiceandEquipment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value issued for service and equipment.", "label": "Common stock issued for services and equipment" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServiceandEquipment", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "POWW_StockIssuedDuringPeriodValueWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued warrants exercise, value.", "label": "Stock issued during period value warrants exercised, value" } } }, "localname": "StockIssuedDuringPeriodValueWarrantsExercised", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "POWW_StockIssuedInLieuOfCashPayments": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issued in lieu of cash payments", "label": "Stock issued in lieu of cash payments" } } }, "localname": "StockIssuedInLieuOfCashPayments", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_StockSubscriptionReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock subscription receivable.", "label": "Stock subscription receivable" } } }, "localname": "StockSubscriptionReceivable", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_StreakVisualAmmunitionPatentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Streak Visual Ammunition Patent [Member].", "label": "Streak Visual Ammunition Patent [Member]" } } }, "localname": "StreakVisualAmmunitionPatentMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "POWW_ToolingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tooling [Member]", "label": "Tooling [Member]" } } }, "localname": "ToolingMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "POWW_TradenameMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tradename [Member]", "label": "Tradename [Member]" } } }, "localname": "TradenameMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "POWW_TwoIndependentContractorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Independent Contractors [Member]", "label": "Two Independent Contractors [Member]" } } }, "localname": "TwoIndependentContractorsMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_UnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriters [Member]", "label": "Underwriters [Member]" } } }, "localname": "UnderwritersMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting Agreement [Member]", "label": "Underwriting Agreement [Member]" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_UntilAprilTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Until April 2025 [Member]", "label": "Until April 2025 [Member]" } } }, "localname": "UntilAprilTwoThousandTwentyFiveMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_UntilAugustTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Until August 2024 [Member]", "label": "Until August 2024 [Member]" } } }, "localname": "UntilAugustTwoThousandTwentyFourMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_UntilFebrauryTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Until February 2024 [Member]", "label": "Until February 2024 [Member]" } } }, "localname": "UntilFebrauryTwoThousandTwentyFourMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_UntilNovemberTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Until November 2025 [Member]", "label": "Until November 2025 [Member]" } } }, "localname": "UntilNovemberTwoThousandTwentyFiveMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_UntilSeptemberTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Until September 2024 [Member]", "label": "Until September 2024 [Member]" } } }, "localname": "UntilSeptemberTwoThousandTwentyFourMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WarrantFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Five [Member]", "label": "Warrant Five [Member]" } } }, "localname": "WarrantFiveMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WarrantFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Four [Member]", "label": "Warrant Four [Member]" } } }, "localname": "WarrantFourMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WarrantIssuedForServices": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrant issued for services", "label": "Warrant issued for services" } } }, "localname": "WarrantIssuedForServices", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "POWW_WarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant One [Member]", "label": "Warrant One [Member]" } } }, "localname": "WarrantOneMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Three [Member]", "label": "Warrant Three [Member]" } } }, "localname": "WarrantThreeMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Two [Member]", "label": "Warrant Two [Member]" } } }, "localname": "WarrantTwoMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WarrantsIssuedForServices": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants issued for services.", "label": "WarrantsIssuedForServices", "verboseLabel": "Warrants issued for services" } } }, "localname": "WarrantsIssuedForServices", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "monetaryItemType" }, "POWW_WillNotBeIssuedPriorToTheStockholderApprovalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Will Not Be Issued Prior to The Stockholder Approval [Member]", "label": "Will Not Be Issued Prior to The Stockholder Approval [Member]" } } }, "localname": "WillNotBeIssuedPriorToTheStockholderApprovalMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WithoutBeingHeldInEscrowOrRequiringPriorStockholderApprovalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Without Being Held in Escrow or Requiring Prior Stockholder Approval [Member]", "label": "Without Being Held in Escrow or Requiring Prior Stockholder Approval [Member]" } } }, "localname": "WithoutBeingHeldInEscrowOrRequiringPriorStockholderApprovalMember", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "POWW_WorkingCapitalAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital adjustments.", "label": "Working capital adjustments" } } }, "localname": "WorkingCapitalAdjustments", "nsuri": "http://ammoinc.com/20230331", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r777", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r777", "r779", "r780" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r777", "r779", "r780" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r779" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r777", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFinStmtErrorCorrectionFlag": { "auth_ref": [ "r777", "r779", "r780", "r782" ], "lang": { "en-us": { "role": { "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction.", "label": "Document Financial Statement Error Correction [Flag]" } } }, "localname": "DocumentFinStmtErrorCorrectionFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r778" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r779" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r779" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r781" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r786" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r783" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r784" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r777", "r779", "r780" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r779" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r774" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r776" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r785" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ammoinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r316", "r743", "r837", "r898", "r899" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r354", "r355", "r356", "r357", "r431", "r555", "r611", "r643", "r644", "r701", "r703", "r706", "r707", "r708", "r718", "r719", "r734", "r741", "r749", "r754", "r835", "r887", "r888", "r889", "r890", "r891", "r892" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r354", "r355", "r356", "r357", "r431", "r555", "r611", "r643", "r644", "r701", "r703", "r706", "r707", "r708", "r718", "r719", "r734", "r741", "r749", "r754", "r835", "r887", "r888", "r889", "r890", "r891", "r892" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r316", "r743", "r837", "r898", "r899" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "srt_PlatformOperatorCryptoAssetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Line Items]" } } }, "localname": "PlatformOperatorCryptoAssetLineItems", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "stringItemType" }, "srt_PlatformOperatorCryptoAssetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Table]" } } }, "localname": "PlatformOperatorCryptoAssetTable", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "stringItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r313", "r561", "r605", "r606", "r607", "r608", "r609", "r610", "r721", "r742", "r753", "r796", "r830", "r831", "r837", "r898" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails", "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r313", "r561", "r605", "r606", "r607", "r608", "r609", "r610", "r721", "r742", "r753", "r796", "r830", "r831", "r837", "r898" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails", "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r354", "r355", "r356", "r357", "r423", "r431", "r460", "r461", "r462", "r554", "r555", "r611", "r643", "r644", "r701", "r703", "r706", "r707", "r708", "r718", "r719", "r734", "r741", "r749", "r754", "r757", "r829", "r835", "r888", "r889", "r890", "r891", "r892" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r354", "r355", "r356", "r357", "r423", "r431", "r460", "r461", "r462", "r554", "r555", "r611", "r643", "r644", "r701", "r703", "r706", "r707", "r708", "r718", "r719", "r734", "r741", "r749", "r754", "r757", "r829", "r835", "r888", "r889", "r890", "r891", "r892" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r254", "r432", "r788", "r821" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r254", "r432", "r788", "r789", "r821" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r824", "r883" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "auth_ref": [ "r317", "r322" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.", "label": "ACCOUNTS RECEIVABLE" } } }, "localname": "AccountsAndNontradeReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AccountsReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "ACCRUED LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r29", "r752" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r211", "r318", "r319", "r724" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r318", "r319" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net", "totalLabel": "Accounts receivable, net", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedInsuranceCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Insurance premium note payable" } } }, "localname": "AccruedInsuranceCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued liabilities", "totalLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r35", "r727" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued sales commissions" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r77", "r204", "r588" ], "calculation": { "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "POWW_PropertyPlantAndEquipmentNet1", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [ "r221", "r222", "r525", "r526", "r527", "r528", "r529", "r530" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r221", "r222", "r525", "r526", "r527", "r528", "r529", "r530" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r121", "r752", "r901" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r464", "r465", "r466", "r631", "r818", "r819", "r820", "r875", "r902" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile Net Loss to Net Cash provided by (used in) operations:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r16", "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "negatedLabel": "Common stock issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r16", "r81", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Issuance of warrants for convertible notes" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising expenses" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r213", "r320", "r325", "r326", "r329", "r897" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Allowance for doubtful accounts receivable, ending balance", "periodStartLabel": "Allowance for doubtful accounts receivable, beginning balance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r213", "r320", "r325" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Less: allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [ "r826" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.", "label": "Increase in allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Write-off of uncollectible amounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r10", "r106", "r139", "r390" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Debt discount amortization" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r10", "r71", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative", "http://ammoinc.com/role/LeasesDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": { "auth_ref": [ "r750", "r872", "r873", "r874" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition.", "label": "Transaction cost" } } }, "localname": "AssetAcquisitionConsiderationTransferredTransactionCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r10", "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Impairment expense" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r172", "r207", "r236", "r288", "r303", "r309", "r321", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r367", "r507", "r509", "r524", "r580", "r664", "r752", "r765", "r832", "r833", "r885" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r199", "r217", "r236", "r321", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r367", "r507", "r509", "r524", "r752", "r832", "r833", "r885" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r435", "r436", "r437", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r459", "r460", "r461", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingImprovementsMember": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building Improvements [Member]" } } }, "localname": "BuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r503", "r747", "r748" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r95", "r96", "r503", "r747", "r748" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business acquisition, amount" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business acquisition, shares" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r793", "r794" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business acquisition, share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r501", "r502" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Net income" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfUnauditedProFormaResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r501", "r502" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Net revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfUnauditedProFormaResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r2", "r3", "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r4", "r102" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Contingent consideration payable", "verboseLabel": "Contingent consideration payable, net of current portion" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r165", "r504" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "ACQUISITIONS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "auth_ref": [ "r98" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 10.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease obligation assumed in business combination.", "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation", "negatedLabel": "Operating lease liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r98" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": { "auth_ref": [ "r97", "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.", "label": "Contingent consideration", "verboseLabel": "Contingent consideration, amount" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r98" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "verboseLabel": "Prepaid expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r98" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "verboseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r98" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": { "auth_ref": [ "r98" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.", "label": "Equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Assumed debt" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r97", "r98" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Fair value of consideration transferred" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r98" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Total Consideration" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Business acquisition, cash acquired" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r50", "r202", "r722" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r51", "r171" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r50", "r143", "r232" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r5", "r143" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase/(decrease) in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCollateralForBorrowedSecurities": { "auth_ref": [ "r109", "r896" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of cash collateral held for borrowed securities, for which the cash is restricted as to withdrawal or usage.", "label": "Cash collateral or restricted cash" } } }, "localname": "CashCollateralForBorrowedSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r195", "r208", "r209", "r210", "r236", "r259", "r264", "r274", "r276", "r282", "r283", "r321", "r358", "r360", "r361", "r362", "r366", "r367", "r396", "r397", "r400", "r403", "r410", "r524", "r622", "r623", "r624", "r625", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r652", "r673", "r693", "r710", "r711", "r712", "r713", "r714", "r787", "r813", "r822" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Cover", "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r208", "r209", "r210", "r282", "r396", "r397", "r398", "r400", "r403", "r408", "r410", "r622", "r623", "r624", "r625", "r741", "r787", "r813" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrants exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Warrants issued to purchase common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Warrants to purchase shares" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative", "http://ammoinc.com/role/LeasesDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r79", "r717" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r755", "r756", "r757", "r759", "r760", "r761", "r762", "r818", "r819", "r875", "r900", "r902" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par or stated value per share", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical", "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r120", "r652" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical", "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r120", "r652", "r670", "r902", "r903" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r120", "r584", "r752" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value, 200,000,000 shares authorized 118,562,806 and 116,485,747 shares issued and 118,294,478 and 116,485,747 outstanding at March 31, 2023 and March 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensatedAbsencesPolicy": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for compensated absences. The accounting policy may include a description of the employers programs and practices associated with compensated absences, accounting policies for compensated absences, and amount of any liability for compensated absences.", "label": "Compensated Absences" } } }, "localname": "CompensatedAbsencesPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r58", "r60", "r104", "r105", "r316", "r716" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r58", "r60", "r104", "r105", "r316", "r617", "r716" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r58", "r60", "r104", "r105", "r316", "r716", "r792" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r113", "r185" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r58", "r60", "r104", "r105", "r316" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r58", "r60", "r104", "r105", "r316", "r716" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r103", "r728" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionLoan": { "auth_ref": [ "r115" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the carrying value of a short-term real estate loan to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project, usually from the proceeds of a mortgage loan. The rate is normally higher than the prime rate, and there is usually an origination fee. The effective yield on these loans tends to be high, and the lender has a security interest in the real property. Note that there are separate concepts for the current and noncurrent portions of long-term construction loans.", "label": "Current portion of construction note payable" } } }, "localname": "ConstructionLoan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConstructionLoanNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the noncurrent portion of a long-term real estate loan to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project (generally one to seven years), usually from the proceeds of a mortgage loan. The rate is normally higher than the prime rate, and there is usually an origination fee. The effective yield on these loans tends to be high, and the lender has a security interest in the real property.", "label": "Construction note payable, net of unamortized issuance costs" } } }, "localname": "ConstructionLoanNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r115", "r173" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r134", "r561" ], "calculation": { "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails": { "order": 2.0, "parentTag": "POWW_OperatingIncomeLoss1", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "verboseLabel": "Cost of Revenues" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r135", "r236", "r321", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r367", "r524", "r832" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r132" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs, fees and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "localname": "CreditLossAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r797", "r816", "r870" ], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "US Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r164", "r490", "r496", "r816" ], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current provision" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r797", "r816", "r870" ], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "US State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r59", "r316" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer Lists [Member]" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r53", "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt conversion, converted Instrument, amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r53", "r54" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt conversion, converted instrument, shares issued" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault": { "auth_ref": [ "r55", "r80" ], "lang": { "en-us": { "role": { "documentation": "Discussion of the facts and amounts pertaining to each failure to comply with an affirmative or negative covenant of a short-term debt instrument, including violating payment terms or an inability to meet certain minimum financial requirements or achieve or maintain certain financial ratios. The discussion would generally be expected to also include whether or not the failure can and will be overcome and a description of the terms of any waivers, including the amount of the waiver and the period of time covered by the waiver.", "label": "Debt default, description" } } }, "localname": "DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r155", "r234", "r368", "r374", "r375", "r376", "r377", "r378", "r379", "r384", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "NOTES PAYABLE \u2013 RELATED PARTY" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r26", "r115", "r116", "r173", "r175", "r240", "r369", "r370", "r371", "r372", "r373", "r375", "r380", "r381", "r382", "r383", "r385", "r386", "r387", "r388", "r389", "r390", "r532", "r736", "r737", "r738", "r739", "r740", "r814" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r26", "r85", "r111", "r115", "r173", "r175" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt description", "verboseLabel": "Debt instrument, description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r107", "r108", "r369", "r532", "r737", "r738" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r37", "r370" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r193", "r736", "r877" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity date", "terseLabel": "Debt maturity date", "verboseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt instrument maturity date description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r39", "r240", "r369", "r370", "r371", "r372", "r373", "r375", "r380", "r381", "r382", "r383", "r385", "r386", "r387", "r388", "r389", "r390", "r532", "r736", "r737", "r738", "r739", "r740", "r814" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r39", "r112" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Debt monthly payments", "terseLabel": "Debt principal and accrued interest", "verboseLabel": "Debt periodic payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Principal payments", "verboseLabel": "Debt instrument principal payment" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt instrument term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r816", "r869", "r870" ], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "US Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r865" ], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "totalLabel": "Total deferred benefit" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r10", "r164", "r191", "r495", "r496", "r816" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r117", "r118", "r174", "r484" ], "calculation": { "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r477", "r478", "r581" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred income tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r816", "r869", "r870" ], "calculation": { "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "US State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r485" ], "calculation": { "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r867" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "negatedLabel": "Net deferred tax assets/(liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r94", "r868" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r94", "r868" ], "calculation": { "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "verboseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r486" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssets": { "auth_ref": [ "r799" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.", "label": "Deposits" } } }, "localname": "DepositsAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r10", "r76" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r10", "r76" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r10", "r293" ], "calculation": { "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails": { "order": 4.0, "parentTag": "POWW_OperatingIncomeLoss1", "weight": -1.0 }, "http://ammoinc.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization expense", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r7", "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Accumulated preferred dividends", "negatedLabel": "Dividends accumulated on preferred stock" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockStock": { "auth_ref": [ "r7", "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.", "label": "Dividends, Preferred Stock, Stock", "negatedLabel": "Preferred stock dividends declared" } } }, "localname": "DividendsPreferredStockStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsStock": { "auth_ref": [ "r7", "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid stock dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Stock", "negatedLabel": "Preferred stock dividend" } } }, "localname": "DividendsStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income/(Loss) per share", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r225", "r246", "r247", "r248", "r249", "r250", "r256", "r259", "r274", "r275", "r276", "r280", "r519", "r520", "r577", "r592", "r731" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic", "verboseLabel": "Income/(loss) per share attributable to common stockholders - basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r225", "r246", "r247", "r248", "r249", "r250", "r259", "r274", "r275", "r276", "r280", "r519", "r520", "r577", "r592", "r731" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted", "verboseLabel": "Income/(loss) per share attributable to common stockholders - diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r255", "r277", "r278", "r279" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "INCOME/(LOSS) PER COMMON SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Total provision for income taxes", "verboseLabel": "Effective Income Tax Rate Reconciliation, Percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomeTaxesDetailsNarrative", "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r237", "r480", "r497" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Computed tax expense" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r866", "r871" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "verboseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends": { "auth_ref": [ "r866", "r871" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend paid to employee stock ownership plan.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Percent", "verboseLabel": "Employee stock awards" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r866", "r871" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Non-deductible meals & entertainment" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [ "r790", "r866" ], "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent", "verboseLabel": "Stock grants" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r866", "r871" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State taxes, net of Federal income tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": { "auth_ref": [ "r866", "r871" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Contingent consideration fair value" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfReconciliationOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensationNoncash": { "auth_ref": [ "r10" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense (reversal of expense) for employee benefits and share-based payment arrangement. Includes, but is not limited to, pension, other postretirement, postemployment and termination benefits.", "label": "Employee Benefit and Share-Based Payment Arrangement, Noncash", "verboseLabel": "Employee stock awards" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensationNoncash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r16", "r196", "r221", "r222", "r223", "r241", "r242", "r243", "r245", "r251", "r253", "r281", "r323", "r324", "r412", "r464", "r465", "r466", "r491", "r492", "r511", "r512", "r513", "r514", "r515", "r516", "r518", "r525", "r526", "r527", "r528", "r529", "r530", "r539", "r612", "r613", "r614", "r631", "r693" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ExciseAndSalesTaxes": { "auth_ref": [ "r224" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.", "label": "Excises taxes" } } }, "localname": "ExciseAndSalesTaxes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r382", "r424", "r425", "r426", "r427", "r428", "r429", "r521", "r551", "r552", "r553", "r737", "r738", "r744", "r745", "r746" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r382", "r424", "r429", "r521", "r551", "r744", "r745", "r746" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r382", "r424", "r429", "r521", "r552", "r737", "r738", "r744", "r745", "r746" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r382", "r424", "r425", "r426", "r427", "r428", "r429", "r521", "r553", "r737", "r738", "r744", "r745", "r746" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r382", "r424", "r425", "r426", "r427", "r428", "r429", "r551", "r552", "r553", "r737", "r738", "r744", "r745", "r746" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfStockholdersEquityNoteWarrantsOrRightsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r13", "r25" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Licensing agreement, life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r206", "r347" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "verboseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r150" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "verboseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r150" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "verboseLabel": "2028" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r150" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "verboseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r150" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "verboseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r150" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "verboseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r345", "r346", "r347", "r348", "r562", "r563" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r149", "r563" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r72", "r73" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r149", "r562" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, net", "totalLabel": "Annual amortization of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAnnualAmortizationOfIntangibleAssetDetails", "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r149" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Patents, net" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r811" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "(Gain)/loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r137", "r675" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Corporate general and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r205", "r335", "r576", "r735", "r752", "r827", "r828" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfAllocationForConsiderationDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "GOODWILL AND INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Other Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r14", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r133", "r236", "r288", "r302", "r308", "r311", "r321", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r367", "r524", "r733", "r832" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Impaired Assets to be Disposed of by Method Other than Sale [Line Items]" } } }, "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleTable": { "auth_ref": [ "r78", "r152" ], "lang": { "en-us": { "role": { "documentation": "When an entity determines it will dispose of a long-lived asset by a method other than sale (for example, by abandonment, distribution in a spin-off), impairment of such assets is separately disclosed from those assets held and used.", "label": "Impaired Assets to be Disposed of by Method Other than Sale [Table]" } } }, "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r0", "r154" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r1", "r129", "r177", "r288", "r302", "r308", "r311", "r578", "r590", "r733" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income/(Loss) before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r349", "r351", "r678" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r351", "r678" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r237", "r474", "r481", "r482", "r488", "r493", "r498", "r499", "r500", "r627" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income tax examination, description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r180", "r192", "r252", "r253", "r296", "r479", "r494", "r593" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for Income Taxes", "negatedLabel": "Income tax (provision) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r220", "r475", "r476", "r482", "r483", "r487", "r489", "r621" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r866" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r9" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r9" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r9" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r9" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedLabel": "Deposits" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r9" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Due to (from) related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r9" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in Current Assets and Liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r795", "r810" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r9" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": { "auth_ref": [ "r261", "r262", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r276" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.", "label": "Effect of dilutive common stock purchase warrants" } } }, "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r260", "r261", "r263", "r276", "r434" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Effect of dilutive equity incentive awards" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r73", "r558", "r559", "r560", "r562", "r729" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Patents" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r139", "r388", "r394", "r739", "r740" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest expenses" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r179" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest expense" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r228", "r230", "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r110", "r894" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "verboseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r804" ], "calculation": { "http://ammoinc.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished product" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r215", "r723", "r752" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ammoinc.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories", "totalLabel": "Inventory net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r181", "r201", "r214", "r330", "r331", "r332", "r556", "r730" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r806" ], "calculation": { "http://ammoinc.com/role/ScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r805" ], "calculation": { "http://ammoinc.com/role/ScheduleOfInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r881", "r882" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r10" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Stock for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r808" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Employee salaries and related expenses" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r880" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r538" ], "calculation": { "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r538" ], "calculation": { "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r538" ], "calculation": { "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r538" ], "calculation": { "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2028" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r538" ], "calculation": { "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r538" ], "calculation": { "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r538" ], "calculation": { "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r538" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Amount Representing Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r34", "r236", "r321", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r367", "r508", "r509", "r510", "r524", "r651", "r732", "r765", "r832", "r885", "r886" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r125", "r176", "r586", "r752", "r815", "r825", "r878" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r36", "r200", "r236", "r321", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r367", "r508", "r509", "r510", "r524", "r752", "r832", "r885", "r886" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r101", "r473", "r864" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Commitment Fee Amount" } } }, "localname": "LineOfCreditFacilityCommitmentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.", "label": "Line of Credit Facility, Interest Rate Description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Line of Credit Facility, Interest Rate During Period" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r31" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r39" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable related party, net of current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r876" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r876" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r876" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r876" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r229" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flow from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r229" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r143", "r144", "r145" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r130", "r145", "r178", "r198", "r218", "r219", "r223", "r236", "r244", "r246", "r247", "r248", "r249", "r252", "r253", "r272", "r288", "r302", "r308", "r311", "r321", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r367", "r520", "r524", "r591", "r672", "r691", "r692", "r733", "r763", "r832" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ammoinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net (Income) Loss", "totalLabel": "Net Income/(Loss)", "verboseLabel": "Net Income/(Loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow", "http://ammoinc.com/role/StatementsOfOperations", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r227", "r246", "r247", "r248", "r249", "r256", "r257", "r273", "r276", "r288", "r302", "r308", "r311", "r733" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net Income/(Loss) Attributable to Common Stock Shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r138" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Expenses" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r26", "r175", "r895" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Promissory note" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Current portion of note payable related party" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration": { "auth_ref": [ "r800", "r817", "r834" ], "lang": { "en-us": { "role": { "documentation": "Indicates related and nonrelated party status for notes payable classified as current.", "label": "Notes Payable, Current, Related and Nonrelated Party Status [Extensible Enumeration]" } } }, "localname": "NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration": { "auth_ref": [ "r801", "r817", "r834" ], "lang": { "en-us": { "role": { "documentation": "Indicates related and nonrelated party status for notes payable classified as noncurrent.", "label": "Notes Payable, Noncurrent, Related and Nonrelated Party Status [Extensible Enumeration]" } } }, "localname": "NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses [Default Label]", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r288", "r302", "r308", "r311", "r733" ], "calculation": { "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://ammoinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income/(Loss) from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r879" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r535" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities", "verboseLabel": "Operating lease, liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/LeasesDetailsNarrative", "http://ammoinc.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r535" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of operating lease liability", "verboseLabel": "Operating lease liability, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r535" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current portion", "verboseLabel": "Operating lease liability non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r534" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use assets - operating leases", "verboseLabel": "Right use of asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r537", "r751" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r536", "r751" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r114", "r169", "r618", "r619" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "ORGANIZATION AND BUSINESS ACTIVITY" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/OrganizationAndBusinessActivity" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accruals" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets:" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other intangible assets, net" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r140" ], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income/(expense)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration": { "auth_ref": [ "r212", "r365", "r544", "r725", "r817" ], "lang": { "en-us": { "role": { "documentation": "Indicates related and nonrelated party status for receivable, after allowance for credit loss, classified as other and current.", "label": "Other Receivable, after Allowance for Credit Loss, Current, Related and Nonrelated Party Status [Extensible Enumeration]" } } }, "localname": "OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Due from related parties" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r8" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Consolidated lease expense", "verboseLabel": "Rent paid" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/LeasesDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r48" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Common stock repurchase plan" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r48" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Preferred stock dividends paid" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r47" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Common stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": { "auth_ref": [ "r45" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).", "label": "Payments to Acquire Businesses and Interest in Affiliates", "negatedLabel": "Gemini acquisition" } } }, "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r45", "r505" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Company received a cash payment" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r142" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payment to acquire property and plant equipment", "negatedLabel": "Purchase of equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendPaymentTerms": { "auth_ref": [ "r27", "r85", "r119" ], "lang": { "en-us": { "role": { "documentation": "Specific information regarding dividend payment dates or timing and whether or not dividends are paid on a cumulative basis.", "label": "Dividend payment terms" } } }, "localname": "PreferredStockDividendPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockDividendRatePerDollarAmount": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "The amount per share used to calculated dividend payments on preferred stock.", "label": "Preferred stock dividend rate per annum" } } }, "localname": "PreferredStockDividendRatePerDollarAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r397", "r702", "r704", "r705", "r709" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred stock, dividend rate, percentage", "verboseLabel": "Dividend rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical", "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "Preferred Stock Dividend" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r755", "r756", "r759", "r760", "r761", "r762", "r900", "r902" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r119", "r396" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r119", "r396" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r119", "r652", "r670", "r902", "r903" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "PREFERRED STOCK" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r119", "r583", "r752" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Series A cumulative perpetual preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of March 31, 2023 and March 31, 2022, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r216", "r333", "r334", "r726" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromAdvancesForConstruction": { "auth_ref": [ "r557" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from borrowing by the entity from developers, builders, government agencies and municipalities for construction that are repaid in cash, generally on a straight-line basis over periods ranging from five to forty years.", "label": "Proceeds from advances for construction" } } }, "localname": "ProceedsFromAdvancesForConstruction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r46" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible promissory notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r6" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r6" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Sale of preferred stock" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r46" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from note payable", "terseLabel": "Proceeds from Notes payable", "verboseLabel": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r46" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from note payable related party issued" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r141" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from disposal of assets" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r809" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "verboseLabel": "Common stock issued for exercised warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails", "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r151", "r186", "r189", "r190" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY, PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r153", "r203", "r589" ], "calculation": { "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "POWW_PropertyPlantAndEquipmentNet1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r579", "r589", "r752" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r11", "r186", "r189", "r587" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r226", "r327" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Allowance for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r807" ], "lang": { "en-us": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [ "r807" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale." } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedAndNonrelatedPartyStatusAxis": { "auth_ref": [ "r238", "r239", "r543", "r544", "r545", "r546", "r646", "r647", "r648", "r649", "r650", "r669", "r671", "r758" ], "lang": { "en-us": { "role": { "documentation": "Information by related and nonrelated party status.", "label": "Related and Nonrelated Party Status [Axis]" } } }, "localname": "RelatedAndNonrelatedPartyStatusAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedAndNonrelatedPartyStatusDomain": { "auth_ref": [ "r238", "r239", "r543", "r544", "r545", "r546", "r646", "r647", "r648", "r649", "r650", "r669", "r671", "r758" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated party status." } } }, "localname": "RelatedAndNonrelatedPartyStatusDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r430", "r543", "r544", "r646", "r647", "r648", "r649", "r650", "r669", "r671", "r700" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyMember": { "auth_ref": [ "r238", "r239", "r543", "r544", "r545", "r546", "r646", "r647", "r648", "r649", "r650", "r669", "r671", "r700" ], "lang": { "en-us": { "role": { "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family.", "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r543", "r544", "r884" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r430", "r543", "r544", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r646", "r647", "r648", "r649", "r650", "r669", "r671", "r700", "r884" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r540", "r541", "r542", "r544", "r547", "r628", "r629", "r630", "r676", "r677", "r678", "r697", "r699" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r49" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Payment of note payable related party", "negatedLabel": "Payments on note payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherDebt": { "auth_ref": [ "r49" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other.", "label": "Repayments of Other Debt", "negatedLabel": "Payments on assumed debt from Gemini" } } }, "localname": "RepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r49" ], "calculation": { "http://ammoinc.com/role/StatementsOfCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Payments on note payable - related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r798", "r812", "r893", "r896" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash [Default Label]", "periodEndLabel": "Restricted cash, end of period" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r50", "r171", "r202", "r232", "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Cash and restricted cash, end of period" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r798", "r812" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Current portion of restricted cash", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r122", "r159", "r585", "r615", "r616", "r626", "r653", "r752" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r196", "r241", "r242", "r243", "r245", "r251", "r253", "r323", "r324", "r464", "r465", "r466", "r491", "r492", "r511", "r513", "r514", "r516", "r518", "r612", "r614", "r631", "r902" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r289", "r290", "r301", "r306", "r307", "r313", "r315", "r316", "r421", "r422", "r561" ], "calculation": { "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails": { "order": 1.0, "parentTag": "POWW_OperatingIncomeLoss1", "weight": 1.0 }, "http://ammoinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total Revenues", "terseLabel": "Revenues", "verboseLabel": "Total Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails", "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r194", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r720" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty expenses" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r316", "r791" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "SCHEDULE OF ACCOUNTS RECEIVABLE" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "SCHEDULE OF ACCRUED LIABILITIES" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.", "label": "SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r95", "r96", "r503" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative", "http://ammoinc.com/role/LeasesDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF INCOME TAX PROVISION BENEFIT" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF RECONCILIATION OF INCOME TAX" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r72", "r73", "r562" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r72", "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "SCHEDULE OF INTANGIBLE ASSETS" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r28", "r126", "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORIES" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfConcentrationOfRisksDetails", "http://ammoinc.com/role/ScheduleOfDisaggregatedRevenueFromCustomersBySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "SCHEDULE OF ALLOCATION FOR CONSIDERATION" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.", "label": "SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT" } } }, "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r65", "r66", "r67", "r70" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r65", "r66", "r67", "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "SCHEDULE OF OPERATING SEGMENTS" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r82", "r83", "r84", "r85", "r86", "r87", "r88", "r157", "r158", "r159", "r208", "r209", "r210", "r282", "r396", "r397", "r398", "r400", "r403", "r408", "r410", "r622", "r623", "r624", "r625", "r741", "r787", "r813" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r57", "r58", "r60", "r61", "r104", "r170" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "SCHEDULE OF CONCENTRATION OF RISKS" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r285", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r316", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r352", "r353", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r735", "r796", "r898" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r284", "r285", "r286", "r287", "r288", "r300", "r305", "r309", "r310", "r311", "r312", "r313", "r314", "r316" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "SEGMENTS" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Segments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://ammoinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r137" ], "calculation": { "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails": { "order": 3.0, "parentTag": "POWW_OperatingIncomeLoss1", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "General and administrative expense" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r802", "r803", "r836" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of shares, exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired.", "label": "Number of shares, forfeited or cancelled", "negatedLabel": "Number of shares, forfeited or cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of shares, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r18", "r19" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of shares, outstanding ending", "periodStartLabel": "Number of shares, outstanding beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r435", "r436", "r437", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r459", "r460", "r461", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r433", "r438", "r457", "r458", "r459", "r460", "r463", "r467", "r468", "r469", "r470" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares issued, price per share", "terseLabel": "Share price per share", "verboseLabel": "Share price" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r146", "r233" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r197", "r285", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r316", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r350", "r352", "r353", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r735", "r796", "r898" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfCapitalExpenditureSegmentDetails", "http://ammoinc.com/role/ScheduleOfTotalAssetsSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r195", "r208", "r209", "r210", "r236", "r259", "r264", "r274", "r276", "r282", "r283", "r321", "r358", "r360", "r361", "r362", "r366", "r367", "r396", "r397", "r400", "r403", "r410", "r524", "r622", "r623", "r624", "r625", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r652", "r673", "r693", "r710", "r711", "r712", "r713", "r714", "r787", "r813", "r822" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Cover", "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r16", "r42", "r196", "r221", "r222", "r223", "r241", "r242", "r243", "r245", "r251", "r253", "r281", "r323", "r324", "r412", "r464", "r465", "r466", "r491", "r492", "r511", "r512", "r513", "r514", "r515", "r516", "r518", "r525", "r526", "r527", "r528", "r529", "r530", "r539", "r612", "r613", "r614", "r631", "r693" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r241", "r242", "r243", "r281", "r561", "r620", "r642", "r645", "r646", "r647", "r648", "r649", "r650", "r652", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r665", "r666", "r667", "r668", "r669", "r671", "r674", "r675", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r693", "r758" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Cover", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfOperations", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r241", "r242", "r243", "r281", "r561", "r620", "r642", "r645", "r646", "r647", "r648", "r649", "r650", "r652", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r665", "r666", "r667", "r668", "r669", "r671", "r674", "r675", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r693", "r758" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/Cover", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfOperations", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r119", "r120", "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Acquisition stock issuances, shares", "verboseLabel": "Number of shares issued for merger, shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r16", "r41", "r85", "r159", "r385" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Common stock issued for convertible notes, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r16", "r85", "r119", "r120", "r159" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Number of shares issued for conversion of notes, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.", "label": "Shares issued for employees benefit, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r16", "r92", "r119", "r120", "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Employee stock awards, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Common stock issued for services, shares", "terseLabel": "Shares for service", "verboseLabel": "Number of shares issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r16", "r119", "r120", "r159", "r622", "r693", "r711" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of Series A Preferred Stock, net of issuance costs, shares", "terseLabel": "Common stock issued new shares, shares", "verboseLabel": "Number of common stock shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Number of shares issued to satisfy issuance commitment", "verboseLabel": "Common stock issued for liquidation damage fees, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.", "label": "Number of shares issued, post reverse split" } } }, "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Number of stock issued as compensation" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r16", "r119", "r120", "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Number of shares issued for pre-split" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": { "auth_ref": [ "r16", "r120", "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Stock Issued During Period, Shares, Treasury Stock Reissued", "negatedLabel": "Treasury shares purchased, shares" } } }, "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r16", "r42", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Acquisition stock issuances", "verboseLabel": "Number of shares issued for merger, value" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r16", "r42", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Common stock issued for convertible notes" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r16", "r42", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Number of shares issued for conversion of notes, value" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.", "label": "Shares issued for employees benefit, value" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r16", "r92", "r119", "r120", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Employee stock awards" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Common stock issued for services", "terseLabel": "Service paid", "verboseLabel": "Number of shares issued for services, value" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r16", "r119", "r120", "r159", "r631", "r693", "r711", "r764" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of Series A Preferred Stock, net of issuance costs", "terseLabel": "Common stock shares issued, value", "verboseLabel": "Proceeds from offering" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Common stock issued for liquidation damage fees, value" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Number of stock issued as compensation, value" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": { "auth_ref": [ "r16", "r89", "r119", "r120", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Treasury shares purchased" } } }, "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r16", "r119", "r120", "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Number of shares retired", "negatedLabel": "Common stock repurchase and cancellation, shares", "verboseLabel": "Shares repurchased" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r16", "r119", "r120", "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock repurchased and cancelled", "negatedLabel": "Common stock repurchase and cancellation" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r16", "r119", "r120", "r159", "r625", "r693", "r713" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock repurchased during period, shares", "verboseLabel": "Shares repurchase" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r120", "r123", "r124", "r147", "r654", "r670", "r694", "r695", "r752", "r765", "r815", "r825", "r878", "r902" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets", "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r156", "r235", "r395", "r397", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r409", "r412", "r517", "r696", "r698", "r715" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "CAPITAL STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r531", "r549" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r531", "r549" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r531", "r549" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r531", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r531", "r549" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEventDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r548", "r550" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENT" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SubsequentEvent" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental cash flow disclosures:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r40", "r89", "r90" ], "calculation": { "http://ammoinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury Stock" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/AcquisitionsDetailsNarrative", "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/ConstructionNotePayableDetailsNarrative", "http://ammoinc.com/role/FactoringLiabilityDetailsNarrative", "http://ammoinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://ammoinc.com/role/InventoryCreditFacilityDetailsNarrative", "http://ammoinc.com/role/LeasesDetailsNarrative", "http://ammoinc.com/role/NotesPayableRelatedPartyDetailsNarrative", "http://ammoinc.com/role/OrganizationAndBusinessActivityDetailsNarrative", "http://ammoinc.com/role/PreferredStockDetailsNarrative", "http://ammoinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r62", "r63", "r64", "r183", "r184", "r187", "r188" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r755", "r756", "r759", "r760", "r761", "r762" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/CapitalStockDetailsNarrative", "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative", "http://ammoinc.com/role/ScheduleOfOutstandingAndExercisableStockPurchaseWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Fair value assumptions, measurement input, percentages" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r877" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Fair value assumptions, measurement input, percentages" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r258", "r276" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average shares of common stock - Diluted", "terseLabel": "Weighted average number of shares outstanding, diluted", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/IncomelossPerCommonShareDetailsNarrative", "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r256", "r276" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted averaged shares of common stock - basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ammoinc.com/role/ScheduleOfIncomelossPerCommonShareDetails", "http://ammoinc.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.1)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147482969/710-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org//350/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org//805/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-44", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "48", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "48", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-51", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-52", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-53", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "54", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-54", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "https://asc.fasb.org//310/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "326", "URI": "https://asc.fasb.org//326/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482379/912-405-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column G))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column H))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column I))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column J))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column K))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r766": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r767": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r768": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r769": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r771": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r772": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r773": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r774": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r775": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r776": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r777": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r778": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r779": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r781": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r782": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r783": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r784": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r785": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r786": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480637/718-40-25-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 102 0001493152-23-021280-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-021280-xbrl.zip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

4C#>K$N0X.EB6JC"YP,M8,263]"/%1U&4IM@M2T>CMC]:/F\P)/W; M^%@S72/$#ELO7"E=2??0(X02H(\DSNG(7WUNJAM4NN%'(_[9IP[$#E# M#?>;R7?,LJ+GG"]'+V99E&ZT(/:N'XYLD =;9OD=NJ/]HKTU@\,=^?0&<65) MB-+3C086O0X*>?("F42\*NR .4TL?;7$ZZ;YFXO9WCC3"[<\JA^W%Y=3[V/X MZH?6EU[\K%0>@5;M=HY?#X8DJ*IB,JXG]DB7M%FR@=8D:5CC+ZBZ8SQSALG]#>['MW8LSH_VVL4;W2I6'YQ_]L842#ZI#@L M4;F5#$<4/]FQ 1\@)+DM&\- C=AM%L%*QG/0GZ_KDAZO_J<:[R5*!SK:C&^K/::#BLDV :I.S5:.EK MM*<.^+2*E_F.WG?6XX:7Y;Q>UB5M^7H&VCF(@-/?&F6#^>$M>?P(5 7N@N]> MOO[1WJ2EH>*X@_Z\_^:I?5L\Z[*@0Y;?G+8TUN$4')!7ENYZ*TY#DD'MMNUD M95S7;Z3Z&V4,\SIJ%7^^X_^S$JG^1J@*/9>3!5XRI4ZBKHC)4 A*Y,VDG&,= MO?0*>PVZ[ O1@4]E5T''G-7'M?/5D9VVL&,0?FD_4E?/:\8Z0=ATSM/-.XE7 MS*!CT81)I\[%WR<2^#1 O[];?*\=\B$Y;[43[A> X>&0IAU38DD.1?K#5_Z? MS/4K@I"+V$#')@H.N9FW>VI'.E;4U"WPPV\F^.']PP^_F>"'I[>1IJ-W:L)Y M^(P^4[4 :ZV8!I]HR%T)D-UV\-?);DQV8[(;#]1NK)MZ6?+9M\]>7[[D M?S[^-C58$>YVF:^ =^H$('Q^=N#K/_AO2SLB+A=(%EH3@KHN6@/Y,M(( ](; M/95G *!00&XM.<>T]N?R4-P2>_$*LDL (,NA29=Y!02/W/.'=[GEWL>ZPTUQ M': %H19^D5Q"8)QGI^ 6D6UT1P%3\8NP?"-&:/6,+/09"H[(J[$.YWJU1V!X MA"^T^P!)QQ?G%7'5.$8T A@,4N9K^@>S+5?;@$^P;I!H"-J:TM4=RZJ6/>=( M_O@XH05<*F^!T%U<)#^*E$<*LBA3MX[U^)1U?BZ:Z(ST;'W:I*O?%O,T6939 M:L7GN4BL*IH-59X5SLK#F%3]0/*C&,MMBT<;0R@ 7$;A?E[UQ,>:Z<5[8F44(Y=OT M.ES6,G&$[W^ME8I@SVN:@-5'_DBO'#2_2C## )$;M3XI8G3#:%SM'?#H9:6H MH+EG\\I-O1X&G#$]X$[K$WAD4E554,@B7_\"%FC8TZP07/EL#.?ETX$1N&R$ MZ-D>">J852L Y_6]%UP%J;;[KR.@V)%VL75 B@!F:!=A$#&C+TN7*7Y7'XM- M<376>ECM4_ <2JKS;QOR:12VBA%H_UIC9BP6$6P]%%HPHR:\'+=R*)H ^](ZNRI:7<8WL"J%+AUC59H:;X]K MW;[&%D9A)O6U6_(S-Q7-Y;)8BVNJTJ8!9#GT#3S,&Y_E'L)\!_'-?=E ?4=+ MBU>%MW@7YV<_1C8W:AOT]U6/AAV)?YB_[;'YW!F#/]EE=O]RP/\-2/B_]N1R MQYXQ/?;C;[[\.N[*51XJD&?*&+7OP5M4 ZD:;E6(.55>HVY;<1.';W0 6T47 MP_G9LL:N*J$B"4M8'DG_0CS0.[ZY.3<^R/]-2< M&@T]O?>A9C:MS(PQY)D+'):VE.X=%S/0\RRJ!W#"#^*Q8&.-#Y 3Q6&58\FUFJ^&XK><69-^)1(<61:9=Z U- QUB MRBVQH!6B=X&6'!9HDVY.4"2Z<>\//<=JJ U,GZ7993Y!XPE284'/:*.-TM(Y MJ%/C2=I\4'I^AI;DK$)';=:RS/JV[H-.XG!J!W[86#-,A'29?WC'*][5\!4G M6Q6@F0?/7G.XVIWU21_0;GZ !HH"%[!KRQS.V5,T"P)UP&8-I<\N3OQ0-%_3 M6KFD19WSPO[D)?,@TK>^ X,4SN)/PY;(U&.,@A1\'[O#K]K9-BQ,30,%5V6O MI_)A#\.30*O?W/;QY+.I[>/>VSZ>?#:U?1SU1J)HV)[]A*-5<*&!_PQ%A$$B M%/ET.H!?=?7\S4D_X>DG79B3IUUFYL&7R)>S>*L$N6V>_2MYJN30OW C]K?) MLM[ 64Y'S(>QVRG?5*F&5KO/48TPE>*<;\7]EXWI\L9\)=+!KR-3C@+ MUO1 M;9@6S3%Y9[R*XEV=,)OGK4LI^43+B6&Y/'G\[:?*$\0AV'8UJTNK.KYX_NNO M%_JIO7P'FAU_]]47D2:EO'+KOI,(,)-8#B6D5;\RFA+E22_^G7D* J-+C];N M^9D^+E.'HFQ$KV*M&NZX<[2X+Y(?Z1'Z9I=K6Z]A^V3#KNH*5Z/@D,.DP![$ M1*FX'K(VS,DBA!1""SN8&L\-,N >JF.WG0V^\H AS4'[3@IM!)C35&QD4)!21+9#" M-?]J4T!N %1+3<,Q1"B0VK>5J[5R8S*4J,KQKA(V.^^>M@6"TZ[)D2&FXY+SE:[MZZ9%Q+I;7@A&>4.UJC*%<"N@$KK&GL?4W_% MG^,UI+F)G+8]?V"8D^"/R_5V-(O"GN&\U,ZFF0[&XUKQE\)I\[>^=/Y MQR<77WS)4EP[MV*:/&97.C^KR,BOU99']\$Z>YQ^\>3K],L_?6.V6T$OX/OTI^H,.P S+)]L"+,M.RPIK^)2J]-!J8/WJ9 MX7-R.WR:SA60BDK4D+4M3LV>,RJ@4L_F^1&! M7GGTKS[CHX3>WYRW'8[IG([L.0A=4VAC%* <,DI5%]BW#(LG_%UEQW,UVR*= M.V/Z#\[V6C<0$_D)A@+1Z'/*O-&,Z\VWE(X MQ6NXRJ@:*X2O+!;.LYD.[FR+FC]FE^!=X"G$:E9XQ()F$T#;U#JR;+C,&E#'S(/122UZVOK6U<]@8%$L=G M F:X$$AR:4AE6EVT. 9PG!@[R9?%]\#.7-9<2K1O>AJ^N;@0JG9\O'MNV.16EJ7H&<>& M7'1!NYT^QH(^:C@NJPJ.]DO=8E5"I^N*7N:CO^,\*EJ])CG%=(QQ+L8>(S(= MBFL]8)]LU.=GMPY[8.X"-?9T9GVP'J%[>N;O&8,O?B29YL)WV815P! GZ2RQ M)@U>J%#"S)&_)E_H\\<6:"N^WT[-B$;]'4[)VUA(LX[L1[[ MCSF[:$1 G^2]QTUXUMH_'_6DAR+PJ!/T'6KV_V$GZ#NB!]Y?/^C[ZE_<:1#E M:O[[O_@]-'8>8TLGGU_)'?ZG.]6?JY&%,)B=0'@Y'9$7.;N=83>O)64DDA ^ M'P;3TFT?L?+LW<;CO7'))ILFRCY#P4&H^+%D_7('>95@RT">'^QC5]]M&'I/ MAN]D JOU*-RNAU7"W(?U4=V51">:285> MF$LOOX9:>"\<=MX M,3MMR_QSO.AS5SH1($GO^'+$+9S560-!@15->><8"-AT7'R]+MPFI9?RIJHW M="CJ_?A]Y?;> .:3)*#OCS3NYW?]'R\/'4M/=^GVD;<5@Q3V+]1X(Z4EQ,B%K49#: [DE*XJY6HZLI_ M.S4OD$DD*[ <9%HZTMIE4>?%/%F4_5OZ359NR7.]2/XV')/6^^\R$&[A*3?9 MMN41X 450IK0]@OQOSOZY]K\W[R>]]Q"Z9U@]LSY,NH+LU03W#)W5T?8.VB* M-2!'K=0P-^2 U_D/6,'DDHT1MP6O#-]]'_'*-=G$Z:Z:293IK# M)XT&_V3Q'[G]:8B[C48]V3A=X/,6Y/X^ O)9<%,P>.P6#ZP\%T/T#&BU?J-# MNMM 0HYG/[7A,6ZMTS96=YF=V_[WNYH=M4OO]:K=S26<=[ ,1<59."%HZ]Q\ M6=5E?;4U8@C_Z8'I"WHJZ&&LFS^C*;QS]NH4(I0!K(B]W[+V5&#-@+H1C8$YHK*:)_["1ZZD\\ MHYW5O<_/Y&;M'ILU3LGOR^[N4'-]H)WD&1G?8PGYB"O#QU#LEIK"GIHL-[,A M?C'I=( "&=J*C*^'\>8 XW$B/"Z!1'B\>'$-,3HJ',Y4#'PW&X4TEAC;G,(4 M@=.SJS.*NUY<))=L,+17R%,?XE\2+>V!,]4-4,[:Z,.M)15'+$R*)YN^:,*U M=-\U!I-&"U1,!::CRUV)6%'KV&'GQ KC0?L7\ G@8*R=(6IX4-8>O#PTQ*01SN[ ! M>1=MU!D61C2U_@]:_Q]/K?_WW_K_>&K]/[V-=-IG[@_FT:*[9(P+9C2O)QB# MFR?H1&E8P3E8%KQ7]YO8V%OVN%M!VPHH6/F)QI?;A<\.H;NX1$3)-!L0SBFQ M44T#SN9V8(JQ!X?W5>RDB@A:1J'/0GC^X%Q02ORZ/56IQLP&0#)AOP7KP!8+_*0#MMM-6JN#A9@#Q4XZ$I!0XDUJ)] MQ30;M'**=2:P1PXL%IY?;@HQ)JLP684';14$Z,RFP+R+5?%VVO/3GI_V_$/= M\]EU5I2>G<7[_]X#F)()DQ68K,!#MP+1R0^9=>D!CRR#CP;H%RPMDB=-MO&M M'E-<,%F'R3H\6.O0%2MIVRP+6B^QF]#ZPL.<;ENOIA3!9 HF4_" 30&Z& V, MM-=!0!NAZPKNAYQJ"9-)F$S"0S<)45%Q4(S4_ &%$Y,!F S 9 >K &(D@?, M*K!BZKA:69D[7VH,?6Y6=)SLPF07)KOP4.U"[ P8^L@3'!5&/4R?JB-)M:FQ M:3(.DW%X^,9AW;B6R8- E]0X,A/,ID:+VW-]F% MR2Y,=N&AVH5UC9T^!_,T9&OJ53%/?1DB(K?,H3!:KT6J8;((DT68+,(#M0A1 M9=(L BNF%MSN_*T,?)]6RV0$)B,P&8&'802JK.LA'X,P@3Z_RG*64\C:CB*& MU(J0IAWU]/G_//O^T>-O]JNDO'>;<*S4[+=H'#R9- [N7^/@R:1Q<'H;Z;0) MK2];"-P(+;6RT+8N$H%13FJ6%)BYLJ#(2L2I5.&OJQ_)OQ@7GC5%JS0S!]FN MF?LBAFU7JE0BBC#"S6- :QH:E<*_1<<07 MI7?%RE[7(6L\^CX$S(3T0KX]"1G\+Q_I/9/F_^K.SZ()Y>, Y.J0&Z8?FBL16NW MY9=H"F5\@UO>OD<$&GHXJN^1,U66> E0D*U%.\$X#$1"#L)Q^/4^=8V=XXOG MX)TL2NYF'+K0X4+8=FYR)YU=/DA&O8-/%A M"S!$/\,BX?64%V5O.$I^>3( %AYRK1RBQ@E+.ZR>OUG6)1B;3# (@D1]I2,) MCT;3%V2*]DVDWULPA'@IK)$731XV4PLUO8I1F[0T/8VFDH4UZ>7'9T"-?4!S MT=7G9WM?G"QTR&S2)'5LG[*PFGD>^>;T>OP=]F6XPURD5Q66UF+T0KDFXJZ?>_!^'::\=(JJNNZO!81QJ9@ M?2GZR[6C2W3&)4I7PBN)# M9$[)DV/GX!IN]> MYO2G^G8V>?EYE'4?8:H2P MAE;9&W*QR(35$%LTRQ;)8^F;"V^-[*N.0DWRNF]:,B#[S;$M=HQX^.[)],-\ M-G5_15NN;WCL!2T\-L*\>WA'\4+F@ ]SR:^8MXI9>Z^(%7X[^ :CF>U2>(G[ MUY;,!Q8R+A6IPOA][C4LZ8TBGD'$5&\J^O*R6-,X9$7,19E3]IMLYHW9AFB$ M]$KPK+8.(%R9RC[%$J*C$!.K9UC1I;'19Y.&O8)+ MJB[N.Q_HX0"/5-'"E)0H(*^*[KX%S4[< _P00EDT4PW<(Q-PEVG]GNS6!DN. M_J,S>(.=H5-Z630YQXB\O-A3$[>(I:"+EJ[18+O11^DZD*:>_/\C\_]E.<#H M8I-V;)D*U*2-EH@HDN/KF5#=B?)WY%^SA60_2R5]%W06 MT-)KU&SY50(/Z?R,_&'\G@\&6E[5%>Y+KDWUJ')7=<>RR_1&Z&TT(D*LDN(U MVW\LRY:6MIQ#L4'%56AX;[<\:#JU^;,J,IF,S@")B.!,K=;F*N[_*%R$3"TY M._'T7AH:SJRD>^X9@[KCC5O5UUEI+NC*ZZ&/+G]Q?L:>;?1BL[*M[_QBL0') M+VQ5C%+="!Q;\JHW..1G^'^5@T,H4=[ ^3T_>XYQW;!0PM"RG@ZYA@56<'+4 M&5D)#(^,@R6Y"OI$W\6W@%)\@[?"200Y9.L*=*EB?,@GYDXGIDS!00NWKY7W M&@=G_%ZNZ\XB+/$IV,&6@UI]8X$YT9F4Z?MKQ&60EZH76-<;F5C\+AS8X\-Z ML"OX-5#@5+?BT6B-%,>R;91P8M:K&9W;HE@?9JCE%Y2H;KV%)O:\-B6J9O\N M,V,3TO*,?&_[WA#J"XW' L9A M^2.]Q@)R6$RZ*6EN:?Y=AZ >PL RX]E5!M@DKY#(JLEJ;_2H=*MU66\=W;_G MXVIH)/0DX*#&*:D\'FLEWK+0/IC!JM_U3I*ZVY?VX(P!F2)N%)/ 5LJXV]A1 MPT%/(4\;/V&TKP_>F/,^PZ.)*T.K2EV"9*)$@!F=8=9#B25T.J[ZJ6S-OA>XR30[@BF3LZ#[XR?@LX, M<0Z8VX^FK'5=5^K133.4K=C=I6G.PSL,9I$#>_\&Y=32I- L#O3H\W6_-KG2 M^/2O;.0T1/+;0 DB1R[>?321-+V+IEXE,SR4> ZM_L7[V!H; =1S)POQ1)* M_+PHT%N(G9#W/G=!-S\_:VG#D.-3#M:2Y))*33K2O!;74BR*)+!I(7+?TB!; M=/OXH,&-0!HI",XJZ;%)GENQL!-FT9,KL>ODP,/I!CZ<5;\&A^N'48$]UMKJ M+2"%SR>0POV#%#Z?0 I'O9'^>^:?_813&CXCY.,'=7N&$43ND,@C?YQ]>W*+ M^X;/OZ=+I'T;[TB_ZC0 \=Y.)M\@,R!P!PK92PI_KOFX[E>22A+SS4EA.NWF MSF&C1UD$1AL4&O[O.32&(6!T",W+K%AQ4"$10OPEQ$^/O_HVKG1\[/!NN?/Z$+LJQ(Q MNZR&\!&NUR&%2EM@@S*!1)>\Z#GHU0V5(4-"AJK*1&>.EW]ZU^W4(L>._7#[ MIB+7)LZO?!*@F5F4Z?F48U7V$^DCG_+7(F=-4T:#C4F?ANO5(:4QH\'MUO?KMQT5"RA+;E M]@S!IB'^E=8)HU^I&6B'!N7\C(:OK^/@ PP-1/3H"*'V&HFZB:(UH+@XRX1* M'&I62*+3_;S#S^\%%_?3_U?6&"L'C_1SMKGIL6[,#,'1U_1NC25RO?^)#]G$ M.S_R%4(HK:U*]R'OB!)9N*P@USZOYQVM19=B3;LUYVE3/D3J!$N%$X!8IU:" ME#'/Z+HI#UV'R5^00V'_#N-DZ0II.%_Z1CD,D08CVUI4V-GWE ('$ T4'/Z& M+!;JNKCJ;SW-8%[X+;[_3I]8L+_OLGGM6KZVFA%;LVMZ=UQPO>D>YV?^)@B. M830 =,FV".'*LMY(1$OOP)Z6)^M3.R[I::\EL:CV)MB1\6TSG*T-1[EB8BQ' MGRF :.>Y4_WLS;-@C\\Y WN_4O >C&%*G1WY(W&N @B0X4D4)2_RFFHW06>;5W<_]H_>%3^BU&P/Y& M)R871.169BH8L91',!A+IDG6>H";0Y*&#"A9%LW=<'7?-M0&9H?10&J/1AMQ M_(@XK&%*\!K)J-N]^\H!ZC9WF8 GPL'K<4>P:49[-<]19DLJ=R5?+(@9WK>D2VO#N.7)Y# QPL) M7Q;M&UJS+P%D$K :IND5E^"2R^2%+\!)860*=C[J;''5XN#D-%GUIJ4[&P ) M\8-6MW 8S&B"/;!'#G4K=!13''MTQZSAM9$"]W"!&4UQTZ^[.3E=9?&OOLC5 M*2=;38:[-U=_ P^TNGK4K^V;ZG:G,1I-CN(#J\D0FD!G=R5PEE*OG>A:]=1+TP M@F1(Y"*M:D4/$ W^Q&84!/L9EGXWP M>,OHF7:F2T>R?QK/S^)YU%<58)S]K"UR"OBME!2_HNAO%\GSPU]KE+IJS_>2 MC6(0*99O' 'J_7E]V5H*(/(0,QF&>_0]&[..BO>F M[3VQ(8?W"N ;==^A$@J#P>5=OIL42C6%MMH!4/"?!S54&P67 &==M,>CFJSV M.(0=]X[K/+GLDE^RAMS,SQ^GR9//GGPN^=FN!LXY7GQ S)88-D!&;PO(K=&R M_^/G7U]\DZP ";GO"',ZYFY\I*>"E/+P;+_]:]]7QLL)N:A&(:P*?F! O@!T M%/:DAR%M"BO4HVS/I@U'PG 3']S Y&+IHF/;:FK> !YRL<)6.%^>E^\N?)Q+ M]6/D66C0$:+>V\Y@;T-R-R]R%^!RM]Y^L%F1LD,&:%VW+2/N+;9MW0#QK@=^ MG+F3%!F]RQZ])SX5&T^&8D.E&RO/X8KL^(PZC'A>X6@/LWFDZZD/14!H") M[T1 &,6-![?.,,-IJCSEE"%RJJ56GAB=%HI>,C>9];X()@4/+SE;>BCF@9W[ M/&!X61?)=VZ>,>4C*EJTE"R],%Q,>U=1=%3;!AAWDNF*#@!(&<^@78S&OJT5 M?:$ 6S[@YEF%\VV-4T\20;1PV&A'NABI%\1H$F:F\&W(XZTI/N,[>XK#M]I0 M*'SHPG%'CO9HO?MF5GO"2T_>700_!=HB(&\P=+8Q].K["9LRP*9\,6%3[A^; M\L6$33GJC?1@L"FMU].;U''T;/$1)\US%\' .;?M^^_-X#^:_SLT,)L-#:3C_+,:VM W2UX#J*]$;_>CZOF0L"OOX!8"U4CO']?T&H=-;NH6*^8Z< [8J$_ M&BZ9M.%P((+-S8%=<7/N15$Q'+HL "%BW(*0/P\:EH)/B(:I2A'^>F MF&OP#F"M<;05$!DQ,I\^&4GV>AA/>&6-.QHW6G^2KM HL6'T/0=RC[) M3MG'(\^XBE/?VD:H.*;1APP;S""/B/OBMBA;6D"Y^Z_F*\GK>,>S0@Y2(YY@ MB-)[GKWSLVCZ0A7*-U/F ^#>>WE[$5HBM/9RQL(+>X4$2!L1L]SVMO>M$^T2 MCE<*KG%PM2#OV(4N+TUX["[/6TH@22')RWIO#4/Y1:2$,Q,1NF(C-*/O=3% BD6 M%V*R4H\?J:?LN+)Y#/9_W%) S$)5K M.W1=^ A1S&[)A5MS"-86.Z! 8*#JO 1,U1 NTP:0P[!,858("*S^IP/["VK M@#HDOW0MR_%XAXQSTXK_>+'Z+SQ-8!(68I*DX28IX:6C7Q4HW,9B4L-:=US< M.NS>3T'S<5FUYY7SI5,KWRK)BAY.K<'C;HM-4D(GJ1WH6HY>G%>/N4+LN]DXE/4H0Y7](@;HJ'K9", M#JFW:V'969+# WZWX?OE3B3]TVCS;I1&YXUC?T,?7?B;FD8ZB:1=@&VRT?/" M,7+RX?,SB=U"4+JHF]WP\%,$[F BU''L?;5ZG,D9=M<)YF1&9(AL@%/=/*Z; M_VFJF]]_W?Q/4]W\J#?2@ZF;'V#VWTFJO4.B3G&_48X.Q-3&EK!KX"?/[=@\ M-^[Z"P'9FJ-#FL)W7PE:D&V57%H(O@I.>%1\+-<+]'\CIJW!U0]$O?. ]$\$ MCRT_G9\)B\(8HOUI H!IS,.?:J]CO'@%JSCK6N450?Z$DR%YP'OV;<^]C7TC M>,U ]OVCT%6C^-TA96498RX\M&X@PG((9&^+_TY;27H81G,0OBUY( JH5NN, MZ][%PGII#()XJ&,)[[)@1&>4>4IA.\>Z[DK#(#IVD\&*CV[SJW@'KMK5%.8N0P) /;DN#)_ M W(C9JA8BY5A M.TR89;+8'^FP_MXV5X2E]]6T?66 6S/7GJ>"OZ[PX:3+W@JJ:%A&V##SA?8D MT0ZC4: U1\H#O("OR-!@Q_M161:\V*53M+2X] 3BMLJ:0^]+PE.Q8)S)' JX M3([#<3D..[VFQE]L:K"H64CG(]86$YL*Q$;%!?!+.<-Y&2(%P;8W.C=WUOMM M_3=IM%('0+']*W74K"<:)-@'2$,4EO?87;XWU(>@#W3#VA;2:2'/#\G0?8G0 MQM%Y4^&)MV*S#./S(9WT, NLU9C*E=QJBJ_F-@/CLQL(?;5IEZDJIBI M+%)/2:SE[)8"V$7RCT,06;3+;\@J-BJ;%//4Z]4S=#^N.PZ?(D.O%N(Z* MUVR_\ #JQET7+5CHZTT%6NB, M9F!.UCZ"A-@PY(;T/F2DF-R*N=1^Z_,KCL"&SEI++EW6T)+L1+M*V+UT<#): M:78MLR"GMG^8(D#AIY(?67<.8AN9*R\O4=U]KB:C^-'S?S09"*UOWE+3 79< M!]CSB@-!(4OYA6;Q\=?,;O"E6>?"7VBO'M!IS3@\&>TKF'4V.C* M<_.Y:@^NKR;W,IAF3(L*!0TM_;[#*)/KNNRK+FN*DL^$G69JP:YKDHG= 1J( M!%(CV%G=C,7W>,[9>4U,6K1DG1MMF-54ET#_18=#0Q]/@R-^ MA"G&YQ1)R C(H/LDW !Z,QZTT6V"?4:93#LC+DHBRJ31"Y"#=5U"GH,6TZH7 M C9A^ /_47@Y(6E(L:ZD'+%%P\6F\_Q5G:V[+GW7G)W5^3/:BA[*%B MN].Y?5SG]MTGW8HIS)]W[L\E,: M^C=??O7-^QK[!QYL0&3OP@DQ9L/>B9Z -P/O+RP?O"=&'!W-BC^E)3Z-]8:Q M3LOJ:,=Z0J;2>%^,0V.1J-"<##E$M-/:.X7I/.VQ3LOJ:,=Z0B8-V4II_=@: MZTP9D( R;H,N3,OO%&;TM,L)637F)*DJP*ZET6R(\I*!WX8QSUI1 MY%4X%U](T+(")/8PXXAF>%K+I[ \3GNLT[(ZVK&>D(F\4N%&<#G6JV(NJA5F MTV3<.U7> ^M0&P0?4N/=?]+!^N74P7K_':Q?3AVLI[>1II+:5%)[R&B*9K0 MFG1O7"P">HOJ8DV9.W#8NSW7FJPJ.]<=8GC>,,7D NK?!03A3ZDJ#NNA/.DM MRZGSSK\S+TY5',RLWL(,[K+"2FYM+,Q6%U7]])+ZV#A8 _1P:4.B%@'FW ?U MF$.P'OB:/"D&'[B(55&LQ..^SK$W]:DI\X.++FR /OT^;.!!D-"<\%)LB&T[ M>Q!64?MZZJ+.YROJ[#<;> F,4,OCK'!>A#,T8WS MSX4YKLOVU ^$?P%F-6%4@3)<00N@E/!_7+,I:72CB-V:=HG6>PFJ=*[[35G? MGUN/,-.DB&.^X5)Z%]D-V7* 4.R35XX=ZMI(AW0&XA9:MW.3:83T$&@* :); MV;Q)1 0CYQ'*0@YJH,OU[TV(C G2%FB!N@K@88])2##2%) )+!5(AW EX,,P M"O?LCW)=*,=H5MCO-'&EZ7R1 N0\$#$(/6P,G[=&9SL"*WF2GH"T4>NT$,G[ M.:W=]PJOL^[1Q@P2XF"&.(RN%E6KL2_L)GS22\KF-E\" MVJ-$,>=*%$?7'WVG[@4A*[M3NGES+2^K(R\UPL52PO(9)A'8$9GPP.Z8Y]BM MV(- ,#QA[O]!11QX"K*C2/>?3*AY^WBQK4Q!KIJ"Z5JKJAB5/)1$L" ^6CQ@ MXGE>C&+=R%"",!K[/]2(BN?G>IM[9=U[F@U#0PMMS0PQA@HX<,(:4@X*.S=> MF?&'0R[G^]?F%Z!1K=/^2E#1$1V$8241'$E+<;Y(A7XYXQQ(=QX]G )F,<73 MIAXH &S*\L-6\W0O@ %18G]7N9-$_"X>JPZ$6#1:#F./$%P\-TOY(7TM;S*; MP!N2\4S$G^E%BX=CD.GG%)/5W2EK@_CY#&(>S!_]UR^>][_M]OXOFOV>7Y]] M:C8ZO[>SS]57-K)]O^I^C<%LM0[<% M&K0S>[]X;0[FKDT7%._+BR]GE]?G9_4U><;I$Q2X^F%,;.SR@<(1'3[1T)-& M!E?#*$V3D8=!.USY8R5D@[2 MH-& 1I+>[J71'OW#2<%N"JB5#G;-P9'(*U48[56W3<.A9*=?"; ])OJC:9R1 M(4O>&-!A_"FFU>@E@;@>3?P0VY-XC*#)35U142%TYRPDB^\)O!%Z:>ZWQ0 M$4S9*V/.G9/UF/.'+/P]CKZIN 7F&KK)1-2@'68:5=6F3@6(HW>X%G%\\D(_ MC>ZBH>O\X2?HEL?,UA("69#>?R@'A#.YQ,C+:D:'7R.\:)AAR#N+-2HQD-(W M#S;EIB:/"I#'P9K4$?LJO8=W]!99!S6$GD:)^(\,)_$3IHX[>"MR%4Y[*:06 M%#A,S52>?_I(-=$=MN?H'*^@FB6\I.5<^90;PO'CB- $$FPG+F$_[87#EN0. M-IT9(=4-;YU>AYH)]%S=W+79$'XS6F0XCC>99&'>U''H$6T5N!#B[B<*QVXV M\)D1=CN/INA5=(D[T3/48N76GTZ);V%W.1'V,O)#O!>*MZX!@L['P$!EMNBLFW\'/4:J<3D<[;_.J@R2%>Z-; MV>XH<>WXW5ATDAS..4EZ+>?CV8?^1W25G)Z=O3O__*'VE3PS-^.$A>]1\)UO M&(;/37Z&2WD+GFG8N^+!. *&%&)\(/5OQ#$Q##Q_DF!OB&2:(5HR1I^'2HU, M_R:.9<@/DF9#^!]%A;QX5MH0^(];/Y"LG"RE:<'7@7>79-B"*4\R++SKQD,$ M*LPEE8ZT PQ/PK>$TT_!"VF4F,[^5#($&LGA;D8GZC.^7ND=S4G>_Y7PZ_WSF M7/7?GUW_C_/N_.KTX\75U\NS6O3^*:)Y]>;??V>.S9WYTK^\;C;.S^O+4:7S M.9GC:0? T_J7_SB[=MY?7#J79Q_.KZXO^Y^O*1?QZ.T592Q75T[_\SOG_.KJ*WSTY>OEZ=_[5V=7 MSL5[^:US=7;Z]?*\#NL^.TE\DERL\Y"*;% %V?J)S&7?=8]:1P<['Y+9;$KA M6V?@#;_=@'T8CC"J&<5_Q9JM5$FLOI#3AW4XU*8;^]YRP][/7C+R_NTDY#E[ MIX9J,@#CCOUA;38B$T=WGJ H0PSJ@:_KEO^I/GV;ZX>\Y5GW!N_R\+E7.B_=6I9-7$Z+<]<@^.V^[1 MP;%5;_6JW6JW.]C2U>$LVP)#F&_G:0U7B+PT&]V3MEW?Q%Z0[:K8+Y!FGOA^ MOS--,RHDQ5_".6UZ2>@J)I]EJ+XK!"89!@3ZCV7.A0ZWVH5IW^*6\X7;H^#% M'&=I%JNREKC:X^BETM X&<9*.Z=PS-^QF)!XS#M3:"@MB;UOTIR/.@Z3?W*N M\ZI=S9W:P2>LH1JB*QCKPF)$M")?ESL78 M 3EG0Z5&[)J>!E[(;C3U \XFP9:_3C^5,2>, MJ!W<^9K;?S^ >+"EB-39C*0NE>/+U'YSKF;HCGKWSAP)Z' @(]+<"6$BK*;H M"P5$61C O>&2;6G;C2G#A:FNK/>AA:.YPM6TL$MJ@@6VH0*^@\6O> LUI^2T M'W_$N$[\89VB:Z?H'MD51,/313'B=-; M4"^-C2=BO:CG+:!9&(PO?>RL+C-9,-"3@"-:\"N@ #0;F*@ 5/24(K6Z!/)2 M.H,PRRP!!YP3](-%0;_N2Y^8B2$;@^+8%9PA'B!__UR_= M>57F:79Z5ZI1X2 _9QA&$(AJ!%O1[&1!QM#F[=#*$'D)YPP<\9PXXLZO*)LB MU@#.^NP'@B(D:N>7%(UW?@D7N6=^]]="2$>)N_,+^8,\F.GNR&N*WHM&HM(+\N"JE+C?9V_K[T0;?V;G9?,+X8"?\%0::,?KGSR[&E_2!V M_B)+J 5GU192"\Y:<&[;?-[Y2_."S/]+-?'\\"489?WOGA^@IY.G/H[BG5_2 M>TJNX'GKH,?.+XJ\\^*?*<_5W+45V9&GG5],>>1LUU;Q^NR')&_M_%)>E+ 9 M!U32K'OY[/R*3J,@FXBW^;7WYLT.Z<]/V[5K:6RN&HNMQ+3*^[W=ZQVSTX M>%,1J2=Y<"4)453Z])WQM203:J:+G_Y:N?.MJ/3>6.-/RB#5XR_[_Y5<1T6W MMYY638SUM'9R6J7$6,F9[IYQ7J;*_,'("C]Q7I)";&):%,W*/\:R%![() SO MG_SZE)O7;7>.Q),LGO(0U6$LS4)?YA.1Y9)EZASH)UW1&E1Z?VG3^DM[26O8 M_W7#'&3O9=+3SDZ\O@CU1:@O0GT1GN\B=-R3_4/WI'OR(NCJ3^Y#VQD#X:D) M;+=F6YN)+W-:-7'65%#9:=7$^8*H8%<<;$^Y"]=1Z@4[<#;KU?=W6UTT#$91 M-@C4\U3X;WGJ.V'1_RFY24VQ-<76%/L2IKY3SJ)MJ4B"Y[9+6%,[#I7UM\%O MU[$7)F,LE>G?J##=:3RW%XIIREW9IM/(IX:3>:6&HP_/.8UBA/BD9+S7TE/@ MZOI46@J\09PS0A?6SWMXUH1RMX _BHB@.!M5P!9M-@0SF3K'QGZ(X+V!P]VE M":OH^A1;'NC.M%[J=$_:'>=SRWGG!0&\_XL7?[OS9K#4#&P5IW?(Y=J MFL7#6X\;C$JV]0NY/,\'&[MI[GT1-AOOU2#.L#_L,0&)=@DM'_NZ9M1UFGJ9 MFH8!3K%?0 X]ZW$7$B?.Z6 :1S>Q-R%YG4T1DO15KVW#FD?8LLAN2C)DB9ZP MS+X(!>*T>VPU['[PS%"#@$U4U!] =S]8G&:SD86I'SAF.^"-^S5KJ1"QEB/D M9A.8(3R5<"?X.2+4>+?E9VY4R3'\O_1VOH&\T JAZ\I7V&;AKR^,*!X$U[[^ M$M<#=E] P'TLKNV2?)B].\48Y(,H&/WRVQ>86S1B"[[H4B@\N#2:I7?P@5@V MZTQN2=':'(3[P^'X*;#A,,A,7D?^E/_[^3FB)49-K*HZP5R]&9G2=8N ED03 M2PC0(J _"P$:.+UJ'BV!RX&=[X^J.L,IR"*Z'C7I/8;W5?58F243Y%SRT)]AL[:9PF9M!D76 MXHGFL:^F>;/^1*Y2_K?0KO.Z4XK1]"!2+,L=N]>FFR/\M4F[[,B6#_521U[U M\[5/XY%U"*L+,KK'8."+$Z_=[:W)&/6/?UW"X];F:Z8LI*P;7#FO77_0);4S MG/VRI#YGAB]RTULD#B>-/OV,UF3U\TQZSTOLG^%,L=ED*]!J"]G$* MXNI%_R1U_.R>_]3KZP77"]ZU!6];/>OR-HI?;/4"NO=O>2E'IM^9W-*?8N[+ MAWJ8&.S^'"GLPD[LU7M04T.^$_ONR6$/.,/!DVS&8K)S'?:^!UJ!&K\67(>+ MCL-??GN2 CL8'EG_H^H@9;KM5I>S-4JB0X\;Z,E.CYQ25N+]S^*F;8# ^LG# M7-*QFD8QYAM'(3GF3K,XQLSF2_H.\?SM@/X#GJ[4Q/1I.)GW F M4^B\4T-%GL)#2=UZV#3NE..'?NI3ZO-"1O72?"[?>G$TIA>WG#_P>_7=C[(D MF#UR-W"!<2&/L'/0=MOM-L\ET0DYA6EFXM[T$\)SY53OB3A40^-(32P':NXX MM5XW@G5A5P3XQZV*E1\V&S#D2*4JGO@APL/20W)BPR!*, EI&DLB^<*\X+-7 MG=;)$?ZBV*D;IPA#>Q/0Y7@R,('P1A7?P"/C?#%';F[P-/9&L!HO;2W4I.PF MBUXOQ?)G<]'Z1$+_+PN5TE.(=4*,*E+=R%G#$0,IZE[]&"JI%QVV(>9 M ^_%]C:I_CR?2;.A7UEX.D(,%]&!%WV2!1[!9]+UYU1E!@N':YEF ML?O63D_?NOS<:7BS_^>(,,@L?U$V3W4?G@^8#X]>?^U;O^?SNG MWM3'+T&F? ,9ACP"1%&J3 &5?NZ3549O^RF&K_>$;RT-2-+?2*V("X>E__6*,W5O)23G8;T]_&,ON\ C^ M^L7YRU/,_D]Q1L^A$M!@_NB_?O&\_VUWT,' JSF_/OO4;!RVG,NSJ[/+?YZ] MV^F5[GC=W.<(;+I8_3OS8S6J2XPJ.^_//_<_GY[W/SJG%Y_?G5_K M9^#2??UX38] TIY],L!O6?76-C!;HA#(4**#VMVQDA*$+@W<'262F$ M\5CE1!TM\"<^.=\BEU2_:1S]2PVI$ST.JKP8713PVUA]5V$&^C'6S-&*QGX( MFIL/KX01)LE;^GUQA60\8)LE%[Z(X9L;'X_@)O*"A"8:#>AMWWD)<$S>#2N8 MN#K1$B-0$TDG7G@%*.L1Z(XT19PY[@5HLG#D\,3\L M;+1>#629<%J>#P#S*PO767&1LE,ME%S:FZNW]:US/9O"^_NQ-_"';YW/WD3Q MUG^.<).[)_:O_J)_AE\M.I__]AA6"SL2AK*6ZB?1S(*N_@JB5:>L*7KA:3 M\M$PRH+1_(<*EH$N\_G/$;(H7'@:-0(?1*#^O-F0+XC-?U\81?V8@FPSGX(\ MD"\\& >1B*P7&Z&:@#P.O)C7XSKB@ M!(+%GD"46.5X2$A#+U 2,QR7D],EB M1R^4Y:$M>*(PF"'0DDB<$>H-]&\_D<@AJ,H M]AZE$-XJ=9%/\&6(%+'LG/A5SOVUV+DZFJ'^AQ\V/0?]#1 K1 M%U#K225PB/Y:Y7CC5 HJ>'9SD_J?*$,O&%*;]CE_24) M K4&@ ?CY MR$\PAIC%%+?/R]/"Z:JHE&'.3XIE+B9BY]#2SY!I@H\B>X:;@B_3U;%PA(@@J[#^PQGHC9<1M% M*3$>9*,8%A[!*F.R@.![,!A,*@\YR,$ZBBD7@XT7GMLM:!E[MH?=FTRRD$P0 M>@EP^8F?32B>!)P8>=4 A$5(<'2YY81\I-ON'-;HH=6CR/K)$]H<#P'0K"71:@+A..KX4>^2#(7:(O-(S/03F;*#P*L@J+\K*A81()81O"0RFR M$=B') (U9DPJLR074::)!XJ4#X:=@_(+.1)'ICD(B)!PMO'K6 MAJW0&Y8 (9:(X\<9$ -D*5GL+&&!3RGAW7 K:TA)/#HQ.P MU[YX,^*:7^(((]-X2'M%-C25)P9PC3'K"]DF^D^]_%"9@Z+_#MV\!#T&U!.- M\=J./6"J['(@[^ M)R"+;X(?ZXGB+<2),"F\-6H#9?Z !/8EZ8C5BS$(<9VT\QW9BBWI1U[JD1RB_$_#?N9%M*??2=+1 MEFLD]8CLM)*H)BP54_1N<" &/_611('W +M426T]5'Q)!>NAGUN*8BZP50!R M*?7\((HU#QI'PXQH89#Y 6*Y8@1-(E\:(A/>GJ%_*N-?Y88E_9CSUK4M.L6X M9L V+LPS6#!:DVR*:AV.E!,D\$E4M>F-^=O4R#)MR>5'JI?VQ9(EHQAACN:) M44"0HBFF6P] VP3-,_"_*42"QTB#\T\_R4"9S??F;S"9WZX_ 1G ?QE'/E4! M6"!)-DA(K(=-%;P,O'95QUE]Y.JBV>RG;.W+!8:14 M#6_#*(ANC#<@C+ZSR_<6ADYA>;1X4MWMQ8,M@<QB=M3T%FD%_4#]A+ M<8&&(R_&68B>_?4*31^?]HOG] /%B9R0R6;-4OS]GAK!-ELA5#30\MV9:B 9 MCWR8B5+?4(_G7:.$>%@/+$[] .THA0E.,<\1B8T-.AYQ3^H@: (T=,UX*N47 M)-!\]&8S%5T87E![.Y^!%8Q*JZ2. M)U.^^7,9'N(1R@8-]2Q M,_KV_RA/X+A/N2J#J'/NRVX>=WEY&[+QA@ (R9\3LKZ&N@X$X<\=9@O%>@\G M7H]8)>;*CM([4 6H>(5#R%%\XX7^?\0& G9V)ZU_F%N1-U)^.*>-B@=G1AJ2 M!..9#< 05,%W2RYR#Y/0(G34*8^=*'$T5L0P0:]RM6)#MU6K7\V&3B43GF/I M7K&'\>"A5.0D&;85\A47ZH$=Y@T"/[D511%C\>*BY9C.OX$+H#^@J#\AGXW9 M=9Z;>[@N"B&;-[/&#C^!73:NA#2:DK:I4_7$=PX<;!)PH2$^E?/3EB.LXP_E MK#TX9B[3Z.[]P_^A+*<6;G^WW>K]"ML\C,F[);[6SPI+GVG0=4A-*K+ MC!E MT[HKC_TXZ23$]4QF,S&%D[S_[JT>\"UR42X$SL:9'"LCN"1.V=R*#:'4J M7J]=I^)M/16OUZY3\7;O(NV.)53::$6RR9*\XXJM\=JZ,Z9AA>RU7M"1BPG0 M!2]2.=MO-A;XOG,_VW^Z%BU5*U5[8M*JVO)>2&^:^S%^"[OU!.T7#I^^_<)[ MN9)D6)WA+7L:8//' $0_W\9NH*]%49_]$S7T*#+I7:"FG\+>KCATMZ[K;IR?N<;NS[)/GH%3PHT_-MIE) EK"WOU31;)E+1-;]7!@;O?/G8/3AZX M4YN;T?&Q>W38@_,[V>+9+8/K7GPE\4[7^:!"2F/]O]YD^M;ICR9^Z%,E+,9# MSGY,,15TXU?OX-@]/#QR#SH+O.>Y#@\NWF%GW^WL[^3%.P\I=?1U /?O#5NZ M=A!TLUOWN@>3/W9/.FO0_9M-3Z9W!&=XXO8.%[2Y2ES""PH,^G)W>=4>,YMJ7+/G.;W7A^U#]_AX0=%\AMOU^K!SX)ZLHYR\V>"U>@Q/9"W*2J??CT2)O0>TN9Y#'AP=@*[0W=X3KS /TW8->#]2F!0SNY[U\ MBV__\M3'M#:%'_7:.-6J\$H0K<=PXPZKH%*N=^W03-=7[R->O4U>K'W0_]&( M6^.\-GJQX)CVC]S]W@/5V:=%L:^:ZWS'@TY_&_SV.0KW/O3[7YJ-/%OM$V-. M;C^U<"[3YKC5/:ATD/#GR'%+Z468QD(U"?^Q4)VDR#,/)F)Q Z70?/>"C/ H MLKP(P:6"A:'^&$@#_C/4]:8>5BEP3:.-+8I%?,A..3X9<4$C9AZGG//A8MFF M@ZH+#\,)A3K[B?.HO>$PXGI8Q&:'F4XQ6>2&[7L$K1@.U33-$1N^AH2K=942 M2(2&V47ZUO"Z[GS!H!U%E<3!Q/FF9GJOX)&)PL)6SB(PV^ M: Y. M9@H>K+Q3+MF;(+R(?G"(&42D,]FP:E)#&JN 3PLSULS1B0&3&#AF(63!&2Y0 M\QSFRITY+"KZ352^<)V;*P=6",1' KB,6;&&K&G#BW6ZE)_/VS:7Q@5_Z5N@ M@4B\"<(?A$#VL"V)K@W12;U4YQ!Y\8BQAF-%.;G/FK[?J[,["H+6_ZT_PG$Q M@^[L]_/K=WW.F-W1]6RUN\^F$@?6C>6N'[1]6)#_82_>@1D^01?J[2UQ>89% MA<[AT9/A3NK8?E+'0U,OUG:9;V?@37O][CE-]I9<(LXMUE(8K924 M=C2.M%[/1&?5Z)V[[ M9$&+JMK].D<-"%$AQ;5#;L1-;\]AK^NV'YIOL(8>I3"9J M]Z#K[A\_4%YN*Y.1C@4U" UHN.G=6.AE_US' @1<_6OS!Z)N$-9$DF18E;?% MD^IV>N[Q.IF(VSFOH\ZQV][?9K[-^M?HE"KL;Z2U4()U_JSQC3T_=C#ZHC:] M/:\/>^[1X1I,;_.9;;UC%$OK9VAM_UK9V8<;WX[N@=NI1LIAM^,>[V_I7-:_ M/&#)_I@12 6JVV,%G WAVEYWWC!NV^8%P5%WWP6BK0JG>Z"(W/;U6>J>YEL5 M1F&, +FQ'1?G$^W.G>A*1_)J!]#]+NYU#^!A(VD5T^WN'V,JZEI+67\RN[<3 M"\3ZJ!W8"JM9)-PN;^\2K_>R%74?>2CT.V<498- K>6W?. H6F\[='M'6(NW M8'*4+N3QQ%GQ?3ALN\>]0W=_T57YJ'UXV@S3JF52V)D3\YD5#UYB 71G"5[8 MBGR+A12+]=]<@N*S)%[VH)6T6]TGSI9D[88/H^SBK#M%&Z"GZC1X+FF/!+LV MI_)A//+52:?-#37 RC7^/791],F_I\U@0EK+ ;\P=^U*I:E@[O9O8B49:PDU MX\J2A',W/T>I0(]" M%X&ZP6ZV2C$.9[.!F9J%86"+N:%):QG/W!UJ_3/F<,\G#R)8K+0&.&. M30-OEN@F.3K;6JM5F+F+O8A#3-TES&I";Z6>? +SRNT0\+ZJ9!C[ X4 K4%T M5R/RV8A\G1J1;T%'6Z+P/QTB7Z=&Y-N]B_3"&346VU MAOJ1UV)8>-?(LH=> M99#=+SR$IK<)WD%E0#C?4?.W<< MQ9 /L,0$YL0. 57%;I33:\WZUN%[LT&S!9D%A2+D%METP382E4*6Z* M57>"*\BX(TN"C>W,,W[([=VGL. Q=V' 0AD$(CD;;/P<\=-]4Z^8N(4VVEZXZO4UP>XX MP>:EXR7V)U$RVI:IU'-:[3VTSL#<$+L>L8.(,(WMSJN:^<&H[#3RJ$%4ZJ?8 MR4C#%[-T']G3L"LR@889PA@5!BKPS!O>XO2IWVM2F*PFX:+R]G0 QY4EV*WX MG7?)O?P,[1=_QH@ MV.@FB<]7 B0NMM QL!SF.@@(PRK']2@BD1]+UR(RNG2W'[HV(U^ZBOT[ Q-? MVCOCC"@'$UT$\GII>1#3%]C J&08^EZ;=_PM7#%0!.C';W'&]>7: 7K=JX7 3ZV]@4:#V9(^2@.O!21>UQ,42$& MCSA"B;3*9K@0.P,_9?'"*!K72?QJ M*YP2+PP::&>FCY"("B2QM.%X7@#$[G&K5R,@_O2:2WNK 6NXRQ-CN OE8%9H M96]UJ00=*,D21[=RM[_2]K^XP,O[9R)#*/96Z[8<@2?\8KVR;\85P$++%1DE MNK$]AHWR">1]63$Y9\8-GKD[JZ\S@="3FD3 "DU_^F9C$%.\RIM@@/GJ^O*L M_P_GG^=77_L?G?ZG3U\_GU^?7WR&:>P?=\D0U!QQ053-FPBV!?X-! HO3F!+8*-N8)BIGZ01)_D!:0?*FHS+X9L@ MP/\.LN";,_6&W[R;XHSG:2/#*#PC#,*1@ Z%@7_8X@0G@E_@/,W/N=NKGJGT MY.5VM^ELBC8!'IH7Q[B/$S2]805P9C?4)(5O__/&>9ZUD: MK0.&=W3PZSQWQI]N#A^O[I[W#+M7HZF]$#2UGVLD=W#XZ[W+--6<)5K&_&(W M"O-TO*317!N1.]QV;Z%HKVI]YI8OH'W4<0\/%FKRGZ?-W(HK5X8TL: _;;J. MMM/NN;W>D=M^:!NQ#4[IH./VCH_#V*[2?A@$MK=^^QI8/Y1UM=ZQF>44SW#]7\?:*GKH[4KW] M/!Z"G5X2W6!TH;)Y/4/SNM3-.5+#6%$Q2;?=ZOU*@6MOB@GN_L1+53!S7NT? MMXX=F$9 OE,L?B'G*641T\ CSJS*P]_B4VLVAE'([602RMDT;[,ZICAW7N($ MZ#R#=W%R:)YH;Y['FF:81\?, U["'F#XAGUI2L.U6X=F9&P3$6/ M5&YRE?R\8_^E%@KDUPS21MB74K2>.[M);)Z;V,,LV!4_\!E9'(=\LG:+RDP\ANZ)-E68C M_V%=AVK7H7;K.M3MUZ%VZSK4W;M(NRV0J:=;C()OF%$M9ZBSDJ4#%C)=O! < MK!'V[?R;NWWM17!U]N0/J0*RDYK'64RA-^#ER.Y'V#S='V12)+.[VDZUNP.6]NFPV4X10T37Q=4';UQS]<.P6> MHJLC(-<@FE(%V0@SCS%K'_Y@8L9L'V](G-_QX@FJ?CX2(Q#^Z_Z7-_2;6XK1 M%[\$906S?H&8FHW7?^]_.7_C4$HS555[!4UDHE1*LPI4>@N;EH)4:@ MTU#+P2ONI A<&C;5$*P#%Q.8&05^_RA>KY&:@ I+N?N\)_TO- 3.:7XB>C30 M;I,H#%6 F7#)\%:-LD#VQP^_^ZA:A: ZX3W'N\A:KR"_P,)%*3?%J_@[5.\R M7A&&X F-)]>M[?-(<.NL4\%E#SS0/8%\AD!H*:B3KW__].G+)>\^UCQ0$==> M!%R>(]FOKZ+K-PXY'W1S1]R3&$Z2H_V4DD!,X .RIY"T2=3+LRGW)1SC5E.U M-QQ\7H0HZBQEGU-8?@JVJS_$YI!A"*_#-/1I%B<9EE(@9S2C(_UDZ6T42WE\ MR^E+NTKD:YA4:XXMF9L)[H Y&VLN\A4M@\XFQ9PRF$M.%GD=K^CA"=?W%L&*C";5-\G07Q@;RJ<^H TP$]%D?+$$SW+RJ /;Z+;:L#B%N6]F@E MVW801]Y(&Z8>%7=XP.[@#;@CP&3\J2=X1:,89Y# H7H@#$;:0#3;,-.O,9I# ML[&PW:R-:!VF5B1V9$GBAHJRE%-TQR7T)'(:5(5AWOB57%#?$2,-_2/*)^W6 M,.IW6!_,->HPY"G3A7(BZQ$:W'H0B(J)-4^#2KUO^+:"LZO7=D8(OT4E^4,% ME-MR+D+G_V4AHMUQN@&5S /K5W=2\0]W)J-4X1N?E 14!;2$=,X+O.$Z]L; M"#!K#)H]2\XEVT5F-70F*0_&/:H?A&@Q1 &L="8BSFYW MDYW_-C#W;,N9PD^\BE/*.@3REXCCLZ<^U_SP_B4M')KE?Q_,YAWOG0/+94R, M$#ZRW,@$C_2JTSMLM?/'[O7X>?P8B:?<,_^N,#YBXW&Y_H_3O-UE\@Q[O *BL[NQR9#+J5T7&= M,S^\6L>MDU^9S0%'@W_*-5S-S>;N)T>@)H:5%9@8J(!S<,Z*2NOBD8.BP\\9P59 " MM_X-*F62FH_&:2C#6G4"PKEJ@ZCJ2\(P@(;O6G3C4PQ +'G1\-$SKQT*@ESG MT3TH^/BIS 6IHE#'P> GGA2Q$*%3#8KZ#L88NME@+AQS]R=H;G$\&&F=RT=2 M6 O< K@8>/^XAN&04;[ B!SSXXORT:@&S MQ%VALLK)-&!A;)LX&P!T^KDR.)V'7J,[/4/S@-W"(W@6>*?=@"SV7&NRJNQ<=XAGGFE':,;U-8B8POCQ/&<3*V2ET@(@!)+!3$)R[^OL$PH> M('SNA,"@YR*"B5/3[PZ0Q&[/M2:KRLYUA]AB/QRYCG2#"110!3L2Q=A&'#7_ MAX0[\R"3"2I9N1; #W7ZM%761XG._O=-8K/N1#'2/55]O;JJ;_M5?;VZJJ_2 M%^G%I%Y>L"6. 9DSZ197)U]6?TD7* V#P%T#%L&U^Z;--05:J_5TRMK.>_OWSQN*2?=$TV%5J$1:-XGE!O6'[0.\[16*Q5T MKMFBFX=07[5;)V:_,>W* +6:%7-_(+L##Z=SO>JTNC: 0VD#]U:SL61G*:-& MVKMC"<"8.Y!P,9Z=QXI$)(@0W/%=JOCR9O#8 MXMF:?I-P0V::2;N)#3#EZ3 MVE7P3BY\8T7&D*Q\O(XRPY(<'&3[D]$QC;@"GCC2;H#TRE.TF)+C!';\=6/890Q7(NJ &5\/UY(8;5HE43VZO#G(R1 MP')&MTJXV.V.B'Q11/ "Z5KW3VPV@"UYL0;/U\=_ M/REW+9WV"4J+0,NTHVITEO4=0CGM,$@/,HPUU+M!7W+J,\$2,)".[?84# M!X4@@V?.PVOJ#D4H]G!XX \C#<>E[9,Y7>Z4D(HDB/,9\4R^>#,2P1@%6N U MO8++JF#U8$;\=T92*KSAO8?IE:@'?O2]@4]@2[I]VGF(>$;8'.<45NZG^# _ M,6_*-QOVVVL65C46ACBAS<:U]Z/F6;NPI'5X%L&68.="@F:CG+]$*_9C-2*3 ME]# "#N%H6*=%"F@Q!%G0^@6U!1&);!5 M.DRJKS]&2?+&X3"=0V1;\Y1J\13JTLBG57.4JB^IK/? '??.P!IFOKFKC1Q2 M>SS'M%A=Y"'[K<)TE[[Q4#;6<)2B:N59?*#D+;U>[LJZ/_8'#*@"QY@G">PZ M(6D("*H;7UD;GD?:=--=KI GR%PG,K"810 [2NR4?KXEP;H:;=S.2]JO\Y*V MGY>T7^,I;##9:,G4-S'X9A2QO_F_O?>3(6+F4M]-"L*?6GYW_M;1 M7W;^]A?_MTWOXX[ *6WC?"Y9_!%0W(6!*JX/H K*S!\< (Y] M !#20/7PDV M%$/<8"#63S7FU:+227AE(E6O[**RXV^5#(7^X7\Y?S3*2-D_DA-IW?K\S%ZQP".<'A]1:X^2Y< M/(EOO0XHT$U&GNTC_N?W";I_.8V53CFCW/Z;T^[!RX)^OH*)N?"JB,/5 9UQ&Z MV[Q8ZW!%2?\IIC;9B4R/W+P%M;N,11ZZ![V>N]]>@R']U"5<9S*OC]SC3M?M MGNQOYQ ?W+4Q_3^N+,[1[#?3NLC%ZY5T%ULOS"6:DVG'.WR2L%Y[1_ M!.SH@0I;Y:Z4@<7958=XQ2>-V851N/>AW__2;+PWL9%/RL-6K-L*GJ!3PLK\S#PBK$!&PV3.B3I#C5LB2KTPQ6B':HKA-NQEDH64BC:-81A_B@EKNL,C$FK>X;'0XL0. MZ%&E(D(C) 3-D&>W350:^\-$.A@PX5O;-1&ZQ^PYK%524[;TTVI/D[3SCVW11EF:3-"QUKS7(#CSXJJE2DKB?.'UN MIGG)72WA<-[#;@"Q[/T#>\1P[27WR(4)XJ[0;\OI M#S%9'WX7S"AYOW!2S899N*#WRG$5(\)8*?1=(:!ZDI,O[3:1+E8JC32L@FS; M8C*EIG8#<0!W8H*=@K&%:**3![P;94"(&5P$EC3R8T9C?^)$@G6856\'$@XV M+QK]W_HC'!=S3LY^/[]^U^=TKIU:Q8L(TZ\;.5T_1/JPD/K#7KP#,WQ,$/;9 MEK@\GZ%"Y_#H26[R*"J:25"G4&P_A>*AB0YKNZBW,_"F?6SWG"8[)R[5, JQ M*MOHG:236_8.:(U:9W"TRE"]>$&U9K,1E]S]N3*EKKCGS#A9[K/;D929Y7Z^ ME:^IO>C/?V^KZ$4OP@8MX*YN>DLZ1VZO=^*V3WI5.:1]]_CHT#TZJ'@2QB\& MQD=[;<@EN.G=.>P=N44A4_-T?;EYQ +JITO4Y:A^Y!P^=T/:OSQ]>3%>'(,"Q!FR+ M)W;4.7;;^YO.;-EQ1>^4@"UNN']CF&!#15;ZQIX?.QA<49O>F->]8Y1/:]#R MYO/(.IT3]ZBW1J+TLYE.=J[?QK>CVW&/]RMQ, >H?U%SC2+ MA[=>LA C>(B+=&VWZ+K;^["1EG&O)?[3=2>Q>SO00?VY3(=^U$X\7^*PGF:7 M=WR)TW39XKJ//"?ZG3.*LD&@UO)X/7 4;8JVW>/>H;O?6]"B2Q?R>'JM^#[T MW.-.#XR)!1OX4=M0YP16(N]L/B<"L_ZFQ3 MG0ELI;J^5#FTV[=O05_Q5NLKW*102"^1K'6B.].Y0.Z7U2#*=1A^#,',6$N) MD6"YE4$4&O HZ9:E;*I9S/GV0M&+&'5*)U6O==]K(JPB$1H1,(E&P(84]WR8 MLWJ!RH)A%C"/E(QQ:K<$?$W8%K"F6$VB[\+S#)$0&9S]&/J)0+@+ G">^.XG MI*AC*0"U.(^5H*,5C8CT#@66T#4N]9J# WOVQS M:]X<>_!:"];84JMM(7U__1>46'%+'3R M5N;[-"O8\)3S!HPX0SM-13JMY!D1II,40K8.E))>U7=^$!0@\P,@C M3=KF.DBAY2K/[B@B:1^K<8"^6K22>"9#;^JGNG']R"?](%:$PIS;-&2HR^L% M7S>F+T)8>LD(]+VVQ_A;ZBS-9M);G'%]N7: 7G?JN=N['=1_ VOIZ;@4*E13;LU[6YBLL0KA2&3PN*K0L&]^5 C\(,5 [.( M9RX)">V.4/?+ 7\\5NBG"&9(_G@SO!1+]%W&U>=>0]A &N<"H_FQN'G)A0IJ MFS2\)IQ%/6RK_$:8\.^+,>=VVJGP.SOAJ>=&.F^7N\XLRK0C07L1[B4G+XC" M&WQ4I'W^B.V(UX_;%$T.5M,W3?=6G1]%HS*(!VR%IV''BOVWUKMG@WT.!M7@T\=-^22EMMP!6_RW,[N,G<8(8ABVGLJ]2+P5:>3+*088- 04FR MQ"$,%80[L;[2%KINX%S6:) N=K'51J?E"$+0%^N5?3.N8 99?L*(.%6HN+UB M/H%",Q=8 JYIS+V8?9W,@F[.) *6QBA&9( -8L(4\B88FKVZOCSK_\/YY_G5 MU_Y'I__IT]?/Y]?G%Y]A&OO'75+WG*M4!>DMA7]&"IB3TBNXTMNR.'V0E,@X MEVPKSJT0T9Q,58KX/LC/F GR+*TUQDG+N8 EWO]N/RGN#8XJ>H.U/SS\C*)H M!H6)IA(H@GMA:!I@@3B'!X6DX?PW0F'*%!D!#, MZ@:[:,._@4#AQ=A-'C;J!H:9^DD:,4(6D':@K,FX'# ) OSO( N^.5-O^,V[ M*ED7&^'J]T<\]G1^%/ MG]#UO;3'Q;I#5M8"6Y)4O9W9WM]?9U .Y?%P@VTCK1>I&[D8285&/I8^M'/' M\[3>C/KF;/;F+ 7!J?;-$7T0EY/##.WRK=G5V;X\0NKL-B%M@OV6%03]?Z>G M9V?OWS]%1/]@_]WDNO.H35)/]'03 M[K3=]E''/43HA^IN:_4/OOHSW#G2/'![^VWWN-NK\JX^GY"Y6U(5_1S*/X@5 M[2_;F$RIZ&VMZ+0V+38.L(O=D=O#MI8O=Q?K:56(YO;WW>[1"4+M[, F[HZI M\<1RP/;RXXQ.V?U?BX&7>"4[",,%UD/WX"5O8CVM*I%=IS$^ MJD$VNS7;FL@W3>1[NTLMNV/\+,5A>U+!=\V= 7&.BTF=3WNZ3S[]QUZI+K6N M-*!HS\$-5GN\GW+6&V8%W?VVVST\<3M/Y&VK!MGLUFQK(M^T4H=HZUVWUWL: MP^Y9J&9+M3EU7O[*)9&,Y9:SF#PXP^3!TNQY/QS&RL-4Y>[QP:]8L/6J%//3 MLVD@B>36HR,UH1[&L6"@#6'[H@GV7M6U9/@.*=J9PL __(F7JF &RV@?M;KY M,L:4@"[#F@H?YRK XH/B2_=:1]0J&T417\9F>RIXY@FTB$7UPSZ[AW01$R=B)=M)Q8#W,!64M%A ME@)1*6L(P6 HJ6=XA@SZ[E'K:!N%1?<@AA[6B*';1PP]K!%#%R]-U47Y-JH= M3ZDT"?B4^(.?J>AQ2]4].ZU:F:,2H998ZLI@MJB%M%O[1B23_'YUT&EUS$<@ MN%YUX),#_8EK26T8894*UVR0#L?U\EIY6D=76U#1Y@"/C%Z"B&ZFAE-7Q>EO M"=Q5([$V&S:VK(9UHR(]*@2]L]6+!?7%%60E^G1L[6C@#0@M SCXK?)&K$'$ MWIV#&QS[7D 8L?0>5BL5( -\""X*[A1 MA6<*Q+,T]$3X3R#.<$'HZ\)R0\>F$Z.]L;[%VY'X-N;B!-AL2S5I(Z4;&2S ;39[;:.?X7IJE#63#6[*^T#V9+E!+5C MO'97!<0'K/ML-C[16W>PHO\%"H(+Q)>PZW'M6YES,+A!OZO MFB&MOGHEG"D!A5+#O\+[;-P1P&;.T/%QLM$2B[W,L>'EW(:-/!<%6LB( MGEB;;8D(&.86-% 5ZUIDK. .V9R(SO&DVS@3B MO%8;*\LM0(/Q@L!=PRGGVO#+.>CD:D6SM_\@IQW,8Y"EN7[ ^+PE:@6SK>XA M:@[WS;R#? I8TL']CW8)N->LB/G7-(;EQ+"]MOHXM\YNVW)QH>)J-*ZR' M$&@R$FA)=MXF268W1SB%]\#CW!\5A%;@JXS>CSM2&!$7I@3J-6%-?Q"AOVZB M)@,5\T?-QC,\RB]Q:H-#?QR#7;RYW110N/0%_8[8G[GRC$2YOXEO2/2;S;6D#$)F/-X(1BH!Y7!M>7-0>[6*+)RI\#)FPV+M^0LQXE" MK:&**T&HE)!]A'-HU5&T6O$-S,N]HCBP/1<6AY->-QA6Z5@!$GG6&Y&#.%G* M&Y;%SK09G; CAQO=$'@A.KBY8P+^OKXI%;PI*[*(+Z0W"S [##MQS"QP_J\W MF;XMY<[%VS)'HB>69J;W[\F.Q0_YIL\U!R&MC:2?(<(UW5@3SP]AUB.6+_FB M]";DVV)6;GHXR!W0.AE>2-:S2B[N@17@Q,M98 5@4&8Q:1&VD'VUWVH;IF,H ML;Y95;M9-F(_,'0OUF!P6A;.+;9^/R>>]Y/83)CN RAKH4##S;G!;9^) ME:+@S6(P'="A M]MUOQT]W+KWBF XN"'NS=MA5_083^MX]-I3I JB=(;D_;=%BZEJ!X(>$;)L- M-*^XJ\"\7J>1<5&2%14W#N_J7"Q@"&&4BA0>1B&"[@JCX+]2GRV6""TFQ$SE MQ]'$8<62B;?P5FP+-[?^^SV$>=.XE?ENQF4@_1 M?.3=EFX]3:MB_YMGWF73:1\KG] MP3U?L[U M49USO7OI,T^LA'WT0>Z._'0FNK+T6[M4"3"CX=:L\*KO^C.+(%2V0),HJ 8] MZC1^ZV$$_<3M]/;==O?(I ^0:,%_8'N][R!MP/!;*-EZU3EPCP^Z[L%!ES6U MN6R)%[6'+Y L_N NB6!RR[7UL>WX!./+_Z'F\Z-<,?5TRD_RQ/V^[]F#S1_A M@^3W0Y=8Z(ARO_"G9BEK=$2YMUN#62L*XF*!\]Z=XI$'43!:"N%A_?XAH/,E MBE7).\O0Y8O,:7[BI;,L&?N7'5]X]VD67H*1LC[R27PS>-UM[[O=WK';/3AX M4P*!(N1Z.(_3S)KGJ43,.5(ROR*-\?SKDKTN/M8I?<.K)8-V#LN!HSO=8W?_ MH.,>GRQ0ULKWE!/3\ZS@Q#T\Z;B'O<-'K^"GJ.*/)3!P\Z]<>K$T500^V!/< MQVPM8E^]R?=?PW5/]6$CR;%T#]S]PY[;.SE9\^*N.YO=VXK> >*IN[U.YTFV M8M,L; F"QWJGL?CP>J=!OS/@*&MPA0>.HIE%N^N>' /+.]E?:R6/)\N*;\1) MSST^/'9[B"'[!/NPB,#RA.KOCALK3^Q8^)N?^Q;^]A?_MZ=W)#R[X;'3MN/9 M#S_A"JD[MB(1<0:-2)?]!F/L"\IUN58M\L +OZ$9%%/IB)0B&"@1]#6DLSR4 MFZAA%DO#TUBG\G,0=X Y.? \]4V/FHUQIKM0Y\ MIE8GA)W@;&'G ^=:!C/Q M?GQ7TK$:8][Y3S'_GUNR@UBYN96\@&BHU(AFREEE4AV,BZ+::&Q\;58E$>>] M*0:6.>A/Z=P)-K4EWQB_GMNRYFMQS%)B7'[,6XN>&+M8(4^,PV(C&+W9H(;@ M>:G)W+' :%2;.&%/COYTO@+"JDNPSXV.PR0]R JMF%N"M1:( Y3":/-!CBQA MR!@//;KX>_@!0@7)+L!VXI)QKAC.*IM9R0226R0)^$0R$3@:XH6S9F,*>PTO M@3$*,ZRY1W6X!W)WBO8R:Z\/IBH'@['EDGGG#'3QZ&U';9@)66.%][A3K3,;^#T2GX-(KDV4U@%V0F5"(_)5= MK#CE?!W'-'X6EM_I.A-8X"UPIR^\J%B-429($M )]>/N=-XZ3(RT+*OLT0_A M@XFW@8S.FDA_DGM5] M(3NO<,HEF3%MNW( $Q8)3@^Y@8R*"HKCIUB/FH(J!".:[,2$LCN7,Y":H*I# M4'#]3T$0I#$+G&:COOW5/:P_E#:-,(CH8)%S$3;%3NH;>T/T#,]8QG.->W[0 MA?L_5]P]\;XIY #'=L*Q*>;@Y 23,ZRMB%4* V:&IPBMGH^2,R<&@5F<&["1 M.2/U5:>3)T$W&]E4DOT"I;=!3,M_X4)(E;DF(8^MK![" JF,),B% Q5>N$QD?\"7F4=T1VH!0[Z:7VJ^\SG1K:# M"M783^W2*0N@!CT&J\&'2@#(CVQ,TGLJE5\=V&NRG25D58W0H1'3BJC.(/5^ M&%@AYT;7:P$%4@UUP4*R_Z)9HG@@_886%66#=)P%YDCX:.=_I(O"0/PD22:> MH43%W]$M5"< 5GQ)ZU1B/I*_6>7Z][,W? EU$;B_5,8M@N3.<;@%WM7+46G< MI?ROV[98'-L*!19V;)D5/\7"G'D.=F*!&@@'ZUDSL5F89JWZ5?#S,F8,'**P M\3_-]4#TZ(K1G^5ZO4=R/0%)*V%GUHBP=4>W[L?,?*%2D81JT0OR= N9&<%>V(54Q;>Z.>57T_ M!R:3U.I[]<7;.GAM[(G.RG%"#FQODA&$R!A\30/ 4#0)M&!J:9'=ECV&^%<6 M6N2JMUKL(X]S$^,W+C.,ZD^1I;B"SV/YI"PG6XX<3'%V\;.1T^"3%_II=!<- M7>>/H/[(9BT<\!0\]?MQ+)GRJX;R?JR^T:C/?S*.?,WKKXD M%1*"+.#?ZU2N6L!7F]K6%/#A/-Q:Z&-MH M8B>PI3/RT8@.1V@?^B,R6SKV\SD^(_QRXF<32AUT\L2W5^TBUS7!+&$]!C(R M3SS4IJAPP$)#OZ(9!/,41N9S /Y<#.J9Z=P4RQP%R,HC)#>WU =@'\,\8D=W$_""#T4J*"\^>U[8AN,: MMF'[L W'-6S#\HM4MN7KK:*6TS]M9SQ:3G>/:-7MPH.M(\TS/V4 M:W.P@G2W/--XY&-WF90KKKR0HEU[.ITOHYDTBSPCK/QQ)'W33!M0U 3;70,"A M2+'JL )=$KFD3,JJGXHU!%,=+7I6/G**%8Q#S$'ML_Q =>8+&"_#VJE422Y" M>(V((IQQ0QW60+Q@EOC&R5)RD:7H<_':$O\8>*@%4?IO\?=)"JQ"E"[6($Q5 M:+-! 7Z.,9/V$8^(89&+^VOKJN5\Z/>_<)2?'_6LK.)$E;Y&%X)B>U^3.8T^ M>.19',#^5S:ZH6=18\>R+V9B GP=Q:@1>1/6A0P@OFLG-[@&PM75[:ZDH]L? M4G6+VBJ[;,$MD/*!Q#4$M2T@A\N-A-D$.@=7F@O;/3"7*@A&/HY4Z:K6+FB+9 ME:HD22?G@L@WL&$?P1 MDJJI_4OT&J7#8*&^=@'F3'7JWT01=_RW4&U7%J]+"1K MD9FQ2 BT/7/[C)6%"HR!B1^:HJ!\D^=?6]Q9=BXD9EMY5_.#QHSHDI/.MSV1 MI2OT""&<1H1P&[0EB=YMTT!PFJ6"TT!G37XBZ^:Q.PV%H8K)83Q0Z1UB5\#' M<'-%@1C-T9B9BXF6ZQM"CW 5E_QVK#PI**)/\S52U!?WN7]1T9J& !!F>:.9L.H M]R2YX?!MBI-9Y7TFJ\=CP_-.WUU81AG941-4(5W''S^"P^ GG_+TH&9#+WDI MIS&,\UJ05PC<7VO?:,GGEVENK<[2I>KMXA4P?Y<[A>LE5FA2-F5'BPO!5UD+ M,4?'Z9[6LV#H@:K(;V5"Y5M30JSL8Z3M)-<@+ ))T.HR8TP(K$+DVVK7'^87 M0Z;3(K,8U@XN@--M<@Y^G)*O(9D@*B?F PH=G M>Y"3DC8'4360; .9NK3I,7G6CO8VN;J#\MRQ%T2E?<9X-(7CW-],\\>M6P!: M<=YQ_9\7\S5A0CW31OK.K^O%V36__':-6M"<$Z;4_<+9BLC+3:&[<>6LX9NA M .74QN3)G3/BDR%B$=45?V(7G5 -"4BC($JHP+Q0=+#L-SSZ2!0D"U!#N\[) M\[7@&,+Z%7("%5Q =@/Y7(+I5O+]89JQ\YK\:,P@6>G4P=8HL?:DY5S!*?MC MD.5A:FW5Q!LIA@!0K.%++]\(SQ\5'LQ P@P2UEG+#XKZJ1EI88[55)8DRTI+ M"H^;0I'4^X'-Y-E99E4JN1COQ@$"T$8*'C7-N*D?'MBM)&3TER2<]E@++=3/ M"/X2"O:2K^MPP+,R&+]0KW2.TU4^OF:YU>/YU.DH"PK(,;: MN(2XB&:'J(9RK@3,+9JHF)F'9)8GF,XVTMVZB>U@TD.!)+(0D\[0_TPDHU]+ M6B*6WSJY#6XL7)(*-^(8IS]*9DL8G&"X(AX?N@<''<[S[+GM@P.W>] M5FN[:]3OU6[W"MWMO"Z.,F]J M7E4]"D/W.BDWA1II4>W@IG&E#.:>H1<2O5^Q(D,7+WWNJ\L=0O3H8&9Y.;@= MA1KM>1C/NY%'8-38NS,V*@B^B0(E;J3M6RLMBEV,Y)J%C7#E7U&6.OP3FS\F MQ" T.B6\I%AN$W@#S-Q UQU,YE9Y(YH^*=14R(XN.73!8- @!%Z8)%Z,/I-( M>_[1*D]@0W,TV9$W@56-<'^B ?!K5=Q,'5_,A[_'VVCQT&8C]Z?@I$N8**JN M&2%+>0XPPJ 0D_9-TAN\Z)8CUD;E'I&C)7\$'3^2LQ)0/1*HGY0Z,D8X (.: M!W-G-Y%VB8X4[/%H0QGL54V\O2>#_:3.8-]^!OM)G<%>Z8OT GUPE\#9F5$C M8WV7UT3O_/I>H*YS'34;Z-C),?X+DI"KV+TDB1"^1#==ECIWW4=7##-C&.D, MS**:084 (\Z]1,(PYIPT#F@VN-J-]:""L>=R2!6C6E'\C43M* *]2@!8$F!Z M!B4%K;Q(?BZMI\=^Z">W>4]L4F\\4%00JM(*%6/X8* 0H00QQ$3/835G&&# M94SA!2)N09B9K_?W0ZGTGXN"ZK8!:)]9GKPLGD:$QY]PUM8-ABTB/2[.X@[. M?W@;1D%THWV2')M!LV\RR3BV43NJGIGCD>^6_%0ZW/0LS.X%VM[;,/9T\8K. MQ,QKE2PT ]U^I7CS7.O?&+#.FYI86!_.6)FQM2V7VV8:FMD\H&M\B&,F";.:?1*'=>";H_DK"U M!:>P6S%P<&;[I\8=]QH?[[;?]J].G?L&9G++62[&=0?F7^KY8:*; MK^>=9F!U$ZIW0L\]99\9!"FPK'A%\<@L1P*Z><)-$?9)9[X.O="".F;/'?T8 M;%1.9^/ +D9&^,6THQJ%CR3#=,J@:QCH1\\:9:3!,)PA-8E&*B@F?.@Y6M'F M[79^?9Y[GQM5MA$U;V0]>-D%&VNI+;;0YW7]%Y389B5-[QX\8=KU;0O,LBYR MCYAY=SM3/SD\.GFJN6]XLN<+SGV/>1BP0YXU\43/<#I[664=&9^//G>)(FL2 M7$6")#?S[#:>NMWP1Z0D$BK0:4V2.W#*.T62[T3G*5 D\,0P\42+Q9E3CFE- M?#MPGCM%?'T3Q5I->3HG..$,LP++M$)A-8'NP)GO%(%>%K.-8^T6(FT1+>-" M9KHEMJD#"?P[P2+/&4=[P M-G\?^]:U=X6=-::IYI([Y.J47WRI%/HU&S1NP=-D38/61:V9AVF=(U7Q)5'_ MA7[N:[TR!6>GY'7E#UP-F4B$Q%Y'#Q$!''PF6$8]IN2.NQW:>H6H%+Y)HK%J M;E:..>>6]1)3YS_GR)Q39+0.0T$IZZWZ"N?9?\W&DM7<:2_LDN]A6"-M"+4E M$>9D/ITKC[HK<3 GSNM0I6_H99(QOM3G.[;CA-H#GLZFJ#1A.2 7(!/D SJW M=3&.Y8%WA,^5U';);<8"XM6P:1U7HFP>040@R\.FWYKK%!I.Q'DNNJR7SE.\ M]AC6EF\O<_\TKK&O&_!\S$>C7Q*;7_32KW%4$U5SIZHOB;B37;9F C9K7D-7 M*D.$F)*<5.8:TKV@37N!=-"?"^8Y L\N,#=2H!KX G- Z0KH1O[NQ3YIA5+X M3&4H44AI\28K,N>O4M24$ Z"QMQ#2C,]!8#3#1(_E:IF+-H)I+*47FK&]) X M,?<)LZN$H?+3,'@@^#(YKPT8:AZ1C 5+9REIIY$.8'(LS1)QE/#@HR#G%/S9 MG&YZ67X-4FJ*ZH=^$1 &$XLF(K;.GYK/PN\>1I_V" F6GJVB3P:1$K70Z@25W[X,E!+'NXF5 MTI"IG/5-=S*_?83%!#N.R4R%^Y:82T#E*O4M>-FWX$HR.DQCM_5(G]INZ600 M>)(*HQAE7ABU$-Z"6+CG(COH-AXD^P8)&+5G+4 M8TEB957GH=<-)V!RT B).YL,N,K(?IODURY>/;QB ]J!XLS1(;B$ 5BU2/GR MS"U\:HG7;!1%7IG$H[(:&-:SCM /$_PWWFQ, \*;'ZJ;*&= $S7R/6? ;;0T MI%3Y[FDO( E4K.LQA^<6-U.2QA("_1IG4B#$KA?ZTR=0]<#/?3(+[IN6\WOQ M/$BG%X+4=!-@@XTX"XGD<$,F0-:W*RW!1>8E96G8T=/X0^04:;B:=55\25_8 MP=5LL$=S*9/2GG[&-3;RCFOOK)(U*I4&*8O4A][MV!]DB%&U!@_""\D&8R[[ MS;BD!:RK (S4E!#VV1E)H'MSH^'U&OL_&!9L*$H&U2'F&;%L9K['3Q>>+8(I MR;*2/#^_D*#)TV3H:8$G(EY+"E1&V?PRJ+[J-!U?ZU&P*0+<);?[?6&FUH3F MF>2=@3G*9H@\F) C4+)RIYYTV];+()\UX4()JJL72$I/,F^A6-A70)[*Y,22 MPQ4^G0DFMY5N2WY4&!@)21S80'(%L+3\M2,[T\-U;F)LJ%[*E6ASENI4M)&( M=84PO:QAU?I4Y9?$J6?8]?*?^(1.05M?@_)E ,R-R'_O:T&."H_'2,UD@$=K MFBF@T*PRXLO?^N3&/-LE"]:\M]R>?XPULF0+"7%MBA75]36J7BG0V0]LXM)L M7'L_Z@J@W5@2ML+PK"Z%L;H16$K"A(V2G&N\5R/"'/V 8C4D;D J!&ENA;H@ MY$S8#/XF?Y*@R^A*$Y 5%JL0]V0L&)T! HOJ='Y%MLGR6NO05^DD=>)=!* M*,S,M[5F7-@@$WZ/1UPZJBWT(EJM5+NRW<[-B"@T@V\UWT6F+)4S66C\G654 M+X+/OO?\&)03C97ZWJ#2G5.WS+KO4$69+9\;1R)S"$)I(0*W&[%4_(4^($,5 M4QJ/V&XVL".5DJ.+)614==(46>W[[OD!I]I%"!+I%2%YFPU&ZKTNY-24X/#J MEP,W%RS'/<9RS*$0_9SH;.Y)IJ0?6TBU&OC&_!0]_OEO-: 9 M.Z90!DUH=Y MVS<+-HUJ'KDS-_H 2-"8OFLFPV66V[EV=]F\LQT.#,S:3%NZUNJ.?_ 6N\E< M<VWD8QXLG'$^I][A%$CLS C^(-I.!?K%K@$2LAI[9[]=8^]L'7MGOUUC[]38.]O&%63XDFM4MW=^32]0 M_\%B@;&/W5#%E"1ONX -4N@?+8]8@8CDE*F^[_ M_DM&_M#D'XNVP"XY,S[\@EJ_L!^+0)(+2-8S#2)8\OX2)(FD""5QM-]V]ARF M1(<(L8 7 5_G>!'L?!,00&ZL4)BF0"&,U!$#LA6-N8@N^'CZ+J)#P=T2$YT*+US;SY2V)W?RF#SU[0?SBL MPSF"&@6[%)V<5I2?(3(CB"IB-"=G*WGQR#W#-(N@4_ M+36GFKL)S890\UQZ/$5D3!=MZU)/H\07"$ZL%O+'LDGYY[@QI3UC8*"!HNXE MP*4\K,*Q#[C@O"E]H<8N17=3DNK: UUB< -[D5*8"%YWT/Y5O]Z\5>^57)PQ M.:JX (F.W,(]H1(DF9?TN=(IT#XS% .:J?N+P6>ZBZ)4 M1^[0H)858LK@A! M_W>/$BA.+8S\6LFH'L41IA7V-'"6-CX MHN-07/4/.YV 3>9^EE1#!JN,>,% MHW##P#.**,I-01Z$?]V"0@^,@CIB46(27/,D0F^CV(-A.5L[SI)SOTN^4 MM2/>7#B1L1*X4%0("[J=I4LE[ HEC:D%%_09FI'5G.CAB36@(:,75 MA0KK' M@"C:?/J2<;])$)Z.N-%S 809[M(#W!2N&J'+Y?N4;0>RA^L=%="'N#R9585Q KCBK?1L&(2IELNY\X M>;T/[_##S[JO]^=7YU^O+CZ>GEVY?1_O_AZ[7SJ7_[C[-JY/+_Z1VU; MK0H@%*CR$;$ZLV94!"EA%MTM%(Y0DF.#'$$S(#_Y!NPW1+<*H MR(;U9AN(G5V4141M"LU(!JV/K&.T(&K:RJ8#R$JKC0_+("3:#WW:]-_/FC\2_3XR/UH[@ITN@E2&\I4P=;&/LC M.A$Z&L_T4@0A0*F6M"_YQ6V3F^GDC6F0.DZDWE&':;AM^JI4 \F#+ MQME*^2H@"\E:F", [IN#WID\I.]\QHC^%PF5(RU*0^?2K?_3,YCG%QZ].>%Q MW'+>GW_N?SX][W]TKD!@G'TZ^WQ]13+DZNN7+Q_I[_[E_SCO^M?]6EA42[>Y MQJS"\O:I OJ6#29^FC+(AYKVDUA%XT]]'\01>LOA__0^79W*S M_SB__KO3/SV]^ KW&C^X^*S_//_\@7Z0C5?HB@>C0:]]A+6Y1 ![,"\ ^2,"+S]>7%Q]9C_UR>7%Z M]@[='SN]\A>HOV)IE)TS+P8T.21O?35VSGZH84;.D(OQV!\J[B/+W^4U&?*= M:S=F#1V5I]V(]7R M9G.)#I-1'=>9CM_VP2"_S$ 6='K>7N>@]7N.5N.EUNRL]38;#UHPSDFJEFC, M]6;,S@GR0^G]D-H% 7J@,[&2:G3J%!6I40@*K826\^[^5WGSWYGH@7["X.[R M.;#70(4<-A-LDX[J$=A%GH&T!9 M8 (@2]&%Z>:NQGOO=_Y]R1U'EREFT='F8[[>"+:=(5AB=>-Q2S*SP/PZU";K MLR9X>6^ N14XLG4#3FU:_F)HN<[]>BJ1C7[R_"YJX4-IMV5R<4U!@GU2U9A MVX%QH*SC!;/ >SU\0S_H'(SP+_5F"0M&"5JB!K!S?YU9S D/2>/"K-(D"MDQ MG< (7C@L886"?Z\9!N4A:WZH&;EFAW>*.&(N5U8(E?LX8U0XD07N>';!8N?T M_05I&%2Q-HU]0O J<5R"W^YYK M!I8""(=@*8!FFYH-7=MHXD5@*:+XNP,C&&\G"_AA[ ]0(5- !:XF&$?HA8-9 M/Z<:-AN6;IC*)2BY3@%V$IZO?.7K^]QEDH:=/]7!/]%T0!Q^,O?>7)<%!_PY M^@A"+. 5X>A<8%97KA!=ZC;/+"&?F*RK<%_FA!8QKF2*$$%(A)0>FZ [R4]N M=8!YXOFA3A[V1L #/00']&4OBTUB\U*9O&/VHD1+Q'Q[/2Y(L_$R:=8R)[?D M;5A-H5_G,Q07 PRM+<.$-\0JKZ="O*2RY>2H?=.88S^B?%G3,85"G&6 :%\T M_<4^XFY98BK!CGSH][]4B+O?XQ[NUN[A[;N'N[5[>#WWL*'S*@1:GG]]+\+1 MF4OS>T60*4F= J<9ZE+,>8_9Z\X;@B5!X!!)4"?9IT(M(EC)Y\==KJ+3L@1] M)O#+@- ^LIAQF$A+]_P8_JE+\(HM%2@Q/]%%?U2W0[6>;YW7W3=K6%W%T719 M(=HAA=Q=$G\(#9DNE5F.);*6220#@2NM>)3)%A;0/,2AQ(Y.;&?1#*E.9YI: MR$TC*U&>:Q4GH%9(@>62XNDLO8UBR?^E$DT8T%)C"@4.;^G/U[TWU*!@^0;F MAIW(5)'%NIIT+K!%N13YG8)S+*M?;<&S][I%;? M,!CZ>_UTL_&ZV^[TWJ"C$)3I),NA]#"A'1W_Q NOT&K@S,T+.SM?K_$:+MWH MSIOQKZBL 1&VEYCKM'M%0[W96-M2MUA!B8V^_K[>>=?I!$Y+#[EQIJ MXD79-9N[LT5G+@A3@90P-6"<%O@O$O#2\H^RQ87OBV,(YP4TCK7^,&LQI6VJ MS^OS2:GA;&-&V4\U*/5((:JM+@X$<[4@*8V"$Q4B@OAF0H?V([SN-0%OJ5:5 MD..6,#))D[=SSF<"($P.X *M:K(JTP\,,ERLM+/14!+Y/=1W/\H2ZER@ D4L MV+XV^/XM*QG;/?ZGC[Q]D@/%KKGF1-E9MN"&Q.K>D<^\!&OU*H0Q_'+NX"^_ M]4NN&3L#T?L(/#$L@X!X*2CWS4?,\8OWED!L$4I$W3EPRTJZ$!_;/K^!G(\TWE4MQ#E76Z M11$JF36EEP*(9(*'M*#0A/KS[(0J5@S2!(__#4E<8Y? M?L-5C1X^5ND.RCHT>5'0XND'[SYYF,@V-N;U8$&@[:04EW%8F!8%;8":9PY%+PT;=>N!<(I3.?I):SO%< M%[7JP0MB;YR%[,:F9*7<]1 9W94291XR$0T3HM4!T[/*;E:6=[?*:]-MUZGQ M6FI]U$.,I"0-U/_/WKLWIZTL_<+_IRK?08_WSE/).;*C"]=DK51AC!,2VSB MA5!VQ22GUR3 M.11"=R @(%5J-&L*LT,<,JWP7D,/<%+TQS ?L.N[\P%YUU0]OD$"F8;V9&/= M R;OK:^Y'BTC_!9GVF;!\3!8\_1YAHD?C=6V)O[0-',TM7[JP-UI&+P%1XFL MH)>T(:U[-\E)C*BM)#V2W)0$)A)VLE=?:J]KD_!+QC:9"$DFN#%;P&Q!ZC;9 M,[0%?IP;- <^]"7 ZK*]%WLA2NF/28GP 8\:@K13@2/P!"NRGZFK7(P7>3A<+UJ/&Q:/! MN-Y/,& 02[I_TLM/8-,(N)TRY'0D!#7S]O0A]WJ$3)(QI 20621FD5@B.8,& M*GB5U$'=OF'JYMW8JS[>+(4@4K"[UNWWZ(3N9G70'N\8;P.XM;>WT7-%#"[&GSO7YZS>%9RJULR MN[JU^ZM;,KNZE>+=MX>JPOD+S"]?- .E@W68"J* Y[19]6 BXY?"[O@[Y% W MK/A(L:";A5>\/=OWFE05^=>O_-;@?NZ>]_PG/SD)=I,TWLR#V;(F5CV7P%P/ M-Z6%)A?^YB3-3R$S_]A]*PB,&'R;N3. MAJ%* =!";\&>3V@AARA^U52[@@>F\[2LI!QAQ\>7B%G M+[FM3U60VAVTB">T.L^#^3/TTA99M%J#E)_2TR[27@M*%VB]AH&\[TU:N/0M M:"(/"0,2<@2G?GAM\=%@B+F'I4A3!70F92"1,*EV]^=RS-1D0-TJ'5_I%@&Z MKYWPU0?&@:,VVF_&Y=ZD#1AFM :#%6>N8OAEC&[FXPZZUIC6V.LAD^R]/CI8 M89=E]TO>&-]^;4"G?'=:+#V:T!7#"%K*8*D]WA@DH>3>_4VL-C ZLUDM(*L% MW%<*IXGH#-HUN,RC$)\*U M4NK9R*1G,37$NKL5(=QP M1895I3NBT\8(UVBMO<>X=<5#??)45=\\310.+$A"!9O0$87!88^YV2'W--BI MMS]6)S/!P[)71!21\D_/*O_]#*WEY88; ' ]!J VN0OE7\L,"0'()_UZ WJ) M@5Q!B:?Z5 VF5LF[Z.-)APV21G#?.@]Y%<#9DPIRFBJOGZZJQ:@[];>0KZDS/&>^Z>V".=%C%C&;#IPC7M@>*E-W'0=SP5[BEN M#PJ:B9PVR=- >STRHIW+AY[ +SU47S.8V_($?E'U_MIU D'.VW1^M'=!VYL@ MX-51K3H4?Q;[G25VZA-@M&:P3ATCO1)ICRRR[VB;9,N2.VPF<;GE7D#5C9([LER\"&VE1/F_I M<1M=O_M$SU6MK=44/F=)%#X:1 M01/G]#+,-6POK"%?D(7!U;EIV7"'&'^YC1X53/7U2?6$)P.K\?JAORHB$<<= M6$F85C&DK8L"43-DRLD$#%(Q3;J@D-PXQ1>:5P ![84T8_>GE#/B/(Y=GCN9 MVK?7Y55I^S=HT\_-]OUTC>'"J0>'QH[4# R*U2#!9;L',H#:#5Z6-4,*M4"O MP0"09F+(&D M1F!*P]S O:DA1+TW;]SNJEUR'(^1ITH+/D@S5K@0!VV?L1GZ M.Z(=#\BGP;AYYU'00YH85-HSC,RABFHS(&XP57AGF9#D.WI#G@TE3O#"C7HX+^ZSE(BX(S4VI&A(8[R![O-8 W4 M=!%3H"YH,IIO$-+&\21B3N(R,$4%>L2KY*6!I(C;:"18DX(]\I!\3%%5B[22 M#9173?62G+0YIB-1YJM#N07%H2?<)_,!W4.]50!R]]W.QKT1.00*9-.=OFFC M292$Z"O!S3[]UE-!]_:RBRX MH! GZFG6KAO-]LL7C7.N?G56NZ[A?UVUN6;M8[W5KC5K9]SUS>E%O7#?[EB[K1C1T@[>*N1'+1VRZH;PPU@QQ1F//!V4YCLQTWW60/?X9YR&@/[G6UT6J\(1U1 ,.;5,?YF9D>_K2;**,XO3DF?@]@:#:" MUS3L$Y[0WH=]#4URK^1>!LD\ Q+V?N)QWV,B/U<=%6QC"1TK_3L5T0/-92)< M-JDE!@F^? &\SYXASZAU6-QHWE.2]1K.;]C^G4"IY?W?N1VT?X?QNJO[OW.T M_7N$GM[$[I(4>*!--RWAW%W)25'WH>R$R7V1X/V0V?LCV]T767BE M^HA<]8VSA !.>[<^00<@G.BA_Y0@'#4S=,\5*\1$> +:[IU#4 HG/=S"VT># M(0H6?](I2+2I-)V5S;NYX8W[0U-"IIM$D\-G$ZKIZ)!VN*_H(8RI:XE+NQF' MUE+3S-KLAVJFB=!GJ+K+.PY.&O"X,U[\JM+@37;O>906_-#7VIOPUH&8HNE["Z\U_-$5 M'0'Q9_"'-N@+2(:A:_=OUF_Z%WI'>GH(Z?P=Z06NR2_$SFHR)O5D+QDU2S8& M*9Q7244HQNED&/! ,[R8V5"@@0 /Z3IZE884?SA>($O:.$ MMDWUE#Z$3+@G MOW(C8\AY![/C\S-J-;_,5#413;PK[I' R+_A0J9ETDO&'EENA MTY\,'S,3YLDB/ILN#..O6/8B*/4>5>WQCDZ*T%,K;?<*_) M.-4W_-PT+A@MJI/7VGV$O,P-G59)]&AJ=%<@PP.U^M2KKY,%O\[5[S6J6_Z!$Z ]@DF\V-C+\C+"22W':/RK*GPID_ MB#^%0XF7+\ %NF?RF5Q)1DU)< 1HV,A!;6J&!@$J7IIINO'=&J=G9$ >(!ZP M$_Z!D7^PO?(BT9)'!\^GO+%\9&U +!D9/E?!6:%';;3&@X.*D#7*0;0/)UR# MV!R71_3(3Z/=Z:BQ 5/CFA?./3&/=&,E?'BN?Y;M^_T3[CN](*4LN&42O(?B M>P5BR6ED:"'OXA?!X1T4O,3R\@7Y"BS0O4L6/+=?X')(Y[T>4@EPMV' DZ MR.G*P\0UN%@;U,H:Z>Z=?K=+'[G#YNI#R_\^O7+FE\4'"A^\9Y)59<^(9]1X M YQ9R2"3OI -#(0(=+"\1P@RLEOO5N().1Y0.1NHS<%"6(DJCT4#9NP6YH8F M@98#:USY#!1/$9D1PB#JQR0%.$8'&_F,<,5, FPHM#")\(+-/R":"L92DR:_ MKMWO:E9W-'#'01$#V4$Z%"D!2Q0GH*ONQ?Z9^@U2*4&<5*".*GMV)?/@\ QN M0VFTEP3HW@4,[IVX!U:XF4*R*^ 4-KV12PJIW#36)&E("@?(/N5"S3RDU"S5 MLU4XYM32/*FITU?0P_$J& &( U#5C <64,3\CDA3LY-5>HT M\3Z<;I/U\L70PB9.&^I@D2K<%CRBAM)V4S%^^RWB(B=6DABZU^(;L*?D6)AB M-\A.D;M2WG1HZ(L$;A<^3Y(( 1:KT+%4Y]TY="232]"[HEDDV=K3"2B$V@PL M"3O8D4#5,"2VM2DH!P[ \?[FJ\E[[K7T9KF :1OXJ5<0U J4 Y?M@ L 98&T MFA-)N =UI(C-Q&CET]3Z%5+;>A,+FQAQ^T0,?CUKQ0Q ]T=1 OO8,JTH<^@ M:!=P3QTZVM.U*2Y_)[ MZ5\[C3WAXN.(=-^E+47F&J!, V'_[ C(ZF K,H"0P!^8%RB7IZ$FL?80Z6A> MZSC3\D=3X(7<6<@=&#_=@9YX&,\\FU,8%MY,\O^:"8;U4!2;ES%"W;1''E$%)L"(FB6J!5%[Q M?1X7_I>V%8DY64,?IJG_'BG*K2 6?&'5V[7+ER_*IR=YGZ%?8WEY5V MO7&U\REJ:1?97OJ_Q"T!3P9K+,8]PPJ,OYZ^=AHLC\)@7-?0B"8OO B#7'2K MNH.)_-,\[AP.#$K'7]P6+G6HU\J?"!)W!KD!$C),MSRPN*J;+VE -3RR[/;='YKY(SLF08=.Q4Q7+@F#"+WR8_?C)/OD?UKJ!=(%+LBF)JH!HD878='<_\5I3(O" (\_])RG\S1A(D_ M9H&4FOQ_E(_TW_\_78<[&D<9N&W(W>$4.&I]P/\90\A*^G2]EH17;[SLB6,Z M"CT_X6Q%A[S64-%4O"N"%+BG'=" G%;!VVZCIND;T,]H&M'IR$U:FX=8$ M+5&RR= 0[YR;%!=-^$X0 IUY9N(/@WSQURM8!55/#6N#H6Y2I:Q >H#\*=BO MP/^TUZG@A+L>6?9(,?R$!50'^ND]__,\-8T>:79?<;5T0A\Y+R5E#:[NX&?\ M5Y;RH,.08M'=,[6I%X12;"'(%H.B0=,J2(5WW:MS)/]R\O(%O4UL(=I@EC8. M& ;S@!.V:+36D&1)D(.\,8N3*BRW!R9D(RV$=T:'Y)@A\=3UAT,2.D#,\W2_ M?.$3[DTJA'WG.$JW[[6-)3.J=+=70.VQKW4T!VOA2>%DV]98A^.^,PV@)O\D M"V^+L_"V>L*=U5O5BT;KIEGCFK6/E>89:6[5:-;J'Z^XSS?->NNL7@78V^+: MGRIM[KI9^P;-L>I7K>L:_<4. +&GAU(QU1',?.05,IUZX3!J>B7C"GHC3 J- M8G"$F0@;5\R:S[%9\[N?-9]CL^93O9%VTH]Z!_T79]Q4R7=3UQ5HRUBOUUG. M)4UILO(,CL!8%..()H8#C6:+JUR=<;4?M>I-N_ZMQC7.S^O5FOOC:J-YW6A6 MVC7N8^-;K7E5N:K6F&C#\?@4]-[!-"@_5^4/MX>J4R\ T2 )I9&IV*8U-&E[ M,=KH?R[D@?I#U:V"NR=SB!['DX((;K8X&SY.+H"Y9>V7"-%L&K24FURN<>N\ M<204K EOU:KD+Y@,41(X51GCZ*GGN+?LX8*]&W(%FPQWX->%U0M0!6-W1I?)%I:UA:5:,=-" M1_KT* VS-PXMH)&$V8!&/ F$,-7&Y77MJK7CP_]LM/[?2[#BR2IPOKY%R$(. M*..)6;BM0A9Z2!9'S)(QQOLGU_A^56NV/M6OH=R_6FNV*_4K[K1V53NO5^N5"_?W),=\6;FJ M?*Q=PADU_+59NZBT:V=])(;Q6%[Z ML EG-&8C2#DXARO-.ESYQ'>MQ&M";1=VN:TI/]IN5JY:%5KXQ9/?>">_@=F) M>SC5?2:^]3VW<+ L.PS.^&'P[@7-_,666^XY,B[C%6P[\:WRK&_-G7#7S?I5 MM7Z-H]7@&.%:C?K75JWYK5ZML: T TMB_C$%06EF4JM;+.8@&+E)N7^>E?OO MOMP_S\K]=X5[=ND4=U"R+^5F2_:_91K0'5RN)S^+1_-0X/*I?EIO4_AY7H=B M?#A*:;4K;7I\TJI^JIW=7.P!DR8O2];T:XI@.EEVU[*(I;W0CDC'>^JU\F9J M)Z1ZQ!6F]WPR4 >H;$T/J9UTDO!_P;7@TCEM; ^]")$#U^1Q\$ ;D5PK&/#7 MZSSM2%*BP8(_F.=DEC?I'=*6=LUFM$;J]L74*E6T@H7L9,M"NLTTW#F BPU8 M?'WETA>)9WM)#6@*\_+%M.,R!YH#*3>O*2[^#.UB[0YY=%LK\.3OWAP9TA,Z M\(W)@)FI/E[VW,">ZM10L1"W2CITX5H0/)M@>BN[OS)G MDSCOM[.ML_33Q,O!+2'M+CE]8L#;"G[\[Y$\F^/T,77W3.W2) M$: PZ>U*>N=PD$67B7WI^<@R-!M[_&1#3KJZ$#<1)TO]+$:1(J.L(($)>I[+ M#L;2TWJ'Z[@:#3K(FEE&;-DI<38YM1>W&J?*[DJQZ"+.)NT98S3=!RP>?VES M:=%D3#..C9A@4BB8,//,9'-X;OB<](8-26%ET1>?*0YBGG@CK=V!=#[A$ H* MR.+%W0O+:[.5GY%.Q/\<;& 9ST%+C,JH<'T+]?X]ZCO.T'[W]NW#P\.)C;HG M=^;]VXK5[6OWR'Z+U#O%>JLJCO)6%,2\7)+?"H(@YLJRF)6TI7;Q<1!WIT8=)CW$X0+V&&<]FC[M$UAVR>(XD@+G* MT-)T3A9(JW:1A[)),K%\8!IW7&4P,'FN;G1/\,J&"*D74"?%?<3*/^3J/'=Q M4>6YCVB@&9H[LP%_&"^$C&NPR>_)TUH.C*3CSD^X&^L>4_%:?///6^5PTQH9 M64+I^$NFZ3\ $6 CG&GZ#T $^;>%MV#[,KV( Y!#W*43!P+39&8ALH32Q!+^ M4ZD *$V.AM)@1I76PZMRR)RLNG\)!\[O7Y/1+C"4"<.H)B(7;=0WLQ=ESI"N M/$#!0 MU+>2XXVC(@3[<>&ET'9C8Q$EDWJ188MAK_TM@V&OO2V"6=>]+$(6W M$J OL$D97L8!2(*AKP4V0CHPL1XH^A**Y7)1%HODSP5 7X^"' 5^G8XQ=K(9 M)-K_$A@DVOL2Y!-!SO0"#D &@O16* ,F*F9Z&0<@"8:)%A@)9B,R@8DFYX:2 M7,R3C%0D2#23D3I#-EX:R4?9(/U4.BGF7Y$EX+55N.IH,-(5TAZFB52$ M!N2ZQ36RALB!5BS7I*$,W%0A'6!X;JA8W#VTS^#^*YQ@NF%<-PQ=MI!W2GFI MC#FQ1,\H&53;_Q)*QY5,TW\ (F#9J[TO(8]1&CLZ3.42&%##;,DE9B*R?GTP MA2A-P'9$SD/F*A<1I9F#H:836 8H[7.KROD%7[:+FZ[,>P2713AR\B<)##OM M?PFBH%G"<\9/21W^,?R4 M!'Z2R@6)X*=(=5>D#S &3C?0+.S!POIIV?_[GY(D%M]SWQ7+4@QG J@XS;9' M&%"=H2X%5#(#5&E9 CLWW/L2DHLTF0BBXBGI;8[!J50N@26C$@VY#@-,>1!H MDO^)D?Y 4PI2&8ZZ(PQXX+BNB>XTVR$3$ZY'ECT"U..8\ GR85'R9BP$OE-[ M[/85XPYQE:X#OQ;+#<@P'926I M) E"+I%*>O<%<* #%%YTX5XX]7#^7=Z!/IN9YXPO)0^U\".]C;_Q)8(FKO2Y#> MBB01Q2Y.I6X)#( 1,WTB_E\&P;("P61!*!<+N>@0#&[.<+6_(\T9 ]S" H!* M=.A^Q7.*S2FTH0(#3/M?0NN87?MF>.FYBT!^*Y,J[>-(3P/&D*BH(J/S6H1WD M/"!D!!)>='XC>9;-MY-_1[ %O10-QPX0[PP\9(8]CI<6\>PU]Z7 MD&!\RV3 L%?6E\"P%[41K&HK,]A+%H1<6937R('5'KOZR(9SP@L-\]]&@9M_ M/J:ZO&QP;=3M&UB1[Z .WL=7-P;^JF4#/C-[&+2--%M3#(53'.Y"Z2ECY#A^ M*RN_)8-8(-W8BT$@!R5@T V9/)764#",MN\EL+JN_2^!)GJ.^Y:N4/O\0/^CI#1Q5_, M%=YSWZ YY#M.XHZ//6FIVKU'T4R@8 M(G_S!EZ(@O K#/!-D MO1(=ZJA'ON$KZ[RJ3;T.?S; 7(^M[[GV>(C?7[&4CM9]SUUA_$%9?V4"DW.% MX+?>>E^#7TWTS=.U?]YB883()83K'0LI?XX[J&=:^'U#(NIHDAA./]7]L:=/ MPVDB@K3#HJC>9&E/!#0OJ&FSFKCV:J84<:'"'K& 3SC)LR+191'?Y+XRQL?Y MN"\LUP9#W1R3^&L2B>'8ZAPN*G\_X;[C76WT%=UFUXXW78+W8O9&]L9GI_SL MAFNBOK/ ?&=DWUG8E>]LPI51ASO#WE/3T7CZ-@3SHALN@;&+L8NQ*QWL^I%U M)XQ=9_'_[LQG)H, L\WV<%PL;F"=<::$[?.XGS>WF*>3YP MV';(R)T>91WV"N&D_I!7&#B&.>1E!MZ8$8/NYE:Q"<]KQ@Z"K*0NSTXO1DQ^ M+<^M/D6$$;7YXAKU*1=F]\_QS3!8_4M]6&5H:3HG"[0-T*HZX):#[O%/ST^X M&^M>,7907'(P:C2WH!WL\>2+@YEXTEV370,XGH(MWV^F8Z<-6K"<4Q=O9P78;5AUWL>B8B8!>[]K^$'4$P)@>& MLC8-X9(:F,-@5K(P*]*0W):#\9'M:+K.,-;!&36&L?:^A 2;DC 9,(R5\24P MC.5BK*1TDV&L9#%6I*H;:%=D.Z;%DEF':MD8T-K[$A+L0,)DP(!6QI? @)8+ MM%BG[LP K?9D/F,K<$ MUHQH_TM@S8CVOP0V92ZU2\@P&(.='?N]BJS>OY($62@6Q34 2@LYCHZF[U_Q M,]#D\K+A09.93 _-_HQL_*?V"<8W?^".\DS31/FYW-0B*9=#7B!UH@>]0O%M M\2WHZB$O,GO7M!8I8^S7!C-L]V4IOX[=)\.CB-EW3"YY)P!G",P+',0"GX47 MD"3F!C+A!F(,3\7$4@0L%1N>BD6/DNBZJP^M4.%?S8ZY,JCJ95-(1FCO@;372GP4>@]J[;Q:KHP#'P /]<5\BU M4QRFP].A.SX=]*P9BM'5%!V'X_@'$++/XB9,M$7^/D:*Q=%I-9>*U>US,@W' M98:LV!+8$M@2V!+8$ABR6LP1.;G6 F@RD*! 2BV!+8$ MM@2V!+8$!J"V!5 2 U#[ 5#;9J48@#IP<\66P); EL"6D)XE, URQ%1$$_J M5RV7Z"S+-DM JF[HFH$H?3].FQ=V\F@:YF#,U1X=9-B0I&EU^VB@,#3#EL"6P); EL"6 MP-!,%#13K5PP-),Z-%-5].X([O5#4WC-^--1;):I84M@2V!+8$M@2V#8)A*V MN:B<,FR3.FQSH720;C-8PY; EL"6P); EL!@S5JPYKI9R[14#PW07%L(>CJR M; U; EL"6P); EL"@S7KPYJSVCG+UJ0.W)RAGF9H#-JP); EL"6P); E,&BS M)K3)95JB60(T51._@))WK=PAK@[,4+JDH\Z9XBC5M\"OE_7[ZX5 P,VTAJ MJ8MEB Q;<4QKS UU_ [,W2[^#N"YDQVK;<9W77SD_Y^7+\[I?L(;IH\L! @Z M,6DDSGA,Z_\<'^.H .GJ.Q(RO,4P\FO8TN[Z#EF=_R,<^DS_P'L*(?9Z;'W/M<=#_/Z*I72T[GON2AD@ROHK M$YB<*P:_]=;[&OQJXG,]?_O/6RR,$+F$<+UC(>7/<0?U3 N_;TA$'4T2P^FG MNC^>6-DI(H*TDQ"4Z$V6]D1"QBA^*/9/QWV8IOY[I"BW@E0X\CJPM>H?KRKM MFV:M]<_;SH>=FEOWAQJ9VHF_<)+7C*P*;4=+NG8AWLL7+M@"R*19DY&EDW9] M@ +$_&OUC=^1;X++IH9.X%^+93E'F_L-R&A3GGR!SE&U %'V\>\PXL-@4!G9 MV*$Y?3T30NO44T:J^Q8T29^*>B'9OW4VBN<!O;5]C]OM=0:J#B9< 8CWUT9?AX9B!-SW@#WE*E:2G< : XE)*@^ M/%?M:Z@W/YCC.>A4_/Z#47>PRA+KV4["64SL[3+NYYIF!VL"=X9-E::C,?-R M:=O_*?5R5&\H*9[R>#YN;G;"7H\Z61HM_C1:I'P9?*AGZKKYH!EWW!!9MFG8 MD !SDU_N];&W]&A:$=<'($I[QN:HTD MW2R2=,.OP*_=T>&>=V+!DFC1#5&"GG)!;::7&"F\VL%Q IQ%Q9@K6;8@*>'\ MR?XD)>Q"4FW-T9FH-EB85R6U4VD!;(LS#HJ[!#REP(_1RFA-3ZEFS!LV>2.W MMQSS,U5,2FMF2ME(T$N7/S]V&0F8JGPES,< M$G8=T[*36V&"M=?M0%U+M:[IJ(9L5,S',?0C[_9EB;KJ;*8&!+?WLE8[1 MFN7-S- VHY71RC9LYM'V)\6RQMRE8OW)5(4*7H(GT:R0S W ]P[$!S9T)0\ M?U<_>X5CM&9Y(S.PS6AEM#[;#1NU_5/Z>V1]1K:-U\%=GG 79OIW*K?+ JQWR!ZCY:![Y#:(.3_A;JQ[Q3AD$3.RTD/6H>ZIS B D74 M9.T!A87,M]QWDN^[,C80W"WY _W*GT5ZCZ$[ELG;OX#(QO/V(-U]AZM"C*PT M;3B&*!E9SY.LP]Q9Z4>9U;ZEV8YIX.L3(2@]9_^QLOF[B?IS..,7T_\_Q,7>N(5U]QUTK=^@]?L#? M$3*Z^(NYTGONFZ*/\!\E[OC8DXJJW4=WTW2MQY9VUW?(BOT?88,R_0/O*=1Y M3::O!J>MSDYCG:9C?HSJS+C5>1\Y,8VATR6#,M%1CWS#5\JP0;6!U^'/!ICK ML?4]UQX/\?LKEM+1NN\Y&&=*67]E I-SI>"WWGI?@U]-=-#3OW_>8F&$R"6$ MZQT+*7^..ZAG6OA]0R+J:)(83C_5_;&G3\-I(H*TPZ*HWL2X3Q+?$YG9T?]T M/M0-%3V22=)5TR [CDQNGC3V;SGX!V2T]-1HSXRM])#F,^-G8B-Y9YDC0X7G MFM8[[C_5:JUV?IX2?/6/PO4MU/OWZ#_*K2"(&'#1N=]F#YLIPX .P%^097'G MIF5C0_/-6^/ZN-M65D:IA]'^N68.Z>MO%V%42PLH5I!E\?9IU*[\[!?1ET>8]:T]OC-, MXVHTP$1WL10,T+@F4'ENF0/X^K&0.Q9$QX0'' ORL2P><08VKO\>X1>^FWK? MT0:(!?BO&.E+1I@GO6W.CZ44W!!.3C6EHP]39N]4T15PE:T^ M0H[-*3:HYJ5B=?N<+-+XB$PXF?J1! J;Z:NEY\D.6.F'YY^Y)^K*Y<]U\8*;$5Y7"09N2 MPM&'*]/!#X@67&5>FJ7])+H2N RW2::K_!ZC!0(5WL&;6J@+?]DRZ;4LKQ*2 M&3N0I-?Y\29I+S%M6:\,B&**[9[6+V46R\[M+COG)S[<+(J[D&;MNM%LOWS1 M..?J5V>UZQK^UU6;:]8^UEOM6K-VQEW?G%[4JURE6FW<7+7K5Q^Y\WKS,JM\ MV*4476<2!CT?^IJ#CK8B(/1-"ZA:3$!LC&V;+U\ #@U&-01HGIHP*P"#5N^( M'1!L:@00V_HKEY<-_N6+NM$].;S%I6S7Q'EFT1AJ!L96+U]@? 7ZN]_#"B;4 M[=?U';U\T5?N$:= DAV'2"!6I=LU!_@-8Q@?W0T&4!TW36M#FA8K!)$VV"NR MHSG8T,2.M48=6U,UQ=(P-:_AF9"TD83W5?I@\C?Q_9M@HO?EBZE,+XV^X:L6 MTLG+IRBQIV)\TT\7\O@W\ZDB1%-%\-PNI -Z?CH *3BRQT_PTP(O7VA4N1T< M4=*?Z2/\>]ZR+* O28L.<"0GK^%)BOR MN',")I(S1Q9>']EXE!]A7^&&%H+";:ZG:)8^YCF\"$77L;IA3 ?Q;\>8G+L MV4<,35LC\9++ U= *P4S6;4]TJD0-/C/)&\+GX ?S3 Q$"V5V!XB;5 6K/V&BO&2[:G2]:BC:UU?A0.";^ (S8;8 MTD58KV\,S<\4VF^XU^34\PT?W *N[2 & 6\B V\6.+NT3)TS\>,">\@BAZSP MGK!S*QYSSL;OPGNL:VED.W+(A@A/PV94A=7]HWVH>^^HTG>0MTOOX<=W%MB5 MER_.+1QX/YC6'^ZU)(CR&Z@-Y33;'H%A'GNDXQWAX#T$.?,A&$R+K-^Z4PSM MR=V9+KO:.,!6'Y0Q_99M@Q5X76VT&F_H]@;#0Y?&49M+:Q:]>D6>0X]@=6!M M6/Z*"CQ&GJEB&VS/2\#>^52Q-:R^8'5=Y)8L.#L P>P+A[7[V'UC486Y=L5" MGJN%':UU-!V\WK3#]JP57IBAW)%OGG -LH.GOJ61K+B[UIU@!3L\DJV*A M;6;6!;@#^W9UU 4W-]'IZ,B#")QK]TT[^%M7G_%'%(=[0-Q05ZB28' +X)4J M(+P*--KL.(J&@VOLEFW3(!JI8.]ND7/\9Z@@14V!9V#_@__^%Z/4V%4KZ")IQMN 0W 6FKC5&H60 2$%AP0C# ."WS87P]Z MQ)IBX$?Q8,04K'BV T9-P[2@>TTE!QC8"& IPON(F 9@S-S-KVIV5S=M]Z$+ M%Q;D)D> [82">T4?*8[_](FM'/I!"C>BV I'NWA+:#ULIC C,:D:L!B3,E!4 M!-!O8O-Y@* /4.>'_SOS#D"M$!.ZH:(2#/O"J<<6O8-T#=V[*AS8&9BKP"=. MF=)7PD(2Y@6BUMT:0F;O(F'#*OBRKJ*_?$'**W',@L,&BR7OLK0N#!JQWW(% MZ?J1 9$CCE0'@Y&!?TZR=D@W'P#Y*=ZO%6P@"2ZS3.J$,+:QP$J[61?ZK"6V MP7-IV-T$7_7RA6G-HK@I4ES@1I_?]:-5"IP4+(;7VAL_DP;^A=I%&YQ!T.B2 MUX.S\YV-^V2?V)F?N\Z>0(F-9(MPEA.UY%Q1UR"/>K\ MIJD['MX+R5 =/6+1JG>N86SW@^L*V-%0:;Q\H9J89L/$).O ?H 5&+9"[!VP MDQX$#W>1CO('&6#5%:Q(IHYHC/Y ,3=^- ^.($"3:_2G"0*7 1395"=XUXS# MAVTT5"#1X%%C>^2$+HD(Q/W 0AF9H/)= IG&KE!W#8K)#S420D#EMD1*MP_5 MY.QKL?]H'SZ:IOJ@Z7C7U7%(AJ,]3,/4W>7#YD"RXG;7L1\WL^05Q/]X,7A? M@7@'8B5L7>]<=0"SB -LRWPDD!4;VO^6A9,2C@QT'9 A5[$Y%=G8Q'1H)A3J M]CAISIA/6\) Y _ W?9?1W-=FJ^!V$0:(V+?\8\')HV-H#S)P3_",0>880[Z M=&-?U\4ND)BPKF9U1P,(XKJ836Z03_S-0(%4@TI<&?T)L8\PHA L**!M"+SH MV?XD*8P-,D;MCUV$<$@(V!G.:.BGJ2>9_!V[!& (-K X/,$<&=F>'7] D+Z& MOV&6=I$%H2+GXGNPPZC;-S2\-)MW8PS\T9X%+DX"C75DCEGNM>9_-: 29Y$1 H3" J=/H <;QGNR@D MF! #M1I@-_KRQ3T&0.;(GKATGH3:@Z%[A@B$^G$6U;B!B4/$8!R&B9_FG<(1C31RP8OKQBS&HZ"HC&WE@R./N!'5A M@6%>:.B!+MH3S"3;Z#-]$BF[\;6+U33;_[2[Q>RIF!<^JJ([-P7B(SF2^C2" M$3%=@A?LLV1=MAUP8X11-CB#D!25JEHT1X6M0K@&>[K&0Y8'3"PDH[RC5AW=B-MQ?*]"70E#;2"! IQ4YEN5 L)]%A)X'LW<384QJ)%T=. MWU3QSKG3W*.>@-^G^=:I?*I?Q3)Q/^!'2#XW@&)(&$Q2X? EULQNGV1E2$,G MX)72.%$A7ZM"8,]?'-(0$#JILR+)%?A;7QM.CJE<",W4D:EC)&)=_!2PE@K^ M-T1O!#%!A*QTQTLT$W^LZYV;OP?%9)K'-&]35STY5C0 OD.!J3$<8/# -:=Q*N<#NZ"7FX8=TNDL@'MR+2;W2VB4YMNHD.W*4,;Z'CJ*)V+]X_ M?JJ=G'!?:DUF]QYHPF7U[C&.=>N_:BT2"N@!0UV6)8D M,^OR+W;8R(+,FYL:F\VJ*E0O.%N#BA?2W: #8F9E -E9UZR)$:=-S(5)(X5P M,W,ICG_K[<;?KS_^Q&=FO%<>??AD8D:0W#_I,[:J<=?!R&2Z5/[P2JZ7]V3( M"ZS]PL[:+TBL_0)KOW!0[1SE MB]/*1>6J6N-:GVJU=BO)I>WRI&C9]O?@BBR4;D41 Q'C8?ADMW.M3Z:,C<-H M@*D?DX^\FUPNYXZY)5TC-SA^BF9]YHZ?PAL]!?)14S9E.M]R3"LYX$LZ=G@N MCWP32KSAE$V:9&TP<<#J?X^D"?]RY7P S54?[L]RI?K'4Z<_:V%7S..8(2M, M_Z>O-5/*?[VY*]Z73]EW"O)'BX4U(OG1=Q5O) MJR6?W_;K0?)]B0CE6S2RC^\498@#%-O&V[;2L1U+Z3JWVNGMDZ7U/]ZXPB'E^02+^7S;T(RQ&$@+$0.E5:+&.)E? AY(@4:X0H> M_!P!6E$^&/; -%$3+N32G)"KM+Y\(FM!Q-)^_%*J7_R^T_Y4>QM(^SN-=$*S MVDNV+%V$2Q!'R7N71MZFBYK5DH9&FQ5#A?] :]9[18>#S(I3=0LDR3P*+'FI M?CL<"D/A=J!4JD]GAGG[9']L#&LE^^_?W\5DMKUG@6%=7EVKZ^$+$%Z$* BT MK? ;AJ#)@F;9YCY&>K7 ,\V$'*$O^^^"AXJ%F8^[ G03-><6+9ET,S"N)-Y% M$L315'JG8C=ZP90.K=K\]TA[=-X9HX%J.BKJ:@-%/^+K1\6+364,>&:>D@LE^)BN23S4DGD<\5\?"P/ MW_2%H'EW+W\T41?A96/H?X44Y SE)&]SERK.,A\EN4ZG,R[D"+Y>$E3JS+U\5,^MBVVXYF2_G\[Q0 MRFW)NO ]5@OLL0:4HTY6:*_:85WECUAJVX5'6]^=-PW)M\V<2YPM7E*EAX%X M!0IM(9X_-ZVJA53-N3!M#SDVZ9U ;&.O3,.]('BM6,X8D@,CN_;H(&ARH:.: M 6<+],1#JU_+4;BH/EZ0TQ$WBOY]VAF=??OY4:CB*-K1'%CRNW<_SGZ\>]=W MG.$KN?)*.L?_[REVY\2T[O ?W;?@/\%C7DER,T#B)1IT<)#(=77%MBDWAGW\ MVANYV5<_?G-^?<\+]:IP]U4JC[I2V5:^DY__J=<^]SL?ST<_I9N[&ZFO__K1 M?*I4;F_G65M,/6O=(-RVOOU6T4=C@4W_)V';&I7^_-&'XQF:TNT7 M%FMDLEY!Q!Y!V-:9AGN$7&"/UPVXM&9:8[RN@I??.MOPN_*2WPFVW3@4ZY4T\Y#!9F8[!X3I1*?RXM\J2QGU&NN9E9\ M\9A4Y@MED2_(A1C]Y=8>+L7G?.FB)MQ\R5.H']IH..-K73&YCP^*_N-'N;G)H7,$&Q;I_-DCFQPQ^C2GX#!B&3\3!@]YOER0 M@:L9M6MKLRZ^H*"(+5R1+PG,RNU;1>*S M*O"26$ID0\FSN*)N.(IQ!R?\U%S,'RK2'26?6Y^:9SHJ?>[LO'*+ @S-IY3T MRDG%MEK$PJ2S0#)?Q$I2$K-:NK46W^)S5G*!EP7LK4K;NO;5F56O*7+H9G)* M@MSLH/+/[[]WY9Z._#;-^Y6\1T6R.Z0L\*6BP OEK+J>I6R*;4/$QJ8(=8Q> MO]L+I-BH"3QH]&YLNO5#-TEY6&Q_JW;^]N^Z:3E7)&3#:2(TNJ5.B#OF)JU\ M=5C;W"6!#)Y8+3?>RT29L.?CI0(D]%?KZ_,[98Q99O'=3>"+99$OY1,Z&5Y= MR^"G4<3@Z:9[J/E'?;RI&86/CPG=.8R009LW-Q+5MG:C7;G@IJ\C+N*5M*&" MDN]QJCG","S259DUG[+&H6"RIB,G2KPLYR.!OU#F;FX\#E4V\=VG$'.\6"SQ MLKCZ6'LCV;"CC?1DNH-EFQ>:0F:3:LBN&&HK,+V]1J:V3]T/?[2ES^/NZ/)C M:9.<]_:VVKOO?U&OG-8OZNUZK<55KLZXUJ=*L_:I<7%6:[:\H?.UKS?U]L\T M"B5=U(2KB!"N(N$7R9_N:K_%WW+_Z4G/-2V(^UP3-5ZZ MF3K6\.)2>[2J-[F=9_E]4CG=HS7Q'%RTREQ1S,P=N.O&]^_O%@H]811?RO.% MHIB(2I].>P=KA-1Y8!"NTY6[[EB\&H\KTI[] Q#MZ_;>;\PMY&+"83@OYV7\ M3U83\^NQ+;:]52#Q<4E,)E%?F#@,_W8@O2J.3! DKG<5EIX%A4-&=W\NG_Z]NNA MY2B;(*/8W$C(S;:9XZ<=HJ^]$LM8DA,DXZI25$.K-.IPN)RJ[XXI-2CB_(R?B-\V"?4=.P'6M$ M'GYA*L8"L-:[$[\ZN;O/XYU<55X#K'4#]$]MQ/WJRRQ;$^X\6!!B !G[#^UD M>=/0;F'>=C;)53?LD07-VY:"I/;O_$AY;/XM;Z3OB93*^81S0PL-M-$@5-L/ MM=QJ@?02WE:\*):P%5X=0#^_XKBH.[JPDQ8$?C8W.>].J _'15K2VKO.9TMY/E>0>;F<8G<6!\/BNZZ>YTL29I@8 MYT$1J^G:;_'&:;A!PQ%]-[1FY^;NK/>MH#TI/Q.R89'*=RY,;.4<9 U8 4\, M.A#L0WPZLC68W%PU!QW-(#D;'&) 3A/K @0;FNJF]R7HXC(VO@ A;/S&7 MS)W[8!0*%K*-#60PGQ2Z/3_^*#=^_=;^-AL)U>9NEK&7%N2>)W+:/OTMTMSZ?FE6^7\ZYF?OV[]R@-:Y=-YIRJCFW.K;,K9&YSPM' M'PA7PO/TY.8[22=.9Q@ST$]>S"WI.+F^N[U$%Z06C>Z MY@"UE<=@*FNV2X6['_6+\][?[T^?*AC>I>3HS5L&IY%U<([R.%\4F.&SG!7- M[Y;*,.D3.%DH\_GR:N3V_$[@8I=:?&B;S\L%/E=:;6!B/ *LAF?,9[I44".# MC4VE57M2NT^W3_)P>-X8-HJYJYU<9PD__5MH>NBA8,AAX*$J;F"IB0_5+>)_ M9('9EIA%%%_<4.9+Q1Q?C- X=FM#P@X\]WO8%1R#O*QM!>U0\"A4?M7;?_ZT MT1Y/.UM]Q4(NF7Z;"D(N._*,(9R_MEP,0]0A9-X]]N!5\>+VZ>>=\ZME_S'E M:M*MNUL(!C-R%1R+#T8Z#N'N$8=CN2%R1MA+#SV".4(Q-WL"("Y/S;RGR_ZFQ&V:C[<2M*F'=*Y M90ZH0\H="Z)CKHT?ZE?GOGLZE@+^Z7ID)4>O2.E=VY6NH+9T$GH5<.X'P4.. M5SSW^K\ABNS=;IU>(QQ4(95L5;Q$8A]OM7KPW.[/#W5X]>>Q;7_J+-80FSR& MNX?G@'YP-CQI7F_/-Z##U=0'J_^QT>Y>%TN_-Z!C\6W/E73$ &J)F(-(Z9H\ MV4Z L WT+Y0P*7\2.LANJ>Y-6,YS4$5T^JJ5_V%6] MK[V_]T_U3KLZNDOLQ8V1@RVI 6AJ9MGBW];9C3+^WJAW5[[=G#QE>7%%1!)< M!@A:]>.XVKB0E25F()2$-30[*(#8M]LF6VTE0=MLK\T)"H@I16Q:154>*E8W3XGBSP'G">C]:9^)/$P WB( MNA &Z7MNCA 2+";=.#L7831O.L\?HS(KQ@.![9FUNK%EU1P,3&-5MN#WZ7WW M=\XPOM;W.LF($NLYF+ 0*VQ=$;'M@W;Z6_\Y4 OBQ*].OQ C&E%CK36)6?B M8(>JNB$)*TI95A*Q1UR[*74I ;7\'*A=L,WH^RHCIV]:4"8VHX:UG\+=TT7M M\8NR0 5<7Z3X#YC7O'+$-T?1N+#7197C[ OWA$_6I2@.;")19!(5G82AC0G+ MYU1+7B;@T&"I\KM6/K-[7TL__BP7M!^PK,?2A'$ZW"G.%Z0%\V4IVP!L+'HYYPA?OQY\:7=7N0VUP\$ ME[T^4163RCD^%WI5:+&*+7#S\WQ;0\^2Y-6N-&XJ.'*R%1G-HN*$PR*J>1D- MC"+Q*L91KZ!YR4S."UY*J.!X!!ZLZ->*IM:-JC+4'$4/#X]JYZ?W;;5Y47[: M_5C*":$8BVKJL69P74KK?M5B 0.3KD\2^3*Y[IG5W;0.VV*\:Y#G6'(R MY\[&U/U[=!PR?Z&<$_F2M$GOW#?9Y.(66W 1 M%T5>PA:LF-_DXMV;J*T1VA92[)$UGD[\77G;3M5N![:W\XK2U[SZ]4%[RF]2 M.);(Y0*/?%HTE/W:T17*.2^MA$>F8S0NYE=W3(A<0/HF^R**>+-8$G?3O$M: M6OHYT[S+W8DFC)N+$I\O M%WBAQ-KV)2.J^+!Z,O#_E&Y\O@[.GR6^Z;M%$) M^A9#\E8,MUU_EN(B#F=ZR.HJN;+1N 7+_X9!O<^C1ZX MMC9 -G>%'KBF.5 ,GOZ Y^#^0>\]-U"L.PV_ 3[J_Q,^6G4*ZA'KTE,&FCY^ MM^H=Y+.V]H2\NP_>0EPT.,P6]?]H']I]]/*%TNV: _S0,:3R#=(0" ,S#DY! M\"OO+))ZM$B_!:>/;$3ZTX$[)5F2GF8H1E?#'R)5"P-,IGV"Q:E]2(HOB4L0 MT_H_Q\?5X,\LZN^HH,C6P!J@Z^X>(SL5_H[I[GI_GZ8#>U5=&=J88.]/[[D'377Z ML'3A59@^++[RATD.[806GJR@JCKUNJ,/Y\=!IGKL?,^UQT-,0<7"5J[[GKO" MMH^R_,H$-LO!+[WUO@6_F9@/SW3\\Q9+(T0P$\5/$M;-CM&MQ,HYU%N!4$^\@QEY?*RP;]\43>Z M)_^\[21F/G>PPFKCJM6XJ)]5VK6SER]:;?S?R]I5N\4USKG&=:U9:=?Q)S*^ M2$\/YQ<1S49XP9=:N6.N M&O2^_B](>;+;1 =_X&A]/D8S5D>SM\-5S1[J"F8AAH;XH^'QWN([X4NBO'52 M"9A6D,&_1]*$L;GRV6W855%5Z]\]Z"VY>UJ*,-13,7A-Q#A][HF+ MXIE$>%.\#;NM:I[]L?-ZW52<1%@C98'A# M ZJ5[1MVMR/%.3RT/;O.30MB$>XG4BRN9J@H4&T4)QLC],'8J6E[9M;JF5F@ MM!N5K7;#RN4O^?R>O[YZ8EP3W2-CA.Q)3Y;3VR=Q((V^/%8J@W$IF3.X^2CP M"CF<1TL:.YPP:M8]F,G-:QETQ( 9 :!HWS6G7R7]'I!5>^SJ(]C<%=M&^/]J M6WF\[=N6 _=_3774=1H6QOKW6A=5'C7[]M9K%%$9#"#KB^.&EJ(CFW8OOWT: M%_OMTO>&_*W:B^,XQUO3>0XFS#;JPQO]OB8U)L\.*QEQ(X]Z&G,I4\-WR^&*:ZZ7S3KB M*F\LKH+(Y_)E7HA0P,?$%1"7X(M+7%MXK/"]CM:IB_K[_M?OK;I^%OP$".8M2N-]*\<1]PR*1;*JP!9D7 M06F+61T%D+AYCYWC.;X@E/B\N+I4:&\?BG7(<$IS%;M.JBHV_-069 MU>;P_NZ[8#3_I*:6FE+IXN,#+]9+W&;.B7QC, 9E-3E>**V&SJP@<[=6.DX9 M2X*(41PKNDT;K>!\O'ZJ57-W3[UT,UU_XN4 MK]<2ZO0?DEB>P@0SQ\=;'= M'E)I.XV>NPMN![;G'P??/OX>=1=GDV1;V M9G&K,%XN%;![B+.I49P0+\6 F%&SKL<)=OOU9Q77'H?(L&?*_CY_EW]_M,M7 M4CY1+S,9CNU1D49F,FK65;1@&Z<6TG5(NA@J/3J>J!ST8/![J#5J3]H3#E9+ MUJA\W^ZTF\)>Q[:[5),>H ./[OVZI\6,W!TNRO%%J M%@5>2G.Y0YP<3 (S\:5BF1>EU;V_MC5='Y&!_9..UUI1!YJA@8.$UK_+[)=9 MN)'KO\=5^T[9>9_5JFD-39B^R-U1RHGY4J9HWS/$7L[1W1DR*<>72P(O1 CY MT[D/-^%D N9,+& ^%G@Y0OGTX? Q :-6Y.%(,[\U&UN5YP6Y@$.#9%IS M!P>DG*&AA2DB#2+PGW4$?P#C/3"Q77HB/P^U9>=/M>NKIV_5A_M-#D&WPV5! MHBDD"U#K&;#]ZD\4ON[0FLF\5(1T\B8-IM.P'3=F9S*VK2A(O)C;-F#*'#,3 M"3X+^3(OY;:]'Q)NZ2J3P><7IFTWC-:H8VNJ1E /,6L3@R9]&_Y0/G]#[<(> MAPTLK-@'\CDLR>'(ZO:5B77+\&EUQ%L@12GFYMK/@FDR8]H*:WC=^/[]W;Q5 M2+8R0EPR(#"QPHC*LF,JTKCY=N"X9G!@^Z41)2E_];%7UPO7?Q)#>!OUB#?] M4Z[96/70=-3SV'-22[H:+E_B"X5BI%N$S)QL(*K8"N+R&$#!O;'0H7Q,4%L+ M*C[+C^/Y0H$OR#MMX7\>9OKK1M<<('!]4!LW4.H7Y]7&4RW_"]R 9_VO'/&K M@IIWC7YN5XV**%UO7P-E;[@>%D"@>672(=.*<3PAS$L@?-="QT/AX!W;X[*X M22XM\1E;\; M-GLH%TG# 3G%F8Z8-&V;8#Q>^J?=VZ?Q'9';X_JQ4IYD^/:[8XXJ"9J+B)RX]Q]._.EW$LZ))7R MO%C*ZNWD#5@7WT5DD2]EML!P \;%=XVIB&.VC=#0:JM4"UBE.G3F1;8SM;0K MY,S:HQ_(_*1\^_&C:"5\[W2C$PIO%;/GK]G-'ZP ZHO$MK.XL"!+O! AT'E. M(UOCE-DV9\>+)%;DBQ'NP#&);2:Q^&-BF1>$,B^48[P4OG1@=RE*F$3/;+R* MG&#ZSO<5PB?I[OSQ1A]LDKU+\NR&X-KGXB)V")97#IDO" 6^% % ,]NSH?AB M*35:)#PQSY?C['G A)= :=,"X4E\#B,U.<(][FU\2)P!08J3/(R:=4/-\E2H MZ9TI>%V]-&.$-6YRSG9*YE_2S[651V37'AU+P?M3,Q1K7'?0P,8["W:099*; M:QY "_;9"$ 2'+Y>/%VWSVZ?"ODO3EN6?A2*<=:3K#I&I/,\.?I#CJQHSP<\ M"EZD[G-RU(!*H198+?%Z6^9R0WFLJ*=L-23KZ(E\2)5Z* M$"PRC\ZHB2MY[.X+%]V>(@-!URN\*3S'JY>K]_D?N=-/QB;]?%PB12JM'/LKBVWF/I"+Q9ACUCWC==U(1C@;, %KBV4 ]9%E);CMG]&WE;OH[30!("Q( 7,5Q+*TS:(TQ I!GP:SYE@QAFM73WD$DH\D5!Y(7B^C7?TL;^(^4R35ZD220: M!#X/_=A*ZU?T+11DM$1#RJ6Y@QV:SCS$JOW)H JC9B54.0U E9IB&5C![&MD M$0\^=;5:-O.Y;W>G@UQ;C@&!A""*(<)J"J]-(_,8->LJ5F6)8KE(5Q!OGVX> M/__^-;[^^-#N[>Z"X@(/1\@Z;&\8*HF846G]ZGR!M[LF[[2//@@G0HPPYK#Q M:'21;8HZB< 6R$EB<#.A#;8IJ(RTO<1DX60T_'"FZ2,'J=30FU<_/K>,WSWA M?!-#OTYGC 4*Y5+SO-3/732S\%FR\,N$QFQ\MC99EJT\2QH\>VI6QW;?$3P= MJ16L)LH=NAH-.LAJ]*B2-D:.[2@&:.#T;-/BZ?>GGZ7NGUX*#L1)@2+TLEOE!:?U "$^;6 MPMP*Y\X),Y_GA9S(YX483ZU7^Y32:I_B0OTYQE"O\OF\-BJ/&W;5BG-F>W9R M''M7V$7B8>[D.0@T;H>2X\52F2]*S*'L19P9=2EO24T<_O/+%_\,O4?V\/*H M[>;:V@ 'I%?H@6N: \7@Z0]XKH4LK?>>&RC6G8;? !_U_YE^>1=!MXJ9(EAX MPW%/&6CZ^-VJ=Y#/VMH3HB1-%N+6R0ZS1?TLW;0HL8MTW94DJ;^!O^//=;V_ MK[TV=Y]@;ZTK0QN_W?O3>^Y!4YT^/$5X!0Y\2?+,,8=AFD3!B.J#D7.A>/O4 MJ]J/POD/]>STSB?7?9-P(N4UX^C#:_&-;Q^FOB^6;Y\:@]-"OMW\J#V6_.\' M7_U[9#M:;TSWC()ATA;KOP4"&' =@MO$2090S% M/JF5:G&8%\3K\A'G: ZLO19\UE"/X/-' MI/SI_;:^Y]N5WY\T+5G^Q-9W/,=+I0+,_%G,'NP%APC_[![IXQ/R,6_+?PAZ ML$SZKZQZKHS[7>U#NX]>OE"Z77. 'SK&KI4#A;(YC+DXV(?XE7>6HN-XU7+ MN&/_8"/8">1J#XQ)YWJ:H1A=#7_(]FY8V2<81FF)235Q"6):_^?XF#O7D*Z^ MXZXQ 'Z/'_!WA(PN_F)>XHZ//42O:O=+!8< 5%5G8-7Y<9"I'CO?<^WQ$%-0L92.UGW/76$[ M3%E^90*;<\$OO?6^!;^9&#W/Y/WS%DLC1#!S',58T$+*GV/:*/(=UFZ0< 3I M9$,44VR?C7%"F17D,?">*GB6MFQVC&[GPP3C*+<8N_CNKW)YV>!?OL#8'/OW M3F:=(EYAM7'5:ES4SRKMVMG+%ZTV_N]E[:K=XAKG7*O=J'[YU+@XJS5;__N? MDB06WW.UKS?U]L\L+WHO2KE>P.R!:EFHWHIB[O:I**IZ]U[LWXL=;+%& _SJ M,?D(-L^>*^>.N6K0V_N_(+%>\/K-_RI#T\:B_#O2G'&BX?E4=8NJV4-=P1+# MH!E_-+%I<1[35Q^!AWPRN2>GA5K_%.:T>.L';+ZR4*6H8I2)A81UI_*HV;<+ M^F=<(L@UWC[]E$Z_?VS>J(KQ)S3[D6)F9(O:B>CR:XLN< O/DUM5Z)1^7XZO MRE8A:W*;<**T-BX4OEZ_F@V2[\;.91=KN36 MYDH3.8IF(-4KN?38\DVZ>R\,G\.M+E=E5+8!UNCFM5<>OBPM4IL/> :$C8P0AF M8?/$4.9@# %([]^CPFRLMR3\#WEGV'IG.C&M.MURVY[,/7P1BU.\Q9B;D+*\Y+&,>0C '\<1QW>#\.8_U>N)!N()C$PLW8%#T&=[\N&&%?/X2OA]:8R^>A%2&5^N9BK7!Y5R0=[/5_6W0L45-6^S*D4]<.3N^+PZ M_'/>]>N,3M&=9D"N"\N1,)=W[S"N825=5N1?A5;N4EXL_W?4_JKYTN+^J@&! M;-GZ?J^J$^U.>6S\C\QY\> YOW#3YG>S:4,.)WI?E,:56FKB=^YPQRXO-EQ1 M35^Q&SU::@@%AM[J;N<6MU5U?:[ @X,1Y=5MJ@]$.6,W"RN$/(<+$I7R?($I M$3 3;IJ$N_3(<%-!YV5>$LM\*<+D ";L<&&O:!^SH;3#CT+7Z$0;UDSFZ(.< MXP6AR$NYU9<6-Y'W7+HE38@BKLT=%;+E#QZRI=IP;GSYI PW*_AB.>SR2;QB MC'@^':DK3I1<1LCAY+-K,,.H8=0P:N*E9G7?,&*ZZ[8]0NK9R,*&\AI9FJF2 MT[DK]$!^8]\^:7^%BU[MNG#V\WS*T&4'O3]TUX/&VL=L3B^,".RJIH'! MFXU?V^C1/SM:1T1ER\;\7? M0J5ED9>$L&YFVR/.TUN\#.Q&!\L!Y[EIU1Z1!=VXU.^*92G8<]\^_=!O\HU* MWOC=*.\[J8@\ZK@'ESR&-V=V94G8/]X45ZH;Q2ZA^I88PKRT'TO]6K4F?>FM M1)CSBK8YQ+QN?/^^'%^&\6&OD++ YR61SQ>REH%W87G_(+$4$21&T+?$ M(./IS=>?PKWQQ:EU5D+&&9U+$B^N9LE>T:/("X( _Z37U6YF\E/#]WG7P-B] M+V0I\4*YG&[V1_0*Y;U5)\5 >QI!\7[5?G.%%F,QW^$H\RQR*K*JV'T=V;8+ MKCVP??M4&W_^7"S\_:ITQ7TG)+LNC5Z:R$\<,<@YNT&7W'W>%>24H^K/!"^X0[H[+,2'+!;<.-V/]FY28?FPL4XC-HM*>74R<$S;&Q.'0+=C]I:+" M/#32FKYM+M#^P,Z#?T.SAZII._:M=G6K:K=/=Z?77X3/]+I "H-ILSI33)^^9X^)>\.Z:[M(KS1FF_VOF]*_T^U7GA*5^DRP=^ZJF%K'NM"Y<-/EOY>]O*GPZK";75BYYW ML5VBF.N9W85[.V"?2K-$NVXPKV.)I5?*PL/-H';FC'_F5Z97/.5*^%;!W.KW MFD)4MF[+S[/3RP^R!N]V[(W&3C(%X4"G\^G^*)O5(.>PH L M,NTIC(-VKNC;J'"1SR=T#)>+" -K@Z%NCA$BGVD\&,BR^]KP6E>,VR>M^"!^ M$O3S+W?]1/,W'@VNIU8>%$MER&]VLTE[.P'?H+?($K5*# +F'J_5\[-F]9== MGLRI#U.MA''?XK7ONVI++& (F.)+=1N;[KVS/*Q@2SQ$L!T;IQ."A;EW>-'X+7)-"F569HE):O^Z-X4_>H,C&'U MZR]!VUF"D+R?NV-W0<,VFIS"P^OL,3%;E:51=VL:W+%4+/'Y4HK;:$15D31V M0HA*>QJ!Q*[4>[^*&^YYJVM6V;B%:Q2=W#XY5]X/#EEF2OA6JEN-,?OZEMB!RP5_6^Q M\:O^Q1G>A=?8+%&T*&U29VE M;'SO/34%U[D4AF)1:<^G, +:M8IOKKSY;4UP.!0L!'SS%7+J1M<R8QM0FLMHL"7(8TQ8Q;4E5P[-CV@H<,.49UP2S"4WV+?(E4>*E"!FBS:?Y M9D^.D95_"8YFRK^U\J=8N[>8P;LD<[FC<&7U!W<9/#%J,FOU3$QK9RT)H MXGPF$S\U7?U6J]T^B??6-2JBJGK1BS'J[V&G:HHZ,(OG9RLA',GM!L>6/DV(YB M %G SGC.+JXMU$.6A=2IXXOQ_8]B__>XBGAC;$\ M>3R[Z&GL7+$;O>1OR*,MYV)2;#M<_;UA=B0BFVG,B7Q#*?EU=?68HLQ94YMI0+,#*R M62,E?]@J'Z?&;WQ\7!!X.5?D\U*,JAP:@KYU%,P(R+ -@['?.TX4,)O:V@#9 MW!5ZX)KF0#%X^@.>:R%+Z[WG!HIUI^'GPT?]?Z9?W<40$&_M:3TDT65/&6CZ M^-VJ=Y#/VMH3HB1-EN&JZA#3GCSUWFL(MSBH*G/93H0'?\?D=+V_KTV*JZDX M*->5H8V7ZOWI/?>@J4X?GB*\.O*S!DOC_,5ISC6B^V59<$P<,/_?H\)R/#Z5 MQPYY9QBG_="9(SLM8O9X[N&+;%&*5^Y6,M)((.YU;[1(*;18TM\3G0\3,/;/ MVTZT3'_,!&[\M&?ZZF#J,25&1(I_*UV- $^FU78DL.!KQ>)(5=LS6C,3?D0MD3,@T3\#DB(<4;=NGSI/S8=>T?I8 M=#K)W#]T8V2I]"K4F2[8V.N<7'MO>+6>F8AL&KPH_]5:1W:UY4=VK5!QQ76< M;7__*AG77_*&(/NG=J?H3C.,M0_NPEB1?[55/K.TY/)*@-E;U@[N52VBY3L3 MX&UQR6WQ ^'MPBV7V\V6"SDE5PQ'UF6K]TG5=[G?#NG(_$"4,_Z-?PB'ZTRX M.Q3NWH_AF;3#I7VH!_:;R'LN6Y(F2+%KS+;D]AC;2\E;SEU4 FPKQ\C9HBB5 MY"FNOV?4,&H8-8=,S7:C"2M=;,YM@F_MVZ>?[:\W]K?\S2='W%7WM !W/14 M8=;L="[1E]M_P[1"U+$T4YJ58*8H_Z/I5!^?.GZB:(E&)3R-)KCDT,O(HG\9 M64HT3R0)6[1%VY'.;SPD8@]<#@G?&7-GF9M,9[2*(B^5I/1R.ZKY3N.L MEJBT']3XP?6U?"O]+<>AO^$XKS*9+;-LP>>F57M$5E>SD>JV"L9PK_CTNUXW MZU^K>CG1_O:+A@,CCR2_ZSV#?#/[KIR.280K=(SBCE E2PSYW1GGJO19MG_5 MY)53J.<5;7,D2$9GK,V'O<+!G"SR0BEK<&49HQ<:M7T!PESF9CWN@KV)0$*8 MKIXKIGC@8U33GL9I05%I3R.4W;6:;Z/ 96';<>HK9PVN6'15L?LZLFUWS1X/ M;I^N;GJ?+G[>?"M7=C9Y<)'?[KHT>F[;=^0,)TYOR+RPMXDL$YQX&ATG+E*^ MQ-"B>M<1OMZW2K\>_JQ$BPNU+F'0N( I>X6.2&[&#@O;(R!PZ&;' VZT1_C MK=5"UKW618JA@CL<@E^\??K]Y=???L/HY-327E)Z-B7*)D.)D$<7@VLSNB.* M^X=KI8AP;:G")0;8FM+9DVC7KRL_])6 +5SIDD1KRWBR5[Q6+$HPRSZU4&)# M))$"?L\AMF)19FS>\6DP7Y %OBRMKIE/O0/86RE/#+2G$7#N2^&W4661+PK; M'AN$8\FYF\H+UE\;#'5SC!#Y3./!0);=UX;7NF+.Z^*5!\52_Q][W]J<-K(M^MU5_@\ZN3OWSE3)'B3>DWU2A3$X)#8X@.TX M7RB!&I M)"()8_CUMU>W7H $ B00F%TU.QCT6+UZ]7H_3C'A^?/'[VU8G:,\ MEH.F 2ZAL,AT1Y3BDOK=L*\DNTZ392_2BC@?T'_M>]41.3:7R+*93(Q#:!MG M]NP=Y1Z,/I>(L;ZR?TQ'HBFFV6PZRW+Y@\\:3/-QG%*3?0\W3% M<.#RP2$Q&E,@9GK5\XR"C+@ M JN\#N^)'I:8=CP- 1!L'8U&V@DO\_J/F?C>ZQ:I3<;@%MB+V0-@X65,> M>*U]2Y]#ZF@+$O> 9 \O0RK&N#T\K?!@\INC)-!(M$*H14EDV60^QN['H%02 M0P,L*.RI@[%[(J#PK6@WQV:WIEUOW3 ;T!5CGD,SIW(^AHDU1ETKU#/OC[SZ MG(G4/6-"X)6+$S6MK+XP[HU;3M#$A\>L-CY7G+DX2%;,G/)8QS[\TKAT*H;= M!DYD'$+.2S@$ZBT]TRY'P;7T)F&B$O59&XO\7TNJMD2I-;UY_U5YRO _E&Q$ MK?H7%^'X!&@6@FB!"5B3L:4LGBRQ.5:0CJ'S]?"0&$!GW M65-1V+8;\9QCFTWS*3:1VZ3V.#;U3ND8U@Q%3A![W/'5&:8^R[,$;>7[("4, MLN*8C]8:M<%@!-<\,;P9PUFQ>Q(/\RM]O4 VU*UBHR*TE$'Z%;5H3?S[^]3/G?7 M^9;D_S$S)93(0X/ X$YPQ*U^\,A M[40V@ M;VZU_^I#G%8=H[1_3ZK97+N+BNB"#=[<=O."C=O*JTGV^/3PN$7(W$B[#IG)I-IM:':,^$'J+,Y,(KZ\)V;?3GNU@SZ*IP\%G M+L7C/0PPN>1C[6$X<^7#=C;Z-*_F.)9/)=AL>G4L,O N+@R3/[ -#.QM7",V M<=PD'R;%;]X!/\4F$TDV': QV4:[8QOG_Q@"1@3^_-^AVQ3^E^$2&$U-:8!T MIHK&3%T=" I+OV!)97?W"S,0M)Z$GP^7VO_-OKJ#=4!\M&?ID!C;76$@R9-_ M5[V#7*M+4T1!497[O'.[VV M;ZZ"/Z"K>^'A?BPBQBLW&VU3%3WL=6^T2-ZS08)]T-I?'1WIO_^T@X4E0@9P MXZ=]T%<'COKLCHGPX1^EZ@C4O+CRC@@6?"]H#*G)_D!K/FWR!U@S \;W145A M3//[ RV]X*JG^.L:=:6.9*PT$H]H_4T-"?I(F\1;$8QBX6IHA!Z"N%]7&0GW M=M_M"KXO ;&^R7M/ )X / &X"L!E^1F\'>=+!LC/:+2F#S]Z[XF$.OD^Z463 MGV%Z6_C<9T^&[2,DULG5L-[P>3V1$UC,6/ZBSVN%93/+P[(-S^T*K<'C@])N MOPT>?U?R=FCV:IV8K!<"TI\W<;L>6@Z':[>W3-;=*UT&\ZF'M\V'DNUQ)-OK MRW9RNV$['MD@#P\/R>X/[4^SG#Q(GK._C) CHX.=W?O62:G MW?;>[6/-1]EDOQ>\CL>UU4$S5W)+"D1/QRAZIKF+')=M]]';UY'Y;,?'LU**(DCZ4AK0^C_-.0E5\3 ME'\00K GCM]Q<1BEQ1MPQ.-U1AS&EOFRA^S>? V"G/USIQA75^/4X?"&^)2< MQ)/.8LP:]EYP%;6-ZG M;C8G:$[0G* Y7&A\YZQ84\J6C60KJUKI'6D=24>B.6Y&;TVYT>^KFWJ9EW]L M,CA^HZ$K9C$3G;CBFE2&+.B8L0E>U'MP:#W-,XF]C5J8<:2N(#=JUGO26V1> ME)^_$O77S@_^37'*1XQG_^X/O=$,V4MPV'@X^!%[F40,9WX$A9V+XZB-W9"YH3J$ MO@T)I[E]&NFZNVL)":SIX?G@L2/FZ=/<:Z;@@/W'=,0&S MI+4MOT_JX?PY3.]?/2P$5P_]*"XR)=%X2+P6'GN<;S;':CV2IQ9_7[1?:"(,CG8XMCG[#([I L]_(;Z[W>REIJ/N_/YU"5!D-9G2!$KJF-%:3I?6EX+PM*:]I^ZJ6NQ.>< M]-[=E4// L<4H@*6F.+)=[= +*G]*V<+B:5^BL@2"HM,._MU59!N](?Z<_;% MZ<'K15J;:V S<#NG@W+[):U,8P]['-7)'5-\&'X]H.8LYB/;6G7>RF+><;04Q!?\ M":2NWE3G#R99]XT9[AW5^\KWYW*J-]ADA$EP7QYY*=,[17&]SEU.G-W)$!3VB<9#"7#;/)N*L9P8ED;UE2X0 >QSUAVC).Y106BBDZRUPRP$% MKGD&37$CDXH?$31G8BA,=!YF=XK-L)AG?^%%@LHFA;AP8]B-22;<@^3#D M>#CD["O';3?TM?0FX6T4]=F":?)_+:G:$J76=%#^/:C]%I-2!45J,SOC+:BS M6[1@ T3) O[A)&3F3UP,M>3#0V(DREK.F)K%M5>DLS\U@ M@R*175T-'.-$B'0,EMO-]JWY712Q,Y(UW?OU^Z'WJHQ0M)%>/ZOUQ/GGSDPFAKKI MX2&1CQ\2 \,>0]=F4*:Y?ZG)LTD>_Y?:)"DO-G(S$T/M+S02"$-$N*>T$S0F: M"#C4S''>L8SR*2=+L>E\ADTD8VGD'>?F;B9]HML_;S%4\!=#OQ_&QOM#Y:;Q MQN^DH[NW5/J+@O3W23R=H#E!DR"$Z''TZ:9K3P"GI:#,<*1U^H+NY,BLN'\9N80P6&"C)_DYY0ZC M'W&(& CJ3LDM\08>)-*<2FT^:*6V]V&D00"O4NWIB]:Y5>64]O./TRG1]S2% M,X$B2$_UM=87,J?UZ9.8R;%)?C6/C7UG]1!/YF8[Z2\U=E?>[2-*\2:?-G@3 MUKLD&>0@6>].D+;$_?_AD+9G5C+S#,I70F(I:9YGN?2)K>QKLT,UM6 S4WR( M\)M=H,)MZ76=/3051Z^O[7Y]S#=20'F MV/(S6(IUN M^W:EU\?%QPG_+FTVP=)_V2&.L)Q7 &,TWI;?3M>/BMJ"31C;=O."C1@+0AQRFPO4<_.T9UOO631C;O,+*]UJ'W(#X^<7/=H-#'/_-I^]R]-DDER()VNU3R"QF4] _)W+-]_YVKCX MLGV.9&@N@MBI^KE]>@/:=2/=ELN9A^>3-^"8O %K1(-.+H$X[]S,*-<]N01R MM;JHCC/:+ZBY.A@F<7()'#J/./D%#G3C3LZ!W6_DR4-PVL63FR >N_B!? 7X M'P&C 7_"GX=NJ_Q?ADM@-#6E =*9*AHS=74@*"S]@F4:2).Z7YB!H/4D_'RX MU/YO+DF3V/A=82#)DW]7/8] MZ.&3V$!_1@@;)?\RZ21S<6$Q!E%Z"YX.25=S8:A#LB+["^L6]W<:]3K1C2+' M %. +)NGB9Q)^!O#W;'^GH6CH\JR,-0QP-:G+\Q8$HT^+#WQV8L>_#,0, M1]8G'XB2ZLSK/GTM7[B1:J'S"].<##$$!4UH2YTO3!5S,XKRJ@IH3KMO^L>Z M"WYQ&(7%)O[[#]X-CXU9P.@7IHV%UNM%&V'VAU\W)#L<8'<.8RMFT#[/53V1 MY<8QX)X2^"$=V<-ANFWS8>!\$5J)1-H6(X6[NQI[?E91.I?__:<=&?OF0U^A-@\%X@^5U2R:N M6QS'MZ9"OEV??)M<)W1H?3L:X!5-R"6835HBE;E@BFZI:_] Z(>KU79: G M&TIRC2)&#P"]2"M(+JA9";#P1#_[(#K<<#9N>(J;/R_JGT+C]?;IO1T);OB# MP T/&$G8N.$H;DJYF\>[MUKU>S\2U'#AH,8IXU^:(;V[$\DMJ$';HZNL:F"" M,,](T)B2(F)&:*=CAXG& -4X.V5M'XQ;?3 &%'>FLM5I6+G\)=?O^?;5#9>K MR #5ZUY3H36F>#5YT)%846I#I D&1G>A8TAODB$AO=#6#?"0M:2KUM007L;% M?)J;OHC1])E<02C48B1*8QRP+C'UY6"+IVQ)/PAK9<)@8)EH#H5J\OWJ8CL;/K2GW,E">AWI7T#>9 M&;*JSQ" 34THVQ)*93Y[(1K:Y5%H__D+X%V(,YBW\Y^7$Y-E;WF^Q!O/UBVI MSYN$?*)N6H7W 873OFHI:N*#[VW1S=E="OC-D3T7JTFR?"K+II*K2],=! ;ZIUA%?>D60T M@X^FNK;6DN"PWE+I)R:3WZ_UAWHO&KW%B_4NHL6U6L90&8)F7>7!W4_W&@TQ44AD?PN*6!BH MF$:GY$],R;R7*O&G4*SF?XA\9*H$[T//;G 901$9P05PU#NPHN>_/R:C M5!?F1[FS:2[/YE,Q'FH<*A8CT (P#I/)/)O()S\(#D,1[_/::BZ;8;/I3492 MK&9@[E(-]^IJW6O4-JXEO8,YCG&OH8$T&OBQL6;U!=T(A;M,:B<2VI^CM0U& M-$&.$3M;B=?=,;4<5LO3AWH8-\-C%,9-#K.UU>49QX3%*!A;*L.F,M&PM9*+ MK94&0UF=('2%%-25#!WS<5("<04-9J%H!"DZP89IQ/AQN:NG^LLH]ZO3^/FZ MZB*6RB8C8#MI;$6D@]4 M4GC$>(V $7)L*IU@D^EMZ=77O]T98;8Q,*N:;S1!,70_)E?(YW)J8?BMF8IH M&%DP?D<@97H$U/T0S7WMZ>E?%\)V:7B"Q;3:B1>O0Q8(7Q$P)3[-LZG<)I,H M8H^M"%@-G\VQZ0#E$YLPFHQ+YX)>NE!,6^N216).^R1H9*5E56L@[4WJ(+VF M%65!&OCRHHRB?'N_$?(_I\F=*UR4 6%T,[H);>2$$JR)=S85PSF^R^7N6L2P M*[Z!A=3!*C+;(S02+2:+M>[TUDCU->@L+::(EX,/,%(,R$V61#.D4A8DC33L M!G92-?F)*+4&NMM35;DKEZ6:T"ND]ZG>.$L@54WV&IBA,"'9W%V\&.8-5A,U MI?E$-(F 6H7IW>E$F22;S6RB$D4^+BQT_$7BKP+3;9.#>7CHBX*S<7DVF^3" MGL7I3CPB47$=%J=JU^JH;71'4R MF CYR".'-X*D0 I,3;F6]*&J2S2X4-!U9.C<,H7LKJ+5;R:/][\&_7TJ9'_! M"O[^1X8T'KR1(EF%($.5FT 6$1?K+YV,G_6W(BEN.7'L+!6!9Q.I6&J0H6,O MRAQ#/AVH,]V6CNHZ$D?DP16E#DBJ=1]T1);LIPR5A]U?_6XWW^F_[%P;LJ%E M)(5N*O"-D8XH[]BCA]$?CSLTW?@\RZ4.38AO@KX(N%:63["I_":FQZ$A+Y($ M@R2VVZ*)JET[S,KTO='Q<2X'G!^KREX_%)._T[6']TV2/D-3>4RP&3K0;K>N M;G^J\4/F[O@5SR79''=HAMOZR(N"6W$YK&1M&UW:OY*=V5C)7EV\>6TV":9U M$4WAO?0.>0=64H(?TYC\N+MZ*.?SZ5)^#YGB%&2LW@#,C"&\[XM'.'FY2[&X M.VZ132: %<>7Y$-'8Q2V&9M.9MA4+L9Z3E#.D0V7<_!SR3N4M5>46PF-:EU2 M3R5,2$T281PS+..W5'O2Z]]__ZKL5<^@D713R\ &DHQ!!_NH0\JD3.ACLW_Y M^+E7@L*>3<00]A79+_[T'+:1,&<:Y$+(8UQI&52@,P;2C9I25!5R]-HRNL=+ MP:=!U295:'JY>&Z59L7H2_FJL0=1;T$,3M". S.4,YI TU:=L:'Y&+I# \.> MBB'L_NVBY3))-IK=5$KQ/;=8YM9@#=?JH\XK79B#R!ORIIPD#6"*V MJGK2&U:/2'\(OKH0T&@4^E7Q)?.6 N?L_J2NM0@XN>8JX",L@YQ@V )K(;$Y M$!LK3S& /1<_V)?E5@0E\HA/-)M(N&@B*PMP!CF"[G($V<:'R7!QS3X/"SL<0 M=O\#NDBVD1_%@//"-A&OF3D[=C9E%7@.52ITJUG";.5=YU5ZJ?[*E-48%*5 MJX2Q"3OQFA-QVK'!CPV]IV-([T%AS\00]A6F[#*2COKH)KDTF]JZ9&AUFF)% MZ<#<%72-Z+^N]CWF0"17[Q[^JC6MOSPW>AWCMC?>)-]ZG5YIBTLK]@6EAW3P M.15'F@;)UC1K@ASA6TEH2S+I-Q0UY:R^<)=T?/C0K,Y'6Z13*_&NCCI(>H,< M>TRA2;^L-&XJ";U*HUPO=_8I<"R@H=F4"?5^XP5!\+J'AGY1+I3?)&]U4PL#4B(\@_R;");)I-9C?IM[+4NKU:RNJN M1PA:\,DPL>%>T QJ\2:]HLH20C??#"'WJG1W'U4>(>B8]Q=T ?X;>!TAZ4$Z0-NNK Y+B-@;9ET]L.A,8J"J*UK,E8W%UU<< 5;4XJA MFAX\7]WMJM?IW@[RMQA]N]+=(&YFPQ8W.G&!MI=>RYDLMD^3\>TYMK9"L0JA M412K)UDNE<=$&AK7W^ N(U O4,ZQ5\ MADTGCD,["XC'2'A9ALM@*;M).OU27E8,%!NXI\UW_)QEBOIT\_OJ4;SR;81'8+^1BKDQD$HY$T%DIF4VPFMVWK^8/#932,#IR3$;7QSP3+ M/;J%OZW%3_RX7:Y0O/FAOW"@LT!)_/(6V?(KWG+ MZL&^00ETO2=MRF%]=G,/;#8#@PMSJQTJ/M.-E_#>TW;NW-&83?)L*K-:8IXV M,Z3-C++[5"J58E,!.KJLNYFKP]'!9V[#U,JF+7^*Q5*]."T_RZV!X<@BZWN> M+[>FI:?A[^^3CG#+[Z0%7N(R+2EKR"@8:=E9.=)R9G[WX9^0E6-> Q+#[I*$ MDFDVGZ?RM^; M-_G4SB-X-V@@*1*F5KP,VL0W/M*^-LA7++L*(NC^I]7L2%5 M?^VL0N_3U_N1UNF#GU;M,LB",FY'P1>=.RQ8P<9+BF.3_!;)MH>*T"C:(^99 MGLNQ^=PA%N1MB463D')^A1V)F6 MEF=S 2HJ/]Y&!J7^)2;#1DCS9JCEC;P7,P$8PV&H,\$8=P#F7OV3NA&RI8>2 M%.L C!ES\?1]'#[M;>;9]=C_?21F!5=X3W'FL+8TRJR!3)[-9+,L?O1I0W>V MH5%&7X(K_:?@RR&XCN,%C;?Z4EBMOI0E15 Z_L&7P5LWVU/>Q'HQHMR0]8(O MU.[K6D"?8B^'"\W*YO66XZ9FE^N7A8Z58.OEEWV:/+2FU5^/B?<_J?8MZNV^ MBMV$F%&IC@PP3YBN"37+*-'/XEO1,LKYG%I7<]G)JL/; MOKU6Q.*=W)WL.EEE]L2282QFDQSF8J:M]+[4#B_*GT?M[C2/3"[%YOE-C*=] M9Y*MC;\H&DCS:99+;=+5Y>"P%X'B@8-'A,I)25#Z18Y.9U37W1X7)")A?FDNQV=0F?7*6LCX? MSW=1571#&Y%7F(LU>QMZ^K^O?N:-=$/*_^ VB3-OVWS:[?3NN "?T>9BXG'T M0>P.BRM"&M2X?SLFCC-S \.>#]T&6W3X+CG$?IK+5;_X32[EO^O\)B6.D6@N M>SO1P?QP^S_0Z006#+%458*>AEC.U@T*^\;EK^OY0(&V] G.*O\OGV^;4OO MF>A&9J[K28G-7AVVO]-- CL;'7,,'L]3V.JH:$P.4Y0VM9>#;,=2QV<^-M:==Z_]> M16S!J617ASR9/AJC(+^DL'+#S##/HV[.ZBZ](ZTCZ;1JS.M W[U4^N6[IR>Q ML/L1F45U,% 5>G09"5,=/L&X=1 MM/]/)=E\(KXCF4+&8!3ML#$"TSR;3$;3#]NKCTJM2T2-)92*JF[X-4&B#*V? M,5)WM$@NCQ6Z;6(NJ^>&.RN]EJ D31'U(#:/'U=)J_UZO_I6?Q3R^YA>Z39R&-%: M$ /S^&)#48'QO,LX:3X#8VJVB$H=/&(C"9JF^12;V&BX9>1H#:]8,.7!3LJJ M5D=#LT]:K4NE_$KNT=::/\!C.4A3?&QY!D!5;M\(A,_U2XP["$[0],KG:%SIWC609+N:.UVMOJIJL:HJ'4H3#I]A.7K4%,-1+<2?^QI LUHC(OU MG^=BV!8Y,.RI&,(>++_*3=(1GUDVD>;8?&[;(MCUX@Y>116SQU8H/M=&*:G< MRV^B#(>9BS=33#%32F%&(V)#[S'TU 6&/8Y9<(%E;=2E!/.NQ70H8<[5\[[< M:YS/W)D]KIR2S[]FN&H]M=]: =^3&Q="YS>.[,8 ]C@FN 4^I"OSCD([H-MD M&VTN4XNJ0DX<7IZW2'U/O.5_J?WW?G>30= MXM_%DII."%SV7=R?E/7OBS^3[N[M1!84D>FXUCF/Y,/K!AOX3"[QA)U:K/L@ M+;G$!??AD!:TDF,U=XF:I0:U3\*94)S;J,,L;9!OM<8']CK3#K\JW)>:?[H9 MB7N-3%G:N@>^5P_:HZ7S%?VU/;8X@F"@Y-THG#:5"W\F]VD?HVA\[[V+ M/%:+R #IU1D+'VD;(]W%$&-/>3;))<(=5N"GX(>I>N_(_-HDX>6C0',1AJF7 M=&DA<"+@/QCI]";(H)C5D6YH4L= (OR ];'9+UQ7WB--4O$1ZF@(:V[7B/Z+ M_Y9'0+6E=ZS1*3U4%PQ4ZG81],@'/<:ENR0+G5\9\>G/_3C,II>!FN2#BB*9 MH/_SEV@"_SU6/9ML);2VJ8":%37K[FLM]* MO6_%B/I6>/!P'X44@&29-NI)B@(&)I31D@T^=H5VJ[V<)>F"7NN&FE&=9/D< MQZ8"C*[X<,ZQ76]J>(4N7(Y-IF!75[>C/.UJQ+N:"*W)8P[SX6PJ>E-T)CO2 MU7)E#@T+,J=DR9S"<_/I1TGZ4T^%6=H=P%A8%#V\(WI(H$BS5T&,!Y9!^,O M@HC?D+K)?8RHCMHR\MJ)_P2B;/^G!"+M51OH2;VAU38D\VPFF6(3_/J>,'X[ MEO3Q-BT.VL%IT];*L%:0P-@ONS*N%B2Q85!]E2\ MO,/%=)MF7O?I:_G"C50+G5^8YF2((2AH0EOJ?&&JF*-1E%=50'/&?=,_UEWP MBW/ZK9/_WW_P;GALS )&L8JL(>'UHHTP7\.O&Y(=#K [A[$5,VB?9Y6>R'+C M&'!/"3S$8WSBF?;.MK\6[NYJ[/E91>E<_O>?]M<#7DFQ5FW4;BO7A6;I^ORL MT<3_WI6JS093*S/%0N,;4[ZM/1WR&KUI;2T>$'R%P;C%IV 9M_[9M.OGO7BJ MU!@XP,K_?N(6^-T2$;C"XV#M8%G5&*./F& 0;/QQ\'D55]I"']WX]5T'#XT*QL $>*C@1)O!YIF 4T^XBF'V-A"H6=F#25 M!O_T*UEXN:G)D15PTR(Q+PB'RG<0-P+YVH\<"@\:;&DHMI5D!* M(=T DJPB:+["6VD4JG3#E3CI@;_>86LD4XE.93[[!K4LD.=18=[*^]^YI=O9 M4O _AY5!83TP]=G;$;W4DSRW48&Q*E7!5#@B MPACZT+K[*%O5%D/^]?LDU6]>;])P;&TW@;?KRC\#UK4 S[[*ARKH_%OJ^>S9 M+D>YXNW,LHGD^AV-CEP["6?3HICZF,NR^4SNM%^;:9-KM$C=SI"V^')%T4<: M-,:\U]! &@U,DH%0DILW3UXS-8.OHY_5Z.8ZKLF0;F3[%LE 2BZ387,!^F6==FW#78O [\1%4IO)2GL)>#+ MH 6[;"YB\"=6,U&>Q:!>,@E\FPJ??*=1[1C$8B& M7#[+YE(1M3OQ'1-KB09[X':ATQD-1F0"6$V9G;X]-^YY.BQ??>]Q#[*>BRXR MMZ9XL)?!",XZ&#*/'J&8>K%SI_1I(NP1X1@K'&*.OSK/P^E__3OLF)N=(F^:51 M*_VN95#V36:5DH5\%-)9,KGX@QTV?Y;I2^U[X)-)-K7AV* CW[Z@!+]D8&&( MO++D\,JJJD"F^Y.@:8)B5,@PY+*J-9#V)G5F721B1_FC-0=E0=IU-KXOBS3! M-H1*XA\5]X)CDWD,7?,GCJR;DCKNXDMIF9R M/JPQIO?VC%MPH!.^."TJ8B&?U#N_*OT8ZH]%_PF]'X)@N$0B;-/C^#&V9#SX M!\/8T@05;ZX0]4CR3";+YM([=98FW:JBG8M31\0S"_M<./IP4]YF';&<>/L27CV#\8QI;I MV6MRB&@9)L]FDFDV&V!X5#29:3[HH.)#-R?$MZ:97]\KC_<_ZWPJ%T,MTI]7 MPMZ9"SETD@[*!,(V0(X>8]RI'&MCMNGPB:C9)!>ETW9E&Q#BM6Z,VGI'DX;P MWCKJ(.G-+JZ8WG[OWDO3Q'OWNA<7#9+ S.@NH#%OM* ^=$H->K9/T9EU,98Z M86PE-US"#J+E@YE,BLU'-7GIU/9Y?XT_I:_-/CH_$SH==8 ?.H$\6O""ZHR@ M(0:_1<*O[&F"3/1:F ]A])&.@-A(@SNB\II%GO@BW7J4!'VJUI3Y:5[]_VITFL@I^MJW/4% MD[C/SSCF__Z?',]Q7QCG.!.D\8765-<;5]G&C\G3UUK]IE"M_"XT*[4J M4ZA>,UT(7\I^T3'0+ZHF&1-&[V,CKZ_*F'QUL$7$.9Z53^3.@58'7L_Q7++5,C^E6U/)*%2NOF4;CW7^$V-(!BR: M/@H(D4!#X5C5A6X=4+P<(USF@N,ON*3]*1W0,5*IEEVN$?K.3U]3V32;R7F5 MUA$"8_Z:1ZM[/K&=F(S,9L^TTS-]-G7X#&7)T+U1^NUG&E4::D[+R/XH=:6 M#C5TH&N\FW M V1MGM?1O5(%C4SIO)8TU#%433\QYI@OB?C7S'UD,#6H0 H:5@9$YB_I;T94 MB6 ?Z9*"="*&;46"V'U$?V#QI?A:F_(P'7M11ZU99 Q-H!0_&;0Q8>(KP7-, M'B#]#;3&"#T-$>V;B/BAC+_"!(5MCQYH,2HF]@M1'4@=4$+@"NN='B\D[CZX M&ZLHJH;5%Z+I,UW,!9@B1C,^](HDP$.OD2R,\1EDX9'G9W]);["<>;Z8FN>+ MIG""X8;&I(X@YH<FKWSCSMC;J ,'.;VA+YQ)LPK.C"Y5[=,E?&$5U*W,@<,[/ MS*6+>'=@7 B72)B7DS.(69&,#RI]'GCN*?(<24<.\0*94-.".$G \AE:K$C! M:&#&?9!@Y$D6Q.;AL@"^9 KXM:1D%?RU&$KS_ADB(S35%[#ITD8(HL?4H"+6 MC(R9J BL&[^>,*NNC'_ SY!T"N$ETR01"L-1 74*->IVZ3- !(,,M=3E9((] M/X,=.PG3F"\)K!QJE')98N)D9TP[(&B&.3Z\#8Z2R5,#,$O\M_7L M2^;!]AU@P 67"N6_9/,"]]*VLW:R M+)]+LSG/G"/*]14TEC']F=3@3V8S)DF%6"L*HA@CAX P31>?G*$US'4)<<\3 M6VF>V.IH.,(G4L"BADRE)K_&CY-OC5O'A\%?P7"7'D@,@NX^+@2 MVRK/A3=M49/5AQDMT(??2:QA:M-B014_FV)V4KA!PTEJI1,%RQ4="PB].[%; M#A#<2 ;I&K<-:R((B2NEI'WS()=1BAM=0"6+&"/J&B.X^CF MP322R21B'+\ MA#8"TU<82C S\6OL%D#-[LY&-P,7 SAY[T),LA[4\.TW]V>,!0K .P\]19< MN9=D127[04W5:A]01R8P9M@K%D3\7'D>_>DG!HE&VR9BNH0Y9-B(T.:6L3SU M+# VXDK!F42*37H.+IJA8!_?RHROW$J7DL"ZFA##>A8')F72IOF@(6(3"O(G M%)NK>"B*6(I0@\%LZ\Z1E^>+V!%REUI8Z SS(F!0BP85:NRE)'0KI? MT'Q&2P_T@-8T=R.^?+N]2MR\I0\O%,XS%PM!\$QK^JOR0QP_Y1Z3O_A/7QL/ M=W>%^C-,&6]4;JJ5Z@V*]4;YKYV6RE62HU]!+?W@T_U(Z7,GR3DS*5@$$YE":UI\-I[S MU_6K]V?YT]=[K+-UI*$,GBO,Q&>0LS\"W5OBTLX/WD[62B(V*Q.QU++4E41(@ 8/Z0W5'&I!\:ZWCN)C,YY(8 MH=NC">XJ)$L##)E!'%ZNE&S0$C[&5NU+ 7C0L49?PFO'RBCHEC/LDW>QS]D+ M6U.A7%6,WD.N\S-_E PSWYKR];KV[9?4:#;[G[[B]1-.::/@Q"6/Y.@1+CG4 MT% P'>9XEWWX)!PY,-P@YX@X'F>@\(55L#5C9FC+7::'%&Q+ 3O%OZ.A :D< M9M3\ =LYF!>2]%+*BLF)%^P@J[DS#Y>-2^:F4+AW)7@05[[.C'2:FO>*N:M% MLC1 %4C)N; DD T]*>,:/@>O0^1HN/'N6:U MTYL(8HG_"8NACC$29#/\!_Z7D0P XS5J5B10U5TXN61<)HP+50-!)(DQE##P M&\[/:&P:Z!."D>O)U3=!'MG4)4#R(FG?2 QC**$SNB/9%K[L[.6BU=_9$-ZQ M)"4X9LEX.L500?BR>+<1/$"6WBB]6!?U5%4<2[(,EV,CO4?Z1%D_$L?615N@ MJQD =ND[ =MCVD?-X^>31(Y4(M^86U90Q(J]9P6R9*T\/M7>R>FN2-CL0V=_BVC[_V74B_!?0I+E%N+_R 6]G$>/\A-1Y0-(IN- M$78I89-"TLR\+V5$)"C^>J!"(KMFNQ''?7! *C0MG%$[G9&FPW4=2>N,!N"R M!/YKYX1A&34FLH(\1Y9>(4$#?ZV#8JT'_+^:'UR8:K!8!6E*7NFQ6C\8"1:P2 =E"P-FC-4+W4!#]YV Q\OS MLR=$/OF2B%/3X/<0<'QW)0U_(-:JK5NT5?75P8Z";/7&=*P[V"/ZTB(A$/3, MX1FO5T20(2$I=DC(0?+\:V&]77P$=4P>914B&CIU:'1'I$;% MN8 X'ZB& ZH6IN0V$(0-@7,/;+\NR*8"K-JCFBREE#4?@_5[S%PE8$D*^;%# M]'K8KAXTYL1?"0JT>V'A4BBG98$;O\+C48^@E@11:&J;:2(PL%.0R4K43QH" MN62N1W;^K(@Z,J3=6EFW-L)@231^"6]#--YMOF\VT$-.'#V[>!E>9(??99,N M(W4WX##PS1UY^5 6 !IKR;Z7OYIF"]1)6B"_1R!0N$Z.S"X%7N19B;QVQK]S7=@2Y P,NX*V44.FI MF2'6\S-*C!#R)>@D>=5X$4""HK/+)M61+$?SM!(;:N%@F." ,=11-8C,R1.: M?^4ZP?@N2U$B;\98.#\SM7X[8H>8"1(T!I$D29JOEN0@7XU/XJ>30S7[[6R: M%P0"!>?0SQYV8N#]9UFJK05?2ZI 9)I/)I))KC5M_\YVWZ\JM_4'R0X06Y>N MRENPKYO1U0MZK;O);)CY46)L+IM@$_F47VB6M3+L:!(>)F%\XK"Z19GNW/%P MMO&;.H;45=8B!M_C[A7OI5D,^*R1H['D_-/S/%0Q1& EVF?8$4CZ,MJGEC9Z M[R!$?<7.,6#-]6*U!DQZDKIM@HZYL]JC45UZ\(#O8LK'%JM")\;/T>R,G'<3 M*-#5#"VF3H9JI(8JM'O$]B7\XV13K+!1W?76@>YO357]IOF61'^^WXM'Z6A. MM*;]\9_:8VK\NZ>U/WTM$HD YQ0^,2[4G#S.1W)BL5)Z?C8<:9C7NJM>7/Y$ MEQ<1/*RVPDJT-"NGC.E+O3Y6NV0)TXC;!RF1V>KT=CNKDSJL"8,=D:)9\EX- M834,RP>C3XQCJH41JX2\U$FXVE5]WJX:6^V+/]:Q<8'?@#=Y&?^;8YN)E6PS MV&-;T\+==5DLH38_D@\D#V?9B5SDILG6-'W551(/-W\>A=2GKPY>SL\ ):=. M%#'T;"[9XB/=$1MRQ[Q$CHW M73(UK,:Z'D(>;06E)*(U8P.,. :ZII%&#$?,LB6S\J8M**^$6>JH RX"JGP3 MUDLMCV#!P5L57V2GC%HYG-AP BMQ1*QQTG3#0 $?R'%VC=J3914N+%52;'@M MH7-^=F6NOP%!.;!-&+PPC2C>&JCC%]:?'1GLEBZQF/%";0\*25@VG1X0IK-# M6%35IR#L+H042>LGZ_0M,!":[(8-( CZ?5W:8"]S:K"WLP9[N5.#O3TUV",Z MEG4>8MMM;]F1/B2^=&JN=QQZ7/2&B=-K66]J@HBPM4 JMLP$?MWYO6 EJF"+ M]=K,4K&N\C14W/V PGQ-:_HZR+WW7HQL>=HY5C?09#JM<@TYF?Z6@L' '3,7 MR\$3\=[:R"(>4 M=C'7]R4ET)$XB;*"XTJ:=P0.@T=-NE+J=*@=Q 9+<1DO- MH+*+]LBBG?=H2S22PVVFI$'WG!DZ&BF@6$!--:$SZ[7$;P\%VHP3T9W1]H4> M^-U-#=\+6G@KM+P :X&!L>^&8S?@V[S?>_+<1R( 2/WCK=2!B+5M<:[.*K/* M-%?=V9H.7_G$]:^QF$R^'"63+K>F?U+/8NWNY7=OC)FTB9'S,P%74L<(,5$/5.I..#*D* M)-2KT=0.URW8<,+&I#; ]][>%N$!^$@).@-%,<0O8^523YB.U00#BG(7@>E! M\)[F?A-/#&;V.J0TC%5-%K%1A^AH#OB9IE,4AIHD,QQ/ J89JZT@@L^\P6?Z#-01"9A*_5CD3$ D%$7QJ8:?)S_3F0&74F"2\PJ%:E06=!)-:I M3KZ'!!N*'0A:(XT$,]#[4%8EPY88!''G9Q1S5WC!D)IP;THZXO(B^" 1]:$P M<1;$:.I$D#$2NPBB+E1^P2M)X'DP,(N+R?O!V>7Z:OXU-'U)A6"V-&B/H*D4 MK!P$*:0]J"/C0NU>##%/1(:3MTZSW 5=58ADQ&A\0[+]\X>6><>Y5KN_ MTNTR=4%1YCC(6)*A0_( DQBD#&FF1J6^(AW#8*=!="D/H2E(#N7B18_ [8IT MLY)_.=.@7*&,VMI(T"; %/B5K(3R#(#4KF:R?*T.$#W>)S(*YT?ZR\MS5]TH7' M*RGU^/0[VOD ^U*7,ZUIZD;2.*52>GSY]/4>G_F3AGP\IQ)Z&#:@<)'VVL]9 M?0S!$XU5V$Y?P2_N00$@J2&W:A<+S8I5K@B,FREHTA1S-\;5>)=U$B0A!F'6 MF[:VX!* E0$%0$,Y.)AR\@.@BW13F!+"3]?MMTM8DD;D= M0;JRWB%1J()SH8VPB5FS,"3'A2$UGCDVE>#97#[#7'%6(L]PU)8M3XI56FG. M.X(WT"2IQP/F-E)D^H^K*U2U3J&VH8>Z7R> MV%JY#RVYX[16TKB4$LA,Y](E%#G?RY11\4GL6?0(ZJ-@ZXUF7K=YF&G?+=;Q MH0K,0@;\3.]PJ 6YAW(&R($?2J(K#][IR^92+>:UCJO)'0S)*$+"!FVZ9M]E MBF.K15O0+F\V7N;=@5;_MM]OC>1M\>$N,Y[KWT;K,E9V%K27O"Q'WP*W-;L* ML]7:"A@WZK[VT+B^MSJP)2X3_NW7AD@C=YV?X5V6J"<>"9@M$^J;LQN(9Y[6 M<=F=YTF]'*3BDZ4!43FB88Z?,#8[84*+7$R+E$ZD$!VT$8TZNE5\OT]3ST].?GM.* MO3ZW_E4T.[M\SPFVO#W!=H<4O%BBDF?Y3,Z_/&5ADW/+-YFS-YF/]2;WFUTM M_7B%_M2D*#>9LS>9W^,FIU)L-K.L!@D?_X6-SBS?Z(2]T5RL-QHI5_WAS:\? MN3Z*1_"2,S,GA(S M=Y:8F3\E9IX2,^.8F+DKAG7*V#R.C,TX>3/"6VM%.3^S_&@)+D?[0PR'LF0V M!P 6:34CH,Z-CFHV![=BDLY@6/"W#9#15T529DB>XR2!K?:.8MIR;&#B-GF# MMJ/4F^FX7^>CGP860#IU:W94JPF()%./K&UAFT.5J+HGGAQS1[=6"%18#A,Z M4#9G%M(.AC(B'I:YT0V83AI/S ^D("R@3:?V@J_;C!#HHP[T/)@=GV2V"II] M#@E37#I=&&=O<75,/-'@T:W5[#(Z%VI:(#(2;F*&9C\+DS]U27LS<20+FCO6 M9,Z@L],PS*NMF]U,EF:AF($;.XM+T:W&DAZ1''8VE /78/L>D61=Z+!YKT$_ M&LR!ZQ0 )S*#W^>*F=#Q9J=XQ_&M%=*;H,NW8K8,@S:P(\2T1Y),"! ZQ5@T MJ6I&%UO*JADV-:"W'?F=-#I"!IP*PQU')"-=-;4#V7[FH$?:]@7$O()A=)$W M9JSC/IIKG$1>A'2D04LG*/:US\G\O'H= 1.&YE]FQ@YMKC/CJ/_0Y+O7IJ?> M_4OG$F]RP7J?>C^K-:U_+Y?ZO_CVS[=HFYE'G&_#M:98W^UHMS_;OVYDK/= MN14H'7;K7[KL.$T@.7'E")1=<[(HU77S+%-29.!^S U^]9"I5$BB.2/^T_Y' M8+YCBVT F8[6="42$%051!I1"SXC'R:S R)8ERX-O;]Z A"0O7D+##W M9G\%[ME.IH==4D637(&OL78=%J,AVOU/[TM#W9P9 M+KG5J*&I1GUH 7.<:X632 LLD@G6#+ACJQ/-C/9=,<;^+Z!?,W'.S%^R"=7) MHH/1;<3SH9JY9N:9PK -L6EZ"X?__,P\_7:5B3TMV"PT81;J3,R&EDM8@#N! M "Z^00-)D9AK?#2PAE=1WO!I&U!60M]Z?E9%;X(H^+_TDGD"90ZOR0&><<,^ MDP%(JQHQ)E>]F5SMAPXS)=!*U3.13VRQ8(O'MACMEFA@FK![G9+'L$M .S^# ME_<%D5&@(>E?^;]GINK,]8N$O2(,A9IL]+$VWP0(-> SI+7G2+G2U%>D76*L MDC1+52$]3P6S.5U7ZB::C4Q"&=OI\ MF"S2S1W!8J;L$<.@=@U"K60"!3Z $HW;?FQGR0YRX.WVFS7M6M*'*I:]M>XM MYC0DYA]D,H&[?=DFCVM-D]Q+1>U/7YO5HTR4YUO3YH_G5)G/]T9Z^M-7!TE$ M>P+L7!#T[%V!/ZD(H;M03,<)R;/& EPR(%_P#5G#TNQQJ,K?Z9A,-6 ;JD0GUF(P9Q@M T^LV[;\+41O,MJ&9/K12TT=8U)@ P+P$O_?3 MC$[2B<#5/-SNZDN>2@6[)Q!8OEO-NP%@:VX!:1^_T"B: F7>:>5IFV\A[GN: M%8FWRFFM;3;\<_BEM\(\(6NFSA@Y>91D M4+33O%A6\9/F6J6!>\MN #K_[#<+'8M=U.GK+DUV8&;!BX2=TI9U5%6P)BI1 MU02OB8[L]7R;-M_GG*R[W[E!R7ZG5%;JU7\H%? M.9\F-ZVGJO?C7=EE%SKJ0(;96-5$?'*7II>% M!M1"6N3^05I(X-L8I*KJD8"W^@M3NKG_<3,+DS)(/,B5F-WU2_)F_'*\=ZT= M'[$F7*?#Z.#V(GX<[.43-BJ+IB$3?!3Q>@]J3?4DZJ6&4S&C]HY2_4UC85#N MC,K\33_UV(:FO00_I/65-1W@I/(>D M;T[A9"Z[,Y7G,YG7QL=,(K-OPO,GDFKL2FL._@*/!.A/5N*RD_2\-L")RVRT MDQ<-,10H^="AS&>R^;# C#A^79GI!4CA)!. .C,\4+ YFWM9)-\])F074SH[ M$=8L81$1Z)Z:1FNV2?38E'5 >9CP3H1V(K0@P%Z;^L@BG9'<2M-%08K>3R1U M(JD@P$)S9P^^M4!/5IJ+#L/IP9!R:U06YTZ5Q3NK+.82I]+B4VEQ3/RMIV$O MAU!WE&')#IA>N6I&]V5!K/@:'=\\.9C2%\P^WTD ML]%V?../Q=8)!U29A&E(ZQ_^3)TRE; MNB0R*]C5)K1!*A_,\= DO 1?L*1^S2(D&OR!!%F!@6MD/^JA+:G[])AI7G8F MM NBYJ29'4P(?]DSYZ)C)'^!6!+Z7#S)Q[ EO?!<;[6.L-/-Z/S,9S5C*QCF M\SM^K&VLD#8$NLF<[&\O2>".1/'DR5PVE[V,OQ1D_$U>1MM&^H?>NE:-(\0T MK4"D,1F"9@8YY9W."/.HT1 : ?:EH37CWA4(M?*R9E;4-6U_.6$T+*#-NI!L4&'L#Q,-S;7<=6=P]M$9!8%F^LE^VD&3T7FVOJU[H0)88T8 M;=H(2.365<4.=Q(VOQ@L#;!5 W3B3G%?$N%.=Z[ NQTW#W@,K8H"DYAFDIU( M V*(!^O[#^Z>Z&"YWW(NIX(JZVT$;O)4>",<[NF6GU3))@7S,6AB=/L0D.3[TRDX[E/0,!/KH"8: M,NL"DCX8_W9.'A2'0!-MX,VZQ:A-PEL0"RL.![%P2 DEW U/-$=GKGDLW$4> MV,[7Q LZ_\DRP#&%OH&KPY%DU+DPTLGSY\P*_':8!P7_$KT?:EB)VF2%^0@. M3/MA$REBXU(6VDBF1PC*,$\'*.Y+NA(4!?P]!6G#$V@0#LY"#0]"' ;CFL3C+LT]AV!*/C !PB3POB<>"T0T%_*XME!0=/L/) MAE 0G'P%]52' 0V0* E,FU9X6]5LWMBSO(!$H$+5G[UY["PRS=Q=J'G74!=& M%5C>(?-/\,J8#2"M+AOS[IM+YFIV/XA.;Q*D13>RC#F<-J*SZP A9(3*4DMP MD7F9-6V(3E2@_A!S%\GC3JPKYDLRQ^*=GU&/IB^3LCS]LO1G)(FVO#-K)R4% M"E55;4('7F,I"]0'WFU-:H_P#T'T83B0U&!T9+_]7*(%!%4 1 3=]XAR[BIH M=3\-CE=7>B?M$PA?@<>3N:%.80(U,V&@Q^*ULS,[S&7!8=$1\?G-Y,E3,#4- M.!,MCV (KR4*%*FH5=@"-9>A1&BD$]LN;I+L] Z@)HGDF.^^8!;8\F M& D2K=HUBR.&@CG!UNX<0L8CDLZ'6/'H2$-LS- @BSYOH<"HUHCNICV5Z&E3M>G(E@AQ? MG8H@LH_7U$:(>G>')WTJ]DNBN<,&ED^/<(55K!-<@Y+,!T#"G'._9 ER4'A( M7*9##7 UH)F"%9IE1KSW6T,WYJE=LF#-"_[V_";6B \*=:?%V$%IK>O-#NIFV M?[\-WU\C+F3=0=ACO3KL&;EM]VQRF(?9S0,K[B1D/U U9+:=H.F7'=*9CDM\ M_IOHNZ1QA1V1)&WE!%IRJ)N*/'&KFWU_]Q-'B>Z0S-8/7R5;4_'/@U1L)U*] M]YQ-6= /0Q;PR_!!0I^^-HK?2M/=WH!;$VY>X98=PG.W7_;&O//U[G3 M-[\B'Y0LO/1H,<*'@I%@I+8PNF5[7'@FY[4#KIWS@&(Y_//IKYN>Q TV&1O& MI3KPIL)-J1$5&?+ADZ&IY^EQ/7D1++E@"=RZ+7 _T.JCVO#(U^?)2PXECQAR MOTVRFTN'9@YI#>X3,[.*;:AAKP34=AV(S:5-3!9C4Y)'$4RP@I=Y,IVW-[9X M\#SM6/V?=BC?YUA7X.UP(YLL?9X)GAZ\_$G!OPSVGI >3(NI0@8C.&5Z=9[1 M>NV_^$2*Y9,YED^G_W93K]U7Z-_EVQ9DI8'7N,8#3] VWZ"YE"@B>* ^OW_D1_<)>)T7M<$Z*FI8_MS4YG/G[X6YO?._)'_O'RM MED_XLU*L MZ[QQ05?%/IYIV1?/!:RM\QGQ]K=G/+;:K;RZ]=-_J[3"4KY;F3J9+7-BDD=^>-/QV/C"!^%SF$,75 M!D0Q/_PA%D01&K.8/%3EFVG]UZCG[\.S%=[TY]"UIX6)#8>@/64NT][:TS+2 M_+P5C<\?'">I9#759X^%ZL-DA7VY^'S'%2;51O90*=\7'5$2/Y^\3&Y*_-%X MV18M]$]?K\+QVQRA!;*MY+BR)4>R])N;_AQ+36%9^">H I'C_16(:)USSB8G MCF630V"4]CZ/W@SN>5#(C'LHE'U.[G^?T\>RSZ$=YFZC^)+_7?AY+R[1 T/- M%@E*+BDWN>R5:DHGBW*1<"3Y[J7__+U[4Y"6$DZXNM/"Z+G(=*>K4 T'[C*W MTNWJYVO=) JSG?X22QL@-);7'@_>B^A-&%[U0Y%KF3FY%GW4S-G=W+'L;IBL MZ>4N_3!*C4;OUZ\QDVE9;YD6EP#GIZ_%L&7G)BZ(H]2XBA9U7O'W0H-+I%/? MEPO.H#2UQ#6_*P6I?"R;' (7LO=9?1Q,WBN_^.X2-],:V[S$S;ZK;3[E(,SO M\>#WSZ14SE7;WSIA;'(^L?]-WD2CB.4FAWF6RZ5O(R&KOO\RPMEG;L-]WLX4 MV"0R&DME,;3S*SX:'>[NOI2J!V?2.]$4\_P:FF)$ML4F[#Z6Y!(F)[BYT4K" M_=-P7,SLT.VQNY!1,62W1WY%R&@G :*YVD4OP^=ZG@]O4-RU7G76"CG,'XL< MWI997]O,>E#L)5+B]6-OTU+S=<5TRE],!VC*L"P#:M_4Q1T+=87 VVT">U?N M_DA&=WJ=3>Z(P-)'2V"%8R&PT-C74!R7?B=JY60YOR/JFG=,'P]U;6+)Q)*Z MPF1?SS=ZIMS+OY;;NY*/2[+%-R&P, KL5RUXI=6S">.*I=43&N-ZO?\]:A@M-WS0"]RW20W(9;D&B8G'/VY??]^(SS*9Y MFI%C=9!W5/JY\\K/P%K;0A7HOH_.T=B;(G1H=_5\)4W/S5+2ZQ M)*YUX!;G)AGBL4_K'PEUS?2SV;UA\>5P7?_0&WZ;]R:9M(^-J M^^Y>90Y>[KO4[HVIZ^AH*@-"E#K%WW>I7+G\>_(L'-GIV8?42:7]I,ZFCJ-_ MR P'LT/LS$R5F=$FA51K.AJG4_E,3A%3J4B'DQSX"*90W?+2UVM)%WH]#?4$ M,F_,&A=442@]80+ ^_;U8%>XAPV*>OA-$T9]TH$R9)X;&9*B(9@XB6!6*$S? ML[94HL/ZK/EI9%Y[Q^*L,'&J@[>]IVJ32^8)9CK2J7V(49!!AK2125?F-1(B M=U@#W6 $CSE/%U^%)8?^A1$& ^ H$DQN<*O)K-B]FI21T-5,S V&JA' MIK@V@;*:R'L653EJ_1R/M/>E=4A,",*;9L,4D MB!D6'@)U<8GP*<9C:%8(-<5!L^D/<-+188R6BWKANYT@%]Y:O1;VW_;LVL*; M$&=SL82['L-42T%Y+L*H:J%C/$E&W])/2^\=>01O*8!IH2.Q*;RW^L0794Y) MKVD-JJ_/>J,*MHU#?)V64^HM=2/^0>G.:^73\D.[8=J,T]5\)2E1QZ(#)T, MG2>E,/J[_L?GH5QJD^;>&^Q8P,0/TWWFN74!O6@)E^/LH7$-T9H4RW$9-I%* M;=>L.[KVN_'@02X<[Q9983,MUARX';:GB;*OQ['C_D- M!(%?D60@CN^"B\& 66/@PVD^L&D9;>1,?VC>?Z^F<]&HKP$8F*\-YM)D3=B]-=K]9(A%%X#>H3Z\2!,;ZUU8*\ZFV$1N MM59\D F!\=_N /IUJ-O-)SBLT:W6L@^LVC#^&QU 7P]QHWDVATVJ7"*HVKZQ M$R>_I32%TYH*X(+)OF^I,1MNWI!V\M@63^8Q M\7"[5JCC@\\%MKPI-OE4@N4S>9;+1*LI!W55[(W=;6QI\&PJQ[/)E1X(;V85 M-+TMT9K6:I6[QZOZ8UD23NEMZ^5G>/'F,>7-X:W5$93G9V:B#LTRPJ)=9(P^ M?GNOS_S?_Y/C^<27*ZG'7*GOY"_N"Z,A0Y!DI.''XU>-NIB"1AKY4U:QI''G M0F%"UY"9"J7W515R8AA-4'J(48=($_#/.DW&DG45,JQDF1$E#4&&D>K.*5)D M24&73$4AYT,3=(-EU)'FD7?%>"Q'G07TDKF;2\LBU_:0 B!!8J"% 'C%S4AI M:^HKTBX[ZL"$A!%&],"[\KL6\IH..VV0)F8APJ/0U__^S\4%4Y:0+/[+W L] M] 4_[,\(*1W\D'2>N;BP>(54%-'.<^ZY_K-O@)X=;6YSZO__@[?#8F0648IZC(>'UHHVP8,'O&Y(M M#K ]A[$7,WB?%VV>R'+C&)!/\>LZ$*&>\$.58G:$.[P<[?;7PMU=C3T_JU2+ MES10?K KJ=::I<;Y6;/&%&O51NVV %J(A43*8L:H9?:PHZ"0?VE)D:#;V4)B0F_$V#'3,]K#.0W*L2;XZODLS M)LQ?R<3?H+?H6,&?G)_]E<%_BL($JRY8#&BHBW5#"I@ F?$8+OQJR"BWDJX! MPB$2=ZN31+\K1TEJ):'3M[5PMZ8J0MJ]X:H7Z LZ?B,F.D'#LFV(#;TN%H2@ MB.I$Q<8J-3$,02%0VR]8C9;>YFL.X!D8<+PFI.CX9R>E'^F@GA-(>IHPH,0M M=6<@&"-0E/%M"A0O0$H_)F_!?H:(NJ"[8["%.:*W'Z".L$:N@=JB&^07;$Z, M-%*X00X'?1(^>RHMC( O'9S *3-?TB%/:B-L>.*=P9CX*.0^;WJ'7S]1$(F. M!?944=4-_1ZKZYV)3W%$RMT7:,6=K:G>O1MSFJ'Q]R\15S[LP(K&,GZNZ"%3 M:DWKZ4+GCNNGT.L+EB,.0L[/"$KL[=R5Q-\E1O;/H'?G0WE"YV?H'P%_FS-G_UG]@3D$S[LH$1O M6M':J*)TL,QH&(*!0$>Z5:EXF^]&0 $I*.*=A4'S\5987_EU__X\^CT5*^(G MQI ,V.R"QPI7N7 7%[!FQZU5H&X<66 3F1R;]0Q*DFQ-=O76^#=N"6MK M$K]^CIZ4AW%2RNUB:_P[HD2W-:D$9,=ZY5!96P.G?V%[^-7;X]_A(*SMN4K< M)OH_WQ*OC_U=;(]_ZX"HMH=/9]F<9P2); X\E2B=$R1H.H.@9(69+F#_MGHCCYK7S5J-WR]3# W[*2[+)KBL M/_8]-)( 9\\Z=#PY9Z(D@AV*C=HWM/JLK7JCUPNYO=J4NU-F]V5JE@5)>Q3D M$:IURY(B*!U)D"N*CB\EA?/4?IPS.-W5^('N;TU_J$A+26([)>8.)A[M85WF M6].WVW(RJ9?O?WSC/WV%U9^?D?4#5=L88%PHV)>]>81F9=C6XP )^DB#6+CC MPQL+FB8H8-,93!=O+_-&=A?S+J$#/FCBW!M+1I\Q>R8!BVN83D&=*:JB[11D M;0?Z_J=/0=B("=>%+R!,E MTB<%JS@:?HZK+TEG0MN'@*R9$P ;MV5,'KZ%$#8+&9I MY%^6)X!C-#3 '+:1"PY1O%AI*%N9#!1BW0TR$Q!BTVE+8(/KZ#[U)?QZ+'0F MF-/KU)D_[B,LEJALDI3AR,!8(:U65(QRYTX#=?J*!,Y48NZK;>BT0@*R>+DC MQ?G[R+(3#OOLU^QM 34(-A=B.C(B[G]08AA1, 2\F]"@!],#B0P!-!!H@E.K MJR.M V_ >@#>:_=&,W,/=#G?"2O(?L%&QQAS$UT?#2C?N3P_PX<=TY4Q5FES M(SCNYG.(:@5''4X%/,QIQN2B=IN"_SW1F2?XERE0Y")>PBW6:N7S,\YF^C]' M*FP;9F =4]>EP1)(TY(<%8%*%\+G*?WI!YM <#R[R"_915W"C\8&R](]9)D_ M2[;?_RGF[23\AD4Q%BM@8M%GFUW-5!')%R*&_PT_WI9&Y&[,D;#UA(4I?GQ/ M(;H(9E@F,R%Y@*ZO*?,0X3G:@@1;)$IBLA_TWAX/>29M\GQT]M\B"2*P/+44 MFT)4A>@H Q6R-!;@X_?$\O<-8_.@$$24#.)4P+J[A)0^5," MZBD!-28L[92 &F$"ZDF.[M5)T.Q+^OF9XQJ"G#D)7$TCXG\;2 I6WZ>(V.0C MG7CHO/P II>-7.'\Z'(SD!P_X4W I@#^!5P*2 $OFC2@22A=XF,F"MC^8R$G MFEGI5*:J,AA@'74PH$586.^1='T$FCDHUE8C:U#-,?5@*D!6_J70TQ!U6K*8 M9DC+;9*5":F>@F'J[GI? $(DR:!M!!=9=5;XPC?\-'!KO2&H_B*:O)G&^6;% M*> /&P@S:777V9O'14G)U&7(N:MS7 M3*F@M.>8D -D]%51IT%[E^^2)@F3&(0(N<8"IO@>HQ+?.:0,JU"72-R6CK/2 MI, 1AD.3)X1\X8BPC";IK]AV1< \L32&#&4H"&29-U7&8$! @X!(\_XZX%N1 MI>XN.IK;84ZH%3;T@B+>2C3$(D&@GH0:Q)I21Y!W0K-FJJJB67]>";JDVW9Z MTS;'ES8]O_(*LT;Y_M:T-GCJ<>5GE-&[N^R+'O[I6=H8O=2:*MROY-75M[O' MV[QW8_39WN;E0J7./!9N'TK,7:G0>*@3I8VI5.\?F@VF4+TF/Q::E5J5:9:* MWZJ5GP^EQHY:G,_T+A=&AAJHZWGB\[QE#;=%[5??6A:+HUKNT#[!OR]ZYO,V42UMY,A56K(74X6J] MABUA2)'!1.A*?JF A=R2*JT1# 0CJ9WSZ;3S5WL,C9N_!!!7QGBKF&BK8ZPM MS(^[1FW#R=&:F_JF*F2?L;"^Q^HB5KI5;5)5#:?3*DH-![_UP4AT4K3+CGKK MTHY9=QH*]0BP8'"9T]Q6II.N@\C91-."7NMZ)/>N@2QK\MMR;*PS"FYN_EOR MTC*T^R0O3QO=\)D)Q'B[)BM[\=,VG2X=\ND@ST#ITEZ$/H?,5P4\V&H1[ M H>CQ^;@NR*F8"!BO$_@?(+W&@C%^&O-HB_R,\E=\EZ=TLBA_'PQ3Y6%PZ5* MX3U\JBQ6^]G??%VZNLL?.U7.H&\'5)GU:NIJBHI-)48(3?77ZND\UUE_[BQ= MAW*6YJO2#I;#_WJ2DI7GW[G<&XK[69HOG(LWAT]<)OG@'#YYN%09!8 A9ZQ^\7B5_UO3'ZX.WN[WQ%/DYRV8OO=JE>VI0 M2PSM:,DZ"OLY'1=+Q>> [$ZQ&C]Q/*_S[_BWN!^B54:*-R[WH%/E\I=K6,V' M28M1J%/M9/WJN5]+WM\^1?]K'>Y9U=+7R:'6 M3J?RO; .JU?.9$"3UF.=&QPMF'3XKSC2(%5U/@ESU<9]^LH[YJW=,\=L*T9R M7P,K0#N:I1D9O9E^E\1\KO4>K]9E-Z@*X/(3*#<<]>> M^]BDS5GXN#;1X0H(30N-8K_V;A22-3'N5D%0+65QF=N$KV+O4P_;[1*BGN!% M<$:F-RY7"]?J(/8$%U1-B!?!12ODP\E6#%'D>]&8)$\?2V([->R$)K3WY>K8 M XUMX+,(.KZRU)JBYR>N^MHM5(2,7>BQ:86$1R?EG@X=6ZF5W>_MO6F'^^ M,@5226W^<6=V9#/_Q"S5_%2Q1Q]9MY'RW ]4(=APFH29**A![;?UV>YX82&, M-,7XT/AY<#4)^:A8(>/JPUGO)H6+_BVZ@GE^/5#C]:B_2*L^AOM[TXK' _G MHWQX,M2'F\;"DB+0J,);/@7<49G]2J6+NW5 M ":*XL?_V ^U;?H<[ZC]%C@5 DU9U1HF+"MFX]A-3*XF]L=O5G\MPG'FS'G[ M*BH@R26<9;\WN??)KR$W?GEQHD'+$/5I?NGS:_<*RH$7_$)ZO^A+(E;U_F4P M+GCIO:W)')=-?_IZL4GUT=+2TM#W+1F3?>.M?:N_&??J^+%9_I,)=]\\?3#$ M]O5=^)JCD9:L:^,Q/7R6S22]4I5B2U'%F%!4TJ*HI_O;0C_W/?]=$/;#"?(' MP0ERF^[;]$?U^F'Z_.W^Z2$;ZR,[ZPJ+R8'>[72H=78])FK?">0C M!7E'&0)!M.XU?]=#F\.ZKH+S;?S9BN-JW^/_9>].>QI5N8?0[$O_!;]]G MO]HM&9XX?S5N[O8S\N-@3;I>F<5H<5,L@A=,OXN? ?[[^0.?$VZ)E5>GA5# M^7,MSWP';PM1+4M>)\^_7(&*+8FI4DI,%2:4Q;Q/A#M\)PCG*]I_\G?GM\IA MYJA>6 K1%]X_T9<6O8/AU9'[?'>J/>IN:R*P5D93JZ"7M8GIF;VYTGI\A)/_ M_T?V9VX6RW%X EK$2/>5+]-$$P)5HR1DI)V9+DTL5UXN?[Y^W M^*IQ3[:/[A6MFFYTW@USF1"@6L/E%99_>7=M:JL;T%F&BH#*EI MVKWI6H+^\C!\::I#M5#M&X]-) ,& M"4T-"FG7-8]PG:#X-[$V'*ME.SAP30MNUQN0IIM]X#K EIJF[>#@-$-U@!7! MUH>4?<^&\ EW*HA9[(>A&2K[:3"I30;1CN-"Z6,V-&M7J+F6_[H!&Y9E._;V M%KS)DOL -EA, Z$-K-2TGI!I@M+2ME3;9A.Y6L!F[0YPV+9I*O:N4*'MM4)K M:@9-);7YSEM"3[9PA)PN-TP+!Y'+V .%6(IEZFQ5'%%'@[J0V=O$K'%\^ MLARJ:F8#G@46AD-L-S_?<'/T-L>X9>EKW/+ZQBUGOL8M?XU;?B?"\VO<\@K' M+7^8DV[*EKBP3)#NSN!"EPVG;"A8Y]G#&N39;8M9EW@8YNZE_>>#$]LPBI_2 MUD@_#(\[6JE\>-M\S$K??GJ080-6?;ALSNX8UXT^*M=VYCAKY(F1N MV(XEHU:QHZ,MPNP-0"$V*\ZFT7$T[1>T='\%-K+<,Q1DJE@5S!?TM] @8>ZP M@:=<6VVYNJ!K+WAP-GM:ME2AK1I@Y:"&W\)QP[ XO(8U]MD5;GID&S@::U M5@YH$K).[IYXR) '"7YMOD2W1K.Q-;MGHG.)[Q,?M%0&K"3 "2W@<,P::S:! ML-EC2%DXQ=UV=7)&M66PLV!ONFFC[UAH@N6CX5+H/^X 6C&PL5'&8!J9716_ MPLG#AJW:[';H=^PS>-BUN%%CH(-6AY?U9,UBF^[*=!DR*(_;6[ N7P?.Y=M= MFS=_/B&)K\VK ()3<]!5 '>J,!.9W?P8=FA=H(,7LJ]Q;'?#U734X^&'P![P M#X[K-%H;#H3-J6A@MD>.+757.$4_*79F@W./D.O!I&XW#5!ZQ\B.7#.(-@=^(CY1SBC *W"[()V00P" MU_,7 A3'E9A;@HY$M&>H?5GG!\.W@!%DFP:8 P/JM_(N:&"#+K?5ZW 5$"? M=I!EEALV6K(V4[U&E+9P0^3$9QZ&E;[UR^D;F;/?V4^II14?AG>YN]*)>]=I M]4&Q#8%B>\L#QI=O^),0)7)QT!@L[/X$/$UN4.-H'E#V+UZ0^;VCGQ85#$M! MHT PEBJ C* %!"%XD#BU/. >: MRRQW8LR* .,2570$B6NAC8P 1O W5, 69O'3NKB+/B!&LV/ [;!F2YTPY^>;-;WQ6PYYZCD4O2 M=\&1@P^#FRI($#A4S$"$<5KS6[ABX]F>ICPHO;&FVL-#^7=!^O54&%:#@7EL M"<&17T-]8"=F@\:\=%+_ZGGZM@(7HDS@]/C<[.2I=-M;:G &A#^*Z8BT9$(( M;LPF(!N&JMN[PG[@,2)_K\#\R]$&6ZSQ )//F+?*';Q-LVV@2PE0I0>O>B4O MLSX0_A/3HWKLLLI=-*P>>D;.R,=WJ1A8MW].I+:M'9;B+DJF!6:[)/:R);>: MV,GY=Y4?S I+4X0-Q'%"560 U5IF8?VD8O^I#Y?8JOT) +5J/ M. E,4G8W/P.<$.\6@]58QOF=U:MU7TIM^S2[0E@MFN,]"5;9W4P2J 0.*638 MV#E: SUQ(%*RKG\TC' <8KP#W<+PC:W"(TCYF +6!44)-'D=)1!V1A5##V(L MA:>C(0]!-79["[<&[$5KJL1LD'U$F WITL@A+(5IZ%R;IPP\)AI\5[K-HD1F MJV6K#LLKAK?Z7YF^\D_91O;6Y2X 0]I00Z&\**R.#!+IF:G!,BT5.[^8:%3?T6-;& _3 M#,KY&/4,[:L]X,:.4,6O2:953*MG6E$9=+A?K7@"2'![R,G';+Y\F.YDNX// M5-E+N>FG5<,#U&:8LSP<7!=.+P_SA\*KMI_?YWB>%X8/])WA<=/*:T59P.\:/2=? M 2&:R80Q;X @ P\GOB^X8#@@)L M/ 20R./A8)U1'2IS0]Z%K)W(ESQ1EIF7'CB\PE(*V;MH,-%/L>J6%^]AO:]C M:0V7E=)AI%QK<8/0%AJJTU=5PPOY RS1T4D'81%ZV;(&E-+:9;GE>)T\S0JY7&E;9/E%#->8 XXMQPH 5$.F";:$@Y3OK_)!@)1ACGA' M>0?P/1W4V[#&<_7Q#Y;4#^A#R;]=U+*L000>J*AYZ_)J7[P-$.,L5QZ=L+JJ M[ K5%F8_@!W;->$177M2]0'B+- BBGE*C[#Q\BEOP:3D>ZI!;H%!/'YJ0&#X M$I^D-U)F-:9P"*RHF-P@NF[V"=DC)C9L)4.T3-:D< M%+\T#=1D6AQ(P><(F-!1!?^DL%!#Q0NR@7W)8-_#CF*B$>-2]. 5^)1!9]L' M26UIY/^,CW8YM]JYFCI_U-H97PVM!MM7@Z5$ *Z_V,0!TY,TAP1=(7[+Y,GB M"+V]%7%5Q #8J[['0*[M<#3EZ32VT(:[=\@Q @#,I?[RP.U#V<.-W:2)T\0_ M6A09QD!FFZ5NAMQ15*,2G?$9\JB$R43E*^!GCZ[2IE^3K^5?K9W.4;R>_BI> M7U_Q>O:K>/VK>/V=Z/)?Q>M?Q>L;+7SJ:@[5R)4-I6*2303,4/.*F9+<';EH M)=2,BSP,[\O/6?5/WNP<9SZE ^3P8?A:-JZTPKG]>BF1)S^ QI<#Y)-H>Q40 MGV#!4#M KZ85\]O)X,5\I^+@<3QQ%!P:K MQP8[TP53W.56()E@#3(E8/47+"#H@(F.R?NHN:,1QDU]]85>0BHY?M>2-9W* MN"D>2DX6=#+;8)N!0M_TD-8)F]?,"T$_8#_F-D%'9=Z*[2W->,%MH&$.H,!< M*)LBP9Y)P"Q0>A8M%#I2,TP@82>WKK9EG=4UJ*@2A>IC*>4?70U8K$Y]QO!, MKH%+6V3G-W59Z]IQD*3]AU8EP]?OR,7-FZ:J(321SS)/!M;ICF\H\E*!OY/[ M-()EMK>"=0/*0, M<(]<"[ZKE!Q%?M&YW^I"9(X@O_-%\$#?='4%<915A@8IC<@168735)Y'OK&1 M\X\<5Q9ZIH,Y;A0WBYXR B6;7$P>7+:WD$=&#]6#9S1RIJ)_-@1#_&E3-KA+ M+7IVYO P9&*B'&HQW'$ /S;;*G47( >S[#=X57D_0_2.8.45WP7OK]'R6R8R M5R1UQ&"'% ,8*YJ-F3C_\C8 G_.L-= BZFK/H:BUD,YB1%DJ,<+#)#/6(8(+ M),!1S!7FI($1;GC&2_MB'W=D10 I#%0N6QJZ7QEV,1K4D150%I:.?5=\ 0HO M8ZF3\#8FYIM,PR%Z?-$4E[7A]&(W5&^RKV(W38]KG6)+33]&LE\[C<9'*OX[ M-7)0JVV/Q.G=P6MX 1\FN'F4+[QHIE(6HQR)UQ?[!2GLS%X*( /,HVDAYWXQ'9^543XA=DM1,4WP M&L' M9B^:K%>L'#V-F$/K"$+AMK'IB2]GHDG4X0Z%J7"YJO^+W%KS"!T "6I M[8K;8T$$147%#<'BYR;B;6/1I\'>L+UE\P7#OV:*%T;L;%5GZ#3MO109"C\& MQ.)R&>A+D=!1,17?=AL@FQ#CB/L'35I8A*.).5F607HGX:]"F!C@IBAXZ9S= M+BO_48T.1EJ8@H\9^)RHFCQO1Q58#1?K?H2WB1>IF$V7VP2LD!=K9:GRUG.V M>^B&/?Q[&"?4@+CH-1A3H7 D+(7Z-/V7%>*R0"AB/ZZ''7.ZH,;ZB;-$ ]A2 M!Z[JQ 4+ MT)?D-<@!ELC>OGO-Z!"A)&>-!_":8 1(9 +.6IOCR.S!3/$:B MRWW;U1 A;.SXC\HR?0=( 48#\+I=)@OH4"RD1K2-1L T0$]-O#F@+].T% M9>U@E.[45UB8)X)GQA(G]2,J)H#%0XKM+?;IEZ3]=&>M&<*AVK!C;W7(L%GS$>(/Q= M_.YQ%^Q:#=\ADA-')ZS%,-WV%KZ9LLH+/]CO+ UI*3Q.@.=X@2UOX%O^UG;5 M75'8LRA1 K-"4:P LHM>)O:IW!<.+=D%!G8;D9KL9$!&+2>@"DR(IV>]T1\B MP+,-UX54=*;9/G?F$=,;@YI5'Q@6L"+6H^[,--2!<"PS&^/*TU3P'Y6PN+JV MX$E0!@C<:*#8&G$]+J[:U->;*JZ0(%L ^H[J5T0UJ>=WP)$#)@8_;\L6=B @ MQAP$T;D#)@H_ ')P>Y%\/5@><("M<6:R=GD@..MNMXOXXEWN:?"B:A R'$4)=C*]A9QN=FM<>4"L)OG/4"V")EE=_,-(\G2>S>J(K2A8D?$@ZN"SKAZ74>##Q MI 0N&R$:?O5,W6.9I+*"J*SRVV\!_'UIY L9843&_#OXW[^)UY=U$W&:[IGH MFUJ*LJ:5MHN99ZC- .9=X;"6M@.(4W,=Q025E$L$U#!P\JF'+; Q^<746.H, M\78?+3EJ(S^QW)X#6H:#S$Y5=QF/%P(5-] Q=8&;2J8%'$*F 0A $"HWFQCN MVNB:1 4J*,FY9DO['ITF%J*RS3+ZIUHA 3L0HMUANUTT;48H7YR@@7T1QV<_ M*^$DZ.Z,/9)XZIO,0I6Q3835T'CI"6&7[?-4INR#F> 7F@4N>8;BE-P>EH(8 MBV!A =;N,N2M"#DFL)6<[-H!5MO81%/Q>'IH =9!DZ=6$:J:Y+[#A_O,3\Y2 M%$=\(QH2B/J$:_@'[ I/>]T^&B MP&9,VIC#"[0!]%Z>E!I8)&&8;*RY^-A;?$VE]B>R67ZQ@!%I#+"8"C M@_[3 KSU0B"NS4H N4["C^/+;M;"6"-]AFW\B]5\NK->AQR+0%BV.>;+!!2K M-1W3UTD91X$/Z\=EW(\-0JW!)A %IAAB' 4XF-T6^"7KL5[)!O6/CW&4TAIQ MC(AIH-RWB).$N'& @C:@1_*[$3>UU!:;]09\%!L>4_MM3V2/LLV !%2 (4XN M\HTBO[-:U D$:@,YMA0!%7DO1324?0UO(H#)@8^+_#5:*)LC8#^V+]C[=66N&4 8;2AX $@@WUHOLT10IA9S_ M[X,IV4>E]-[&9K63!HKP2>^"B&.BFK;=W6[ M.JK*\ M/<&D'N8&IIY?7 9>X M&#/4O0)/+*H@2X71_YGY/S*?\F]L(K- #$:QK^!4LWT5B**K1EMMT1N8& MYS7S75G_+_./HXV#?)AUA42O"NZ3!1.:)C-.J+UO2,&)'HMZC&%:F1(8W%XA MJT"TX"D@Z!_@A1YPJZ'8; ,3(0 !O9>OZF%>]-)?/##H/"Y@O+-.!/GGW HM^34_K#74'F7>IA MF-]//YE75\;S\'/./,D]#%6UH?9NM-*^+&'S_B:U\ J5DD?AM/9D_W55I7Q. MHJT:VUL\[T7*,P?LH9^S&MLO8,^$_P1]=\KU/;_O#D_D+]=OA'-SEY;D[?-V=Z'Q!8-4=#8 CBWK';9R4/'S M^\(OV 510-Y[RHD DQ);[+=='C6C:#C;=GA_I@)V*86BL4T>J^!GG:Q9O8/* M4AVQS=V.;IKD":!.R9@#P?K*\59YM%_6+F=[RY)Y!H$FV"/;,9]& MAG9WT/S PI0 KP] EUI2J,J.I3JA'_FG9SER/ Y <1.WX2#>1#> %CVKYH>G M68,*V3 HN8 WQZ/A""RWC9R:^W 6BA9*.:]K=7!<,HZUKO\PX@Z9Q9@FU]*P M\R[KI,##C/ G)@!63/.$G=;3PBT@#E>SE3B/]UG,!YI6(2%X4:[2BK;>JRA03H5R,T0\]: MP6,^^?&!GC(($Y7MP69[\$L4T+&I*92XB($*+U&).D'CD[S7#?]X=!&0/2*K M!T(K5HQ9% B1M6SP^G9N;U''SA&.0+&8T>,9C/,.>#F$R+*(;8RH('F.[%$, M]0NAP@7>J24*)0))"%1>TU/>$M6;:A-.R"8Q%3TY[M$.KG#2"QCSM56_J07Q M$39Y9I0+AL.LINPO:68JLT[\C W-J>F 4\XLLA40)\_,3.1*H[P]P/5"3!2].B*$AQ] M+;-)FL-D$8@/$A)3(E]\J579)F4L](Y>Q%P)%:!22211#:&]UP;)2_4(->ZB M!EQ,;=2LIMO%;3=C$'O4]@V9G3DPK(S+W_GNGU]M^UA?L>VX&1)8O>E_(%-E M@GVA6M0S/L'&3X6[%"8^\S#L*G;J=##\?2WG/H4QCVZJ[:V,W\-[Q+A/2P_# MQ_3I]>5!O6G8\/+J>:5V=O#?OT]K]?IWX>+@2H!_G]7.A?IQ^>K@JXS_DS!Q M-I]:;[)L#>PYU^2MN/[[-]J#WU'1S6<,E4PM(R_*G- MV[C[.6."Z3K$T'$%/EL:$_@QY=D?5D>VU*ZPK^FN9\6&WNZW$ R7PRKX6[0' M R5)].KS(^]DN@L+K(,9C4E9K+F>2R.I,6'<(N5MP#?,3'K1B__[-:I>6#UX M,S]P_ &%\?/=\0ZW7*_W=D.=^7JN!9H1B)K1KG"%<+,1G!58:]VQ!VO6%5[& M.=U K14H_!7,XE/V!OQW-O^A/=+9V%^V#$#U3A6L>?>('X!UB_9?PO?C=94*3-&*:_.'N;K"B4R!5F#40$'LZ/D":S(T WXFWQ9#OC ME@LPGQ]+2.:KP:%$=A^J,HTHY@36I.%FJR:'5'XR.7@6:R)>1QA\'!85WHA% MHS/3-HQ%KBH=NHU3Z] L?@ L&IO\M@(LDB:WKV?.%^Y:T;SI4=X(F1B$.?R8 M".-/M*.3^F.RRG1.#WMJ)SVC?Y2MO+:5#XD][) /$\[X-H8T!9.F<:.TR.1R M6&7VPTZO2:;RJ.(FNQ[ M!P_#ZUPS>YS=/^Y>!E.!L*I$E^%E<.VPF7KE^&#_YO1 J!T*,QKU''/FROF: M%^P[F+_UCR"[C@F0G)HP5L)\L6A&&S[ZC5*Y0FECDVM/\0UZY; ME]MYR:SDGVO-T02Z"4F5,1N,2X3 UXR>+?8@,2M^6PELX@$6 .GP(6XP;2U_ M^Z>E5>1&5?&!%#XOH00=-SW#Z^:YM.Q#W/#7V_IM[?SFMF.\ME=R:=)R+@TS M'Y&0$[,JUTT/TEB2Z-O!=E\I3YJ&#DXJ<>?\+OY^/I MR:)BYC7>M-F9@16G35KMQM^@+HCI3%%,YW+?PP E?1[K,O^9#-08 +#$^7A2 MG RH.19\#W>TF;.'K]Q7(U+%8,;\N>JP(2F8YB@]=.7SZFGY>FB<=1^&[3^_ M]=;KN?/[3^';_ ASQ\R/,0AP'3J;_RNNA +V$PWYC)Z7/Y[^:S*K\^HO8E_R MGX1%I>S(SSGD_XYW)US4[N[^B0)PDKLR:M/..@[1AHW\[[>=T;F(63%7RHNI M3#'&(1!_MEA(O!F\'C"G4U!0;I/]*\E!,RM$QYPOBXZ7S&3$=+8@9C-Q;MXI M!Y\!/A\)2U,^3*4EX6A!E(II,5W*+@5'XUG90<#*+BP^G(LF7.]KU*A'L=FY MZU[J395ROZ0'[?Q!T1ZZ=HC?'32&[LM3;=!H+<#N)LC')%:=J%F>JK;]C^"? MAP>!%>]$,ZE.DQ%O/IUTDJ":;Z494'6N:UP^OQWA#Z*4R@&;G8[""?KK#"QW M!=>WS,M?RY4MC:&GQ7R^*.:S"7)Q5I/H^])LK@U36L3[NV.KS1WM=:>C*7!! M_PC 0M/::\/2I72V].WGCN]S71"UIVN>Y03-L_PB:SJYTTW6.),PB7=")K<[ M<.SKAZX38M>_\C>E0O6I6\P7EZB>3F?2:7;I8YKJV+C.<)($/\HTT*871"AZ M3E!,%UX]DRXQYRKSJA@SW.?:5.6"6$A)8JJ0GIN'IQ?FXK&[6_75 M+4\G3XFY0E$L%!?EX3, _XONWH_R/R_5K)T#SU->1C>':C%F]?^(-]\6JY5_W,T-TE)2C?? M8:GLJT:WA7*>XD&W9-TL(3=. AE1*(C%8FZJC%@+T:P:@(MJ2$G@2XN9--BZ MQ;BDL(T1_JJ!N*BF$@_$7$Y,924QEYIN'"S"N\+YO:"DL8IH6>>J&>VA'#(: M46GS9IGI@ZIMN_@I^]V#]M!3E"4:NI[:Q5*?I%2\SG7 "QM#-281WN:71'AI MSBOG6O3VIRLA,UV=ER^J M*A=L-D?9HIF#5-N[,"W/$&28A:P3 P\QU)Z0G/[Q8Q SHU)FR9[1C^;YGQE0 MV1% K3MEZ8/A56XM'O?<&RI&ANFBXUXV]XM[3]H*-(\1YUL$<".ITV\L*QZI M=F!V&MO7N+'&P3'CU:S*S,>'EN.Z7B ]KN\1E MVZ=942J6Q$)ZF@;Y ?SX'XL:-V8C+T2*7_[\?ZV7]^W^?'(4T6 H+-0+V@!\ M.???V=FGV]6QU9;,B?]X4#_>:YT.[-(BFI?B^5BX/+O>OS:E_=1);O MV_0]Q7,E_ILT/GY]7SK?>]?Y)EW4E];W44CJP^I]? C:M(;4Y?S#,)=-[=]( MY^>IQQ4UI/;&Y6VJH>\TV65#.:?9,(IZY8_CNE;CAR&$;<+9%G@8JO9YYZG28I M&7/%*YF0D$VFA\;CJJ?6K*!B(T'S=HM*>21&DOMB_IW*L^#'_)ER]/P]=' M_>IILW2RL&KX6E]GP=0DA:D^!FNZ/C?GE(BL' M+4@+H6ZQ3U+_M'Q]?9%N9&(;H;YIF^LZ4"[4V;4X>.GK1CJ?R396<*!WUP!U M!:T=HP,09LQK?M?-.1'HY!Y^>T>UI H',/[),VZZP&8@X7*UCWI EI%A1+G M,1Z:UK[I-IR6JX^?W2?=\RIK4!>0;[-:*Y>O[\K=P_9:0Z&1KG2R=PH:M*3P M<_A*]4R,[UW7[TP)SG%<=7P^^1I<_RH85+HD9H!#99+Z4KSOTJV/XI+#/'' M*D3A./\'])Z]PS#AQP;&=4?%:64HD=G8<]5F \^10YM&4],U?["MZ5K3-$[! M&WS&YGW:WH*J\AE\M_\._^J$@5K+3AT>,>P*Q;]&?#=CDTF6:S'[LQR+I;EM MPP>M'CO%<9@K'=Q6S\];+X5@<'%Y"MD$ZM"WT2,4%S+C9SI"K"2;N^=D5))) MV:*82^I3\U9;?FEV]FS]EJBY#/93THR \2TGI3W O+VY,>^">*NWN7V5_3<> M&0NOCW+GI&&5'H,YGK''FC0\;1FX%K_I5?] MT&3BJ8>;A*!+<3CX>U\M4DIIL9#*+("1JRC5F@\#+[S^L5>F5[\]G^V_2,M/+U#+'>62H6EZ)GCF'EY4 MF7?-?L.6/XZ>N42TE,12OB2FTHN8/^M0-D6]@?Q.*ET+]N'&;7?TQ\7DO8J-1J;3=2_-0:RN*S?6%1]\6#( MI*+'O8>A<=I.]>SIL7BU>JS%)KM))"E%QB(4KQ85AN7J7WBG>_#YP"J);GMP?G MU[6KZD%]%04HZX; ^DM&?"SBL=_K2?4AF=CZD,E+/ RSSVK-[-W^&9JEE:)B M'.-8YN64G>VMJ @79$,1HG:\2,%!S0.))\=LJOEHFMV>::L*J&;+BQ:^!]!$ M\7:D#"3_,,SD>D.IE$]?_'Z:I0PDCJH_5AQQ!H5RK8GW00%")J2K:4KUK'GV M?+M7SOR+<_/CBS/.]H_JA_M2-NTJ'SE]/Q6G,1QJAF8#^SXR3<7&M/U>+]5+ M/73EZOGP^<_=PW!0:#__TEM'F6%I$ZG[WOZ$GF4J;M-Y_UGE\:!=CND Z7XJCTRNY?R8# MP]!@FW%D*KT>O=PV]+/[@T4:UF'?N]PVQI=)/)B*5T5BQ*R_083Z&6.]-ZJAH7E@GJ=BRY5&^R MW9Q1/SD]7=$TI)F+6W"K&#;HLT8NF8%U/%C%A(E5833_NZ MK67R"ZE(_(+R(=]]]//CM?_=T&[BF?=>'/,^5UEQ$.?9CL>SCT-*X?*XDIC!E:X$M #?CRXT&7#*1O*P;.K]7#NZ/1H5CC' M;)YE'H85J?YT=R_+[B#_\:);^<3H5NEAJ+S8]+@ZOI> M%"Y.R^?70OE\7SBXO*E>8%_!3<6[-H/(:T32?$2;,UV*)Q%4:^@RDYVA*F1LG]1!.SP87A2?^JX@_V" M$NJF,2$"YE%^ LE_!<.6$_#9#P7#[E.GTL7]1>&IV_H*AHT$P_J9:NFUDMU[ MO6E_Y&!8:18.3NV O=A9_H3>P/LZUU^U>R'!__7IYB7B[,YJMV>9;ZP4>QG M*L[7?!@V#QKM^Z?,^=EQ9A/Q-7]O0GAS[S\"-/G.)AF7WKT\3+B6)40*<@4Q M-8/#\5.$XQ:XC/2'OHQXGI)>(T_9CH^;BR&&-:%=VRUN:.][G0T!13F?P3 M];3VVK!T*9-)?_NYD^"X7(2 *FLDH$/7@FMQ+94Z6+_B7SX!I2Z/\L^=I_[O MZHH\S3%Y+MYVB)B\#7UX0DJ&\A("R\6LF,]-[[[P/B/Q2Y"9*P5N-B.F9D@G M>N]R\E;M:$T](.U&YOCVS&AE'^\626<;"_]YRW\X7!HEU"B)\WT"=//&L/^M1Y&'9X_#RZ/[=%K/+E?8_O1?]>&0:90Z1X#V=FS* MI@!B&5$J?M1$MB50Z-*!BOVS,=/MS3I)/)5F5D^E7CN2:]/4P?SQ2-3\<_K< M;!53QG-Z&4*3K_[A$,BC2@:EAPB0EI'#G1$+TK]0G7W/X(RGQ)G"?TN2EQ73 ML!W+I)R@8J[U7K/G)Y,1,80UYLO%S)69E?5WYXJ)\<#X\J%T# MQSK0U,:?BOZKLXAO;7;G]+7IR#IFU=,6A4B^PH*BQ+K=/I#)\VK##@5!?L^^*= M&&XC./+'ER[3VB:R^?%?'[^5OW_YIDOJ[S;Y=79I$1)*HG9U+HF MPU2"=J>)1SY7'2E2_!%B7?++=>%/7K^_EI?ANI^=7_&,?MC:%'5BW24!V?+J_\ M'DO(B;&/M."@P0<_^T\TY;J4.@QIV.&W);0H/CI[*1\,I&-5\YL6AI^:9JI$ M?KOBII=9,9O#OO]QE@FAB+B]-08.:1(XQEJ)/_W)'1CYZ\/J0%T-.);6 !RL M$E!5I70(:[-)B/,9KEPSPMY@M94:@)YMM;?=7"'HE- MW441KQFP4]O!*K(V=G1"&UP95P8PYWBR-K KE$&UQ%?)NCZ((:4UL+(::. R M#K[@2HUWP\[>S6O[UCG7]E9,5L);&TB[G4AX(K528D[GE5\G9-M;XK# M+1?ZP!_$0C+L8YA^6W\I>GMU/]T]U.9?^ON54#>D4.X(-," MH)YJ_&>'PFGU?)>];1Z??]Y>VU_:+JJ&=M;)ZX^$$A!DDJB MT%<%JK(E#N28@BSX&$TLJ Z8;@%6"^6VI1)?%_J:T^&_LH6ZZ3J=OFH[HG!Z M6A'^1IQ)IWX\N!O8)1*;#_@B97,;MP MT &A7>&'+?BCTH-9"S9[.T[F=2U8B1BE-R=": R"/V5;LW>%:UC6Z<.N!SLM M'-[;!8AT!-D_"S(-63/L[2T9MOBJ==VN("LO-(J"34-!K7-,0N9"$O)4,]1: MJP(0U!R "O& ,[;4GFE9U.^@(F.YO3,(LA^:"/Y4(146H)CG56N5+4LVVK2] M:/JE?S%E0_&NQ;\5OY)!ZIQ>G)B5]&ESFJ2<9^-QSF&IM),J 'OU4O5FV-\2 M?/]B*I7"_XW)5100G%1#/1:6034 N5$$*$]!@"K1E.U<@3*T[R)0V%RFAYZF M/"B]!_?"M52.!/ET$?6IE:"#LW]8='^7F_GSUB+HD'2,.,4*T2&_DRZN$C&J MYX<^:NRD0[B!X/SV,]G&6#I._+6]!8Q!!>[-)B=YK IY)O XXDJ&X0)['S+6 M2G 40&M3O6XH%Q8R/@0M<,:&SAI:(VL4(IP1F!K^^@Y,5J'N -0;0DLE?)YD0L9= XCZKN;@8H[2N M[]7'="%;.E\$EQ(.\4Z98Z)+>16\\>\QE>E@'HPHD^H54956B0:F_&CL_3FZ MLHZ+;\8#MO5-X<#$4L%XO6E56/"=)"2*+JY4"AZ\!-FV51O'W*","Q3_7:$& M*KH)HK!-+@\;3J"HZ.75[##WL53!1BC! B <>\#.Z6.0O"V7%!K/-!G).LJ^PKQ? U[.WFH150HN#"?<0.3AVG= 4 MU0[#C+V1=L'<#[@]P#U,@1+0XO$,HA HR-+;WFK*=F=7N%,%15-PCW#,%VPT M (\YMB-'QNRAH86K!<:A[OD[ )8H :*>]UVA//XIGWT4L[R/*L'ZOC]%Z,LQ M0T'%]7\D7/ M8GYHA'%U&I 2G MW\;)+_+&Q!FTTXA4BDO)VU^ 2LK\@)G$H(!U 8."#;%_XK4#DK%@H$*FKSGF]HNF(C:<*I4Z MDQ>#/[H/3SXH"I=6>2G/*2LO%1Z&EZJIE,[-Z]M*H%*%BGO M_U6(T@W*3ZJ@P]IV3$PRZK?U;=">:^'X&-S108O<"PA,S9I\:RX(:J4H:[V(QMR'YL\EG&4)T0^QD*#OKC1OQ$\0\)'9SQ"8-V0: MB5R#Y+2T7B@I-R_E2)-:-7(.[Y_O>K6[2\>X;/YT.O'Z'\:C3ZE[MBOT84RZ$S&ZJ])< 3*_XUVZ"$KA\ MCP2P3SC$6.8:L+^$&'QI23'X=6+7X7W_4+O?SUX\RRN.R"\3,Y<1GH_KM[#* MU"5FSXW+S?'(??8-4G,=\G)X>7I6_F,,,N5*]KW+N85]7;EUQ^Z38_2&0"G$ MW'69$B.JH.<]T"AMUU,O)^FHL+YF@/Z)B<%AI/0EYO96&#_AYQ/+MA;#T$)F MCIR2^3$T4TNG>^V6^5Q=* US7@PMA!IHK@M#TV)ZS0DFN]M;)(],)T8 ME(.\E-A,@^Q4YX*'1J,%@7%YC5.6\FMLK_L7SU?5?2T<6_.V/9(G,L5-'_N> M63K93MSBHFA23&-"PWCRXNJT<&0[AAF+$);:!16*TH%\/-K>"H:PC>18",DI M%LDX-6NBQ7@%9$+P9^8$BZ4@8BM_U#LOW9^G[_*)\:,EA(_F3:]8$[;FQ5PQ MD:&)VUM3@^_QEUN:_W*3BU[?<+DWM\Y3[T_JUWXC^RXN=[PP=I67FTV)I>RD MVYT0/RPDQ0_+9&4FQ>.7W\'EU,4#\[-$CK?'I[?WJ(^0K%TG!RAGSE OQ2,R.AR(9)*E)!$K.Q0XFFYP'D9Z/CE=R:_"(_GZ6KO9(BK9..UWLYF;R8S21V5YF8 M9!"6LJ-[G/U[T MM)08/2T\# ]OU&'6,2[O7Y1O/T\/RO6#^J9"I5^Y+7,?Z4[=WM+)AV2V6E1M M 4^Y*/"HR(]I WW94CNF"S^"]S8Q*"/4FZ;CV(JLPQ/E/_ _!WMCRMXX>DUU M'%D4CLHB_P28F]DWFZ)P5^75*4BNR-9LC-RJ#!:QJ#<5$<+A"+\I] @^*.%BE5 MRJ0>AO7<0>->:RNUWT$B7BT*^G9N J2*N&)1P8(Q"\6I)[FZTLX9JQS!H1U:2>36E0.S[.1D<.O8CNYE"1* ML?U[)R?XR@YP@)Y#*HF028F\K1>@_0F0NVQY6)MFV1.)>&^K<*91>M9YQR+" M7Q_+M[?F0'-A&I979L?R=$K"=--?:;7\4C7V-:FX&)9+\V(Y?_'C05%^JJFG M3:FT-BP'14=Z0TKKLK'\C=O)I(IB)K;UZ$0LIZ(\O\10":1%*%E&8_5X+['76JSPMD[40T<:'[^/A7QDWEM N+/'(ZA1<9"+JF[[NW- MR6_EV2@L1C;YQ..^LF.L\.C-O8.R/(56P5&*68*LQ/ MK)]*C?Z$ED'9IGR'D: +U^^C<4,:#A7'\*A5WQPL+89#8%9-$"0BM):EB.B^)^4RBMRV^HV2RUC,!4KR$+?]4O3R^ M[F=*A?9:(?7&BK6T6"A)"5-?N5\RVF<[)I9-:+J]%8^GDP1P/+XF2[0Q$-]'0AFNA*7D0DO1E-,X6LF$[/B::9>704 M!E6BK\KNOW@U^9 M]0+HS=A9 DPJ3 ANCF G.B2:KF51'PKTU3(_+6J(_K;!QH]@X@!C#E/YKJ#% M1TBGW42%[68$8_5J:K_T=/+BV#-@K.@=:<&;X5M8!09G"RFQ,"^;S=N7T\_[S#&B\2JB]$:V+@%392=A@K4!>_KT17/<#T?XRXBK;6]O$8)Y22P4$OM0D9LL M_F#Q7IQ0P5$-.Q[0J49G$]F38"O_.C_(GO\>WMP$J/G_LC7_F;#D_SV"QP!+0O^'1Y3<9'G./(K M_L?U^BTP!Q%;D!6".R;_ TT.V.NND$SQ'CO:WIJS.J0X$S\::_5W553+\O5- MX>5>7A,_>D-WO^0V#>FT)&8+B%@ MV?QH)1"4"@4Q5TQT@JZ*'\5"M;QW^Z+=7CXZ1R%O!Q$4,_P#$'OK["Z5"2VO M$7-&+!9G93Q"#-_9WEHWXTGN-AG/=U(3^$YL(\3RS6UMO_E2>'*+:^(X2^M] M6,QFQ6QV(:UG.I>)!99C_SDN_E;WSCMQR:JK8C!+ U@AFQ:SF62VG,Q46#NI M,3#NS&7M >.0LIWJ'T5\JFLVG06 O(Y03HS4*+'5D4H.-*/.Y MXZ\HLS=<>5NA+Z]A(Q+&/Q3G/ARE.VWE9?OYI''X)^"%=[.<:F+'J0F!N!U; M;?ZCN!9*Q-%2J7G/\^UG9C5E1 MD:Y,')96>_!RR<=U+!>QG M;MHWA6ANC"*Z>G/5CR[GF)9/R+M]7^^QE!40@5M*36E@G;* M:@_#VYRY]U(_39MY::5EM:M64 YI -?V5A<8"766(W;6XZ8=KYBD]!!LP*/K M%*'T*B%C$V!QG)<-+])ULV__\ZFTN2A^1RN2]_8?AMI!+=7IW/1O+G,^4@![ MZ^DRO R ")RA7CD^V+\Y/1!JA\+AS?7-U8%P5CVOGMV<"53"+%R4[RF,)=R< M[Q]<">>U\YU*^;QR<'I:WH/'1NJ<.53G"AS/"_D=# +_(\BN8_X0ID>=2QAT MCH;%\=%O% ^>$'MFH?!O7M@X"#E/3WZ("\K=D[ [B#I36*@Z6)I#RU^;5HW$ MM8/=P$$1Z/_[#=B]=^O94B;DQ6_MG^[W_KP^'X>'^E;9OM?OI6_7; MY&N!BQ_KQ6*U&W^G4UDQG2F*Z5SN>\S5<90H(DK$75*:FO)'0<2?2?^5< \C MB0A_Q24L_"=A42D_\G-"T*D=_A:$]RK2#G/%C%C(QSD@X@\<"Y[IZ)99 -V0 MXJ[[YAB6Y7MM^_=1Y?GW56D!++MC'7_&[C\!G7(>("8BSV20Q/]NJ:C"8;4* M#,D4"V(ZMKM.\MEF18MIC4<2CXJ]F<<0X_8H30=*TQ)+F_*%Y8AU9CH*57SST*'P]"\'?W*WZ6SS4E\I _DA)"CWUQW54F7="NO7J9KA/"D\?RL)R&'6G*_[&(K@?PD*?B8_#-U9;726(^G14E:36*5V56[2A: _#QJ^T5CS3[8:S&9Z31-"W6Z/3C M<]2_WX"V2=>X6AQ.9TMBL3A=0YR9SW^?U?$UH6"/D'8U?'OT'&F&4RMCM1<, MS84767>I7P;/C<5MA1H@S2A=TPM2 #TG**;;T-697&QSKC(3TUYI/6\RCTZN M[)T!UC-K,KQ8*K;!;"A652X\#,VK2VE@7NAR;C7!IG55LJR^CR[.@L60KV[: MKI44_HMTV$MX A3"_5;VKG7]Q[Q+?[S.N5(JL75N_F%X?.C<'/TN/.X=%[ZQ MVBJ,.U& R7OJZN"42JPNRE>;&T'ZE7$V]Y&JQO86$)*A,GY* T6I.7?SV=5L M+3(47+91EU*T%_B"?7PBMU5XBR'4';G;PV^].5%_(V*D4S].ZA7Z2_KQ713D MR35&H+)QQ;K6.C<=U08]&WE>9#9G5LKP4759*?OPH*@:*J]M63\ 56^T0[NW M/V][?'=C@SBC(Z&C:UP :]%LV[0&N">_CU^K>UQZ'1KV0%F 0+&,!T* MBU.@U5)URNGLR=;TBO\D("0GJDH9_Z^LUSAO\L'YC^).M@1YF!*SJ8F3HG!X M+'\Q 6I["_/5U5>UZ3ILY Z+P$I9-H&,=2<:>4CDR09LC/D87DESX9542F72 M6<0K^BNW.;RZTD\/G9=>_5XN; ZOI!+*SG36_ROW#O J-P6I$(=ZLA;"GW0. M\4W.K)"3;>];#UOD-1(TA4L&3=^N#0W MSF52'LYA9]%-X9Q9):9I+'_":)S.AE MCXP-!KSBA17X%S8V;S5JZ;OA_=GK55#1@TL(FK^&") )3=:=JG/C;;%B"?87 M]@P?U[%C]TB^;@:0!J7?^'-[>S@'W( ;0\J3>\#Z7^&R',Q_S.[F__*Q43,$ MV;+H62ITT <)R:S40MQO>N]=DJ>L(-O8WII8.#X3/>=\:.GL]TD/ M !WJJ.GOWR-IVX/BLJDXYV-#[GU0L21.DQU\RM_(($F$$M,]"$U$1P=&(%O[._?6= MVM=2T_J.#-@?F61(*W%IAF(GF-] "E*>-\C_5";))[2R+DS;V4&7 771]%J. M6;)A,T04!Q'#Z0K8H?3 :QIJA8. @\A&GV,OZ9V\33!MX%MW77 M+(O03V6EODT=*T0!6?%U=57745^6:<;(]I;<[&CJ"[%1^"CZK4 ?P[H>3H^^ MG?\<]25R-RHC;>;QA8$:Y;LFG7$]GBG_L&VWR0AKTJC,2@=[K=O7Y@7?UP7P M>+76N@Y &3$6,[ZQF$%CT;:7:=^MR_/^FH_*%,,W[309-OU1BS[P.SAK@D>P1LF%C#.<.XD^S#C MVX>9D'TX\RF7T8(O5\J+Z4DZ5-DFK=MV]:#M&YUX N1&"2@LSSUL.O"1%M5] M&=O*;6_YR!C7CG*-B+;OC6'P=^G[%JX.+W]56JGK7X6/AE=)AUJ&$"\6)#&3 MBFO@SYN_!H,M6+%PU0 QVM:0E?$^[W'L);_66Z>=!1NC?8TQEMI%JRT]%O:/ M2^I'0X 9SO=V7"CD\V(J-JN98T(PP@JEDFO0L/JFJC%Q%X<%N;5B0=7;G[>] M8'<>#EQGNOMZ_:#\?/?A<&#JZ=Z. 1E)+"7WTF65\#C%V\)Z#KQHOB6RK_?5 M'H#0L4DJQ#6)WP F7)O>KCP$R-X-*S7;41I_I(^* *.'6H9#)IT\<4'HFY;3 MP9./:*MAW2#0F0D\+9 3&.;'#YA2RUJO>)X9FH[G=EWF]0J/,45OH1V2.9M7 M77WA6PZVO(]I,+QOA(=92OU/'X"1/W6?/AIFS7;$)6@;N9*8RTQ2616%G,:R M[ID['H)1;%S% 7, /MDK^#:%-AIQ0 VV:GOA,W) ,\V$V718K^YY#O4!,^R M97%$A56_+/UW?J0:\(43UU"%-//-I"+((0H'ADZS;8XLT^T)U:HHG)Y6_&@I M_S:(F(:>I4A[X8R'V S&)TQA0@@=X6+T)Z9 M1V/\8%%:M#NXWYX\@$L!R$R<21KULU[ _9J*UN1Q$.!;1E/KR7J$1^%5"-@S=Z[_3KK:1[;V8Z2Q'GS.^F<_U?>X[R) MFUY*4\!\22Q-:+&)B,;OTC)?-$4E1,=DA7^$O[7O@M,WP;COC_J6L"42\]V^ M/5RWBNM^BY-?.3_\?7J@GZ3T#0:*%T"7%0>)Q6(J _]+UA%'.!!W9.(>",LX MML1$@U*;1Y?9#(H7^ [ 6C84$%(O./;9PYFSX\:54N[9DJY^2)Q)/MLRW)3Y M3$XLE)*9$%J+FK<#QI+X'D0N0IDGFV:$>U$@V?,_<+B*F%S<87E6,N@MK%V( M'R&>E,82Y1%>IY%]>/)!458FD/H,6:(&;]9RN![*."K MR -L4Z0:DX/.86!]^\DGJ$LY%CU+"!F+(%FT[]M;;=50+1"^#-&.AD3:Q+2Z3L6I$5XC'JK?$M7GB?1B11C?^ M)NUF/HXS<:]+X"E8*5"*FX+.. JJN!@EK@)R<'M2#"Y=Z,@O*C$) _ =>0[8 MN1Q(3 ^RR0W!HH0FVBFD\:NMEMH$C(L@%H(%O; 8:>FY@#Q-4MG;FLVL51,> M0N4[BH#4?-)_542W!L5+_C[&KPYGS4U9B7Q\"V(.3W\?F\7JX859:$7Q<[Y\ MF#>(MRG8.'-6C=MC^0S;6YY#!Z>H&D*-WS$K$K')Z6 (_Y$H-P+_)_1-5U

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�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